GeneSymbol,0,1,clust,pathway
,0.06503714,0.18078008,3,
0610009B22Rik,-0.11900597,-0.049039464,2,
0610010K14Rik,0.11699425,0.31263578,3,
0610040J01Rik,-0.0013482759,0.057549246,2,
1110004F10Rik,0.030049989,-0.030607983,2,
1110051M20Rik,-0.21831077,0.048127968,2,
1110059G10Rik,-0.3821127,0.009173928,2,
1190005I06Rik,0.076984644,0.018178297,1,
1190007I07Rik,-0.13103078,0.026186403,2,
1500011B03Rik,-0.24005082,-0.07074134,2,
1700001P01Rik,-0.28047344,0.10520938,2,
1700007K13Rik,-0.14463577,-0.16479,2,
1700009N14Rik,0.09425797,0.3724455,0,
1700012B09Rik,-0.058845427,-0.049873043,2,
1700013F07Rik,-0.12499763,0.079221584,2,
1700013G24Rik,-0.25384432,-0.011600842,2,
1700013H16Rik,-0.17086191,-0.052025955,2,
1700015G11Rik,-0.19573446,0.058724947,2,
1700016H13Rik,-0.24131581,-0.081770316,2,
1700018F24Rik,-0.13027632,-0.12850112,2,
1700019D03Rik,-0.045226943,0.10127584,3,
1700019N19Rik,-0.17871368,-0.020641,2,
1700020N01Rik,-0.06478784,0.02568019,2,
1700024G13Rik,-0.13888174,0.014314179,2,
1700028P14Rik,-0.15134439,0.09328864,2,
1700029J07Rik,-0.24946685,-0.047433637,2,
1700037H04Rik,-0.14772981,-0.059145827,2,
1700057G04Rik,-0.3164747,0.036506336,2,
1700066M21Rik,-0.13111171,0.031615622,2,
1700093K21Rik,-0.28984442,-0.24363108,2,
1700123L14Rik,0.07870774,0.19096988,3,
1700125H20Rik,0.020995883,0.33303457,3,
1810009J06Rik,-0.20884049,-0.21826915,2,
1810037I17Rik,-0.17390236,-0.16775052,2,
1810046K07Rik,-0.11752626,-0.040160663,2,
2200002D01Rik,-0.18283616,0.027481528,2,
2210010C04Rik,0.016325207,-0.15360418,1,
2210016L21Rik,-0.21077536,-0.052586045,2,
2310011J03Rik,-0.17637473,-0.11721235,2,
2310022B05Rik,-0.27524483,-0.06531277,2,
2310039H08Rik,-0.26431143,-0.20279889,2,
2310050C09Rik,-0.19176745,0.07683487,2,
2310057J18Rik,-0.0787473,0.035852034,2,
2310057N15Rik,-0.060520455,0.11096752,2,['Keratinization']
2410004P03Rik,-0.15412462,-0.15023147,2,
2510039O18Rik,-0.059596673,-0.09850056,2,
2610002M06Rik,0.04423343,-0.024175711,2,
2610042L04Rik,-0.13112481,-0.19206478,2,
2610528A11Rik,-0.13049111,-0.0033315308,2,
2700049A03Rik,-0.04953763,0.16021562,3,
2700062C07Rik,-0.174833,0.003659078,2,
2900026A02Rik,-0.11615924,-0.14626507,2,
3110021N24Rik,-0.1432508,-0.05999718,2,
3110082I17Rik,-0.3039512,0.34607574,0,
4833439L19Rik,-0.051385693,0.025972823,2,
4921524L21Rik,-0.08185995,0.082571186,2,
4921536K21Rik,-0.41745093,-0.0071722628,2,
4930402F06Rik,-0.06956344,-0.11994533,2,
4930415L06Rik,0.050018065,0.059425533,3,
4930438A08Rik,-0.16258664,-0.21654044,2,
4930447C04Rik,-0.123212166,0.14216506,2,
4930447F04Rik,-0.06303588,-0.038012225,2,
4930474N05Rik,0.15304576,-0.2589775,1,
4930486L24Rik,0.06399254,-0.022082655,1,
4930503B20Rik,-0.14786147,0.07613255,2,
4930505A04Rik,-0.24639447,0.0068501607,2,
4930522H14Rik,0.0022484197,0.08878128,3,
4930544G11Rik,0.52744466,-0.30824164,1,
4930550C14Rik,-0.27052578,-0.005748818,2,
4930568D16Rik,-0.30919465,-0.03384036,2,
4930590J08Rik,-0.118731655,-0.13897341,2,
4930595M18Rik,-0.14935519,0.3973694,0,
4930596D02Rik,0.16290975,-0.2407758,1,
4931406C07Rik,-0.22263452,0.010245862,2,
4932414N04Rik,-0.16422403,-0.04831233,2,
4932429P05Rik,0.10345905,-0.11646026,2,
4932438A13Rik,-0.10786712,0.028840188,2,
4933400A11Rik,0.04907427,0.11025133,3,
4933405O20Rik,-0.2461633,-0.0026281725,2,
4933409G03Rik,-0.015466652,-0.0019055103,2,
4933411K16Rik,-0.050217953,0.02126382,2,
4933414I15Rik,-0.12229803,0.18353017,2,
4933416I08Rik,-0.13821204,0.038479198,2,
4933417A18Rik,-0.15282987,0.02810547,2,
4933436I01Rik,-0.30375743,-0.18652028,2,
5031410I06Rik,-0.036083665,-0.045798227,2,
5031439G07Rik,0.04656839,0.02992497,3,
5730455P16Rik,-0.21321283,-0.03935346,2,
6030458C11Rik,-0.11686832,-0.10825015,2,
6430548M08Rik,-0.2087552,0.0917879,2,
6820408C15Rik,-0.2036089,0.014394153,2,
8030462N17Rik,-0.28410548,0.018311802,2,
9130019O22Rik,-0.027809825,0.045937195,2,['Generic Transcription Pathway']
9130409I23Rik,-0.17380144,-0.071810335,2,
9530002B09Rik,-0.21370538,-0.15231846,2,
9530003J23Rik,-0.32073832,-0.047824305,2,
9530053A07Rik,-0.11610161,-0.10217351,2,
A1bg,0.186645,-0.059816312,1,"['Platelet degranulation ', 'Neutrophil degranulation']"
A1cf,0.16021712,0.12320989,0,"['mRNA Editing: C to U Conversion', 'Formation of the Editosome']"
A2m,0.22702464,-0.17095634,1,"['Platelet degranulation ', 'Intrinsic Pathway of Fibrin Clot Formation', 'Degradation of the extracellular matrix', 'HDL assembly']"
A3galt2,-0.11161071,0.078334436,2,
A430005L14Rik,0.024216114,0.03617564,2,
A4galt,-0.43467253,-0.19801222,2,
A4gnt,-0.026125634,-0.13268651,2,['O-linked glycosylation of mucins']
A530064D06Rik,-0.0859256,-0.4029837,1,
A630001G21Rik,-0.14282297,-0.14194581,2,
A930033H14Rik,-0.044742376,-0.1183767,2,
AA986860,-0.14692453,-0.2906348,2,
AB124611,-0.1575568,-0.03579576,2,
AF067061,-0.18941039,0.021016516,2,
AI182371,-0.081222,-0.20339048,2,
AI593442,0.035757132,0.012609351,2,
AI597479,-0.2512768,0.16693768,2,
AK157302,-0.18109293,-0.03799672,2,['Mitochondrial iron-sulfur cluster biogenesis']
AU015836,0.022836149,0.086179584,0,
AU022252,-0.10630757,-0.05007465,2,
AU040320,-0.10240905,-0.16863082,2,
AU041133,-0.31214312,-0.003448397,2,
AW549877,-0.27895543,-0.0903006,2,
AW554918,-0.16095984,-0.13000111,2,
AY761185,-0.37879863,-0.07206002,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Aaas,0.02147178,0.43335384,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHOA GTPase cycle']"
Aacs,-0.27189198,-0.027886482,2,['Synthesis of Ketone Bodies']
Aadac,-0.06466172,-0.11178324,2,['Phase I - Functionalization of compounds']
Aadacl2,-0.20731466,0.050695457,2,
Aadat,-0.24462876,0.013631765,2,"['Lysine catabolism', 'Tryptophan catabolism']"
Aagab,0.014013521,-0.12226841,1,
Aak1,0.16806982,-0.3338976,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Aamp,0.025146859,0.09409984,0,"['NOD1/2 Signaling Pathway', 'Signaling by EGFR', 'Thromboxane signalling through TP receptor']"
Aanat,-0.10585384,-0.19244906,2,['Serotonin and melatonin biosynthesis']
Aar2,-0.23166852,0.32356152,0,
Aars,-0.10825634,-0.022997206,2,
Aars2,-0.07756303,0.070548795,2,
Aasdh,-0.14633591,-0.00046508343,2,
Aasdhppt,-0.02331,0.18006137,3,['Vitamin B5 (pantothenate) metabolism']
Aass,-0.42550018,0.061897386,2,['Lysine catabolism']
Aatf,-0.15535696,0.41925794,0,
Abat,-0.3174005,-0.024655595,2,['Degradation of GABA']
Abca1,0.25174966,-0.20942816,1,"['HDL assembly', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux']"
Abca12,-0.3521359,-0.028444663,2,['ABC transporters in lipid homeostasis']
Abca13,-0.06316283,0.079238504,2,['Neutrophil degranulation']
Abca17,-0.1459241,0.02622269,2,
Abca3,-0.054464877,-0.07821027,1,"['ABC transporters in lipid homeostasis', 'Surfactant metabolism']"
Abca4,-0.031470977,-0.23146048,1,"['The canonical retinoid cycle in rods (twilight vision)', 'ABC-family proteins mediated transport']"
Abca5,-0.31842306,0.09573501,2,['ABC transporters in lipid homeostasis']
Abca6,-0.023382235,0.11609455,2,['ABC transporters in lipid homeostasis']
Abca7,-0.009137217,-0.2099028,1,['ABC transporters in lipid homeostasis']
Abca8a,-0.28797653,-0.16299741,2,
Abca8b,-0.33561566,-0.02454909,2,['ABC-family proteins mediated transport']
Abcb10,-0.1837209,0.16830634,2,
Abcb11,-0.11519375,-0.24349418,2,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol']"
Abcb1a,0.2593064,-0.089103445,1,"['ABC-family proteins mediated transport', 'Atorvastatin ADME']"
Abcb1b,0.12950112,0.14988178,3,
Abcb4,-0.11287683,-0.01220004,2,['ABC-family proteins mediated transport']
Abcb6,-0.14679413,0.27181667,0,['Mitochondrial ABC transporters']
Abcb7,-0.14816174,0.24803585,0,['Mitochondrial ABC transporters']
Abcb8,-0.07122684,0.22225302,2,['Mitochondrial ABC transporters']
Abcb9,-0.25682744,-0.22397275,2,['ABC-family proteins mediated transport']
Abcc1,-0.2894059,0.047991056,2,"['Heme degradation', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'ABC-family proteins mediated transport', 'Cytoprotection by HMOX1', 'Paracetamol ADME', 'Transport of RCbl within the body']"
Abcc12,-0.30086192,0.028389066,2,
Abcc2,-0.06684452,-0.0481035,2,"['Heme degradation', 'ABC-family proteins mediated transport', 'Aspirin ADME', 'Paracetamol ADME', 'Atorvastatin ADME']"
Abcc3,-0.027940592,-0.22560762,2,"['Recycling of bile acids and salts', 'ABC-family proteins mediated transport', 'Aspirin ADME', 'Paracetamol ADME']"
Abcc4,-0.23010239,0.006553156,2,"['Platelet degranulation ', 'ABC-family proteins mediated transport', 'Azathioprine ADME', 'Paracetamol ADME']"
Abcc5,-0.3138464,-0.106715485,2,"['Hyaluronan biosynthesis and export', 'ABC-family proteins mediated transport', 'Azathioprine ADME', 'Paracetamol ADME']"
Abcc6,-0.064240016,-0.058814026,2,['ABC-family proteins mediated transport']
Abcc8,0.043296408,-0.105337836,2,"['ATP sensitive Potassium channels', 'Regulation of insulin secretion']"
Abcc9,-0.0133200465,-0.030660253,2,"['ATP sensitive Potassium channels', 'ABC-family proteins mediated transport', 'Ion homeostasis']"
Abcd1,-0.29161713,0.16929579,2,"['ABC transporters in lipid homeostasis', 'Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Beta-oxidation of very long chain fatty acids', 'Class I peroxisomal membrane protein import']"
Abcd2,-0.29089153,0.07251606,2,
Abcd3,-0.3633426,0.08490562,2,"['ABC transporters in lipid homeostasis', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'Class I peroxisomal membrane protein import']"
Abcd4,-0.27152854,0.07839984,2,"['Uptake of dietary cobalamins into enterocytes', 'Transport of RCbl within the body']"
Abce1,-0.10092627,0.515159,0,"['OAS antiviral response', 'Interferon alpha/beta signaling']"
Abcf1,-0.30146125,0.35975942,0,['ABC-family proteins mediated transport']
Abcf2,-0.21381442,0.49470168,0,
Abcf3,-0.29484412,0.104392014,0,
Abcg1,0.09037836,-0.11516061,1,"['ABC transporters in lipid homeostasis', 'HDL remodeling']"
Abcg2,0.0045735356,0.11888639,0,
Abcg4,-0.025271967,0.017553862,2,['ABC transporters in lipid homeostasis']
Abcg5,0.08057142,-0.052726354,1,['ABC transporters in lipid homeostasis']
Abcg8,0.07985833,-0.07258147,1,['ABC transporters in lipid homeostasis']
Abhd10,-0.15509444,0.12306961,2,['Glucuronidation']
Abhd11,-0.040569995,-0.044736456,2,
Abhd12,0.036901817,-0.17275642,1,['Arachidonate production from DAG']
Abhd12b,-0.118345134,0.11835033,2,
Abhd13,0.023294218,-0.024977095,2,
Abhd14a,-0.1413479,-0.06346187,2,
Abhd16a,-0.095555715,-0.124319464,2,
Abhd16b,-0.33618593,0.0028861735,2,
Abhd17a,0.10962225,-0.122480616,1,['RAS processing']
Abhd17b,0.17372654,0.042849734,3,['RAS processing']
Abhd17c,0.32527626,-0.08722227,1,['RAS processing']
Abhd18,-0.119183674,-0.04322327,2,
Abhd2,-0.17993462,0.015760086,2,
Abhd3,-0.24362835,-0.2634855,2,['Synthesis of PC']
Abhd4,-0.04519116,-0.09862358,2,['Acyl chain remodelling of PE']
Abhd5,0.0136233065,-0.1619042,2,
Abhd6,-0.009373364,-0.1523624,1,['Arachidonate production from DAG']
Abhd8,0.07013633,-0.06609552,1,
Abi1,0.39813814,-0.18359959,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Abi2,0.29986593,-0.24431448,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Abi3,0.05335319,-0.017574668,1,
Abitram,-0.13161854,-0.044780146,2,
Abl1,0.60603094,-0.09284645,1,"['Regulation of actin dynamics for phagocytic cup formation', 'Role of ABL in ROBO-SLIT signaling', 'Myogenesis', 'RHO GTPases Activate WASPs and WAVEs', 'HDR through Single Strand Annealing (SSA)', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Cyclin D associated events in G1', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Abl2,0.41802108,-0.10995455,1,
Ablim1,0.20998318,-0.21838947,1,
Ablim2,-0.09080415,-0.08804166,2,
Ablim3,0.06780589,-0.01950357,2,
Abo,-0.0026538547,-0.060461953,2,['ABO blood group biosynthesis']
Abr,0.23257673,-0.14896743,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Abraxas1,0.17437765,0.22132197,3,"['Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Abraxas2,0.09415891,0.2484257,3,
Abt1,-0.27659348,0.42643532,0,
Abtb1,-0.031148775,0.060608897,0,
Acaa1a,-0.27570033,0.049024414,2,
Acaa1b,-0.16634528,0.10987979,2,"['alpha-linolenic acid (ALA) metabolism', 'Beta-oxidation of very long chain fatty acids', 'Neutrophil degranulation', 'Peroxisomal protein import']"
Acaa2,-0.3000602,-0.0028692798,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acaca,-0.027802465,-0.08814924,2,"['ChREBP activates metabolic gene expression', 'Biotin transport and metabolism', 'Carnitine metabolism', 'Fatty acyl-CoA biosynthesis']"
Acacb,-0.022876916,-0.09918334,2,"['ChREBP activates metabolic gene expression', 'Biotin transport and metabolism', 'Carnitine metabolism']"
Acad10,-0.2765383,0.17482407,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acad11,-0.18588816,0.029985258,2,
Acad8,-0.20873474,0.23949674,2,
Acad9,-0.010503806,-0.01439927,2,['Complex I biogenesis']
Acadl,-0.047852285,-0.13670173,2,
Acadm,-0.084906176,-0.18713515,2,"['mitochondrial fatty acid beta-oxidation of unsaturated fatty acids', 'Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA', 'Beta oxidation of octanoyl-CoA to hexanoyl-CoA']"
Acads,-0.2770978,-0.12884735,2,"['Beta oxidation of hexanoyl-CoA to butanoyl-CoA', 'Beta oxidation of butanoyl-CoA to acetyl-CoA']"
Acadsb,-0.14852916,-0.07803945,2,['Branched-chain amino acid catabolism']
Acadvl,-0.17095767,-0.11920469,2,['Beta oxidation of palmitoyl-CoA to myristoyl-CoA']
Acan,0.035358936,-0.294336,1,"['Degradation of the extracellular matrix', 'Keratan sulfate biosynthesis', 'Keratan sulfate degradation', 'ECM proteoglycans']"
Acap1,0.20860285,-0.121849634,1,
Acap2,-0.08825264,-0.20230953,2,
Acat1,-0.13225687,-0.13063006,2,"['Branched-chain amino acid catabolism', 'Utilization of Ketone Bodies', 'Synthesis of Ketone Bodies']"
Acat2,-0.4084601,-0.116792366,2,['Cholesterol biosynthesis']
Acat3,-0.2480748,0.067629695,2,
Acbd3,0.236469,-0.15431848,1,
Acbd4,-0.10029616,-0.22748812,2,['Peroxisomal lipid metabolism']
Acbd5,-0.24529275,0.10535348,2,"['Peroxisomal lipid metabolism', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'Class I peroxisomal membrane protein import']"
Acbd6,-0.24199829,-0.026069077,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acbd7,-0.21257871,-0.02581966,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acd,0.23705478,0.23741792,3,"['Telomere Extension By Telomerase', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Telomere C-strand synthesis initiation', 'Removal of the Flap Intermediate from the C-strand']"
Ace,0.24310382,-0.26118627,1,['Metabolism of Angiotensinogen to Angiotensins']
Ace2,0.08546081,-0.15455288,1,['Metabolism of Angiotensinogen to Angiotensins']
Ace3,-0.11388071,-0.15255226,2,
Acer1,-0.2818706,-0.04871507,2,['Sphingolipid de novo biosynthesis']
Acer2,-0.27789074,-0.06528798,2,['Sphingolipid de novo biosynthesis']
Acer3,-0.29822832,-0.056469996,2,['Sphingolipid de novo biosynthesis']
Ache,0.14517659,-0.102100044,1,
Acin1,0.16410159,0.29082268,3,['Apoptotic cleavage of cellular proteins']
Ackr1,0.20789509,-0.12501177,1,
Ackr2,0.16120572,-0.028199244,1,['Chemokine receptors bind chemokines']
Ackr3,0.20305085,-0.21608031,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ackr4,-0.0071377666,0.06639168,2,['Chemokine receptors bind chemokines']
Acly,-0.1714508,-0.018584874,2,"['Neutrophil degranulation', 'Fatty acyl-CoA biosynthesis']"
Acmsd,-0.39078483,-0.20817918,2,
Acnat1,-0.1489902,-0.09983769,2,
Acnat2,-0.00011335456,-0.041665345,2,
Aco1,0.037267487,0.10108249,0,['Iron uptake and transport']
Aco2,-0.016286626,0.05974864,2,['Citric acid cycle (TCA cycle)']
Acod1,0.17960915,-0.13062054,1,
Acot1,-0.27706343,0.09390033,2,"['Mitochondrial Fatty Acid Beta-Oxidation', 'Peroxisomal protein import']"
Acot11,-0.29290065,0.16277584,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acot12,-0.29011834,0.0026589946,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acot13,-0.2422673,0.07907303,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acot2,-0.12608017,-0.010117111,2,"['Mitochondrial Fatty Acid Beta-Oxidation', 'Peroxisomal protein import']"
Acot3,-0.25532663,-0.017528387,2,"['Mitochondrial Fatty Acid Beta-Oxidation', 'Peroxisomal protein import']"
Acot4,-0.084472425,0.07953091,2,"['Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Acot5,-0.12830845,-0.08785083,2,"['Mitochondrial Fatty Acid Beta-Oxidation', 'Peroxisomal protein import']"
Acot7,-0.15955693,-0.083195746,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acot8,-0.17247643,0.062228393,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'alpha-linolenic acid (ALA) metabolism', 'Beta-oxidation of pristanoyl-CoA', 'Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Acot9,-0.17719923,0.1154271,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acox1,-0.1625947,0.054473404,2,"['alpha-linolenic acid (ALA) metabolism', 'Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Acox2,-0.13680898,-0.049176957,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Beta-oxidation of pristanoyl-CoA', 'Peroxisomal protein import']"
Acox3,-0.42698732,0.0071860375,2,"['Beta-oxidation of pristanoyl-CoA', 'Peroxisomal protein import']"
Acoxl,-0.25634712,0.047552325,2,['Beta-oxidation of pristanoyl-CoA']
Acp1,0.1868967,-0.043789838,1,
Acp2,-0.105648525,0.024907986,2,
Acp4,-0.20123364,0.14824855,2,
Acp5,0.014273135,-0.24936543,1,['Vitamin B2 (riboflavin) metabolism']
Acp6,-0.39568055,0.06480114,2,['Synthesis of PA']
Acp7,-0.0411396,-0.22829483,1,
Acpp,-0.38251853,0.0024477986,2,['Neutrophil degranulation']
Acr,-0.0672532,-0.07461647,2,['Acrosome Reaction and Sperm:Oocyte Membrane Binding']
Acrbp,-0.119614124,0.035840616,2,
Acrv1,-0.091725454,0.01928393,2,
Acsbg1,-0.26353338,-0.03251045,2,['Synthesis of very long-chain fatty acyl-CoAs']
Acsbg2,-0.13652033,-0.079306446,2,['Synthesis of very long-chain fatty acyl-CoAs']
Acsbg3,-0.15955609,-0.19321172,2,
Acsf2,-0.24244304,-0.1265468,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Acsf3,-0.3057719,0.11484761,2,['Synthesis of very long-chain fatty acyl-CoAs']
Acsl1,-0.2402803,-0.0235594,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Synthesis of very long-chain fatty acyl-CoAs']"
Acsl3,-0.15857537,-0.07312502,2,"['Intracellular metabolism of fatty acids regulates insulin secretion', 'Synthesis of very long-chain fatty acyl-CoAs']"
Acsl4,-0.11775243,-0.06591264,2,"['Intracellular metabolism of fatty acids regulates insulin secretion', 'Synthesis of very long-chain fatty acyl-CoAs']"
Acsl5,-0.11005422,-0.18451959,2,['Synthesis of very long-chain fatty acyl-CoAs']
Acsl6,-0.22658317,-0.045624804,2,['Synthesis of very long-chain fatty acyl-CoAs']
Acsm1,-0.22485164,-0.17670818,2,"['Conjugation of benzoate with glycine', 'Conjugation of phenylacetate with glutamine']"
Acsm2,-0.083615914,-0.08438999,2,"['Conjugation of salicylate with glycine', 'Conjugation of benzoate with glycine', 'Conjugation of phenylacetate with glutamine', 'Aspirin ADME']"
Acsm3,-0.18174085,-0.06729598,2,
Acsm4,-0.033129204,-0.079202436,2,"['Conjugation of salicylate with glycine', 'Aspirin ADME']"
Acsm5,-0.2642094,-0.12519027,2,"['Conjugation of salicylate with glycine', 'Aspirin ADME']"
Acss1,-0.13210267,0.0117617035,2,['Ethanol oxidation']
Acss2,-0.109697334,0.0055681537,2,"['Transcriptional activation of mitochondrial biogenesis', 'Ethanol oxidation']"
Acss3,-0.22762063,0.10815573,2,['Synthesis of Ketone Bodies']
Acta1,0.35457373,-0.18646252,1,['Striated Muscle Contraction']
Acta2,0.5373594,-0.13844858,1,['Smooth Muscle Contraction']
Actb,0.37460646,-0.0499261,1,"['Gap junction degradation', 'Formation of annular gap junctions', 'Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'Adherens junctions interactions', 'Recycling pathway of L1', 'VEGFA-VEGFR2 Pathway', 'Interaction between L1 and Ankyrins', 'Cell-extracellular matrix interactions', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate WASPs and WAVEs', 'RHO GTPases Activate Formins', 'MAP2K and MAPK activation', 'Clathrin-mediated endocytosis', 'RHOBTB2 GTPase cycle']"
Actbl2,-0.08939887,0.037622865,2,
Actc1,0.18116233,-0.08076206,1,"['Striated Muscle Contraction', 'RHOA GTPase cycle', 'RHOB GTPase cycle']"
Actg1,0.44950747,-0.13154426,1,"['Platelet degranulation ', 'Gap junction degradation', 'Formation of annular gap junctions', 'Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'Adherens junctions interactions', 'Recycling pathway of L1', 'VEGFA-VEGFR2 Pathway', 'Interaction between L1 and Ankyrins', 'Cell-extracellular matrix interactions', 'B-WICH complex positively regulates rRNA expression', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate WASPs and WAVEs', 'RHO GTPases Activate Formins', 'MAP2K and MAPK activation', 'UCH proteinases', 'DNA Damage Recognition in GG-NER', 'Clathrin-mediated endocytosis', 'RHOF GTPase cycle']"
Actg2,0.12623236,-0.24627502,1,['Smooth Muscle Contraction']
Actl10,-0.16173038,-0.009360537,2,
Actl6a,0.3812933,0.30532616,3,"['RMTs methylate histone arginines', 'UCH proteinases', 'DNA Damage Recognition in GG-NER', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Actl6b,0.17004992,0.33480945,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Actl7a,0.04688037,0.04215101,2,
Actl7b,-0.13738334,0.1439106,2,
Actl9,-0.121444486,-0.0030976622,2,
Actn1,0.2058423,-0.4212415,1,"['Platelet degranulation ', 'Regulation of cytoskeletal remodeling and cell spreading by IPP complex components', 'RHOD GTPase cycle', 'RHOBTB2 GTPase cycle', 'RHOF GTPase cycle']"
Actn2,0.29129714,-0.2861177,1,"['Platelet degranulation ', 'Striated Muscle Contraction', 'Unblocking of NMDA receptors, glutamate binding and activation', 'RAF/MAP kinase cascade']"
Actn3,0.1220466,-0.25121957,1,['Striated Muscle Contraction']
Actn4,0.31334773,-0.2886433,1,['Platelet degranulation ']
Actr10,0.16264333,0.11942198,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic']"
Actr1a,0.09930021,0.12260594,3,"['MHC class II antigen presentation', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'AURKA Activation by TPX2']"
Actr1b,-0.016423775,0.1323794,3,"['MHC class II antigen presentation', 'Neutrophil degranulation']"
Actr2,0.31853092,-0.10591705,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Neutrophil degranulation', 'Clathrin-mediated endocytosis']"
Actr3,0.14423352,-0.17210859,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Clathrin-mediated endocytosis']"
Actr3b,0.18877473,-0.15425794,1,
Actr5,0.26441258,0.2809609,3,
Actr6,0.19396316,0.24360308,3,
Actr8,0.096771196,0.3062695,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Actrt2,-0.05415495,0.133962,2,
Actrt3,-0.09244648,-0.010031103,2,
Acvr1,0.16222721,-0.07890452,3,
Acvr1b,0.23009752,-0.17913507,1,['Signaling by Activin']
Acvr1c,0.048939932,-0.07869313,2,['Signaling by Activin']
Acvr2a,0.038478017,6.965718e-06,2,"['Signaling by Activin', 'Signaling by BMP']"
Acvr2b,0.1110514,-0.024854636,1,"['Signaling by Activin', 'Signaling by BMP']"
Acvrl1,0.28213975,-0.12229762,1,['Signaling by BMP']
Acy1,-0.10802825,-0.20051308,2,
Acyp1,-0.32684207,-0.097983345,2,
Acyp2,-0.275138,0.04867173,2,
Ada,-0.08111545,0.18868063,0,['Purine salvage']
Adad1,-0.28585804,-0.0876823,2,
Adad2,-0.31369668,0.088384114,2,
Adal,-0.104511544,0.21051076,0,"['Abacavir metabolism', 'Purine salvage']"
Adam10,0.40246555,-0.19805619,1,"['Degradation of the extracellular matrix', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Neutrophil degranulation', 'Post-translational protein phosphorylation', 'NOTCH3 Activation and Transmission of Signal to the Nucleus']"
Adam11,0.015680764,0.04068529,2,['LGI-ADAM interactions']
Adam12,0.054772466,-0.24595839,1,['Invadopodia formation']
Adam15,0.17341341,-0.44388813,1,"['Degradation of the extracellular matrix', 'Invadopodia formation']"
Adam17,0.31557226,-0.37261683,1,"['Regulated proteolysis of p75NTR', 'TNF signaling']"
Adam19,-0.052218474,-0.030152204,2,['Invadopodia formation']
Adam1a,-0.20912473,-0.020023147,2,
Adam1b,-0.09638392,-0.13657244,2,
Adam2,-0.0777072,-0.14956972,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Adam21,-0.085999295,0.16691017,0,['Interaction With Cumulus Cells And The Zona Pellucida']
Adam22,0.14239185,-0.18824345,1,['LGI-ADAM interactions']
Adam25,-0.12820214,-0.22656456,2,
Adam26a,-0.27962017,-0.22272612,2,
Adam28,-0.103483565,-0.2907393,2,
Adam29,0.07739464,0.15764005,0,
Adam3,-0.23366232,-0.08219203,2,
Adam30,-0.19566663,0.07332854,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Adam32,-0.29126635,0.14148517,2,
Adam5,-0.21974817,-0.012190006,2,
Adam6b,-0.22679442,-0.06432083,2,
Adam7,-0.1574394,-0.06461192,2,
Adam8,0.072409004,-0.2030751,1,"['Degradation of the extracellular matrix', 'Neutrophil degranulation']"
Adam9,0.073735215,-0.34524465,1,
Adamts1,0.052393794,-0.101530455,1,['O-glycosylation of TSR domain-containing proteins']
Adamts10,-0.008556129,0.020764057,0,['O-glycosylation of TSR domain-containing proteins']
Adamts12,0.13695575,-0.020653145,1,['O-glycosylation of TSR domain-containing proteins']
Adamts13,0.14010316,-0.11010873,1,['O-glycosylation of TSR domain-containing proteins']
Adamts14,0.112103105,-0.13053259,1,"['Collagen biosynthesis and modifying enzymes', 'O-glycosylation of TSR domain-containing proteins']"
Adamts15,0.07527769,-0.07420856,1,['O-glycosylation of TSR domain-containing proteins']
Adamts16,0.014805402,-0.09479967,1,['O-glycosylation of TSR domain-containing proteins']
Adamts17,0.020295007,0.053058624,0,['O-glycosylation of TSR domain-containing proteins']
Adamts18,0.1438067,0.117642835,0,['O-glycosylation of TSR domain-containing proteins']
Adamts19,0.024760723,0.104294665,0,['O-glycosylation of TSR domain-containing proteins']
Adamts2,0.076935746,-0.08989046,1,"['Collagen biosynthesis and modifying enzymes', 'O-glycosylation of TSR domain-containing proteins']"
Adamts20,-0.071054816,-0.023976197,2,['O-glycosylation of TSR domain-containing proteins']
Adamts3,0.12974344,-0.044889428,1,"['Collagen biosynthesis and modifying enzymes', 'O-glycosylation of TSR domain-containing proteins']"
Adamts5,0.11221294,0.028612884,1,"['Degradation of the extracellular matrix', 'O-glycosylation of TSR domain-containing proteins']"
Adamts6,0.021013068,0.15423241,0,['O-glycosylation of TSR domain-containing proteins']
Adamts7,0.08973512,0.07629778,0,['O-glycosylation of TSR domain-containing proteins']
Adamts8,0.057625595,-0.10978572,1,
Adamts9,-0.024132423,0.061036997,0,['O-glycosylation of TSR domain-containing proteins']
Adamtsl1,0.019220436,-0.023388786,1,['O-glycosylation of TSR domain-containing proteins']
Adamtsl2,0.021820826,-0.10436558,1,['O-glycosylation of TSR domain-containing proteins']
Adamtsl3,0.05096935,-0.06070635,1,['O-glycosylation of TSR domain-containing proteins']
Adamtsl4,-0.07722141,-0.034126777,2,['O-glycosylation of TSR domain-containing proteins']
Adamtsl5,0.11737424,0.04881593,1,['O-glycosylation of TSR domain-containing proteins']
Adap1,0.05675834,-0.015718862,2,
Adap2,0.03408022,0.16193165,3,
Adar,0.26076877,0.34670883,0,"['C6 deamination of adenosine', 'Formation of editosomes by ADAR proteins']"
Adarb1,-0.056636587,-0.047567625,2,"['C6 deamination of adenosine', 'Formation of editosomes by ADAR proteins']"
Adarb2,-0.016793665,0.20559041,0,
Adat1,-0.25483912,0.03357889,2,
Adat2,-0.3593894,0.12739366,0,
Adck1,-0.24315396,-0.06969969,2,
Adck2,-0.29044944,-0.0794531,2,
Adck5,-0.35547072,-0.15286194,2,
Adcy1,0.16335574,-0.2922597,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcy10,0.13264927,-0.086628444,1,"[""Hedgehog 'off' state""]"
Adcy2,0.16764702,-0.21718286,1,
Adcy3,0.061797846,-0.32847807,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcy4,0.10508677,-0.29331753,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcy5,0.21338171,-0.2399809,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'Adrenaline,noradrenaline inhibits insulin secretion', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcy6,0.09655572,-0.29077527,1,
Adcy7,0.13032453,-0.25286967,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcy8,0.106648475,-0.33299303,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcy9,0.021262089,-0.2801658,1,"['PKA activation', 'Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'G alpha (z) signalling events', ""Hedgehog 'off' state""]"
Adcyap1,0.07171121,-0.08775256,2,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Adcyap1r1,0.13876364,-0.31190076,1,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Add1,0.0028970737,0.011460859,2,"['Caspase-mediated cleavage of cytoskeletal proteins', 'Miscellaneous transport and binding events']"
Add2,-0.08851649,0.25104305,0,['Miscellaneous transport and binding events']
Add3,-0.15667515,-0.03718829,2,"['Miscellaneous transport and binding events', 'RHOD GTPase cycle', 'RHOF GTPase cycle']"
Adgb,0.066730544,-0.03317234,2,
Adgra1,-0.07492901,0.10249938,2,
Adgra2,0.10050544,0.0069176224,3,
Adgra3,0.097353704,-0.109763555,1,
Adgrb1,0.25860894,-0.28311664,1,
Adgrb2,0.025740493,-0.050838634,2,
Adgrb3,0.19166961,-0.20219947,1,
Adgrd1,-0.13249697,-0.12436245,2,
Adgre1,0.2449717,-0.21290162,1,['Class B/2 (Secretin family receptors)']
Adgre5,0.17453006,-0.20221458,1,
Adgrf2,-0.060166832,-0.08665024,2,
Adgrf3,-0.12242115,-0.023775311,2,
Adgrf5,-0.24769546,-0.14874473,2,['Surfactant metabolism']
Adgrg1,0.124714,-0.2359047,1,
Adgrg3,-0.3499413,0.08394146,2,['Neutrophil degranulation']
Adgrg4,-0.24170117,-0.040050928,2,
Adgrg5,-0.25298965,-0.12374108,2,
Adgrg6,0.09163191,-0.20178545,1,['EGR2 and SOX10-mediated initiation of Schwann cell myelination']
Adgrg7,-0.29502648,0.0035496557,2,
Adgrl1,0.007965645,-0.29373902,2,
Adgrl2,-0.27309588,-0.24931541,2,
Adgrl3,-0.035751816,-0.14847925,2,
Adgrl4,-0.021710012,-0.2525908,2,
Adgrv1,0.01786886,-0.16588522,1,
Adh1,-0.24722762,-0.17585097,2,"['Abacavir metabolism', 'RA biosynthesis pathway', 'Ethanol oxidation']"
Adh4,-0.3307427,-0.086070314,2,"['RA biosynthesis pathway', 'Ethanol oxidation']"
Adh5,-0.22074766,-0.0876981,2,['Ethanol oxidation']
Adh6a,-0.22613186,0.10952371,2,
Adh7,-0.34861946,-0.09728031,2,['Ethanol oxidation']
Adhfe1,-0.3457132,0.046071935,2,['Interconversion of 2-oxoglutarate and 2-hydroxyglutarate']
Adi1,-0.028879978,-0.079226084,2,['Methionine salvage pathway']
Adipoq,0.33989766,-0.2559437,1,['AMPK inhibits chREBP transcriptional activation activity']
Adipor1,0.08060516,-0.36687335,1,['AMPK inhibits chREBP transcriptional activation activity']
Adipor2,-0.034564596,-0.11966274,2,['AMPK inhibits chREBP transcriptional activation activity']
Adk,-0.09934346,-0.07822087,2,['Purine salvage']
Adm,0.06972821,0.026903408,3,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Adm2,0.13579279,0.018806187,3,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Adnp,-0.047258154,0.33572873,3,
Ado,-0.24873924,-0.15612863,2,['Degradation of cysteine and homocysteine']
Adora1,0.16390878,-0.20704937,1,"['Adenosine P1 receptors', 'G alpha (i) signalling events']"
Adora2a,0.078053266,-0.32294175,1,"['Adenosine P1 receptors', 'G alpha (s) signalling events', 'Surfactant metabolism']"
Adora2b,0.21871902,-0.18274218,1,"['Adenosine P1 receptors', 'G alpha (s) signalling events', 'Surfactant metabolism']"
Adora3,0.074642666,-0.15623878,1,
Adpgk,-0.19155504,0.13121949,2,
Adprhl1,-0.12457425,-0.14090225,2,
Adprm,-0.38421577,-0.021873614,2,['Phosphate bond hydrolysis by NUDT proteins']
Adprs,-0.25685167,0.07047632,2,['POLB-Dependent Long Patch Base Excision Repair']
Adra1a,-0.00680049,-0.25418347,1,"['Adrenoceptors', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events']"
Adra1b,0.112718105,-0.039124742,1,
Adra1d,0.12517996,-0.43074977,1,
Adra2a,0.04574354,-0.16634797,1,"['Adrenoceptors', 'Adrenaline signalling through Alpha-2 adrenergic receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Surfactant metabolism']"
Adra2b,0.02493876,-0.21083838,1,"['Adrenoceptors', 'Adrenaline signalling through Alpha-2 adrenergic receptor', 'G alpha (i) signalling events', 'G alpha (z) signalling events']"
Adra2c,0.1362044,-0.24817854,1,"['Adrenoceptors', 'Adrenaline signalling through Alpha-2 adrenergic receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Surfactant metabolism']"
Adrb1,0.34120977,-0.36002102,1,"['Adrenoceptors', 'G alpha (s) signalling events']"
Adrb2,0.43405917,-0.32719252,1,"['Adrenoceptors', 'G alpha (s) signalling events', 'Ub-specific processing proteases', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Adrb3,0.12681112,-0.32483786,1,"['Adrenoceptors', 'G alpha (s) signalling events']"
Adrm1,0.28376797,0.25317565,3,"['UCH proteinases', 'Ub-specific processing proteases']"
Adsl,-0.1712969,-0.024950206,2,['Purine ribonucleoside monophosphate biosynthesis']
Adss,-0.10935919,-0.07484585,2,['Purine ribonucleoside monophosphate biosynthesis']
Adssl1,-0.098310605,-0.114959955,2,['Purine ribonucleoside monophosphate biosynthesis']
Aebp1,-0.10835474,-0.038266357,2,
Aebp2,0.09556769,0.22654355,3,"['PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines']"
Aen,-0.11913916,0.27153403,0,
Afap1,0.18864672,-0.1535543,1,
Afap1l1,-0.058888778,-0.113624796,2,
Afdn,0.40596616,-0.34516287,1,['Adherens junctions interactions']
Aff1,0.22593556,0.14998336,3,
Aff2,-0.05457409,0.044095136,2,
Aff3,-0.039813474,0.015865985,2,
Aff4,0.038282372,0.39742163,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Afg3l1,0.077010974,-1.6556493e-06,3,
Afg3l2,-0.07865109,0.17544642,2,['Processing of SMDT1']
Afmid,-0.2813965,-0.12818156,2,
Afp,0.32297957,0.01088009,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Aftph,-0.050120525,-0.036875777,1,
Aga,-0.024191687,-0.19679275,2,['Neutrophil degranulation']
Agap1,0.070663825,-0.14439078,1,
Agap2,0.1651484,-0.15345857,1,
Agbl1,-0.12298147,-0.119657315,2,
Agbl2,-0.24207632,-0.026590295,2,
Agbl4,-0.2468839,-0.029454593,2,
Ager,0.39671418,-0.022090273,1,"['TAK1-dependent IKK and NF-kappa-B activation  ', 'Advanced glycosylation endproduct receptor signaling', 'TRAF6 mediated NF-kB activation']"
Agfg1,0.11385783,-0.0025633192,1,['Clathrin-mediated endocytosis']
Agfg2,-0.16656512,-0.1738912,2,
Aggf1,-0.20785359,0.052022893,2,
Agk,-0.110196106,-0.15538709,2,['Glycerophospholipid biosynthesis']
Agl,-0.2579895,-0.045723382,2,"['Neutrophil degranulation', 'Glycogen breakdown (glycogenolysis)']"
Agmat,-0.21494724,-0.041026182,2,['Agmatine biosynthesis']
Agmo,-0.42916432,-0.20546944,2,['Triglyceride biosynthesis']
Ago1,0.21434346,0.26533896,0,"['MicroRNA (miRNA) biogenesis', 'Small interfering RNA (siRNA) biogenesis', 'Post-transcriptional silencing by small RNAs']"
Ago2,0.16356353,0.42996508,0,"['MicroRNA (miRNA) biogenesis', 'Small interfering RNA (siRNA) biogenesis', 'Post-transcriptional silencing by small RNAs', 'Transcriptional regulation by small RNAs']"
Ago3,-0.069725014,0.28293884,0,"['MicroRNA (miRNA) biogenesis', 'Small interfering RNA (siRNA) biogenesis', 'Post-transcriptional silencing by small RNAs']"
Ago4,-0.07756777,0.19944309,0,"['MicroRNA (miRNA) biogenesis', 'Small interfering RNA (siRNA) biogenesis', 'Post-transcriptional silencing by small RNAs']"
Agpat1,-0.18688348,-0.17047675,2,
Agpat2,-0.25294405,-0.15589179,2,"['Synthesis of PA', 'Neutrophil degranulation']"
Agpat3,-0.18922411,-0.11593762,2,"['Synthesis of PA', 'COPI-independent Golgi-to-ER retrograde traffic']"
Agpat4,-0.24447994,-0.030911127,2,['Synthesis of PA']
Agpat5,-0.23368853,-0.1276056,2,['Synthesis of PA']
Agps,-0.23146243,0.10886156,2,
Agr2,-0.1521806,-0.23255052,2,
Agr3,-0.07846028,-0.26006496,2,
Agrn,0.19654183,-0.29646724,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'ECM proteoglycans', 'Retinoid metabolism and transport']"
Agrp,0.052088097,-0.34655958,1,
Agt,0.45753497,-0.30772066,1,
Agtpbp1,-0.105193876,-0.052280836,2,
Agtr1a,0.2770064,-0.18193713,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Agtr1b,0.31738973,-0.09046487,1,
Agtr2,0.08256327,-0.16782159,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Agtrap,0.025028242,-0.061686862,2,
Agxt,-0.06533691,0.009388636,2,"['Glyoxylate metabolism and glycine degradation', 'Peroxisomal protein import']"
Agxt2,-0.15250775,-0.01568825,2,['Glyoxylate metabolism and glycine degradation']
Ahctf1,0.009722185,0.30802348,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Ahcy,0.023639636,-0.016032528,2,"['Methylation', 'Sulfur amino acid metabolism']"
Ahcyl,-0.21232176,-0.13300231,2,"['Methylation', 'Sulfur amino acid metabolism']"
Ahcyl1,0.07125656,-0.1305037,1,['Ion homeostasis']
Ahcyl2,0.0010991938,0.027757483,2,['Bicarbonate transporters']
Ahi1,0.06784724,-0.09705332,1,
Ahnak,0.099321626,-0.12328847,1,
Ahr,0.36706012,0.059434008,3,
Ahrr,0.020587532,0.074948505,3,
Ahsa1,0.10052822,0.05996611,3,
Ahsa2,-0.111231886,-0.02404851,2,
Ahsg,0.21907495,-0.09735459,1,"['Platelet degranulation ', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Neutrophil degranulation', 'Post-translational protein phosphorylation']"
Aicda,0.12508279,0.056833085,1,
Aida,-0.054385707,-0.06925207,2,
Aif1,0.25598106,-0.18053593,1,
Aifm1,0.19712615,0.18698363,3,
Aifm2,-0.18311207,0.15212485,2,
Aifm3,-0.07478221,0.11156568,2,
Aim2,0.12153837,0.19907083,3,"['Cytosolic sensors of pathogen-associated DNA ', 'The AIM2 inflammasome']"
Aimp1,0.06499754,0.07605545,0,
Aimp2,0.054023776,0.17127055,0,
Aip,0.36026376,0.053486705,3,['Aryl hydrocarbon receptor signalling']
Aipl1,0.16326666,-0.27088672,1,
Aire,0.17864703,0.15064166,3,
Ajap1,-0.057738032,-0.12026854,2,
Ajuba,0.29776335,0.19851248,3,"['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Regulation of PLK1 Activity at G2/M Transition']"
Ak1,-0.086437784,0.02860782,2,['Interconversion of nucleotide di- and triphosphates']
Ak2,0.017727867,0.036625955,2,['Interconversion of nucleotide di- and triphosphates']
Ak3,-0.09150521,-0.0010543677,2,['Factors involved in megakaryocyte development and platelet production']
Ak4,-0.04540519,-0.0009057645,2,['Interconversion of nucleotide di- and triphosphates']
Ak5,-0.098732255,0.1240661,2,['Interconversion of nucleotide di- and triphosphates']
Ak6,0.1564839,0.44482988,0,"['Interconversion of nucleotide di- and triphosphates', 'RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Ak7,-0.17193577,0.031830586,2,
Ak8,-0.005054625,-0.014512125,2,['Interconversion of nucleotide di- and triphosphates']
Ak9,-0.08826887,0.15185818,2,['Interconversion of nucleotide di- and triphosphates']
Akap1,0.13699654,-0.024651755,3,['Factors involved in megakaryocyte development and platelet production']
Akap10,0.22174965,-0.112121806,1,['Factors involved in megakaryocyte development and platelet production']
Akap11,-0.042253323,0.03687593,2,
Akap12,0.24743798,-0.049992274,3,"['RHOD GTPase cycle', 'RHOF GTPase cycle']"
Akap14,-0.024479078,-0.06531116,2,
Akap17b,-0.18313396,-0.11929448,2,
Akap3,0.04949045,0.03310141,3,
Akap4,0.045075104,0.23486514,3,
Akap5,0.38850594,-0.23914243,1,['Trafficking of AMPA receptors']
Akap6,0.001509795,0.03000845,2,
Akap7,-0.068123475,-0.036254343,2,
Akap8,0.14603138,0.21228236,3,
Akap8l,-0.17466442,0.073320426,2,
Akap9,0.14182802,0.0014878899,3,
Akip1,0.0893179,0.0669879,3,
Akirin2,0.08549149,0.0753875,3,
Akp3,-0.14341877,-0.08068881,2,
Akr1a1,-0.25950867,-0.051349875,2,"['Glutathione conjugation', 'Formation of xylulose-5-phosphate']"
Akr1b10,-0.20198582,-0.1715377,2,"['Estrogen biosynthesis', 'Retinoid metabolism and transport']"
Akr1b3,-0.27982673,-0.15802068,2,"['Pregnenolone biosynthesis', 'Fructose biosynthesis']"
Akr1b7,-0.21700037,-0.08491145,2,['Estrogen biosynthesis']
Akr1b8,-0.11561918,-0.22820318,2,['Estrogen biosynthesis']
Akr1c12,-0.011612718,-0.06052604,2,
Akr1c13,-0.07374746,-0.15711033,1,
Akr1c14,-0.13639347,-0.18718156,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Retinoid metabolism and transport']"
Akr1c18,-0.17925063,-0.19699456,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Retinoid metabolism and transport']"
Akr1c20,-0.18177381,-0.051624984,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Retinoid metabolism and transport']"
Akr1c21,-0.19587436,0.034917563,2,
Akr1c6,-0.3903481,-0.061882094,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)', 'RA biosynthesis pathway', 'Retinoid metabolism and transport']"
Akr1cl,-0.048112795,-0.0774055,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Retinoid metabolism and transport']"
Akr1d1,-0.20466265,-0.08458628,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol']"
Akr7a5,-0.061126843,0.10953385,0,['Aflatoxin activation and detoxification']
Akt1,0.7565062,-0.10079766,1,"['PIP3 activates AKT signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'MTOR signalling', 'AKT phosphorylates targets in the cytosol', 'AKT phosphorylates targets in the nucleus', 'Negative regulation of the PI3K/AKT network', 'eNOS activation', 'AKT-mediated inactivation of FOXO1A', 'Integrin signaling', 'Deactivation of the beta-catenin transactivating complex', 'CD28 dependent PI3K/Akt signaling', 'CTLA4 inhibitory signaling', 'G beta:gamma signalling through PI3Kgamma', 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'VEGFR2 mediated vascular permeability', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Association with Co-factors', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Cyclin E associated events during G1/S transition ', 'Cyclin A:Cdk2-associated events at S phase entry', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'RAB GEFs exchange GTP for GDP on RABs', 'Regulation of PTEN stability and activity', 'Extra-nuclear estrogen signaling', 'Negative regulation of NOTCH4 signaling', 'FLT3 Signaling', 'Regulation of localization of FOXO transcription factors', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'KEAP1-NFE2L2 pathway']"
Akt1s1,0.22822678,0.054168466,3,"['MTOR signalling', 'mTORC1-mediated signalling', 'AKT phosphorylates targets in the cytosol', 'HSF1-dependent transactivation']"
Akt2,0.67330575,-0.13394336,1,"['PIP3 activates AKT signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'Activation of AKT2', 'Inhibition of TSC complex formation by PKB', 'AKT phosphorylates targets in the cytosol', 'AKT phosphorylates targets in the nucleus', 'Negative regulation of the PI3K/AKT network', 'AKT-mediated inactivation of FOXO1A', 'Deactivation of the beta-catenin transactivating complex', 'CD28 dependent PI3K/Akt signaling', 'CTLA4 inhibitory signaling', 'G beta:gamma signalling through PI3Kgamma', 'VEGFR2 mediated vascular permeability', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Association with Co-factors', 'Cyclin E associated events during G1/S transition ', 'Cyclin A:Cdk2-associated events at S phase entry', 'RAB GEFs exchange GTP for GDP on RABs', 'Regulation of PTEN stability and activity', 'FLT3 Signaling', 'Regulation of localization of FOXO transcription factors', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'KEAP1-NFE2L2 pathway']"
Akt3,0.6858704,-0.12789491,1,"['PIP3 activates AKT signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'AKT phosphorylates targets in the cytosol', 'AKT phosphorylates targets in the nucleus', 'Negative regulation of the PI3K/AKT network', 'AKT-mediated inactivation of FOXO1A', 'CD28 dependent PI3K/Akt signaling', 'CTLA4 inhibitory signaling', 'G beta:gamma signalling through PI3Kgamma', 'VEGFR2 mediated vascular permeability', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Association with Co-factors', 'Cyclin E associated events during G1/S transition ', 'Cyclin A:Cdk2-associated events at S phase entry', 'RAB GEFs exchange GTP for GDP on RABs', 'Regulation of PTEN stability and activity', 'FLT3 Signaling', 'Regulation of localization of FOXO transcription factors', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'KEAP1-NFE2L2 pathway']"
Aktip,0.059971448,0.004731106,1,
Alad,0.09642161,0.07712876,3,"['Heme biosynthesis', 'Neutrophil degranulation']"
Alas1,-0.0012736799,0.28289768,0,['Heme biosynthesis']
Alas2,-0.06844976,0.17601052,0,['Heme biosynthesis']
Alb,0.24431963,-0.11927013,1,"['Platelet degranulation ', 'Recycling of bile acids and salts', 'Heme biosynthesis', 'Heme degradation', 'Scavenging of heme from plasma', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'HDL remodeling', 'Cytoprotection by HMOX1', 'Aspirin ADME']"
Albfm1,-0.063878275,-0.042223677,2,
Alcam,0.2636226,-0.17385307,1,
Aldh18a1,-0.3317338,-0.10023431,2,['Glutamate and glutamine metabolism']
Aldh1a1,0.009202671,-0.08093839,2,"['RA biosynthesis pathway', 'Fructose catabolism', 'Ethanol oxidation']"
Aldh1a2,-0.07742309,0.03486496,2,['RA biosynthesis pathway']
Aldh1a3,-0.14259075,0.05828498,2,['RA biosynthesis pathway']
Aldh1a7,-0.27200225,-0.1283578,2,
Aldh1b1,-0.2522171,0.045550704,2,['Ethanol oxidation']
Aldh1l1,0.0052221613,0.10490449,2,['Metabolism of folate and pterines']
Aldh1l2,-0.10028664,-0.06797209,2,['Metabolism of folate and pterines']
Aldh2,-0.3224627,-0.0239347,2,"['Metabolism of serotonin', 'Smooth Muscle Contraction', 'Ethanol oxidation']"
Aldh3a1,0.067183346,0.050367463,0,['Phase I - Functionalization of compounds']
Aldh3a2,-0.4033182,0.027545704,2,"['Sphingolipid de novo biosynthesis', 'Alpha-oxidation of phytanate', 'Class I peroxisomal membrane protein import', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Aldh3b1,-0.32236224,-0.2246943,2,"['Sphingolipid de novo biosynthesis', 'Neutrophil degranulation']"
Aldh3b2,-0.31369376,-0.12320138,2,['Sphingolipid de novo biosynthesis']
Aldh3b3,-0.18133107,-0.1025888,2,['Sphingolipid de novo biosynthesis']
Aldh4a1,-0.1627467,-0.25612602,2,"['Glyoxylate metabolism and glycine degradation', 'Proline catabolism']"
Aldh5a1,-0.035151254,-0.18010701,2,['Degradation of GABA']
Aldh6a1,-0.29672822,0.03231216,2,['Branched-chain amino acid catabolism']
Aldh7a1,-0.24480297,0.06428526,2,"['Choline catabolism', 'Lysine catabolism']"
Aldh8a1,-0.34050733,0.053784426,2,['RA biosynthesis pathway']
Aldh9a1,-0.26334423,-0.009033328,2,
Aldoa,-0.1784101,0.09468576,2,"['Platelet degranulation ', 'Neutrophil degranulation', 'Glycolysis', 'Gluconeogenesis']"
Aldoart1,0.009011304,0.039038356,0,
Aldoart2,-0.23658004,0.08325781,0,
Aldob,-0.047531296,0.10816283,0,"['Glycolysis', 'Gluconeogenesis', 'Fructose catabolism']"
Aldoc,0.08758598,-0.029420944,1,"['Neutrophil degranulation', 'Glycolysis', 'Gluconeogenesis']"
Alg1,-0.20863023,0.034440015,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg10b,-0.24746378,-0.09442723,2,
Alg11,-0.18966132,-0.06205101,2,
Alg12,-0.13715364,-0.09184085,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg13,-0.182139,-0.0032240942,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg14,-0.2936245,-0.016631423,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg2,-0.2600974,-0.025933182,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg3,-0.20800349,-0.024837237,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg5,-0.23871802,-0.26184207,2,['Synthesis of dolichyl-phosphate-glucose']
Alg6,-0.3264298,-0.12238292,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg8,-0.27585015,-0.11705062,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alg9,-0.18433933,0.060612667,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Alk,0.53979784,-0.24813972,1,['Signaling by ALK']
Alkal1,-0.063731425,-0.10877487,2,
Alkal2,-0.008900325,-0.06705196,2,
Alkbh1,-0.10521878,0.16701381,0,
Alkbh2,-0.13152027,-0.021542283,2,
Alkbh3,-0.012530285,0.009210441,2,
Alkbh4,-0.1176115,0.18448538,0,
Alkbh5,0.06671001,0.35767263,0,['Reversal of alkylation damage by DNA dioxygenases']
Alkbh6,-0.16091387,0.06299302,2,
Alkbh7,-0.092276365,0.007690788,0,
Alkbh8,-0.03804155,0.34487966,0,
Allc,-0.0032690454,-0.014811648,2,
Alms1,-0.053121507,-0.2876456,1,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Alox12,-0.14851846,-0.07886001,2,"['Synthesis of Hepoxilins (HX) and Trioxilins (TrX)', 'Synthesis of Lipoxins (LX)', 'Synthesis of 12-eicosatetraenoic acid derivatives', 'Biosynthesis of DHA-derived SPMs', 'Biosynthesis of DPAn-6 SPMs', 'Biosynthesis of DPAn-3-derived maresins']"
Alox12b,-0.22706547,-0.06383844,2,['Synthesis of 12-eicosatetraenoic acid derivatives']
Alox12e,-0.21680492,-0.03958735,2,
Alox15,0.027853765,-0.10420149,2,"['Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of 12-eicosatetraenoic acid derivatives', 'Synthesis of 15-eicosatetraenoic acid derivatives', 'Biosynthesis of DHA-derived SPMs', 'Biosynthesis of protectins', 'Biosynthesis of E-series 18(S)-resolvins', 'Biosynthesis of E-series 18(R)-resolvins', 'Biosynthesis of DPAn-6 SPMs', 'Biosynthesis of DPAn-3-derived protectins and resolvins']"
Alox5,-0.038255822,-0.12883602,2,"['Synthesis of 5-eicosatetraenoic acids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of Lipoxins (LX)', 'Neutrophil degranulation', 'Biosynthesis of D-series resolvins', 'Biosynthesis of maresins', 'Biosynthesis of E-series 18(S)-resolvins', 'Biosynthesis of aspirin-triggered D-series resolvins', 'Biosynthesis of E-series 18(R)-resolvins', 'Biosynthesis of DPAn-3-derived protectins and resolvins', 'Biosynthesis of DPAn-3-derived maresins', 'Biosynthesis of DPAn-3-derived 13-series resolvins', 'Biosynthesis of electrophilic -3 PUFA oxo-derivatives']"
Alox5ap,-0.05229274,-0.20347509,1,"['Synthesis of 5-eicosatetraenoic acids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of Lipoxins (LX)']"
Alox8,-0.18472333,-0.1696991,2,['Synthesis of 15-eicosatetraenoic acid derivatives']
Aloxe3,-0.29962885,-0.0014933195,2,['Synthesis of 12-eicosatetraenoic acid derivatives']
Alpi,-0.021074861,0.010662308,2,"['Synthesis of PA', 'Post-translational modification: synthesis of GPI-anchored proteins', 'Intra-Golgi traffic', 'Digestion']"
Alpk1,0.20241842,0.010970874,3,
Alpk2,-0.19310765,-0.17871979,2,
Alpl,0.12853512,-0.21775134,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Alppl2,-0.17411964,0.13271531,2,"['Post-translational modification: synthesis of GPI-anchored proteins', 'Intra-Golgi traffic']"
Als2,0.12897342,0.052632216,1,"['RAB GEFs exchange GTP for GDP on RABs', 'RAC1 GTPase cycle']"
Als2cl,-0.05676781,-0.057642743,2,
Alx1,-0.18285201,-0.16408688,2,
Alx3,-0.22008203,-0.09803128,2,
Alx4,-0.029572112,-0.045529347,2,
Alyref,-0.014419395,0.5092379,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Alyref2,0.023869464,0.33004457,0,
Amacr,-0.28877974,0.12992306,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Beta-oxidation of pristanoyl-CoA', 'Peroxisomal protein import']"
Ambn,0.08459579,-0.09218049,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Ambp,0.113183506,-0.12741521,1,['Scavenging of heme from plasma']
Ambra1,0.18624608,-0.036751673,3,['Macroautophagy']
Amd1,-0.012455441,0.16286859,3,['Metabolism of polyamines']
Amd2,-0.00036384145,0.12300846,3,
Amdhd1,-0.19607304,-0.15265965,2,['Histidine catabolism']
Amdhd2,-0.32822445,-0.17071849,2,['Synthesis of UDP-N-acetyl-glucosamine']
Amelx,-0.04541242,0.048015565,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Amer1,0.19878,-0.009071416,3,"['Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane']"
Amer2,-0.15168846,-0.040515497,2,
Amer3,-0.26810616,-0.18857023,2,
Amfr,0.11910052,0.13238761,3,['N-glycan trimming in the ER and Calnexin/Calreticulin cycle']
Amh,0.11970782,-0.045141563,1,
Amhr2,-0.064728804,-0.015891138,2,['Signaling by BMP']
Amigo1,-0.14433217,-0.25411743,2,
Ammecr1,-0.28101248,0.26035446,2,
Amn,-0.07370515,-0.20056596,2,
Amot,0.16244666,-0.21694584,1,['Signaling by Hippo']
Amotl1,0.31439903,-0.16357344,1,['Signaling by Hippo']
Amotl2,0.22092459,-0.2442369,1,['Signaling by Hippo']
Ampd1,-0.11342516,-0.066970475,2,['Purine salvage']
Ampd2,-0.20515387,-0.12490096,2,['Purine salvage']
Ampd3,-0.15698434,0.011212348,2,"['Neutrophil degranulation', 'Purine salvage']"
Amph,0.08432391,-0.314829,1,['Clathrin-mediated endocytosis']
Amt,-0.0016137026,-0.07752148,1,['Glycine degradation']
Amtn,-0.015855508,-0.06568763,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Amy1,-0.17584124,0.051753554,2,['Digestion of dietary carbohydrate']
Amy2a1,-0.34472516,-0.06321585,2,
Amy2a2,-0.15226614,-0.04465716,2,['Digestion of dietary carbohydrate']
Amy2a4,-0.1774813,0.085114,2,['Digestion of dietary carbohydrate']
Anapc1,0.18836717,0.26853955,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Anapc10,0.2939519,0.30316746,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Anapc11,0.3377755,0.3694719,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Anapc13,0.08326614,0.2971904,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Anapc15,0.10454653,0.3024874,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6']"
Anapc15-ps,0.13775611,0.0995347,3,
Anapc16,0.18181212,0.30516186,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6']"
Anapc2,0.2608056,0.19754711,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Anapc4,0.2286054,0.3354214,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Anapc5,0.2319678,0.2701024,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Anapc7,0.20558077,0.26667994,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ang,-0.01605985,-0.09216041,2,['Adherens junctions interactions']
Ang2,-0.19855389,0.044544507,2,
Ang4,-0.24689846,0.021358851,2,
Ang5,-0.30689484,-0.16035794,2,
Angel1,-0.27491078,0.07550728,2,
Angel2,-0.25884855,0.25676832,0,
Angpt1,0.49704626,-0.2124396,1,"['Tie2 Signaling', 'RAF/MAP kinase cascade']"
Angpt2,0.35706967,-0.22335835,1,['Tie2 Signaling']
Angpt4,0.25358126,-0.1579435,1,['Tie2 Signaling']
Angptl1,0.018157331,-0.21795473,1,
Angptl2,0.18147038,-0.11397127,1,
Angptl3,0.13733181,-0.18862472,1,['Assembly of active LPL and LIPC lipase complexes']
Angptl4,0.16246602,-0.25732705,1,['Assembly of active LPL and LIPC lipase complexes']
Angptl7,0.022921639,-0.12937245,2,
Angptl8,-0.036372773,-0.17597926,2,['Assembly of active LPL and LIPC lipase complexes']
Ank,-0.2144845,-0.19126846,2,['Miscellaneous transport and binding events']
Ank1,0.111870795,-0.39357677,1,"['Interaction between L1 and Ankyrins', 'Neurofascin interactions', 'COPI-mediated anterograde transport']"
Ank2,0.23926039,-0.4368088,1,
Ank3,0.22896054,-0.38889673,1,
Ankdd1a,-0.13133092,0.043989614,2,
Ankdd1b,-0.36021277,-0.16807729,2,
Ankfn1,-0.18485366,-0.12771514,2,
Ankfy1,0.103941746,-0.16840142,1,['RHOD GTPase cycle']
Ankhd1,-0.2134081,-0.028144378,2,
Ankib1,-0.38802978,0.041696947,2,
Ankk1,-0.15705456,-0.120541535,2,
Ankle1,0.07255942,-0.019244254,1,
Ankle2,0.07039185,0.10195694,3,"['Initiation of Nuclear Envelope (NE) Reformation', 'RAC2 GTPase cycle', 'RHOG GTPase cycle']"
Ankmy1,-0.287,-0.2517465,2,
Ankmy2,0.086603016,-0.2696662,1,
Ankra2,0.17407204,-0.051324394,1,
Ankrd1,0.19761783,0.075085714,3,
Ankrd10,-0.3196132,-0.028153067,2,
Ankrd12,-0.02511646,0.17925583,3,
Ankrd16,-0.12225443,0.06454939,2,
Ankrd17,-0.17382349,0.058487948,2,
Ankrd2,0.091580704,-0.10515322,1,
Ankrd23,-0.18217282,-0.068229385,2,
Ankrd24,-0.12495495,-0.024514424,2,
Ankrd27,-0.14845069,-0.024074072,2,['RAB GEFs exchange GTP for GDP on RABs']
Ankrd28,0.040079992,0.17470853,0,"['Telomere Extension By Telomerase', 'COPII-mediated vesicle transport']"
Ankrd34b,-0.1620297,-0.032429397,2,
Ankrd37,-0.10348206,0.11802462,0,
Ankrd40,-0.12749697,0.0037125654,2,
Ankrd42,0.023895767,-0.034832772,2,
Ankrd44,-0.26912627,-0.05490342,0,
Ankrd45,-0.018410888,-0.1380851,1,
Ankrd46,-0.16198371,0.019825486,2,
Ankrd49,0.07341737,-0.08168616,1,
Ankrd50,-0.042389512,0.061035648,2,
Ankrd52,-0.128593,0.08283743,2,
Ankrd54,-0.026247835,-0.19500598,1,
Ankrd55,-0.17245615,-0.04156151,2,
Ankrd6,0.071775086,0.090962455,3,
Ankrd60,0.09484379,0.116495825,3,
Ankrd61,-0.206776,-0.0016632689,2,
Ankrd66,-0.25615665,-0.17223509,2,
Ankrd9,0.080701455,0.08747865,3,['Neddylation']
Anks1,-0.008737902,0.15610974,0,
Anks1b,0.0869168,-0.15022372,1,
Anks3,-0.1134275,0.0620602,2,
Anks4b,-0.27011538,-0.22611542,2,
Anks6,-0.08388299,-0.103509665,2,
Ankub1,-0.20894177,-0.0044413083,2,
Ankzf1,0.08394118,0.033499178,2,
Anln,0.34260917,0.21610387,3,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Ano1,0.018741028,-0.22549145,1,['Stimuli-sensing channels']
Ano2,-0.06420476,-0.11993956,2,['Stimuli-sensing channels']
Ano3,-0.18335772,-0.2190571,2,['Stimuli-sensing channels']
Ano5,-0.17646521,0.0013732978,2,['Stimuli-sensing channels']
Ano6,-0.28520766,-0.17423953,2,"['Stimuli-sensing channels', 'Neutrophil degranulation']"
Ano7,-0.11554341,-0.040895622,2,['Stimuli-sensing channels']
Anp32a,0.17842974,0.3406413,3,['HuR (ELAVL1) binds and stabilizes mRNA']
Anp32b,0.07805296,0.27374467,0,
Anp32e,0.03388258,0.44929194,3,
Anpep,0.24492647,-0.3423629,1,['Neutrophil degranulation']
Antkmt,-0.28817168,-0.055010546,2,
Antxr1,0.075145304,-0.058210943,1,
Antxr2,-0.15481214,0.10852343,2,
Antxrl,-0.27066764,0.028427044,2,
Anxa1,0.21633138,-0.19124073,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Anxa10,-0.26501262,-0.11161501,2,
Anxa11,-0.21033283,0.0027739322,2,
Anxa2,0.37297562,-0.17190589,1,"['Neutrophil degranulation', 'Dissolution of Fibrin Clot']"
Anxa4,0.16692576,-0.028018918,1,
Anxa5,0.46846315,-0.046416156,1,['Platelet degranulation ']
Anxa6,0.24279392,-0.10781229,1,
Anxa7,-0.10402552,-0.06688736,2,
Aoc1,-0.31564778,0.17553487,0,
Aoc1l1,-0.24825303,0.0543748,2,
Aoc1l2,-0.21495937,-0.019300567,2,
Aoc1l3,-0.34102455,0.1428429,2,
Aoc2,-0.1030887,0.10530603,0,['Phase I - Functionalization of compounds']
Aoc3,-0.03378319,-0.08299003,1,['Phase I - Functionalization of compounds']
Aopep,0.06717044,-0.07943664,1,['Metabolism of Angiotensinogen to Angiotensins']
Aox1,-0.21139832,-0.08009139,2,
Aox2,-0.2581967,-0.015401269,2,
Aox3,-0.37931505,-0.027804011,2,
Aox4,-0.2511838,0.039762296,2,
Ap1b1,-0.026065521,-0.19247404,1,"['MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap1g1,0.031470425,-0.20979847,1,"['MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap1g2,0.13866813,-0.15324026,1,['Lysosome Vesicle Biogenesis']
Ap1m1,0.07739692,-0.33298293,1,"['MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Neutrophil degranulation']"
Ap1m2,0.15501334,-0.22064319,1,
Ap1s1,-0.009960732,-0.21054931,2,"['MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap1s2,-0.0066913436,-0.2922645,1,"['MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap1s3,0.029771378,-0.20324627,1,"['MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap2a1,0.19422133,-0.20573494,1,"['Retrograde neurotrophin signalling', 'MHC class II antigen presentation', 'Trafficking of GluR2-containing AMPA receptors', 'Recycling pathway of L1', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDLR internalisation and degradation', 'LDL clearance']"
Ap2a2,0.2516276,-0.32926592,1,"['Retrograde neurotrophin signalling', 'MHC class II antigen presentation', 'Trafficking of GluR2-containing AMPA receptors', 'Recycling pathway of L1', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Neutrophil degranulation', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDLR internalisation and degradation', 'LDL clearance']"
Ap2b1,0.39843488,-0.25925106,1,"['Retrograde neurotrophin signalling', 'MHC class II antigen presentation', 'Trafficking of GluR2-containing AMPA receptors', 'Recycling pathway of L1', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDLR internalisation and degradation', 'LDL clearance']"
Ap2m1,0.2503519,-0.33591792,1,"['Retrograde neurotrophin signalling', 'Gap junction degradation', 'Formation of annular gap junctions', 'MHC class II antigen presentation', 'Trafficking of GluR2-containing AMPA receptors', 'Recycling pathway of L1', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDLR internalisation and degradation', 'LDL clearance']"
Ap2s1,0.22456609,-0.18556276,1,"['Retrograde neurotrophin signalling', 'MHC class II antigen presentation', 'Trafficking of GluR2-containing AMPA receptors', 'Recycling pathway of L1', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDLR internalisation and degradation', 'LDL clearance']"
Ap3b1,0.114512816,-0.17280623,1,['Golgi Associated Vesicle Biogenesis']
Ap3b2,0.072456904,-0.17643556,1,
Ap3d1,-0.14331657,-0.045537002,0,
Ap3m1,-0.37902477,-0.07055145,2,
Ap3m2,-0.04577325,-0.11746175,2,
Ap3s1,0.044677358,-0.09894346,1,['Golgi Associated Vesicle Biogenesis']
Ap3s2,-0.08784535,-0.16660881,2,
Ap4b1,-0.016581535,-0.24664146,1,"['Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap4e1,0.018322391,-0.13502741,1,"['Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Ap4m1,-0.023367118,-0.100622386,2,['Lysosome Vesicle Biogenesis']
Ap4s1,-0.124704026,-0.024700686,2,['Lysosome Vesicle Biogenesis']
Ap5b1,-0.046456173,-0.1620077,2,
Ap5m1,0.01722564,-0.11161508,1,
Ap5s1,0.01630909,-0.0705805,2,
Ap5z1,-0.1618845,-0.122728094,2,
Apaf1,0.31926805,0.17686225,3,"['Formation of apoptosome', 'Activation of caspases through apoptosome-mediated cleavage', 'Neutrophil degranulation', 'Regulation of the apoptosome activity']"
Apba1,0.15156022,-0.13272364,1,['Dopamine Neurotransmitter Release Cycle']
Apba2,0.054274525,-0.06385538,1,
Apba3,0.06675224,-0.25532016,1,
Apbb1,0.32068357,0.019311028,1,['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']
Apbb1ip,0.26354983,-0.43711057,1,"['Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'MAP2K and MAPK activation']"
Apbb2,0.05410843,-0.044681065,2,
Apc,0.4650324,0.09024669,3,
Apc2,0.2347059,0.04134211,3,
Apcdd1,-0.10519025,0.0706393,2,
Apcs,0.077771746,-0.15256758,1,
Apeh,-0.033445377,0.085176684,2,"['Neutrophil degranulation', 'Eukaryotic Translation Termination']"
Apela,-0.0069770827,-0.11848956,1,
Apex1,0.15348965,0.24355264,3,"['Displacement of DNA glycosylase by APEX1', 'POLB-Dependent Long Patch Base Excision Repair', 'Resolution of AP sites via the multiple-nucleotide patch replacement pathway', 'PCNA-Dependent Long Patch Base Excision Repair', 'Abasic sugar-phosphate removal via the single-nucleotide replacement pathway', 'Resolution of Abasic Sites (AP sites)']"
Apex2,0.033316836,-0.013120919,2,
Aph1a,0.23837858,-0.019095706,1,"['Nuclear signaling by ERBB4', 'Regulated proteolysis of p75NTR', 'NRIF signals cell death from the nucleus', 'EPH-ephrin mediated repulsion of cells', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Noncanonical activation of NOTCH3']"
Aph1b,0.18634981,-0.025490118,1,"['Nuclear signaling by ERBB4', 'Regulated proteolysis of p75NTR', 'NRIF signals cell death from the nucleus', 'EPH-ephrin mediated repulsion of cells', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Noncanonical activation of NOTCH3']"
Aph1c,0.026989385,-0.03915501,2,
Api5,0.058177676,0.026351806,2,
Apip,0.028543409,0.17336598,3,"['Formation of apoptosome', 'Regulation of the apoptosome activity']"
Aplf,0.07221781,0.22064814,3,
Apln,0.041064076,-0.114934176,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Aplnr,0.2007329,-0.2242079,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Aplp1,0.16158621,-0.15974782,1,
Aplp2,0.40997666,-0.23679572,1,"['Platelet degranulation ', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Apmap,-0.072282635,-0.065606885,2,
Apoa1,0.25384596,-0.14252216,1,"['Platelet degranulation ', 'ABC transporters in lipid homeostasis', 'Scavenging of heme from plasma', 'Scavenging by Class B Receptors', 'Scavenging by Class A Receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'Chylomicron assembly', 'HDL assembly', 'Chylomicron remodeling', 'HDL clearance', 'HDL remodeling', 'Heme signaling', 'Retinoid metabolism and transport']"
Apoa2,0.24768879,-0.084785424,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'Chylomicron assembly', 'Chylomicron remodeling', 'Retinoid metabolism and transport']"
Apoa4,0.15239775,-0.1696512,1,"['Chylomicron assembly', 'Chylomicron remodeling', 'Retinoid metabolism and transport']"
Apoa5,0.013002299,0.018261816,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'Chylomicron remodeling']"
Apob,0.25734213,-0.09662332,1,"['Cell surface interactions at the vascular wall', 'Scavenging by Class B Receptors', 'Scavenging by Class A Receptors', 'Scavenging by Class H Receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Platelet sensitization by LDL', 'Regulation of TLR by endogenous ligand', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDL assembly', 'Post-translational protein phosphorylation', 'Chylomicron assembly', 'Chylomicron remodeling', 'Chylomicron clearance', 'LDL clearance', 'LDL remodeling', 'VLDL clearance', 'Heme signaling', 'Retinoid metabolism and transport']"
Apobec1,0.019992549,-0.0044789994,1,"['mRNA Editing: C to U Conversion', 'Formation of the Editosome']"
Apobec2,0.1643073,0.07796401,1,"['mRNA Editing: C to U Conversion', 'Formation of the Editosome']"
Apobec3,0.20945616,0.06753714,1,"['mRNA Editing: C to U Conversion', 'Formation of the Editosome']"
Apobec4,0.093479194,0.07621761,0,"['mRNA Editing: C to U Conversion', 'Formation of the Editosome']"
Apobr,0.028772803,-0.10392332,1,['VLDL clearance']
Apoc1,0.05976812,-0.27290118,1,"['VLDL assembly', 'VLDL clearance']"
Apoc2,0.16715403,-0.17262657,1,"['Chylomicron assembly', 'Chylomicron remodeling', 'HDL remodeling', 'Retinoid metabolism and transport']"
Apoc3,0.066426426,-0.18012413,1,
Apoc4,0.05872473,-0.12340394,1,"['VLDL assembly', 'VLDL clearance']"
Apod,-0.09403634,-0.020619655,2,['Transport of fatty acids']
Apoe,0.46438375,-0.20013705,1,"['Scavenging by Class A Receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'Chylomicron assembly', 'Chylomicron remodeling', 'Chylomicron clearance', 'HDL remodeling', 'Retinoid metabolism and transport']"
Apof,0.06633503,-0.17590572,1,
Apoh,0.33194944,-0.09459735,1,['Platelet degranulation ']
Apol8,-0.05198433,0.1517848,0,"['Scavenging of heme from plasma', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Apom,0.18359374,-0.1219557,1,['Retinoid metabolism and transport']
Apoo,-0.10864033,0.1258542,2,
Apool,-0.20052351,-0.04402414,2,['Platelet degranulation ']
App,0.55343837,-0.1902261,1,"['Platelet degranulation ', 'ECM proteoglycans', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'G alpha (q) signalling events', 'G alpha (i) signalling events', 'Lysosome Vesicle Biogenesis', 'Formyl peptide receptors bind formyl peptides and many other ligands', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'Advanced glycosylation endproduct receptor signaling', 'Post-translational protein phosphorylation', 'TRAF6 mediated NF-kB activation', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Appbp2,0.0757737,-0.22581434,1,
Appl1,0.27594694,-0.2634037,1,['Caspase activation via Dependence Receptors in the absence of ligand']
Appl2,-0.08275358,-0.25812685,2,
Aprt,-0.100358866,0.07885483,0,"['Neutrophil degranulation', 'Purine salvage']"
Aptx,0.15046678,0.3198325,3,
Aqp1,-0.07582045,-0.20742792,2,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Passive transport by Aquaporins']"
Aqp11,-0.27311513,-0.2356364,2,['Passive transport by Aquaporins']
Aqp12,-0.30019322,-0.13109371,2,['Passive transport by Aquaporins']
Aqp2,0.13184072,-0.14822489,1,"['Vasopressin regulates renal water homeostasis via Aquaporins', 'Passive transport by Aquaporins']"
Aqp3,-0.061360683,-0.21714388,2,"['Vasopressin regulates renal water homeostasis via Aquaporins', 'Passive transport by Aquaporins']"
Aqp4,0.11729369,-0.23286782,1,"['Vasopressin regulates renal water homeostasis via Aquaporins', 'Passive transport by Aquaporins']"
Aqp5,-0.18879022,-0.086889185,2,['Passive transport by Aquaporins']
Aqp6,-0.2946553,-0.22108954,2,
Aqp7,-0.14184815,-0.18021543,2,"['Transport of glycerol from adipocytes to the liver by Aquaporins', 'Passive transport by Aquaporins']"
Aqp8,-0.11277778,-0.06250791,2,['Passive transport by Aquaporins']
Aqp9,-0.20911714,-0.103837036,2,"['Transport of glycerol from adipocytes to the liver by Aquaporins', 'Passive transport by Aquaporins']"
Aqr,-0.289475,0.49997556,0,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'mRNA Splicing - Major Pathway']"
Ar,0.50101745,-0.041781124,1,"['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors', 'Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'Ub-specific processing proteases', 'RUNX2 regulates osteoblast differentiation']"
Araf,0.45265198,-0.160972,1,"['RAF activation', 'MAP2K and MAPK activation', 'Negative regulation of MAPK pathway']"
Arap1,0.19257592,-0.27221993,1,"['PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arap2,0.34040344,-0.15119597,1,
Arap3,0.13758497,-0.36384973,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Arc,0.20693876,-0.2229171,1,
Arcn1,-0.022367626,-0.023183033,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Areg,0.25425348,-0.43438864,1,"['PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'COPII-mediated vesicle transport', 'EGFR interacts with phospholipase C-gamma', 'RAF/MAP kinase cascade', 'Cargo concentration in the ER', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Extra-nuclear estrogen signaling']"
Arel1,-0.105666086,0.086144395,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Arf1,0.2766298,-0.23896362,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of PIPs at the Golgi membrane', 'trans-Golgi Network Vesicle Budding', 'MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Intra-Golgi traffic']"
Arf2,0.16339815,-0.08572721,1,
Arf3,0.06139476,-0.32176465,1,"['Synthesis of PIPs at the Golgi membrane', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Arf4,-0.0015908122,-0.26470625,1,"['VxPx cargo-targeting to cilium', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Arf5,-0.002058601,-0.13274059,1,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Arf6,0.39228737,-0.3668516,1,"['TBC/RABGAPs', 'Clathrin-mediated endocytosis', 'MET receptor recycling']"
Arfgap1,-0.032134745,-0.3148576,1,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Clathrin-mediated endocytosis']"
Arfgap2,0.019596586,-0.17138055,1,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Arfgap3,0.11900095,-0.17004246,1,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'RHOG GTPase cycle']"
Arfgef1,-0.08154209,-0.0044935415,2,
Arfgef2,0.15243171,-0.13779835,1,
Arfgef3,-0.062316626,-0.0051946533,2,
Arfip1,0.04245311,-0.27635926,1,
Arfip2,-0.012381817,-0.21720569,1,['Retrograde transport at the Trans-Golgi-Network']
Arfrp1,-0.16407223,0.087149195,2,['Retrograde transport at the Trans-Golgi-Network']
Arg1,0.23824617,-0.058116216,1,"['Neutrophil degranulation', 'Urea cycle']"
Arg2,0.24091206,-0.14091669,1,['Urea cycle']
Arhgap1,0.18650901,-0.25001258,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle', 'RND2 GTPase cycle']"
Arhgap10,0.2894228,-0.16799584,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap11a,0.10185148,0.43984112,3,['RHOA GTPase cycle']
Arhgap12,-0.2212913,-0.19242582,2,"['RAC1 GTPase cycle', 'RHOD GTPase cycle', 'RHOV GTPase cycle', 'RHOF GTPase cycle']"
Arhgap15,0.22415023,-0.12236841,1,"['RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Arhgap17,0.104966275,-0.30014867,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RAC3 GTPase cycle']"
Arhgap18,-0.052829865,-0.05870173,2,"['RHOA GTPase cycle', 'RHOC GTPase cycle']"
Arhgap19,-0.02063121,-0.0006116222,2,['RHOA GTPase cycle']
Arhgap20,0.07912919,-0.03535507,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap21,0.16020279,-0.12854204,1,
Arhgap22,-0.1887914,-0.09527401,2,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap23,0.053382434,-0.073896505,1,"['RHOA GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap24,-0.018892476,-0.11532717,2,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap25,-0.11879456,-0.13081504,2,['RAC1 GTPase cycle']
Arhgap26,0.2176892,-0.25733322,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle']"
Arhgap27,0.30214897,-0.045280457,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap28,-0.1615385,-0.020003522,2,['RHOA GTPase cycle']
Arhgap29,0.20721667,-0.15698025,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap30,0.13022721,-0.046758197,1,
Arhgap31,0.12676096,-0.060588934,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOU GTPase cycle']"
Arhgap32,0.41228068,-0.052017696,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Arhgap33,0.141126,-0.17454556,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOQ GTPase cycle']"
Arhgap35,0.39713767,-0.30228788,1,"['Sema4D mediated inhibition of cell attachment and migration', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Arhgap36,0.058072157,-0.15571748,1,
Arhgap39,-0.004812257,-0.067459226,2,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Arhgap4,-0.04733866,-0.18135901,2,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap40,-0.11923637,-0.051316384,2,"['RHOA GTPase cycle', 'CDC42 GTPase cycle']"
Arhgap42,0.15312941,-0.21985081,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Arhgap44,0.18807764,-0.17263342,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap45,-0.02162727,-0.13594739,1,"['Neutrophil degranulation', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgap5,0.22010665,-0.26743564,1,
Arhgap6,0.21905805,-0.21395075,1,"['RHOA GTPase cycle', 'RAC3 GTPase cycle']"
Arhgap8,0.068323754,-0.12331594,1,['RHOA GTPase cycle']
Arhgap9,0.020396484,-0.2390655,1,"['Neutrophil degranulation', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgdia,0.4058608,-0.1797716,1,"['Axonal growth inhibition (RHOA activation)', 'Axonal growth stimulation', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle']"
Arhgdib,0.37879455,-0.2580112,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Arhgdig,0.30148256,-0.0821434,1,"['RHOB GTPase cycle', 'CDC42 GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle']"
Arhgef1,0.3527704,-0.2802612,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Arhgef10,0.14798406,-0.18187828,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgef10l,0.048673976,-0.27235296,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Arhgef11,0.18575329,-0.36593878,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'Sema4D induced cell migration and growth-cone collapse', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgef12,0.3630535,-0.30449882,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'Sema4D induced cell migration and growth-cone collapse', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle']"
Arhgef15,0.2973251,-0.064354956,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgef16,0.23939791,-0.17471513,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'CDC42 GTPase cycle', 'RHOG GTPase cycle']"
Arhgef17,0.08494631,-0.13038619,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Arhgef18,0.19957958,-0.15034412,1,"['NRAGE signals death through JNK', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RAC1 GTPase cycle']"
Arhgef19,0.23900013,-0.041930873,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Arhgef2,0.3481443,-0.13695656,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle']"
Arhgef25,0.2416171,-0.22349876,1,
Arhgef26,0.14660542,0.061394244,0,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'CDC42 GTPase cycle', 'RHOG GTPase cycle']"
Arhgef28,0.23576374,-0.31588572,1,
Arhgef3,0.16796462,-0.119449645,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle']"
Arhgef33,-0.0023548761,-0.044120487,2,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events']"
Arhgef37,0.3284116,-0.20742352,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events']"
Arhgef38,0.17885205,-0.077647194,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events']"
Arhgef39,0.33533806,-0.05581405,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RAC1 GTPase cycle']"
Arhgef4,0.2344757,-0.19358937,1,
Arhgef40,0.3181627,-0.19256684,1,
Arhgef5,0.1517208,-0.24936898,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOG GTPase cycle']"
Arhgef6,0.3215349,-0.26905233,1,
Arhgef7,0.49897927,-0.24447452,1,"['EGFR downregulation', 'NRAGE signals death through JNK', 'Ephrin signaling', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RAC1 GTPase cycle', 'RHOQ GTPase cycle', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Arhgef9,0.13348362,-0.1402917,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'CDC42 GTPase cycle', 'RHOQ GTPase cycle', 'GABA receptor activation']"
Arid1a,0.40438485,0.22837183,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Arid1b,0.27123696,0.31037593,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Arid2,0.20208819,0.30522355,3,
Arid3a,-0.13010727,-0.041209944,2,
Arid3b,0.024849225,0.045969974,2,
Arid3c,0.10284972,0.08732097,3,
Arid4a,0.2818924,0.45700604,3,['HDACs deacetylate histones']
Arid4b,0.18852128,0.2991668,3,['HDACs deacetylate histones']
Arid5a,0.22135347,0.22379795,3,
Arid5b,0.038428687,-0.0539019,2,['HDMs demethylate histones']
Arih1,0.36449605,0.12346575,3,['ISG15 antiviral mechanism']
Arih2,0.050055236,-0.11153085,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Arl1,-0.2682685,-0.08549745,2,['Retrograde transport at the Trans-Golgi-Network']
Arl10,-0.039486654,-0.09095162,2,
Arl11,0.008267525,-0.2017631,1,
Arl13a,-0.2659261,0.08323423,2,
Arl13b,0.13668703,0.13477774,3,"['ARL13B-mediated ciliary trafficking of INPP5E', 'RHOQ GTPase cycle', 'Aggrephagy']"
Arl14,-0.13912871,0.057703815,2,
Arl14ep,0.0032899536,0.112718485,2,
Arl14epl,-0.05975597,-0.17041734,2,
Arl15,-0.26017562,-0.089385875,2,
Arl16,-0.10503272,-0.06155054,2,
Arl2,0.06891189,0.13468944,3,"['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane', 'RAS processing']"
Arl2bp,-0.19358279,-0.025306722,2,['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane']
Arl3,-0.039725505,-0.08082382,2,['Trafficking of myristoylated proteins to the cilium']
Arl4a,-0.10940009,-0.17013176,2,
Arl4c,-0.005387363,-0.17939389,2,
Arl4d,0.1427671,-0.12019261,1,
Arl5a,-0.034824524,-0.041644875,2,
Arl5b,-0.0902256,-0.03617511,2,
Arl5c,-0.23125075,0.08030841,2,
Arl6,-0.15313874,-0.006248963,2,['BBSome-mediated cargo-targeting to cilium']
Arl6ip1,-0.21334127,-0.054200087,2,
Arl6ip4,-0.16372421,-0.17216939,2,
Arl6ip5,-0.23156023,-0.14583004,2,['Glutamate Neurotransmitter Release Cycle']
Arl8b,-0.11261114,-0.25985065,2,
Arl9,-0.13104527,-0.00025258234,2,
Armc1,0.013825601,0.13967952,0,
Armc10,-0.34048176,-0.08273395,2,
Armc12,-0.18299706,-0.13022777,2,
Armc2,-0.17863156,-0.09790345,2,
Armc3,-0.25942004,0.08677452,2,
Armc5,-0.20977181,0.123230465,2,
Armc6,-0.26756072,-0.10026965,2,
Armc7,-0.23144352,-0.21038899,2,
Armc8,-0.2235875,-0.08282106,2,['Neutrophil degranulation']
Armc9,-0.09515327,0.09532628,2,
Armcx1,-0.006434788,0.04991193,3,
Armcx2,-0.3917086,0.107537016,2,
Armcx3,-0.1253989,0.12713884,0,['RAC2 GTPase cycle']
Armh3,0.100243516,-0.14206474,1,
Armt1,-0.10848432,0.041091498,2,
Arnt,0.3460776,0.13648807,3,"['Regulation of gene expression by Hypoxia-inducible Factor', 'Phase I - Functionalization of compounds', 'Endogenous sterols', 'Xenobiotics', 'Aryl hydrocarbon receptor signalling']"
Arnt2,0.27897972,0.06181879,3,"['Phase I - Functionalization of compounds', 'Endogenous sterols', 'Xenobiotics', 'Aryl hydrocarbon receptor signalling']"
Arntl,0.42308614,0.13896899,3,
Arntl2,0.24914831,0.23183657,3,
Arpc1a,0.23211552,-0.042299237,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Clathrin-mediated endocytosis']"
Arpc1b,0.31692332,-0.16790652,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs']"
Arpc2,0.2509569,-0.15627602,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Clathrin-mediated endocytosis']"
Arpc3,0.28197086,-0.115916595,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Clathrin-mediated endocytosis']"
Arpc4,0.2161748,-0.06345933,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Clathrin-mediated endocytosis']"
Arpc5,0.25712112,-0.18919815,1,"['Regulation of actin dynamics for phagocytic cup formation', 'EPHB-mediated forward signaling', 'RHO GTPases Activate WASPs and WAVEs', 'Neutrophil degranulation', 'Clathrin-mediated endocytosis']"
Arpc5l,0.09993868,-0.05032858,1,
Arpin,-0.20567812,0.1070152,2,
Arpp19,-0.10989995,0.105500914,2,['MASTL Facilitates Mitotic Progression']
Arpp21,-0.31971338,-0.09589204,2,
Arr3,0.22176647,-0.32325,1,
Arrb1,0.49512547,-0.29072687,1,"['G alpha (s) signalling events', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Activation of SMO', 'MAP2K and MAPK activation', 'Ub-specific processing proteases', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Arrb2,0.44508868,-0.31443655,1,"['G alpha (s) signalling events', 'Thrombin signalling through proteinase activated receptors (PARs)', 'WNT5A-dependent internalization of FZD4', 'Activation of SMO', 'MAP2K and MAPK activation', 'Ub-specific processing proteases', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Arrdc1,0.04375467,0.19147465,3,
Arrdc2,-0.14500253,-0.16870232,2,
Arrdc3,0.15578082,-0.21876936,1,
Arrdc4,-0.110347964,-0.28766462,2,
Arrdc5,-0.16244005,0.028383786,2,
Arsa,-0.11500108,0.015005822,2,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases', 'Neutrophil degranulation']"
Arsb,-0.17177811,-0.09783351,2,
Arsg,-0.1499138,0.05722306,2,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases']"
Arsi,0.07655508,0.05042462,3,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases']"
Arsj,-0.31351212,0.036387905,2,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases']"
Arsk,-0.31069937,0.12637208,2,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases']"
Art1,-0.39896974,-0.1636176,2,['Alpha-defensins']
Art2b,0.03278986,0.035635244,2,
Art5,-0.19118662,-0.036533482,2,
Artn,0.3781181,-0.27836475,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Arv1,-0.09028865,-0.21308212,2,['Cholesterol biosynthesis']
Arx,-0.14508171,0.015244376,2,
Arxes1,-0.14350918,-0.2079827,2,
Arxes2,-0.14356932,0.06267673,2,
As3mt,-0.30902624,-0.025113007,2,['Methylation']
Asah1,-0.2713333,-0.1709033,2,"['Glycosphingolipid metabolism', 'Neutrophil degranulation']"
Asah2,-0.20311545,-0.0731728,2,['Glycosphingolipid metabolism']
Asap1,0.26131415,-0.3024521,1,['VxPx cargo-targeting to cilium']
Asap2,0.06750287,-0.33308074,1,
Asap3,0.1976733,0.0025304533,1,
Asb1,0.07520114,0.0049882177,1,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb10,-0.3960883,0.11184542,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb11,0.0077022375,0.053751286,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb12,-0.0060660574,-0.07078546,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb13,-0.09151673,0.0941087,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb14,-0.2009477,-0.15960962,2,
Asb15,-0.08965481,0.0912825,2,
Asb16,-0.15503912,0.068939604,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb17,-0.026413819,0.079743445,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb18,0.05126166,0.16638316,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb2,0.19476902,-0.0643529,1,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb3,-0.10676921,-0.007919452,2,
Asb4,0.08691089,-0.06835562,1,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb6,0.12773688,0.08271726,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb7,-0.074085005,0.13735738,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Asb8,-0.12221182,0.028068846,2,
Asb9,0.10684833,-0.016291322,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ascc1,-0.07895895,0.034152497,2,
Ascc2,-0.12316631,0.1445186,2,
Ascc3,-0.2545867,0.16616537,2,
Ascl1,0.14289989,-0.04260938,3,
Ascl2,0.29757142,0.07141935,3,
Ascl3,0.12100027,-0.0076090684,3,
Asf1a,0.3468823,0.37947956,3,['Formation of Senescence-Associated Heterochromatin Foci (SAHF)']
Asf1b,0.2830953,0.4460527,3,
Asgr1,0.07470641,-0.1428026,1,['Asparagine N-linked glycosylation']
Asgr2,-0.15794657,0.00028266924,2,['Asparagine N-linked glycosylation']
Ash1l,0.20678209,0.39702737,3,['PKMTs methylate histone lysines']
Ash2l,0.40417922,0.31677768,3,"['Formation of the beta-catenin:TCF transactivating complex', 'PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Asic1,0.029650807,-0.02585444,1,['Stimuli-sensing channels']
Asic2,-0.015323434,0.11422158,2,['Stimuli-sensing channels']
Asic3,-0.012340294,-0.06961216,2,['Stimuli-sensing channels']
Asic5,-0.051205143,0.11527898,2,['Stimuli-sensing channels']
Asl,-0.0015200798,-0.11346301,2,['Urea cycle']
Asmt,-0.21725781,-0.18268935,2,
Asns,-0.14077961,-0.0003646849,2,['Aspartate and asparagine metabolism']
Aspa,-0.26680169,-0.28593794,2,['Aspartate and asparagine metabolism']
Aspdh,-0.1447317,-0.096584246,2,
Aspg,-0.38689187,-0.14987777,2,['Aspartate and asparagine metabolism']
Asph,0.054166302,-0.13778606,1,"['Stimuli-sensing channels', 'Ion homeostasis']"
Asphd1,-0.004889211,0.071228296,3,
Asphd2,-0.23506807,-0.07495044,2,
Aspm,0.2427297,0.4228456,3,
Aspn,-0.089896336,-0.3723751,1,
Asprv1,-0.04326224,0.17717111,3,
Aspscr1,0.07063746,0.10308147,3,
Asrgl1,-0.2213742,-0.27193007,2,['Phenylalanine metabolism']
Ass1,-0.10126452,-0.35018435,1,['Urea cycle']
Aste1,-0.1823157,0.028931413,2,
Astl,-0.24000882,0.094515,2,
Astn1,-0.23451588,0.06613321,2,
Asxl1,0.3052698,0.25947785,3,['UCH proteinases']
Asxl2,0.2922737,0.42874646,3,
Asxl3,0.0033913418,0.08146594,2,
Asz1,-0.033136323,0.03968368,2,
Atad1,-0.3726582,0.08438906,2,['Class I peroxisomal membrane protein import']
Atad2,0.16678192,0.22777326,3,['TFAP2 (AP-2) family regulates transcription of growth factors and their receptors']
Atad2b,0.069346815,0.32729658,3,
Atad3a,-0.07471262,0.19307552,0,['Neutrophil degranulation']
Atad5,0.21654946,0.5117956,3,
Atcay,-0.102425925,0.044955645,2,
Ate1,-0.14434326,-0.023303961,2,
Atf1,0.22593854,-0.22554779,1,['CREB phosphorylation']
Atf2,0.59842455,0.008831809,3,"['HATs acetylate histones', 'Activation of the AP-1 family of transcription factors']"
Atf3,0.40583894,0.17150964,3,
Atf4,0.30113593,0.054399136,3,
Atf5,-0.09933593,0.035122,0,
Atf6,0.3396223,-0.08670311,1,['ATF6 (ATF6-alpha) activates chaperones']
Atf6b,0.25321653,-0.027318373,1,
Atf7,0.17908229,0.07559935,3,
Atf7ip,0.077136755,0.27223343,3,['PKMTs methylate histone lysines']
Atf7ip2,-0.021630235,0.19922751,3,
Atg10,0.107678205,-0.0039182263,3,
Atg101,0.09683176,0.014265073,3,['Macroautophagy']
Atg12,0.26335838,0.06438419,3,"['Macroautophagy', 'PINK1-PRKN Mediated Mitophagy', 'Receptor Mediated Mitophagy']"
Atg13,0.16150337,-0.013990365,3,['Macroautophagy']
Atg14,0.14108211,-0.12594093,1,['Macroautophagy']
Atg16l1,0.12144345,-0.1197093,3,['Macroautophagy']
Atg16l2,0.098234855,0.09645019,3,
Atg2a,-0.0104269935,-0.17410326,2,
Atg2b,-0.055519786,0.05714121,3,
Atg3,0.18392944,0.055894498,3,['Macroautophagy']
Atg4a,0.08795643,0.03422447,3,['Macroautophagy']
Atg4b,0.09192572,-0.13435149,1,
Atg4c,0.056946065,-0.045005307,2,['Macroautophagy']
Atg4d,0.04267198,-0.06567541,2,['Macroautophagy']
Atg5,0.3974264,-0.023740068,3,"['Macroautophagy', 'PINK1-PRKN Mediated Mitophagy', 'Receptor Mediated Mitophagy']"
Atg7,0.37410176,0.15141232,3,"['Macroautophagy', 'Neutrophil degranulation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Atg9a,0.18062139,-0.023326207,3,['Macroautophagy']
Atg9b,0.18166448,-0.00014916218,3,['Macroautophagy']
Atic,0.03575587,0.029545154,2,['Purine ribonucleoside monophosphate biosynthesis']
Atl1,-0.14944243,-0.20650488,2,
Atl2,-0.28950626,0.018542355,2,
Atl3,-0.04308253,-0.26558036,2,
Atm,0.5361974,0.33105606,3,"['DNA Damage/Telomere Stress Induced Senescence', 'Autodegradation of the E3 ubiquitin ligase COP1', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Sensing of DNA Double Strand Breaks', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Nonhomologous End-Joining (NHEJ)', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'TP53 Regulates Transcription of Genes Involved in Cytochrome C Release', 'TP53 Regulates Transcription of Caspase Activators and Caspases', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'G2/M DNA damage checkpoint', 'Stabilization of p53', 'Pexophagy']"
Atmin,0.124790885,0.094602,3,
Atn1,0.18780133,0.15351105,0,
Atoh1,0.1085591,-0.027287258,3,
Atoh7,-0.08891649,-0.09166187,2,
Atox1,-0.22392765,-0.3594088,2,['Ion influx/efflux at host-pathogen interface']
Atp10a,-0.06274122,0.102725215,2,['Ion transport by P-type ATPases']
Atp10b,-0.050024077,-0.06101792,2,['Ion transport by P-type ATPases']
Atp11a,-0.1761868,-0.036919516,2,"['Neutrophil degranulation', 'Ion transport by P-type ATPases']"
Atp11b,0.02945348,0.17768651,0,"['Neutrophil degranulation', 'Ion transport by P-type ATPases']"
Atp11c,-0.14514284,-0.058018256,2,['Ion transport by P-type ATPases']
Atp12a,-0.10702373,-0.109113425,2,['Ion transport by P-type ATPases']
Atp13a1,-0.19760454,0.03446705,2,['Ion transport by P-type ATPases']
Atp13a2,-0.053874347,-0.26070043,1,['Ion transport by P-type ATPases']
Atp1a1,0.049525626,-0.18550332,1,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1a2,-0.006723693,-0.2662304,1,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1a3,0.055368442,-0.16234599,1,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1a4,-0.11851737,-0.17925133,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1b1,-0.2680481,-0.23871675,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1b2,-0.03284007,-0.16782402,1,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1b3,-0.058512498,-0.24149717,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp1b4,0.044648502,-0.16567902,2,['Downregulation of SMAD2/3:SMAD4 transcriptional activity']
Atp23,-0.057186972,-0.11687027,2,
Atp2a1,-0.005360508,-0.13616732,1,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2a2,0.11793229,-0.47290322,1,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2a3,0.18834804,-0.26151034,1,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2b1,0.08190266,0.0026444667,3,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2b2,0.10351189,-0.22107756,1,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2b3,-0.07483566,-0.20624,2,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2b4,0.15554523,-0.40030432,1,"['Reduction of cytosolic Ca++ levels', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Atp2c1,-0.16435748,0.006788704,2,['Ion transport by P-type ATPases']
Atp2c2,-0.15854122,-0.1770393,2,['Ion transport by P-type ATPases']
Atp4a,-0.061303668,-0.14066815,2,
Atp4b,-0.03708654,-0.07984727,2,['Ion transport by P-type ATPases']
Atp5a1,0.21789035,0.05000548,3,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5b,0.10532096,-0.1199233,1,"['Mitochondrial protein import', 'Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5c1,0.14032501,0.058103755,3,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5d,0.05096288,-0.031803556,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5e,-0.03678899,-0.15760905,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5g1,-0.066602886,-0.025776342,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5g2,-0.046333283,-0.18417905,2,
Atp5g3,0.0043593785,-0.09382229,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5h,0.09050221,-0.040503528,1,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5j,-0.020992257,-0.102886125,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5j2,-0.08932696,-0.18312031,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5k,0.015552577,0.10044346,0,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5l,0.0096724685,-0.0765103,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5md,-0.09648244,-0.10911948,2,
Atp5mpl,0.0048401537,-0.13136165,2,
Atp5o,0.12175345,0.012458866,3,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp5pb,0.073693536,-0.0065080244,1,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Atp6ap1,0.1260974,-0.23518492,1,"['Insulin receptor recycling', 'RHOA GTPase cycle', 'Transferrin endocytosis and recycling', 'Ion channel transport']"
Atp6ap1l,-0.20803027,-0.017194342,2,
Atp6ap2,0.055703133,-0.1558709,1,"['Metabolism of Angiotensinogen to Angiotensins', 'Neutrophil degranulation']"
Atp6v0a1,-0.15247203,-0.20266546,2,"['ROS and RNS production in phagocytes', 'Neutrophil degranulation', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Ion channel transport']"
Atp6v0a2,-0.08950691,0.014242737,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Ion channel transport']"
Atp6v0a4,-0.07401885,0.033043113,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Ion channel transport']"
Atp6v0b,-0.105383225,0.069832884,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v0c,-0.0023803734,-0.0044170297,2,"['ROS and RNS production in phagocytes', 'Neutrophil degranulation', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v0d1,-0.17904438,-0.066108346,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v0d2,0.23186152,-0.17165402,1,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v0e,-0.20543784,0.0014960532,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v0e2,-0.075505555,0.032390606,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1a,-0.0503575,-0.11047241,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1b1,-0.106200166,0.03423737,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1b2,-0.05918729,0.049406584,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1c1,0.013116793,-0.16445233,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1c2,-0.124146156,0.01635623,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1d,-0.088313915,-0.11492264,2,"['ROS and RNS production in phagocytes', 'Neutrophil degranulation', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1e1,-0.2009576,0.042763643,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1e2,-0.06160568,0.02339679,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1f,-0.057498645,-0.020955175,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1g1,-0.022585168,-0.0107903825,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1g2,-0.11251946,0.022328176,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1g3,-0.08845675,0.04732871,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp6v1h,-0.09526464,0.054513253,2,"['ROS and RNS production in phagocytes', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Atp7a,-0.05827921,0.053637404,2,"['Ion influx/efflux at host-pathogen interface', 'Ion transport by P-type ATPases']"
Atp7b,-0.047738176,-0.13405322,2,['Ion transport by P-type ATPases']
Atp8a1,-0.060757745,-0.08626227,2,"['Neutrophil degranulation', 'Ion transport by P-type ATPases']"
Atp8a2,-0.21160366,-0.12688307,2,['Ion transport by P-type ATPases']
Atp8b1,-0.20341638,-0.12286361,2,['Ion transport by P-type ATPases']
Atp8b2,-0.053039577,-0.06148949,2,['Ion transport by P-type ATPases']
Atp8b3,-0.16296555,-0.047794983,2,['Ion transport by P-type ATPases']
Atp8b4,-0.17701246,0.058667745,2,"['Neutrophil degranulation', 'Ion transport by P-type ATPases']"
Atp8b5,-0.060024727,0.06653772,2,
Atp9a,-0.11147241,0.09391483,2,['Ion transport by P-type ATPases']
Atp9b,-0.11879395,0.015535373,2,
Atpaf1,-0.058080297,-0.037968192,2,
Atpaf2,-0.15456986,-0.23501854,2,
Atpif1,-0.107317835,-0.07036195,2,
Atpsckmt,-0.14805263,0.119322464,2,
Atr,0.37608552,0.40913463,3,
Atraid,-0.23060766,-0.091138914,2,
Atrip,0.2875817,0.4161075,3,"['Activation of ATR in response to replication stress', 'HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Fanconi Anemia Pathway', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Atrn,-0.18079858,-0.12604757,2,
Atrnl1,-0.01895246,-0.025011582,2,
Atrx,0.27166283,0.34433153,3,['Inhibition of DNA recombination at telomere']
Atxn1,0.22428064,0.3554792,3,
Atxn10,0.049370155,0.02784838,3,
Atxn1l,0.058790557,0.21668237,0,
Atxn2,0.51680565,0.16318977,3,
Atxn2l,0.12176255,0.28202468,3,
Atxn3,0.36127886,0.12227169,3,"['Josephin domain DUBs', 'FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes']"
Atxn7,0.30234468,0.17571117,3,['Ub-specific processing proteases']
Atxn7l1,0.20542061,0.19755007,3,
Atxn7l2,-0.005587917,0.13690995,0,
Atxn7l3,-0.012777006,0.30510384,3,
Auh,-0.4399848,-0.06657754,2,
Aup1,-0.07265542,-0.0032468436,2,
Aurka,0.44228575,0.32995084,3,"['APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Regulation of PLK1 Activity at G2/M Transition', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'Regulation of TP53 Activity through Phosphorylation', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'AURKA Activation by TPX2', 'Interaction between PHLDA1 and AURKA']"
Aurkaip1,0.19086194,0.27079973,3,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Aurkb,0.44391003,0.48879886,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA replication proteins', 'RHO GTPases Activate Formins', 'Regulation of TP53 Activity through Phosphorylation', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Aurkc,0.18715066,0.35703626,3,
Aven,0.097695686,0.049809188,3,"['Formation of apoptosome', 'Regulation of the apoptosome activity']"
Avil,-0.18674377,0.05954189,2,
Avl9,-0.023389602,0.07824387,2,
Avp,0.25426957,-0.080843344,1,"['Vasopressin-like receptors', 'G alpha (q) signalling events', 'G alpha (s) signalling events', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Transport of organic anions', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Avpr1a,0.054215472,-0.22609018,1,"['Vasopressin-like receptors', 'G alpha (q) signalling events']"
Avpr1b,0.0062339515,-0.22689168,1,"['Vasopressin-like receptors', 'G alpha (q) signalling events']"
Avpr2,0.08118045,-0.32646737,1,"['Vasopressin-like receptors', 'G alpha (s) signalling events', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Awat1,-0.11531883,0.09172335,2,"['Arachidonic acid metabolism', 'Wax biosynthesis']"
Awat2,-0.18890056,-0.124647744,2,"['Acyl chain remodeling of DAG and TAG', 'The retinoid cycle in cones (daylight vision)', 'Wax biosynthesis']"
Axdnd1,-0.07038389,-0.04906579,2,
Axin1,0.39545038,-0.086799674,3,"['Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'TCF dependent signaling in response to WNT', 'Degradation of AXIN', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'Ub-specific processing proteases']"
Axin2,0.20707346,0.16485631,3,"['TCF dependent signaling in response to WNT', 'Degradation of AXIN', 'Ub-specific processing proteases']"
Axl,0.47825778,-0.33178777,1,['VEGFA-VEGFR2 Pathway']
Azgp1,-0.03734825,-0.08830595,2,['Miscellaneous transport and binding events']
Azi2,0.15037273,0.17205565,3,
Azin1,0.026606835,-0.06605203,2,['Regulation of ornithine decarboxylase (ODC)']
Azin2,0.09128958,-0.047534797,2,['Agmatine biosynthesis']
B230219D22Rik,-0.13525814,0.07049243,2,
B2m,0.23182778,-0.112296656,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'DAP12 interactions', 'DAP12 signaling', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
B3galnt1,-0.3195788,-0.22717261,2,['Glycosphingolipid metabolism']
B3galnt2,-0.22728826,-0.29621825,2,['O-linked glycosylation']
B3galt1,-0.12984845,-0.22017129,2,['Lewis blood group biosynthesis']
B3galt2,-0.27318203,-0.23224129,2,['Lewis blood group biosynthesis']
B3galt4,-0.0665825,-0.030459242,2,['Lewis blood group biosynthesis']
B3galt5,-0.08144217,-0.16328476,2,['Lewis blood group biosynthesis']
B3galt6,-0.1230907,-0.19737558,1,['A tetrasaccharide linker sequence is required for GAG synthesis']
B3gat1,-0.11988814,-0.24419715,2,['A tetrasaccharide linker sequence is required for GAG synthesis']
B3gat2,-0.16438927,-0.1664088,2,['A tetrasaccharide linker sequence is required for GAG synthesis']
B3gat3,-0.06636596,-0.24204087,1,['A tetrasaccharide linker sequence is required for GAG synthesis']
B3glct,-0.07176746,-0.013226222,2,['O-glycosylation of TSR domain-containing proteins']
B3gnt2,-0.13822238,-0.15479434,2,"['Keratan sulfate biosynthesis', 'O-linked glycosylation of mucins']"
B3gnt3,-0.12794398,-0.0055813654,2,"['Keratan sulfate biosynthesis', 'O-linked glycosylation of mucins']"
B3gnt4,-0.19390525,-0.17635456,2,"['Keratan sulfate biosynthesis', 'O-linked glycosylation of mucins']"
B3gnt5,-0.23820421,-0.1376754,2,['O-linked glycosylation of mucins']
B3gnt6,-0.027101355,-0.14022386,2,['O-linked glycosylation of mucins']
B3gnt7,-0.15471503,-0.15924409,2,"['Keratan sulfate biosynthesis', 'O-linked glycosylation of mucins']"
B3gnt8,-0.14139672,-0.03748525,2,['O-linked glycosylation of mucins']
B3gnt9,0.03843588,-0.13587895,2,['O-linked glycosylation of mucins']
B3gntl1,-0.09547282,-0.21261291,2,['O-linked glycosylation of mucins']
B4galnt1,-0.12642373,-0.0062315166,2,['Glycosphingolipid metabolism']
B4galnt2,-0.2089112,-0.21599224,2,"['Asparagine N-linked glycosylation', 'Lewis blood group biosynthesis']"
B4galnt3,-0.2152788,-0.30292395,2,
B4galnt4,-0.23802225,-0.066364154,2,
B4galt1,-0.22311041,-0.21221396,2,"['Keratan sulfate biosynthesis', 'Interaction With Cumulus Cells And The Zona Pellucida', 'Lactose synthesis', 'Neutrophil degranulation', 'N-Glycan antennae elongation']"
B4galt2,-0.40105852,-0.18398868,2,"['Keratan sulfate biosynthesis', 'N-Glycan antennae elongation']"
B4galt3,-0.18513493,0.008605175,2,"['Keratan sulfate biosynthesis', 'N-Glycan antennae elongation']"
B4galt4,-0.01517432,-0.07764056,2,"['Keratan sulfate biosynthesis', 'N-Glycan antennae elongation']"
B4galt5,-0.06879744,-0.10210918,2,"['Keratan sulfate biosynthesis', 'O-linked glycosylation of mucins', 'N-Glycan antennae elongation']"
B4galt6,-0.1954565,-0.16677117,2,"['Keratan sulfate biosynthesis', 'O-linked glycosylation of mucins', 'N-Glycan antennae elongation']"
B4galt7,-0.14997508,-0.10621263,2,['A tetrasaccharide linker sequence is required for GAG synthesis']
B4gat1,0.03268094,-0.11440295,1,"['Keratan sulfate biosynthesis', 'O-linked glycosylation']"
B630019K06Rik,0.037846055,0.18328357,3,
B9d1,-0.12835748,0.069766,2,['Anchoring of the basal body to the plasma membrane']
B9d2,-0.16066542,0.15483129,2,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
BC005624,-0.21253663,0.049110178,2,
BC025920,-0.061744273,-0.20084189,2,
BC028528,-0.10272167,0.027852383,2,
BC034090,0.06980347,-0.2457707,1,
BC048507,0.11866164,0.23630689,3,
BC048562,-0.089522496,0.06521759,2,
BC048679,-0.14433907,-0.20683219,2,
BC051665,-0.019431531,-0.15950257,1,
BC055324,-0.16142206,0.22149186,2,
BC147527,-0.22328065,0.07648907,2,
Baat,-0.15630239,-0.25459093,2,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Peroxisomal protein import']"
Babam1,0.23063938,0.15434188,3,"['Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Babam2,0.20424059,0.13908394,3,"['Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Bace1,0.3374197,-0.20423897,1,
Bace2,-0.04655105,-0.265899,2,
Bach1,0.09811416,0.10929214,3,"['Heme signaling', 'Regulation of BACH1 activity']"
Bach2,0.11128649,0.0443321,3,
Bad,0.41606683,-0.11394249,1,"['Activation of BAD and translocation to mitochondria ', 'BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'NRAGE signals death through JNK']"
Bag1,0.2095941,0.14613,3,['Regulation of HSF1-mediated heat shock response']
Bag2,-0.046669196,0.1655441,0,['Regulation of HSF1-mediated heat shock response']
Bag3,0.1582185,0.14348753,3,['Regulation of HSF1-mediated heat shock response']
Bag4,0.28429976,0.015287838,3,"['Regulation of HSF1-mediated heat shock response', 'TNF signaling']"
Bag5,0.10390471,0.047888417,3,['Regulation of HSF1-mediated heat shock response']
Bag6,0.006094682,0.070177846,3,
Bahd1,0.16223845,0.23720409,3,
Baiap2,0.32583368,-0.25456947,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Baiap2l1,0.2689313,-0.2492312,1,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Baiap2l2,-0.03549329,-0.30841446,1,['RHOF GTPase cycle']
Baiap3,-0.17525032,-0.22000277,2,
Bak1,0.25724083,-0.0749499,3,"['Activation and oligomerization of BAK protein', 'Release of apoptotic factors from the mitochondria', 'Pyroptosis']"
Bambi,0.0431274,0.0041332743,2,['Downregulation of TGF-beta receptor signaling']
Banf1,0.32236874,0.4288723,3,"['Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation']"
Bank1,0.07455934,-0.40020922,1,
Banp,0.22372207,0.001781778,3,['Regulation of TP53 Activity through Association with Co-factors']
Bap1,0.28732607,0.32338035,3,"['UCH proteinases', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']"
Bard1,0.38345644,0.37333506,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'UCH proteinases', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Nonhomologous End-Joining (NHEJ)', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Barhl1,-0.2895123,-0.030709127,2,
Barhl2,-0.22214137,0.0052988236,2,
Barx1,-0.02248713,-0.11257965,2,
Basp1,0.2989824,0.011082661,3,['RHOF GTPase cycle']
Batf,0.31962606,0.045571875,1,
Batf2,0.018478252,-0.040260542,2,
Batf3,0.35417452,-0.005768727,1,
Bax,0.30352002,-0.1334059,3,"['Release of apoptotic factors from the mitochondria', 'Activation, translocation and oligomerization of BAX', 'Pyroptosis', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest']"
Baz1a,0.21272491,0.18060891,3,
Baz1b,0.170175,0.33719474,3,['B-WICH complex positively regulates rRNA expression']
Baz2a,0.22841446,0.42297766,3,
Baz2b,0.22458866,0.23283795,3,
Bbc3,0.2340423,-0.0043865573,3,
Bbip1,-0.30563533,0.18910992,2,
Bbof1,-0.26513207,0.21444732,2,
Bbox1,-0.05843837,-0.13564882,2,['Carnitine synthesis']
Bbs1,-0.058690988,-0.046450928,2,['BBSome-mediated cargo-targeting to cilium']
Bbs10,-0.02112744,0.41700423,0,
Bbs12,-0.14141154,0.20830244,2,
Bbs2,-0.14202945,0.0466823,2,['BBSome-mediated cargo-targeting to cilium']
Bbs4,0.0027864277,-0.059572905,2,['BBSome-mediated cargo-targeting to cilium']
Bbs5,-0.08690089,0.106126755,2,['BBSome-mediated cargo-targeting to cilium']
Bbs7,-0.07540574,0.14141168,2,['BBSome-mediated cargo-targeting to cilium']
Bbs9,-0.095318876,0.18004258,2,['BBSome-mediated cargo-targeting to cilium']
Bbx,0.10565376,-0.020162186,1,
Bcam,-0.27496165,-0.15673022,2,
Bcan,0.014136753,-0.17312469,1,"['Degradation of the extracellular matrix', 'A tetrasaccharide linker sequence is required for GAG synthesis', 'Chondroitin sulfate biosynthesis', 'Dermatan sulfate biosynthesis', 'CS/DS degradation', 'ECM proteoglycans']"
Bcap29,-0.1488938,-0.24499229,2,
Bcap31,0.05924292,-0.1831282,1,"['Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase', 'RHOA GTPase cycle', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Bcar1,0.55197406,-0.26770204,1,"['Downstream signal transduction', 'p130Cas linkage to MAPK signaling for integrins', 'VEGFA-VEGFR2 Pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases']"
Bcar3,0.13183731,-0.029691873,1,
Bcas1,-0.049051277,-0.094052695,2,
Bcas2,-0.19963276,0.2162848,0,['mRNA Splicing - Major Pathway']
Bcas3,-0.052927826,-0.064020306,2,
Bcat1,-0.23817544,0.12440687,2,['Branched-chain amino acid catabolism']
Bcat2,-0.4253377,0.061559048,2,['Branched-chain amino acid catabolism']
Bccip,-0.03461763,0.56766737,0,
Bche,0.21067388,-0.18235151,1,"['Synthesis, secretion, and deacylation of Ghrelin', 'Aspirin ADME']"
Bckdha,-0.23044856,0.050790448,2,
Bckdhb,-0.24741954,0.17683777,2,"['Glyoxylate metabolism and glycine degradation', 'Branched-chain amino acid catabolism']"
Bckdk,-0.3702085,-0.022320494,2,['Branched-chain amino acid catabolism']
Bcl10,0.38206986,-0.09313998,1,"['Activation of NF-kappaB in B cells', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'CLEC7A (Dectin-1) signaling', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Bcl11a,0.0533949,0.12840004,3,
Bcl11b,0.37967986,0.023283523,3,
Bcl2,0.3833843,0.014864244,3,"['Activation of BAD and translocation to mitochondria ', 'BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'The NLRP1 inflammasome']"
Bcl2a1a,0.3355709,0.034542993,3,
Bcl2a1b,0.02284998,-0.026426135,2,
Bcl2a1c,-0.113707006,0.033925112,2,
Bcl2a1d,0.062265877,0.20354508,3,
Bcl2l1,0.42674205,0.087633766,3,"['BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'The NLRP1 inflammasome', 'RAS processing']"
Bcl2l10,0.120258786,-0.04516819,1,
Bcl2l11,0.35081404,-0.12792957,1,"['Activation of BIM and translocation to mitochondria ', 'BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'NRAGE signals death through JNK']"
Bcl2l12,-0.020857496,0.13688421,3,
Bcl2l13,-0.123528995,-0.1356014,2,
Bcl2l14,-0.022810597,0.048565045,0,
Bcl2l15,-0.18824166,0.10920357,2,
Bcl2l2,0.1686693,0.016467676,3,
Bcl3,0.419929,0.06104746,1,
Bcl6,0.42543095,-0.23231427,1,
Bcl6b,0.14920673,-0.023441866,1,
Bcl7a,0.01638229,0.08144497,2,
Bcl7b,0.084521495,0.15232366,3,
Bcl7c,0.05631478,0.28459162,3,
Bcl9,0.19783694,0.16778949,3,['Formation of the beta-catenin:TCF transactivating complex']
Bcl9l,0.09901073,0.12588763,3,['Formation of the beta-catenin:TCF transactivating complex']
Bclaf1,0.20144892,0.16343968,3,
Bco1,-0.14594093,0.0060909158,2,['Retinoid metabolism and transport']
Bcor,0.22713894,0.15537353,3,
Bcorl1,0.12567364,-0.03585889,3,
Bcr,0.43551257,-0.34104186,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Bcs1l,-0.070982136,-0.029075813,2,
Bdh1,-0.21900508,0.04213871,2,"['Utilization of Ketone Bodies', 'Synthesis of Ketone Bodies']"
Bdh2,-0.13229638,-0.009086758,2,['Synthesis of Ketone Bodies']
Bdkrb1,0.16199954,-0.28959677,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Bdkrb2,0.08971711,-0.17469525,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Bdnf,0.5088981,-0.34891745,1,"['Activated NTRK2 signals through PLCG1', 'Activated NTRK2 signals through FRS2 and FRS3', 'NTRK2 activates RAC1']"
Bdp1,0.1510446,0.22085603,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Becn1,0.4175606,-0.16534518,1,"['Macroautophagy', 'Ub-specific processing proteases']"
Begain,0.06498124,-0.057584677,1,
Bend3,-0.04343811,0.102568895,2,
Bend6,-0.015328128,0.036523614,2,
Bend7,-0.13728382,0.047891937,2,
Best1,-0.115624584,0.044444956,2,['Stimuli-sensing channels']
Best2,-0.091968775,0.015407941,2,
Best3,-0.14508875,0.08518216,2,['Stimuli-sensing channels']
Bet1,-0.09651498,-0.26380262,1,"['COPII-mediated vesicle transport', 'COPI-mediated anterograde transport']"
Bet1l,-0.10857039,-0.12744835,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic']"
Bex1,-0.063565634,-0.12158051,2,
Bex2,-0.02153264,-0.054063413,2,
Bex3,0.20757963,0.013093637,3,['NADE modulates death signalling']
Bfar,-0.057181448,0.10898024,2,
Bfsp1,-0.045238927,0.0047835335,2,
Bfsp2,-0.06927028,-0.12940495,2,
Bglap,0.32092005,-0.31101832,1,
Bglap2,0.31127882,-0.21119797,1,"['Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins']"
Bglap3,0.09182517,-0.15177082,1,
Bgn,0.08970131,-0.29150325,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'Chondroitin sulfate biosynthesis', 'Dermatan sulfate biosynthesis', 'CS/DS degradation', 'ECM proteoglycans']"
Bhlhb9,-0.20282838,0.09024608,2,
Bhlhe22,-0.060554676,0.24058822,3,
Bhlhe23,-0.009227159,-0.02442833,2,
Bhlhe40,0.11480096,0.037398238,3,
Bhlhe41,0.16642189,0.20754698,3,
Bhmt,-0.265861,-0.08562678,2,"['Sulfur amino acid metabolism', 'Choline catabolism']"
Bhmt2,-0.07830733,-0.13322979,2,['Sulfur amino acid metabolism']
Bicc1,-0.2562909,0.14110321,2,
Bicd1,0.11216365,0.11541741,3,['COPI-independent Golgi-to-ER retrograde traffic']
Bicd2,-0.042727917,0.1268809,2,['COPI-independent Golgi-to-ER retrograde traffic']
Bicdl1,-0.12334692,-0.13261591,2,
Bicdl2,-0.21072939,0.12985036,2,
Bicra,0.011829381,0.28101528,3,
Bicral,0.07210783,0.23035856,3,
Bid,0.32649213,-0.07919187,1,"['Activation of BAD and translocation to mitochondria ', 'Activation and oligomerization of BAK protein', 'BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'Activation, translocation and oligomerization of BAX', 'Activation, myristolyation of BID and translocation to mitochondria']"
Bik,0.19947836,0.07813708,3,
Bin1,0.25794992,-0.2776049,1,['Clathrin-mediated endocytosis']
Bin2,0.08495698,-0.23453835,1,
Bin3,0.10021944,-0.13982381,1,
Birc2,0.4269652,0.15027459,3,"['Apoptotic cleavage of cellular proteins', 'NOD1/2 Signaling Pathway', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'TNFR2 non-canonical NF-kB pathway', 'Regulation of necroptotic cell death', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway', 'Ub-specific processing proteases', 'IKK complex recruitment mediated by RIP1']"
Birc3,0.3896962,0.1607119,3,
Birc5,0.31134224,0.44779322,3,
Birc6,0.25522217,0.18513152,3,
Birc7,0.2820806,0.15266019,3,
Blcap,-0.19719091,0.063035786,2,
Blk,0.38821998,-0.2879354,1,
Blm,0.27058044,0.39100882,3,"['Processive synthesis on the C-strand of the telomere', 'SUMOylation of DNA damage response and repair proteins', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Blmh,-0.1951682,-0.011903073,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Blnk,0.16780077,-0.26168525,1,['Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']
Bloc1s1,-0.045655314,-0.1970124,1,"['Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis']"
Bloc1s2,-0.025564479,-0.08212303,2,
Bloc1s3,0.049269605,-0.05520609,2,['Golgi Associated Vesicle Biogenesis']
Bloc1s4,-0.086044244,-0.17481388,2,['Golgi Associated Vesicle Biogenesis']
Bloc1s5,0.010987139,0.09397333,2,
Bloc1s6,-0.1370318,-0.0019473397,2,['Golgi Associated Vesicle Biogenesis']
Blvra,0.03305314,-0.047139462,2,"['Heme degradation', 'Cytoprotection by HMOX1']"
Blvrb,-0.28904277,-0.116595335,2,"['Heme degradation', 'Cytoprotection by HMOX1']"
Blzf1,0.17704345,-0.20621103,1,['Golgi Cisternae Pericentriolar Stack Reorganization']
Bmerb1,-0.15857837,0.050078984,2,
Bmf,0.13421762,-0.12296539,1,"['BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'Activation of BMF and translocation to mitochondria']"
Bmi1,0.49242127,0.19433117,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Bmp1,0.15794234,-0.30845028,1,"['Collagen biosynthesis and modifying enzymes', 'Anchoring fibril formation', 'Crosslinking of collagen fibrils', 'HDL assembly']"
Bmp10,-0.0027190216,-0.10956449,2,"['Signaling by BMP', 'Molecules associated with elastic fibres']"
Bmp15,0.0036797365,0.033655956,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Bmp2,0.21808416,-0.09931527,1,"['Signaling by BMP', 'Molecules associated with elastic fibres']"
Bmp2k,0.06952186,-0.32645893,1,
Bmp3,0.0034768935,0.04547078,2,
Bmp4,0.26349318,-0.02671669,3,"['Molecules associated with elastic fibres', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Bmp5,-0.06142396,0.087989934,2,
Bmp6,-0.004857328,-0.12062815,2,
Bmp7,0.22146983,-0.032437727,3,['Molecules associated with elastic fibres']
Bmp8a,-0.021112796,-0.05012673,2,
Bmp8b,-0.21195853,0.099357106,2,
Bmper,-0.15594646,0.06479233,2,
Bmpr1a,0.19054434,0.065716594,3,['Signaling by BMP']
Bmpr1b,0.20286742,0.035343297,3,['Signaling by BMP']
Bmpr2,0.22417735,-0.04989743,1,['Signaling by BMP']
Bms1,-0.15695173,0.4230689,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Bmt2,-0.10295225,0.13485117,2,['Amino acids regulate mTORC1']
Bmx,0.38600948,-0.27688456,1,"['Apoptotic cleavage of cellular proteins', 'Synthesis of PIPs at the plasma membrane']"
Bmyc,0.44242644,0.14856383,3,
Bnip1,-0.35018414,-0.09324814,2,['COPI-dependent Golgi-to-ER retrograde traffic']
Bnip2,0.19689545,-0.15296426,1,['Myogenesis']
Bnip3,0.35798755,-0.0044475584,3,
Bnip3l,0.20566805,-0.016850356,3,['TP53 Regulates Transcription of Genes Involved in Cytochrome C Release']
Bnip5,-0.121838786,0.024864195,2,
Bod1,0.15188907,0.16568735,3,
Bod1l,0.06084986,0.2680472,3,
Bok,-0.015523253,-0.0022649532,2,
Bola1,-0.073676825,-0.0959497,2,
Bola2,-0.15832981,-0.02130979,2,
Bola3,-0.14268202,-0.058728606,2,
Boll,0.06143164,0.19729868,3,
Bop1,-0.23494768,0.45644248,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Bora,0.059379686,0.42437896,3,['Regulation of PLK1 Activity at G2/M Transition']
Borcs5,-0.098100446,-0.06353856,2,
Borcs6,-0.13748176,-0.019679908,2,
Borcs7,-0.18814977,-0.11564626,2,
Borcs8,-0.14019606,-0.015904596,2,
Bpgm,-0.15550397,0.08438499,2,['Glycolysis']
Bphl,-0.25286672,-0.11158499,2,['Phase I - Functionalization of compounds']
Bpi,-0.084582254,0.051314104,2,"['Toll Like Receptor 4 (TLR4) Cascade', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Bpifa1,0.08205332,0.055862375,3,['Antimicrobial peptides']
Bpifa2,-0.10974089,0.06865308,2,['Antimicrobial peptides']
Bpifa6,-0.08861201,-0.005356911,2,
Bpifb1,-0.31843275,-0.024261154,2,['Antimicrobial peptides']
Bpifb2,-0.1615678,-0.06567808,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Antimicrobial peptides', 'Post-translational protein phosphorylation']"
Bpifb3,-0.24632107,-0.05907456,2,
Bpifb4,-0.3865659,-0.02703816,2,['Antimicrobial peptides']
Bpifb5,-0.1748957,0.12726127,2,
Bpifb6,-0.28307614,0.054251425,2,['Antimicrobial peptides']
Bpifb9a,0.04863599,0.047882553,0,
Bpifb9b,-0.1557004,0.0502219,2,
Bpnt1,0.012237577,0.09021957,2,['Cytosolic sulfonation of small molecules']
Bpnt2,-0.04106313,-0.34733564,1,['Cytosolic sulfonation of small molecules']
Bptf,0.14910795,0.671461,3,
Braf,0.5485536,-0.22876096,1,"['Spry regulation of FGF signaling', 'Frs2-mediated activation', 'RAF activation', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway', 'Negative regulation of MAPK pathway']"
Brap,0.4555427,-0.075191736,3,"['RAF activation', 'Negative regulation of MAPK pathway']"
Brat1,0.19222099,0.015530559,1,
Brca1,0.5769019,0.39667603,3,"['SUMOylation of DNA damage response and repair proteins', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Nonhomologous End-Joining (NHEJ)', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Brca2,0.49353895,0.28615868,3,"['HDR through MMEJ (alt-NHEJ)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Presynaptic phase of homologous DNA pairing and strand exchange']"
Brcc3,0.29431573,0.24369924,3,"['Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Brd1,0.37516978,0.277702,3,"['HATs acetylate histones', 'Regulation of TP53 Activity through Acetylation']"
Brd2,0.1260732,0.41737297,3,
Brd3,0.007917956,0.005732182,2,
Brd4,0.29922226,0.4413948,3,
Brd7,0.28613994,0.16637482,3,['Regulation of TP53 Activity through Acetylation']
Brd8,0.15459381,0.20583329,3,
Brd9,0.082205355,0.21813907,3,
Brdt,0.09498587,0.2173199,3,
Brf1,0.10538413,0.2899124,0,
Brf2,0.026741793,0.19422504,0,
Bri3bp,-0.10399266,0.24754918,2,
Brinp1,-0.1288481,-0.08322171,2,
Brinp2,0.018515702,-0.054392133,2,
Brip1,0.25327048,0.36610076,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Brix1,-0.16339266,0.33243173,0,
Brk1,0.21988618,-0.021250345,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Brme1,-0.20900552,-0.11679162,2,
Brms1,0.1650564,0.21133402,3,['HDACs deacetylate histones']
Brms1l,0.1385187,0.25729772,3,
Brox,0.112914376,0.07215351,3,
Brpf1,0.32213154,0.13335183,3,"['HATs acetylate histones', 'Regulation of TP53 Activity through Acetylation']"
Brpf3,0.40820527,0.040135358,3,"['Platelet degranulation ', 'HATs acetylate histones', 'Regulation of TP53 Activity through Acetylation']"
Brs3,-0.19224331,0.011974905,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Brsk1,0.13056509,0.04333248,3,
Brsk2,0.1759675,-0.06532555,1,
Brwd1,0.29577366,0.08955406,3,"['Interleukin-7 signaling', 'Chromatin modifying enzymes']"
Brwd3,0.27831408,0.08008561,3,
Bscl2,-0.015381084,-0.15798126,2,
Bsdc1,-0.25867453,0.057638783,2,
Bsg,0.16905816,-0.2745321,1,
Bsn,0.16793716,-0.2315159,1,
Bsnd,-0.11634355,-0.119542286,2,['Stimuli-sensing channels']
Bsph2,-0.34785888,0.049893726,2,
Bst1,0.051559277,-0.06218093,2,
Bst2,0.15057988,0.08240894,0,['Neutrophil degranulation']
Bsx,-0.22161795,-0.1864403,2,
Btaf1,0.24287434,0.33120176,3,
Btbd1,-0.12231858,-0.077821724,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Btbd10,-0.2106447,-0.18878888,2,
Btbd11,-0.07030491,-0.0117127765,2,
Btbd17,-0.070372,-0.051799826,2,
Btbd19,-0.18563682,0.06731164,2,
Btbd35f14,-0.2709994,-0.19500448,2,
Btbd35f27,-0.342101,0.17755313,2,
Btbd35f6,-0.20404069,-0.028879419,2,
Btbd35f7,-0.26304865,-0.14428906,2,
Btbd6,0.104676515,0.05638893,0,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Btbd9,0.07949755,-0.05376149,1,
Btc,0.24962364,-0.3829091,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'EGFR interacts with phospholipase C-gamma', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'Extra-nuclear estrogen signaling']"
Btd,-0.19513741,0.025862064,2,
Btf3,-0.17488861,0.20650287,0,
Btf3l4,0.10102228,0.23946956,0,
Btg1,-0.17430067,0.34770274,0,
Btg1b,0.08535755,0.19738293,3,
Btg1c,-0.27271545,0.19403544,2,
Btg2,0.1455295,0.26401797,3,['TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']
Btg3,-0.18075432,-0.012826368,2,
Btg4,-0.041925427,0.13723981,2,
Btk,0.4493659,-0.34047043,1,"['Regulation of actin dynamics for phagocytic cup formation', 'DAP12 signaling', 'FCERI mediated Ca+2 mobilization', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'RHO GTPases Activate WASPs and WAVEs', 'G beta:gamma signalling through BTK', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Btla,-0.045657776,-0.3244568,1,
Btn1a1,0.0063130483,-0.238849,1,['Butyrophilin (BTN) family interactions']
Btn2a2,0.03338109,-0.14286911,2,['Butyrophilin (BTN) family interactions']
Btrc,0.5132967,0.13534266,3,
Bub1,0.30543172,0.47954848,3,
Bub1b,0.31612188,0.4982036,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Bub3,0.24029118,0.52938235,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Bud13,-0.08458937,0.4391557,0,
Bud23,-0.08545782,0.4275117,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Bud31,-0.07963093,0.4707025,0,['mRNA Splicing - Major Pathway']
Bves,0.038415022,-0.3130756,1,
Bysl,-0.040987533,0.48163968,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Bzw1,-0.084251426,0.28387952,0,
Bzw2,-0.031288274,-0.059584405,2,
C130050O18Rik,-0.2566746,0.09050254,2,
C1d,-0.2802142,0.23392053,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
C1galt1,-0.0043407814,-0.14323634,2,['O-linked glycosylation of mucins']
C1galt1c1,0.007622059,-0.071042605,2,['O-linked glycosylation of mucins']
C1qa,0.33785033,-0.34782952,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Regulation of Complement cascade']"
C1qb,0.16406405,-0.23171663,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Regulation of Complement cascade']"
C1qbp,0.16813476,0.039607964,1,
C1qc,0.21122192,-0.162735,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Regulation of Complement cascade']"
C1ql1,-0.094879225,-0.108582325,2,
C1ql2,-0.26514632,-0.15414068,2,
C1ql3,-0.22026742,-0.33972034,2,
C1ql4,-0.093326695,0.15598981,2,
C1qtnf1,-0.33903903,-0.033937454,2,
C1qtnf2,-0.14916617,-0.07479708,2,
C1qtnf3,-0.2995527,0.05005038,2,
C1qtnf4,-0.26734668,-0.05908748,2,
C1qtnf5,-0.08662113,0.020977663,2,
C1ra,-0.09357246,-0.28099233,2,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Regulation of Complement cascade']"
C1rb,0.0594398,-0.14817868,1,
C1rl,-0.24474823,0.03075509,2,
C1s1,-0.1097522,-0.09752405,2,
C1s2,-0.002225589,-0.1832578,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Regulation of Complement cascade']"
C2,-0.13259186,-0.10675052,2,"['Initial triggering of complement', 'Activation of C3 and C5', 'Regulation of Complement cascade']"
C2cd2,-0.38726646,-0.034156356,2,
C2cd2l,-0.0015073309,0.046019897,2,
C2cd3,-0.15421394,-0.1943177,2,['Anchoring of the basal body to the plasma membrane']
C2cd4c,-0.19955902,-0.030498091,2,
C2cd5,0.34890333,0.11170463,3,
C2cd6,-0.04920473,0.027334735,2,
C3,0.10092828,-0.23058075,1,"['Alternative complement activation', 'Activation of C3 and C5', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Peptide ligand-binding receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'G alpha (i) signalling events', 'Neutrophil degranulation', 'Post-translational protein phosphorylation', 'Regulation of Complement cascade']"
C3ar1,0.046780102,-0.0689245,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events', 'Neutrophil degranulation', 'Regulation of Complement cascade']"
C4a,-0.18472321,0.14432058,2,
C4b,0.06945135,-0.37803128,1,"['Initial triggering of complement', 'Activation of C3 and C5', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'Regulation of Complement cascade']"
C4bp,0.03775899,-0.16929339,1,
C5ar1,0.06940939,-0.1589001,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events', 'Neutrophil degranulation', 'Regulation of Complement cascade']"
C5ar2,0.12031182,-0.23270054,1,"['Peptide ligand-binding receptors', 'Regulation of Complement cascade']"
C6,0.011024771,-0.3162328,1,"['Terminal pathway of complement', 'Regulation of Complement cascade']"
C7,-0.0991343,-0.26605192,2,"['Terminal pathway of complement', 'Regulation of Complement cascade']"
C77080,0.009084701,-0.20037675,1,
C8a,0.07325785,-0.0924429,1,"['Terminal pathway of complement', 'Regulation of Complement cascade']"
C8b,0.0071965917,-0.16879015,2,"['Terminal pathway of complement', 'Regulation of Complement cascade']"
C8g,-0.0665743,-0.23163044,2,"['Terminal pathway of complement', 'Regulation of Complement cascade']"
C9,0.13876826,-0.26879066,1,"['Terminal pathway of complement', 'Regulation of Complement cascade']"
C9orf72,0.27148068,0.089058995,3,
Cab39,0.08750075,-0.121023566,2,"['Energy dependent regulation of mTOR by LKB1-AMPK', 'Neutrophil degranulation']"
Cab39l,0.084876865,0.023784205,3,['Energy dependent regulation of mTOR by LKB1-AMPK']
Cabcoco1,-0.26400962,-0.062440667,2,
Cabin1,0.36085966,0.033461116,3,['Formation of Senescence-Associated Heterochromatin Foci (SAHF)']
Cables1,0.29465222,0.11164687,3,"['Cyclin E associated events during G1/S transition ', 'Cyclin A:Cdk2-associated events at S phase entry']"
Cables2,-0.07917763,0.1954888,2,
Cabp1,0.20315361,-0.19775103,1,
Cabp2,-0.25112042,0.004960604,2,
Cabp4,0.019159688,0.0032032845,2,
Cabp5,-0.34649274,0.09126979,2,
Cabp7,-0.06926254,-0.3671947,1,
Cabs1,-0.24842253,0.027279833,2,
Cabyr,0.0061736177,0.10371382,2,
Cacfd1,-0.18997398,0.19179666,2,
Cachd1,-0.06843462,-0.13702276,2,
Cacna1a,0.24088483,-0.29005843,1,"['Presynaptic depolarization and calcium channel opening', 'Regulation of insulin secretion']"
Cacna1b,0.1924635,-0.23988391,1,['Presynaptic depolarization and calcium channel opening']
Cacna1c,0.25217482,-0.30268198,1,"['Regulation of insulin secretion', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase']"
Cacna1d,0.1930186,-0.32112277,1,['Regulation of insulin secretion']
Cacna1e,0.15120251,-0.090488866,1,
Cacna1f,0.19096671,-0.18138956,1,
Cacna1g,0.146957,-0.15730238,1,
Cacna1h,0.13777918,-0.16704263,1,
Cacna1i,0.19378844,-0.12316441,1,
Cacna1s,0.15936276,-0.30094448,1,
Cacna2d1,0.120562695,0.03390936,3,
Cacna2d2,0.024409875,-0.18536445,2,"['Presynaptic depolarization and calcium channel opening', 'Regulation of insulin secretion', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase']"
Cacna2d3,0.007346311,-0.16055627,1,['Presynaptic depolarization and calcium channel opening']
Cacna2d4,0.05984404,-0.012385259,2,
Cacnb1,0.015037793,-0.041345745,2,"['Presynaptic depolarization and calcium channel opening', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase']"
Cacnb2,-0.03356069,-0.15040897,2,"['Presynaptic depolarization and calcium channel opening', 'Regulation of insulin secretion', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase']"
Cacnb3,0.029494546,-0.27306774,1,"['Presynaptic depolarization and calcium channel opening', 'Regulation of insulin secretion']"
Cacnb4,0.25885233,-0.24966553,1,['Presynaptic depolarization and calcium channel opening']
Cacng1,0.033104323,-0.13974878,1,
Cacng2,0.17111097,-0.18554358,1,"['Presynaptic depolarization and calcium channel opening', 'Trafficking of AMPA receptors', 'LGI-ADAM interactions']"
Cacng3,0.05688239,-0.14658467,1,"['Trafficking of AMPA receptors', 'LGI-ADAM interactions']"
Cacng4,0.15311529,-0.1824702,1,"['Presynaptic depolarization and calcium channel opening', 'Trafficking of AMPA receptors', 'Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase', 'LGI-ADAM interactions']"
Cacng5,0.14790209,-0.105146475,1,
Cacng6,0.013617497,-0.11086645,2,"['Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase']"
Cacng7,0.10848864,-0.18760939,1,"['Phase 0 - rapid depolarisation', 'Phase 2 - plateau phase']"
Cacng8,0.09499454,-0.07442143,1,
Cactin,-0.09669209,0.46809402,0,
Cacul1,0.14565593,0.13816363,3,
Cacybp,0.10212574,0.16944255,3,
Cad,-0.34224808,-0.016163124,2,['Pyrimidine biosynthesis']
Cadm1,0.27673262,-0.1924984,1,"['Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization']"
Cadm2,-0.19025163,-0.22935303,2,['Adherens junctions interactions']
Cadm3,0.10797431,-0.36282852,1,"['Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization']"
Cadm4,-0.10279594,-0.20739678,2,
Cadps,-0.34231502,-0.1894286,2,
Calb1,0.19147907,-0.19018848,1,
Calb2,0.115138695,-0.3296788,1,
Calca,0.2850208,-0.19547774,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Calcb,-0.11095319,-0.035008132,2,
Calcoco1,0.003890649,0.007519386,2,
Calcoco2,0.0753996,0.06762784,3,
Calcr,0.24954098,-0.15168181,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Calcrl,0.26281568,-0.030425176,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Cald1,0.02421949,-0.13941552,2,['Smooth Muscle Contraction']
Calhm1,-0.081984214,-0.16650586,2,
Calhm2,-0.06807628,0.0049368963,2,
Calhm3,-0.051956598,0.05693525,0,
Calhm4,-0.3176881,0.10004759,2,
Calhm6,0.0984911,0.038065895,1,
Calm1,0.20561484,-0.44094402,1,"['CaMK IV-mediated phosphorylation of CREB', 'Calmodulin induced events', 'Cam-PDE 1 activation', 'Platelet degranulation ', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'PKA activation', 'Synthesis of IP3 and IP4 in the cytosol', 'Calcineurin activates NFAT', 'eNOS activation', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Stimuli-sensing channels', 'FCERI mediated Ca+2 mobilization', 'Ca2+ pathway', 'Reduction of cytosolic Ca++ levels', 'Sodium/Calcium exchangers', 'Unblocking of NMDA receptors, glutamate binding and activation', 'CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde', 'Smooth Muscle Contraction', 'Activation of Ca-permeable Kainate Receptor', 'VEGFR2 mediated vascular permeability', 'Ion homeostasis', 'CLEC7A (Dectin-1) induces NFAT activation', 'RHO GTPases activate IQGAPs', 'RHO GTPases activate PAKs', 'RAF activation', 'RAF/MAP kinase cascade', 'Glycogen breakdown (glycogenolysis)', 'Protein methylation', 'Extra-nuclear estrogen signaling', 'Ion transport by P-type ATPases', 'Activation of RAC1 downstream of NMDARs', 'RAS processing']"
Calm2,0.320486,-0.21927412,1,"['CaMK IV-mediated phosphorylation of CREB', 'Calmodulin induced events', 'Cam-PDE 1 activation', 'Platelet degranulation ', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'PKA activation', 'Synthesis of IP3 and IP4 in the cytosol', 'Calcineurin activates NFAT', 'eNOS activation', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Stimuli-sensing channels', 'FCERI mediated Ca+2 mobilization', 'Ca2+ pathway', 'Reduction of cytosolic Ca++ levels', 'Sodium/Calcium exchangers', 'Unblocking of NMDA receptors, glutamate binding and activation', 'CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde', 'Smooth Muscle Contraction', 'Activation of Ca-permeable Kainate Receptor', 'VEGFR2 mediated vascular permeability', 'Ion homeostasis', 'CLEC7A (Dectin-1) induces NFAT activation', 'RHO GTPases activate IQGAPs', 'RHO GTPases activate PAKs', 'RAF activation', 'RAF/MAP kinase cascade', 'Glycogen breakdown (glycogenolysis)', 'Protein methylation', 'Extra-nuclear estrogen signaling', 'Ion transport by P-type ATPases', 'Activation of RAC1 downstream of NMDARs', 'RAS processing']"
Calm3,0.27113527,-0.40560934,1,"['CaMK IV-mediated phosphorylation of CREB', 'Calmodulin induced events', 'Cam-PDE 1 activation', 'Platelet degranulation ', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'PKA activation', 'Synthesis of IP3 and IP4 in the cytosol', 'Calcineurin activates NFAT', 'eNOS activation', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Stimuli-sensing channels', 'FCERI mediated Ca+2 mobilization', 'Ca2+ pathway', 'Reduction of cytosolic Ca++ levels', 'Sodium/Calcium exchangers', 'Unblocking of NMDA receptors, glutamate binding and activation', 'CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde', 'Smooth Muscle Contraction', 'Activation of Ca-permeable Kainate Receptor', 'VEGFR2 mediated vascular permeability', 'Ion homeostasis', 'CLEC7A (Dectin-1) induces NFAT activation', 'RHO GTPases activate IQGAPs', 'RHO GTPases activate PAKs', 'RAF activation', 'RAF/MAP kinase cascade', 'Glycogen breakdown (glycogenolysis)', 'Protein methylation', 'Extra-nuclear estrogen signaling', 'Ion transport by P-type ATPases', 'Activation of RAC1 downstream of NMDARs', 'RAS processing']"
Calm4,0.28984547,-0.2538661,1,['Neutrophil degranulation']
Calm5,0.34978655,-0.15884712,1,
Calml3,0.35180786,-0.24000463,1,
Calml4,0.3958825,-0.26227668,1,
Caln1,-0.039462086,-0.07556537,2,
Calr,0.38964784,-0.012852656,1,"['ER-Phagosome pathway', 'Scavenging by Class A Receptors', 'Calnexin/calreticulin cycle', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Calr3,-0.17975187,0.020034507,2,
Calr4,0.018977266,-0.103389695,2,
Calu,0.21634996,0.04072647,3,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Caly,-0.062343154,-0.07189104,2,
Camk1,0.22547872,-0.15925273,1,['Activation of RAC1 downstream of NMDARs']
Camk1d,0.06665468,-0.0686887,1,
Camk1g,0.20385279,-0.14493114,1,
Camk2a,0.46766308,-0.24018422,1,"['HSF1-dependent transactivation', 'Trafficking of AMPA receptors', 'Ca2+ pathway', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Ion homeostasis', 'RAF activation', 'RAF/MAP kinase cascade', 'Interferon gamma signaling', 'Ion transport by P-type ATPases']"
Camk2b,0.46510446,-0.23747092,1,"['HSF1-dependent transactivation', 'Trafficking of AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Ion homeostasis', 'RAF activation', 'RAF/MAP kinase cascade', 'Interferon gamma signaling', 'Ion transport by P-type ATPases']"
Camk2d,0.50151634,-0.14405844,1,"['HSF1-dependent transactivation', 'Trafficking of AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Ion homeostasis', 'RAF activation', 'RAF/MAP kinase cascade', 'Interferon gamma signaling', 'Ion transport by P-type ATPases']"
Camk2g,0.52721626,-0.25665402,1,"['HSF1-dependent transactivation', 'Trafficking of AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Ion homeostasis', 'RAF activation', 'RAF/MAP kinase cascade', 'Interferon gamma signaling', 'Ion transport by P-type ATPases']"
Camk2n1,-0.1601098,-0.0434111,2,
Camk2n2,-0.031455316,-0.14093216,1,
Camk4,0.21913709,-0.22524491,1,
Camkk1,0.11966657,-0.12132587,3,"['CaMK IV-mediated phosphorylation of CREB', 'CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde', 'Activation of RAC1 downstream of NMDARs']"
Camkk2,0.24791123,-0.2597747,1,"['CaMK IV-mediated phosphorylation of CREB', 'CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde', 'Activation of RAC1 downstream of NMDARs']"
Camkmt,0.1281051,0.17525731,3,"['Inactivation, recovery and regulation of the phototransduction cascade', 'Protein methylation']"
Caml,-0.20004117,-0.10871785,2,
Camp,0.09187147,-0.10482356,1,"['Neutrophil degranulation', 'Antimicrobial peptides']"
Camsap1,-0.13511752,-0.17492488,2,
Camsap2,-0.33686143,0.02328228,2,
Camsap3,-0.117162056,-0.0044147,2,
Camta2,0.04340459,0.055160124,3,
Cand1,0.20502469,0.15250333,3,"['Neutrophil degranulation', 'Neddylation', 'Iron uptake and transport']"
Cand2,0.17232743,-0.042203166,3,
Cant1,-0.13330033,0.035470225,2,['Neutrophil degranulation']
Canx,0.13536559,-0.2174218,1,"['MHC class II antigen presentation', 'Calnexin/calreticulin cycle', 'Interleukin-27 signaling', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Cap1,0.15943065,-0.1417053,1,['Neutrophil degranulation']
Cap2,0.16954854,-0.11375308,1,
Capg,-0.095157154,0.10066626,0,
Capn1,0.27091438,-0.4188419,1,"['Degradation of the extracellular matrix', 'Neutrophil degranulation']"
Capn10,-0.04202256,-0.01992526,2,['Degradation of the extracellular matrix']
Capn11,-0.1621758,-0.006623267,2,['Degradation of the extracellular matrix']
Capn12,-0.2923905,-0.11138396,2,
Capn13,-0.09451412,0.00827472,2,['Degradation of the extracellular matrix']
Capn15,-0.14499205,-0.14001797,2,['Degradation of the extracellular matrix']
Capn2,0.17808305,-0.36690646,1,['Degradation of the extracellular matrix']
Capn3,-0.034912683,-0.1999571,2,['Degradation of the extracellular matrix']
Capn5,0.03749937,-0.19239184,1,['Degradation of the extracellular matrix']
Capn6,0.01380169,-0.14771976,2,['Degradation of the extracellular matrix']
Capn7,-0.039395608,-0.031638894,0,['Degradation of the extracellular matrix']
Capn8,-0.17452024,-0.24582897,2,['Degradation of the extracellular matrix']
Capn9,-0.055351913,0.005245758,2,['Degradation of the extracellular matrix']
Capns1,0.11302663,-0.39968982,1,
Capns2,-0.21514471,-0.17012829,2,['Degradation of the extracellular matrix']
Caprin1,-0.10227454,0.2787989,0,
Caprin2,-0.3205738,0.02025279,2,
Capsl,-0.10627242,-0.10869943,2,
Capza1,0.2194543,0.08140295,3,
Capza2,0.17594607,0.12117566,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Advanced glycosylation endproduct receptor signaling', 'Factors involved in megakaryocyte development and platelet production']"
Capza3,0.15907118,0.16918863,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic']"
Capzb,0.22719736,0.052265808,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'RHOD GTPase cycle', 'RHOF GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Car12,-0.17614253,0.06573064,2,
Car14,-0.3081397,0.025308238,2,['Reversible hydration of carbon dioxide']
Car2,0.24262244,0.061859317,3,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Reversible hydration of carbon dioxide']"
Car3,0.04645326,0.0030239783,2,['Reversible hydration of carbon dioxide']
Car4,-0.21760494,0.0817002,2,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Reversible hydration of carbon dioxide']"
Car5b,-0.40670937,-0.12886418,2,['Reversible hydration of carbon dioxide']
Car6,-0.1760024,0.13172203,2,['Reversible hydration of carbon dioxide']
Car7,-0.19489582,0.13770285,2,['Reversible hydration of carbon dioxide']
Car8,0.07395295,-0.16969618,1,
Car9,0.14864428,-0.07345508,3,['Reversible hydration of carbon dioxide']
Card10,0.19165078,-0.046744738,1,
Card11,0.3572997,0.0023353887,1,"['Activation of NF-kappaB in B cells', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'CLEC7A (Dectin-1) signaling']"
Card14,0.19919214,-0.14110628,1,
Card6,-0.061656658,0.063872434,2,
Card9,0.23874289,-0.3104331,1,['CLEC7A (Dectin-1) signaling']
Carf,-0.22353753,0.019490069,2,
Carhsp1,-0.19834484,-0.098737806,2,
Carm1,0.4940015,0.17050305,3,"['RMTs methylate histone arginines', 'Regulation of lipid metabolism by PPARalpha', 'Estrogen-dependent gene expression', 'Cytoprotection by HMOX1']"
Carmil1,0.09936946,0.06354009,1,['Factors involved in megakaryocyte development and platelet production']
Carmil3,-0.07068349,0.018064216,2,
Carnmt1,-0.25000834,0.10958186,2,['Histidine catabolism']
Carns1,-0.2554043,-0.023902815,2,
Cars,-0.20740403,0.23715572,0,
Cars2,-0.2373952,0.01952402,2,
Cartpt,-0.14082159,-0.23709689,2,
Casc1,-0.28456926,0.067090996,2,
Casc3,-0.06307371,0.4860029,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Casd1,-0.013871335,-0.063094154,2,
Cask,0.1222053,-0.22172691,1,"['Dopamine Neurotransmitter Release Cycle', 'Neurexins and neuroligins']"
Caskin1,-0.23238307,0.04042846,2,
Caskin2,-0.013120591,-0.1973479,2,
Casp1,0.3641138,-0.05912439,1,"['NOD1/2 Signaling Pathway', 'Interleukin-1 processing', 'Pyroptosis']"
Casp12,0.19039027,0.0014922236,1,
Casp14,0.07033298,-0.09105819,1,
Casp2,0.37408024,0.058796078,3,"['NOD1/2 Signaling Pathway', 'NADE modulates death signalling', 'TP53 Regulates Transcription of Caspase Activators and Caspases']"
Casp3,0.64561623,0.04061286,3,"['Activation of caspases through apoptosome-mediated cleavage', 'Apoptotic cleavage of cellular proteins', 'SMAC, XIAP-regulated apoptotic response', 'Apoptosis induced DNA fragmentation', 'Signaling by Hippo', 'NADE modulates death signalling', 'Caspase-mediated cleavage of cytoskeletal proteins', 'Apoptotic cleavage of cell adhesion  proteins', 'Caspase activation via Dependence Receptors in the absence of ligand', 'Other interleukin signaling', 'Pyroptosis']"
Casp4,0.26226395,-0.006118586,1,"['NOD1/2 Signaling Pathway', 'Pyroptosis']"
Casp6,0.4018713,0.07539484,3,"['Apoptotic cleavage of cellular proteins', 'Caspase-mediated cleavage of cytoskeletal proteins', 'Breakdown of the nuclear lamina']"
Casp7,0.39824632,0.1267839,3,"['Activation of caspases through apoptosome-mediated cleavage', 'SMAC (DIABLO) binds to IAPs ', 'SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ', 'Apoptotic cleavage of cellular proteins', 'SMAC, XIAP-regulated apoptotic response', 'Caspase-mediated cleavage of cytoskeletal proteins']"
Casp8,0.4556371,0.13423198,3,"['Apoptotic cleavage of cellular proteins', 'Caspase activation via Death Receptors in the presence of ligand', 'NOD1/2 Signaling Pathway', 'TRIF-mediated programmed cell death', 'Caspase-mediated cleavage of cytoskeletal proteins', 'Regulation by c-FLIP', 'CASP8 activity is inhibited', 'Regulation of TNFR1 signaling', 'CLEC7A/inflammasome pathway', 'Regulation of necroptotic cell death', 'Dimerization of procaspase-8', 'Activation, myristolyation of BID and translocation to mitochondria', 'Apoptotic execution phase', 'FasL/ CD95L signaling', 'TRAIL  signaling', 'Regulation of NF-kappa B signaling']"
Casp8ap2,0.29438362,0.22862048,3,['SUMOylation of transcription cofactors']
Casp9,0.4359804,0.10971438,3,"['Formation of apoptosome', 'Activation of caspases through apoptosome-mediated cleavage', 'NOD1/2 Signaling Pathway', 'AKT phosphorylates targets in the cytosol', 'Caspase activation via Dependence Receptors in the absence of ligand', 'Regulation of the apoptosome activity']"
Casq1,-0.11492102,-0.1374242,2,"['Stimuli-sensing channels', 'Ion homeostasis']"
Casq2,0.002674482,-0.23074415,2,"['Stimuli-sensing channels', 'Ion homeostasis']"
Casr,0.26532358,-0.11038092,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Cass4,-0.09711074,-0.26802513,1,
Cast,0.019295335,-0.30586883,1,['Degradation of the extracellular matrix']
Castor1,-0.046931643,0.055991445,2,['Amino acids regulate mTORC1']
Castor2,-0.11072483,-0.030701168,2,['Amino acids regulate mTORC1']
Casz1,-0.041144755,0.10718183,2,
Cat,0.14207867,-0.06375306,1,"['Detoxification of Reactive Oxygen Species', 'Neutrophil degranulation', 'Peroxisomal protein import']"
Catsper1,-0.078802735,-0.14271268,2,['Sperm Motility And Taxes']
Catsper2,-0.07730448,0.023336485,2,
Catsper3,4.2470615e-06,-0.06728764,2,['Sperm Motility And Taxes']
Catsper4,0.013121405,0.046789095,3,['Sperm Motility And Taxes']
Catsperb,-0.029228477,-0.03150726,2,['Sperm Motility And Taxes']
Catsperd,0.07812022,0.085547015,3,['Sperm Motility And Taxes']
Catspere2,-0.10539411,0.032812875,2,
Catsperg1,-0.22634515,0.015159271,2,['Sperm Motility And Taxes']
Catsperg2,-0.0016752118,-0.03043515,2,
Catsperz,-0.068256736,0.032287255,2,
Cav1,0.5654554,-0.33434078,1,"['eNOS activation', 'NOSTRIN mediated eNOS trafficking', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'VEGFR2 mediated vascular permeability', 'RHOA GTPase cycle', 'Extra-nuclear estrogen signaling', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Cav2,0.42939952,-0.435755,1,['Extra-nuclear estrogen signaling']
Cav3,0.28252143,-0.41129062,1,
Cavin1,0.24358176,-0.26556885,1,"['RNA Polymerase I Transcription Termination', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Cavin2,0.12216525,-0.16196157,1,
Cavin3,0.0795531,-0.24791208,1,
Cavin4,-0.16632715,0.022447119,2,
Cbfa2t2,-0.00772759,0.12056187,3,
Cbfa2t3,0.3446192,-0.024024867,3,
Cbfb,0.39845133,0.10148008,3,"['RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)', 'Transcriptional regulation by RUNX2', 'RUNX1 regulates estrogen receptor mediated transcription', 'Regulation of RUNX1 Expression and Activity', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'RUNX1 regulates transcription of genes involved in BCR signaling', 'RUNX1 regulates transcription of genes involved in differentiation of myeloid cells', 'RUNX1 regulates transcription of genes involved in interleukin signaling', 'RUNX2 regulates bone development', 'Regulation of RUNX3 expression and activity', 'RUNX3 regulates p14-ARF', 'Estrogen-dependent gene expression']"
Cbl,0.49596623,-0.38944635,1,"['Interleukin-6 signaling', 'Spry regulation of FGF signaling', 'Regulation of KIT signaling', 'EGFR downregulation', 'TGF-beta receptor signaling activates SMADs', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Negative regulation of MET activity', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Regulation of signaling by CBL', 'Negative regulation of FLT3']"
Cblb,0.37856093,-0.24753635,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Cblc,0.3074917,-0.3666916,1,
Cblif,-0.16804877,-0.17964634,2,['Uptake of dietary cobalamins into enterocytes']
Cbll1,0.3290445,0.094082475,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Cbln1,0.02546928,-0.07390763,1,
Cbln2,-0.13817292,-0.082201764,2,
Cbln4,-0.1259657,-0.12826554,2,
Cbr1,-0.05174241,0.004927144,2,['Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']
Cbr2,-0.11510638,0.027996754,2,
Cbr3,-0.15589246,-0.045930177,2,['Phase I - Functionalization of compounds']
Cbr4,-0.14453329,0.02092645,2,['Fatty acyl-CoA biosynthesis']
Cbs,-0.06948113,-0.04894922,2,['Cysteine formation from homocysteine']
Cbwd1,-0.15533668,0.14578116,0,
Cbx1,0.16642001,0.29301846,3,
Cbx2,0.22250299,0.35459185,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription']"
Cbx3,0.20343076,0.3224152,3,
Cbx4,0.28190595,0.35732162,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription']"
Cbx5,0.27914172,0.28444496,3,['Factors involved in megakaryocyte development and platelet production']
Cbx6,0.12951405,0.08457004,3,"['RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription']"
Cbx7,0.28128368,0.20017983,3,
Cbx8,0.3201388,0.3397827,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription']"
Cby1,0.34863874,-0.0012485397,3,['Deactivation of the beta-catenin transactivating complex']
Cby2,-0.3860015,-0.11723804,2,
Cc2d1a,0.01672741,-0.08737281,2,
Cc2d1b,0.00186874,0.0024460985,2,['Sealing of the nuclear envelope (NE) by ESCRT-III']
Cc2d2a,-0.060776573,-0.08798225,2,['Anchoring of the basal body to the plasma membrane']
Ccar1,0.026526457,0.126399,0,
Ccar2,0.1037164,0.15479627,3,
Ccbe1,0.042846028,-0.13972102,1,
Ccdc102a,-0.20517954,-0.29426658,2,
Ccdc103,-0.24093884,0.0919213,2,
Ccdc105,-0.064181075,0.09941361,2,
Ccdc112,-0.11778709,0.0332099,2,
Ccdc113,-0.1904145,0.15590222,2,
Ccdc115,0.00857592,-0.09588209,2,['RHOA GTPase cycle']
Ccdc116,-0.04991834,0.019625572,2,
Ccdc12,-0.113261804,0.38031793,0,
Ccdc120,0.06623667,0.031117609,3,
Ccdc122,-0.12834482,-0.0114952335,2,
Ccdc124,-0.05696445,0.348995,0,
Ccdc125,-0.108783565,0.06305752,2,
Ccdc126,-0.19291073,-0.062416557,2,
Ccdc127,-0.12645355,0.07593578,2,
Ccdc13,-0.06963845,0.072769344,2,
Ccdc130,-0.17889632,0.34580013,0,
Ccdc134,-0.09995507,-0.112590574,2,
Ccdc137,-0.042788222,-0.058885746,2,
Ccdc138,-0.15234384,0.076712795,2,
Ccdc14,0.040774897,-0.05172506,2,
Ccdc141,-0.051884573,-0.14085157,2,
Ccdc15,-0.31792298,-0.074097246,2,
Ccdc150,-0.06794981,-0.10448474,2,
Ccdc153,-0.08789303,0.16591513,0,
Ccdc158,-0.066408604,0.046685513,2,
Ccdc159,-0.2212822,0.0028910066,2,
Ccdc169,-0.47160804,-0.009555735,2,
Ccdc17,0.074778154,-0.11007201,1,
Ccdc170,-0.23789378,-0.1831348,2,
Ccdc171,-0.14210278,0.04882891,2,
Ccdc172,-0.345255,-0.027260711,2,
Ccdc174,-0.19881855,-0.15307502,2,
Ccdc175,-0.20584272,0.037993416,2,
Ccdc18,-0.12832075,0.117415965,2,
Ccdc180,-0.127925,-0.032947324,2,
Ccdc181,-0.1278342,0.025561372,2,
Ccdc182,-0.25610492,0.046081424,2,
Ccdc185,-0.13666634,0.08919258,2,
Ccdc186,-0.16532633,-0.0048051123,2,
Ccdc190,-0.10127961,-0.0064758463,2,
Ccdc22,0.06684008,-0.14787103,2,['Neddylation']
Ccdc24,-0.099123806,0.0990657,2,
Ccdc27,-0.223197,0.058704466,2,
Ccdc28b,-0.26464683,-0.0157259,2,
Ccdc30,-0.18883923,-0.008787028,2,
Ccdc32,0.0014214716,0.06574416,0,
Ccdc34,-0.10405617,-0.08312365,2,
Ccdc38,-0.22229403,-0.1021644,2,
Ccdc39,-0.13892235,0.10105012,2,
Ccdc42,-0.23650381,0.10088874,2,
Ccdc43,-0.20285238,-0.009833028,2,
Ccdc47,-0.0947768,0.07206541,2,
Ccdc50,-0.10961745,-0.05289959,2,
Ccdc51,0.019758757,0.08851464,2,
Ccdc54,0.0755127,0.030488972,3,
Ccdc57,-0.277645,0.027676681,2,
Ccdc58,-0.17197755,-0.012931311,2,
Ccdc59,-0.042042267,-0.0093003735,2,['Surfactant metabolism']
Ccdc6,0.17294252,-0.3115105,1,
Ccdc60,-0.25502795,-0.12676896,2,
Ccdc61,-0.1340584,-0.052179426,2,
Ccdc62,-0.26764762,-0.09220556,2,
Ccdc63,-0.11789752,0.109126896,2,
Ccdc65,-0.178051,0.00835458,2,
Ccdc66,-0.14582428,0.0035356162,2,
Ccdc68,0.025891595,-0.16421632,2,
Ccdc69,-0.12509082,-0.03641976,2,
Ccdc70,-0.050486103,4.0063755e-05,2,
Ccdc73,-0.23616003,-0.15146306,2,
Ccdc78,-0.19421351,0.097641654,2,
Ccdc8,0.24961098,0.1677739,3,
Ccdc80,-0.38229364,-0.103435524,2,
Ccdc82,-0.15746252,-0.013671754,2,
Ccdc84,-0.17044577,0.018244902,2,
Ccdc85a,0.030124912,-0.09180173,2,
Ccdc85b,-0.034717377,-0.24255346,2,
Ccdc85c,-0.12688418,0.01208817,2,
Ccdc86,-0.02299552,0.25479832,0,
Ccdc88a,0.20722575,-0.19889246,1,"['RND3 GTPase cycle', 'RND1 GTPase cycle']"
Ccdc88c,-0.24408986,-0.16244169,2,
Ccdc9,-0.13780713,0.09542933,2,
Ccdc90b,-0.16478327,0.038273785,2,
Ccdc91,-0.033022884,-0.055202734,2,
Ccdc92,0.04897623,0.08890664,3,
Ccdc92b,0.04959858,0.04850547,2,
Ccdc93,-0.022703601,-0.05458165,2,
Ccdc96,-0.4165054,0.053691015,2,
Ccdc97,-0.1055625,0.20317978,2,
Ccer1,-0.22246191,-0.06894492,2,
Cchcr1,-0.029274203,0.19089271,3,
Ccin,-0.069224425,-0.2260969,2,
Cck,0.27979493,-0.32623538,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Cckar,0.01895727,-0.3313148,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Cckbr,0.09545778,-0.3322957,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'Gastrin-CREB signalling pathway via PKC and MAPK']"
Ccl1,0.13331194,-0.061082203,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl11,0.28168064,-0.16951661,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl12,0.30933735,-0.06571534,1,['Chemokine receptors bind chemokines']
Ccl17,0.28221923,-0.031831153,1,['Chemokine receptors bind chemokines']
Ccl19,0.20257771,0.033934314,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl2,0.4383459,-0.18494691,1,
Ccl20,0.25003928,-0.024824956,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl21a,0.07473856,-0.1268674,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl21b,-0.13744228,0.09393212,2,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl21c,-0.23951857,-0.17677091,2,
Ccl22,0.22103584,-0.11294975,1,['Chemokine receptors bind chemokines']
Ccl24,0.122496955,-0.07014673,1,
Ccl25,0.21920079,-0.122232646,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl26,0.15832296,0.0052380385,1,
Ccl27a,0.11007245,-0.0599065,1,
Ccl27b,0.14416166,-0.100030206,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl28,0.16647243,0.007116061,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl3,0.24747582,-0.116600156,1,['Chemokine receptors bind chemokines']
Ccl4,0.32085907,-0.16403064,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl5,0.3426371,-0.019447017,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccl6,0.14577334,-0.04586689,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Ccl7,0.21381521,-0.057344098,1,['Chemokine receptors bind chemokines']
Ccl8,0.22749001,0.0071192775,1,
Ccl9,0.26031715,-0.065180294,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Ccm2,0.3121762,-0.11411193,1,
Ccm2l,-0.1584718,-0.17758764,2,
Ccn1,0.22873874,-0.096349254,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Ccn2,0.44453144,-0.2697463,1,
Ccn3,0.0096468,-0.03828698,2,
Ccn4,0.09444618,-0.06770569,1,
Ccn5,-0.00825696,0.09429776,3,
Ccna1,0.40598887,0.48899886,3,"['G0 and Early G1', 'Telomere Extension By Telomerase', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Regulation of APC/C activators between G1/S and early anaphase', 'SCF(Skp2)-mediated degradation of p27/p21', 'Senescence-Associated Secretory Phenotype (SASP)', 'DNA Damage/Telomere Stress Induced Senescence', 'Ub-specific processing proteases', 'Processing of DNA double-strand break ends', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'G2 Phase', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin A/B1/B2 associated events during G2/M transition', 'p53-Dependent G1 DNA Damage Response', 'Cyclin A:Cdk2-associated events at S phase entry']"
Ccna2,0.40807375,0.4967103,3,"['G0 and Early G1', 'Telomere Extension By Telomerase', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Regulation of APC/C activators between G1/S and early anaphase', 'SCF(Skp2)-mediated degradation of p27/p21', 'Senescence-Associated Secretory Phenotype (SASP)', 'DNA Damage/Telomere Stress Induced Senescence', 'Ub-specific processing proteases', 'Processing of DNA double-strand break ends', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'G2 Phase', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin A/B1/B2 associated events during G2/M transition', 'p53-Dependent G1 DNA Damage Response', 'Cyclin A:Cdk2-associated events at S phase entry']"
Ccnb1,0.27652708,0.4908803,3,"['APC/C:Cdc20 mediated degradation of Cyclin B', 'Regulation of APC/C activators between G1/S and early anaphase', 'Phosphorylation of the APC/C', 'Phosphorylation of Emi1', 'Condensation of Prophase Chromosomes', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Activation of NIMA Kinases NEK9, NEK6, NEK7', 'Initiation of Nuclear Envelope (NE) Reformation', 'Nuclear Pore Complex (NPC) Disassembly', 'Depolymerisation of the Nuclear Lamina', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'Mitotic Prophase', 'Cyclin A/B1/B2 associated events during G2/M transition', 'G2/M DNA replication checkpoint', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Transcriptional regulation by RUNX2']"
Ccnb1ip1,-0.16387728,0.2756907,2,
Ccnb2,0.15196201,0.49587527,3,"['Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Activation of NIMA Kinases NEK9, NEK6, NEK7', 'Initiation of Nuclear Envelope (NE) Reformation', 'Nuclear Pore Complex (NPC) Disassembly', 'Cyclin A/B1/B2 associated events during G2/M transition', 'G2/M DNA replication checkpoint', 'The role of GTSE1 in G2/M progression after G2 checkpoint']"
Ccnb3,0.26369515,0.27142465,3,
Ccnc,0.293956,0.3125903,3,['SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription']
Ccnd1,0.56071067,0.29722863,3,"['SCF(Skp2)-mediated degradation of p27/p21', 'RMTs methylate histone arginines', 'Cyclin D associated events in G1', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates Cell Cycle', 'Transcriptional regulation by RUNX2', 'Regulation of RUNX1 Expression and Activity', 'RUNX3 regulates p14-ARF', 'Drug-mediated inhibition of CDK4/CDK6 activity']"
Ccnd2,0.3936858,0.038973026,3,"['Cyclin D associated events in G1', 'Regulation of RUNX1 Expression and Activity', 'Drug-mediated inhibition of CDK4/CDK6 activity']"
Ccnd3,0.39590752,0.13018177,3,"['MAPK6/MAPK4 signaling', 'Cyclin D associated events in G1', 'Regulation of RUNX1 Expression and Activity', 'Drug-mediated inhibition of CDK4/CDK6 activity']"
Ccndbp1,-0.17053872,-0.06220535,2,
Ccne1,0.48442635,0.25179052,3,"['G0 and Early G1', 'SCF(Skp2)-mediated degradation of p27/p21', 'DNA Damage/Telomere Stress Induced Senescence', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'CDK-mediated phosphorylation and removal of Cdc6', 'Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'p53-Dependent G1 DNA Damage Response', 'PTK6 Regulates Cell Cycle', 'RHOBTB3 ATPase cycle']"
Ccne2,0.30042356,0.39325228,3,"['G0 and Early G1', 'SCF(Skp2)-mediated degradation of p27/p21', 'DNA Damage/Telomere Stress Induced Senescence', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'CDK-mediated phosphorylation and removal of Cdc6', 'Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'p53-Dependent G1 DNA Damage Response']"
Ccnf,0.3964541,0.4031821,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ccng1,0.31973454,0.22473878,3,['Regulation of TP53 Degradation']
Ccng2,0.21591172,0.20929892,3,
Ccnh,0.31298944,0.40906546,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Cyclin A:Cdk2-associated events at S phase entry', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Ccni,0.12482341,0.17821199,3,
Ccnj,0.11299737,0.28355563,3,
Ccnjl,0.11280759,0.23949969,3,
Ccnk,0.26390016,0.42798662,3,
Ccnl1,0.018224359,0.37691438,3,
Ccnl2,0.058444012,0.04299598,3,
Ccno,0.2982435,0.2559443,3,
Ccnq,-0.28878543,0.14188938,2,
Ccnt1,0.28115872,0.41888753,3,"['Formation of RNA Pol II elongation complex ', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Transcription Elongation', 'Estrogen-dependent gene expression']"
Ccnt2,0.3250946,0.42073557,3,"['Formation of RNA Pol II elongation complex ', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Transcription Elongation']"
Ccny,0.11075203,0.34548417,3,
Ccnyl1,-0.20465496,0.08711422,2,
Ccp110,0.11112791,0.15402402,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'Ub-specific processing proteases', 'AURKA Activation by TPX2', 'RHOV GTPase cycle']"
Ccpg1,0.02092798,-0.09327506,2,
Ccr1,0.36771396,-0.120488994,1,['G alpha (i) signalling events']
Ccr10,0.26749623,-0.104336485,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr1l1,0.37037057,-0.141711,1,
Ccr2,0.43260297,-0.02815853,1,
Ccr3,0.28792334,-0.091935456,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr4,0.16165963,-0.15755907,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr5,0.35226527,-0.22100365,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr6,0.22770399,-0.25493574,1,"['Beta defensins', 'Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr7,0.23116516,-0.26943526,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr8,0.35598764,-0.032207683,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccr9,0.2035532,-0.018784007,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Ccrl2,0.028424678,-0.016813094,2,['Chemokine receptors bind chemokines']
Ccs,-0.088336036,-0.16793345,2,['Detoxification of Reactive Oxygen Species']
Ccsap,-0.18074915,0.012907911,2,
Cct2,0.07521607,0.40059355,0,"['Association of TriC/CCT with target proteins during biosynthesis', 'Neutrophil degranulation', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle']"
Cct3,0.08249292,0.33920008,3,"['Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Cct4,0.01822825,0.40680254,0,"['Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Cct5,0.031385053,0.44110432,0,"['Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Cct6b,0.09543709,0.09365381,3,"['Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Cct7,-0.033277586,0.3681744,0,"['Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle']"
Cct8,0.11598961,0.44081268,3,"['Association of TriC/CCT with target proteins during biosynthesis', 'Neutrophil degranulation', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Cct8l1,-0.17601095,0.2119644,2,
Ccz1,-0.07931132,0.0720342,2,['RAB GEFs exchange GTP for GDP on RABs']
Cd101,-0.016717913,-0.23016109,1,['Generation of second messenger molecules']
Cd14,0.45312315,-0.090629905,1,"['Caspase activation via Death Receptors in the presence of ligand', 'Toll Like Receptor 4 (TLR4) Cascade', 'Transfer of LPS from LBP carrier to CD14', 'MyD88-independent TLR4 cascade ', 'TRIF-mediated programmed cell death', 'Regulation of TLR by endogenous ligand', 'Neutrophil degranulation', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IKK complex recruitment mediated by RIP1', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Cd151,0.24637665,-0.17389609,1,['Type I hemidesmosome assembly']
Cd160,0.08024365,-0.07401317,1,
Cd163,0.20202705,-0.15780064,1,['Scavenging of heme from plasma']
Cd164,-0.048899632,-0.040678244,2,
Cd164l2,-0.29000106,0.00905131,2,
Cd177,-0.052186754,0.01740594,2,"['Common Pathway of Fibrin Clot Formation', 'Cell surface interactions at the vascular wall', 'Neutrophil degranulation']"
Cd180,0.079225704,-0.09532808,1,['Toll Like Receptor 4 (TLR4) Cascade']
Cd19,0.2690256,-0.27686158,1,"['PIP3 activates AKT signaling', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Regulation of Complement cascade', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Cd1d1,0.18764956,-0.18650357,1,
Cd1d2,-0.31971523,-0.09941882,2,
Cd2,0.2170658,-0.24947375,1,
Cd200,-0.02809984,-0.29294026,1,
Cd200r1,-0.006995767,-0.26169497,1,
Cd200r2,-0.0040529775,-0.074984305,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd200r3,-0.029510925,-0.111960314,2,
Cd200r4,-0.22341499,-0.06798987,2,
Cd207,0.036860526,-0.08367291,1,['Cross-presentation of soluble exogenous antigens (endosomes)']
Cd209a,0.42611876,-0.16488215,1,
Cd209b,0.2877108,-0.12877727,1,
Cd209c,-0.004100111,-0.088873655,1,
Cd209d,-0.003220675,-0.0133775305,2,
Cd209e,-0.006907863,-0.1946072,1,"['CD209 (DC-SIGN) signaling', 'Butyrophilin (BTN) family interactions']"
Cd209f,-0.09102832,-0.1523525,2,
Cd209g,-0.02121009,0.14119676,3,
Cd22,0.20231411,-0.4577493,1,
Cd226,0.15326631,-0.09498059,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd244a,0.2733923,0.03880214,1,['Cell surface interactions at the vascular wall']
Cd247,0.2577106,-0.28034368,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'PD-1 signaling']"
Cd248,0.018193152,-0.31984472,1,
Cd24a,0.2675076,-0.062970765,1,
Cd27,0.26361352,-0.24175493,1,['TNFs bind their physiological receptors']
Cd274,0.32165352,-0.15987845,1,['PD-1 signaling']
Cd276,0.033974018,-0.14975178,1,
Cd28,0.4197657,-0.2665571,1,"['PIP3 activates AKT signaling', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'CD28 dependent Vav1 pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Cd2ap,0.27056146,-0.34840578,1,
Cd2bp2,-0.15710534,0.2987772,0,['mRNA Splicing - Major Pathway']
Cd300a,0.0017946084,-0.01243029,2,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Cd300c2,-0.10369297,-0.2572861,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd300e,-0.19017562,-0.08025019,2,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'DAP12 interactions']"
Cd300ld,-0.13183734,-0.0055517093,2,
Cd300lf,-0.14092596,-0.31226835,2,
Cd300lg,-0.22981936,-0.052462883,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd320,-0.17405953,0.12582994,2,
Cd33,0.109713405,-0.28591797,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Cd34,0.40540603,-0.24657555,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd36,0.12241858,-0.20981121,1,"['Platelet degranulation ', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'Scavenging by Class B Receptors', 'Intracellular metabolism of fatty acids regulates insulin secretion', 'Regulation of TLR by endogenous ligand', 'Neutrophil degranulation']"
Cd37,0.03388511,-0.0908583,1,
Cd38,0.32952905,-0.25070032,1,['Nicotinate metabolism']
Cd3d,0.17854965,-0.27128565,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'PD-1 signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Cd3e,0.20201027,-0.23687626,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'PD-1 signaling']"
Cd3eap,0.011121688,0.12116255,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Cd3g,0.2552252,-0.3083802,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'PD-1 signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Cd4,0.45964846,-0.15345034,1,"['Alpha-defensins', 'Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'PD-1 signaling', 'Other interleukin signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Cd40,0.47821525,-0.16852087,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Cd40lg,0.48068506,-0.20677587,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Cd44,0.48697484,-0.31794417,1,
Cd45,-0.04482218,-0.024469113,2,
Cd46,0.116287656,-0.3003224,1,['Regulation of Complement cascade']
Cd47,0.19035897,-0.27163947,1,"['Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'Signal regulatory protein family interactions', 'Neutrophil degranulation']"
Cd48,0.17274721,-0.32644618,1,['Cell surface interactions at the vascular wall']
Cd5,0.30200443,-0.31254598,1,
Cd52,-0.15216202,-0.09169785,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Cd53,0.0943439,-0.30209166,1,['Neutrophil degranulation']
Cd55,-0.1596497,-0.046386547,2,"['Class B/2 (Secretin family receptors)', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'Regulation of Complement cascade']"
Cd55b,-0.14007778,-0.28680953,2,
Cd59a,-0.13777547,-0.11476909,2,
Cd59b,-0.06403893,-0.32368666,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'Regulation of Complement cascade']"
Cd6,0.13462108,-0.16045259,1,
Cd63,0.17652889,-0.21796572,1,"['Platelet degranulation ', 'Neutrophil degranulation']"
Cd68,0.36895475,-0.1417333,1,['Neutrophil degranulation']
Cd69,0.25569403,-0.16537786,1,
Cd7,0.121392496,-0.28778872,1,
Cd70,0.13788047,-0.033925354,1,['TNFs bind their physiological receptors']
Cd72,0.0787591,-0.36789107,1,['Other semaphorin interactions']
Cd74,0.30476508,-0.18528216,1,"['Cell surface interactions at the vascular wall', 'MHC class II antigen presentation']"
Cd79a,0.2410174,-0.30842888,1,"['CD22 mediated BCR regulation', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Cd79b,0.27274597,-0.2082647,1,"['CD22 mediated BCR regulation', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Cd80,0.4662565,-0.20941702,1,"['PIP3 activates AKT signaling', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'CD28 dependent Vav1 pathway', 'CTLA4 inhibitory signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Cd81,0.3190063,-0.20179176,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Regulation of Complement cascade']"
Cd82,0.28090346,-0.12090091,1,
Cd83,0.043864746,-0.23458508,1,
Cd84,0.08480886,-0.08472419,1,
Cd86,0.28445828,-0.29940227,1,"['PIP3 activates AKT signaling', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'CD28 dependent Vav1 pathway', 'CTLA4 inhibitory signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Cd8a,0.22550307,-0.3100269,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd8b1,0.09949681,-0.2042358,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd9,0.3733869,-0.31868425,1,"['Platelet degranulation ', 'Acrosome Reaction and Sperm:Oocyte Membrane Binding']"
Cd93,-0.025618892,-0.21555614,1,['Neutrophil degranulation']
Cd96,-0.021111833,-0.087248035,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Cd99,-0.07097196,-0.019632991,2,
Cd99l2,-0.073365115,-0.065556824,2,
Cda,-0.09072991,0.038617063,2,"['Neutrophil degranulation', 'Pyrimidine salvage']"
Cdadc1,-0.068953566,-0.06657596,2,
Cdan1,0.039941035,0.18976554,3,
Cdc123,-0.23128001,-0.087364785,2,
Cdc14a,0.11363903,0.17019093,3,"['Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'MAPK6/MAPK4 signaling']"
Cdc14b,0.119947076,0.29881915,3,['MAPK6/MAPK4 signaling']
Cdc16,0.23046534,0.31449094,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cdc20,0.2968286,0.5275925,3,"['Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components', 'Inactivation of APC/C via direct inhibition of the APC/C complex', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of Emi1', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Ub-specific processing proteases', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cdc20b,0.15749617,0.44351614,3,
Cdc23,0.22492579,0.41770744,3,
Cdc25a,0.52120113,0.29550564,3,"['Activation of ATR in response to replication stress', 'Ub-specific processing proteases', 'Cyclin E associated events during G1/S transition ', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Cyclin A:Cdk2-associated events at S phase entry']"
Cdc25b,0.46232077,0.11861374,3,"['Cyclin A/B1/B2 associated events during G2/M transition', 'Cyclin A:Cdk2-associated events at S phase entry']"
Cdc25c,0.50751483,0.18310831,3,"['Polo-like kinase mediated events', 'Activation of ATR in response to replication stress', 'RHO GTPases activate PKNs', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex']"
Cdc26,0.17738101,0.25311175,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cdc27,0.28485557,0.3460068,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cdc34,0.3264171,0.22420928,3,"['Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'CLEC7A (Dectin-1) signaling', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cdc34b,0.160602,0.07401144,3,
Cdc37,0.4979909,-0.02971949,1,"['Signaling by ERBB2', 'Regulation of necroptotic cell death', 'Downregulation of ERBB2 signaling', 'RHOBTB2 GTPase cycle', 'Drug-mediated inhibition of ERBB2 signaling']"
Cdc37l1,0.0134520745,0.026523402,2,['Platelet degranulation ']
Cdc40,-0.18220936,0.4863789,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Cdc42,0.58217466,-0.2974038,1,"['GPVI-mediated activation cascade', 'EGFR downregulation', 'Regulation of actin dynamics for phagocytic cup formation', 'CD28 dependent Vav1 pathway', 'EPHB-mediated forward signaling', 'DCC mediated attractive signaling', 'VEGFA-VEGFR2 Pathway', 'Myogenesis', 'RHO GTPases activate KTN1', 'RHO GTPases activate IQGAPs', 'RHO GTPases activate PAKs', 'RHO GTPases Activate WASPs and WAVEs', 'RHO GTPases Activate Formins', 'MAPK6/MAPK4 signaling', 'G beta:gamma signalling through CDC42', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Cdc42bpa,0.15706721,-0.20015402,1,"['RAC1 GTPase cycle', 'RHOQ GTPase cycle']"
Cdc42bpb,0.029066084,-0.24968064,2,['RHOQ GTPase cycle']
Cdc42bpg,-0.15525775,-0.19047597,2,
Cdc42ep1,0.13944288,0.033900194,1,
Cdc42ep2,-0.029414888,-0.06753851,2,"['MAPK6/MAPK4 signaling', 'RHOQ GTPase cycle']"
Cdc42ep3,0.03506037,0.03719521,3,"['MAPK6/MAPK4 signaling', 'RHOQ GTPase cycle']"
Cdc42ep4,0.091583185,-0.050118588,2,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle']"
Cdc42ep5,-0.01505818,0.0435172,2,['MAPK6/MAPK4 signaling']
Cdc45,0.27840135,0.41663307,3,"['Activation of ATR in response to replication stress', 'Activation of the pre-replicative complex']"
Cdc5l,-0.1049765,0.62212056,0,['mRNA Splicing - Major Pathway']
Cdc6,0.34627336,0.4448697,3,"['Activation of ATR in response to replication stress', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6']"
Cdc7,0.30038798,0.22933137,3,"['Activation of ATR in response to replication stress', 'Activation of the pre-replicative complex']"
Cdc73,0.2752615,0.24625154,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the beta-catenin:TCF transactivating complex', ""Hedgehog 'on' state"", 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Cdca2,0.058940265,0.3599993,3,
Cdca3,0.12314711,0.37854394,3,
Cdca4,-0.14490397,-0.018286193,2,
Cdca5,-0.01410628,0.38067266,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Resolution of Sister Chromatid Cohesion']"
Cdca7,-0.08850496,0.38406044,3,
Cdca7l,0.12890694,0.00062702375,3,
Cdca8,0.2764123,0.5180634,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA replication proteins', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cdcp1,0.066709206,0.021927109,1,
Cdcp3,-0.11227154,-0.05207144,2,
Cdh1,0.57982075,-0.16572009,1,
Cdh10,0.015963677,-0.1489196,2,['Adherens junctions interactions']
Cdh11,0.24854556,-0.15180475,1,['Adherens junctions interactions']
Cdh12,0.19625573,0.016396709,3,['Adherens junctions interactions']
Cdh13,-0.03512561,-0.09815611,2,['Adherens junctions interactions']
Cdh15,0.2849885,-0.14923213,1,"['Adherens junctions interactions', 'Myogenesis']"
Cdh17,0.27800837,-0.33890587,1,['Adherens junctions interactions']
Cdh18,0.21544383,0.11012869,3,['Adherens junctions interactions']
Cdh2,0.5412629,-0.26570362,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Adherens junctions interactions', 'Myogenesis', 'Post-translational protein phosphorylation']"
Cdh20,0.13875152,0.11071595,3,
Cdh22,0.15270819,-0.11518037,1,
Cdh23,0.15590219,-0.27309456,1,
Cdh24,0.16004567,-0.055076174,1,['Adherens junctions interactions']
Cdh26,0.19835348,-0.08650824,1,
Cdh3,0.3965478,-0.23427305,1,['Adherens junctions interactions']
Cdh4,0.37231153,-0.11496025,1,"['Adherens junctions interactions', 'Myogenesis']"
Cdh5,0.41764677,-0.35057524,1,"['Adherens junctions interactions', 'VEGFR2 mediated vascular permeability']"
Cdh6,0.18287618,-0.09009997,1,['Adherens junctions interactions']
Cdh7,-0.059782367,-0.25772202,2,['Adherens junctions interactions']
Cdh8,0.07355498,-0.2353957,1,['Adherens junctions interactions']
Cdh9,0.043877788,-0.118921526,1,
Cdhr1,0.028110785,0.12999563,3,
Cdhr2,-0.10179893,-0.05454511,2,
Cdhr5,-0.23776495,-0.03755052,2,
Cdip1,-0.07482366,0.035949796,2,
Cdipt,0.1766668,-0.20263249,1,['Synthesis of PI']
Cdk1,0.44164068,0.43115973,3,"['MAPK3 (ERK1) activation', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Regulation of APC/C activators between G1/S and early anaphase', 'Phosphorylation of the APC/C', 'Phosphorylation of Emi1', 'Condensation of Prophase Chromosomes', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Activation of NIMA Kinases NEK9, NEK6, NEK7', 'Initiation of Nuclear Envelope (NE) Reformation', 'Nuclear Pore Complex (NPC) Disassembly', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Depolymerisation of the Nuclear Lamina', 'Anchoring of the basal body to the plasma membrane', 'MAPK6/MAPK4 signaling', 'Ovarian tumor domain proteases', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'Regulation of TP53 Degradation', 'Mitotic Prophase', 'Cyclin A/B1/B2 associated events during G2/M transition', 'G2/M DNA replication checkpoint', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'Transcriptional regulation by RUNX2']"
Cdk10,-0.14524092,-0.017064499,2,
Cdk11b,0.16541857,0.14831527,3,['Recruitment of mitotic centrosome proteins and complexes']
Cdk12,0.09847746,0.50161564,0,['TP53 Regulates Transcription of DNA Repair Genes']
Cdk13,0.24336255,0.4567369,3,"['TP53 Regulates Transcription of DNA Repair Genes', 'Neutrophil degranulation']"
Cdk14,0.1935045,0.30380148,3,
Cdk15,0.10846476,0.2984023,3,
Cdk16,0.10764139,0.2946821,3,
Cdk17,0.07423645,0.2094723,3,
Cdk18,0.035884693,0.35766542,3,
Cdk19,0.16505414,0.24144633,3,
Cdk2,0.5482122,0.4337713,3,"['G0 and Early G1', 'Telomere Extension By Telomerase', 'Activation of ATR in response to replication stress', 'Regulation of APC/C activators between G1/S and early anaphase', 'SCF(Skp2)-mediated degradation of p27/p21', 'Senescence-Associated Secretory Phenotype (SASP)', 'DNA Damage/Telomere Stress Induced Senescence', 'Processing of DNA double-strand break ends', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'G2 Phase', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'p53-Dependent G1 DNA Damage Response', 'Cyclin A:Cdk2-associated events at S phase entry', 'PTK6 Regulates Cell Cycle', 'Transcriptional regulation of granulopoiesis']"
Cdk20,0.1076143,0.25703818,3,
Cdk2ap1,0.1585805,0.19252175,3,
Cdk4,0.5893647,0.34564105,3,"['SCF(Skp2)-mediated degradation of p27/p21', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'RMTs methylate histone arginines', 'Cyclin D associated events in G1', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates Cell Cycle', 'Transcriptional regulation by RUNX2', 'Transcriptional regulation of granulopoiesis', 'Drug-mediated inhibition of CDK4/CDK6 activity']"
Cdk5,0.5422458,0.104025915,3,"['DARPP-32 events', 'CRMPs in Sema3A signaling', 'Regulation of TP53 Activity through Phosphorylation', 'NGF-stimulated transcription']"
Cdk5r1,0.24245691,-0.06923708,1,"['CRMPs in Sema3A signaling', 'Regulation of TP53 Activity through Phosphorylation', 'NGF-stimulated transcription']"
Cdk5r2,-0.029352428,-0.18123545,2,['NGF-stimulated transcription']
Cdk5rap1,-0.35146937,-0.020371703,2,
Cdk5rap2,0.08105291,0.1036992,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cdk5rap3,-0.05444408,0.1432917,2,
Cdk6,0.44114557,0.19419825,3,"['Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Cyclin D associated events in G1', 'Regulation of RUNX1 Expression and Activity', 'Drug-mediated inhibition of CDK4/CDK6 activity']"
Cdk7,0.2659572,0.37239248,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Cyclin A:Cdk2-associated events at S phase entry', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Cdk8,0.2729751,0.37744933,3,['SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription']
Cdk9,0.39241615,0.30625197,3,"['Formation of RNA Pol II elongation complex ', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Transcription Elongation', 'Estrogen-dependent gene expression']"
Cdkal1,-0.17614244,-0.09457716,2,
Cdkl1,-0.1518462,0.05018438,2,
Cdkl2,-0.2735722,0.031598814,2,
Cdkl5,0.11264969,-0.32107916,1,
Cdkn1a,0.53528726,0.21931075,3,"['SCF(Skp2)-mediated degradation of p27/p21', 'AKT phosphorylates targets in the cytosol', 'Senescence-Associated Secretory Phenotype (SASP)', 'DNA Damage/Telomere Stress Induced Senescence', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'p53-Dependent G1 DNA Damage Response', 'Cyclin A:Cdk2-associated events at S phase entry', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Transcriptional regulation of granulopoiesis']"
Cdkn1b,0.6563621,0.2645355,3,"['SCF(Skp2)-mediated degradation of p27/p21', 'AKT phosphorylates targets in the cytosol', 'Senescence-Associated Secretory Phenotype (SASP)', 'DNA Damage/Telomere Stress Induced Senescence', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'p53-Dependent G1 DNA Damage Response', 'Cyclin A:Cdk2-associated events at S phase entry', 'PTK6 Regulates Cell Cycle', 'FLT3 Signaling', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling']"
Cdkn1c,0.5082767,0.07377035,3,['Cyclin D associated events in G1']
Cdkn2a,0.44534436,0.009583408,3,
Cdkn2aip,-0.32457468,0.019381506,2,
Cdkn2aipnl,-0.04339299,0.009956592,0,
Cdkn2b,0.39347112,0.1638151,3,"['Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Cyclin D associated events in G1']"
Cdkn2c,0.31438044,-0.023970759,3,
Cdkn2d,0.23894793,0.3132877,3,
Cdkn3,0.09195798,0.37170357,3,
Cdnf,0.04989239,-0.024951505,3,
Cdo1,-0.15495504,-0.20849174,2,['Degradation of cysteine and homocysteine']
Cdon,0.24055937,-0.07531549,1,"['Myogenesis', 'Ligand-receptor interactions', 'Activation of SMO']"
Cdr2,0.12380335,-0.10123234,1,
Cdr2l,-0.17872164,-0.2578221,2,
Cdrt4,-0.2673409,-0.17112058,2,
Cds1,-0.22533067,-0.0897899,2,['Synthesis of PI']
Cds2,-0.20371602,-0.26167443,2,['Synthesis of PG']
Cdsn,0.02469204,0.05038028,2,['Formation of the cornified envelope']
Cdt1,0.24330139,0.53780264,3,"['Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Cdx1,0.108434565,-0.17891875,1,
Cdx2,0.28865048,0.08421207,3,
Cdx4,-0.22514784,-0.0038824508,2,
Cdyl,0.07947906,0.11531703,3,
Cdyl2,-0.1490937,-0.036783908,2,
Ceacam1,0.32884866,-0.23063986,1,"['Fibronectin matrix formation', 'Post-translational modification: synthesis of GPI-anchored proteins', 'Cell surface interactions at the vascular wall', 'Neutrophil degranulation']"
Ceacam10,-0.016788341,0.045897808,2,
Ceacam11,-0.32363737,-0.11231287,2,
Ceacam12,-0.17609543,-0.006042151,2,
Ceacam16,-0.11847983,-0.020707555,2,
Ceacam18,-0.2754032,-0.1535297,2,
Ceacam19,-0.11275599,-0.07842732,2,
Ceacam20,-0.10431689,0.11211196,2,
Ceacam5,0.14294432,-0.12185298,1,
Cebpa,0.46178013,0.096447684,3,['Transcriptional regulation of granulopoiesis']
Cebpb,0.47756794,0.10907436,3,['Senescence-Associated Secretory Phenotype (SASP)']
Cebpe,-0.016831713,0.046603378,2,
Cebpg,0.12951027,-0.053273696,1,
Cebpz,-0.10786975,0.36050034,0,
Cebpzos,-0.24111208,0.058570497,2,
Cecr2,0.13965796,0.40649962,3,
Cel,-0.06184328,-0.29163632,2,['Digestion of dietary lipid']
Cela1,-0.15560658,0.049881473,2,
Cela2a,-0.08120829,-0.07948786,2,['Formation of the cornified envelope']
Cela3a,-0.14932975,-0.07283294,2,
Cela3b,-0.08932053,-0.08985395,2,
Celf1,-0.04285783,0.14030732,0,
Celf2,-0.11179978,0.014578226,2,
Celsr1,0.048824806,-0.051806808,2,
Celsr2,-0.02464812,-0.045016624,2,
Celsr3,0.16806175,-0.038205992,1,
Cemip,-0.071153894,-0.15120497,2,['Hyaluronan biosynthesis and export']
Cemip2,-0.15317765,-0.16814506,2,
Cend1,0.07445421,-0.15258816,1,
Cenpa,0.21587127,0.5923859,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpb,0.10322702,0.13673972,3,
Cenpc1,0.13410957,0.32357216,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpe,0.19134763,0.428059,3,
Cenpf,0.17214036,0.3354864,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenph,0.023304919,0.37050048,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpi,0.15122603,0.47037897,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpj,-0.015721127,0.09283401,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain', 'AURKA Activation by TPX2']"
Cenpk,0.05554662,0.4075824,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpl,-0.03895338,0.23864688,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpm,0.11514403,0.1944962,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpn,0.10772117,0.41279608,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpo,-0.17408812,0.19867465,2,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpp,0.08014141,0.3791344,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpq,-0.07859359,0.14977245,2,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenps,0.120362476,0.39928842,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Fanconi Anemia Pathway', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpt,-0.0057043093,0.31487063,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpu,0.11771288,0.16338791,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Cenpv,-0.3313789,-0.17686257,2,
Cenpw,0.07917065,0.34989628,3,['Deposition of new CENPA-containing nucleosomes at the centromere']
Cenpx,-0.017529301,0.2977444,3,"['Deposition of new CENPA-containing nucleosomes at the centromere', 'Fanconi Anemia Pathway']"
Cep104,-0.2609365,-0.028469611,2,
Cep112,-0.20154998,0.02951249,2,
Cep120,0.01719585,0.2654005,3,
Cep128,-0.048602935,0.032053772,2,
Cep131,-0.07891149,-0.13275434,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep135,-0.0393225,0.280654,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep152,0.01537307,0.1802835,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep162,-0.21045418,-0.111458145,2,['Anchoring of the basal body to the plasma membrane']
Cep164,0.24420075,0.1794739,3,
Cep170,-0.09073689,0.052303076,2,
Cep170b,-0.20113584,0.10879791,2,
Cep19,-0.10702073,0.18540218,2,
Cep192,0.09282863,-0.000732076,1,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep20,-0.068195835,0.063983135,2,
Cep290,-0.021237265,-0.13905089,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'Neutrophil degranulation', 'AURKA Activation by TPX2']"
Cep295,-0.30798993,0.06608751,2,
Cep295nl,-0.33002564,0.053414073,2,
Cep350,-0.035031006,0.34011057,3,
Cep41,-0.19394706,0.08556515,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep43,0.023521403,0.053281214,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep44,-0.2146748,-0.045221347,2,
Cep55,0.27349627,0.456956,3,
Cep57,-0.09497166,0.01884991,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep57l1,-0.2736995,-0.07645517,2,
Cep63,0.19677849,-0.038111344,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep68,-0.10616037,-0.110828005,2,
Cep70,-0.08152138,-0.053636327,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep72,0.010343937,-0.10313141,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep76,0.0067093126,0.096688695,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep78,-0.013849365,0.06305369,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Cep83,0.05084911,0.0060886736,2,['Anchoring of the basal body to the plasma membrane']
Cep85,-0.13026206,-0.057032578,2,
Cep85l,-0.083560705,-0.029668916,2,
Cep89,0.04004475,-0.09680727,1,['Anchoring of the basal body to the plasma membrane']
Cep97,0.04628012,0.030833365,2,"['Anchoring of the basal body to the plasma membrane', 'RHOV GTPase cycle']"
Cept1,-0.03464701,-0.07058662,2,"['Synthesis of PC', 'Synthesis of PE']"
Cer1,0.091056906,0.05154848,3,['Signaling by BMP']
Cerk,-0.2794931,-0.15370263,2,['Glycosphingolipid metabolism']
Cerkl,-0.3476814,-0.08366096,2,
Cers1,-0.20090362,-0.07509196,2,['Sphingolipid de novo biosynthesis']
Cers2,-0.032452494,-0.12793249,2,['Sphingolipid de novo biosynthesis']
Cers3,-0.2184672,0.044248283,2,['Sphingolipid de novo biosynthesis']
Cers4,-0.22036822,-0.094652764,2,['Sphingolipid de novo biosynthesis']
Cers5,-0.23438236,0.08320165,2,['Sphingolipid de novo biosynthesis']
Cers6,-0.21389827,-0.15957238,2,['Sphingolipid de novo biosynthesis']
Cert1,-0.08812778,-0.16984718,2,
Ces1c,-0.22909315,-0.10663761,2,
Ces1d,-0.18662661,0.037798718,2,"['Metabolism of Angiotensinogen to Angiotensins', 'Phase I - Functionalization of compounds', 'Physiological factors', 'Aspirin ADME']"
Ces1e,-0.27574554,0.04513094,2,
Ces1f,-0.16696353,-0.14375809,2,
Ces1g,-0.22908893,0.046586618,2,
Ces2a,-0.33910453,-0.08900228,2,
Ces2b,-0.32910812,-0.084007725,2,
Ces2c,-0.16400684,0.04392077,2,
Ces2e,-0.14827065,-0.0081538325,2,
Ces2g,-0.16693354,0.03436765,2,
Ces2h,-0.33962342,-0.08653278,2,"['Phase I - Functionalization of compounds', 'Aspirin ADME']"
Ces3a,-0.23642765,-0.11448282,2,"['Phase I - Functionalization of compounds', 'LDL clearance']"
Ces3b,-0.24514288,-0.077332586,2,
Ces5a,-0.3120425,0.0714339,2,
Cetn1,-0.056917265,0.07839038,2,['Aggrephagy']
Cetn2,0.3489896,0.5335485,3,"['Regulation of PLK1 Activity at G2/M Transition', 'SUMOylation of DNA damage response and repair proteins', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'AURKA Activation by TPX2']"
Cetn3,0.12125933,0.27352598,3,
Cetn4,-0.15083283,0.15791228,2,
Cfap100,-0.4873125,-0.09375249,2,
Cfap126,-0.17824242,-0.0778712,2,
Cfap157,-0.0986946,0.028224545,2,
Cfap206,-0.08531088,-0.022639994,2,
Cfap20dc,-0.22859815,0.17229216,2,
Cfap221,-0.15085661,0.19038221,2,
Cfap299,-0.35005087,-0.16246374,2,
Cfap36,-0.20659053,-0.0029255769,2,
Cfap418,-0.08784889,-0.039535414,2,
Cfap43,-0.22240531,0.1663222,0,
Cfap44,-0.104941055,-0.00527026,2,
Cfap45,-0.12818067,0.19700018,2,
Cfap52,-0.37267333,0.25841972,2,
Cfap53,-0.40761745,0.06421537,2,
Cfap54,-0.2154948,-0.034378614,2,
Cfap58,-0.023639008,0.13307448,3,
Cfap61,-0.107491694,-0.06378874,2,
Cfap65,-0.18459606,0.064685024,2,
Cfap69,-0.14581974,0.11951478,2,
Cfap73,-0.30660772,-0.12123155,2,
Cfap91,-0.28889686,-0.06303406,2,
Cfb,-0.0381563,-0.1527919,2,"['Alternative complement activation', 'Activation of C3 and C5', 'Regulation of Complement cascade']"
Cfc1,-0.09925706,-0.15632372,2,
Cfd,0.10051567,-0.23002775,1,"['Platelet degranulation ', 'Alternative complement activation', 'Neutrophil degranulation']"
Cfdp1,0.15064406,0.32454753,3,
Cfh,0.03562837,-0.09838541,1,
Cfhr1,-0.06662471,-0.23656903,2,['Regulation of Complement cascade']
Cfhr2,-0.09265586,-0.055217683,2,
Cfhr4,-0.21959786,-0.06359235,2,['Regulation of Complement cascade']
Cfi,-0.10284779,-0.1091515,2,['Regulation of Complement cascade']
Cfl1,0.47458988,-0.008906299,1,
Cfl2,0.19663677,-0.1923553,1,
Cflar,0.39829168,-0.038431566,3,"['Regulation by c-FLIP', 'CASP8 activity is inhibited', 'Regulation of TNFR1 signaling', 'Dimerization of procaspase-8', 'TRAIL  signaling']"
Cfp,0.031619873,-0.24371563,1,"['Alternative complement activation', 'Activation of C3 and C5', 'O-glycosylation of TSR domain-containing proteins', 'Neutrophil degranulation', 'Regulation of Complement cascade']"
Cftr,0.25925964,-0.02449352,3,"['ABC-family proteins mediated transport', 'RHO GTPases regulate CFTR trafficking', 'Ub-specific processing proteases', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'RHOQ GTPase cycle', 'Aggrephagy']"
Cga,0.0014231765,-0.11173281,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glycoprotein hormones', 'Thyroxine biosynthesis', 'Hormone ligand-binding receptors', 'G alpha (s) signalling events', 'TFAP2 (AP-2) family regulates transcription of growth factors and their receptors', 'Reactions specific to the complex N-glycan synthesis pathway']"
Cgas,0.15116675,0.25768074,3,
Cgn,0.25092426,0.07334834,3,
Cgnl1,0.22230534,-0.12986343,3,
Ch25h,-0.23494639,-0.13470544,2,['Synthesis of bile acids and bile salts']
Chac1,0.08044256,-0.22432132,1,['Glutathione synthesis and recycling']
Chac2,-0.10803888,-0.012791231,2,['Glutathione synthesis and recycling']
Chad,-0.08622634,-0.28023052,1,
Chaf1a,0.16972284,0.52127814,3,
Chaf1b,0.23165998,0.41104808,3,
Champ1,-0.012869252,0.29938412,3,
Chat,0.056821138,-0.16289096,1,
Chchd1,-0.101468936,0.0019521795,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Chchd10,-0.012531667,0.089753054,0,
Chchd2,0.13358322,-0.10914172,1,
Chchd3,-0.20207445,-0.12001427,2,
Chchd4,0.045431327,0.19545807,3,
Chchd6,-0.12971179,-0.076721855,2,
Chchd7,-0.13946128,-0.008020888,2,
Chd1,0.14173988,0.58339125,0,
Chd1l,0.22752202,0.38277647,3,"['Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER']"
Chd2,-0.12213751,0.29579416,2,
Chd3,0.23596151,0.44904858,3,"['HDACs deacetylate histones', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Chd4,0.19155927,0.34104747,3,"['HDACs deacetylate histones', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription', 'NGF-stimulated transcription']"
Chd5,0.16103622,0.29426217,3,
Chd6,-0.058326762,0.26203507,3,
Chd7,0.19738312,0.17791851,3,
Chd8,0.384135,0.33847347,3,['Deactivation of the beta-catenin transactivating complex']
Chd9,0.20904183,0.27711716,3,"['Regulation of lipid metabolism by PPARalpha', 'Cytoprotection by HMOX1']"
Chdh,-0.111783445,-0.14100763,2,['Choline catabolism']
Chek1,0.46968597,0.41228637,3,"['Signaling by SCF-KIT', 'Activation of ATR in response to replication stress', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Transcriptional Regulation by E2F6']"
Chek2,0.49792725,0.29330075,3,"['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'G2/M DNA damage checkpoint', 'Stabilization of p53', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex']"
Cherp,0.024643535,0.41733336,0,
Chfr,0.12958069,0.18552113,3,
Chga,0.0450363,-0.11864226,1,['Antimicrobial peptides']
Chgb,-0.19879736,-0.06821182,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Chia1,-0.17517358,-0.078147136,2,['Digestion of dietary carbohydrate']
Chic1,-0.17611428,-0.04043643,2,
Chid1,-0.14502476,0.06978401,2,['Platelet degranulation ']
Chil1,0.045688506,-0.12142167,1,['Neutrophil degranulation']
Chil3,0.2237866,0.08008204,3,
Chil5,-0.08789117,0.03927103,2,
Chil6,-0.20000067,0.0065025124,2,
Chit1,-0.3616268,0.006344034,2,"['Digestion of dietary carbohydrate', 'Neutrophil degranulation']"
Chka,-0.033540044,-0.20073529,1,"['Synthesis of PC', 'Synthesis of PE']"
Chkb,-0.03838775,-0.14868523,2,"['Synthesis of PC', 'Synthesis of PE']"
Chl1,0.031391192,-0.28470886,1,
Chm,-0.078134835,-0.1131759,2,
Chml,-0.03259519,-0.09556928,2,
Chmp1a,-0.035953674,0.011685963,2,
Chmp2a,0.19369747,-0.038391735,3,"['Macroautophagy', 'Lysosome Vesicle Biogenesis', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chmp2b,0.3218821,0.042562544,3,"['Macroautophagy', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chmp3,0.11895213,0.09944638,3,"['Macroautophagy', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chmp4b,0.15228963,-0.0993592,1,"['Macroautophagy', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chmp4c,0.19891219,0.0110286465,3,"['Macroautophagy', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chmp5,0.13612181,0.13386881,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Chmp6,0.12146492,-0.00041324558,3,"['Macroautophagy', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chmp7,0.06641359,0.048642445,3,"['Macroautophagy', 'Pyroptosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Chn1,0.2732428,-0.16526704,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Chn2,0.13077845,-0.10326445,1,['RAC1 GTPase cycle']
Chordc1,0.116431795,0.008631032,3,
Chp1,-0.09060576,-0.095574655,2,['Hyaluronan uptake and degradation']
Chpf,-0.07768127,-0.051292498,2,['Chondroitin sulfate biosynthesis']
Chpf2,-0.14396942,-0.19890574,2,['Chondroitin sulfate biosynthesis']
Chpt1,0.0537935,-0.115981266,1,['Synthesis of PC']
Chrac1,0.15294063,0.20607917,3,
Chrd,0.024804698,0.055779446,2,
Chrdl1,-0.125105,0.010207703,2,"['Signaling by BMP', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Chrdl2,-0.10132312,0.07673762,2,
Chrm1,0.09870998,-0.27758145,1,"['Muscarinic acetylcholine receptors', 'G alpha (q) signalling events']"
Chrm2,0.18615384,-0.1357595,1,"['Muscarinic acetylcholine receptors', 'G alpha (i) signalling events', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Chrm3,-0.12891136,-0.27797624,2,"['Muscarinic acetylcholine receptors', 'G alpha (q) signalling events']"
Chrm4,0.028725838,-0.2899612,1,"['Muscarinic acetylcholine receptors', 'G alpha (i) signalling events']"
Chrm5,-0.16263306,-0.3811321,2,"['Muscarinic acetylcholine receptors', 'G alpha (q) signalling events']"
Chrna1,0.081983,-0.08399479,1,"['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrna10,-0.20266156,-0.09145768,2,
Chrna2,0.12078851,-0.08762898,1,"['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrna3,0.35830358,-0.23360795,1,"['Highly sodium permeable postsynaptic acetylcholine nicotinic receptors', 'Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrna4,0.0944531,-0.114205554,1,"['Highly sodium permeable postsynaptic acetylcholine nicotinic receptors', 'Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrna5,-0.049060605,-0.06699491,2,"['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrna6,-0.028728852,-0.11584571,1,"['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrna7,0.13315289,-0.16675141,1,['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors']
Chrna9,-0.2914562,-0.06875478,2,['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors']
Chrnb1,0.04229603,-0.22217736,1,
Chrnb2,0.015701896,-0.23775086,1,"['Highly sodium permeable postsynaptic acetylcholine nicotinic receptors', 'Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrnb3,-0.17609775,-0.050364062,2,"['Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors']"
Chrnb4,0.083896145,-0.03475649,1,"['Highly sodium permeable postsynaptic acetylcholine nicotinic receptors', 'Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors', 'Neutrophil degranulation']"
Chrnd,0.13760105,-0.15483975,1,['Highly sodium permeable postsynaptic acetylcholine nicotinic receptors']
Chrne,0.007697451,0.0056056962,2,['Highly sodium permeable postsynaptic acetylcholine nicotinic receptors']
Chrng,-0.089875534,-0.16419815,2,
Chst1,0.004529723,-0.17281796,2,['Keratan sulfate biosynthesis']
Chst10,-0.22984676,-0.02068296,2,['Reactions specific to the complex N-glycan synthesis pathway']
Chst11,-0.13976403,-0.124577515,2,['Chondroitin sulfate biosynthesis']
Chst12,-0.12037416,-0.11444373,2,['Chondroitin sulfate biosynthesis']
Chst13,-0.11374438,-0.1708604,2,['Chondroitin sulfate biosynthesis']
Chst14,-0.045220308,-0.07458514,2,['Dermatan sulfate biosynthesis']
Chst15,0.0005032896,0.022247395,2,['Chondroitin sulfate biosynthesis']
Chst2,-0.113803975,-0.19076078,2,['Keratan sulfate biosynthesis']
Chst3,0.015809635,-0.18499698,1,['Chondroitin sulfate biosynthesis']
Chst4,-0.030614218,-0.084755875,2,
Chst5,-0.122014135,-0.0658281,2,['Keratan sulfate biosynthesis']
Chst7,-0.13795924,-0.19183925,2,['Chondroitin sulfate biosynthesis']
Chst8,-0.12378077,-0.068861976,2,['Reactions specific to the complex N-glycan synthesis pathway']
Chst9,-0.31372833,-0.2783041,2,['Chondroitin sulfate biosynthesis']
Chsy1,-0.12370105,-0.22554779,1,['Chondroitin sulfate biosynthesis']
Chsy3,-0.0072488175,-0.08869276,1,['Chondroitin sulfate biosynthesis']
Chtf18,0.1137625,0.478592,3,
Chtop,-0.029555641,0.35171697,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Chuk,0.5436613,0.01697637,3,
Churc1,-0.21794696,-0.032434706,2,
Ciao1,-0.058061227,0.09384534,2,
Ciao2a,-0.15585272,0.14810574,2,
Ciao2b,-0.17524135,0.044037577,2,
Ciao3,-0.26163098,-0.02457073,2,
Ciapin1,-0.10067138,0.08046922,2,
Ciart,0.14093065,-0.03194371,3,
Cib1,0.02080539,0.1260161,3,
Cib2,-0.11584816,-0.040160507,2,
Cibar1,-0.17521346,0.10937578,2,
Cibar2,-0.24943635,-0.021830838,2,
Cic,-0.031806976,0.19038461,3,
Cidea,0.0496588,-0.14746594,2,['Lipid particle organization']
Cideb,0.03852664,-0.0037425773,1,
Cidec,0.019398937,-0.2408516,2,['Lipid particle organization']
Ciita,0.3823541,-0.027217569,3,
Cilp,0.10592617,-0.16972868,1,
Cilp2,-0.16077471,0.017732501,2,
Cinp,-0.1260749,0.03647978,2,
Cip2a,0.2929199,0.1584817,3,
Cipc,0.10105794,-0.013646485,3,
Cir1,0.028709533,0.22729687,0,
Cirbp,0.0038416884,0.11787817,2,
Cisd1,0.00524049,-0.09015175,2,
Cisd2,-0.007290545,-0.06502565,2,
Cisd3,-0.192139,-0.03650698,2,
Cish,0.37611008,-0.05338186,1,['Neddylation']
Cit,0.36848947,-0.01507493,1,
Cited1,0.14425716,0.19748755,3,"['Activation of the TFAP2 (AP-2) family of transcription factors', 'Estrogen-dependent gene expression']"
Cited2,0.1648517,0.12544672,3,"['Regulation of gene expression by Hypoxia-inducible Factor', 'Activation of the TFAP2 (AP-2) family of transcription factors']"
Cited4,-0.012853995,0.100407384,3,['Activation of the TFAP2 (AP-2) family of transcription factors']
Ciz1,0.09127934,0.1333738,3,
Ckap2,0.12532102,0.3822456,3,
Ckap2l,0.15658519,0.3245479,3,
Ckap4,-0.3484975,-0.1073333,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Surfactant metabolism', 'Neutrophil degranulation', 'Post-translational protein phosphorylation', 'RND3 GTPase cycle', 'RND2 GTPase cycle']"
Ckap5,0.26142132,0.4055165,3,
Ckb,-0.100265235,0.015150676,2,"['Creatine metabolism', 'RND3 GTPase cycle']"
Cklf,-0.06651189,-0.102533855,2,
Ckm,0.06349748,0.09634054,3,['Creatine metabolism']
Ckmt1,0.11353175,0.055066045,3,['Creatine metabolism']
Ckmt2,-0.015061843,-0.16327709,2,['Creatine metabolism']
Cks1b,0.31181592,0.37411207,3,"['SCF(Skp2)-mediated degradation of p27/p21', 'Cyclin D associated events in G1']"
Cks1brt,0.28474793,0.39644864,3,
Cks2,0.23953223,0.3939298,3,
Clasp1,-0.026997924,0.27091396,3,
Clasp2,0.16384684,0.23626158,3,
Clasrp,-0.08338522,0.04315725,2,
Clba1,-0.15159379,-0.041276503,2,
Clca1,-0.16855253,-0.047197893,2,['Stimuli-sensing channels']
Clca3a1,-0.061707903,-0.12174023,2,
Clca3a2,-0.1700351,0.06559224,2,
Clcc1,-0.0031008658,-0.3015842,1,
Clcf1,0.012086941,0.00798142,2,['IL-6-type cytokine receptor ligand interactions']
Clcn1,-0.063049674,0.0066598295,2,['Stimuli-sensing channels']
Clcn2,-0.19508083,-0.099107005,2,['Stimuli-sensing channels']
Clcn3,-0.30564833,-0.012863043,2,
Clcn5,0.09264359,0.026116554,1,['Stimuli-sensing channels']
Clcn6,-0.35868356,-0.15711547,2,['Stimuli-sensing channels']
Clcn7,-0.023614382,0.03518075,2,['Stimuli-sensing channels']
Clcnka,-0.20286459,0.12212373,2,['Stimuli-sensing channels']
Clcnkb,-0.10986657,0.17494534,2,['Stimuli-sensing channels']
Cldn1,0.1438317,-0.19121924,1,
Cldn10,0.02246356,-0.099165775,2,
Cldn11,0.06257721,-0.32430124,1,
Cldn12,-0.09298359,-0.21590322,2,
Cldn13,0.08106951,-0.047303062,1,
Cldn14,-0.14849727,-0.28180498,2,
Cldn15,-0.094193906,-0.011401527,2,
Cldn16,-0.00079965877,-0.19687685,2,
Cldn17,-0.24517177,-0.10345358,2,
Cldn18,-0.13035949,-0.021872554,2,
Cldn19,-0.004109376,-0.072111025,2,
Cldn2,0.061671622,-0.17507821,1,
Cldn23,-0.086495124,-0.070201375,2,
Cldn3,0.19368131,-0.18607326,1,
Cldn34b2,-0.32006884,0.09015602,2,
Cldn34d,-0.29785252,-0.1495603,2,
Cldn4,0.28782937,-0.16414806,1,
Cldn5,0.28334093,-0.17706569,1,
Cldn6,-0.17311098,-0.045419313,2,
Cldn7,0.20066395,-0.11092062,1,
Cldn8,-0.09034191,-0.28101915,2,
Cldn9,-0.047083944,-0.09061998,2,
Cldnd1,-0.372697,0.21685395,2,
Clec12a,-0.05707675,-0.18584436,2,
Clec14a,-0.22764142,-0.27362305,2,
Clec16a,-0.055215966,0.0015649021,2,
Clec1b,0.042222243,-0.26420835,1,"['GPVI-mediated activation cascade', 'Heme signaling']"
Clec2d,-0.17928565,-0.019081665,2,
Clec2e,-0.066697575,-0.016532458,2,
Clec2f,-0.20933299,-0.023451833,2,
Clec2g,-0.29757556,-0.07084494,2,
Clec2h,-0.15375276,0.04371856,2,
Clec2i,-0.20925403,-0.07879304,2,
Clec3a,0.035801046,0.045139562,2,
Clec3b,-0.25323337,0.120645374,2,
Clec4a2,0.044059254,-0.08960023,1,
Clec4a3,-0.14111446,-0.08984478,2,
Clec4a4,-0.038993593,0.029538885,0,
Clec4b1,-0.13391823,-0.16731626,2,
Clec4b2,-0.118338585,-0.14490242,2,
Clec4d,0.017983472,-0.1648412,1,"['Dectin-2 family', 'Neutrophil degranulation']"
Clec4e,0.15174356,-0.21228771,1,['Dectin-2 family']
Clec4n,0.06635764,-0.3827164,1,"['Dectin-2 family', 'Neutrophil degranulation']"
Clec5a,0.01059515,-0.17983963,1,"['DAP12 interactions', 'Neutrophil degranulation']"
Clec9a,0.081239425,-0.059209973,1,
Clgn,-0.05646926,-0.111273885,2,
Clhc1,-0.3285067,-0.064807825,2,
Clic1,-0.14150988,-0.10519733,2,
Clic3,-0.21494953,-0.118689075,2,
Clic4,0.21628594,0.00045618133,1,
Clic5,0.22666767,-0.06332,1,
Clic6,0.1965674,0.07743471,3,
Clint1,-0.07424485,-0.16966996,2,
Clip1,0.2176197,-0.04270004,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Clip2,-0.11507417,0.12933952,2,
Clip3,0.106053315,0.079863004,3,['Regulation of TNFR1 signaling']
Clip4,-0.06762451,0.35793647,3,
Clk1,0.04792977,0.19684146,0,
Clk2,-0.2061809,0.0749224,2,
Clk3,0.0046108994,0.08690396,3,
Clk4,-0.23378429,0.177724,0,
Clmn,-0.22644474,-0.07421372,2,
Clmp,-0.28028014,0.0021274106,2,
Cln3,-0.1674344,-0.06765515,2,
Cln5,-0.38127202,-0.02782297,2,
Cln6,-0.38468495,0.045555603,2,
Cln8,-0.35163814,-0.016829005,2,
Clnk,0.055434693,-0.26558048,1,
Clns1a,-0.17314525,0.39161754,0,
Clock,0.33278093,0.17821419,3,
Clp1,-0.13786902,0.4588586,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Clpb,-0.023022268,0.12596115,0,
Clpp,0.06907371,0.018616464,0,
Clps,-0.054062486,-0.08617731,2,"['Digestion of dietary lipid', 'Retinoid metabolism and transport']"
Clptm1l,0.10735171,0.2707564,3,
Clpx,-0.011462231,-0.023435324,2,
Clrn1,-0.10562732,-0.15007374,2,
Clspn,0.3032143,0.3307838,3,"['Apoptotic cleavage of cellular proteins', 'Activation of ATR in response to replication stress', 'Ub-specific processing proteases', 'Processing of DNA double-strand break ends']"
Clstn1,0.18997064,-0.080064684,1,
Clstn3,-0.32891238,-0.116541445,2,
Clta,0.117917314,-0.13993397,1,
Cltb,0.08705505,-0.28798953,1,"['Gap junction degradation', 'Formation of annular gap junctions', 'Lysosome Vesicle Biogenesis', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Cltc,0.30527535,-0.20630723,1,"['Retrograde neurotrophin signalling', 'Gap junction degradation', 'Formation of annular gap junctions', 'MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Recycling pathway of L1', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'VLDLR internalisation and degradation', 'LDL clearance', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Cltrn,-0.3481636,-0.300838,2,
Clu,0.22027563,-0.17073505,1,"['Platelet degranulation ', 'Terminal pathway of complement', 'Antimicrobial peptides', 'Regulation of Complement cascade']"
Cluap1,0.014362081,0.13942651,3,['Intraflagellar transport']
Cluh,-0.25608948,0.1606387,2,
Clvs1,-0.2549671,0.025865054,2,['Lysosome Vesicle Biogenesis']
Clvs2,-0.078009404,-0.003533387,2,['Lysosome Vesicle Biogenesis']
Clybl,0.03152906,-0.035036106,2,
Cma1,0.11290881,-0.17911388,1,"['Signaling by SCF-KIT', 'Activation of Matrix Metalloproteinases', 'Metabolism of Angiotensinogen to Angiotensins']"
Cmah,-0.09877021,-0.1656234,2,
Cmas,-0.17707306,-0.088955775,2,
Cmc1,-0.17601013,-0.11974441,2,
Cmc2,-0.17316768,-0.15442902,2,
Cmip,0.011583268,-0.13569325,2,
Cmklr1,-0.06602209,-0.04610462,2,['Class A/1 (Rhodopsin-like receptors)']
Cmpk1,-0.23275502,0.08734363,2,
Cmpk2,0.0765726,0.07049069,0,
Cmss1,-0.10774272,0.3370546,0,
Cmtm1,0.017073486,-0.19714175,1,
Cmtm2a,0.00023564686,-0.055770393,2,
Cmtm2b,-0.12087028,-0.12100291,2,
Cmtm3,-0.1351604,-0.022182722,2,
Cmtm4,-0.10162586,-0.10293282,2,
Cmtm5,-0.19979328,-0.07669613,2,
Cmtm6,-0.29992098,-0.043324083,2,['Neutrophil degranulation']
Cmtm7,-0.047519725,0.010241902,2,
Cmtm8,-0.2661368,-0.004221743,2,
Cmtr1,-0.04560515,0.26215395,0,
Cmtr2,-0.20188491,-0.19095737,2,
Cmya5,0.11735517,-0.017108042,3,
Cnbd1,-0.07391238,0.03178946,2,
Cnbd2,-0.052776195,-0.045811314,2,
Cnbp,0.06787835,0.12991309,0,
Cndp1,-0.33253902,-0.06480018,2,
Cndp2,-0.26436454,-0.022005582,2,"['Glutathione synthesis and recycling', 'Paracetamol ADME']"
Cnep1r1,0.18165433,-0.086116545,1,['Depolymerisation of the Nuclear Lamina']
Cnfn,-0.11665639,-0.13175601,2,
Cnga1,-0.08522728,-0.31207252,2,"['Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade']"
Cnga2,-0.07738434,-0.44119164,2,['VxPx cargo-targeting to cilium']
Cnga3,-0.16779561,-0.37532002,2,
Cnga4,-0.083643354,-0.24464779,2,['VxPx cargo-targeting to cilium']
Cngb1,-0.04099803,-0.46965393,1,"['Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade', 'VxPx cargo-targeting to cilium']"
Cngb3,-0.058029026,-0.44179067,1,
Cnih1,-0.178661,0.043755602,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Cnih2,-0.029299362,-0.26123756,1,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Cnih3,-0.018315466,-0.21098159,1,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Cnih4,-0.1752947,-0.045272894,2,
Cnksr1,0.009904515,-0.17545839,2,['MAP2K and MAPK activation']
Cnksr2,0.3816812,-0.19923548,1,['MAP2K and MAPK activation']
Cnksr3,-0.08012682,0.020306466,2,
Cnmd,-0.32587764,-0.1693137,2,
Cnn1,0.09978144,-0.09552918,1,
Cnn2,-0.09274028,-0.2153149,2,['Neutrophil degranulation']
Cnn3,-0.07667929,-0.14448667,2,
Cnnm1,-0.2527431,-0.07741225,2,
Cnnm2,-0.028230764,-0.06512632,2,
Cnnm3,-0.13893309,0.051274076,2,
Cnnm4,-0.34838808,-0.023337185,2,
Cnot1,-0.043105155,0.37199926,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot10,-0.03001865,0.32168415,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot11,-0.058869146,0.32703495,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot2,-0.088039294,0.30422717,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot3,-0.18106572,0.36000475,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot4,-0.01012628,0.419107,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot6,-0.10333023,0.4554061,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot6l,-0.03902353,0.39090157,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot7,-0.117191456,0.40246812,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot8,-0.15362854,0.4335013,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnot9,-0.00483636,0.34471428,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Cnp,0.11558315,-0.24116713,1,
Cnppd1,0.14587952,0.16813163,3,
Cnpy1,-0.2308578,-0.10723176,2,
Cnpy2,-0.053670052,0.04937687,2,
Cnpy3,-0.03223999,-0.031612232,2,['Trafficking and processing of endosomal TLR']
Cnpy4,0.15048562,-0.057847425,1,
Cnr1,0.34177268,-0.26424044,1,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Cnr2,0.06301524,-0.11326694,1,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Cnrip1,-0.027655568,-0.022892293,2,
Cnst,-0.11776907,-0.05838442,2,
Cntd1,-0.16335362,0.22451803,2,
Cntf,0.21027273,-0.2072684,1,['IL-6-type cytokine receptor ligand interactions']
Cntfr,0.02601078,-0.08933661,1,['IL-6-type cytokine receptor ligand interactions']
Cntln,0.17271611,0.045188747,3,
Cntn1,0.11684555,-0.32601357,1,
Cntn2,0.008966482,-0.2864599,1,
Cntn3,-0.14880195,-0.071836,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Cntn4,0.32314035,-0.08517085,1,
Cntn5,-0.09031085,-0.08123803,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Cntn6,-0.028104309,-0.054395888,2,
Cntnap1,0.11998742,-0.24833213,1,
Cntnap2,0.08888482,-0.08367688,1,
Cntnap4,0.17534542,-0.059252538,1,
Cntnap5a,-0.13441369,-0.057761043,2,
Cntnap5c,-0.14546944,0.05670142,2,
Cntrl,0.13084,0.08696916,3,
Cntrob,0.13529927,0.14040665,0,
Coa3,-0.25294662,-0.2761208,2,
Coa5,-0.19462317,0.07492612,2,
Coa6,-0.098669596,-0.112081,2,
Coasy,-0.19305684,-0.001291918,2,['Coenzyme A biosynthesis']
Cobl,-0.06753512,-0.056208722,2,
Cobll1,0.0766243,0.023378171,3,
Coch,-0.17809387,-0.0060424423,2,
Cog1,-0.038948648,-0.009726063,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Cog2,-0.13895461,0.042793367,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Cog3,-0.15227401,-0.07824213,2,
Cog4,-0.25242963,-0.096129894,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Cog5,-0.1735659,-0.13259456,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Cog6,-0.1377791,-0.04130054,2,
Cog7,-0.21374564,-0.083910875,2,
Cog8,-0.19015855,-0.08528777,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Coil,-0.066343434,0.36971328,0,
Col10a1,0.0407805,-0.30033424,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Non-integrin membrane-ECM interactions', 'Collagen chain trimerization']"
Col11a1,0.0644681,-0.034106717,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Non-integrin membrane-ECM interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col11a2,-0.07171875,-0.44187927,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Non-integrin membrane-ECM interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col12a1,-0.071018554,-0.16645776,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Collagen chain trimerization']"
Col13a1,-0.036250222,-0.22851586,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Integrin cell surface interactions', 'Collagen chain trimerization']"
Col14a1,-0.027306354,-0.19225563,2,"['Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Collagen chain trimerization']"
Col15a1,0.24183072,-0.21753813,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Collagen chain trimerization']"
Col16a1,0.020888256,-0.115973756,2,"['Collagen biosynthesis and modifying enzymes', 'Integrin cell surface interactions', 'Collagen chain trimerization']"
Col17a1,-0.14210717,-0.17664269,2,"['Collagen biosynthesis and modifying enzymes', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Type I hemidesmosome assembly', 'Collagen chain trimerization']"
Col18a1,0.2321759,-0.24964319,1,"['Collagen degradation', 'Activation of Matrix Metalloproteinases', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Collagen chain trimerization']"
Col19a1,-0.2498792,-0.39584357,2,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization']"
Col1a1,0.31061482,-0.25022194,1,"['GPVI-mediated activation cascade', 'Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Assembly of collagen fibrils and other multimeric structures', 'Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'Crosslinking of collagen fibrils', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'GP1b-IX-V activation signalling', 'Platelet Adhesion to exposed collagen', 'Platelet Aggregation (Plug Formation)', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col1a2,0.03877249,-0.17418079,1,"['GPVI-mediated activation cascade', 'Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Assembly of collagen fibrils and other multimeric structures', 'Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'Crosslinking of collagen fibrils', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'GP1b-IX-V activation signalling', 'Platelet Adhesion to exposed collagen', 'Platelet Aggregation (Plug Formation)', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col20a1,-0.13564368,-0.15892528,2,"['Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization']"
Col22a1,-0.101331055,0.018930672,2,"['Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization']"
Col23a1,-0.1613195,-0.079956055,2,"['Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization']"
Col26a1,-0.18932797,-0.25456956,2,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization']"
Col27a1,-0.15159924,-0.36057493,2,"['Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col28a1,-0.24536014,-0.1635827,2,"['Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization']"
Col2a1,0.17623618,-0.3242891,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col3a1,0.18670303,-0.25211444,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col4a1,0.07505292,-0.2960826,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Crosslinking of collagen fibrils', 'Laminin interactions', 'Non-integrin membrane-ECM interactions', 'NCAM1 interactions']"
Col4a2,0.029183693,-0.27051908,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Crosslinking of collagen fibrils', 'Laminin interactions', 'Non-integrin membrane-ECM interactions', 'NCAM1 interactions']"
Col4a3,0.11825526,-0.35059524,1,
Col4a4,-0.0663167,-0.22766663,1,"['Collagen biosynthesis and modifying enzymes', 'Integrin cell surface interactions']"
Col4a5,0.031569842,-0.25487214,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Crosslinking of collagen fibrils', 'Laminin interactions', 'Non-integrin membrane-ECM interactions']"
Col4a6,-0.08877221,-0.23889501,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Crosslinking of collagen fibrils', 'Laminin interactions', 'Non-integrin membrane-ECM interactions']"
Col5a1,0.045566656,-0.2539983,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col5a2,0.08375608,-0.25729522,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col5a3,0.027459316,-0.080736384,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Non-integrin membrane-ECM interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'MET activates PTK2 signaling', 'Collagen chain trimerization']"
Col6a1,0.0747577,-0.37585354,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'Collagen chain trimerization']"
Col6a2,0.053484283,-0.21468912,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'Collagen chain trimerization']"
Col6a3,0.052725136,-0.24882533,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'Collagen chain trimerization']"
Col6a4,0.0002828767,-0.32918265,1,
Col6a5,-0.031148685,-0.39499307,1,
Col6a6,0.02240843,-0.21130225,1,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'Collagen chain trimerization']"
Col7a1,0.13666977,-0.2051723,1,"['Collagen degradation', 'Extracellular matrix organization', 'Collagen biosynthesis and modifying enzymes', 'COPII-mediated vesicle transport', 'Integrin cell surface interactions', 'Anchoring fibril formation', 'Cargo concentration in the ER', 'Collagen chain trimerization']"
Col8a1,-0.120060936,-0.20717905,2,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Collagen chain trimerization']"
Col8a2,-0.1379635,-0.27551392,2,"['Collagen degradation', 'Collagen biosynthesis and modifying enzymes', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'Collagen chain trimerization']"
Col9a1,-0.013326578,-0.23298725,1,
Col9a2,-0.13154174,-0.27260035,2,
Col9a3,-0.052183695,-0.36249512,1,"['Collagen biosynthesis and modifying enzymes', 'Signaling by PDGF', 'Assembly of collagen fibrils and other multimeric structures', 'Integrin cell surface interactions', 'ECM proteoglycans', 'NCAM1 interactions', 'Collagen chain trimerization']"
Colca2,-0.07791568,-0.079955526,2,
Colec10,-0.08546273,-0.12347138,2,"['Lectin pathway of complement activation', 'Initial triggering of complement']"
Colec11,-0.10708655,-0.11855827,2,
Colgalt1,-0.25913787,-0.17424838,2,['Collagen biosynthesis and modifying enzymes']
Colgalt2,-0.13269961,-0.3067493,2,['Collagen biosynthesis and modifying enzymes']
Colq,-0.061498947,-0.14508663,2,
Commd1,0.2381593,0.12885271,3,['Neddylation']
Commd10,0.19152722,0.050712883,3,['Neddylation']
Commd1b,-0.13374658,-0.11963694,2,
Commd2,0.03168646,0.103507794,3,['Neddylation']
Commd3,-0.10306768,0.10567827,2,"['Neutrophil degranulation', 'Neddylation']"
Commd4,-0.027313448,0.14241442,3,['Neddylation']
Commd5,-0.047707457,0.008014024,2,
Commd6,-0.04250695,0.081133254,2,['Neddylation']
Commd7,0.013144425,0.009620202,2,['Neddylation']
Commd8,0.061127737,0.11157506,3,['Neddylation']
Commd9,0.056426562,0.017178841,3,"['Neutrophil degranulation', 'Neddylation']"
Comp,0.12999637,-0.28306592,1,"['Integrin cell surface interactions', 'ECM proteoglycans']"
Comt,0.0055383346,-0.23429734,1,"['Methylation', 'Enzymatic degradation of dopamine by COMT', 'Enzymatic degradation of Dopamine by monoamine oxidase']"
Comtd1,-0.07318772,-0.0488873,2,
Cop1,0.205364,0.2985663,3,"['Autodegradation of the E3 ubiquitin ligase COP1', 'Neddylation']"
Copa,-0.008266411,-0.16211693,1,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Copb1,-0.0006087319,-0.037355073,1,"['Neutrophil degranulation', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Copb2,-0.078902334,-0.02866188,0,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Cope,-0.11953831,0.04921773,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Copg1,0.0012649251,-0.09827016,1,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Copg2,-0.20690985,-0.1312841,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Coprs,0.079701304,0.13844706,3,['RMTs methylate histone arginines']
Cops2,0.25899926,0.21804124,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation', 'RHOBTB1 GTPase cycle']"
Cops3,0.29916623,0.1430026,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation']"
Cops4,0.3392769,0.2810071,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation', 'RHOBTB1 GTPase cycle']"
Cops5,0.3825592,0.21698824,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation']"
Cops6,0.17820239,0.18916465,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation']"
Cops7a,0.15553059,0.107933216,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation']"
Cops7b,0.22463518,0.17474543,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation']"
Cops8,0.27300918,0.25368646,3,"['DNA Damage Recognition in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation']"
Cops9,0.12546192,0.06801092,3,
Copz1,-0.006686779,0.0373601,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Copz2,-0.14762516,-0.022874132,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Coq10a,-0.18829775,-0.12295388,2,['Respiratory electron transport']
Coq10b,0.024965648,0.0057994286,2,
Coq2,0.076359995,-0.036312908,1,"['Mitochondrial protein import', 'Ubiquinol biosynthesis']"
Coq3,-0.19886605,-0.044380892,2,['Ubiquinol biosynthesis']
Coq4,-0.23438181,-0.101552516,2,
Coq5,-0.2149771,-0.14335603,2,
Coq6,-0.35606053,-0.10048494,2,
Coq7,-0.0368277,0.013295829,2,
Coq8a,-0.26290056,-0.09068477,2,
Coq8b,-0.051134765,-0.14382337,2,
Coq9,-0.08044571,-0.16124217,2,
Corin,0.14475024,-0.19270232,1,['Physiological factors']
Coro1a,0.26367,-0.069451265,1,
Coro1b,0.18185481,-0.009767122,1,
Coro1c,0.20991398,-0.04836055,1,
Coro2a,0.07648215,0.0961386,3,
Coro2b,-0.14385398,-0.18941648,2,
Coro7,-0.08110809,0.048265003,2,
Cort,-0.11764214,-0.3273478,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Cotl1,0.05476861,0.08462105,3,['Neutrophil degranulation']
Cox10,-0.016720472,-0.13536103,2,['Heme biosynthesis']
Cox11,-0.10535671,-0.099220656,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox14,-0.12681817,-0.09165742,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox15,-0.14342381,-0.14003083,2,['Heme biosynthesis']
Cox16,-0.07593759,-0.1894118,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox17,-0.07583296,-0.08797396,2,
Cox18,-0.16539098,-0.14614607,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox19,-0.110343486,0.057125594,0,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox20,-0.3380428,-0.012011449,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox4i1,0.19037849,-0.06011366,1,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox4i2,-0.10891626,-0.08202436,2,
Cox5a,-0.029416438,0.04064443,0,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox5b,0.03694063,-0.011882203,2,
Cox5b-ps,0.059304256,-0.10110847,1,
Cox6a1,-0.03512755,0.0012634306,0,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox6a2,0.041045696,-0.04646395,1,
Cox6b1,0.017973123,-0.086576425,1,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox6b2,0.066534184,0.071775354,2,
Cox6c,-0.008646004,-0.17105186,2,
Cox7a1,-0.06507291,-0.16275054,2,
Cox7a2,0.06775713,-0.042448483,1,
Cox7a2l,-0.21633379,-0.15815122,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox7b,-0.057833537,-0.093192086,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox7b2,-0.2357133,-0.06918682,2,
Cox7c,0.10732599,0.046249293,0,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox8a,-0.039433528,-0.1259535,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Cox8b,0.0003763543,-0.07672492,2,
Cox8c,-0.23848249,0.052267272,2,
Cp,0.108313486,-0.10121118,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Metal ion SLC transporters', 'Post-translational protein phosphorylation', 'Iron uptake and transport']"
Cpa1,-0.06671652,-0.19214563,2,
Cpa2,-0.21377638,-0.11502594,2,
Cpa3,-0.17463334,-0.23382556,2,['Metabolism of Angiotensinogen to Angiotensins']
Cpa4,-0.04883285,-0.081555784,2,
Cpa5,-0.25628284,0.035005964,2,
Cpb1,-0.11180637,-0.21514475,2,['Metabolism of Angiotensinogen to Angiotensins']
Cpb2,0.21120574,-0.08272212,1,"['Metabolism of Angiotensinogen to Angiotensins', 'Regulation of Complement cascade']"
Cpd,-0.030345565,-0.32326052,1,"['Golgi Associated Vesicle Biogenesis', 'RND3 GTPase cycle', 'RND1 GTPase cycle']"
Cpe,0.06394375,-0.2738436,1,
Cpeb1,0.15038966,0.48916838,0,
Cpeb2,0.016318854,0.47813997,0,
Cpeb3,0.058136165,0.5057241,0,
Cpeb4,-0.03823628,0.38297775,0,
Cphx1,-0.13540868,0.033083174,2,
Cplane2,-0.09215254,-0.0058514476,2,
Cplx1,-0.22880632,-0.07906527,2,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'GABA synthesis, release, reuptake and degradation']"
Cplx2,-0.27312165,-0.12912779,2,
Cplx3,-0.247524,-0.013880732,2,
Cplx4,-0.12846579,-0.0041376376,2,
Cpm,0.03910032,-0.16826643,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Cpn1,-0.027622707,-0.062216252,1,['Regulation of Complement cascade']
Cpn2,-0.17357327,-0.07629625,2,['Regulation of Complement cascade']
Cpne1,-0.041413683,0.12929334,2,"['Glycerophospholipid biosynthesis', 'Neutrophil degranulation']"
Cpne3,0.14293993,-0.1820288,1,"['Glycerophospholipid biosynthesis', 'Neutrophil degranulation']"
Cpne4,-0.09457527,0.10789131,2,
Cpne6,-0.097560875,-0.07753773,2,['Glycerophospholipid biosynthesis']
Cpne7,-0.22493325,-0.15716009,2,['Glycerophospholipid biosynthesis']
Cpox,-0.108370796,0.13186052,2,['Heme biosynthesis']
Cpped1,-0.057817835,0.026756492,2,['Neutrophil degranulation']
Cps1,-0.2397247,0.04615717,2,['Urea cycle']
Cpsf1,0.021193534,0.46389827,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cpsf2,-0.008621877,0.45923316,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cpsf3,0.011349388,0.51157093,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cpsf4,0.12064937,0.39025313,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cpsf4l,-0.15360126,0.26081997,2,
Cpsf6,0.16433315,0.41363677,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cpsf7,-0.19969049,0.40354082,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs', 'RHOBTB1 GTPase cycle']"
Cpt1a,0.00615874,-0.077327445,2,"['Carnitine metabolism', 'Signaling by Retinoic Acid']"
Cpt1b,-0.06815415,-0.17114024,2,"['Carnitine metabolism', 'Signaling by Retinoic Acid']"
Cpt1c,0.04918815,-0.25177103,1,
Cpt2,-0.03775541,-0.02461068,2,['Carnitine metabolism']
Cptp,-0.07626082,-0.18258852,2,['Glycosphingolipid metabolism']
Cpvl,-0.22043775,-0.06989541,2,
Cpxcr1,-0.15946819,-0.038848422,2,
Cpxm1,-0.13919286,-0.03891928,2,
Cpz,-0.15224573,-0.10756981,2,
Cr1l,-0.04599886,-0.013889937,2,"['Neutrophil degranulation', 'Regulation of Complement cascade']"
Cr2,0.07790154,-0.24424148,1,
Crabp1,-0.18392783,0.0031988034,2,['RA biosynthesis pathway']
Crabp2,0.20617999,0.1021028,3,['Signaling by Retinoic Acid']
Cracd,-0.19904728,0.10583509,0,
Cracdl,0.078733794,-0.022206072,1,
Cracr2a,-0.15256666,0.020613812,2,
Cradd,0.09080406,0.1015911,3,['TP53 Regulates Transcription of Caspase Activators and Caspases']
Cramp1,0.03848085,0.093071885,3,
Crat,-0.26167318,-0.006122709,2,"['Beta-oxidation of pristanoyl-CoA', 'Peroxisomal protein import']"
Crb1,0.104791634,-0.1623512,1,
Crb2,0.22864486,-0.12638919,1,
Crb3,-0.054915752,-0.06658586,2,
Crbn,0.17891793,0.24218354,3,
Crcp,0.14313337,0.37942833,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Creb1,0.62034744,-0.10834303,1,"['AKT phosphorylates targets in the nucleus', 'CREB phosphorylation', 'NCAM signaling for neurite out-growth', 'CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling', 'Gastrin-CREB signalling pathway via PKC and MAPK', 'NGF-stimulated transcription', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling']"
Creb3,0.24485746,0.10455733,3,
Creb3l1,0.15757798,-0.041853704,3,
Creb3l2,0.33638448,-0.025269309,3,
Creb3l3,0.3017514,0.023071216,3,['CREB3 factors activate genes']
Creb3l4,0.25833523,0.0042247837,3,
Creb5,0.2869338,-0.06444985,1,
Crebbp,0.58576006,0.16784067,3,
Crebl2,-0.24089214,-0.11591092,2,
Crebrf,-0.1183225,-0.0598876,2,['CREB3 factors activate genes']
Crebzf,-0.011338206,0.14686058,3,
Creg1,-0.092432246,-0.11679832,2,['Neutrophil degranulation']
Creg2,-0.26254475,-0.13622813,2,
Creld1,-0.21875313,0.03598741,2,
Creld2,0.059219066,0.059035033,2,
Crem,0.24182278,-0.009652861,3,
Crh,0.20956641,-0.3624791,1,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Crhbp,-0.24464853,-0.025228132,2,['Class B/2 (Secretin family receptors)']
Crhr1,0.14771411,-0.15167613,1,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Crhr2,0.0839438,-0.21052125,1,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Crip1,0.04247241,-0.080201,2,
Crip2,-0.040422577,0.00021732786,2,
Cript,-0.01679477,-0.22973378,1,
Crisp1,-0.2740949,-0.14350565,2,
Crisp2,-0.25648412,0.20400023,2,['Neutrophil degranulation']
Crisp3,-0.082835115,-0.030885944,2,
Crisp4,-0.06565575,-0.15945038,2,
Crispld1,-0.109222606,-0.021866413,2,
Crk,0.56330925,-0.3138275,1,"['ARMS-mediated activation', 'Downstream signal transduction', 'Regulation of actin dynamics for phagocytic cup formation', 'p130Cas linkage to MAPK signaling for integrins', 'VEGFA-VEGFR2 Pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'MET activates RAP1 and RAC1', 'MET receptor recycling', 'Regulation of signaling by CBL']"
Crkl,0.4919806,-0.4709783,1,"['Frs2-mediated activation', 'Downstream signal transduction', 'MET activates RAP1 and RAC1', 'MET receptor recycling', 'Erythropoietin activates RAS', 'Regulation of signaling by CBL']"
Crlf1,-0.056941673,0.05420095,2,"['IL-6-type cytokine receptor ligand interactions', 'Interleukin-27 signaling']"
Crlf2,0.0687346,-0.1786446,1,
Crlf3,0.024433605,0.26250523,3,
Crls1,-0.21331544,0.07091132,2,"['Acyl chain remodelling of PG', 'Synthesis of CL']"
Crmp1,-0.018103234,-0.024057869,2,['CRMPs in Sema3A signaling']
Crnkl1,-0.06157678,0.36054435,0,['mRNA Splicing - Major Pathway']
Crocc,-0.023836851,0.21941076,3,
Crot,-0.21540357,-0.018577881,2,"['Beta-oxidation of pristanoyl-CoA', 'Peroxisomal protein import']"
Crp,0.31932268,-0.27163064,1,['Classical antibody-mediated complement activation']
Crppa,-0.23612729,-0.1913538,2,
Crtam,-0.07145176,-0.13443899,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Crtap,-0.062245145,-0.20246042,1,['Collagen biosynthesis and modifying enzymes']
Crtc1,0.16467881,0.03172677,3,
Crtc2,0.20880638,-0.16769238,1,
Crtc3,0.11218526,-0.033071026,3,
Crx,0.0025718063,-0.121823415,2,
Cry1,0.20580666,0.2056813,3,
Cry2,0.23056681,0.20068379,3,
Cryaa,-0.073562436,-0.024554048,2,
Cryab,0.3108494,-0.14511518,1,['HSF1-dependent transactivation']
Cryba1,-0.19814666,-0.1671634,2,
Cryba2,-0.26712307,-0.25913018,2,
Cryba4,-0.069013454,-0.047144923,2,
Crybb1,-0.18415363,-0.0979717,2,
Crybb2,-0.16124924,-0.016604822,2,
Crybb3,-0.08177841,-0.049128234,2,
Cryga,-0.18649799,-0.07793692,2,
Crygb,-0.14522286,-0.13323717,2,
Crygc,-0.16104952,-0.080834165,2,
Crygd,-0.1700776,-0.068069644,2,
Cryge,-0.12959875,-0.25135815,2,
Crygf,-0.09586661,-0.13039532,2,
Crygn,-0.08350321,-0.09312042,2,
Crygs,-0.13711405,0.066039614,2,
Cryl1,-0.16262211,0.20003031,0,['Formation of xylulose-5-phosphate']
Crym,-0.23874113,0.010563604,2,['Lysine catabolism']
Cryz,0.12247389,0.1603107,3,
Cryzl1,-0.3011806,0.0060974415,2,
Cryzl2,-0.17442144,0.06360648,2,
Cs,-0.068269454,-0.0043146033,2,['Citric acid cycle (TCA cycle)']
Csad,-0.091652185,-0.36625624,1,
Csde1,0.086726665,0.2096676,0,
Cse1l,0.010961473,0.5994538,0,
Csf1,0.50673854,-0.21128674,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Other interleukin signaling', 'Post-translational protein phosphorylation']"
Csf1r,0.43387482,-0.3834947,1,['Other interleukin signaling']
Csf2,0.40143245,-0.23923986,1,"['Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RAF/MAP kinase cascade', 'Interleukin receptor SHC signaling']"
Csf2ra,0.38893047,-0.23761226,1,
Csf2rb,0.3339914,-0.1393729,1,"['Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RAF/MAP kinase cascade', 'Interleukin receptor SHC signaling']"
Csf2rb2,0.4220522,-0.22720145,1,
Csf3,0.27456158,-0.15511283,1,"['Signaling by CSF3 (G-CSF)', 'Inactivation of CSF3 (G-CSF) signaling']"
Csf3r,0.19412248,-0.22359724,1,
Csgalnact1,-0.01982201,-0.12381098,1,['Chondroitin sulfate biosynthesis']
Csgalnact2,-0.27131006,-0.28305978,2,['Chondroitin sulfate biosynthesis']
Csk,0.5088907,-0.40002435,1,"['GAB1 signalosome', 'Phosphorylation of CD3 and TCR zeta chains', 'Integrin signaling', 'PD-1 signaling', 'MAP2K and MAPK activation', 'RHOH GTPase cycle', 'Negative regulation of FLT3']"
Csl,-0.104550645,-0.1400375,2,
Csn1s1,-0.2736983,0.13528569,2,['Miscellaneous transport and binding events']
Csn1s2a,0.008286715,0.07514064,0,
Csn1s2b,-0.12818132,0.03792779,2,
Csn2,0.11172833,0.054918427,3,
Csn3,-0.201566,-0.020279152,2,['Miscellaneous transport and binding events']
Csnk1a1,0.37923974,0.07100344,3,"['Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'GLI3 is processed to GLI3R by the proteasome', 'Activation of SMO']"
Csnk1d,0.27216303,0.31357992,3,"['COPII-mediated vesicle transport', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'AURKA Activation by TPX2']"
Csnk1e,0.40248343,0.27875492,3,"['WNT mediated activation of DVL', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'AURKA Activation by TPX2']"
Csnk1g1,0.2202414,-0.05316813,1,
Csnk1g2,0.14705035,0.06175955,3,
Csnk1g3,0.2997586,0.019084126,3,
Csnk2a1,0.38861218,0.26593754,3,"['Synthesis of PC', 'WNT mediated activation of DVL', 'Condensation of Prometaphase Chromosomes', 'Signal transduction by L1', 'Regulation of TP53 Activity through Phosphorylation', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'Receptor Mediated Mitophagy', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN stability and activity']"
Csnk2a2,0.33012438,0.064468235,1,"['Synthesis of PC', 'WNT mediated activation of DVL', 'Condensation of Prometaphase Chromosomes', 'Signal transduction by L1', 'Regulation of TP53 Activity through Phosphorylation', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'Receptor Mediated Mitophagy', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN stability and activity']"
Csnk2b,0.23808967,0.12641707,1,"['Synthesis of PC', 'WNT mediated activation of DVL', 'Condensation of Prometaphase Chromosomes', 'Signal transduction by L1', 'Neutrophil degranulation', 'Regulation of TP53 Activity through Phosphorylation', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'Receptor Mediated Mitophagy', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN stability and activity']"
Csnka2ip,-0.3195591,0.020444581,2,
Cspg4,0.027253458,-0.2664445,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'Chondroitin sulfate biosynthesis', 'Dermatan sulfate biosynthesis', 'CS/DS degradation']"
Cspg5,0.027262393,-0.26262838,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'Chondroitin sulfate biosynthesis', 'Dermatan sulfate biosynthesis', 'CS/DS degradation']"
Cspp1,-0.1872454,0.08837917,2,
Csrnp1,-0.21645343,-0.054886386,2,
Csrnp2,-0.08216049,-0.03132582,2,
Csrp1,-0.085281976,-0.06449359,2,
Csrp3,0.20158798,-0.08726593,1,
Cst10,-0.15246543,0.035880934,2,
Cst11,-0.16758093,0.052142344,2,
Cst12,-0.2057704,0.0020271374,2,
Cst13,-0.19666415,0.0073568528,0,
Cst3,0.11987334,-0.13521351,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Neutrophil degranulation', 'Post-translational protein phosphorylation']"
Cst6,-0.094991066,-0.16817208,2,
Cst7,-0.21789335,-0.07195752,2,
Cst8,-0.22028077,0.15635745,2,
Cst9,-0.18442698,0.011701657,2,
Csta1,-0.15837802,-0.025433442,2,
Csta2,-0.34052852,-0.17371975,2,
Csta3,0.022277169,-0.073694825,2,
Cstb,0.12455954,-0.045599725,1,['Neutrophil degranulation']
Cstdc1,-0.23591249,-0.09835551,2,
Cstdc2,-0.34169692,-0.034941394,2,
Cstdc4,-0.08285376,-0.12593381,2,
Cstdc5,-0.15368351,-0.08198599,2,
Cstdc6,-0.16431358,-0.12803438,2,
Cstf1,0.07970277,0.30140418,3,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cstf2,-0.111756794,0.47496623,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cstf2t,-0.11202603,0.4598281,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cstf3,-0.001467717,0.37437874,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Cstl1,-0.08973092,0.0014808375,2,
Ctag2,-0.10281074,-0.13772833,2,
Ctag2l1,-0.111637555,0.23213957,2,
Ctbp1,0.5264054,0.2900358,3,"['Deactivation of the beta-catenin transactivating complex', 'SUMOylation of transcription cofactors', 'Repression of WNT target genes']"
Ctbp2,0.4713155,0.09659375,3,['Repression of WNT target genes']
Ctc1,-0.026023023,0.3195578,3,"['Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation']"
Ctcf,0.42754877,0.15909603,3,
Ctcfl,0.20113483,0.057083957,3,
Ctdnep1,0.12229609,-0.125451,1,['Depolymerisation of the Nuclear Lamina']
Ctdp1,0.15076381,0.32421368,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Ctdsp1,0.04659494,0.11768751,3,
Ctdsp2,0.17585324,0.17986311,3,
Ctdspl,0.13782018,0.0024662376,3,
Ctf1,0.26156434,-0.14346196,1,['IL-6-type cytokine receptor ligand interactions']
Ctf2,0.17629504,-0.116200246,1,
Cth,-0.1569585,-0.17692654,2,"['Degradation of cysteine and homocysteine', 'Cysteine formation from homocysteine']"
Cthrc1,-0.064225376,-0.011593,2,
Ctif,-0.07834158,0.20385742,0,
Ctla2a,-0.13502878,0.04101771,2,
Ctla2b,-0.15908483,-0.0044840113,2,
Ctla4,0.27593696,-0.33161333,1,
Ctnna1,0.4656247,-0.22507764,1,"['Adherens junctions interactions', 'VEGFR2 mediated vascular permeability', 'Myogenesis', 'RHO GTPases activate IQGAPs']"
Ctnna2,0.4435287,-0.14603,1,['Myogenesis']
Ctnna3,0.12661253,-0.0967862,2,
Ctnnal1,-0.18723959,-0.03669803,2,
Ctnnb1,0.5040672,-0.1757636,1,"['Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'TCF dependent signaling in response to WNT', 'Formation of the beta-catenin:TCF transactivating complex', 'LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production', 'Apoptotic cleavage of cell adhesion  proteins', 'Deactivation of the beta-catenin transactivating complex', 'Ca2+ pathway', 'Adherens junctions interactions', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'VEGFR2 mediated vascular permeability', 'Myogenesis', 'RHO GTPases activate IQGAPs', 'Transcriptional Regulation by VENTX', 'RUNX3 regulates WNT signaling']"
Ctnnbip1,0.04696925,-0.024657713,3,['Deactivation of the beta-catenin transactivating complex']
Ctnnbl1,-0.032183923,0.4352347,0,['mRNA Splicing - Major Pathway']
Ctnnd1,0.37956473,-0.3374752,1,"['Adherens junctions interactions', 'VEGFR2 mediated vascular permeability']"
Ctnnd2,0.26120836,-0.16770878,1,
Ctns,-0.29385468,0.004138983,2,"['Transport of inorganic cations/anions and amino acids/oligopeptides', 'Miscellaneous transport and binding events']"
Ctps,-0.21801463,0.46049887,0,['Interconversion of nucleotide di- and triphosphates']
Ctps2,-0.11836266,0.2642806,0,['Interconversion of nucleotide di- and triphosphates']
Ctr9,0.19214705,0.46742308,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Ctrb1,-0.022856098,-0.18757926,2,['Activation of Matrix Metalloproteinases']
Ctrc,-0.079759285,-0.08328363,2,
Ctrl,-0.08142775,-0.10150011,2,
Cts3,0.1723327,-0.033343814,1,
Cts6,-0.017786223,-0.040842343,2,
Cts7,-0.012349689,-0.21656525,1,
Cts8,0.032395292,-0.16905406,1,
Ctsa,-0.121947065,-0.1282547,2,"['Glycosphingolipid metabolism', 'MHC class II antigen presentation', 'Sialic acid metabolism', 'Neutrophil degranulation']"
Ctsb,0.18498674,-0.26742527,1,"['Collagen degradation', 'Trafficking and processing of endosomal TLR', 'Assembly of collagen fibrils and other multimeric structures', 'MHC class II antigen presentation', 'Neutrophil degranulation']"
Ctsc,-0.08168082,-0.3604456,1,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Neutrophil degranulation']"
Ctsd,0.15412533,-0.19530492,1,"['Collagen degradation', 'Metabolism of Angiotensinogen to Angiotensins', 'MHC class II antigen presentation', 'Neutrophil degranulation']"
Ctse,-0.13986737,-0.11821765,2,['MHC class II antigen presentation']
Ctsf,-0.11727652,0.00313064,2,['MHC class II antigen presentation']
Ctsg,0.26791656,-0.24430849,1,"['Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Metabolism of Angiotensinogen to Angiotensins', 'Interleukin-1 processing', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Ctsh,-0.1973423,-0.0655241,2,"['MHC class II antigen presentation', 'Surfactant metabolism', 'Neutrophil degranulation']"
Ctsj,-0.030291451,-0.16839175,1,
Ctsk,0.34920818,-0.2856494,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Trafficking and processing of endosomal TLR', 'MHC class II antigen presentation', 'RUNX1 regulates transcription of genes involved in differentiation of keratinocytes']"
Ctsl,0.1055378,-0.10201607,1,"['Collagen degradation', 'Trafficking and processing of endosomal TLR', 'Assembly of collagen fibrils and other multimeric structures', 'MHC class II antigen presentation', 'RUNX1 regulates transcription of genes involved in differentiation of keratinocytes']"
Ctsll3,-0.064003885,-0.16325158,2,
Ctsm,-0.032621898,0.0089221345,2,
Ctso,-0.1662539,-0.14551032,2,['MHC class II antigen presentation']
Ctsq,0.07458104,-0.022306576,1,
Ctsr,0.150241,-0.040357925,1,
Ctss,0.21490814,-0.09121548,1,"['Degradation of the extracellular matrix', 'Trafficking and processing of endosomal TLR', 'Assembly of collagen fibrils and other multimeric structures', 'MHC class II antigen presentation', 'Neutrophil degranulation']"
Ctsz,-0.037367757,-0.24161823,1,"['Metabolism of Angiotensinogen to Angiotensins', 'COPII-mediated vesicle transport', 'Lysosome Vesicle Biogenesis', 'Cargo concentration in the ER', 'Neutrophil degranulation']"
Cttn,0.48392907,-0.24981324,1,
Cttnbp2,0.13484497,0.0157654,3,
Cttnbp2nl,0.09375226,0.10176374,3,
Ctu1,0.13890338,0.2390093,0,
Ctu2,0.1600048,0.36483634,0,
Ctxn1,-0.09890073,-0.12923919,2,
Ctxn3,-0.13592906,0.106704,0,
Cubn,0.06171705,-0.13820584,1,
Cuedc2,-0.07564604,-0.13285452,2,
Cul1,0.51699126,0.26061472,3,"['Activation of NF-kappaB in B cells', 'Prolactin receptor signaling', 'SCF-beta-TrCP mediated degradation of Emi1', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Regulation of PLK1 Activity at G2/M Transition', 'FCERI mediated NF-kB activation', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Orc1 removal from chromatin', 'Cyclin D associated events in G1', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Regulation of RUNX2 expression and activity', 'Neddylation', 'Interleukin-1 signaling', 'Iron uptake and transport', 'Regulation of BACH1 activity', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cul2,0.34094614,0.08902298,3,"['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cul3,0.3802921,0.10288299,3,"['Degradation of DVL', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'Neddylation', 'RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle', 'RHOBTB3 ATPase cycle', 'KEAP1-NFE2L2 pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Cul4a,0.39179313,0.34180132,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Neddylation']"
Cul4b,0.32376453,0.33736497,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Neddylation']"
Cul5,0.3505488,0.12783809,3,
Cul7,0.35924396,0.15568326,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Cul9,0.24243948,0.14513755,3,
Cuta,-0.22349884,-0.109473065,2,
Cux1,-0.036052022,0.060183555,2,
Cux2,-0.16374561,-0.016137313,2,
Cwc15,-0.12052944,0.38756874,0,['mRNA Splicing - Major Pathway']
Cwc22,-0.106512755,0.48299083,0,['mRNA Splicing - Major Pathway']
Cwc25,-0.12562479,0.37482,0,['mRNA Splicing - Major Pathway']
Cwc27,-0.12052487,0.5234095,0,['mRNA Splicing - Major Pathway']
Cwf19l1,-0.11598869,0.20207766,0,
Cwf19l2,-0.16188163,0.40558416,0,
Cx3cl1,0.2578294,-0.10086786,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cx3cr1,0.26569572,-0.09015911,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxadr,0.0014220714,-0.1587488,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall']"
Cxcl1,0.29453918,-0.1577682,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Cxcl10,0.39112025,-0.1874682,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcl11,0.11508343,0.094088554,0,
Cxcl12,0.40803766,-0.26352826,1,"['Signaling by ROBO receptors', 'Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcl13,0.27124965,-0.06512534,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcl14,0.24228951,-0.04568266,1,
Cxcl15,0.397027,-0.06193412,1,
Cxcl16,0.12752916,-0.088809125,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcl17,-0.27069047,-0.07043816,2,
Cxcl2,0.34016377,-0.04238344,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Cxcl3,0.24482879,-0.05983808,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Cxcl4,0.064509384,0.011049824,2,
Cxcl5,0.3333654,-0.2396703,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcl9,0.2902993,-0.18539546,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcr1,0.30643907,-0.30010936,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Cxcr2,0.3382004,-0.22510011,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Cxcr3,0.4216885,-0.16849926,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcr4,0.513936,-0.2847111,1,
Cxcr5,0.26707733,-0.17662421,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxcr6,0.14004135,0.042293534,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Cxxc1,0.27039054,0.24766427,3,
Cxxc4,0.13475785,-0.06756622,3,
Cxxc5,0.13636056,-0.07519571,1,
Cyb561,-0.112590075,-0.09475265,2,
Cyb561d2,-0.01009444,-0.27296314,1,
Cyb5a,-0.17435633,-0.045114648,2,"['Vitamin C (ascorbate) metabolism', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Cyb5b,-0.17830795,0.058317453,2,['Phase I - Functionalization of compounds']
Cyb5d1,-0.2129932,0.084001355,2,
Cyb5d2,-0.10844111,-0.10858556,2,
Cyb5r1,-0.15518165,0.03792593,2,"['Platelet degranulation ', 'Erythrocytes take up carbon dioxide and release oxygen']"
Cyb5r2,-0.115221806,0.027460236,2,['Erythrocytes take up carbon dioxide and release oxygen']
Cyb5r3,-0.22373278,-0.1880841,2,"['Vitamin C (ascorbate) metabolism', 'Phase I - Functionalization of compounds', 'Neutrophil degranulation']"
Cyb5r4,-0.099475175,-0.043426048,2,['Erythrocytes take up carbon dioxide and release oxygen']
Cyb5rl,-0.26378685,0.049942646,2,['Erythrocytes take up carbon dioxide and release oxygen']
Cyba,0.26383778,-0.4128067,1,"['ROS and RNS production in phagocytes', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'Detoxification of Reactive Oxygen Species', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate NADPH Oxidases', 'Neutrophil degranulation', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Cybb,0.2073994,-0.19841877,1,"['ROS and RNS production in phagocytes', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'Detoxification of Reactive Oxygen Species', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate NADPH Oxidases', 'Neutrophil degranulation', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Cybrd1,-0.12971726,0.03664924,2,['Iron uptake and transport']
Cyc1,-0.05791404,-0.087730095,2,['Respiratory electron transport']
Cycs,0.22076368,-0.08928195,1,"['Release of apoptotic factors from the mitochondria', 'Formation of apoptosome', 'Activation of caspases through apoptosome-mediated cleavage', 'Transcriptional activation of mitochondrial biogenesis', 'Detoxification of Reactive Oxygen Species', 'Pyroptosis', 'TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Regulation of the apoptosome activity', 'Cytoprotection by HMOX1']"
Cyct,0.20107836,-0.065088764,1,
Cyfip1,0.32623476,-0.11273564,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'Neutrophil degranulation', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Cyfip2,0.32686442,-0.09793873,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle']"
Cygb,0.057366434,-0.041810673,1,"['eNOS activation', 'Intracellular oxygen transport']"
Cyhr1,-0.03900463,-0.044803597,2,
Cyld,0.2592957,0.10147163,3,"['NOD1/2 Signaling Pathway', 'TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Ub-specific processing proteases', 'Negative regulators of DDX58/IFIH1 signaling']"
Cym,0.112357214,-0.11427317,1,
Cyp11a1,-0.23365092,-0.014981558,2,"['Pregnenolone biosynthesis', 'Endogenous sterols']"
Cyp11b1,-0.32014185,-0.10166115,2,"['Glucocorticoid biosynthesis', 'Endogenous sterols']"
Cyp11b2,-0.27791056,-0.24847025,2,"['Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis', 'Endogenous sterols']"
Cyp17a1,-0.25240016,-0.057982117,2,"['Androgen biosynthesis', 'Glucocorticoid biosynthesis']"
Cyp19a1,0.0106277,-0.08584606,2,"['Estrogen biosynthesis', 'Endogenous sterols']"
Cyp1a1,-0.19068852,-0.0398468,2,"['Xenobiotics', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)', 'Biosynthesis of protectins']"
Cyp1a2,-0.12017211,-0.07437842,2,"['Methylation', 'Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)', 'Aflatoxin activation and detoxification', 'Biosynthesis of protectins', 'Biosynthesis of maresin-like SPMs']"
Cyp1b1,-0.06664047,-0.041503426,2,"['Endogenous sterols', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)']"
Cyp20a1,-0.10264923,0.08711043,2,
Cyp21a1,-0.11897195,-0.14286284,2,
Cyp24a1,-0.03438552,0.017581854,2,"['Vitamin D (calciferol) metabolism', 'Vitamins']"
Cyp26a1,-0.22584176,-0.05267528,2,
Cyp26b1,-0.1955084,-0.09677421,2,"['Vitamins', 'RA biosynthesis pathway']"
Cyp26c1,-0.29600856,-0.015264373,2,"['Vitamins', 'RA biosynthesis pathway']"
Cyp27a1,-0.22288156,-0.13213702,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Endogenous sterols']"
Cyp27b1,-0.10583112,-0.07661474,2,"['Vitamin D (calciferol) metabolism', 'Vitamins']"
Cyp2a12,-0.19300975,0.053718034,2,"['Fatty acids', 'Xenobiotics', 'CYP2E1 reactions', 'Aflatoxin activation and detoxification']"
Cyp2a4,-0.17303431,0.060362272,2,"['Fatty acids', 'Xenobiotics', 'CYP2E1 reactions']"
Cyp2a5,-0.30780295,-0.2153629,2,
Cyp2ab1,-0.36463684,0.018261181,2,
Cyp2b10,-0.23650335,-0.14199652,2,
Cyp2b13,-0.32958868,-0.22835994,2,
Cyp2b19,-0.29704934,-0.084584616,2,
Cyp2b23,-0.24885009,-0.026703777,2,
Cyp2b9,-0.1637074,0.019870825,2,
Cyp2c23,-0.2222644,-0.15549296,2,
Cyp2c29,-0.16022187,-0.088459454,2,['Xenobiotics']
Cyp2c37,-0.32935047,-0.044456802,2,
Cyp2c38,-0.23045814,-0.09672323,2,
Cyp2c39,-0.30095458,-0.058516406,2,
Cyp2c40,-0.32653126,-0.12020636,2,
Cyp2c50,-0.31290084,-0.07630286,2,
Cyp2c54,-0.09954209,-0.008949942,2,
Cyp2c55,-0.25453725,-0.11075121,2,
Cyp2c65,-0.23346187,-0.049939897,2,"['Xenobiotics', 'CYP2E1 reactions', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)', 'Biosynthesis of maresin-like SPMs', 'Aspirin ADME']"
Cyp2c66,-0.22208138,-0.19468433,2,"['Xenobiotics', 'CYP2E1 reactions', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)', 'Biosynthesis of maresin-like SPMs', 'Aspirin ADME']"
Cyp2c67,-0.25075227,-0.120793715,2,
Cyp2c68,-0.38032064,-0.072867006,2,
Cyp2c70,-0.16661379,-0.17651033,2,
Cyp2d10,-0.1806773,-0.08038402,2,
Cyp2d11,-0.2340507,-0.28412318,2,
Cyp2d22,-0.2362996,-0.16662934,2,"['Fatty acids', 'Miscellaneous substrates', 'Xenobiotics', 'CYP2E1 reactions', 'Biosynthesis of maresin-like SPMs', 'Aspirin ADME']"
Cyp2d26,-0.19007762,-0.09082601,2,
Cyp2d34,-0.30230162,-0.065967456,2,
Cyp2d40,-0.2256675,-0.23269537,2,
Cyp2d9,-0.19139199,-0.027747637,2,
Cyp2e1,-0.06346731,-0.04710307,2,"['Xenobiotics', 'CYP2E1 reactions', 'Biosynthesis of maresin-like SPMs', 'Aspirin ADME', 'Paracetamol ADME']"
Cyp2f2,-0.21199846,-0.14351872,2,"['Fatty acids', 'Xenobiotics', 'CYP2E1 reactions']"
Cyp2j11,-0.36572275,-0.19989154,2,
Cyp2j12,-0.26552802,-0.13587753,2,
Cyp2j13,-0.36322024,-0.09910151,2,
Cyp2j5,-0.09235403,-0.0020307107,2,
Cyp2j6,-0.37292433,-0.008762392,2,"['Fatty acids', 'Xenobiotics', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)']"
Cyp2j8,-0.20723714,-0.020670386,2,
Cyp2j9,-0.26161703,-0.1405698,2,
Cyp2r1,-0.25990778,0.07376956,2,"['Vitamin D (calciferol) metabolism', 'Vitamins']"
Cyp2s1,-0.286398,-0.09449388,2,"['Miscellaneous substrates', 'Xenobiotics', 'CYP2E1 reactions']"
Cyp2u1,-0.1721147,-0.08347071,2,"['Miscellaneous substrates', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)']"
Cyp39a1,-0.360075,-0.055993658,2,"['Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Endogenous sterols']"
Cyp3a11,-0.33865547,-0.056112837,2,"['Phase I - Functionalization of compounds', 'Xenobiotics', 'Aflatoxin activation and detoxification', 'Biosynthesis of maresin-like SPMs', 'Aspirin ADME', 'Atorvastatin ADME']"
Cyp3a13,-0.2880163,-0.11716827,2,"['Miscellaneous substrates', 'Xenobiotics']"
Cyp3a16,-0.35139933,-0.10708443,2,"['Xenobiotics', 'Aflatoxin activation and detoxification']"
Cyp3a25,-0.3493734,-0.028452042,2,"['Miscellaneous substrates', 'Xenobiotics']"
Cyp3a41a,-0.2702117,-0.27589375,2,"['Xenobiotics', 'Aflatoxin activation and detoxification']"
Cyp3a41b,-0.18014026,-0.00776118,2,"['Xenobiotics', 'Aflatoxin activation and detoxification']"
Cyp3a44,-0.29972276,-0.12823789,2,"['Xenobiotics', 'Aflatoxin activation and detoxification']"
Cyp46a1,-0.17576952,-0.098249085,2,"['Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Endogenous sterols']"
Cyp4a10,-0.28440323,-0.028295867,2,"['Fatty acids', 'Eicosanoids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)']"
Cyp4a12a,-0.25525925,-0.046185326,2,
Cyp4a12b,-0.2789954,0.022426918,2,"['Fatty acids', 'Eicosanoids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)']"
Cyp4a14,-0.13152245,-0.021520436,2,
Cyp4a29,-0.2899971,-0.0011189162,2,
Cyp4a30b,-0.2596443,0.006470738,2,
Cyp4a32,-0.4180682,-0.10359116,2,
Cyp4b1,-0.08258568,-0.05916981,2,"['Fatty acids', 'Eicosanoids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)']"
Cyp4f13,-0.37750718,-0.07109067,2,
Cyp4f14,-0.21706419,-0.045669448,2,"['Eicosanoids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)']"
Cyp4f18,-0.26384363,-0.21781522,2,"['Fatty acids', 'Eicosanoids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)']"
Cyp4f39,-0.037672315,0.17739585,3,"['Fatty acids', 'Eicosanoids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)']"
Cyp51,-0.25396296,0.076121576,2,"['Cholesterol biosynthesis', 'Endogenous sterols']"
Cyp7a1,-0.052873235,-0.20156087,2,"['Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Endogenous sterols']"
Cyp7b1,-0.073964484,-0.19041446,2,"['Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Endogenous sterols']"
Cyp8b1,-0.005920258,-0.07814436,2,
Cypt12,-0.345008,0.07800061,2,
Cypt14,-0.13287823,-0.12302677,2,
Cypt2,-0.14621103,-0.1259526,2,
Cypt4,-0.21300548,0.2563123,2,
Cyria,-0.23735702,0.20124964,2,
Cys1,-0.15124477,-0.24041049,2,
Cysltr1,-0.0056587327,-0.15155117,1,"['Leukotriene receptors', 'G alpha (q) signalling events']"
Cysltr2,0.09570933,-0.057307243,1,"['Glucagon signaling in metabolic regulation', 'Leukotriene receptors', 'G alpha (q) signalling events', 'G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Cysrt1,-0.234303,-0.038925484,2,
Cyth1,0.02980556,-0.388812,1,['Intra-Golgi traffic']
Cyth2,0.30496714,-0.28761,1,['Intra-Golgi traffic']
Cyth3,0.30042276,-0.017581962,1,['Intra-Golgi traffic']
Cyth4,0.19739166,-0.12838969,1,['Intra-Golgi traffic']
Cytip,-0.13354258,-0.024189167,2,
Cytl1,-0.08241709,-0.16485226,2,
Cyyr1,-0.058249995,0.019369656,2,
Czib,-0.045766477,0.14300692,2,
D11Wsu47e,0.0010407956,-0.004756241,2,
D130043K22Rik,0.12586565,-0.11532935,3,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
D17H6S53E,-0.2751267,-0.050726242,2,
D1Pas1,-0.08947507,0.42778248,0,
D2hgdh,-0.10737116,-0.20030525,2,['Interconversion of 2-oxoglutarate and 2-hydroxyglutarate']
D430019H16Rik,-0.15732439,0.009893553,2,
D630023F18Rik,-0.12963933,-0.21063703,2,
D630039A03Rik,-0.28931046,0.034558278,2,
D630045J12Rik,-0.14461288,-0.08391685,2,
D8Ertd738e,-0.15210775,-0.027071064,2,
Daam1,0.19172314,-0.24994983,1,"['PCP/CE pathway', 'RHO GTPases Activate Formins', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Daam2,0.11618923,-0.078318216,1,
Dab1,0.3935326,-0.32340205,1,['Reelin signalling pathway']
Dab2,0.38086596,-0.23230629,1,
Dab2ip,0.37324414,-0.041032165,3,['Regulation of RAS by GAPs']
Dach1,0.20308699,0.18349256,3,
Dach2,-0.1756194,0.041441485,2,
Dact1,0.114738524,-0.0022964017,3,['Degradation of DVL']
Dact2,-0.115207426,0.18148601,0,
Dact3,-0.12085646,-0.008942361,2,
Dad1,-0.02282746,0.037725814,2,
Dag1,0.25372025,-0.40860665,1,"['O-linked glycosylation', 'Regulation of expression of SLITs and ROBOs']"
Dagla,-0.04416055,0.037904378,2,['Arachidonate production from DAG']
Daglb,-0.16839992,-0.10781011,2,['Arachidonate production from DAG']
Dalrd3,-0.09060061,-0.012691381,0,
Dand5,-0.22005387,-0.07966812,2,
Dao,-0.1921088,-0.12013672,2,
Dap3,0.020740658,0.12749428,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Dapk1,0.28823832,-0.21077868,1,
Dapk2,0.063846074,-0.14409544,2,
Dapk3,0.114987604,-0.19358751,1,
Dapp1,0.12400544,-0.28612325,1,['Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']
Dars,-0.023937847,0.2345134,0,
Dars2,-0.18229644,-0.137971,2,
Daw1,-0.2971121,0.5568406,0,
Daxx,0.49053305,0.035366572,3,
Dazap1,-0.08732503,0.0917655,2,
Dazap2,-0.24596857,0.09766756,2,
Dazl,0.005230686,0.29013667,3,
Dbf4,0.14901778,0.23107025,3,"['Activation of ATR in response to replication stress', 'Activation of the pre-replicative complex']"
Dbh,0.0329415,-0.14158581,1,['Catecholamine biosynthesis']
Dbi,0.20988289,-0.05708012,1,['Mitochondrial Fatty Acid Beta-Oxidation']
Dbil5,-0.025420243,-0.030638793,2,
Dbn1,0.22171126,-0.19728395,1,
Dbndd1,-0.25437084,0.21357441,2,
Dbndd2,-0.19836792,-0.00719677,2,
Dbnl,0.2332956,-0.21820028,1,
Dbp,0.012896888,0.047283888,3,
Dbr1,-0.061660316,0.16953647,0,
Dbt,-0.3387133,0.28090242,0,"['Glyoxylate metabolism and glycine degradation', 'Branched-chain amino acid catabolism', 'RHOH GTPase cycle']"
Dbx1,-0.17689463,0.021854619,2,
Dcaf1,0.10677626,0.27726543,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Dcaf10,0.15937029,0.22065867,3,['Neddylation']
Dcaf11,0.13810821,0.16570064,3,['Neddylation']
Dcaf12,0.052862592,0.17559385,3,
Dcaf12l1,-0.03765646,0.14723727,2,
Dcaf12l2,-0.04246604,0.0474989,2,
Dcaf13,-0.193002,0.37401247,0,"['Major pathway of rRNA processing in the nucleolus and cytosol', 'Neddylation']"
Dcaf15,0.015385974,0.2791896,0,
Dcaf17,0.13382277,0.06476134,3,['Neddylation']
Dcaf4,0.15808068,0.24031036,3,['Neddylation']
Dcaf5,0.15090656,0.233477,3,['Neddylation']
Dcaf6,0.18803957,0.29882133,3,['Neddylation']
Dcaf7,0.2977418,0.21226646,3,['Neddylation']
Dcaf8,0.103623785,0.26102152,3,['Neddylation']
Dcaf8l,-0.20429558,0.010011611,2,
Dcakd,-0.25947183,0.13810673,2,
Dcbld1,-0.20043384,-0.20076941,2,
Dcbld2,-0.19516951,-0.061524805,2,
Dcc,0.19913663,-0.2202597,1,"['Netrin-1 signaling', 'DCC mediated attractive signaling', 'Caspase activation via Dependence Receptors in the absence of ligand']"
Dcdc2a,-0.12601493,-0.023439258,2,
Dcdc2b,-0.08879388,0.14442796,2,
Dcdc2c,-0.17971222,0.11047717,2,
Dchs1,0.06146151,-0.10841904,1,
Dck,-0.04790789,0.091854006,2,"['Pyrimidine salvage', 'Purine salvage']"
Dclk1,0.079317145,-0.068680294,2,
Dclk3,-0.024168605,0.23644921,3,
Dclre1a,0.045922656,0.30158404,3,
Dclre1b,0.04091189,0.24831882,3,['Fanconi Anemia Pathway']
Dclre1c,0.15113981,0.27531105,3,['Nonhomologous End-Joining (NHEJ)']
Dcn,0.27853328,-0.3010112,1,"['Degradation of the extracellular matrix', 'A tetrasaccharide linker sequence is required for GAG synthesis', 'Chondroitin sulfate biosynthesis', 'Dermatan sulfate biosynthesis', 'CS/DS degradation', 'ECM proteoglycans']"
Dcp1a,-0.009525241,0.3469033,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Dcp1b,-0.032555275,0.23599097,0,"[""mRNA decay by 5' to 3' exoribonuclease""]"
Dcp2,-0.056980982,0.33418518,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA']"
Dcpp1,0.122106254,0.16236004,3,
Dcpp3,-0.14923884,0.010613143,2,
Dcps,-0.17253603,0.14148496,2,"[""mRNA decay by 3' to 5' exoribonuclease""]"
Dcstamp,0.046582315,-0.20688511,1,
Dct,-0.117566265,-0.25436336,2,['Melanin biosynthesis']
Dctd,-0.0624915,0.12753837,2,['Interconversion of nucleotide di- and triphosphates']
Dctn1,0.18315114,-0.029030913,3,"['MHC class II antigen presentation', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'AURKA Activation by TPX2']"
Dctn2,0.14853501,0.26071644,3,"['MHC class II antigen presentation', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'AURKA Activation by TPX2']"
Dctn3,0.16391249,0.015762387,3,"['MHC class II antigen presentation', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'AURKA Activation by TPX2']"
Dctn4,0.1471173,0.07024656,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic']"
Dctn5,0.1448683,0.13110277,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic']"
Dctn6,0.022658655,0.10358517,3,"['MHC class II antigen presentation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic']"
Dctpp1,-0.14640822,0.16740765,2,
Dcun1d2,0.17325537,0.059305646,3,['Neddylation']
Dcun1d3,0.08124796,0.17167714,3,['Neddylation']
Dcun1d4,0.13278657,0.06424707,3,['Neddylation']
Dcun1d5,0.12655932,0.2337327,3,['Neddylation']
Dcx,0.33941314,-0.13164236,1,
Dcxr,-0.21048056,-0.060227647,2,['Formation of xylulose-5-phosphate']
Dda1,0.07676061,0.22349255,3,['Neddylation']
Ddah1,-0.22173256,-0.16885841,2,['eNOS activation']
Ddah2,-0.029998973,-0.061596602,2,['eNOS activation']
Ddb1,0.38472492,0.54450077,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Neddylation']"
Ddb2,0.30701044,0.42640254,3,"['Ub-specific processing proteases', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Neddylation']"
Ddc,-0.00075837405,-0.22529285,1,"['Catecholamine biosynthesis', 'Serotonin and melatonin biosynthesis']"
Ddhd1,-0.3585246,-0.0933902,2,
Ddhd2,-0.14559421,-0.11262081,2,['Synthesis of PA']
Ddi1,0.0050135506,-0.0062898896,2,
Ddi2,-0.0071280836,0.012258068,2,
Ddit3,0.31939596,0.116151154,1,
Ddit4,0.16856624,-0.08117407,3,['TP53 Regulates Metabolic Genes']
Ddit4l,-0.015003569,-0.15520054,1,
Ddn,-0.08731819,-0.25085524,2,
Ddo,-0.3089101,-0.18765065,2,"['Glyoxylate metabolism and glycine degradation', 'Peroxisomal protein import']"
Ddost,-0.054087035,-0.040695436,2,['Neutrophil degranulation']
Ddr1,0.23098947,-0.24191554,1,['Non-integrin membrane-ECM interactions']
Ddr2,-0.113692194,-0.0018148506,2,['Non-integrin membrane-ECM interactions']
Ddrgk1,-0.174987,0.17234343,2,['RHOA GTPase cycle']
Ddt,0.042282563,-0.16769701,1,
Ddx1,0.20129634,0.46353185,0,
Ddx10,-0.2891115,0.38433763,0,
Ddx11,0.15758635,0.39960968,3,
Ddx17,0.13533336,0.50568324,0,['SUMOylation of transcription cofactors']
Ddx18,-0.17086688,0.43360263,0,
Ddx19a,0.13996783,0.2365828,3,
Ddx19b,0.031625733,0.21413888,3,
Ddx20,0.1458762,0.41870832,3,['snRNP Assembly']
Ddx21,0.07739537,0.5881752,0,"['B-WICH complex positively regulates rRNA expression', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Ddx23,-0.13046475,0.48345932,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Ddx24,-0.23585564,0.41296366,0,
Ddx25,-0.016633911,0.230353,0,
Ddx27,-0.2154454,0.4194309,0,
Ddx28,-0.3041485,0.29460242,0,
Ddx31,-0.30075935,0.35259846,0,
Ddx39a,-0.0077247187,0.51540333,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Ddx39b,-0.11637932,0.49716908,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'RHOBTB2 GTPase cycle']"
Ddx3x,0.22748366,0.43595442,0,['Neutrophil degranulation']
Ddx3y,0.0762587,0.38255852,0,
Ddx4,0.019968482,0.1881757,3,
Ddx41,0.13291323,0.37203708,3,"['STING mediated induction of host immune responses', 'Regulation of innate immune responses to cytosolic DNA']"
Ddx42,-0.022788504,0.3188443,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Ddx46,-0.0819787,0.3579515,0,['mRNA Splicing - Major Pathway']
Ddx47,-0.23325717,0.27444568,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Ddx49,-0.31733748,0.5515927,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Ddx5,0.118129134,0.67587006,0,
Ddx50,-0.0912995,0.057004057,0,
Ddx51,-0.32501075,0.29224595,0,
Ddx52,-0.21686418,0.39361537,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Ddx54,-0.11153208,0.33584496,0,
Ddx55,-0.19406717,0.34792864,0,
Ddx56,-0.28194028,0.39173454,0,
Ddx58,0.4144274,0.20719142,3,"['ISG15 antiviral mechanism', 'Ub-specific processing proteases', 'OAS antiviral response', 'Negative regulators of DDX58/IFIH1 signaling']"
Ddx59,-0.11761201,0.06888658,2,
Ddx6,0.06349033,0.47780192,0,"[""mRNA decay by 5' to 3' exoribonuclease""]"
Ddx60,-0.0055893203,0.3117056,0,
Deaf1,-0.006380014,0.11783353,3,
Decr1,-0.17578304,0.031650383,2,['mitochondrial fatty acid beta-oxidation of unsaturated fatty acids']
Decr2,-0.2624063,0.013325216,2,"['Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Dedd,-0.056649137,0.28049535,0,
Dedd2,0.0035770023,0.090057924,3,
Def8,-0.13717932,0.19708942,2,
Defa21,-0.2936414,0.010767852,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa23,-0.29214287,-0.30661723,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa24,-0.22518831,-0.07080739,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa25,-0.20545277,-0.018539703,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa26,-0.2571768,-0.16168943,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa27,-0.5066685,-0.11566704,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa28,-0.2072955,0.06622741,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa29,-0.43472975,0.16416916,2,
Defa30,-0.43673304,-0.091567226,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa34,-0.41588405,-0.16456246,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa35,-0.24158785,-0.07327639,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa36,-0.3209442,-0.13142009,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa37,-0.18956546,0.08184988,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa38,-0.21551493,-0.1762973,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa39,-0.38751867,-0.016525367,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa40,-0.16586141,-0.07856542,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defa41,-0.15353344,-0.033906676,2,"['Defensins', 'Alpha-defensins', 'Neutrophil degranulation']"
Defb1,0.06796245,-0.003830316,1,"['Beta defensins', 'Defensins']"
Defb10,-0.062388334,-0.13203739,2,
Defb12,-0.108579084,-0.16760935,2,
Defb13,0.07559982,0.14391014,3,
Defb14,0.29680842,-0.022829672,1,"['Beta defensins', 'Defensins']"
Defb15,-0.09746477,0.043314267,2,
Defb18,-0.34290183,-0.19172093,2,"['Beta defensins', 'Defensins']"
Defb19,-0.18775347,-0.15427148,2,"['Beta defensins', 'Defensins']"
Defb2,-0.106149204,0.09148855,2,
Defb20,-0.26486352,0.015339912,2,
Defb21,-0.16085084,-0.09487167,2,"['Beta defensins', 'Defensins']"
Defb22,-0.34746563,-0.06334833,2,
Defb23,-0.24412142,-0.0011569032,2,
Defb25,-0.2875759,-0.20167409,2,"['Beta defensins', 'Defensins']"
Defb29,-0.20428587,-0.046377517,2,
Defb3,-0.05706565,0.06762673,2,
Defb30,-0.16095029,-0.13951845,2,"['Beta defensins', 'Defensins']"
Defb33,-0.16549845,-0.101743035,2,
Defb34,-0.4109499,0.056442138,2,
Defb35,-0.076835945,-0.00090632134,2,
Defb36,-0.17491926,-0.10144504,2,"['Beta defensins', 'Defensins']"
Defb39,-0.17827547,-0.21874352,2,
Defb4,-0.16735741,-0.1618989,2,"['Beta defensins', 'Defensins']"
Defb41,-0.22867422,-0.06577384,2,
Defb42,-0.3595976,0.1743767,2,"['Beta defensins', 'Defensins']"
Defb43,-0.06569956,0.10743188,2,"['Beta defensins', 'Defensins']"
Defb45,-0.2535588,-0.16586341,2,
Defb46,-0.2574917,0.021685403,2,
Defb47,-0.20591393,-0.20769188,2,"['Beta defensins', 'Defensins']"
Defb48,-0.1381836,-0.21853688,2,['Beta defensins']
Defb9,-0.1518258,-0.10663154,2,
Degs1,-0.22095853,-0.101142086,2,"['Sphingolipid de novo biosynthesis', 'Neutrophil degranulation']"
Degs2,-0.15301852,-0.09364781,2,['Sphingolipid de novo biosynthesis']
Dek,0.09546258,0.4669733,3,"['B-WICH complex positively regulates rRNA expression', 'Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors']"
Denn2b,-0.07385019,-0.11379658,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd10,-0.06813259,-0.076645985,2,
Dennd11,-0.040889822,0.06485904,2,
Dennd1a,0.091226816,-0.039035656,3,['RAB GEFs exchange GTP for GDP on RABs']
Dennd1b,0.112040415,-0.011735912,1,['RAB GEFs exchange GTP for GDP on RABs']
Dennd1c,-0.16059446,-0.09061673,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd2a,-0.1655637,-0.15399407,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd2c,-0.21693446,-0.040840365,2,
Dennd2d,-0.12997952,-0.07333666,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd3,-0.15855591,-0.038458858,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd4a,-0.2261107,-0.14631326,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd4b,-0.20928203,0.029937498,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd4c,-0.047727987,-0.26512524,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd5a,-0.03365897,-0.14558882,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd5b,-0.19838883,-0.1454997,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd6a,-0.076098084,-0.1274697,2,['RAB GEFs exchange GTP for GDP on RABs']
Dennd6b,0.041101974,-0.013622113,2,['RAB GEFs exchange GTP for GDP on RABs']
Denr,-0.017357958,0.32296377,0,
Depdc1a,0.1400609,0.38307235,3,
Depdc1b,-0.1550117,0.1397107,2,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle', 'RHOF GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Depdc5,-0.041096583,0.10188087,2,['Amino acids regulate mTORC1']
Depdc7,-0.00046476885,0.16459009,0,
Deptor,0.2932875,0.10663556,3,
Dera,-0.1119017,0.2099887,0,"['Neutrophil degranulation', 'Pentose phosphate pathway']"
Derl1,0.06643695,-0.12200199,2,"['ABC-family proteins mediated transport', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle']"
Derl2,-0.07026322,-0.09786676,2,"['ABC-family proteins mediated transport', 'Hedgehog ligand biogenesis']"
Derl3,-0.0062809265,0.019679941,2,['ABC-family proteins mediated transport']
Derpc,-0.09002201,0.32439765,3,
Des,0.08264638,0.13954985,3,['Striated Muscle Contraction']
Desi1,-0.121769816,-0.1431357,2,
Det1,0.11939392,0.14346577,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Deup1,-0.04037498,0.042952374,2,
Dexi,-0.027020864,-0.008320882,2,
Dffa,0.02458225,0.042064972,2,['Apoptosis induced DNA fragmentation']
Dffb,0.1616425,0.018499952,3,['Apoptosis induced DNA fragmentation']
Dgat1,-0.1296188,-0.38423064,2,"['Acyl chain remodeling of DAG and TAG', 'Neutrophil degranulation', 'Triglyceride biosynthesis']"
Dgat2,-0.11642619,-0.13232498,2,"['Acyl chain remodeling of DAG and TAG', 'Triglyceride biosynthesis']"
Dgcr6,-0.20412152,0.14261927,2,
Dgcr8,0.12112696,0.29022112,0,
Dgka,0.1566791,-0.16936098,1,['Effects of PIP2 hydrolysis']
Dgkb,-0.05782461,-0.4000513,1,['Effects of PIP2 hydrolysis']
Dgkd,0.02093934,-0.32299867,1,['Effects of PIP2 hydrolysis']
Dgke,-0.028401658,-0.23507002,1,['Effects of PIP2 hydrolysis']
Dgkg,-0.029208604,-0.26695973,1,['Effects of PIP2 hydrolysis']
Dgkh,0.1279127,-0.24046074,1,['Effects of PIP2 hydrolysis']
Dgki,-0.014306493,-0.33107033,1,['Effects of PIP2 hydrolysis']
Dgkq,-0.042822357,-0.33117154,1,['Effects of PIP2 hydrolysis']
Dgkz,0.1277883,-0.2390357,1,['Effects of PIP2 hydrolysis']
Dglucy,-0.20045647,-0.29878676,2,
Dguok,-0.061119672,0.24081503,3,['Purine salvage']
Dhcr24,-0.18532051,0.0066951,2,"['Cholesterol biosynthesis', 'Cholesterol biosynthesis via desmosterol', 'Cholesterol biosynthesis via lathosterol']"
Dhcr7,-0.26184753,0.008370428,2,"['Cholesterol biosynthesis via desmosterol', 'Cholesterol biosynthesis via lathosterol']"
Dhdds,-0.2964675,-0.08659549,2,['Synthesis of Dolichyl-phosphate']
Dhdh,-0.233388,-0.1935639,2,
Dhfr,0.19082646,0.015758641,1,['Metabolism of folate and pterines']
Dhh,0.17067958,0.037181515,3,"['Hedgehog ligand biogenesis', 'Release of Hh-Np from the secreting cell', 'Ligand-receptor interactions', 'Activation of SMO']"
Dhps,-0.028879374,0.15314409,0,['Hypusine synthesis from eIF5A-lysine']
Dhrs11,-0.22692433,0.10218012,2,
Dhrs3,-0.2771072,-0.011803858,2,"['The retinoid cycle in cones (daylight vision)', 'RA biosynthesis pathway']"
Dhrs4,-0.33478665,0.12405733,2,"['RA biosynthesis pathway', 'Peroxisomal protein import']"
Dhrs7,-0.22602315,-0.11807096,2,
Dhrs7b,-0.2903732,0.04056598,2,['Plasmalogen biosynthesis']
Dhrs9,-0.25153196,-0.021542551,2,"['The canonical retinoid cycle in rods (twilight vision)', 'RA biosynthesis pathway']"
Dhtkd1,-0.19240274,0.079583906,2,['Glyoxylate metabolism and glycine degradation']
Dhx15,-0.14305891,0.5794558,0,['mRNA Splicing - Major Pathway']
Dhx16,-0.013035956,0.3934978,0,['mRNA Splicing - Major Pathway']
Dhx29,0.05639458,0.24687222,0,
Dhx30,-0.28458786,-0.12951982,2,
Dhx32,-0.27647057,0.52362615,0,
Dhx33,-0.15612432,0.3587277,0,
Dhx34,-0.21224526,0.35645375,0,
Dhx35,-0.23732784,0.3029293,0,
Dhx36,0.15349971,0.27447534,0,['DEx/H-box helicases activate type I IFN and inflammatory cytokines production ']
Dhx37,-0.15928094,0.36264014,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Dhx38,-0.094425224,0.512732,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Dhx40,-0.23365776,0.11495925,0,
Dhx57,-0.090922974,0.123578176,2,
Dhx58,0.20605086,0.32081497,3,
Dhx8,-0.006794998,0.40219593,0,
Dhx9,0.16524263,0.5031875,0,
Diablo,0.34421542,0.11035255,3,"['Release of apoptotic factors from the mitochondria', 'SMAC (DIABLO) binds to IAPs ', 'SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ', 'SMAC, XIAP-regulated apoptotic response', 'Regulation of the apoptosome activity']"
Diaph1,0.19262484,-0.21051247,1,"['RHO GTPases Activate Formins', 'ERBB2 Regulates Cell Motility', 'Neutrophil degranulation', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RHOD GTPase cycle', 'RHOF GTPase cycle']"
Diaph2,0.1207572,-0.18867244,1,"['RHO GTPases Activate Formins', 'RHOD GTPase cycle', 'RHOF GTPase cycle']"
Diaph3,0.3216994,0.13857035,3,"['RHO GTPases Activate Formins', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Dicer1,0.11902329,0.45471105,0,
Dido1,0.15917203,0.38624,3,
Dimt1,-0.15190157,0.44536495,0,
Dio1,-0.13185388,0.07773819,2,
Dio2,-0.028493475,-0.13816543,2,['Regulation of thyroid hormone activity']
Dio3,0.15187357,-0.13014649,3,['Regulation of thyroid hormone activity']
Dip2a,-0.20182574,-0.20902729,2,
Dip2b,-0.06938334,0.2818357,3,
Dip2c,-0.007926757,0.032771874,2,
Dipk1b,-0.170628,-0.11091335,2,
Dipk1c,-0.23420335,-0.07729628,2,
Dipk2a,-0.21140605,-0.048071794,2,
Diras1,0.04531355,-0.18728106,1,
Diras2,0.022069208,-0.10322611,1,
Dis3,-0.13757475,0.3945099,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Dis3l,-0.32252854,0.2985509,0,
Dis3l2,-0.33507466,0.23452376,0,
Disc1,0.3898473,-0.27309284,1,
Disp1,0.06717921,-0.1474835,1,
Disp2,-0.068858534,0.019389171,2,['Release of Hh-Np from the secreting cell']
Disp3,-0.08810621,-0.03457951,2,
Dixdc1,-0.0068923486,-0.0063987076,2,
Dkc1,0.03942737,0.53846204,0,['Telomere Extension By Telomerase']
Dkk1,0.054034505,-0.040519185,2,['Negative regulation of TCF-dependent signaling by WNT ligand antagonists']
Dkk2,-0.09303828,0.0786155,2,['Negative regulation of TCF-dependent signaling by WNT ligand antagonists']
Dkk3,0.0039516604,0.0065478166,2,
Dkk4,-0.11472636,0.097142905,2,['Negative regulation of TCF-dependent signaling by WNT ligand antagonists']
Dkkl1,-0.21433373,-0.092090115,2,
Dlat,-0.108789824,-0.0010930587,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Glyoxylate metabolism and glycine degradation', 'Signaling by Retinoic Acid', 'Pyruvate metabolism']"
Dlc1,0.13171923,-0.29361492,1,
Dld,0.025064899,-0.11577179,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Glyoxylate metabolism and glycine degradation', 'Signaling by Retinoic Acid', 'Glycine degradation', 'Pyruvate metabolism', 'Branched-chain amino acid catabolism', 'Lysine catabolism', 'Citric acid cycle (TCA cycle)']"
Dleu7,-0.09401103,0.10729681,2,
Dlg1,0.40771177,-0.3071855,1,"['Trafficking of AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Activation of Ca-permeable Kainate Receptor', 'RAF/MAP kinase cascade', 'Synaptic adhesion-like molecules']"
Dlg2,0.33318895,-0.11490996,1,"['Unblocking of NMDA receptors, glutamate binding and activation', 'RAF/MAP kinase cascade', 'Neurexins and neuroligins']"
Dlg3,0.28062603,-0.17899285,1,"['Unblocking of NMDA receptors, glutamate binding and activation', 'Activation of Ca-permeable Kainate Receptor', 'RAF/MAP kinase cascade', 'Neurexins and neuroligins', 'Synaptic adhesion-like molecules']"
Dlg4,0.42613187,-0.38359758,1,"['Trafficking of AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Activation of Ca-permeable Kainate Receptor', 'RHO GTPases activate CIT', 'RAF/MAP kinase cascade', 'LGI-ADAM interactions', 'Neurexins and neuroligins', 'Synaptic adhesion-like molecules']"
Dlg5,0.051487796,-0.025342342,1,"['RHOU GTPase cycle', 'RHOV GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Dlgap1,0.26476496,-0.14247668,1,['Neurexins and neuroligins']
Dlgap2,0.048163433,-0.13210952,1,['Neurexins and neuroligins']
Dlgap3,0.044844735,-0.062095642,1,['Neurexins and neuroligins']
Dlgap4,-0.09842389,-0.3702011,1,['Neurexins and neuroligins']
Dlgap5,0.15211025,0.47884476,3,
Dlk1,0.14282757,0.0158188,3,
Dll1,0.21076146,-0.07615589,1,['NOTCH3 Activation and Transmission of Signal to the Nucleus']
Dll3,0.041478194,0.055964194,2,
Dll4,0.43014726,-0.11982571,1,['NOTCH3 Activation and Transmission of Signal to the Nucleus']
Dlst,-0.07940067,-0.012640457,2,"['Glyoxylate metabolism and glycine degradation', 'Lysine catabolism', 'Citric acid cycle (TCA cycle)']"
Dlx1,0.24036941,-0.080366895,3,
Dlx2,0.11749918,-0.07651729,1,
Dlx3,0.017689036,0.040803257,3,
Dlx4,-0.068900995,-0.12178984,1,
Dlx5,0.04754343,-0.028774116,2,
Dlx6,0.07729161,-0.06846016,1,
Dmac1,-0.27936852,0.044931617,2,
Dmac2l,-0.05364725,-0.025627857,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
Dmap1,0.3306397,0.3181173,3,
Dmbt1,-0.20179689,-0.063171916,2,
Dmc1,0.15899612,0.35895786,3,
Dmd,0.31277055,-0.32158834,1,['Striated Muscle Contraction']
Dmgdh,-0.015511906,0.0065877493,2,['Choline catabolism']
Dmkn,-0.13292857,-0.103767104,2,
Dmp1,0.20240286,-0.16941905,1,"['ECM proteoglycans', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Dmpk,-0.04527516,-0.050903086,2,['Ion homeostasis']
Dmrt1,-0.043863222,0.026456209,2,
Dmrt2,0.28040332,0.27970818,3,
Dmrta1,-0.24828032,0.1979337,2,
Dmrtc1b,-0.13866112,-0.0846163,2,
Dmtf1,-0.039587166,0.023334559,2,
Dmtn,-0.07516396,0.077958874,2,['Miscellaneous transport and binding events']
Dmwd,-0.2603235,0.22144458,2,
Dmxl1,-0.0020391583,0.13885082,3,
Dmxl2,0.04891767,-0.035192564,3,
Dna2,0.27990597,0.3330187,3,"['Removal of the Flap Intermediate from the C-strand', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'Removal of the Flap Intermediate', 'G2/M DNA damage checkpoint']"
Dnaaf1,-0.31757954,0.0056190155,2,
Dnaaf10,0.1783614,0.09508537,3,
Dnaaf2,-0.23390602,0.17132024,2,
Dnaaf3,-0.39521474,0.15321304,2,
Dnaaf4,-0.05577934,0.12520604,2,
Dnaaf5,-0.22168036,0.064384975,2,
Dnaaf6,-0.12433058,0.14512795,2,
Dnah1,-0.12883563,0.12186603,2,
Dnah10,0.029939571,0.070208475,3,
Dnah11,0.02026769,0.06474248,2,
Dnah12,-0.029205993,-0.1508661,2,
Dnah17,-0.08242196,0.036421172,2,
Dnah2,-0.10128459,0.11835704,2,
Dnah3,-0.05669747,0.080511704,2,
Dnah5,-0.076412156,0.04222832,2,
Dnah6,0.12549561,0.026406005,3,
Dnah7a,-0.014605323,0.122492224,3,
Dnah7b,-0.02324305,0.122704625,3,
Dnah7c,0.048182014,-0.0047630123,2,
Dnah8,-0.17551726,0.105880626,2,
Dnah9,0.071250625,-0.02790593,2,
Dnai1,-0.1258106,0.15924428,2,
Dnai2,-0.07869361,0.045986462,2,
Dnai3,-0.30384615,0.056248955,2,
Dnai4,-0.11939488,0.06407967,2,
Dnaja1,0.2665383,0.04029205,3,['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand']
Dnaja2,-0.07603839,0.14174071,2,['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand']
Dnaja3,0.32855326,0.14869417,3,
Dnaja4,0.2077479,0.12857851,3,['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand']
Dnajb1,0.14396138,0.0912954,3,"['Regulation of HSF1-mediated heat shock response', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase', 'HSF1-dependent transactivation', 'MAPK6/MAPK4 signaling']"
Dnajb11,0.03374736,0.10431255,0,
Dnajb12,0.059983157,0.06392214,3,
Dnajb13,0.10493307,0.10301684,3,
Dnajb14,0.007553131,0.20293407,0,
Dnajb2,0.02495463,0.16561283,3,
Dnajb3,-0.07494854,0.079186805,2,
Dnajb4,0.05118039,0.11535429,3,
Dnajb5,0.04159792,0.16962373,3,
Dnajb6,-0.097618826,0.15909474,0,['Regulation of HSF1-mediated heat shock response']
Dnajb7,-0.079911776,-0.10290188,2,
Dnajb8,-0.1365688,0.06847451,2,
Dnajb9,0.06736837,-0.048585616,2,
Dnajc1,-0.17652823,0.06798617,2,
Dnajc10,0.03524729,0.0042649405,2,
Dnajc11,-0.18893607,-0.09157347,2,
Dnajc12,-0.40585274,-0.19694869,2,
Dnajc13,-0.010961399,-0.14811878,2,['Neutrophil degranulation']
Dnajc14,-0.054714985,-0.08005925,2,
Dnajc15,-0.15213594,-0.14875962,2,
Dnajc16,0.035885517,0.053837124,0,
Dnajc17,-0.13704532,0.07108338,0,
Dnajc18,0.052913185,0.11755576,3,
Dnajc19,0.064529,0.14232168,0,
Dnajc2,0.034154408,0.35095713,0,['Regulation of HSF1-mediated heat shock response']
Dnajc21,-0.08613809,0.22989903,0,
Dnajc22,-0.2121422,0.11789464,2,
Dnajc24,-0.15969013,-0.10095096,2,['Synthesis of diphthamide-EEF2']
Dnajc27,-0.10782583,-0.15805279,2,
Dnajc3,0.18451148,0.026559032,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Neutrophil degranulation', 'Post-translational protein phosphorylation']"
Dnajc4,0.06396319,-0.12832773,1,
Dnajc5,-0.015356572,0.092489265,2,"['Neutrophil degranulation', 'GABA synthesis, release, reuptake and degradation']"
Dnajc5b,-0.043983284,0.16737156,2,
Dnajc5g,-0.11243699,0.19682805,0,
Dnajc6,-0.062304173,-0.38791904,1,"['Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Clathrin-mediated endocytosis']"
Dnajc7,0.10882424,0.099330105,3,
Dnajc8,-0.065886416,0.3497423,0,['mRNA Splicing - Major Pathway']
Dnajc9,-0.09731449,0.3582938,3,
Dnal1,-0.11723356,0.07713483,2,
Dnal4,0.22602056,-0.24419676,1,['Retrograde neurotrophin signalling']
Dnali1,-0.26646695,0.2938828,2,
Dnase1l2,-0.3727886,-0.1498287,2,
Dnase1l3,-0.325049,0.1378535,2,
Dnase2a,-0.17514834,-0.14386068,2,['Lysosome Vesicle Biogenesis']
Dnase2b,-0.28008094,0.09037921,2,
Dnd1,-0.2060982,0.14451371,2,
Dner,0.10743689,-0.09254497,1,
Dnlz,-0.16348162,0.086426236,2,
Dnm1,0.36788058,-0.24064524,1,"['Toll Like Receptor 4 (TLR4) Cascade', 'Gap junction degradation', 'Formation of annular gap junctions', 'MHC class II antigen presentation', 'Recycling pathway of L1', 'Clathrin-mediated endocytosis']"
Dnm1l,0.13522506,-0.19564241,1,['Apoptotic execution phase']
Dnm2,0.2156546,-0.36533833,1,"['Toll Like Receptor 4 (TLR4) Cascade', 'Gap junction degradation', 'Formation of annular gap junctions', 'NOSTRIN mediated eNOS trafficking', 'MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Recycling pathway of L1', 'Clathrin-mediated endocytosis']"
Dnm3,0.19030626,-0.38005716,1,"['Toll Like Receptor 4 (TLR4) Cascade', 'MHC class II antigen presentation', 'Recycling pathway of L1', 'Clathrin-mediated endocytosis']"
Dnmbp,0.35685477,-0.15448086,1,
Dnmt1,0.45750442,0.27326125,3,"['PRC2 methylates histones and DNA', 'SUMOylation of DNA methylation proteins']"
Dnmt3a,0.33680356,0.3617183,3,"['PRC2 methylates histones and DNA', 'RMTs methylate histone arginines']"
Dnmt3b,0.27644694,0.28999537,3,"['PRC2 methylates histones and DNA', 'SUMOylation of DNA methylation proteins']"
Dnmt3l,0.062964335,0.27631146,3,
Dnpep,-0.19645302,-0.08895688,2,
Dntt,0.2732079,0.3553107,3,
Dnttip1,0.1215387,0.19626169,3,
Dnttip2,-0.3262301,0.23471935,0,
Doc2a,-0.18902165,-0.11184099,2,
Doc2b,-0.28848818,-0.18885116,2,
Dock1,0.46556145,-0.25084627,1,"['Regulation of actin dynamics for phagocytic cup formation', 'DCC mediated attractive signaling', 'VEGFA-VEGFR2 Pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock10,0.015048914,-0.036300626,2,
Dock11,0.2703653,-0.019777954,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock2,0.35564387,-0.17918822,1,"['Neutrophil degranulation', 'RHOA GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock3,0.13868465,-0.2282708,1,
Dock4,0.20482716,0.008946936,0,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock5,0.39292014,-0.18720128,1,"['RAC1 GTPase cycle', 'RHOG GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock6,0.117955066,-0.04808118,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock7,0.22087276,-0.2855782,1,
Dock8,0.22487585,-0.09630063,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOJ GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Dock9,0.055893984,-0.15682206,1,
Dohh,-0.24070269,0.2817272,0,['Hypusine synthesis from eIF5A-lysine']
Dok1,0.31510454,-0.27585068,1,"['PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'RET signaling']"
Dok2,0.35227716,-0.1620027,1,"['Tie2 Signaling', 'RET signaling']"
Dok3,0.07929928,-0.301494,1,['Neutrophil degranulation']
Dok4,0.2482728,-0.1453442,1,['RET signaling']
Dok5,0.1911957,-0.18768336,1,['RET signaling']
Dok6,0.13191758,-0.27012524,1,['RET signaling']
Dok7,0.16070792,-0.029731145,1,
Dolk,-0.124897555,-0.28920284,2,['Synthesis of Dolichyl-phosphate']
Dolpp1,-0.21634895,-0.09114203,2,['Synthesis of Dolichyl-phosphate']
Donson,0.031668283,0.32819945,3,
Dop1a,-0.30304328,0.06667992,2,
Dop1b,-0.24471587,0.08155726,2,
Dot1l,0.2997292,0.22659744,3,['PKMTs methylate histone lysines']
Dpagt1,-0.29893425,-0.15963496,2,"['Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein']"
Dpcd,0.13751358,0.16417824,3,
Dpep1,0.12531863,-0.12218704,3,"['Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Aflatoxin activation and detoxification']"
Dpep3,-0.2613733,-0.11056664,2,"['Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Aflatoxin activation and detoxification']"
Dpf1,0.0743775,0.06968151,1,
Dpf2,0.2123369,0.20204465,3,
Dpf3,0.1797689,0.0033916747,1,
Dph1,-0.21992904,0.13603498,2,['Synthesis of diphthamide-EEF2']
Dph2,-0.12710191,-0.13074166,2,['Synthesis of diphthamide-EEF2']
Dph3,-0.19557367,0.013427556,2,['Synthesis of diphthamide-EEF2']
Dph5,-0.12673919,0.16621332,0,['Synthesis of diphthamide-EEF2']
Dph6,-0.11030494,0.07928466,2,['Synthesis of diphthamide-EEF2']
Dph7,-0.27443278,0.09466787,2,
Dpm1,-0.256616,-0.18947619,2,['Synthesis of dolichyl-phosphate mannose']
Dpm2,-0.19441459,-0.26190552,2,"['Synthesis of dolichyl-phosphate mannose', 'Synthesis of glycosylphosphatidylinositol (GPI)']"
Dpm3,-0.14225847,-0.24178708,2,['Synthesis of dolichyl-phosphate mannose']
Dpp10,-0.1516519,-0.055283926,2,
Dpp3,-0.24028125,-0.083273344,2,
Dpp4,0.15872537,-0.24516597,1,"['Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)']"
Dpp6,-0.047327098,-0.004044095,2,
Dpp7,-0.039190467,0.013949997,2,['Neutrophil degranulation']
Dpp8,-0.0788859,-0.18357165,2,
Dpp9,0.21382733,0.1165227,3,
Dppa2,-0.21141258,0.23342894,0,
Dppa3,-0.15790758,0.13780016,2,
Dppa4,0.009089152,0.1339439,2,
Dppa5a,-0.06799432,0.21967839,2,
Dpt,-0.0061903633,-0.06660757,2,
Dpy19l1,-0.0444904,0.07223161,2,
Dpy19l2,-0.2966924,-0.29131213,2,
Dpy19l3,-0.13737224,-0.12774697,2,
Dpy19l4,-0.021655591,-0.01612217,2,
Dpy30,0.30499873,0.30172804,3,
Dpyd,-0.28340015,-0.037803203,2,['Pyrimidine catabolism']
Dpys,-0.29958987,-0.12076744,2,['Pyrimidine catabolism']
Dpysl2,0.3254302,-0.24030383,1,"['CRMPs in Sema3A signaling', 'Recycling pathway of L1']"
Dpysl3,0.165015,0.00756133,1,['CRMPs in Sema3A signaling']
Dpysl4,0.10428972,0.00070749864,3,
Dpysl5,0.09148875,-0.09974031,2,['CRMPs in Sema3A signaling']
Dqx1,-0.26113796,0.42163336,0,
Dr1,0.3087688,0.19059007,3,
Dram2,-0.23672351,-0.022799114,2,
Drap1,0.22968027,0.15151994,3,
Draxin,-0.14834924,-0.028977275,2,
Drc1,-0.05807845,-0.109150656,2,
Drc3,-0.36038217,-0.07573837,2,
Drc7,-0.08189076,0.06603566,2,
Drd1,0.24839807,-0.35104972,1,"['Dopamine receptors', 'G alpha (s) signalling events']"
Drd2,0.2581816,-0.43783355,1,['Dopamine receptors']
Drd3,0.16459519,-0.149554,1,"['Dopamine receptors', 'G alpha (i) signalling events']"
Drd4,0.054704465,-0.17938413,1,"['Dopamine receptors', 'G alpha (i) signalling events']"
Drd5,-0.03977347,-0.38564804,1,"['Dopamine receptors', 'G alpha (s) signalling events']"
Drg1,-0.063589014,0.15635696,0,
Drg2,-0.23053545,0.22126476,0,
Drosha,0.037945136,0.38240364,0,
Drp2,0.13815936,-0.06748643,1,
Dsc1,0.009011249,0.05469141,2,"['Neutrophil degranulation', 'Keratinization', 'Formation of the cornified envelope']"
Dsc2,0.0046202107,0.09185902,2,"['Keratinization', 'Formation of the cornified envelope']"
Dsc3,0.22162007,0.13799489,3,"['Keratinization', 'Formation of the cornified envelope']"
Dscam,0.08166502,-0.2725035,1,['DSCAM interactions']
Dscaml1,-0.09620171,-0.0052276794,2,['DSCAM interactions']
Dscc1,0.1526043,0.54381233,3,['Polymerase switching on the C-strand of the telomere']
Dse,-0.35099658,-0.20301263,2,['Dermatan sulfate biosynthesis']
Dsel,-0.100221656,-0.29376888,1,['Dermatan sulfate biosynthesis']
Dsg1a,0.20848174,0.055086188,1,"['Apoptotic cleavage of cell adhesion  proteins', 'Neutrophil degranulation', 'Keratinization', 'Formation of the cornified envelope', 'RND3 GTPase cycle', 'RND2 GTPase cycle']"
Dsg1b,-0.1127093,0.051990043,2,
Dsg1c,-0.015663942,-0.079186566,2,
Dsg2,0.20925583,-0.037304748,1,"['Apoptotic cleavage of cell adhesion  proteins', 'Keratinization', 'Formation of the cornified envelope', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Dsg3,0.18917772,-0.11908513,1,
Dsg4,-0.091139495,0.08927757,0,"['Keratinization', 'Formation of the cornified envelope']"
Dsn1,0.0021193759,0.38367182,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Neutrophil degranulation', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Dsp,0.35765615,0.050213534,1,"['Apoptotic cleavage of cell adhesion  proteins', 'Neutrophil degranulation', 'Keratinization', 'Formation of the cornified envelope', 'RND3 GTPase cycle', 'RND1 GTPase cycle']"
Dspp,0.34555945,-0.15018383,1,
Dst,0.07861613,-0.32481122,1,"['Type I hemidesmosome assembly', 'RHOU GTPase cycle', 'RHOV GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Dstn,0.07936404,0.047041044,2,
Dstyk,-0.2833968,-0.020286638,2,
Dtd1,-0.12925449,0.21334353,0,
Dtd2,-0.22195657,0.18120584,2,
Dtl,0.3777919,0.38904136,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Neddylation']"
Dtna,0.05744213,-0.19598804,1,
Dtnb,0.07118673,-0.15630832,1,
Dtnbp1,0.1345774,-0.12674934,1,['Golgi Associated Vesicle Biogenesis']
Dtwd1,-0.2615452,-0.327973,2,
Dtx1,0.26825207,-0.009022177,1,['Activated NOTCH1 Transmits Signal to the Nucleus']
Dtx2,0.07048676,-0.109752744,2,['Activated NOTCH1 Transmits Signal to the Nucleus']
Dtx3l,0.07305779,0.013737253,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Dtx4,0.079004705,-0.12736085,1,"['Activated NOTCH1 Transmits Signal to the Nucleus', 'Regulation of innate immune responses to cytosolic DNA', 'IRF3-mediated induction of type I IFN']"
Dtymk,-0.08731238,0.24762613,3,['Interconversion of nucleotide di- and triphosphates']
Duox1,-0.041868,-0.2756492,1,['Thyroxine biosynthesis']
Duox2,0.08326982,-0.3206876,1,['Thyroxine biosynthesis']
Duoxa1,-0.22800456,-0.17212844,2,
Duoxa2,-0.24844345,-0.30357638,2,
Dus1l,-0.2989617,0.27045748,0,
Dus2,-0.2708481,-0.016203692,0,
Dus3l,-0.030444166,0.20147966,0,
Dus4l,0.09556059,-0.03446188,1,
Dusp1,0.3498425,-0.117152974,1,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dusp10,0.20405798,-0.085453935,1,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dusp11,-0.11842143,0.3185844,0,
Dusp12,-0.00010542555,0.27086243,0,
Dusp13,-0.3507991,-0.120505966,2,
Dusp16,0.26680124,-0.0074631786,3,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dusp19,-0.2047968,0.0055505014,2,
Dusp2,0.17260435,-0.029638717,3,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dusp22,0.20829162,-0.1662748,1,
Dusp26,-0.0790426,0.09285421,2,
Dusp27,-0.24423207,-0.10043346,2,
Dusp28,-0.258741,0.19531304,2,
Dusp29,-0.28444153,-0.04354052,2,
Dusp3,0.37254363,-0.0030774872,3,['ERKs are inactivated']
Dusp4,0.24886696,-0.10845351,1,"['RAF-independent MAPK1/3 activation', 'ERKs are inactivated', 'Negative regulation of MAPK pathway']"
Dusp5,0.0886016,-0.19136414,1,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dusp6,0.21555728,-0.07105243,1,"['RAF-independent MAPK1/3 activation', 'ERKs are inactivated', 'Negative regulation of MAPK pathway']"
Dusp7,0.24998778,-0.20478742,1,"['RAF-independent MAPK1/3 activation', 'ERKs are inactivated', 'Negative regulation of MAPK pathway']"
Dusp8,0.28627014,-0.14456686,1,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dusp9,0.26353845,-0.12680377,1,"['RAF-independent MAPK1/3 activation', 'Negative regulation of MAPK pathway']"
Dut,0.032218423,0.44274187,3,['Interconversion of nucleotide di- and triphosphates']
Duxbl1,-0.10397496,-0.12411474,2,
Dvl1,0.39825004,0.05036508,3,"['WNT mediated activation of DVL', 'PCP/CE pathway', 'Degradation of DVL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins']"
Dvl2,0.46199343,-0.13868785,3,"['WNT mediated activation of DVL', 'Signaling by Hippo', 'PCP/CE pathway', 'Asymmetric localization of PCP proteins', 'Degradation of DVL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'WNT5A-dependent internalization of FZD4', 'RHO GTPases Activate Formins', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Dvl3,0.34746778,-0.088957004,1,"['WNT mediated activation of DVL', 'PCP/CE pathway', 'Degradation of DVL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins']"
Dxo,-0.048356958,0.219304,0,
Dydc1,-0.24427609,0.12713882,2,
Dym,-0.17353265,0.07763122,2,
Dynap,-0.33454376,-0.103910275,2,
Dync1h1,0.15993005,0.2425048,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'AURKA Activation by TPX2', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dync1i1,0.14826852,0.024096258,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dync1i2,0.17200352,0.026737332,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'AURKA Activation by TPX2', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dync1li1,0.17217025,0.045439348,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'RHO GTPases Activate Formins', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dync1li2,0.15643533,0.08834064,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dync2h1,0.06094797,0.037811305,3,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Dync2i1,-0.029060075,0.28485432,3,['Intraflagellar transport']
Dync2i2,-0.08487587,0.17008367,2,['Intraflagellar transport']
Dync2li1,-0.0076580727,0.08945772,3,['Intraflagellar transport']
Dynll1,0.2783428,-0.029182933,3,"['Activation of BIM and translocation to mitochondria ', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Macroautophagy', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'Intraflagellar transport', 'RHO GTPases Activate Formins', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'AURKA Activation by TPX2', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dynll2,0.18507148,0.042999595,3,"['Activation of BMF and translocation to mitochondria', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Macroautophagy', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Intraflagellar transport', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation']"
Dynlrb1,0.124506794,0.12673353,3,['Intraflagellar transport']
Dynlrb2,0.025313804,0.07869534,3,['Intraflagellar transport']
Dynlt1a,-0.1573368,-0.071091756,2,['Neutrophil degranulation']
Dynlt1b,0.07546519,-0.027049571,2,['Neutrophil degranulation']
Dynlt1c,0.09665621,-0.0126111135,3,['Neutrophil degranulation']
Dynlt1f,-0.13877083,0.08276605,2,['Neutrophil degranulation']
Dynlt2a1,-0.15792492,0.09479651,2,['Intraflagellar transport']
Dynlt2a3,-0.06181768,0.026315887,2,['Intraflagellar transport']
Dynlt2b,-0.16888662,0.0793232,2,['Intraflagellar transport']
Dynlt3,-0.045722146,0.07778486,3,
Dynlt4,-0.099234544,0.01833959,2,
Dynlt5,-0.21853012,0.0027148915,2,['Intraflagellar transport']
Dyrk1a,0.34184813,0.031332854,3,['G0 and Early G1']
Dyrk1b,0.04432558,0.018678933,2,
Dyrk2,0.26529482,0.20245153,3,['Regulation of TP53 Activity through Phosphorylation']
Dyrk4,0.06441679,0.13277872,0,
Dysf,-0.020543236,-0.21090554,1,
Dytn,-0.08152316,-0.121715896,2,
Dzank1,-0.14845361,0.12954289,2,
Dzip1,0.17272516,0.023241127,3,"[""Hedgehog 'on' state""]"
Dzip1l,-0.26038712,0.044076584,2,
Dzip3,0.13570558,0.13343291,3,['Antigen processing: Ubiquitination & Proteasome degradation']
E030018B13Rik,-0.29470438,0.116078466,2,
E030030I06Rik,0.0778774,0.047474295,3,
E130114P18Rik,-0.29180035,0.13351904,2,
E130309D02Rik,-0.285437,0.057005513,2,
E2f1,0.5293162,0.21620144,3,"['G2 Phase', 'Cyclin D associated events in G1']"
E2f2,0.45870155,0.19928499,3,['Cyclin D associated events in G1']
E2f3,0.39775893,0.33269173,3,"['G2 Phase', 'Cyclin D associated events in G1']"
E2f4,0.43441528,0.37277356,3,"['G0 and Early G1', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Cyclin D associated events in G1']"
E2f5,0.37130812,0.14225513,3,"['G0 and Early G1', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Cyclin D associated events in G1']"
E2f6,0.255342,0.3514719,3,['Transcriptional Regulation by E2F6']
E2f7,0.23193063,0.306584,3,['TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest']
E2f8,0.25722033,0.31569803,3,['TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest']
E330021D16Rik,-0.21759735,-0.06761416,2,
E430018J23Rik,-0.13794062,-0.14031792,2,['Generic Transcription Pathway']
E4f1,0.08668902,0.19280392,3,
Eaf1,0.10191092,0.103861995,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Eaf2,0.030050373,0.36122984,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Eapp,-0.42083564,0.077345274,2,
Ears2,-0.12063886,0.08369599,0,
Ebag9,-0.13854328,0.036352355,2,
Ebf1,0.19341718,0.059435237,3,
Ebf2,0.059390567,0.13832156,3,
Ebi3,0.23159426,-0.17933984,1,"['Interleukin-35 Signalling', 'Interleukin-27 signaling']"
Ebna1bp2,-0.19528186,0.3583712,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Ebp,-0.3328225,-0.025362454,2,"['Cholesterol biosynthesis via desmosterol', 'Cholesterol biosynthesis via lathosterol']"
Ebpl,-0.21094465,0.011560424,2,
Ecd,-0.045373898,0.26081362,0,
Ece1,0.11601771,-0.08852536,1,['Peptide ligand-binding receptors']
Ecel1,-0.049179625,-0.022626681,2,
Ech1,-0.29336184,0.07219672,2,['Peroxisomal protein import']
Echdc1,-0.25220957,0.12941222,2,
Echdc2,-0.30494258,-0.013749834,2,
Echs1,-0.3168392,-0.08133652,2,"['Branched-chain amino acid catabolism', 'Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA', 'Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA', 'Beta oxidation of octanoyl-CoA to hexanoyl-CoA', 'Beta oxidation of hexanoyl-CoA to butanoyl-CoA', 'Beta oxidation of butanoyl-CoA to acetyl-CoA']"
Eci1,-0.11649099,-0.07229008,2,['mitochondrial fatty acid beta-oxidation of unsaturated fatty acids']
Eci2,-0.15032749,0.08268395,2,"['Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Eci3,-0.1910703,0.12984195,2,
Ecm1,-0.21698324,-0.26856723,2,['Platelet degranulation ']
Ecm2,-0.06699046,0.04421354,2,
Ecpas,0.18229666,0.16600612,3,
Ecrg4,0.075541764,-0.06753413,1,
Ecsit,0.07247818,0.029145172,1,
Ect2,0.29974687,0.3593169,3,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Ect2l,-0.005547175,0.28733206,3,
Eda,0.21703899,-0.06718375,3,['TNFs bind their physiological receptors']
Eda2r,0.09785511,0.024145352,3,['TNFs bind their physiological receptors']
Edar,0.06319188,0.08931806,3,['TNFs bind their physiological receptors']
Edaradd,0.039058223,6.471833e-05,2,
Edc3,-0.09639888,0.54842895,0,"[""mRNA decay by 5' to 3' exoribonuclease""]"
Edc4,-0.12957942,0.39493898,0,
Eddm3b,-0.18827665,-0.046770442,2,
Edem1,0.08601173,0.1413569,3,
Edem2,-0.097803965,0.11222528,2,
Edem3,-0.20439209,-0.10651408,2,
Edf1,0.22237174,0.18209463,3,
Edil3,-0.04969298,-0.12271567,2,
Edn1,0.55180717,-0.29032335,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Edn2,0.046791937,-0.1491711,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Edn3,0.26730615,-0.0019086445,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Ednra,0.36932898,-0.23535594,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Ednrb,0.19464298,-0.12704596,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Edrf1,-0.076834254,-0.18360883,2,
Eea1,0.19371754,-0.32318053,1,['Toll Like Receptor 9 (TLR9) Cascade']
Eed,0.23031789,0.3329564,3,"['PRC2 methylates histones and DNA', 'Oxidative Stress Induced Senescence', 'PKMTs methylate histone lysines', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Eef1a1,0.1380127,0.29738656,0,"['Eukaryotic Translation Elongation', 'HSF1 activation', 'Neutrophil degranulation', 'Protein methylation']"
Eef1a2,0.089925304,0.09414675,0,
Eef1akmt1,0.027488226,0.19634607,0,['Protein methylation']
Eef1akmt2,-0.137802,0.48217463,0,['Protein methylation']
Eef1akmt3,-0.33171389,-0.050073534,2,
Eef1aknmt,0.040476236,0.26511574,3,
Eef1b2,-0.047751665,0.16962485,0,['Eukaryotic Translation Elongation']
Eef1d,-0.17800738,0.2476431,0,
Eef1e1,0.09327365,0.35818905,0,
Eef1g,-0.19995901,0.33766636,0,['Eukaryotic Translation Elongation']
Eef2,-0.02861967,0.37695384,0,"['Peptide chain elongation', 'Synthesis of diphthamide-EEF2', 'Neutrophil degranulation', 'Protein methylation']"
Eef2k,0.3306737,0.010942868,3,['mTORC1-mediated signalling']
Eef2kmt,0.009708068,0.1530708,3,['Protein methylation']
Eefsec,-0.17191578,0.14186256,0,
Eepd1,-0.09973275,-0.004956413,2,
Efcab1,-0.1592,-0.0724217,2,
Efcab11,-0.024001138,-0.10718516,2,
Efcab12,-0.15191665,-0.1782608,2,
Efcab14,-0.25546426,-0.037432745,2,
Efcab2,-0.33335984,0.0396214,2,
Efcab3,-0.109222986,-0.068308204,2,
Efcab5,-0.20868927,-0.03876272,2,
Efcab6,0.037344895,-0.096885026,2,
Efcab9,-0.073621936,-0.13938694,2,
Efcc1,-0.13657232,0.13421232,2,
Efemp1,0.327382,0.07874765,1,
Efemp2,0.01487198,-0.1624886,1,['Molecules associated with elastic fibres']
Efhc1,-0.053637765,0.022472898,2,
Efhc2,-0.22267456,-0.03682819,2,
Efhd2,0.108909905,-0.08273346,1,
Efl1,-0.15143019,0.37536225,0,
Efna1,0.31639165,-0.24489784,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Efna2,0.39636564,-0.18074666,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Efna3,0.2527576,-0.052514274,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Efna4,0.21494424,-0.25457552,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Efna5,0.33995306,-0.16293176,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Efnb1,0.4343208,-0.21894066,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Efnb2,0.36895013,-0.19266908,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Efnb3,0.4019442,-0.20136732,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Efr3a,-0.14075866,-0.17247917,2,
Efr3b,-0.12428115,-0.20864776,2,
Efs,-0.022692569,-0.1487321,2,
Eftud2,-0.11405346,0.6536209,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Egf,0.5973645,-0.3358589,1,"['Platelet degranulation ', 'Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'PI3K events in ERBB2 signaling', 'EGFR interacts with phospholipase C-gamma', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'Extra-nuclear estrogen signaling', 'NOTCH3 Activation and Transmission of Signal to the Nucleus']"
Egfem1,-0.15526824,0.007993787,2,
Egfl6,-0.35534254,-0.13046129,2,
Egfl7,0.33332634,-0.15122318,1,
Egfl8,-0.20851225,0.009020587,2,
Egflam,0.08779648,-0.15574832,1,
Egfr,0.63121814,-0.3557607,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'PI3K events in ERBB2 signaling', 'EGFR interacts with phospholipase C-gamma', 'EGFR Transactivation by Gastrin', 'Signal transduction by L1', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'PTK6 promotes HIF1A stabilization', 'Downregulation of ERBB2 signaling', 'Extra-nuclear estrogen signaling', 'NOTCH3 Activation and Transmission of Signal to the Nucleus']"
Egln1,0.12444766,-0.0015450408,3,['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha']
Egln2,0.03814651,-0.17005868,2,['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha']
Egln3,0.19705243,-0.046160586,1,
Egr1,0.41622344,-0.032956377,1,
Egr2,0.17306633,0.20624255,3,['NGF-stimulated transcription']
Egr3,0.22606646,0.12741055,3,
Egr4,-0.2697432,-0.05465262,2,
Ehbp1,-0.03760038,-0.26558465,1,
Ehbp1l1,0.12843631,0.0145437345,1,
Ehd1,-0.06144466,-0.3060965,1,['Factors involved in megakaryocyte development and platelet production']
Ehd2,-0.02167712,-0.34905946,1,['Factors involved in megakaryocyte development and platelet production']
Ehd3,0.042089332,-0.27594775,1,['Factors involved in megakaryocyte development and platelet production']
Ehd4,-0.025656547,-0.3226772,1,
Ehhadh,-0.19595537,0.054027542,2,"['Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Ehmt1,0.23392802,0.21708658,3,"['Senescence-Associated Secretory Phenotype (SASP)', 'PKMTs methylate histone lysines', 'Regulation of TP53 Activity through Methylation', 'Transcriptional Regulation by E2F6']"
Ehmt2,0.41892812,0.1517654,3,"['Senescence-Associated Secretory Phenotype (SASP)', 'PKMTs methylate histone lysines', 'Regulation of TP53 Activity through Methylation', 'RNA Polymerase I Transcription Initiation', 'Transcriptional Regulation by E2F6']"
Ei24,-0.26698837,0.1270402,2,
Eid1,0.123291865,0.08520965,3,
Eid2,-0.27115664,-0.024070337,2,
Eif1,-0.19020294,0.32888195,0,
Eif1a,-0.18770646,0.16733018,0,
Eif1ad,-0.14060207,0.043609492,2,
Eif1ad10,-0.27579755,0.20256422,0,
Eif1ad11,-0.18138264,0.08989881,0,
Eif1ad14,-0.15947045,0.07291258,2,
Eif1ad15,-0.13807158,0.24541803,0,
Eif1ad16,-0.12445513,0.07913609,0,
Eif1ad17,-0.2727666,0.25258487,0,
Eif1ad19,-0.17197952,0.00067859294,2,
Eif1ad2,-0.27096128,0.10397426,0,
Eif1ad3,-0.19529174,0.10402815,0,
Eif1ad6,-0.20860203,-0.10922435,2,
Eif1ad7,-0.16583835,-0.10580505,2,
Eif1ad8,-0.21356091,0.014050186,2,
Eif1ax,0.0955108,0.32082298,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif1b,0.0063092015,0.3494768,0,
Eif2a,-0.014651381,0.30265865,0,
Eif2ak1,-0.24631333,0.13150279,0,
Eif2ak2,0.44753996,0.12476852,1,['ISG15 antiviral mechanism']
Eif2ak3,0.27864936,0.054556403,1,
Eif2ak4,-0.01187587,0.223177,0,
Eif2b1,-0.15552682,0.22619994,0,['Recycling of eIF2:GDP']
Eif2b2,-0.030610425,0.32597774,3,['Recycling of eIF2:GDP']
Eif2b3,-0.062474422,0.18430434,0,['Recycling of eIF2:GDP']
Eif2b4,-0.07454407,0.063344315,0,['Recycling of eIF2:GDP']
Eif2b5,-0.04423318,0.2180519,3,['Recycling of eIF2:GDP']
Eif2d,-0.070661545,0.26760402,0,
Eif2s1,-0.10263158,0.4212948,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'PERK regulates gene expression', 'ABC-family proteins mediated transport', 'Translation initiation complex formation', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Recycling of eIF2:GDP']"
Eif2s2,-0.07327186,0.32414687,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'PERK regulates gene expression', 'ABC-family proteins mediated transport', 'Translation initiation complex formation', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Recycling of eIF2:GDP']"
Eif2s3x,-0.13256042,0.36850172,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'PERK regulates gene expression', 'ABC-family proteins mediated transport', 'Translation initiation complex formation', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Recycling of eIF2:GDP']"
Eif2s3y,-0.10987257,0.28433585,0,
Eif3a,-0.06847973,0.4241024,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3b,-0.10083379,0.54511416,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3c,-0.2650214,0.44145298,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3d,-0.14369142,0.28952658,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3e,-0.011673082,0.30839762,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3f,0.042367805,0.41245392,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3g,-0.22502333,0.3743006,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3h,-0.084314,0.2808032,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3i,-0.10985873,0.41468993,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3j1,-0.082866795,0.18866254,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3j2,-0.15370749,0.22859082,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3k,-0.15040848,0.32561824,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3l,0.015273605,0.19158491,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif3m,-0.16337639,0.40908584,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif4a1,0.120457254,0.46967414,0,"['ISG15 antiviral mechanism', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'Deadenylation of mRNA', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif4a2,-0.11050429,0.37585208,0,"['ISG15 antiviral mechanism', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'Deadenylation of mRNA', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif4a3,-0.19886145,0.6122928,0,"['ISG15 antiviral mechanism', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Deadenylation of mRNA', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Eif4a3l1,-0.15972975,0.5037163,0,
Eif4b,-0.044864096,0.55072707,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'mTORC1-mediated signalling', 'Deadenylation of mRNA', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif4e,0.26223496,0.49429175,0,"['ISG15 antiviral mechanism', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'mTORC1-mediated signalling', 'Deadenylation of mRNA', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif4e1b,0.08987999,0.3206066,0,
Eif4e2,-0.012589708,0.30484527,0,['ISG15 antiviral mechanism']
Eif4e3,0.04284635,0.26153213,0,['ISG15 antiviral mechanism']
Eif4ebp1,0.36703452,0.1911137,3,"['mTORC1-mediated signalling', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S']"
Eif4ebp2,0.077072434,0.16497076,0,
Eif4ebp3,-0.08089117,0.18334328,0,
Eif4enif1,-0.055678885,0.20157006,0,
Eif4g1,0.14916429,0.47237095,0,"['ISG15 antiviral mechanism', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'mTORC1-mediated signalling', 'Deadenylation of mRNA', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Eif4g2,0.13496453,0.3707873,0,
Eif4g3,-0.027762886,0.4181345,0,
Eif4h,-0.14628303,0.29314348,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif5,-0.0003305838,0.41740903,0,"['Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit']"
Eif5a,-0.16849053,0.35283136,0,['Hypusine synthesis from eIF5A-lysine']
Eif5a2,-0.18709193,0.3403206,0,['Hypusine synthesis from eIF5A-lysine']
Eif5b,-0.111342005,0.3188159,0,['GTP hydrolysis and joining of the 60S ribosomal subunit']
Eif6,-0.13163318,0.3342496,0,
Eipr1,-0.12021051,-0.023444438,2,
Elac1,-0.3860437,0.2932339,0,
Elac2,-0.05325883,0.49226278,0,
Elane,0.1071459,-0.11756186,1,"['Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Pyroptosis', 'Neutrophil degranulation', 'Antimicrobial peptides', 'Regulation of Complement cascade']"
Elapor1,-0.21540608,-0.020991176,2,
Elapor2,-0.23593594,-0.024917636,2,
Elavl1,0.3994431,0.36721992,3,"['HuR (ELAVL1) binds and stabilizes mRNA', 'mRNA Splicing - Major Pathway']"
Elavl2,-0.18218128,0.13463195,2,['mRNA Splicing - Major Pathway']
Elavl3,0.15083064,0.07171371,1,
Elavl4,0.0436079,0.10713831,0,
Elf1,0.097311735,0.15718679,0,['RUNX1 regulates transcription of genes involved in interleukin signaling']
Elf2,0.08102465,-0.11616195,2,['RUNX1 regulates transcription of genes involved in BCR signaling']
Elf3,-0.029097488,-0.17270859,2,['Pre-NOTCH Transcription and Translation']
Elf4,0.12729406,0.10605955,3,
Elf5,0.029221505,-0.0677871,2,
Elfn1,-0.07549091,-0.068100184,2,
Elfn2,-0.22561707,-0.009415119,2,
Elk1,0.2756734,-0.0378914,1,
Elk4,0.22910213,-0.07292119,3,
Ell,0.2358095,0.21755895,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Transcription Elongation']"
Ell2,0.024002114,0.19896452,3,['RNA polymerase II transcribes snRNA genes']
Ell3,0.10044487,0.07310656,3,['RNA polymerase II transcribes snRNA genes']
Elmo1,0.411822,-0.24060117,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases']"
Elmo2,0.28701824,-0.3001411,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'RHOG GTPase cycle']"
Elmo3,0.21823835,-0.20547868,1,
Elmod1,0.002840333,0.24809292,3,
Elmod2,-0.24118611,0.021352196,2,
Elmod3,-0.058475513,0.16579328,2,
Eln,0.13070475,-0.22000594,1,"['Degradation of the extracellular matrix', 'Elastic fibre formation', 'Molecules associated with elastic fibres']"
Eloa,0.19631056,0.34759414,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Elob,0.3200646,0.24745975,3,"['Formation of RNA Pol II elongation complex ', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation', 'Neddylation', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Elobl,0.32459643,0.124913335,3,
Eloc,0.28161225,0.2427222,3,"['Formation of RNA Pol II elongation complex ', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation', 'Neddylation', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Elof1,0.04171231,0.12681085,3,
Elovl1,-0.18453416,-0.25481468,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Synthesis of very long-chain fatty acyl-CoAs']"
Elovl2,-0.12803262,-0.108022824,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Synthesis of very long-chain fatty acyl-CoAs']"
Elovl3,-0.1958563,-0.21096644,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Synthesis of very long-chain fatty acyl-CoAs']"
Elovl4,-0.109310515,-0.10879428,2,
Elovl5,-0.18510593,-0.14043567,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Synthesis of very long-chain fatty acyl-CoAs']"
Elovl6,-0.23186794,-0.35235542,2,['Synthesis of very long-chain fatty acyl-CoAs']
Elovl7,-0.3146985,-0.19898917,2,['Synthesis of very long-chain fatty acyl-CoAs']
Elp1,-0.039153647,0.32397658,0,
Elp2,-0.10404351,0.28941223,0,
Elp3,0.012832776,0.42991528,0,
Elp4,-0.19105457,0.27918997,0,
Elp5,-0.059158877,0.27153274,0,
Elp6,-0.044446062,0.24577601,3,
Emb,-0.055939432,0.13072467,2,['Proton-coupled monocarboxylate transport']
Emc1,-0.20818037,0.037361227,2,
Emc2,-0.35829926,-0.0061348355,2,
Emc3,-0.30323237,-0.055882122,2,['RHOA GTPase cycle']
Emc4,-0.30134797,-0.037163876,2,
Emc6,-0.2102973,0.1056174,2,
Emc7,-0.12869957,0.23185615,2,
Emc8,-0.06685156,-0.046521127,2,
Emc9,-0.2964815,-0.13188979,2,
Emcn,-0.089750156,-0.19333148,2,
Emd,0.22103992,0.04511965,3,"['Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation', 'Depolymerisation of the Nuclear Lamina', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Eme1,0.22290216,0.28494865,3,"['Resolution of D-loop Structures through Holliday Junction Intermediates', 'Fanconi Anemia Pathway']"
Eme2,0.1605693,0.2111477,3,"['Resolution of D-loop Structures through Holliday Junction Intermediates', 'Fanconi Anemia Pathway']"
Emg1,-0.21204002,0.33709243,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Emilin1,0.11708247,-0.22352254,1,['Molecules associated with elastic fibres']
Eml3,-0.2078413,0.00091669656,2,
Eml4,0.22542648,-0.056408454,1,
Eml5,-0.020428443,-0.025520645,2,
Emp1,-0.012219253,-0.08264339,1,
Emp2,0.028703347,-0.29283938,1,
Emsy,0.17449065,0.1817299,3,
Emx1,-0.060546298,-0.05373134,2,
Emx2,0.20513205,-0.106550984,3,
En1,0.12834953,-0.011268711,3,
En2,0.17967682,0.015463737,3,
Enah,0.23202811,-0.229225,1,['Signaling by ROBO receptors']
Enam,0.09493754,0.05878187,3,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Enc1,0.11061609,0.085421644,3,
Endod1,0.010888364,-0.35218355,1,['Platelet degranulation ']
Endog,0.20025916,0.30198947,3,
Endov,-0.21954772,-0.037313085,2,
Eng,0.33938652,-0.19427614,1,
Engase,-0.066885844,0.2998144,3,['N-glycan trimming in the ER and Calnexin/Calreticulin cycle']
Enho,-0.08661665,-0.08253603,2,
Enkd1,-0.12546611,0.14044994,2,
Enkur,-0.19262917,0.07814108,2,
Eno1,0.13292922,-0.0043727537,1,"['Glycolysis', 'Gluconeogenesis']"
Eno1b,0.12407786,0.0017372547,1,"['Glycolysis', 'Gluconeogenesis']"
Eno2,-0.034536112,0.09879333,0,"['Glycolysis', 'Gluconeogenesis']"
Eno3,-0.17904241,0.061984774,2,"['Glycolysis', 'Gluconeogenesis']"
Eno4,-0.13202444,0.12707281,0,
Enoph1,-0.18850586,0.16617577,2,['Methionine salvage pathway']
Enpep,0.12847027,-0.13187906,1,['Metabolism of Angiotensinogen to Angiotensins']
Enpp1,-0.15918638,-0.09710777,2,
Enpp2,-0.20779835,-0.2527524,2,
Enpp3,-0.18798965,-0.07372526,2,
Enpp4,-0.17011423,-0.017425891,2,['Neutrophil degranulation']
Enpp6,-0.20112152,-0.22772092,2,['Glycerophospholipid catabolism']
Enpp7,-0.15882878,0.06152451,2,['Glycosphingolipid metabolism']
Ensa,0.08891942,0.12590218,3,
Enthd1,-0.08434191,-0.2623052,1,
Entpd1,0.0341797,0.029567415,1,['Phosphate bond hydrolysis by NTPDase proteins']
Entpd2,0.103303194,0.08394217,3,['Phosphate bond hydrolysis by NTPDase proteins']
Entpd3,-0.10482431,0.11314522,2,['Phosphate bond hydrolysis by NTPDase proteins']
Entpd4,-0.0096152965,0.11310844,2,['Phosphate bond hydrolysis by NTPDase proteins']
Entpd5,-0.1212189,0.046796888,2,['Phosphate bond hydrolysis by NTPDase proteins']
Entpd6,-0.104862586,0.013153577,2,['Phosphate bond hydrolysis by NTPDase proteins']
Entpd8,-0.16631521,0.1319269,2,['Phosphate bond hydrolysis by NTPDase proteins']
Entr1,-0.2079967,0.080536045,2,
Eny2,0.22398849,0.498217,3,
Eogt,0.035700727,0.26219377,3,
Eomes,0.1397992,-0.024376722,1,
Ep300,0.4111131,0.19523033,3,"['Regulation of gene expression by Hypoxia-inducible Factor', 'Formation of the beta-catenin:TCF transactivating complex', 'NOTCH1 Intracellular Domain Regulates Transcription', 'LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production', 'Attenuation phase', 'SUMOylation of transcription cofactors', 'B-WICH complex positively regulates rRNA expression', 'CD209 (DC-SIGN) signaling', 'Metalloprotease DUBs', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Methylation', 'PI5P Regulates TP53 Acetylation', 'Activation of the TFAP2 (AP-2) family of transcription factors', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'RUNX3 regulates NOTCH signaling', 'Regulation of RUNX3 expression and activity', 'RUNX3 regulates p14-ARF', 'Estrogen-dependent gene expression', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'TRAF3-dependent IRF activation pathway', 'TRAF6 mediated IRF7 activation', 'Regulation of FOXO transcriptional activity by acetylation', 'STAT3 nuclear events downstream of ALK signaling', 'Nuclear events mediated by NFE2L2']"
Ep400,0.33132833,0.32086933,3,"['Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'DNA Damage/Telomere Stress Induced Senescence']"
Epas1,0.30250883,0.14752573,3,"['Regulation of gene expression by Hypoxia-inducible Factor', 'Cellular response to hypoxia', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Neddylation']"
Epb41,0.1287515,-0.16609235,1,['Neurexins and neuroligins']
Epb41l1,0.1912894,-0.06449078,1,
Epb41l2,0.0530123,-0.11027501,1,['Neurexins and neuroligins']
Epb41l3,0.04458303,-0.27408913,1,['Neurexins and neuroligins']
Epb41l4a,-0.05949637,0.008047293,2,
Epb41l4b,0.13370682,0.030561935,1,
Epb41l5,0.033803366,-0.1335927,1,['Neurexins and neuroligins']
Epb42,-0.021918997,-0.17023474,2,
Epc1,0.2098142,0.17900538,3,['Transcriptional Regulation by E2F6']
Epc2,0.1860078,0.16290988,3,
Epcam,0.3738999,-0.0071967086,1,['Cell surface interactions at the vascular wall']
Epdr1,-0.116408974,-0.009183804,2,
Epg5,-0.12780157,-0.08784056,2,
Epgn,0.3073971,-0.3033608,1,"['PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'EGFR interacts with phospholipase C-gamma', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Extra-nuclear estrogen signaling']"
Epha1,0.29020992,-0.24626537,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Epha10,0.05065153,0.10166556,0,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Epha2,0.48651296,-0.25465903,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Epha3,0.2772589,-0.11053796,1,
Epha4,0.3569347,-0.16055559,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Epha5,0.19641106,-0.013859755,1,
Epha6,0.3738974,-0.05938197,1,
Epha7,0.10972182,-0.1683867,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Epha8,0.24518606,-0.24140808,1,"['EPH-Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells']"
Ephb1,0.39196327,-0.17969777,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Ephb2,0.54444563,-0.08583766,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Ephb3,0.2180197,-0.074191414,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Ephb4,0.4963166,-0.19086696,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Ephb6,0.18112206,-0.18060541,1,"['EPH-Ephrin signaling', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells']"
Ephx1,-0.15985669,-0.15491949,2,['Phase I - Functionalization of compounds']
Ephx2,-0.3186528,-0.016125103,2,"['Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Biosynthesis of maresins', 'Peroxisomal protein import']"
Epm2a,0.23829056,-0.09139802,3,
Epm2aip1,-0.19555628,0.021361887,2,
Epn1,0.29254875,-0.14385194,1,"['EGFR downregulation', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Epn2,0.23758544,-0.080455065,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Epn3,-0.025912989,-0.3816876,1,
Epo,0.44933555,-0.25267044,1,"['Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Erythropoietin activates RAS']"
Epop,-0.042831514,-0.021788066,2,
Epor,0.4071199,-0.37046266,1,"['Signaling by Erythropoietin', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Erythropoietin activates RAS']"
Epp13,-0.21838799,-0.1388502,2,
Eppin,-0.22264995,0.024575977,2,['Antimicrobial peptides']
Eprs,-0.052200984,0.2420012,0,
Eps15,0.1724254,-0.06967596,1,"['EGFR downregulation', 'Negative regulation of MET activity', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Eps15l1,0.21817632,-0.16882506,1,"['EGFR downregulation', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Eps8,0.3233871,-0.31957102,1,
Eps8l1,-0.004539043,0.027784768,2,
Eps8l2,0.054447927,-0.16721539,1,
Eps8l3,0.056847207,0.003744556,2,
Epsti1,-0.18067873,-0.109021865,2,['RND1 GTPase cycle']
Epx,-0.12186152,-0.016985102,2,['Neutrophil degranulation']
Epyc,-0.13307495,0.045511544,2,
Eral1,-0.16537361,0.04057515,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Erap1,0.17226455,-0.09249144,1,"['Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Eras,0.11464909,-0.026802404,1,
Erbb2,0.59039325,-0.29442975,1,"['Signaling by ERBB2', 'SHC1 events in ERBB2 signaling', 'PIP3 activates AKT signaling', 'GRB7 events in ERBB2 signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'Sema4D induced cell migration and growth-cone collapse', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Downregulation of ERBB2 signaling', 'Drug-mediated inhibition of ERBB2 signaling']"
Erbb3,0.49567026,-0.29965302,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PIP3 activates AKT signaling', 'GRB7 events in ERBB2 signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'PI3K events in ERBB2 signaling', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Downregulation of ERBB2 signaling']"
Erbb4,0.6219204,-0.28913298,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'Nuclear signaling by ERBB4', 'Downregulation of ERBB4 signaling', 'PIP3 activates AKT signaling', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Downregulation of ERBB2 signaling', 'Estrogen-dependent gene expression']"
Erbin,0.34583056,-0.11631517,1,"['Signaling by ERBB2', 'Downregulation of ERBB2 signaling', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'Drug-mediated inhibition of ERBB2 signaling']"
Erc1,0.36796957,0.022881333,1,
Erc2,0.14301835,0.0031376565,3,
Ercc1,0.29461247,0.54947233,3,"['HDR through Single Strand Annealing (SSA)', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Fanconi Anemia Pathway']"
Ercc2,0.2588459,0.35478172,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Ercc3,0.28122506,0.39707437,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Ercc4,0.17229179,0.3453169,3,"['HDR through Single Strand Annealing (SSA)', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Fanconi Anemia Pathway']"
Ercc5,0.27627543,0.36594728,3,
Ercc6,0.42113736,0.44599184,3,"['B-WICH complex positively regulates rRNA expression', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'RNA Polymerase I Transcription Initiation']"
Ercc6l,0.051598474,0.48836946,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ercc6l2,0.10522186,0.37127987,0,
Ercc8,0.09978369,0.47687292,3,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Neddylation']"
Ereg,0.34422934,-0.2936678,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'EGFR interacts with phospholipase C-gamma', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'Extra-nuclear estrogen signaling']"
Erfe,0.09358834,-0.03293025,1,
Erg28,-0.21316199,0.041074313,2,
Ergic1,-0.22398347,-0.09091335,2,
Ergic2,-0.20227224,-0.00808337,2,
Ergic3,-0.18153232,-0.07762334,2,
Erh,0.00024318151,0.33374605,0,
Eri1,-0.08125482,0.43719083,0,
Eri2,-0.0076026237,0.13832904,0,
Eri3,0.013083261,0.08076668,2,
Erich1,-0.11648831,-0.012083515,2,
Erich2,-0.18966693,-0.110413566,2,
Erich3,-0.1394476,0.08686335,2,
Erich5,-0.1649009,-0.03489469,2,
Erich6,-0.18338951,0.050875872,2,
Erlec1,0.02142328,0.040956825,3,"['ABC-family proteins mediated transport', 'Hedgehog ligand biogenesis']"
Erlin1,0.047839385,-0.108871214,2,['ABC-family proteins mediated transport']
Erlin2,0.027713573,-0.09987782,2,['ABC-family proteins mediated transport']
Ermn,-0.057917494,0.0130015835,2,
Ern1,0.4169268,-0.08442363,1,['IRE1alpha activates chaperones']
Ern2,0.039089877,0.06645688,2,
Ero1a,0.08597825,-0.20162153,1,"['Insulin processing', 'Detoxification of Reactive Oxygen Species']"
Ero1b,0.218192,-0.04652846,1,['Insulin processing']
Erp27,-0.02779886,-0.11924555,2,
Erp29,0.044972736,-0.067538545,1,
Erp44,0.04212018,-0.19858314,1,['Neutrophil degranulation']
Errfi1,0.027205965,-0.35887596,1,
Esam,0.1017007,-0.19283964,1,['Cell surface interactions at the vascular wall']
Esco1,0.015166841,0.3025255,3,['Establishment of Sister Chromatid Cohesion']
Esco2,0.2454403,0.42710245,3,['Establishment of Sister Chromatid Cohesion']
Esd,-0.22008215,-0.08949046,2,['Glutathione conjugation']
Esf1,-0.42378157,0.5309883,0,
Esp1,-0.066479705,-0.034640603,2,
Esp18,-0.46599475,-0.06826545,2,
Esp24,-0.36117566,0.033210322,2,
Esp3,-0.15415996,-0.12214408,2,
Esp31,-0.11902204,0.083898306,2,
Esp34,-0.31888103,0.1152817,2,
Esp36,-0.13778396,0.034859154,2,
Esp38,-0.3067372,0.044715032,2,
Esp4,-0.3097775,0.11677324,2,
Espl1,0.14980328,0.51793957,3,['Separation of Sister Chromatids']
Espn,0.12822522,-0.21816216,1,
Espnl,-0.32888353,-0.044685718,2,
Esr1,0.6122027,0.04533501,3,"['Nuclear signaling by ERBB4', 'PIP3 activates AKT signaling', 'Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors', 'Ovarian tumor domain proteases', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'TFAP2 (AP-2) family regulates transcription of growth factors and their receptors', 'RUNX1 regulates estrogen receptor mediated transcription', 'ESR-mediated signaling', 'Extra-nuclear estrogen signaling', 'Estrogen-dependent gene expression']"
Esr2,0.55459607,0.0042648697,3,"['PIP3 activates AKT signaling', 'Nuclear Receptor transcription pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ESR-mediated signaling', 'Extra-nuclear estrogen signaling']"
Esrp1,0.030563006,-0.09500244,1,
Esrp2,0.011994227,0.03624649,2,
Esrra,0.2015123,0.13934064,3,['Nuclear Receptor transcription pathway']
Esrrb,0.3092901,0.20210281,3,['Nuclear Receptor transcription pathway']
Esrrg,0.16905461,0.15249608,3,['Nuclear Receptor transcription pathway']
Ess2,0.018501293,0.24097717,3,
Esx1,-0.20649031,-0.14416288,2,
Esyt1,-0.048648473,-0.030995825,2,"['Glycosphingolipid metabolism', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Esyt2,-0.15916361,0.055920962,2,['Glycosphingolipid metabolism']
Esyt3,-0.050172444,-0.0026115254,2,['Glycosphingolipid metabolism']
Etaa1,0.0026918768,0.18927622,3,
Etf1,-0.15133955,0.3735886,0,"['Eukaryotic Translation Termination', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Etfa,-0.059635233,-0.18130836,2,['Respiratory electron transport']
Etfb,-0.12963058,-0.22064634,2,"['Respiratory electron transport', 'Protein methylation']"
Etfbkmt,-0.13896447,0.02212559,2,['Protein methylation']
Etfdh,-0.13187042,-0.14369339,2,['Respiratory electron transport']
Etfrf1,-0.15426546,0.1807714,2,
Ethe1,-0.14638892,-0.14673397,2,['Sulfide oxidation to sulfate']
Etl4,-0.051480673,-0.219596,2,
Etnk1,-0.12812883,-0.12285574,2,['Synthesis of PE']
Etnk2,-0.070447184,-0.04496445,2,['Synthesis of PE']
Etnppl,-0.2622537,-0.06312263,2,['Synthesis of PE']
Ets1,0.29354477,-0.042582035,1,['Oncogene Induced Senescence']
Ets2,0.24825647,0.012645383,3,['Oncogene Induced Senescence']
Etv1,0.11087561,-0.0687407,1,
Etv2,-0.083474115,-0.089382604,2,
Etv3,0.15336491,0.20626439,3,
Etv4,0.30669522,0.021829413,3,['MAPK6/MAPK4 signaling']
Etv5,0.08071805,0.014492474,1,
Etv6,0.32156837,0.008755655,1,
Eva1b,-0.20500855,0.014133115,2,
Eva1c,-0.14433311,-0.015816985,2,
Evc,0.073199086,0.14226116,3,"[""Hedgehog 'on' state""]"
Evc2,-0.024129432,0.11529111,2,"[""Hedgehog 'on' state""]"
Evi2a,-0.032914754,-0.053091522,2,
Evi2b,-0.0837757,-0.008501859,2,
Evi5,0.025786174,0.14665538,3,
Evi5l,-0.21116899,-0.13738215,2,
Evl,0.17481118,-0.14802288,1,"['Signaling by ROBO receptors', 'RHO GTPases Activate Formins']"
Evpl,0.085577436,-0.2430186,1,['Formation of the cornified envelope']
Evx1,0.049505234,0.029430505,2,
Evx2,-0.32362875,-0.14262651,2,
Ewsr1,0.34728524,0.37090483,3,
Exd1,-0.07005658,-0.03964611,2,
Exd2,-0.07407526,0.18478662,0,
Exo1,0.15238163,0.5004327,3,"['Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Exoc1,0.051469866,-0.10155142,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exoc2,0.22228472,-0.08742441,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exoc3,0.08454384,-0.17520487,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exoc3l,-0.05144243,-0.17246835,2,
Exoc3l2,-0.02600433,-0.0037775226,2,
Exoc3l4,0.058794536,-0.025566075,1,
Exoc4,0.2567956,-0.101626426,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exoc5,0.18873477,-0.18088368,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exoc6,0.19473328,-0.123065434,1,
Exoc6b,0.06525645,-0.07130343,1,
Exoc7,0.19709283,-0.1402417,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exoc8,0.18541284,-0.18562344,1,"['Insulin processing', 'VxPx cargo-targeting to cilium']"
Exog,0.018856334,0.1775915,3,
Exosc1,-0.34723642,0.467183,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc10,-0.17936137,0.4690907,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Exosc2,-0.19353575,0.41714492,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc3,-0.24037209,0.34084013,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc4,-0.18072294,0.3888382,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc5,-0.20604865,0.27524814,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc7,-0.096471116,0.22548716,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc8,-0.17866032,0.21105891,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exosc9,-0.16818933,0.3030277,0,"[""mRNA decay by 3' to 5' exoribonuclease"", 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Exph5,-0.08062175,0.06183893,2,
Ext1,0.08171707,-0.012796107,1,['HS-GAG biosynthesis']
Ext2,0.08954483,-0.13431688,1,['HS-GAG biosynthesis']
Extl1,-0.051298402,-0.04858463,2,
Extl2,-0.22614844,-0.009672967,2,
Extl3,-0.05801543,0.05047301,2,
Eya1,0.14288782,0.13092673,3,['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']
Eya2,0.05817544,0.2659341,3,['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']
Eya3,0.21631396,0.18925232,3,['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']
Eya4,0.112989135,0.19810057,3,['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']
Ezh1,0.27245498,0.16072382,3,
Ezh2,0.4943608,0.28789583,3,"['PRC2 methylates histones and DNA', 'Oxidative Stress Induced Senescence', 'PKMTs methylate histone lysines', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Ezr,0.45606333,-0.3249966,1,"['Netrin-1 signaling', 'Recycling pathway of L1']"
F10,0.10381953,-0.18298024,1,"['Extrinsic Pathway of Fibrin Clot Formation', 'Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins']"
F11,0.18745117,-0.14999588,1,['Intrinsic Pathway of Fibrin Clot Formation']
F11r,0.35384268,-0.1335113,1,"['Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Tight junction interactions']"
F12,0.16567752,-0.14071605,1,['Intrinsic Pathway of Fibrin Clot Formation']
F13a1,0.16476554,-0.114721484,1,"['Platelet degranulation ', 'Common Pathway of Fibrin Clot Formation']"
F13b,0.094245136,-0.061540946,1,['Common Pathway of Fibrin Clot Formation']
F2,0.49275228,-0.344407,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins', 'Cell surface interactions at the vascular wall', 'Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Platelet Aggregation (Plug Formation)', 'Regulation of Complement cascade']"
F2r,0.26922885,-0.3564673,1,"['Common Pathway of Fibrin Clot Formation', 'Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'Thrombin signalling through proteinase activated receptors (PARs)']"
F2rl1,0.18316005,-0.294524,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
F2rl2,0.18297529,-0.40388486,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'Thrombin signalling through proteinase activated receptors (PARs)']"
F2rl3,0.30831578,-0.4146443,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'Thrombin signalling through proteinase activated receptors (PARs)']"
F3,0.16865042,-0.15620184,1,
F5,0.13593678,-0.17126963,1,"['Platelet degranulation ', 'Common Pathway of Fibrin Clot Formation', 'COPII-mediated vesicle transport', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Cargo concentration in the ER', 'Post-translational protein phosphorylation']"
F7,0.22370261,-0.112866774,1,"['Extrinsic Pathway of Fibrin Clot Formation', 'Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins']"
F8,0.16038239,-0.2232108,1,"['Platelet degranulation ', 'Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Gamma carboxylation, hypusine formation and arylsulfatase activation', 'COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
F830045P16Rik,-0.25033617,-0.15056638,2,
F8a,-0.08188742,-0.07063505,2,
F9,0.16846503,-0.12088926,1,"['Extrinsic Pathway of Fibrin Clot Formation', 'Intrinsic Pathway of Fibrin Clot Formation', 'Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins']"
Fa2h,-0.27956295,-0.16137107,2,['Sphingolipid de novo biosynthesis']
Faah,-0.17070122,0.03438601,2,['Arachidonic acid metabolism']
Faap100,0.18508625,0.24858168,3,['Fanconi Anemia Pathway']
Faap20,-0.0080309445,0.20933744,3,['Fanconi Anemia Pathway']
Faap24,0.1686778,0.21239176,3,['Fanconi Anemia Pathway']
Fabp1,0.069644175,-0.100232214,2,"['Triglyceride catabolism', 'Heme degradation', 'Regulation of lipid metabolism by PPARalpha', 'Cytoprotection by HMOX1']"
Fabp2,-0.11193627,-0.3123837,2,['Triglyceride catabolism']
Fabp3,-0.010074435,-0.09248932,2,['Triglyceride catabolism']
Fabp4,0.14902876,-0.2795073,1,['Triglyceride catabolism']
Fabp5,0.08151206,-0.05356416,3,"['Triglyceride catabolism', 'Signaling by Retinoic Acid', 'Neutrophil degranulation']"
Fabp6,0.13008896,-0.1669991,1,"['Recycling of bile acids and salts', 'Triglyceride catabolism']"
Fabp7,0.18462266,0.053068317,3,['Triglyceride catabolism']
Fadd,0.34132746,0.07869951,3,"['Caspase activation via Death Receptors in the presence of ligand', 'TRIF-mediated programmed cell death', 'Regulation by c-FLIP', 'CASP8 activity is inhibited', 'TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'Regulation of necroptotic cell death', 'Dimerization of procaspase-8', 'FasL/ CD95L signaling', 'TRAIL  signaling']"
Fads1,-0.1942223,-0.033307128,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism']"
Fads2,-0.06960018,-0.24107535,2,"['Linoleic acid (LA) metabolism', 'alpha-linolenic acid (ALA) metabolism']"
Fads6,-0.087617464,-0.17096612,2,
Faf1,0.18241662,0.043607075,3,
Faf2,-0.025203357,0.05455602,2,"['Neutrophil degranulation', 'RHOA GTPase cycle']"
Fah,-0.09325561,0.046942975,2,['Tyrosine catabolism']
Fahd1,0.0809405,0.060809553,3,['Citric acid cycle (TCA cycle)']
Fahd2a,-0.10956052,-0.037514336,2,
Faim,0.14326148,-0.14461029,1,
Faim2,-0.047937762,-0.0950674,2,
Fam102a,-0.2430871,-0.06596151,2,
Fam102b,0.052250043,0.14002062,0,
Fam104a,-0.024133714,0.11058523,0,
Fam107a,0.0056792884,-0.10073152,2,
Fam107b,-0.17087315,-0.15464857,2,
Fam110a,0.13660209,-0.037275396,1,
Fam110b,-0.13937815,-0.10079528,2,
Fam114a1,-0.06855677,-0.09368525,2,
Fam118a,-0.0037551483,0.14032617,0,
Fam118b,-0.043563608,0.21188875,0,
Fam120b,0.15674278,0.1367548,3,
Fam120c,-0.3494014,-0.084769696,2,
Fam122a,0.12535723,-0.17207463,1,
Fam122b,-0.18537334,-0.044708457,2,
Fam124a,-0.06978615,0.08289251,2,
Fam126a,-0.18600202,-0.1956233,2,
Fam126b,-0.11251948,-0.22505668,2,
Fam131b,0.0038470044,0.044490498,2,
Fam131c,-0.0219753,0.11041991,2,
Fam135a,-0.21992941,0.11211575,2,['RND1 GTPase cycle']
Fam135b,-0.16223103,-0.25140384,2,
Fam13a,-0.27026886,0.0507991,2,"['RHOA GTPase cycle', 'RAC1 GTPase cycle']"
Fam13b,-0.16067436,0.15739636,2,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Fam151b,-0.08558483,0.059251394,2,
Fam161a,-0.112460084,0.040960092,2,
Fam161b,-0.35897106,-0.04279477,2,
Fam163b,-0.06448635,0.0039538518,2,
Fam166a,-0.16608123,0.0101217395,2,
Fam166b,-0.07358184,-0.015771367,2,
Fam166c,-0.16864549,-0.11466444,2,
Fam167a,0.09436686,-0.077894285,1,
Fam168a,-0.07848752,0.025448244,2,
Fam168b,-0.0938096,0.04514821,2,
Fam169a,-0.046120126,0.05565314,2,['RHOF GTPase cycle']
Fam170a,-0.012505244,-0.25355512,2,
Fam170b,-0.17168687,-0.02790208,2,
Fam171b,-0.3064564,0.044045202,2,
Fam172a,-0.20623761,0.12869391,2,
Fam174b,-0.20575888,-0.1642387,2,
Fam177a,-0.20283958,-0.10055638,2,
Fam178b,-0.14528348,-0.072387554,2,
Fam180a,-0.13719189,-0.06311758,2,
Fam181a,-0.1888504,-0.25649422,2,
Fam183b,-0.20356415,0.051628146,2,
Fam184a,-0.23020166,-0.03481177,2,
Fam184b,-0.10264159,0.08968787,2,
Fam185a,-0.106520094,0.024929268,2,
Fam187a,-0.29313138,-0.06228984,2,
Fam187b,-0.17834821,0.004821409,2,
Fam189a1,-0.16342138,-0.019500192,2,
Fam189a2,-0.03694798,0.021675123,2,
Fam193a,-0.03884665,0.013351252,2,
Fam193b,-0.37324846,0.005941967,2,
Fam199x,0.18897304,0.14846355,3,
Fam204a,-0.07816854,-0.16087195,2,
Fam205a2,-0.23464073,0.07664387,2,
Fam205a3,-0.28637984,0.0011827669,2,
Fam209,-0.11354069,-0.054739777,2,
Fam20a,0.040297285,0.14770494,3,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Fam20b,-0.09050026,0.052051596,2,
Fam20c,-0.06339589,0.01657596,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Fam210a,-0.27219087,0.006496522,2,
Fam214a,-0.28443873,-0.078562796,2,
Fam214b,-0.092557326,-0.03369891,2,
Fam216a,-0.12601483,3.501094e-05,2,
Fam216b,-0.39999476,-0.008956987,2,
Fam217b,-0.091113925,-0.0074037192,2,
Fam227a,-0.14355744,-0.13721998,2,
Fam229b,-0.044260282,0.08881527,2,
Fam234a,-0.079035066,0.057987455,0,
Fam234b,-0.34374902,-0.046137094,2,
Fam243,-0.1998128,-0.053996682,2,
Fam24a,-0.111313745,0.09023744,2,
Fam32a,-0.22320227,0.2388423,0,
Fam3a,-0.15426394,-0.015218355,2,
Fam3b,-0.20860665,0.010056651,2,
Fam3c,-0.15086417,0.016836533,2,['Platelet degranulation ']
Fam43b,-0.2103712,-0.070231155,2,
Fam47c,0.010626058,0.1288425,3,
Fam50b,-0.2072286,-0.00834263,2,
Fam53a,-0.02879671,-0.07720018,2,
Fam53c,-0.08901027,-0.0067612375,2,
Fam71b,-0.26214,-0.060861863,2,
Fam71d,-0.29686254,-0.17541613,2,
Fam71e1,-0.3187582,-0.054913152,2,
Fam71f1,-0.15306757,-0.039088476,2,
Fam71f2,-0.12449668,-0.009291035,2,
Fam72a,-0.11423874,0.058912694,2,
Fam81a,0.20138901,0.0880832,3,
Fam83a,0.12366769,0.013929,3,
Fam83b,0.17057317,-0.043654785,3,"['RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Fam83c,-0.18635523,-0.004363123,2,
Fam83d,0.09261056,0.25898212,3,
Fam83f,-0.17477767,0.026722273,2,
Fam83g,-0.2641252,-0.040228523,2,
Fam83h,0.164543,-0.0021806085,3,
Fam89b,-0.14321506,-0.07203257,2,
Fam8a1,-0.032857265,0.17649934,2,
Fam91a1,-0.18128943,-0.06858083,2,['RHOH GTPase cycle']
Fam98a,-0.09267836,0.01607579,2,
Fam98b,-0.13518158,0.121681124,2,
Fam98c,-0.28491795,-0.16277003,2,
Fan1,0.054620363,0.2989901,3,['Fanconi Anemia Pathway']
Fanca,0.24454443,0.17877357,3,['Fanconi Anemia Pathway']
Fancc,0.20316122,0.31667438,3,['Fanconi Anemia Pathway']
Fancd2,0.26168227,0.35432205,3,['Fanconi Anemia Pathway']
Fancd2os,-0.10940461,-0.012087986,2,
Fance,0.14627409,0.23537636,3,['Fanconi Anemia Pathway']
Fancf,0.12830812,0.32776156,3,['Fanconi Anemia Pathway']
Fancg,0.22829278,0.19666816,3,['Fanconi Anemia Pathway']
Fanci,0.25230622,0.32756555,3,['Fanconi Anemia Pathway']
Fancl,0.13917306,0.32767877,3,['Fanconi Anemia Pathway']
Fancm,0.2424348,0.33894822,3,['Fanconi Anemia Pathway']
Fank1,-0.14344169,0.15874805,0,
Fap,0.16847186,0.047757946,3,
Far1,-0.3086316,-0.063139796,2,['Wax biosynthesis']
Far2,-0.28546017,-0.047744796,2,['Wax biosynthesis']
Farp1,0.07134593,-0.04365571,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOF GTPase cycle']"
Farp2,0.16826858,-0.08843836,1,"['SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'RAC1 GTPase cycle']"
Fars2,-0.21603882,0.15930767,0,
Farsa,-0.066161744,0.04698022,0,
Farsb,-0.12217147,0.25013018,0,
Fas,0.52657336,-0.07633334,1,"['Regulation by c-FLIP', 'CASP8 activity is inhibited', 'Dimerization of procaspase-8', 'FasL/ CD95L signaling']"
Fasl,0.2541356,-0.029159945,1,"['Regulation by c-FLIP', 'CASP8 activity is inhibited', 'Dimerization of procaspase-8', 'FasL/ CD95L signaling']"
Fasn,-0.0228811,-0.24895425,2,"['ChREBP activates metabolic gene expression', 'Vitamin B5 (pantothenate) metabolism', 'Fatty acyl-CoA biosynthesis']"
Fastk,-0.05833114,0.07351441,2,
Fastkd1,-0.18366325,-0.021021385,2,
Fastkd2,-0.15214455,0.0057160375,2,
Fastkd5,-0.2901286,0.020754432,2,
Fat1,0.25456086,-0.2260535,1,
Fat2,-0.1882761,-0.051362097,2,
Fat3,-0.0950842,-0.041910667,2,
Fat4,0.2087761,-0.087085456,1,
Fate1,-0.24095644,-0.16583599,2,
Fau,-0.15311846,0.2710092,0,
Faxc,-0.18933775,-0.07191104,2,
Fbf1,-0.04108273,-0.26227224,2,['Anchoring of the basal body to the plasma membrane']
Fbh1,0.1598993,0.3840637,3,
Fbl,-0.13172698,0.6210775,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Fblim1,0.17421429,-0.2687674,1,['Cell-extracellular matrix interactions']
Fbll1,-0.20225182,0.4029859,0,
Fbln1,-0.069295526,-0.2394432,2,
Fbln2,0.09265369,-0.23809756,1,['Molecules associated with elastic fibres']
Fbln5,-0.06970073,-0.08438337,2,"['Elastic fibre formation', 'Molecules associated with elastic fibres']"
Fbn1,0.15938492,-0.12978262,1,"['Degradation of the extracellular matrix', 'Elastic fibre formation', 'Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Fbn2,0.22069836,-0.09544446,1,"['Degradation of the extracellular matrix', 'Elastic fibre formation', 'Molecules associated with elastic fibres']"
Fbp1,-0.11698082,0.0043949177,2,['Gluconeogenesis']
Fbp2,-0.28597337,0.042270795,2,['Gluconeogenesis']
Fbrs,-0.049324416,-0.057083834,2,
Fbrsl1,-0.14369078,-0.16748005,2,
Fbxl12,0.04056664,0.22493587,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl13,0.004089691,-0.028787883,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl14,0.10872299,0.2237008,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl15,0.12178728,-0.0793285,1,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl16,0.13920024,0.051875,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl17,0.1038178,0.1857103,3,['Regulation of BACH1 activity']
Fbxl18,0.1549273,-0.008777805,3,"['FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl19,0.28679794,0.2458272,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl2,0.25714192,0.058261696,3,
Fbxl20,0.023398481,0.17831539,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl21,0.13569443,0.070268095,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl22,-0.065112166,0.07609986,2,
Fbxl3,0.25106472,0.17779993,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl4,0.21661524,0.21953176,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl5,0.14314461,0.14611815,3,"['Neddylation', 'Iron uptake and transport', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl6,-0.356636,-0.117973246,2,
Fbxl7,0.13665023,0.30747464,3,"['FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxl8,-0.16748539,-0.08868854,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo10,0.18208967,0.04043244,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo11,0.10893891,0.12930219,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo15,0.07186867,0.16137683,3,
Fbxo16,0.022078639,0.010678448,3,
Fbxo17,0.26843688,0.07718675,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo2,0.24958281,-0.012947135,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo21,0.2110506,0.1946135,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo22,0.32735142,0.16687974,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo24,-0.110096335,-0.0019375406,2,
Fbxo25,-0.0059654396,0.030848661,2,
Fbxo27,0.06572541,0.10870093,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo28,-0.06710086,0.20161739,3,
Fbxo3,0.07539193,0.013184276,2,
Fbxo30,-0.13231073,0.1642151,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo31,0.11613197,0.16609587,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo32,0.16380152,0.096332386,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo33,-0.13726479,-0.008722083,2,
Fbxo34,-0.18266827,0.09634487,2,
Fbxo36,-0.006163683,0.16090101,3,
Fbxo38,0.020940432,-0.12639028,2,
Fbxo4,0.35873935,0.16998431,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo40,0.11263516,0.26924008,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo41,-0.05682158,0.03728493,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo42,-0.016780565,0.14773257,3,
Fbxo43,0.25813448,0.17353575,3,
Fbxo44,0.23381777,0.13822243,3,
Fbxo45,0.18026583,0.2459111,3,
Fbxo46,-0.09997318,0.07416722,2,
Fbxo47,-0.2828436,-0.07097911,2,
Fbxo48,-0.30813837,-0.10807704,2,
Fbxo5,0.20762168,0.4168196,3,"['SCF-beta-TrCP mediated degradation of Emi1', 'Regulation of APC/C activators between G1/S and early anaphase', 'Phosphorylation of Emi1', 'Mitotic Metaphase/Anaphase Transition']"
Fbxo6,0.24241123,0.14165342,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo7,0.08452917,0.16494846,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxo8,-0.017338015,-0.12687443,2,
Fbxo9,0.21243393,0.17153114,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw10,0.0036369578,0.13844194,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw11,0.5190547,0.1386404,3,"['Activation of NF-kappaB in B cells', 'Downstream TCR signaling', 'Regulation of PLK1 Activity at G2/M Transition', 'FCERI mediated NF-kB activation', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw15,-0.15714078,0.022257216,2,
Fbxw19,-0.01914489,-0.009443777,2,
Fbxw2,0.19719218,0.11499064,0,
Fbxw21,-0.21034831,-0.21878031,2,
Fbxw4,0.2077052,0.08970189,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw5,0.084409684,0.08455275,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw7,0.4210933,0.10107006,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw8,0.24210629,0.1562977,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fbxw9,0.14610936,0.14432587,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Fcamr,-0.20379673,-0.14712349,2,['Cell surface interactions at the vascular wall']
Fcer1a,0.15083721,-0.22595935,1,"['Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation']"
Fcer1g,0.27236608,-0.405735,1,"['GPVI-mediated activation cascade', 'Cell surface interactions at the vascular wall', 'Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation', 'Dectin-2 family', 'Neutrophil degranulation', 'Platelet Adhesion to exposed collagen']"
Fcer2a,0.18031338,-0.16391778,1,
Fcf1,-0.18916313,0.28365952,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Fcgbp,-0.10567206,0.11968391,2,
Fcgr1,0.30489337,-0.24905212,1,"['Cross-presentation of soluble exogenous antigens (endosomes)', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis']"
Fcgr2b,0.28028268,-0.24450138,1,
Fcgr3,0.33456475,-0.31816918,1,
Fcgr4,0.3300152,-0.30163223,1,"['Post-translational modification: synthesis of GPI-anchored proteins', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'Neutrophil degranulation']"
Fcgrt,0.28051642,-0.033535402,1,
Fcho1,0.006705765,-0.15874435,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Fcho2,0.16121805,-0.0959307,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Fchsd1,-0.1394505,-0.017742436,2,
Fchsd2,0.076391906,-0.032203566,1,
Fcmr,-0.015789738,-0.10044972,1,
Fcna,-0.058550328,-0.14777087,2,"['Lectin pathway of complement activation', 'Initial triggering of complement', 'Ficolins bind to repetitive carbohydrate structures on the target cell surface', 'Neutrophil degranulation']"
Fcnb,0.09914133,-0.18135726,1,"['Lectin pathway of complement activation', 'Initial triggering of complement', 'Ficolins bind to repetitive carbohydrate structures on the target cell surface', 'Neutrophil degranulation']"
Fcrl6,0.16128512,-0.21535768,1,
Fcrla,-0.06897847,-0.16566455,1,
Fcrls,-0.12509671,0.035668984,2,
Fcsk,-0.0517082,-0.017616348,2,['GDP-fucose biosynthesis']
Fdft1,-0.24872054,-0.03297698,2,['Cholesterol biosynthesis']
Fdps,-0.28161645,0.018766923,2,['Cholesterol biosynthesis']
Fdx1,-0.2717618,-0.087796494,2,"['Mitochondrial iron-sulfur cluster biogenesis', 'Pregnenolone biosynthesis', 'Endogenous sterols', 'Electron transport from NADPH to Ferredoxin']"
Fdx2,-0.20757769,-0.13950334,2,"['Mitochondrial iron-sulfur cluster biogenesis', 'Pregnenolone biosynthesis', 'Endogenous sterols', 'Electron transport from NADPH to Ferredoxin']"
Fdxacb1,-0.16042216,0.25771573,0,
Fdxr,-0.25806803,-0.11612246,2,"['Pregnenolone biosynthesis', 'Endogenous sterols', 'Electron transport from NADPH to Ferredoxin']"
Fech,0.07848195,0.12262452,0,
Fem1a,0.041219775,0.033836037,2,['Neddylation']
Fem1al,-0.047121886,-0.099024996,2,
Fem1b,0.02510375,0.16540936,0,['Neddylation']
Fem1c,0.09006072,-0.1185512,1,['Neddylation']
Fen1,0.18069533,0.48443988,3,
Fer,0.093950175,-0.44523552,1,['Signaling by SCF-KIT']
Ferd3l,-0.10389321,-0.13322037,2,
Fermt1,0.017983787,-0.15837726,1,
Fermt2,0.14029007,-0.2853968,1,"['Cell-extracellular matrix interactions', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Fermt3,0.22840156,-0.24416614,1,['Platelet degranulation ']
Fes,0.44000068,-0.424945,1,"['Signaling by SCF-KIT', 'Sema3A PAK dependent Axon repulsion', 'CRMPs in Sema3A signaling']"
Fetub,-0.11976798,-0.1501541,2,
Fev,-0.03220694,-0.061539166,2,
Fez1,0.0042728223,-0.06585363,1,
Fez2,-0.09570429,0.123979256,2,
Fezf2,-0.104495764,0.0067180158,2,
Ffar1,0.040941264,-0.20210092,1,"['Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)', 'G alpha (q) signalling events', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Free fatty acid receptors']"
Ffar2,0.0758623,-0.12834722,1,"['G alpha (q) signalling events', 'Free fatty acid receptors']"
Ffar3,-0.1952524,-0.13749637,2,"['G alpha (q) signalling events', 'Free fatty acid receptors']"
Ffar4,0.19386575,-0.16881986,1,"['Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'G alpha (q) signalling events']"
Fga,0.21046858,-0.30201918,1,"['Platelet degranulation ', 'Common Pathway of Fibrin Clot Formation', 'Integrin cell surface interactions', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'MAP2K and MAPK activation', 'Regulation of TLR by endogenous ligand', 'Post-translational protein phosphorylation']"
Fgb,0.298223,-0.20419542,1,"['Platelet degranulation ', 'Common Pathway of Fibrin Clot Formation', 'Integrin cell surface interactions', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'MAP2K and MAPK activation', 'Regulation of TLR by endogenous ligand']"
Fgd1,0.18284447,-0.047720734,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'CDC42 GTPase cycle']"
Fgd2,0.21941529,-0.14199372,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'CDC42 GTPase cycle']"
Fgd3,0.1347159,-0.21831548,1,
Fgd4,0.35892412,-0.0677459,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'CDC42 GTPase cycle']"
Fgd6,-0.079077825,0.094678424,2,
Fgf1,0.29720238,-0.21297702,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR1b ligand binding and activation', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'FGFR2b ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf10,0.35529602,-0.16208673,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR1b ligand binding and activation', 'FGFR2b ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf11,0.123088986,-0.27078986,1,
Fgf12,0.12139778,-0.30828553,1,
Fgf13,0.092594594,-0.33019605,1,
Fgf14,0.09477485,-0.0019996003,0,
Fgf15,0.41719553,-0.17961141,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'betaKlotho-mediated ligand binding', 'FGFR4 ligand binding and activation', 'Phospholipase C-mediated cascade; FGFR4', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf16,0.45225725,-0.22299322,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf17,0.33576354,-0.21116282,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf18,0.36520523,-0.03587549,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf2,0.5237835,-0.2682974,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR1b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'FGFR2b ligand binding and activation', 'Syndecan interactions', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf20,0.31477922,-0.2675279,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf21,0.48203018,-0.26888937,1,['Cellular hexose transport']
Fgf22,0.29957172,-0.27829328,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR1b ligand binding and activation', 'FGFR2b ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf23,0.37943158,-0.24109365,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR1c and Klotho ligand binding and activation', 'FGFR2c ligand binding and activation', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Post-translational protein phosphorylation']"
Fgf3,0.36115217,-0.33682683,1,
Fgf4,0.39494234,-0.12075594,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf5,0.41646817,-0.19987594,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf6,0.32692122,-0.19776757,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf7,0.29471835,-0.20378394,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR2b ligand binding and activation', 'Phospholipase C-mediated cascade; FGFR2', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'Negative regulation of FGFR2 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf8,0.42156643,-0.19861378,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgf9,0.3212873,-0.2367534,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR4 ligand binding and activation', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR2c ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgfbp1,0.028931987,0.015856829,2,['FGFR2b ligand binding and activation']
Fgfbp3,0.035239518,-0.1495059,1,['FGFR2b ligand binding and activation']
Fgfr1,0.5367145,-0.26418442,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR1b ligand binding and activation', 'FGFR1c ligand binding and activation', 'FGFR1c and Klotho ligand binding and activation', 'Signal transduction by L1', 'Phospholipase C-mediated cascade: FGFR1', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'Negative regulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Fgfr1op2,0.099288724,0.07050394,3,
Fgfr2,0.5093776,-0.27228048,1,
Fgfr3,0.35962942,-0.21452613,1,
Fgfr4,0.3973111,-0.25207812,1,
Fgfrl1,0.29911992,-0.06741988,1,['FGFRL1 modulation of FGFR1 signaling']
Fgg,0.16403037,-0.32369265,1,"['Platelet degranulation ', 'Common Pathway of Fibrin Clot Formation', 'Integrin cell surface interactions', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'MAP2K and MAPK activation', 'Regulation of TLR by endogenous ligand', 'Post-translational protein phosphorylation']"
Fggy,0.0069652935,-0.0118867755,2,
Fgl1,0.09690794,-0.016086971,3,
Fgl2,0.17408663,-0.115855716,1,['Neutrophil degranulation']
Fgr,0.4776499,-0.3122581,1,"['FCGR activation', 'Platelet sensitization by LDL', 'Neutrophil degranulation']"
Fh1,-0.093773335,0.16464852,2,['Citric acid cycle (TCA cycle)']
Fhad1,-0.22359438,-0.15910718,2,
Fhdc1,-0.059452944,-0.059808407,2,
Fhip1a,0.02335122,-0.03488388,2,
Fhip1b,-0.080082156,-0.052407756,2,
Fhip2a,-0.08652897,0.17681861,0,
Fhit,-0.12733348,0.08505848,2,
Fhl1,0.033311598,-0.1186821,1,
Fhl2,0.53585315,-0.28200302,1,
Fhl4,-0.15508758,0.038229864,2,
Fhl5,-0.012122844,0.017050123,2,
Fhod1,0.18558931,-0.08019934,1,
Fibcd1,-0.030552102,0.020466305,2,
Fibp,-0.05309715,0.08809427,2,
Fig4,-0.015570456,-0.08762851,1,"['Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane']"
Figla,-0.09117003,0.23701632,3,
Fign,-0.043508433,0.024323734,2,
Fignl1,0.03433665,0.39561647,3,
Fignl2,-0.27550554,-0.026722409,2,
Filip1,0.017419355,-0.16976732,2,
Filip1l,-0.03788908,0.060775883,2,
Fip1l1,0.1343039,0.3616395,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Fis1,0.012642044,-0.09561489,2,['Class I peroxisomal membrane protein import']
Fitm2,-0.10150242,0.031115865,2,['Lipid particle organization']
Fiz1,-0.2118609,-0.13404682,2,
Fjx1,-0.1645792,-0.077478714,2,
Fkbp10,0.055165436,0.022112178,0,
Fkbp11,-0.030453868,-0.32357758,1,
Fkbp14,-0.11313481,0.010757947,2,
Fkbp15,-0.13021384,-0.063966356,2,
Fkbp1a,0.44938013,-0.004918165,3,"['mTORC1-mediated signalling', 'Calcineurin activates NFAT', 'TGF-beta receptor signaling activates SMADs']"
Fkbp1b,0.27974406,-0.08410201,3,"['Stimuli-sensing channels', 'Ion homeostasis']"
Fkbp2,-0.052317373,-0.18931314,2,
Fkbp3,0.35713705,0.29518586,3,
Fkbp4,0.14858715,-0.0645116,3,"['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase', 'ESR-mediated signaling', 'Estrogen-dependent gene expression']"
Fkbp5,0.43602198,0.13108227,3,"['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'ESR-mediated signaling']"
Fkbp6,0.03777744,0.28124225,3,
Fkbp7,-0.121195994,-0.1006545,2,
Fkbp8,0.25553322,0.13623583,3,['Ub-specific processing proteases']
Fkbp9,-0.15810083,0.14618762,2,
Fkbpl,0.063082196,0.22718506,3,['The role of GTSE1 in G2/M progression after G2 checkpoint']
Fkrp,-0.10205371,-0.25294626,2,
Fktn,-0.06672755,-0.28010142,2,
Flacc1,-0.31327388,-0.12266569,2,
Flad1,-0.111682214,-0.046143882,2,['Vitamin B2 (riboflavin) metabolism']
Flcn,0.19052005,0.037166815,1,['Amino acids regulate mTORC1']
Flg2,0.03203353,-0.13970234,1,
Fli1,0.23042749,-0.20878658,3,
Flii,-0.00899406,0.06256787,2,
Flna,0.51621455,-0.32151026,1,"['Platelet degranulation ', 'GP1b-IX-V activation signalling', 'Cell-extracellular matrix interactions', 'RHO GTPases activate PAKs']"
Flnb,0.34864,-0.18797888,1,['ISG15 antiviral mechanism']
Flnc,0.29377615,-0.23996118,1,['Cell-extracellular matrix interactions']
Flot1,0.33016798,-0.1780741,1,"['RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death', 'Synaptic adhesion-like molecules', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Flot2,0.27199557,-0.034859374,3,"['RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death', 'Synaptic adhesion-like molecules', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RND3 GTPase cycle', 'RND1 GTPase cycle']"
Flrt1,0.046186898,-0.13851841,2,
Flrt2,0.0066444674,-0.09225962,2,['Downstream signaling of activated FGFR1']
Flrt3,0.2676993,-0.09502095,1,['Downstream signaling of activated FGFR1']
Flt1,0.5265064,-0.39324072,1,
Flt3,0.39969954,-0.04595648,1,
Flt3l,0.3495028,0.018236037,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'FLT3 Signaling', 'Negative regulation of FLT3', 'FLT3 signaling through SRC family kinases']"
Flt4,0.43331993,-0.35462427,1,['VEGF binds to VEGFR leading to receptor dimerization']
Flvcr1,-0.14282396,0.09755528,2,"['Heme biosynthesis', 'Iron uptake and transport']"
Flvcr2,-0.06643424,0.048942234,2,
Flywch1,0.002641161,0.012169316,2,
Flywch2,-0.19466938,-0.28475568,2,
Fmc1,-0.32245615,-0.0943453,2,
Fmn1,0.27802527,-0.11576518,1,
Fmn2,0.010015605,-0.12899604,1,
Fmnl1,0.08709603,0.05580839,3,"['RHO GTPases Activate Formins', 'RAC1 GTPase cycle']"
Fmnl2,0.20274675,0.036358457,3,"['RHO GTPases Activate Formins', 'RHOC GTPase cycle']"
Fmnl3,0.12712072,0.055955913,1,"['RHO GTPases Activate Formins', 'RHOA GTPase cycle', 'RHOC GTPase cycle']"
Fmo2,-0.18002574,-0.17513448,2,['FMO oxidises nucleophiles']
Fmo3,-0.27143273,-0.13508174,2,['FMO oxidises nucleophiles']
Fmo5,-0.16118243,-0.098618545,2,
Fmod,0.0056871097,-0.2976533,1,"['Keratan sulfate biosynthesis', 'Keratan sulfate degradation']"
Fmr1,0.33953255,0.3578005,0,
Fmr1nb,-0.17526816,0.21440798,2,
Fn1,0.51772714,-0.3737323,1,"['Platelet degranulation ', 'Degradation of the extracellular matrix', 'Extracellular matrix organization', 'Fibronectin matrix formation', 'Cell surface interactions at the vascular wall', 'Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'Syndecan interactions', 'ECM proteoglycans', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'MAP2K and MAPK activation', 'MET activates PTK2 signaling', 'Post-translational protein phosphorylation', 'GPER1 signaling']"
Fn3k,-0.30876398,-0.014440747,2,"['Gamma carboxylation, hypusine formation and arylsulfatase activation']"
Fn3krp,-0.31466457,0.029845478,2,"['Gamma carboxylation, hypusine formation and arylsulfatase activation']"
Fnbp1,0.043109518,-0.15236735,1,"['Clathrin-mediated endocytosis', 'RHOQ GTPase cycle', 'RND2 GTPase cycle']"
Fnbp1l,0.11940378,-0.080211505,1,
Fnbp4,-0.05356715,0.068387374,2,
Fndc10,-0.23968814,-0.12710755,2,
Fndc3a,-0.21322335,0.021219995,2,
Fndc3c1,-0.10938419,0.15720639,2,
Fndc4,-0.057755176,0.084828876,2,
Fndc5,-0.04169629,-0.10111645,2,
Fndc7,-0.14525962,-0.110070705,2,
Fnip1,-0.04213232,-0.07233489,2,['Amino acids regulate mTORC1']
Fnip2,-0.06709793,0.08807169,2,['Amino acids regulate mTORC1']
Fnta,0.24767673,0.056194786,1,"['Apoptotic cleavage of cellular proteins', 'Inactivation, recovery and regulation of the phototransduction cascade', 'RAS processing']"
Fntb,0.03807681,0.004222799,2,"['Inactivation, recovery and regulation of the phototransduction cascade', 'RAS processing']"
Folh1,0.079193465,-0.24708802,1,['Aspartate and asparagine metabolism']
Folr1,-0.016229253,-0.22450422,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'COPI-mediated anterograde transport']"
Folr2,-0.038392246,-0.0999212,2,"['Post-translational modification: synthesis of GPI-anchored proteins', 'Metabolism of folate and pterines', 'Neutrophil degranulation']"
Fos,0.36647037,-0.10531772,1,"['Oxidative Stress Induced Senescence', 'FCERI mediated MAPK activation', 'Activation of the AP-1 family of transcription factors']"
Fosb,0.34996113,0.0060641607,3,
Fosl1,0.2465644,-0.16189508,1,
Fosl2,0.24255489,-0.11416862,1,
Foxa1,0.3832551,0.003563777,3,['Estrogen-dependent gene expression']
Foxa2,0.3826411,0.055478826,3,
Foxa3,-0.1423031,-0.11049384,2,
Foxc1,0.08546426,-0.072178714,1,
Foxc2,0.15639362,-0.024351994,3,
Foxd1,-0.0007901253,-0.112880856,2,
Foxd3,0.028989932,-0.042326503,2,
Foxe1,0.012196683,-0.15119427,2,
Foxe3,0.035024703,-0.00023615801,2,
Foxf1,0.022936419,-0.006703321,2,
Foxg1,0.40232447,-0.1117071,3,['FOXO-mediated transcription of cell cycle genes']
Foxh1,0.060117528,0.050105017,3,
Foxi1,-0.116303235,-0.0070318766,2,
Foxj1,0.07048608,0.11017388,0,
Foxj3,-0.27006668,-0.014343595,2,
Foxk1,0.20235819,0.27642918,3,['UCH proteinases']
Foxk2,0.34766388,0.18446392,3,['UCH proteinases']
Foxl2,0.20154795,0.26616338,3,['SUMOylation of transcription factors']
Foxm1,0.5296993,0.32706508,3,
Foxn1,-0.056397043,0.10163552,2,
Foxn2,-0.1524852,0.049328115,2,
Foxn3,-0.115471706,0.07147514,2,
Foxn4,0.012798479,-0.03645777,2,
Foxo1,0.5700982,0.017961321,3,"['AKT phosphorylates targets in the nucleus', 'AKT-mediated inactivation of FOXO1A', 'MAPK6/MAPK4 signaling', 'Regulation of localization of FOXO transcription factors', 'Regulation of FOXO transcriptional activity by acetylation', 'FOXO-mediated transcription of cell cycle genes']"
Foxo3,0.58676124,0.041337036,3,"['Signaling by NODAL', 'AKT phosphorylates targets in the nucleus', 'MAPK6/MAPK4 signaling', 'FLT3 Signaling', 'Regulation of localization of FOXO transcription factors', 'Regulation of FOXO transcriptional activity by acetylation', 'FOXO-mediated transcription of cell cycle genes', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling']"
Foxo4,0.60495496,0.041549023,3,"['AKT phosphorylates targets in the nucleus', 'Ub-specific processing proteases', 'Regulation of localization of FOXO transcription factors', 'FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes', 'FOXO-mediated transcription of cell cycle genes']"
Foxo6,0.36668643,0.09482145,3,"['AKT phosphorylates targets in the nucleus', 'Regulation of localization of FOXO transcription factors']"
Foxp1,0.23630792,0.21887873,3,
Foxp2,0.22513108,0.21609369,3,
Foxp3,0.42911306,0.15094514,3,['RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)']
Foxp4,-0.043758698,-0.05856688,2,
Foxr1,0.029128784,-0.0218654,3,
Foxr2,-0.006690367,0.032604724,2,
Foxred1,0.008170344,-0.024417954,1,
Foxred2,-0.080391705,-0.020658016,2,
Fpgs,0.109222375,0.08372664,3,['Metabolism of folate and pterines']
Fpgt,-0.13283788,-0.13523936,2,['GDP-fucose biosynthesis']
Fpr-rs3,-0.033159703,-0.049897168,2,"['G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Fpr-rs4,-0.032402404,-0.026203968,2,"['G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Fpr-rs6,-0.05580777,-0.045596518,2,"['G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Fpr-rs7,-0.16690038,-0.14458932,2,"['G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Fpr1,0.16592816,-0.38314348,1,"['G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands', 'Neutrophil degranulation']"
Fpr2,0.01648782,-0.28923705,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands', 'Neutrophil degranulation']"
Fpr3,0.08341833,-0.34865865,1,"['G alpha (i) signalling events', 'Formyl peptide receptors bind formyl peptides and many other ligands']"
Fra10ac1,-0.1350782,0.11335391,2,
Fras1,0.24353819,-0.20499896,1,
Frat2,0.33802614,0.05309865,3,"['Beta-catenin phosphorylation cascade', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane']"
Frem1,0.11523622,-0.16987701,1,
Frem2,-0.12627834,-0.035826407,2,
Frem3,0.021409031,0.070935644,2,
Frg1,-0.06005582,0.42133996,0,
Frk,0.14261933,-0.2464248,1,"['Neutrophil degranulation', 'Regulation of PTEN stability and activity']"
Frmd3,-0.27582857,-0.11079574,2,
Frmd4a,0.15800914,-0.11142798,1,
Frmd4b,-0.22203216,0.08060251,2,
Frmd5,0.085499376,-0.14511292,2,
Frmd6,0.06153098,0.12608722,3,
Frmd7,-0.091346785,0.012760931,2,
Frmd8,-0.2434756,-0.13627747,2,
Frmpd1,-0.017782765,0.06259226,3,
Frmpd4,0.054282565,-0.005567314,2,
Frrs1,-0.10123137,-0.0054463814,2,
Frrs1l,-0.25876483,-0.017184628,2,
Frs2,0.3209388,-0.19077896,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'Frs2-mediated activation', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RET signaling', 'Activated NTRK2 signals through FRS2 and FRS3', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Frs3,0.4821111,-0.23754208,1,"['FRS-mediated FGFR1 signaling', 'FRS-mediated FGFR2 signaling', 'FRS-mediated FGFR3 signaling', 'FRS-mediated FGFR4 signaling', 'RAF/MAP kinase cascade', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Fry,-0.02208486,-0.18739527,1,
Fryl,-0.1194517,-0.05748651,2,
Frzb,-0.13109688,0.050008968,2,
Fsbp,-0.38491273,0.041025657,2,
Fscb,0.034286864,-0.09528215,1,
Fscn1,-0.1302223,0.022930851,2,
Fscn2,-0.16879672,-0.10056203,2,
Fsd1l,-0.081323095,0.119855456,2,
Fsd2,0.005089131,-0.020009072,2,
Fshb,0.09528533,-0.22014453,1,"['Glycoprotein hormones', 'Hormone ligand-binding receptors', 'G alpha (s) signalling events']"
Fshr,-0.030190114,-0.02069451,2,"['Hormone ligand-binding receptors', 'G alpha (s) signalling events']"
Fsip1,-0.23324135,0.029584358,2,
Fsip2,-0.22927698,-0.017962875,2,
Fst,-0.13420694,0.02764673,2,['Antagonism of Activin by Follistatin']
Fstl1,-0.037456576,-0.19680426,2,"['Signaling by BMP', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Fstl3,-0.11886673,-0.06268727,2,"['Antagonism of Activin by Follistatin', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Fstl4,-0.19330122,0.0058431826,2,
Fstl5,-0.17334017,-0.11439426,2,
Ftcd,-0.1936167,-0.23947902,2,['Histidine catabolism']
Ftdc2,-0.105190046,-0.113459535,2,
Fth1,-0.003406533,0.056813445,0,"['Golgi Associated Vesicle Biogenesis', 'Neutrophil degranulation', 'Iron uptake and transport']"
Ftl1,-0.11591755,-0.1169615,2,
Ftmt,-0.017431362,0.058307108,2,['Iron uptake and transport']
Fto,-0.023778832,0.047312558,2,['Reversal of alkylation damage by DNA dioxygenases']
Ftsj1,-0.30061063,0.2605338,0,
Ftsj3,-0.34570813,0.46688244,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Fubp1,-0.26762465,0.155008,2,
Fubp3,-0.082231164,0.029603072,2,
Fuca1,-0.11679667,0.016488954,2,"['Neutrophil degranulation', 'Reactions specific to the complex N-glycan synthesis pathway']"
Fuca2,-0.1483985,-0.105910406,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Neutrophil degranulation', 'Post-translational protein phosphorylation']"
Fundc1,0.2712954,-0.17205381,1,['Receptor Mediated Mitophagy']
Fuom,-0.109004684,0.036301844,2,['GDP-fucose biosynthesis']
Furin,0.40535483,-0.19047457,1,"['Collagen degradation', 'Elastic fibre formation', 'Activation of Matrix Metalloproteinases', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins', 'NGF processing', 'Signaling by PDGF', 'Pre-NOTCH Processing in Golgi', 'TGF-beta receptor signaling activates SMADs', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Assembly of active LPL and LIPC lipase complexes']"
Fus,0.30885136,0.26737335,0,['mRNA Splicing - Major Pathway']
Fut1,-0.12660255,0.035165288,2,['ABO blood group biosynthesis']
Fut11,-0.17043768,0.12370218,2,['Lewis blood group biosynthesis']
Fut2,-0.053651165,-0.24303529,2,"['ABO blood group biosynthesis', 'Lewis blood group biosynthesis']"
Fut4,0.24569032,-0.040645946,1,['Lewis blood group biosynthesis']
Fut7,-0.071142375,-0.07116257,2,['Lewis blood group biosynthesis']
Fut8,-0.17840892,-0.11771981,2,['Reactions specific to the complex N-glycan synthesis pathway']
Fut9,-0.10746411,-0.06711026,2,['Lewis blood group biosynthesis']
Fuz,-0.012041309,0.2079689,3,"[""Hedgehog 'off' state""]"
Fv1,-0.09714381,0.05591615,2,
Fxn,-0.0061101145,0.041126736,0,"['Mitochondrial protein import', 'Mitochondrial iron-sulfur cluster biogenesis']"
Fxr1,-0.029590322,0.24681373,0,
Fxr2,0.02226787,0.23479547,0,
Fxyd1,0.033020906,-0.199003,1,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Fxyd2,-0.1535239,-0.20745818,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Fxyd3,-0.33348718,0.0026408841,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Fxyd4,-0.0363678,-0.22653118,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Fxyd6,-0.4018449,-0.14496827,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Fxyd7,-0.13756332,-0.013953105,2,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Fyb,0.2108455,-0.37301984,1,"['Generation of second messenger molecules', 'Signal regulatory protein family interactions']"
Fyco1,-0.2209081,-0.20614971,2,
Fyn,0.6429915,-0.3611276,1,"['GPVI-mediated activation cascade', 'Signaling by ERBB2', 'PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'Cell surface interactions at the vascular wall', 'FCGR activation', 'PECAM1 interactions', 'DAP12 signaling', 'Nephrin family interactions', 'NCAM signaling for neurite out-growth', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'CD28 dependent Vav1 pathway', 'CTLA4 inhibitory signaling', 'EPHB-mediated forward signaling', 'EPHA-mediated growth cone collapse', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells', 'Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'CRMPs in Sema3A signaling', 'DCC mediated attractive signaling', 'VEGFA-VEGFR2 Pathway', 'Dectin-2 family', 'CD209 (DC-SIGN) signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Platelet Adhesion to exposed collagen', 'Reelin signalling pathway', 'NTRK2 activates RAC1', 'Regulation of signaling by CBL']"
Fyttd1,-0.092254214,0.32474494,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Fzd1,0.10557985,0.03592515,3,"['PCP/CE pathway', 'Asymmetric localization of PCP proteins', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane']"
Fzd10,0.022849763,-0.11919868,2,
Fzd2,0.22910161,-0.19688454,1,"['Ca2+ pathway', 'Asymmetric localization of PCP proteins', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2']"
Fzd3,0.22875562,-0.13642313,1,"['Ca2+ pathway', 'PCP/CE pathway', 'Asymmetric localization of PCP proteins']"
Fzd4,0.03462471,-0.032269757,2,"['Ca2+ pathway', 'Asymmetric localization of PCP proteins', 'Regulation of FZD by ubiquitination', 'WNT5A-dependent internalization of FZD4', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Fzd5,0.19426969,-0.048851218,1,"['Ca2+ pathway', 'Asymmetric localization of PCP proteins', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'Regulation of FZD by ubiquitination', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2']"
Fzd6,0.101719394,-0.014864064,2,"['Ca2+ pathway', 'PCP/CE pathway', 'Regulation of FZD by ubiquitination']"
Fzd7,0.124178156,-0.14988497,1,"['PCP/CE pathway', 'Asymmetric localization of PCP proteins']"
Fzd8,0.17821017,0.045899846,3,"['Asymmetric localization of PCP proteins', 'Regulation of FZD by ubiquitination']"
Fzd9,0.08656617,-0.07656041,2,
Fzr1,0.33149892,0.25831142,3,"['Autodegradation of Cdh1 by Cdh1:APC/C', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'Phosphorylation of Emi1', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin A:Cdk2-associated events at S phase entry', 'Antigen processing: Ubiquitination & Proteasome degradation']"
G0s2,0.12374384,0.08080888,3,
G2e3,-0.1979267,0.13724677,2,
G3bp1,0.23105314,0.39852494,0,
G3bp2,0.19840245,0.36764097,0,
G6pc,0.12595947,0.022687687,3,['Gluconeogenesis']
G6pc2,-0.10279747,0.11694649,0,['Gluconeogenesis']
G6pc3,-0.069585696,0.13268465,0,['Gluconeogenesis']
G6pd2,-0.065092176,0.20146862,0,
G6pdx,-0.25527605,0.11802057,2,"['TP53 Regulates Metabolic Genes', 'Pentose phosphate pathway']"
Gaa,-0.23807444,-0.008546551,2,"['Neutrophil degranulation', 'Glycogen breakdown (glycogenolysis)']"
Gab1,0.45328668,-0.32350537,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'GAB1 signalosome', 'PI3K events in ERBB2 signaling', 'PI-3K cascade:FGFR1', 'PI-3K cascade:FGFR2', 'PI-3K cascade:FGFR3', 'PI-3K cascade:FGFR4', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'MET activates PI3K/AKT signaling', 'RET signaling', 'MET activates PTPN11', 'MET activates RAP1 and RAC1', 'MET receptor recycling', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)']"
Gab2,0.4061521,-0.33325228,1,
Gab3,0.116778,-0.20680636,1,
Gabarap,0.24631003,-0.18920352,1,"['Macroautophagy', 'TBC/RABGAPs']"
Gabarapl1,0.16441676,-0.0929358,3,['Macroautophagy']
Gabarapl2,0.22818369,-0.13856608,3,"['Macroautophagy', 'TBC/RABGAPs']"
Gabbr1,0.20003082,-0.28795636,1,"['Activation of G protein gated Potassium channels', 'G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'GABA B receptor activation', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gabbr2,0.2413825,-0.27037713,1,"['Activation of G protein gated Potassium channels', 'G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'GABA B receptor activation', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gabpa,-0.08756441,0.1710647,2,['Transcriptional activation of mitochondrial biogenesis']
Gabpb1,-0.14053254,0.13194247,2,['Transcriptional activation of mitochondrial biogenesis']
Gabpb2,-0.097402014,0.05115363,2,
Gabra1,0.09078139,-0.2919198,1,['GABA receptor activation']
Gabra2,-0.08003834,-0.26672146,2,['GABA receptor activation']
Gabra3,-0.010514873,-0.27281275,2,['GABA receptor activation']
Gabra4,0.102025926,-0.030106807,1,['GABA receptor activation']
Gabra5,-0.023795439,-0.017995605,2,['GABA receptor activation']
Gabra6,0.17513524,-0.25083464,1,['GABA receptor activation']
Gabrb1,-0.01596357,-0.17878504,2,['GABA receptor activation']
Gabrb2,0.09030513,-0.09191744,1,['GABA receptor activation']
Gabrb3,0.13881922,-0.0372529,1,['GABA receptor activation']
Gabrd,-0.047644895,-0.18642765,2,
Gabre,-0.15426633,-0.22310053,2,
Gabrg1,0.07025192,-0.25077462,1,
Gabrg2,0.021801926,-0.29135492,1,['GABA receptor activation']
Gabrg3,-0.08749203,-0.23451494,2,['GABA receptor activation']
Gabrp,-0.16288894,-0.09947724,2,
Gabrq,-0.10633742,-0.074990004,2,['GABA receptor activation']
Gabrr1,0.0752858,-0.03808958,1,['GABA receptor activation']
Gabrr2,-0.16134763,-0.081271335,2,['GABA receptor activation']
Gabrr3,0.042802457,0.021741197,2,['GABA receptor activation']
Gad1,0.04964551,-0.1878604,1,"['GABA synthesis', 'GABA synthesis, release, reuptake and degradation']"
Gad2,-0.049929645,-0.37158838,1,"['GABA synthesis', 'GABA synthesis, release, reuptake and degradation']"
Gadd45a,0.31994385,0.24869034,3,['TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest']
Gadd45b,0.27030787,0.23479892,3,
Gadd45g,0.1814222,0.22210371,3,
Gadd45gip1,-0.04550045,0.0918832,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Gadl1,-0.25067618,-0.29490975,2,
Gak,0.042905934,-0.22494118,1,
Gal,0.16294712,-0.15516199,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Gal3st1,-0.34813353,-0.1643745,2,
Gal3st2b,-0.37735546,-0.013849676,2,
Gal3st3,-0.07308786,0.10528694,2,
Galc,-0.24124739,-0.14358069,2,['Glycosphingolipid metabolism']
Gale,-0.29417816,-0.1276971,2,['Galactose catabolism']
Galk1,-0.21069956,-0.18532458,2,['Galactose catabolism']
Galk2,-0.17688762,-0.092491135,2,
Galm,-0.16120592,-0.1142242,2,
Galns,-0.1620836,0.0029158506,2,"['Keratan sulfate degradation', 'Neutrophil degranulation']"
Galnt1,-0.026293896,-0.10247632,2,"['COPI-independent Golgi-to-ER retrograde traffic', 'O-linked glycosylation of mucins']"
Galnt10,-0.0060041896,-0.046969753,2,['O-linked glycosylation of mucins']
Galnt11,-0.08632662,-0.03653867,2,['O-linked glycosylation of mucins']
Galnt12,-0.28906357,-0.06729817,2,['O-linked glycosylation of mucins']
Galnt13,-0.26789683,-0.15166122,2,['O-linked glycosylation of mucins']
Galnt14,0.096321054,0.00580386,3,['O-linked glycosylation of mucins']
Galnt15,-0.117823616,-0.098260276,2,['O-linked glycosylation of mucins']
Galnt16,0.046000782,-0.12531357,2,['O-linked glycosylation of mucins']
Galnt17,-0.015263023,-0.06094612,2,['O-linked glycosylation of mucins']
Galnt18,-0.0857219,-0.05271001,2,['O-linked glycosylation of mucins']
Galnt2,-0.15549426,-0.06980958,2,"['COPI-independent Golgi-to-ER retrograde traffic', 'O-linked glycosylation of mucins']"
Galnt3,-0.046687614,-0.051394004,2,"['FGFR3c ligand binding and activation', 'O-linked glycosylation of mucins']"
Galnt4,0.016593857,-0.02207315,2,['O-linked glycosylation of mucins']
Galnt5,-0.009125113,-0.10043663,2,['O-linked glycosylation of mucins']
Galnt6,-0.2254702,-0.14611842,2,['O-linked glycosylation of mucins']
Galnt7,0.019321134,-0.13845772,2,['O-linked glycosylation of mucins']
Galnt9,-0.05851768,-0.19562046,2,['O-linked glycosylation of mucins']
Galntl5,-0.14890599,-0.0011143207,2,['O-linked glycosylation of mucins']
Galntl6,-0.042771947,-0.03634531,2,['O-linked glycosylation of mucins']
Galp,-0.06624354,0.034857236,2,
Galr1,-0.014887336,0.017292017,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Galr2,0.0185828,0.015760116,0,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Galr3,-0.26645622,-0.09326204,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Galt,-0.4471969,-0.16857725,2,
Gamt,-0.124220975,0.34102723,0,['Creatine metabolism']
Gan,0.07796063,0.053905096,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ganab,-0.1969494,-0.19934426,2,
Ganc,-0.10056642,-0.046595737,2,
Gap43,0.10781865,-0.29245657,1,['L1CAM interactions']
Gapdh,0.5184158,0.18719035,3,"['Glycolysis', 'Gluconeogenesis']"
Gapdhs,-0.19381782,0.22339888,0,
Gapt,-0.27896282,-0.065003626,2,
Gapvd1,-0.008204528,-0.07962166,2,"['Clathrin-mediated endocytosis', 'RAB GEFs exchange GTP for GDP on RABs']"
Gar1,-0.006073517,0.46426785,0,['Telomere Extension By Telomerase']
Garem1,0.12685686,-0.22824492,1,
Garem2,-0.20851451,-0.07107606,2,
Garnl3,-0.19598828,-0.15928626,2,
Gars,-0.12463676,0.1275289,2,
Gart,0.093066216,0.13973333,0,['Purine ribonucleoside monophosphate biosynthesis']
Gas1,-0.022276359,-0.16692068,2,"['Ligand-receptor interactions', 'Activation of SMO']"
Gas2,-0.0517499,0.035140943,2,['Caspase-mediated cleavage of cytoskeletal proteins']
Gas2l1,-0.23417792,0.13292655,2,
Gas2l2,-0.080696434,-0.013742464,2,
Gas6,0.10412371,-0.20634784,1,"['Platelet degranulation ', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins', 'Cell surface interactions at the vascular wall', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Gas7,-0.048844546,-0.03752799,2,
Gas8,-0.015305663,0.116135344,2,['Activation of SMO']
Gast,0.103602216,-0.24512367,1,"['G alpha (q) signalling events', 'Gastrin-CREB signalling pathway via PKC and MAPK']"
Gata1,0.29700536,0.09573865,3,"['RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Factors involved in megakaryocyte development and platelet production']"
Gata2,0.2560525,0.114756726,3,"['RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Factors involved in megakaryocyte development and platelet production']"
Gata3,0.5480553,-0.012369265,3,"['Ub-specific processing proteases', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
Gata4,0.4027472,-0.0075723543,3,['Factors involved in megakaryocyte development and platelet production']
Gata5,-0.020662777,-0.099760294,2,['Factors involved in megakaryocyte development and platelet production']
Gata6,0.09264794,-0.08177427,3,"['Surfactant metabolism', 'Factors involved in megakaryocyte development and platelet production']"
Gatad1,0.19415784,0.12363285,3,
Gatad2a,0.32946444,0.21207349,3,"['HDACs deacetylate histones', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Gatad2b,0.26545042,0.23734222,3,"['HDACs deacetylate histones', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Gatb,-0.09205619,-0.028976418,2,
Gatc,-0.21539728,0.040804178,2,
Gatd1,-0.20678271,0.057300493,2,
Gatm,0.03452827,0.081610754,0,['Creatine metabolism']
Gba,-0.06468554,-0.2568315,2,['Glycosphingolipid metabolism']
Gba2,-0.14303598,-0.08480637,2,['Glycosphingolipid metabolism']
Gbe1,-0.15283452,-0.17713162,2,['Glycogen synthesis']
Gbf1,-0.08092657,-0.09577974,2,"['trans-Golgi Network Vesicle Budding', 'VxPx cargo-targeting to cilium', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Gbgt1,-0.08476153,0.025348077,0,
Gbp2,0.15152195,-0.030813118,3,
Gbp2b,0.12050563,0.011851165,3,
Gbp3,0.063469365,0.116529234,3,
Gbp4,-0.12838747,-0.099494435,2,
Gbp7,0.012571554,0.072211966,2,
Gbx1,-0.17045009,-0.06165037,2,
Gbx2,0.095937625,-0.20876881,1,
Gc,0.10781011,-0.06702379,1,['Vitamin D (calciferol) metabolism']
Gcat,-0.0075709354,0.0045996676,2,
Gcc1,-0.36716917,-0.0382797,2,['Retrograde transport at the Trans-Golgi-Network']
Gcc2,0.06377935,0.24645908,0,
Gcdh,-0.22150488,-0.17419016,2,['Lysine catabolism']
Gcfc2,-0.020829761,0.28719592,0,
Gcg,0.31767985,-0.12063932,1,"['Glucagon signaling in metabolic regulation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'G alpha (q) signalling events', 'G alpha (s) signalling events', 'Glucagon-type ligand receptors', 'Synthesis, secretion, and deacylation of Ghrelin']"
Gcgr,0.10431424,-0.0033528616,1,
Gch1,-0.007886687,-0.21193293,1,"['Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation']"
Gchfr,-0.07872746,-0.08524351,2,"['Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation']"
Gck,0.20712359,0.18041638,3,"['Regulation of Glucokinase by Glucokinase Regulatory Protein', 'Glycolysis']"
Gckr,-0.08402955,0.25385183,0,['Regulation of Glucokinase by Glucokinase Regulatory Protein']
Gclc,0.00202385,-0.11406845,2,['Glutathione synthesis and recycling']
Gclm,-0.21612789,-0.14790687,2,['Glutathione synthesis and recycling']
Gcm1,-0.10291557,-0.031179849,2,
Gcm2,0.014350338,0.07265959,2,
Gcn1,-0.102521,0.42247614,0,
Gcnt1,0.108833894,-0.19347645,1,['O-linked glycosylation of mucins']
Gcnt2,0.0025092633,0.13023509,0,
Gcnt3,-0.05429453,-0.102139324,2,['O-linked glycosylation of mucins']
Gcnt4,-0.20450719,0.038750138,2,['O-linked glycosylation of mucins']
Gcnt7,-0.1406364,0.013527783,2,['O-linked glycosylation of mucins']
Gcsh,-0.027931921,-0.0673,2,"['Glyoxylate metabolism and glycine degradation', 'Glycine degradation']"
Gda,0.043178532,-0.04498224,2,['Purine catabolism']
Gdap1,-0.2678841,0.1051925,2,['Class I peroxisomal membrane protein import']
Gdap1l1,-0.25768855,-0.13215093,2,
Gdap2,-0.04086336,0.15397371,3,
Gde1,-0.19106823,0.03377202,2,['Glycerophospholipid catabolism']
Gdf1,-0.07490434,-0.114843585,2,
Gdf10,-0.05340634,-0.09925632,2,
Gdf11,0.019400138,0.07189342,2,
Gdf15,0.1368549,-0.18051754,1,
Gdf2,0.14314954,0.035314385,3,['Signaling by BMP']
Gdf3,0.096023984,0.063461095,3,
Gdf5,-0.043154787,-0.03378645,2,['Molecules associated with elastic fibres']
Gdf6,-0.22582512,0.047154974,2,
Gdf7,0.05686325,-0.10645004,1,
Gdf9,0.04915225,0.02842631,2,
Gdi1,0.064597756,-0.12120035,1,['RAB GEFs exchange GTP for GDP on RABs']
Gdi2,-0.007129672,-0.09708045,2,"['Neutrophil degranulation', 'RAB GEFs exchange GTP for GDP on RABs']"
Gdnf,0.48036748,-0.36625746,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Gdpd1,-0.1741724,-0.043874532,2,
Gdpd2,-0.10851122,-0.033340342,2,
Gdpd3,-0.35465497,-0.11745235,2,
Gdpd4,-0.28531438,-0.0728285,2,
Gdpd5,-0.28970408,-0.15462387,2,
Gem,-0.09413452,-0.10081958,2,
Gemin2,-0.048391,0.4648027,0,['snRNP Assembly']
Gemin4,-0.03262692,0.22456826,0,['snRNP Assembly']
Gemin5,-0.1776283,0.3458865,0,['snRNP Assembly']
Gemin6,-0.0147193875,0.27313074,0,['snRNP Assembly']
Gemin7,0.03762328,0.35924816,0,['snRNP Assembly']
Gemin8,-0.15216461,0.21621038,0,['snRNP Assembly']
Gen1,0.054602943,0.3299635,3,['Resolution of D-loop Structures through Holliday Junction Intermediates']
Get1,-0.19686845,-0.0340601,2,
Get3,-0.13132544,-0.020415667,2,
Get4,0.014741449,-0.0729144,2,
Gfap,0.4049626,-0.20480387,1,
Gfer,-0.029667683,0.07866327,0,
Gfi1,0.27213058,0.19014429,3,
Gfi1b,0.12935834,0.2656229,3,
Gfm1,-0.14246912,0.15025128,0,['Mitochondrial translation elongation']
Gfm2,-0.25137714,0.033710882,2,['Mitochondrial translation termination']
Gfod1,-0.26007044,0.08132531,2,['RHOQ GTPase cycle']
Gfod2,-0.25885132,-0.14868566,2,
Gfpt1,-0.17465396,-0.02543289,2,['Synthesis of UDP-N-acetyl-glucosamine']
Gfpt2,-0.2796314,-0.072882295,2,['Synthesis of UDP-N-acetyl-glucosamine']
Gfra1,0.39270544,-0.25867286,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Gfra2,0.09901372,-0.074792415,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Gfra3,0.24422507,-0.2074157,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Gfra4,0.19277038,-0.24676652,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Gfral,0.04749399,-0.29253876,1,
Gfus,-0.28830543,0.21723112,0,['GDP-fucose biosynthesis']
Gga1,0.2270824,-0.1569222,1,
Gga2,0.008279055,-0.16953021,2,
Gga3,0.3495327,-0.27697518,1,['MET receptor recycling']
Ggact,-0.20624523,-0.02449675,2,
Ggct,-0.11601533,-0.24321812,2,['Glutathione synthesis and recycling']
Ggcx,0.13537966,-0.13060978,1,['Gamma-carboxylation of protein precursors']
Ggh,0.01918518,-0.04708085,2,['Neutrophil degranulation']
Ggn,-0.14619577,0.10635065,2,
Ggnbp1,-0.15937705,0.08881908,2,
Ggnbp2,-0.20655645,-0.04468157,2,
Ggps1,-0.2072736,-0.10074038,2,['Cholesterol biosynthesis']
Ggt1,-0.037995934,-0.24714766,1,"['Glutathione synthesis and recycling', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Aflatoxin activation and detoxification', 'Paracetamol ADME']"
Ggt5,-0.035441194,-0.2634889,1,"['Glutathione synthesis and recycling', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Aflatoxin activation and detoxification', 'Paracetamol ADME']"
Ggt6,-0.109364964,-0.25062856,2,"['Glutathione synthesis and recycling', 'Aflatoxin activation and detoxification', 'Paracetamol ADME']"
Ggt7,-0.11896136,-0.101060204,2,"['Glutathione synthesis and recycling', 'Aflatoxin activation and detoxification', 'Paracetamol ADME']"
Ggta1,-0.1428419,-0.1379072,2,
Gh,0.31123635,-0.33666497,1,"['Prolactin receptor signaling', 'Synthesis, secretion, and deacylation of Ghrelin', 'Growth hormone receptor signaling']"
Gh1,-0.21789934,-0.16028494,2,
Ghitm,-0.2541014,0.05447869,2,
Ghr,0.17032084,-0.28347155,1,"['Prolactin receptor signaling', 'Growth hormone receptor signaling']"
Ghrh,0.11353392,-0.32620755,1,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Ghrhr,-0.20725168,-0.17120835,2,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Ghrl,0.25574636,-0.3147323,1,"['G alpha (q) signalling events', 'Synthesis, secretion, and deacylation of Ghrelin']"
Ghsr,0.054288317,-0.33701947,1,['G alpha (q) signalling events']
Gid4,-0.1650198,0.03711345,2,
Gid8,-0.15922396,-0.20568031,2,
Gigyf1,-0.0503097,-0.012668285,2,
Gigyf2,0.04259691,0.24432279,0,
Gimap3,-0.27580687,0.05241398,2,
Gimap6,0.04177128,-0.019559436,1,
Gimap7,-0.26497978,0.012531587,2,
Gimap8,-0.11400036,0.04126805,2,
Gin1,-0.16104805,0.050517358,2,
Gins1,0.050414138,0.44336745,3,['Unwinding of DNA']
Gins2,0.07380112,0.40872923,3,['Unwinding of DNA']
Gins3,0.15072648,0.28288937,3,['Unwinding of DNA']
Gins4,0.104492694,0.36860815,3,['Unwinding of DNA']
Gip,0.11473396,-0.22830866,1,"['Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)', 'G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Gipc1,0.40546474,-0.3290678,1,
Gipc2,0.17126665,-0.1123189,1,
Gipc3,-0.045127373,-0.14393051,1,
Gipr,-0.0078022294,-0.13117328,2,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Git1,0.45534408,-0.18904613,1,"['Ephrin signaling', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle']"
Git2,0.1932209,-0.25407824,1,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle']"
Gja1,0.43768638,-0.14253543,1,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'Gap junction assembly', 'Gap junction degradation', 'Regulation of gap junction activity', 'Formation of annular gap junctions', 'RHOQ GTPase cycle']"
Gja3,0.03040631,-0.13150574,2,['Gap junction assembly']
Gja4,-0.011886728,-0.07925397,2,['Gap junction assembly']
Gja5,0.18164784,-0.13229969,3,['Gap junction assembly']
Gja6,0.2111456,-0.08367059,1,
Gja8,-0.0065096198,-0.09787713,2,['Gap junction assembly']
Gjb1,0.25076142,-0.09488396,1,['Oligomerization of connexins into connexons']
Gjb2,-0.02989034,-0.053165413,2,['Transport of connexons to the plasma membrane']
Gjb3,-0.17021044,0.020507772,2,['Gap junction assembly']
Gjb4,0.011681925,-0.06891474,2,['Gap junction assembly']
Gjb5,0.006397208,0.0408556,2,['Gap junction assembly']
Gjb6,0.038975243,-0.23488596,1,['Gap junction assembly']
Gjc1,-0.087237,-0.068453364,2,"['Electric Transmission Across Gap Junctions', 'Gap junction assembly']"
Gjc2,-0.112665154,-0.040374577,2,['Gap junction assembly']
Gjc3,-0.113799535,-0.15763865,2,
Gjd2,0.30957136,-0.12547636,3,"['Electric Transmission Across Gap Junctions', 'Gap junction assembly']"
Gjd3,-0.22979575,-0.18928654,2,['Gap junction assembly']
Gje1,0.0075882534,0.020931924,2,
Gk,-0.34775758,-0.19992718,2,['Triglyceride biosynthesis']
Gk2,-0.23798583,0.027563624,2,['Triglyceride biosynthesis']
Gk5,-0.245231,-0.009383501,2,
Gkap1,-0.032360177,-0.04311245,2,
Gkn1,-0.0073708245,0.018040203,2,
Gkn2,-0.055279285,-0.10420861,1,
Gla,-0.28953227,-0.23896053,2,"['Glycosphingolipid metabolism', 'Neutrophil degranulation']"
Glb1,-0.2340321,-0.013928341,2,"['Glycosphingolipid metabolism', 'Keratan sulfate degradation', 'HS-GAG degradation', 'Sialic acid metabolism', 'Neutrophil degranulation']"
Glb1l,-0.36785182,-0.0779833,2,"['Glycosphingolipid metabolism', 'Keratan sulfate degradation', 'HS-GAG degradation']"
Glb1l2,0.0018796222,0.08091129,3,
Glb1l3,-0.23475535,-0.18304554,2,
Glcci1,-0.14302014,-0.0564233,2,
Glce,-0.23229414,-0.2040522,2,
Gldc,0.02569901,0.09946279,2,['Glycine degradation']
Gldn,-0.017424617,-0.09735977,1,
Gle1,-0.12954919,0.3180069,0,['Transport of Mature mRNA derived from an Intron-Containing Transcript']
Glg1,-0.0039504906,-0.0018332003,2,['Cell surface interactions at the vascular wall']
Gli1,0.43414113,0.29360256,3,"['Degradation of GLI1 by the proteasome', ""Hedgehog 'off' state"", ""Hedgehog 'on' state""]"
Gli2,0.45100182,0.17673106,3,"[""Hedgehog 'off' state"", ""Hedgehog 'on' state""]"
Gli3,0.42805532,0.26539922,3,"['GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'off' state"", ""Hedgehog 'on' state""]"
Glipr1,-0.248213,-0.05136896,2,['Neutrophil degranulation']
Glipr2,0.11527994,-0.011853479,1,
Glis1,-0.012551381,-0.023214197,2,
Glis2,0.10419269,0.09831381,3,
Glis3,-0.034292404,0.13918203,3,
Glmn,0.18770148,0.18565956,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Glmp,-0.11837723,-0.05727295,2,
Glo1,0.01196425,-0.10622626,1,['Pyruvate metabolism']
Glod4,-0.036696166,-0.06592214,2,
Glp1r,0.2757905,-0.29871804,1,"['Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Glp2r,0.060263537,-0.05330445,1,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Glra1,-0.109519534,0.019577762,2,['Neurotransmitter receptors and postsynaptic signal transmission']
Glra2,-0.14174554,0.08608781,2,['Neurotransmitter receptors and postsynaptic signal transmission']
Glra3,-0.17600602,0.022600254,2,['Neurotransmitter receptors and postsynaptic signal transmission']
Glra4,-0.093542784,0.027711434,2,
Glrb,-0.075994484,0.027430875,2,['Neurotransmitter receptors and postsynaptic signal transmission']
Glrx,0.18235601,0.10221356,0,['Interconversion of nucleotide di- and triphosphates']
Glrx2,0.038505193,0.1347889,0,
Glrx3,0.1511978,-0.100787066,1,
Glrx5,0.04551114,0.13098605,0,['Mitochondrial iron-sulfur cluster biogenesis']
Gls,-0.3438588,-0.28609398,2,"['Glutamate Neurotransmitter Release Cycle', 'TP53 Regulates Metabolic Genes', 'Glutamate and glutamine metabolism']"
Gls2,-0.16135296,-0.25812712,2,"['Glutamate Neurotransmitter Release Cycle', 'TP53 Regulates Metabolic Genes', 'Glutamate and glutamine metabolism']"
Glt1d1,-0.41895753,-0.18280542,2,
Glt28d2,-0.13451266,-0.04773954,2,
Glt6d1,-0.0903724,0.14216559,2,
Glt8d1,-0.34801972,-0.18428406,2,
Gltp,-0.19679494,-0.063559465,2,['Glycosphingolipid metabolism']
Glud1,-0.14846486,-0.07999811,2,"['Transcriptional activation of mitochondrial biogenesis', 'Glutamate and glutamine metabolism']"
Glul,0.08400531,-0.3866407,1,"['Astrocytic Glutamate-Glutamine Uptake And Metabolism', 'Glutamate and glutamine metabolism']"
Glyat,-0.13067083,-0.06558359,2,"['Conjugation of salicylate with glycine', 'Conjugation of benzoate with glycine', 'Aspirin ADME']"
Glycam1,0.075956166,-0.044434667,1,
Glyctk,-0.1883259,0.15694866,0,
Glyr1,0.07956167,-0.031541705,3,
Gm10053,0.25363255,-0.06087905,1,"['Release of apoptotic factors from the mitochondria', 'Formation of apoptosome', 'Activation of caspases through apoptosome-mediated cleavage', 'Transcriptional activation of mitochondrial biogenesis', 'Detoxification of Reactive Oxygen Species', 'Pyroptosis', 'TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Regulation of the apoptosome activity', 'Cytoprotection by HMOX1']"
Gm10184,0.13062517,0.5584636,3,['Sensing of DNA Double Strand Breaks']
Gm10220,-0.060057025,-0.020256389,2,
Gm10320,-0.19658692,-0.09796481,2,['Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']
Gm10334,0.08430895,-0.34113768,1,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Gm10499,-0.12597965,-0.10712263,2,
Gm10722,-0.24664116,0.059014972,2,
Gm10801,-0.029584281,0.0034878573,2,
Gm1110,-0.23428969,-0.31075397,2,
Gm11127,-0.070379354,-0.21106797,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Gm1140,0.011326194,-0.026228242,2,
Gm11639,-0.11289921,-0.07285803,2,
Gm11758,-0.10040701,0.0246516,2,
Gm11808,0.25950646,0.17718804,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Downregulation of ERBB4 signaling', 'Spry regulation of FGF signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'NOD1/2 Signaling Pathway', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC-Cdc20 mediated degradation of Nek2A', 'SRP-dependent cotranslational protein targeting to membrane', 'EGFR downregulation', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'TCF dependent signaling in response to WNT', 'Downstream TCR signaling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Separation of Sister Chromatids', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Regulation of PLK1 Activity at G2/M Transition', 'Stimuli-sensing channels', 'FCERI mediated NF-kB activation', 'Regulation of innate immune responses to cytosolic DNA', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Deactivation of the beta-catenin transactivating complex', 'ABC-family proteins mediated transport', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Regulation of FZD by ubiquitination', 'PINK1-PRKN Mediated Mitophagy', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'Negative regulation of MAPK pathway', 'Regulation of necroptotic cell death', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'HDR through Homologous Recombination (HRR)', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Josephin domain DUBs', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Negative regulation of MET activity', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin D associated events in G1', 'G2/M Checkpoints', 'Stabilization of p53', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'VLDLR internalisation and degradation', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Neddylation', 'ER Quality Control Compartment (ERQC)', 'Regulation of expression of SLITs and ROBOs', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Interleukin-1 signaling', 'Peroxisomal protein import', 'Regulation of signaling by CBL', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Iron uptake and transport', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'Aggrephagy', 'RAS processing', 'Pexophagy', 'Inactivation of CSF3 (G-CSF) signaling', 'Negative regulation of FLT3', 'Regulation of BACH1 activity', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'KEAP1-NFE2L2 pathway', 'Regulation of NF-kappa B signaling', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Gm12166,-0.02760517,0.055838548,2,
Gm12184,0.30051228,0.24172409,3,
Gm12253,-0.23737857,-0.051004738,2,
Gm12689,-0.18303424,-0.16989024,2,
Gm12830,-0.028812049,0.17964572,0,
Gm12887,-0.2663311,0.07877489,2,
Gm13030,-0.1318083,-0.04674243,2,
Gm13057,-0.18853389,0.0146327475,2,
Gm1330,-0.22495751,-0.007801553,2,
Gm13304,0.19293147,-0.04350948,1,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Gm13305,-0.054615915,-0.047881678,2,
Gm13306,0.028942997,0.07039442,2,"['Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Gm13547,0.027993778,-0.029614931,1,
Gm13691,-0.26672193,0.48600802,0,
Gm13693,-0.30331036,0.20336305,0,
Gm13694,-0.12789506,0.36595994,0,
Gm13695,-0.1692173,0.21323052,0,
Gm13696,-0.068612166,0.45629153,0,
Gm13697,-0.16372396,0.3437391,0,
Gm13698,-0.25392506,0.29745215,0,
Gm13871,-0.39003447,-0.006722121,2,
Gm14305,-0.19540487,0.033056885,2,
Gm14327,-0.09014224,-0.02567333,2,
Gm14406,-0.22395478,-0.03292586,2,
Gm14569,-0.14487624,-0.26106796,2,
Gm14743,-0.17194614,-0.115487896,2,
Gm15155,-0.19756883,0.067102306,2,
Gm1527,-0.08740908,-0.052469794,2,
Gm15446,-0.3019061,-0.12024359,2,
Gm16223,-0.16379479,0.16927116,2,
Gm16867,0.04120385,0.11508871,0,
Gm17660,-0.15402263,-0.032635044,2,
Gm19684,-0.42146176,-0.022788022,2,
Gm2000,-0.12616259,0.28709942,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Gm20390,0.070176914,-0.19406612,1,
Gm20403,0.0006244833,-0.043578736,2,
Gm2042,-0.2100635,0.024416916,2,
Gm20431,0.3228876,0.12833112,3,
Gm20441,-0.17504878,0.044105407,2,
Gm20489,0.36719385,-0.15485501,1,
Gm20509,-0.27361822,0.35004014,0,
Gm20521,-0.08976882,0.2727739,0,
Gm20538,-0.11264417,-0.025807282,2,
Gm20547,-0.04544703,-0.07109349,2,
Gm20594,-0.21870622,-0.24725658,2,
Gm20695,-0.051092245,-0.016666641,2,
Gm20708,-0.20601076,-0.11226151,2,
Gm20765,-0.14208639,-0.08005374,2,
Gm20835,-0.39780855,-0.05815982,2,
Gm20852,-0.07403342,0.12930174,2,
Gm20854,-0.28731212,0.17195839,2,
Gm21312,-0.22009827,0.048189405,2,
Gm21411,-0.04597608,-0.013037408,2,['Generic Transcription Pathway']
Gm21454,-0.2080552,0.1002813,2,
Gm21586,0.16312675,-0.0030291863,1,
Gm21833,-0.036539305,-0.16861066,2,
Gm21970,-0.07693626,-0.20325886,2,
Gm21987,-0.1062312,-0.040945068,2,
Gm2663,-0.030287765,-0.047927726,1,
Gm26938,-0.068307385,0.027447002,2,
Gm27021,-0.30574226,-0.14806631,2,
Gm27029,0.017143765,0.20397878,0,
Gm27179,0.016090706,0.05076372,2,
Gm28038,0.06454897,0.09509859,2,
Gm28040,-0.028849905,-0.14474896,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Gm28079,-0.25090653,-0.11751759,2,
Gm28305,-0.13955136,0.015199692,2,
Gm28635,0.39741057,-0.2023385,1,"['Adherens junctions interactions', 'VEGFR2 mediated vascular permeability']"
Gm29094,0.058607556,0.02031782,1,
Gm29609,-0.034042433,-0.09045669,2,
Gm2a,-0.10866967,0.016210187,2,"['Glycosphingolipid metabolism', 'Neutrophil degranulation']"
Gm3550,-0.15991075,0.2165462,0,
Gm3839,0.4445692,-0.074070975,1,
Gm3893,-0.24027587,-0.05335042,2,
Gm428,-0.3658202,-0.25340542,2,
Gm43302,0.03260156,0.11545562,3,
Gm4340,-0.12834634,0.2660622,0,
Gm43517,0.28511187,-0.03481905,3,
Gm44501,-0.1050354,0.03849609,2,
Gm45753,0.06799452,-0.06628413,1,
Gm4884,-0.116623856,-0.29455778,2,
Gm49322,-0.3608893,0.10115551,2,
Gm49333,-0.09607281,-0.056453582,2,['Peptide ligand-binding receptors']
Gm49336,0.07629176,0.43348068,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Gm4952,-0.31031498,-0.19489563,2,
Gm5096,-0.119314864,0.05877499,2,"['Sulfur amino acid metabolism', 'Choline catabolism']"
Gm5134,0.028097983,0.0029570495,2,
Gm5414,-0.093085304,0.05071476,2,"['Keratinization', 'Formation of the cornified envelope']"
Gm5426,0.0010264051,-0.15028127,2,
Gm5431,-0.24467453,0.015748098,2,
Gm5592,-0.18064106,-0.19855078,2,
Gm5741,0.17985754,-0.42767686,1,
Gm5771,0.0033989246,-0.31506628,1,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Gm5916,-0.36686715,-0.032162346,2,
Gm5938,-0.18304889,-0.1830523,2,
Gm5941,-0.19927095,-0.035232667,2,
Gm6034,-0.21298532,0.050532114,2,
Gm6040,-0.10260797,-0.26413703,2,
Gm6133,-0.102995455,0.26266152,0,
Gm6169,0.34698212,0.038815357,3,
Gm648,-0.17239277,0.036057215,2,
Gm6583,-0.21246122,0.059149347,2,
Gm6588,-0.2387268,-0.052280396,2,
Gm6763,-0.32695395,-0.1264922,2,
Gm6812,-0.010520985,-0.049832277,2,
Gm7030,0.11373776,-0.1034946,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Gm8020,-0.19291423,-0.15514997,2,
Gm8251,-0.23905447,0.04448772,0,
Gm884,-0.074554674,-0.028271643,2,
Gm8909,0.1008472,0.047073916,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Gm960,0.00027463573,0.10008364,3,
Gm973,0.053137604,0.2807319,3,
Gm9733,-0.07153291,-0.39253303,1,"['Cell surface interactions at the vascular wall', 'DAP12 interactions', 'Signal regulatory protein family interactions', 'Neutrophil degranulation']"
Gm9745,-0.20677733,0.07468853,2,['Cholesterol biosynthesis']
Gm9774,0.06340246,0.3652871,3,
Gmds,-0.14625946,-0.0015312606,2,['GDP-fucose biosynthesis']
Gmfb,0.037482157,-0.03311875,1,
Gmfg,-0.031569324,-0.18417674,1,['Neutrophil degranulation']
Gmip,-0.014879965,-0.030252777,2,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Gml,-0.224764,-0.044590887,2,
Gml2,-0.09073841,-0.16510953,2,
Gmnc,-0.015062209,0.22540201,3,
Gmnn,0.23458119,0.46164998,3,"['Assembly of the pre-replicative complex', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Gmppa,-0.10170021,-0.03552022,2,
Gmppb,-0.12643601,-0.17493118,2,
Gmpr,-0.12797838,-0.093483195,2,['Purine salvage']
Gmpr2,-0.15546268,-0.052560795,2,['Purine salvage']
Gmps,-0.21002948,0.4176993,0,"['Purine ribonucleoside monophosphate biosynthesis', 'Azathioprine ADME']"
Gna11,0.2180761,-0.37198755,1,"['PLC beta mediated events', 'G-protein activation', 'Acetylcholine regulates insulin secretion', 'G alpha (q) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'Thromboxane signalling through TP receptor', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Gna12,0.32382092,-0.4034377,1,"['G alpha (12/13) signalling events', 'Thrombin signalling through proteinase activated receptors (PARs)']"
Gna13,0.37996605,-0.41794991,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'Thromboxane signalling through TP receptor', 'Thrombin signalling through proteinase activated receptors (PARs)', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Gna14,0.2731161,-0.3795508,1,"['PLC beta mediated events', 'G-protein activation', 'Acetylcholine regulates insulin secretion', 'G alpha (q) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'Thromboxane signalling through TP receptor', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Gna15,0.22735417,-0.4007085,1,"['PLC beta mediated events', 'G-protein activation', 'Acetylcholine regulates insulin secretion', 'G alpha (q) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'Thromboxane signalling through TP receptor', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Gnai1,0.38546035,-0.39666048,1,"['Adenylate cyclase inhibitory pathway', 'ADP signalling through P2Y purinoceptor 12', 'Adrenaline,noradrenaline inhibits insulin secretion', 'G alpha (i) signalling events', 'Extra-nuclear estrogen signaling']"
Gnai2,0.41847268,-0.38516837,1,"['Adenylate cyclase inhibitory pathway', 'ADP signalling through P2Y purinoceptor 12', 'Adrenaline,noradrenaline inhibits insulin secretion', 'G alpha (i) signalling events', 'Extra-nuclear estrogen signaling']"
Gnai3,0.46422368,-0.32546416,1,"['Adenylate cyclase inhibitory pathway', 'ADP signalling through P2Y purinoceptor 12', 'G alpha (i) signalling events', 'Extra-nuclear estrogen signaling']"
Gnal,0.058750425,-0.4646188,1,"['Adenylate cyclase activating pathway', 'Adenylate cyclase inhibitory pathway', 'Olfactory Signaling Pathway']"
Gnao1,0.37525892,-0.37198502,1,['Ca2+ pathway']
Gnaq,0.31172633,-0.42375484,1,"['PLC beta mediated events', 'G-protein activation', 'Acetylcholine regulates insulin secretion', 'G alpha (q) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'Thromboxane signalling through TP receptor', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Gnas,0.35868546,-0.31715748,1,"['Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Prostacyclin signalling through prostacyclin receptor', 'G alpha (s) signalling events', 'Glucagon-type ligand receptors', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'GPER1 signaling']"
Gnat1,0.16936193,-0.37223396,1,"['Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade', 'G alpha (i) signalling events']"
Gnat2,0.0329231,-0.36626852,1,"['Ca2+ pathway', 'G alpha (i) signalling events']"
Gnat3,0.17960848,-0.31918648,1,"['Adenylate cyclase inhibitory pathway', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'ADP signalling through P2Y purinoceptor 12', 'G alpha (i) signalling events', 'Extra-nuclear estrogen signaling', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Gnaz,0.3226054,-0.35267794,1,['G alpha (z) signalling events']
Gnb1,0.33533922,-0.32064047,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Activation of the phototransduction cascade', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Olfactory Signaling Pathway', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Sensory perception of sweet, bitter, and umami (glutamate) taste', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gnb1l,-0.14733577,0.035430197,2,
Gnb2,0.30961025,-0.35779902,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gnb3,0.29005656,-0.31170923,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Sensory perception of sweet, bitter, and umami (glutamate) taste', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gnb4,0.3232147,-0.36609882,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gnb5,0.26068428,-0.37532452,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gne,-0.27915525,-0.21276033,2,['Sialic acid metabolism']
Gng10,0.30385333,-0.35668373,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng11,0.19336611,-0.42379957,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng12,0.2577307,-0.28418872,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng13,0.2363307,-0.46063265,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Olfactory Signaling Pathway', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Sensory perception of sweet, bitter, and umami (glutamate) taste', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng2,0.34827745,-0.4090007,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng3,0.20991975,-0.32726175,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng4,0.27806666,-0.29571828,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng5,0.38479683,-0.20481996,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng7,0.29132485,-0.33076063,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gng8,0.19351245,-0.29876286,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gngt1,0.25044382,-0.38825095,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gngt2,0.30525738,-0.28764182,1,"['Activation of G protein gated Potassium channels', 'G-protein activation', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'ADP signalling through P2Y purinoceptor 12', 'G beta:gamma signalling through PI3Kgamma', 'Prostacyclin signalling through prostacyclin receptor', 'Adrenaline,noradrenaline inhibits insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'G beta:gamma signalling through PLC beta', 'G alpha (s) signalling events', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'G alpha (z) signalling events', 'Glucagon-type ligand receptors', 'Thromboxane signalling through TP receptor', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Presynaptic function of Kainate receptors', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through CDC42', 'Extra-nuclear estrogen signaling', 'GPER1 signaling', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Gnl1,-0.17034441,0.46341312,0,
Gnl2,-0.3670137,0.5000141,0,
Gnl3,-0.080325045,0.49335515,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Gnl3l,-0.23955846,0.46840683,0,
Gnmt,-0.08227555,0.059198983,2,['Glyoxylate metabolism and glycine degradation']
Gnpat,-0.36201113,-0.077174485,2,"['Synthesis of PA', 'Plasmalogen biosynthesis', 'Peroxisomal protein import']"
Gnpda1,-0.095423974,-0.024746252,2,['Glycolysis']
Gnpda2,-0.094720416,-0.166329,2,['Glycolysis']
Gnpnat1,-0.34235367,-0.17421147,2,['Synthesis of UDP-N-acetyl-glucosamine']
Gnptab,-0.0611909,-0.095781505,2,
Gnptg,-0.29015967,-0.019839976,2,
Gnrh1,0.2702203,-0.32386166,1,"['Hormone ligand-binding receptors', 'G alpha (q) signalling events']"
Gnrhr,0.07473756,-0.29820904,1,"['Hormone ligand-binding receptors', 'G alpha (q) signalling events']"
Gns,-0.30574772,-0.096616335,2,"['Keratan sulfate degradation', 'Lysosome Vesicle Biogenesis', 'Neutrophil degranulation']"
Golga1,-0.13579771,0.018918049,2,['Retrograde transport at the Trans-Golgi-Network']
Golga2,0.114882655,0.052959714,1,"['Golgi Cisternae Pericentriolar Stack Reorganization', 'COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'RHOD GTPase cycle']"
Golga3,-0.041423198,-0.053453986,2,
Golga4,0.064959824,0.051512055,2,['Retrograde transport at the Trans-Golgi-Network']
Golga5,0.04062162,-0.012507653,2,
Golga7,0.016199851,-0.3795582,1,"['Neutrophil degranulation', 'RAS processing']"
Golga7b,-0.23987971,-0.20350696,2,
Golgb1,-0.08511194,-0.12139858,2,"['Golgi Associated Vesicle Biogenesis', 'COPI-mediated anterograde transport']"
Golim4,-0.33552966,-0.1192049,2,
Golm1,-0.24556366,-0.26136035,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Golm2,-0.31777596,0.020148652,2,
Golph3,0.074527256,-0.03609984,1,
Golph3l,-0.1298578,0.010682874,2,
Golt1b,-0.19745801,0.009892302,2,
Gon7,-0.28840873,0.073719606,2,
Gopc,0.07766554,-0.2829222,1,"['RHO GTPases regulate CFTR trafficking', 'RHOQ GTPase cycle']"
Gorab,-0.014953795,0.020921271,2,
Gorasp1,0.03520087,0.11370828,2,"['Golgi Cisternae Pericentriolar Stack Reorganization', 'COPII-mediated vesicle transport', 'COPI-mediated anterograde transport']"
Gorasp2,0.27041113,-0.043265175,1,['Golgi Cisternae Pericentriolar Stack Reorganization']
Gosr1,-0.2022186,-0.11705703,2,"['COPI-mediated anterograde transport', 'Intra-Golgi traffic']"
Gosr2,-0.19552103,-0.13880597,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'COPI-mediated anterograde transport', 'Intra-Golgi traffic']"
Got1,-0.12444516,-0.16104536,2,"['Gluconeogenesis', 'Aspartate and asparagine metabolism']"
Got1l1,-0.19481239,-0.20841816,2,
Got2,0.014096328,-0.27206725,1,"['Glyoxylate metabolism and glycine degradation', 'Gluconeogenesis', 'Aspartate and asparagine metabolism', 'Glutamate and glutamine metabolism']"
Gp complex,0.09549408,-0.018332463,1,
Gp1ba,0.2835471,-0.19099626,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'GP1b-IX-V activation signalling', 'Platelet Adhesion to exposed collagen', 'Platelet Aggregation (Plug Formation)']"
Gp1bb,0.28543577,-0.20041732,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'GP1b-IX-V activation signalling', 'Platelet Adhesion to exposed collagen', 'Platelet Aggregation (Plug Formation)']"
Gp2,0.06499333,-0.20853959,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Gp5,0.29542464,-0.09297627,1,
Gp6,0.24207903,-0.39568895,1,"['GPVI-mediated activation cascade', 'Cell surface interactions at the vascular wall', 'Platelet Adhesion to exposed collagen']"
Gp9,0.32727334,-0.27836952,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'GP1b-IX-V activation signalling', 'Platelet Adhesion to exposed collagen', 'Platelet Aggregation (Plug Formation)']"
Gpa33,-0.040750053,0.045767367,2,
Gpaa1,0.002648313,0.03975045,2,['Attachment of GPI anchor to uPAR']
Gpalpp1,-0.057796128,-0.073467426,2,
Gpam,-0.11108858,-0.20476007,2,"['Synthesis of PA', 'Triglyceride biosynthesis']"
Gpank1,-0.22996333,-0.011284997,2,
Gpat2,-0.33353132,-0.16154337,2,"['Synthesis of PA', 'Triglyceride biosynthesis']"
Gpat3,-0.3933636,-0.14239685,2,['Synthesis of PA']
Gpat4,-0.3645655,-0.08120076,2,['Synthesis of PA']
Gpatch1,-0.008761562,0.36029184,0,
Gpatch11,-0.070262365,0.051771592,2,
Gpatch2,-0.26064423,0.46011075,0,
Gpatch2l,-0.10946055,-0.0102094505,2,
Gpatch4,0.013540582,0.3287371,0,
Gpatch8,-0.13342074,0.31399015,0,
Gpbar1,0.07553402,-0.08483976,1,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (s) signalling events']"
Gpbp1,-0.2625305,-0.10384336,2,
Gpbp1l1,0.054102916,-0.22329922,1,
Gpc1,0.2664017,-0.370508,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Cell surface interactions at the vascular wall', 'Signaling by ROBO receptors', 'Retinoid metabolism and transport']"
Gpc2,0.02735011,-0.18756005,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Retinoid metabolism and transport']"
Gpc3,0.12723848,-0.1132082,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'Retinoid metabolism and transport']"
Gpc4,0.14908612,-0.10495876,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Retinoid metabolism and transport']"
Gpc5,-0.019108785,-0.19929154,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Release of Hh-Np from the secreting cell', 'Retinoid metabolism and transport']"
Gpc6,0.10563722,-0.20499979,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Retinoid metabolism and transport']"
Gpcpd1,-0.09080631,0.11776131,0,
Gpd1,-0.26606488,-0.1318282,2,['Synthesis of PA']
Gpd1l,-0.20776421,-0.23330635,2,['Synthesis of PA']
Gpd2,-0.18723094,-0.078263044,2,"['Synthesis of PA', 'Triglyceride catabolism']"
Gper1,0.15083571,-0.2264125,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events', 'GPER1 signaling']"
Gpha2,-0.18130732,-0.08726466,2,"['Hormone ligand-binding receptors', 'G alpha (s) signalling events']"
Gphb5,-0.32653525,-0.1358514,2,"['Hormone ligand-binding receptors', 'G alpha (s) signalling events']"
Gphn,0.1379193,-0.13389823,1,['Molybdenum cofactor biosynthesis']
Gpi1,-0.1679568,0.10740007,2,"['TP53 Regulates Metabolic Genes', 'Neutrophil degranulation', 'Glycolysis', 'Gluconeogenesis']"
Gpihbp1,-0.012579358,-0.05696682,2,"['Post-translational modification: synthesis of GPI-anchored proteins', 'Assembly of active LPL and LIPC lipase complexes', 'Chylomicron remodeling', 'Retinoid metabolism and transport']"
Gpkow,0.008894625,0.14762637,2,['mRNA Splicing - Major Pathway']
Gpld1,0.15093237,-0.08908503,1,
Gpm6a,0.15272893,-0.106110156,1,
Gpn1,-0.003735183,0.38577512,0,
Gpn2,0.06583551,0.14626233,3,
Gpn3,0.012733198,0.32640433,0,
Gpnmb,0.15593958,-0.23177482,1,['PTK6 promotes HIF1A stabilization']
Gpr1,-0.048479717,-0.23392335,1,
Gpr119,-0.03456298,-0.11487328,2,"['Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)']"
Gpr12,-0.09410753,0.08589223,2,
Gpr137c,-0.30124336,-0.058982678,2,
Gpr139,0.106935374,0.2299078,0,
Gpr142,-0.05181686,-0.080263615,2,
Gpr143,-0.105356276,-0.120484926,2,"['Amine ligand-binding receptors', 'G alpha (q) signalling events']"
Gpr146,-0.041070707,-0.08575265,2,
Gpr149,0.0022995262,0.20470181,0,
Gpr15,-0.19251314,-0.15637992,2,['G alpha (s) signalling events']
Gpr150,0.00965327,-0.060727626,2,['G alpha (s) signalling events']
Gpr151,-0.26831883,-0.07169793,2,
Gpr152,-0.13854976,-0.03232597,2,
Gpr153,-0.24880794,-0.090488814,2,
Gpr155,-0.24305373,0.17013735,2,
Gpr156,0.083245814,-0.102433234,1,
Gpr157,-0.101751275,-0.10556958,2,
Gpr158,-0.034244746,-0.1779525,2,
Gpr160,-0.119199924,0.18780749,0,
Gpr161,0.35634214,-0.08782467,1,"[""Hedgehog 'off' state"", ""Hedgehog 'on' state""]"
Gpr162,-0.18048793,-0.08351286,2,
Gpr171,-0.054781288,0.018279172,2,
Gpr174,-0.0070852293,-0.04115033,2,
Gpr179,-0.011336607,0.03678845,2,
Gpr18,-0.05576229,-0.12663332,2,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Gpr180,-0.3039693,-0.021254547,2,
Gpr183,-0.1190283,0.029913167,2,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Gpr19,-0.033080343,0.08369995,2,
Gpr20,-0.17881884,0.19322734,2,['G alpha (s) signalling events']
Gpr21,-0.09909903,-0.20699659,2,
Gpr22,-0.05346615,0.17726128,2,
Gpr25,-0.0040978407,-0.019509709,2,['G alpha (s) signalling events']
Gpr27,-0.18521343,0.19290966,2,['G alpha (s) signalling events']
Gpr3,0.16735992,-0.27675396,1,
Gpr34,-0.27982712,-0.2728852,2,
Gpr35,-0.024288988,-0.101404235,2,['Class A/1 (Rhodopsin-like receptors)']
Gpr37,-0.040745623,-0.016756129,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Gpr37l1,-0.19849062,-0.34968507,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Gpr39,-0.09039819,-0.015383428,2,
Gpr4,-0.07835363,-0.2363606,2,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (q) signalling events']"
Gpr50,-0.047338024,-0.059099272,2,
Gpr55,-0.019911794,-0.22561969,1,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Gpr6,-0.20366064,0.0011176815,2,
Gpr63,-0.19689083,-0.036043596,2,
Gpr75,-0.17851458,0.09204699,2,
Gpr82,-0.16898431,-0.07573526,2,
Gpr83,0.18855013,-0.04931854,1,['G alpha (s) signalling events']
Gpr84,-0.120085336,-0.20127651,2,
Gpr87,-0.05721835,-0.2458125,1,
Gpr88,-0.32905602,0.10553755,2,
Gprasp1,-0.2064732,-0.01255664,2,
Gprasp2,-0.026637135,-0.1264218,2,
Gprc5a,-0.28552842,-0.058132302,2,
Gprc5d,-0.38630286,-0.24862777,2,
Gprc6a,0.15041734,-0.20153567,1,"['G alpha (q) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Gprin1,-0.021147225,0.032800604,2,
Gprin2,-0.035856333,0.025891481,2,
Gps1,0.1836817,0.181395,3,
Gps2,-0.018555816,0.4123822,3,['NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux']
Gpsm1,0.19829702,-0.32440287,1,['G alpha (i) signalling events']
Gpsm2,0.07388183,-0.22281024,1,['G alpha (i) signalling events']
Gpsm3,-0.0076315743,-0.01664288,2,['G alpha (i) signalling events']
Gpt,-0.14763632,0.099492945,2,['Alanine metabolism']
Gpt2,-0.11128934,-0.038921468,2,['Alanine metabolism']
Gpx1,0.04850105,-0.09198682,1,"['Synthesis of 12-eicosatetraenoic acid derivatives', 'Synthesis of 15-eicosatetraenoic acid derivatives', 'Detoxification of Reactive Oxygen Species']"
Gpx2,0.093356214,-0.038091287,1,
Gpx3,-0.018187692,-0.15290919,1,['Detoxification of Reactive Oxygen Species']
Gpx4,0.07197072,-0.17466436,1,"['Synthesis of 12-eicosatetraenoic acid derivatives', 'Synthesis of 15-eicosatetraenoic acid derivatives', 'Biosynthesis of D-series resolvins', 'Biosynthesis of E-series 18(S)-resolvins', 'Biosynthesis of aspirin-triggered D-series resolvins', 'Biosynthesis of E-series 18(R)-resolvins']"
Gpx5,-0.08870178,-0.15634894,2,['Detoxification of Reactive Oxygen Species']
Gpx6,0.022157473,-0.13367178,1,['Detoxification of Reactive Oxygen Species']
Gpx7,-0.050860997,-0.04540208,2,['Detoxification of Reactive Oxygen Species']
Gpx8,0.13514961,-0.029562714,1,['Detoxification of Reactive Oxygen Species']
Gramd1a,-0.106189944,-0.099818006,2,
Gramd1b,-0.35255912,0.04807419,2,
Gramd2,0.060756527,0.10268792,3,
Gramd4,-0.16557105,-0.12012351,2,
Grap,0.08186764,-0.32969132,1,['Signaling by SCF-KIT']
Grap2,0.24789336,-0.373446,1,"['Signaling by SCF-KIT', 'Generation of second messenger molecules', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'CD28 co-stimulation', 'FLT3 Signaling']"
Grb10,0.40399134,-0.2903966,1,"['Signaling by SCF-KIT', 'IRS activation', 'Signal attenuation', 'Insulin receptor signalling cascade', 'RET signaling', 'FLT3 Signaling']"
Grb14,0.3459027,-0.19433492,1,['Tie2 Signaling']
Grb2,0.51541615,-0.40691996,1,"['PI3K Cascade', 'SOS-mediated signalling', 'SHC1 events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'Spry regulation of FGF signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'Signalling to RAS', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'Downstream signal transduction', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'Regulation of actin dynamics for phagocytic cup formation', 'Tie2 Signaling', 'EGFR Transactivation by Gastrin', 'DAP12 signaling', 'SHC-related events triggered by IGF1R', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'NCAM signaling for neurite out-growth', 'Costimulation by the CD28 family', 'CD28 dependent Vav1 pathway', 'Signal regulatory protein family interactions', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RHO GTPases Activate WASPs and WAVEs', 'RAF/MAP kinase cascade', 'Negative regulation of MET activity', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Signal attenuation', 'Insulin receptor signalling cascade', 'MET activates RAS signaling', 'MET activates PI3K/AKT signaling', 'RET signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'MET activates PTPN11', 'MET activates RAP1 and RAC1', 'MET receptor recycling', 'Interleukin-15 signaling', 'RHOU GTPase cycle', 'Erythropoietin activates RAS', 'Activated NTRK2 signals through FRS2 and FRS3', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL', 'FLT3 Signaling', 'Signaling by CSF3 (G-CSF)', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Grb7,0.41344193,-0.295469,1,"['GRB7 events in ERBB2 signaling', 'Signaling by SCF-KIT', 'Downstream signal transduction', 'Tie2 Signaling', 'RET signaling', 'RND1 GTPase cycle']"
Grcc10,0.008919631,0.15576923,2,
Greb1,0.11565554,0.2073021,3,['Estrogen-dependent gene expression']
Greb1l,-0.22798212,-0.22346564,2,
Grem1,0.051617768,-0.025631137,2,
Grem2,-0.08587313,-0.039727453,2,['Signaling by BMP']
Grhl2,-0.020124132,0.096914254,2,
Grhl3,-0.1838228,-0.12080137,2,
Grhpr,-0.16405623,-0.06277967,2,['Glyoxylate metabolism and glycine degradation']
Gria1,0.24913135,-0.25943163,1,"['COPII-mediated vesicle transport', 'Activation of AMPA receptors', 'Trafficking of AMPA receptors', 'Trafficking of GluR2-containing AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Cargo concentration in the ER', 'Synaptic adhesion-like molecules']"
Gria2,0.2933776,-0.306904,1,
Gria3,0.23280004,-0.15397404,1,"['Activation of AMPA receptors', 'Trafficking of AMPA receptors', 'Trafficking of GluR2-containing AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Synaptic adhesion-like molecules']"
Gria4,0.26092002,-0.28746226,1,"['Activation of AMPA receptors', 'Trafficking of AMPA receptors', 'Trafficking of GluR2-containing AMPA receptors', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Synaptic adhesion-like molecules']"
Grid1,-0.16676602,-0.011356541,2,
Grid2,0.23099919,-0.23884465,1,
Grid2ip,0.05577421,-0.17116705,1,
Grifin,-0.250968,-0.043949857,2,
Grik1,0.17830214,-0.14406559,1,
Grik3,0.025615443,-0.068343915,1,"['Activation of Ca-permeable Kainate Receptor', 'Presynaptic function of Kainate receptors']"
Grik4,0.13247623,-0.114261605,1,['Activation of Ca-permeable Kainate Receptor']
Grik5,0.11325658,-0.15408292,1,['Activation of Ca-permeable Kainate Receptor']
Grin1,0.42399156,-0.30251253,1,"['EPHB-mediated forward signaling', 'Unblocking of NMDA receptors, glutamate binding and activation', 'RAF/MAP kinase cascade', 'Synaptic adhesion-like molecules', 'Assembly and cell surface presentation of NMDA receptors']"
Grin2a,0.36112472,-0.306028,1,"['Unblocking of NMDA receptors, glutamate binding and activation', 'Synaptic adhesion-like molecules', 'Assembly and cell surface presentation of NMDA receptors']"
Grin2b,0.51635855,-0.3627949,1,
Grin2c,0.14049816,-0.16534798,1,"['Unblocking of NMDA receptors, glutamate binding and activation', 'Synaptic adhesion-like molecules', 'Assembly and cell surface presentation of NMDA receptors']"
Grin2d,0.27615783,-0.096423544,1,"['Unblocking of NMDA receptors, glutamate binding and activation', 'RAF/MAP kinase cascade', 'Synaptic adhesion-like molecules', 'Assembly and cell surface presentation of NMDA receptors']"
Grin3a,0.11284961,-0.038816508,1,['Assembly and cell surface presentation of NMDA receptors']
Grin3b,0.041255604,-0.21594962,1,
Grina,-0.21585728,-0.21030858,2,
Grip1,0.20953028,-0.17280085,1,['Trafficking of GluR2-containing AMPA receptors']
Grip2,-0.06560355,-0.296381,1,['Trafficking of GluR2-containing AMPA receptors']
Gripap1,-0.049733277,-0.08243752,2,
Grk1,0.07133453,-0.18137021,1,
Grk2,0.5582099,-0.12579525,1,"['Calmodulin induced events', 'G alpha (q) signalling events', 'G alpha (s) signalling events', 'Activation of SMO', 'Cargo recognition for clathrin-mediated endocytosis']"
Grk3,0.37869954,-0.08692862,1,"['G alpha (s) signalling events', 'Cargo recognition for clathrin-mediated endocytosis']"
Grk4,0.23788263,-0.33488718,1,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Grk5,0.29310164,-0.07769045,1,['G alpha (s) signalling events']
Grk6,0.36201623,-0.017247366,1,['G alpha (s) signalling events']
Grm1,0.28552473,-0.20959961,1,"['G alpha (q) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Neurexins and neuroligins']"
Grm2,0.13176343,-0.048587617,1,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Grm3,0.18512,-0.27142748,1,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Grm4,-0.042265862,-0.14683186,1,
Grm6,0.107454374,-0.19319515,1,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Grm7,-0.33237335,-0.16664916,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Grm8,0.048581973,-0.16844243,1,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Grn,0.29251972,-0.03670705,1,['Neutrophil degranulation']
Grp,0.16306116,-0.00042048175,3,"['Peptide ligand-binding receptors', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'G alpha (q) signalling events']"
Grpel1,-0.060456462,0.020260392,0,
Grpel2,-0.12428612,-0.0143381255,2,
Grpr,-0.009618169,0.0646472,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Grsf1,-0.048390545,-0.17966169,2,
Grwd1,-0.185531,0.43022773,0,
Grxcr1,-0.22579597,0.0067474283,2,
Grxcr2,-0.38105798,0.09117069,2,
Gsap,-0.035427693,-0.2502405,1,
Gsc,-0.15446696,0.01111974,2,
Gsdma3,-0.23282902,-0.15782475,2,
Gsdmc,-0.23517567,-0.06467808,2,
Gsdmd,0.09394402,0.06093402,0,"['Release of apoptotic factors from the mitochondria', 'Interleukin-1 processing', 'Pyroptosis', 'Regulation of TLR by endogenous ligand', 'Neutrophil degranulation']"
Gsdme,-0.4051346,-0.20369567,2,"['Release of apoptotic factors from the mitochondria', 'Pyroptosis', 'Regulation of TLR by endogenous ligand']"
Gse1,0.040765677,-0.015701871,1,
Gsg1,0.003148419,0.097042,0,
Gsg1l,-0.16540368,0.0058840835,2,
Gsk3a,0.34706864,0.120539695,3,
Gsk3b,0.5930608,0.13740377,3,"['Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Regulation of HSF1-mediated heat shock response', 'CRMPs in Sema3A signaling', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'B-WICH complex positively regulates rRNA expression', 'GLI3 is processed to GLI3R by the proteasome', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2']"
Gskip,-0.08213818,0.13446654,2,
Gsn,0.36837128,-0.26025447,1,"['Caspase-mediated cleavage of cytoskeletal proteins', 'Neutrophil degranulation']"
Gspt1,-0.0906696,0.31567287,0,"['Eukaryotic Translation Termination', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Gspt2,-0.260996,0.24227001,0,"['Eukaryotic Translation Termination', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Gsr,0.050801046,-0.017063502,0,"['Detoxification of Reactive Oxygen Species', 'Interconversion of nucleotide di- and triphosphates', 'TP53 Regulates Metabolic Genes']"
Gss,-0.025396803,-0.1444514,1,['Glutathione synthesis and recycling']
Gsta1,-0.1748317,-0.016983064,0,"['Glutathione conjugation', 'Heme degradation', 'Azathioprine ADME']"
Gsta2,-0.063287914,-0.109739296,2,"['Glutathione conjugation', 'Heme degradation', 'Azathioprine ADME']"
Gsta3,-0.13342492,-0.13928862,2,"['Glutathione conjugation', 'Heme degradation', 'Azathioprine ADME']"
Gsta4,0.007707637,-0.05971084,1,
Gsta5,0.23284322,-0.04364447,1,"['Glutathione conjugation', 'Heme degradation', 'Azathioprine ADME']"
Gstcd,-0.060678523,0.021126116,2,
Gstk1,-0.083126165,0.03640718,0,"['Glutathione conjugation', 'Peroxisomal protein import']"
Gstm1,0.016093928,-0.21188755,1,['Glutathione conjugation']
Gstm2,-0.27698997,0.076541536,2,"['Glutathione conjugation', 'Azathioprine ADME', 'Paracetamol ADME']"
Gstm3,-0.06599244,-0.014379737,2,['Glutathione conjugation']
Gstm4,-0.076959215,-0.10749808,2,"['Glutathione conjugation', 'Biosynthesis of maresin conjugates in tissue regeneration (MCTR)']"
Gstm5,-0.2232336,-0.06686323,2,['Glutathione conjugation']
Gstm6,-0.2547844,-0.15935712,2,['Glutathione conjugation']
Gstm7,-0.16326001,-0.17267875,2,['Glutathione conjugation']
Gsto1,-0.06769775,0.012041128,0,"['Methylation', 'Glutathione conjugation', 'Vitamin C (ascorbate) metabolism']"
Gsto2,-0.10631061,-0.11963316,2,"['Glutathione conjugation', 'Vitamin C (ascorbate) metabolism']"
Gstp1,0.06725566,-0.22321992,1,"['Glutathione conjugation', 'Detoxification of Reactive Oxygen Species', 'Neutrophil degranulation', 'Paracetamol ADME']"
Gstp2,-0.030962575,-0.17290069,1,
Gstp3,-0.2369212,-0.11199638,2,
Gstt1,-0.07186578,-0.07215432,2,"['Glutathione conjugation', 'Paracetamol ADME']"
Gstt2,-0.16236505,-0.1308657,2,['Glutathione conjugation']
Gstt3,-0.1328473,-0.0611217,2,
Gstt4,-0.1218835,-0.11953837,2,
Gstz1,-0.11038248,0.022824854,2,"['Glutathione conjugation', 'Regulation of pyruvate dehydrogenase (PDH) complex', 'Tyrosine catabolism']"
Gsx1,-0.13950889,-0.16825327,2,
Gsx2,0.11727468,0.05988267,3,
Gtdc1,-0.2259981,-0.0022619972,2,
Gtf2a1,0.29418454,0.31590825,3,"['RNA Polymerase II Pre-transcription Events', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'Estrogen-dependent gene expression']"
Gtf2a1l,0.089225404,0.17986895,0,
Gtf2a2,0.19581595,0.3762369,3,"['RNA Polymerase II Pre-transcription Events', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'Estrogen-dependent gene expression']"
Gtf2b,0.27152693,0.41735333,0,"['RNA Polymerase II Pre-transcription Events', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Gtf2e1,0.21079992,0.27756733,3,"['RNA Polymerase II Pre-transcription Events', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Gtf2e2,0.20031469,0.29753894,3,"['RNA Polymerase II Pre-transcription Events', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Gtf2f1,0.3361988,0.39797837,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Gtf2f2,0.18473436,0.35556352,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Gtf2h1,0.25356108,0.3456071,3,
Gtf2h2,0.22742489,0.41834068,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Gtf2h3,0.2793547,0.41658214,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Gtf2h4,0.22362189,0.49778202,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Gtf2h5,0.22980161,0.42783162,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Gtf2i,0.45268685,-0.00068737235,3,
Gtf2ird1,-0.016917938,-0.10395325,2,
Gtf3a,0.07939752,0.24489811,0,['RNA Polymerase III Transcription Initiation From Type 1 Promoter']
Gtf3c1,0.010833582,0.1209491,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter']"
Gtf3c2,0.018156221,0.28996995,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter']"
Gtf3c3,-0.027024968,0.3272924,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter']"
Gtf3c4,0.01740746,0.10211125,2,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter']"
Gtf3c5,0.107860036,0.016003467,1,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter']"
Gtf3c6,0.0025376114,0.09764721,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter']"
Gtpbp1,-0.10353487,-0.06409573,2,
Gtpbp10,-0.25500664,0.097068794,0,
Gtpbp2,0.008227637,-0.055080127,2,['Platelet degranulation ']
Gtpbp3,-0.2824583,0.026320001,2,
Gtpbp4,-0.2786359,0.30286315,0,
Gtpbp6,-0.1728314,-0.17539072,2,
Gtpbp8,-0.18568166,0.02929126,2,
Gtse1,0.18985781,0.47226,3,"['G2/M Checkpoints', 'The role of GTSE1 in G2/M progression after G2 checkpoint']"
Gtsf1,-0.056987386,0.12501763,2,
Gtsf1l,-0.13781466,-0.04246888,2,
Guca1a,-0.19207717,-0.19734052,2,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Guca1b,-0.058178443,-0.33369678,1,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Guca2a,-0.25464264,-0.11334009,2,['Digestion']
Guca2b,-0.07538096,-0.061520558,2,['Digestion']
Gucy1a1,-0.054484,-0.22624716,2,['Smooth Muscle Contraction']
Gucy1a2,-0.08373915,-0.16046427,2,['Smooth Muscle Contraction']
Gucy1b1,0.008858893,-0.18066254,1,['Smooth Muscle Contraction']
Gucy1b2,-0.10414093,-0.24223359,2,['Smooth Muscle Contraction']
Gucy2c,-0.08728888,-0.24290371,2,['Digestion']
Gucy2d,-0.13615425,-0.36920103,2,
Gucy2e,-0.01806652,-0.43001437,1,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Gucy2f,-0.07965163,-0.281236,2,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Gucy2g,-0.033864863,-0.3060916,2,
Guf1,-0.16810825,-0.010372129,2,
Guk1,-0.026258808,0.052377287,2,"['Interconversion of nucleotide di- and triphosphates', 'Azathioprine ADME']"
Gulo,-0.3067154,-0.24891888,2,
Gulp1,0.2892603,-0.36664647,1,
Gusb,-0.06989127,-0.15788476,2,"['HS-GAG degradation', 'Hyaluronan uptake and degradation', 'Neutrophil degranulation']"
Gvin1,-0.2160417,-0.010318303,2,
Gxylt1,-0.11586885,0.02155257,2,
Gxylt2,-0.008571028,-0.16817884,1,
Gyg,-0.16507968,-0.0733732,2,"['Glycogen synthesis', 'Neutrophil degranulation', 'Glycogen breakdown (glycogenolysis)']"
Gykl1,-0.37071615,-0.079791725,2,['Triglyceride biosynthesis']
Gypa,0.10283011,-0.21436243,1,
Gypc,0.14204903,-0.115324914,1,
Gys1,0.083214484,-0.0057097864,3,['Glycogen synthesis']
Gys2,0.17333081,-0.08930343,3,
Gzf1,-0.012216019,-0.042341214,2,
Gzma,0.2993742,-0.18427461,1,
Gzmb,0.44965717,-0.020459812,1,"['Pyroptosis', 'Activation, myristolyation of BID and translocation to mitochondria']"
Gzmc,0.04257292,-0.0064463615,2,
Gzmd,-0.060587525,-0.040104777,2,
Gzme,-0.024485962,-0.021185802,2,
Gzmf,-0.16056292,-0.049316976,2,
Gzmg,-0.080029055,-0.010405121,2,['Metabolism of Angiotensinogen to Angiotensins']
Gzmk,0.06872936,-0.11335864,1,
Gzmm,-0.22057185,-0.07328123,2,['Alternative complement activation']
Gzmn,0.053939164,-0.015045708,1,
H13,-0.104090676,-0.02082933,2,['Regulation of HMOX1 expression and activity']
H1f0,0.40021837,0.357516,3,"['Apoptosis induced DNA fragmentation', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)']"
H1f1,0.24625972,0.18796133,3,"['Apoptosis induced DNA fragmentation', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)']"
H1f10,-0.019641468,0.24349718,0,
H1f2,0.27924952,0.19784309,3,
H1f3,0.1982426,0.10505306,3,"['Apoptosis induced DNA fragmentation', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)']"
H1f4,0.37494954,0.34955484,3,"['Apoptosis induced DNA fragmentation', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)']"
H1f5,0.20507525,0.29265568,3,"['Apoptosis induced DNA fragmentation', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)']"
H1f6,0.05226561,0.20522368,3,
H1f7,-0.040463734,0.14621168,2,
H1f8,-0.12598811,0.24602425,2,
H1f9,-0.012210236,0.27033496,3,
H2-Aa,0.17294823,-0.037007622,1,
H2-Ab1,0.17154732,-0.113608174,1,
H2-Bl,0.066193074,-0.23069982,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-D1,0.12832236,-0.21888764,1,
H2-DMa,0.043617208,-0.091960676,1,
H2-DMb1,0.115398556,-0.03271567,1,
H2-DMb2,0.062102705,-0.042903133,1,
H2-Eb1,0.21045503,-0.25563413,1,
H2-Eb2,0.19941497,-0.24482052,1,"['Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'MHC class II antigen presentation', 'PD-1 signaling']"
H2-K1,0.31675556,-0.19324718,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Ke6,-0.21496221,-0.1192069,2,['Fatty acyl-CoA biosynthesis']
H2-M1,0.06801443,-0.26107293,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M10.1,0.13769104,-0.13800924,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M10.2,0.120535605,0.007026306,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M10.3,0.07656573,-0.20240581,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M10.4,0.052403912,-0.23001538,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M10.5,0.11761935,-0.15632309,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M10.6,0.01736319,-0.21258646,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M11,0.0776803,-0.18537247,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M2,0.12402272,-0.12848572,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M3,0.1136282,-0.099955246,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M5,0.18231256,-0.2241929,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-M9,0.032814644,-0.18512815,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Oa,-0.026003571,-0.064625114,2,['MHC class II antigen presentation']
H2-Ob,0.10320625,-0.033285044,1,['MHC class II antigen presentation']
H2-Q1,0.09824051,-0.24414305,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Q10,0.041989934,-0.09630195,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Q2,0.19070686,-0.15954572,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Q4,-0.0008910431,-0.1727788,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Q6,0.13858882,-0.14426203,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-Q7,0.04064914,-0.11552206,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-T22,-0.046532672,-0.21610837,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-T23,0.039018814,-0.1722766,1,"['ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
H2-T3,0.10298234,-0.13130482,1,
H2-aa,0.021634398,-0.21292259,1,
H2-ab1,-0.0295094,-0.23011237,2,
H2-bi,-0.1892096,0.046149768,2,
H2-bl,-0.21581773,-0.096243165,2,
H2-d,-0.13619557,0.016946925,2,
H2-d1,0.08550025,0.030478938,3,
H2-dma,-0.11683229,0.06118746,2,
H2-dmb1,0.17016606,0.088503584,1,
H2-dmb2,0.13964069,0.021316994,1,
H2-ea-ps,0.0039054959,-0.018459704,1,
H2-eb1,-0.21734162,-0.14399672,2,
H2-k1,-0.18725502,-0.17590429,2,
H2-l,-0.09197354,-0.19970156,2,
H2-m1,-0.123247616,-0.10567497,2,
H2-m10.1,-0.12084925,-0.06787857,2,
H2-m10.2,-0.18905288,-0.091646686,2,
H2-m10.3,-0.12676774,-0.0051690447,2,
H2-m10.4,-0.20844908,-0.0140471505,2,
H2-m10.5,-0.015535626,0.0006052018,2,
H2-m10.6,-0.033062752,-0.013501443,2,
H2-m11,-0.13017756,-0.07489785,2,
H2-m2,-0.21421033,-0.14120641,2,
H2-m3,-0.26151523,-0.010510909,2,
H2-m5,-0.33872747,0.10353134,2,
H2-m9,-0.20746057,-0.14092235,2,
H2-oa,-0.100462034,-0.14831944,2,
H2-ob,-0.033983216,-0.15809087,2,
H2-q1,-0.27287167,-0.3439555,2,
H2-q10,0.023875955,0.06994772,2,
H2-q2,0.057541,-0.09260867,1,
H2-q4,-0.1998072,-0.26319435,2,
H2-q6,-0.2252952,-0.10994353,2,
H2-q7,0.005403517,-0.035601366,2,
H2-q8,-0.19795007,-0.023043158,2,
H2-q9,-0.04908858,-0.1601261,2,
H2-t-ps,-0.018194377,-0.14224249,2,
H2-t10,-0.015539644,-0.1582894,1,
H2-t18,-0.19153725,-0.041015662,2,
H2-t22,-0.15853849,-0.16749696,2,
H2-t23,-0.082791165,-0.29018453,2,
H2-t24,-0.09735375,-0.03619733,2,
H2-t3,-0.2429808,-0.028698128,2,
H2-t9,-0.15004097,0.034197766,2,
H2ab1,0.33210084,0.319638,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ab2,0.3108627,0.29117894,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ab3,0.36831996,0.35193622,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac1,0.27387324,0.35376376,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2ac10,0.20105213,0.420056,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac11,0.061136592,0.20050475,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac12,0.18044718,0.4518409,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac13,-0.15562439,0.24295002,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac15,0.19477856,0.4195656,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac18,0.12999932,0.2883089,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac19,0.15755993,0.41054237,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac20,0.25685066,0.53776336,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac21,0.36020127,0.40967926,3,"['RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs']"
H2ac22,-0.05769762,0.13412438,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac23,-0.20612425,0.2060506,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac24,-0.022740122,0.1350568,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac4,0.21375632,0.41772193,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac6,0.014167105,0.20270766,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac7,0.09147677,0.23249084,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2ac8,-0.14217232,0.18392707,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2aj,0.2619721,0.33854672,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2al1b,0.18193424,0.20164849,3,
H2al1e,0.40486956,0.27452165,3,
H2al1g,-0.38655847,0.010598927,2,
H2al1h,-0.24639675,-0.021599634,2,
H2al1i,0.076667026,0.19032311,3,
H2al1j,0.25517976,0.32674757,3,
H2al1k,0.16241255,0.29114434,3,
H2al1m,0.22024831,0.3521278,3,
H2al1n,0.22588865,0.19009031,3,
H2al1o,0.31337765,0.1501959,3,
H2al2a,0.10702701,0.3077145,3,
H2al2b,0.15957965,0.2693042,3,
H2al2c,0.19082642,0.21188231,3,
H2al3,0.039712127,0.041540314,2,
H2ap,-0.14690153,-0.048500624,2,
H2aw,0.25951976,0.45921627,3,"['RMTs methylate histone arginines', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs']"
H2ax,0.3958309,0.49334025,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2az1,0.39428395,0.537242,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2az2,0.26808974,0.6060075,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
H2bc1,0.29169995,0.40253714,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc11,-0.0160704,0.32775542,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc12,0.20884931,0.38839436,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc13,-0.042632442,0.251806,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc15,0.20323141,0.1885983,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc18,0.25803956,0.3731211,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc21,0.2382503,0.3940519,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc22,0.10488351,0.3451533,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc23,0.17330202,0.29335186,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc24,0.14176895,0.23911522,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc3,0.3271668,0.4344318,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc4,0.13684435,0.23322235,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc6,-0.022369098,0.21902962,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc7,-0.119871736,0.2560397,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bc8,0.004484398,0.2820591,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bl1,0.13734053,0.35123923,3,
H2bu2,0.2483479,0.37341386,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'HATs acetylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H2bw2,0.40204588,0.33922666,3,
H3c1,-0.11018609,0.15423876,2,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c10,0.0987142,0.23867129,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c11,-0.02191284,0.16164011,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c13,0.04053625,0.27647716,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c14,-0.042107385,0.2536487,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c15,0.24586906,0.38201338,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c2,-0.050075863,0.23918292,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c3,-0.13783334,0.29830047,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c4,-0.05516055,0.25053135,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c6,0.12393554,0.23581111,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c7,0.15507619,0.4473974,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3c8,0.091338746,0.34689477,3,"['Interleukin-7 signaling', 'PRC2 methylates histones and DNA', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3f3a,0.30302086,0.40486708,3,"['PRC2 methylates histones and DNA', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H3f3b,0.105253756,0.33446994,3,"['PRC2 methylates histones and DNA', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
H4c1,-0.21297114,0.28879863,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c11,0.3066836,0.37547475,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c12,-0.014131147,0.21371777,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c14,0.020148732,0.33106014,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c17,-0.05795976,0.16315787,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c18,-0.08873836,0.3241922,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c2,-0.01162063,0.36854208,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c3,-0.05694326,0.2995425,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c4,-0.04312876,0.25401604,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c6,-0.094472,0.23715281,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c8,-0.15144095,0.109534256,2,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4c9,-0.08309808,0.245528,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H4f16,0.23774111,0.3743644,3,"['PRC2 methylates histones and DNA', 'Condensation of Prophase Chromosomes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'SUMOylation of chromatin organization proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'G2/M DNA damage checkpoint', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Estrogen-dependent gene expression']"
H60a,0.08996852,0.031867124,1,
H60b,-0.021339767,0.048344914,2,
H60c,0.028837651,0.17838229,3,
H6pd,-0.283186,0.16157626,0,
Haao,-0.23742916,0.007848749,2,['Tryptophan catabolism']
Habp2,-0.11474246,-0.13422039,2,
Habp4,0.10477451,0.18133435,0,
Hacd1,-0.17908661,-0.19181485,2,
Hacd2,-0.13156915,-0.21849836,2,['Synthesis of very long-chain fatty acyl-CoAs']
Hacd3,-0.19806875,-0.020515397,2,['Synthesis of very long-chain fatty acyl-CoAs']
Hacd4,-0.15172853,-0.12622616,2,['Synthesis of very long-chain fatty acyl-CoAs']
Hace1,-0.04632182,0.33535376,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Hacl1,-0.13267995,0.06073504,2,"['Alpha-oxidation of phytanate', 'Peroxisomal protein import']"
Hadh,-0.21257934,-0.06780459,2,"['Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA', 'Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA', 'Beta oxidation of octanoyl-CoA to hexanoyl-CoA', 'Beta oxidation of hexanoyl-CoA to butanoyl-CoA', 'Beta oxidation of butanoyl-CoA to acetyl-CoA']"
Hadha,-0.07375716,-0.28533214,2,"['Acyl chain remodeling of CL', 'Beta oxidation of myristoyl-CoA to lauroyl-CoA', 'Beta oxidation of palmitoyl-CoA to myristoyl-CoA', 'Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA', 'Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA', 'Beta oxidation of octanoyl-CoA to hexanoyl-CoA', 'Beta oxidation of hexanoyl-CoA to butanoyl-CoA']"
Hadhb,-0.13867547,0.13463567,2,"['Acyl chain remodeling of CL', 'Beta oxidation of myristoyl-CoA to lauroyl-CoA', 'Beta oxidation of palmitoyl-CoA to myristoyl-CoA', 'Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA', 'Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA', 'Beta oxidation of octanoyl-CoA to hexanoyl-CoA', 'Beta oxidation of hexanoyl-CoA to butanoyl-CoA']"
Hagh,-0.26185292,0.04618632,2,
Haghl,-0.3331285,0.09706862,2,
Hal,-0.23614691,-0.16925165,2,['Histidine catabolism']
Hamp,0.04896571,-0.04776262,2,
Hamp2,-0.23493695,-0.1031073,2,
Hand1,0.20248161,0.13079923,3,
Hand2,0.2714499,0.03796071,3,
Hao1,-0.115802415,-0.068077356,2,"['Glyoxylate metabolism and glycine degradation', 'Peroxisomal protein import']"
Hao2,-0.18041337,-0.19448748,2,"['Peroxisomal lipid metabolism', 'Peroxisomal protein import']"
Hap1,0.18991846,-0.2942229,1,
Hapln1,-0.24685769,-0.10033986,2,['ECM proteoglycans']
Hapln2,-0.26160875,-0.09876874,2,
Hars,-0.08493141,0.28040344,0,
Hars2,-0.08969159,0.06690299,0,
Has2,-0.09625123,-0.10566594,2,['Hyaluronan biosynthesis and export']
Haspin,0.14355224,0.40142176,3,
Hat1,0.14746767,0.45018783,3,['HATs acetylate histones']
Haus1,-0.1302444,0.09713456,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus2,-0.054928865,-0.03434762,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus3,-0.16480342,0.032930296,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus4,0.19538397,0.22639774,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus5,0.06928355,0.08415911,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus6,-0.07958465,0.11801352,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus7,-0.14370592,0.11400089,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Haus8,-0.06699851,-0.09514371,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Havcr1,-0.13348344,-0.032242455,2,
Havcr2,0.31449652,-0.05173827,1,
Hax1,0.25238353,-0.066152416,1,
Hba-a1,-0.088321194,0.27556378,0,
Hba-a2,-0.12918378,0.1655182,2,
Hba-x,0.19378515,0.05207375,1,
Hbb-bh1,0.028252978,0.028702172,0,
Hbb-bh2,-0.23700608,0.11580778,2,
Hbb-bs,-0.05929155,0.010028287,2,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Scavenging of heme from plasma', 'Neutrophil degranulation', 'Cytoprotection by HMOX1', 'Heme signaling']"
Hbb-bt,-0.05535839,0.039479766,2,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Scavenging of heme from plasma', 'Neutrophil degranulation', 'Cytoprotection by HMOX1', 'Heme signaling']"
Hbb-y,-0.030639278,0.011838339,2,
Hbegf,0.38218284,-0.4002534,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'EGFR interacts with phospholipase C-gamma', 'EGFR Transactivation by Gastrin', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'PTK6 promotes HIF1A stabilization', 'Downregulation of ERBB2 signaling', 'Extra-nuclear estrogen signaling']"
Hbp1,0.30432272,0.1880172,3,
Hbs1l,-0.16106744,0.33517182,0,"[""mRNA decay by 3' to 5' exoribonuclease""]"
Hc,0.13717125,-0.22167684,1,"['Terminal pathway of complement', 'Activation of C3 and C5', 'Peptide ligand-binding receptors', 'G alpha (i) signalling events', 'Regulation of Complement cascade']"
Hcar1,0.05300545,-0.06521352,1,"['Hydroxycarboxylic acid-binding receptors', 'G alpha (i) signalling events']"
Hcar2,0.14791536,-0.047585748,1,"['Hydroxycarboxylic acid-binding receptors', 'Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Hccs,-0.05004108,-0.03825838,2,
Hcfc1,0.39613858,0.43286154,3,"['HATs acetylate histones', 'UCH proteinases']"
Hcfc1r1,-0.39099747,-0.045224342,2,
Hcfc2,0.22296935,0.1516575,3,
Hck,0.4715789,-0.31656432,1,"['FCGR activation', 'Regulation of signaling by CBL', 'Signaling by CSF3 (G-CSF)', 'Inactivation of CSF3 (G-CSF) signaling']"
Hcls1,0.350525,-0.39869398,1,
Hcn1,-0.17129509,0.009452423,2,['HCN channels']
Hcn2,0.018935878,-0.01541281,2,['HCN channels']
Hcn3,-0.02045784,-0.08377749,2,['HCN channels']
Hcn4,0.13216718,-0.1451955,1,
Hcrt,0.15456842,-0.09087871,1,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Hcrtr1,0.1549756,-0.0107893925,1,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Hcrtr2,0.05016598,-0.08231,1,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Hcst,0.09407193,-0.3911175,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Hdac1,0.5096702,0.2226108,3,"['G0 and Early G1', 'Formation of the beta-catenin:TCF transactivating complex', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'HDACs deacetylate histones', 'Notch-HLH transcription pathway', 'Deactivation of the beta-catenin transactivating complex', 'SUMOylation of chromatin organization proteins', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Regulation of PTEN gene transcription', 'Regulation of MECP2 expression and activity', 'STAT3 nuclear events downstream of ALK signaling', 'Factors involved in megakaryocyte development and platelet production']"
Hdac10,0.3560254,0.23910405,3,['Notch-HLH transcription pathway']
Hdac11,0.19166845,0.41270697,3,['Notch-HLH transcription pathway']
Hdac2,0.4945046,0.28979707,3,
Hdac3,0.44955072,0.2558871,3,
Hdac4,0.40985507,0.272951,3,"['Notch-HLH transcription pathway', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins', 'RUNX3 regulates p14-ARF']"
Hdac5,0.43747157,0.12505068,3,
Hdac6,0.50663376,0.16984868,3,"['HSF1 activation', 'Notch-HLH transcription pathway', 'Cilium Assembly', 'Aggrephagy']"
Hdac7,0.4717675,0.16860946,3,"['SUMOylation of DNA damage response and repair proteins', 'Notch-HLH transcription pathway']"
Hdac8,0.37200922,0.36194727,3,"['Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Notch-HLH transcription pathway']"
Hdac9,0.1664822,0.40941793,3,
Hdc,-0.2947279,-0.114935294,2,['Histidine catabolism']
Hddc3,-0.13693699,-0.027177922,2,
Hdgf,0.02823525,0.032507375,0,
Hdgfl2,-0.17127794,-0.05018913,2,
Hdgfl3,-0.35979262,0.05988912,2,
Hdhd2,-0.21886136,-0.12362176,2,
Hdhd5,-0.19584042,0.21440952,2,
Hdlbp,-0.14219226,-0.027183944,2,['HDL clearance']
Heatr1,-0.27258998,0.28449348,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Heatr3,-0.4142431,0.20811228,2,
Heatr4,-0.28412437,-0.07134399,2,
Heatr5a,-0.19729498,-0.06773722,2,
Heatr5b,-0.25695032,-0.09615507,2,
Heatr6,-0.08423414,0.19421254,0,
Hebp1,-0.26569667,-0.124347664,2,
Heca,-0.041138224,-0.00082936435,2,
Hectd1,0.018973568,-0.10172633,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Hectd2,0.078834705,0.17914382,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Hecw1,0.1734234,0.29235056,3,['Degradation of DVL']
Hecw2,-0.07230535,0.13630411,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Heg1,0.020384286,-0.11544109,2,
Helb,-0.103804596,0.22193187,3,
Hells,0.090700924,0.5734245,3,
Helq,0.09941615,0.33222193,3,
Helt,-0.17220074,-0.022887072,2,
Helz,0.07010346,0.2132792,3,
Helz2,0.20548618,0.37957156,3,"['Regulation of lipid metabolism by PPARalpha', 'Cytoprotection by HMOX1']"
Hemk1,-0.47530583,0.06142343,2,
Henmt1,-0.0854326,0.024310578,2,
Hepacam,-0.3662314,-0.009707462,2,
Hepacam2,-0.098105825,-0.23173319,2,
Heph,-0.094946235,0.045467064,2,"['Metal ion SLC transporters', 'Iron uptake and transport']"
Herc1,-0.092441976,0.16370566,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Herc2,0.20976423,0.16339543,3,"['SUMOylation of DNA damage response and repair proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Herc3,-0.063246526,0.0606242,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Herc4,-0.027894536,0.10957739,0,['Antigen processing: Ubiquitination & Proteasome degradation']
Herc6,0.13941206,0.0641468,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Herpud1,0.027492872,-0.07888885,1,
Herpud2,-0.0012577428,0.147098,3,
Hes1,0.37808824,0.14734614,3,
Hes3,-0.15399732,-0.0023885495,2,
Hes5,0.14040105,-0.0050911885,3,
Hes6,0.0010663399,-0.046397842,2,
Hes7,-0.077034004,0.13629812,2,
Hesx1,-0.0020046153,-0.14168437,2,
Hexa,-0.17334178,-0.19338933,2,"['Glycosphingolipid metabolism', 'Keratan sulfate degradation', 'CS/DS degradation', 'Hyaluronan uptake and degradation']"
Hexb,-0.20015514,-0.08924056,2,"['Glycosphingolipid metabolism', 'Keratan sulfate degradation', 'CS/DS degradation', 'Hyaluronan uptake and degradation', 'Neutrophil degranulation']"
Hexdc,-0.20796971,-0.08115156,2,
Hexim1,0.12661056,0.35484973,3,
Hexim2,0.046516914,0.18966308,3,
Hey1,0.2728029,0.11570537,3,
Hey2,0.3420983,0.16893409,3,
Heyl,0.00069302705,0.14884531,3,
Hfe,0.112383455,0.23272489,3,['Transferrin endocytosis and recycling']
Hfm1,-0.110333465,0.5234594,0,
Hgd,-0.20296857,-0.09323896,2,['Tyrosine catabolism']
Hgf,0.42301697,-0.17745271,1,"['Platelet degranulation ', 'PIP3 activates AKT signaling', 'RAF/MAP kinase cascade', 'MET Receptor Activation', 'Negative regulation of MET activity', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'MET activates RAS signaling', 'MET activates PI3K/AKT signaling', 'MET activates PTPN11', 'MET activates PTK2 signaling', 'MET interacts with TNS proteins', 'MET activates RAP1 and RAC1', 'MET receptor recycling', 'MET activates STAT3', 'Drug-mediated inhibition of MET activation']"
Hgfac,-0.021670917,-0.054222852,2,['MET Receptor Activation']
Hgh1,-0.19524409,0.372317,0,
Hgsnat,-0.3066118,0.046255577,2,"['HS-GAG degradation', 'Neutrophil degranulation']"
Hhat,0.019192254,-0.06808276,2,['Hedgehog ligand biogenesis']
Hhatl,-0.25974303,-0.08376135,2,
Hhex,-0.14494547,-0.044391293,2,
Hhip,0.17889929,0.13271518,3,['Ligand-receptor interactions']
Hhla1,-0.14967564,-0.06125621,2,
Hibadh,-0.21593086,0.054577254,2,['Branched-chain amino acid catabolism']
Hibch,-0.19350763,0.04038006,2,['Branched-chain amino acid catabolism']
Hic1,0.2954317,0.20883381,3,['SUMOylation of transcription factors']
Hic2,-0.13418525,-0.19067651,2,
Hid1,-0.031970378,-0.05711646,2,
Hif1a,0.58741605,0.046251174,3,"['Regulation of gene expression by Hypoxia-inducible Factor', 'Cellular response to hypoxia', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Ub-specific processing proteases', 'PTK6 promotes HIF1A stabilization', 'Neddylation']"
Hif1an,0.22451785,0.07636126,3,['Cellular response to hypoxia']
Hif3a,0.25765395,0.02191384,3,"['Regulation of gene expression by Hypoxia-inducible Factor', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Neddylation']"
Higd1b,-0.13081853,0.08814131,2,
Higd1c,-0.25654483,0.12975524,2,
Higd2a,-0.10939291,0.062229034,2,
Hikeshi,-0.009128453,0.23104309,0,['Regulation of HSF1-mediated heat shock response']
Hilpda,-0.03323498,-0.101776436,2,['Lipid particle organization']
Hinfp,-0.01471396,0.18411879,3,
Hint1,0.18423146,0.11542458,3,
Hip1,0.17726721,-0.1438861,1,['Clathrin-mediated endocytosis']
Hip1r,0.10251951,-0.377676,1,"['Golgi Associated Vesicle Biogenesis', 'Clathrin-mediated endocytosis']"
Hipk1,0.23014341,-0.077432014,3,['Regulation of TP53 Activity through Phosphorylation']
Hipk2,0.3711533,0.14694618,3,"['SUMOylation of transcription cofactors', 'Regulation of TP53 Activity through Phosphorylation', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of MECP2 expression and activity']"
Hipk3,0.27534235,-0.04487774,3,
Hipk4,0.12974842,-0.03203923,3,
Hira,0.23168088,0.2796823,3,['Formation of Senescence-Associated Heterochromatin Foci (SAHF)']
Hirip3,0.017584957,0.21112332,3,
Hivep1,-0.09037792,-0.02033604,2,
Hivep2,-0.16246848,-0.08143641,2,
Hivep3,0.1792281,0.20053086,3,
Hjurp,0.24478585,0.36289135,3,
Hjv,0.145969,-0.07596886,1,
Hk1,0.12256182,-0.1039243,1,
Hk2,0.067564204,-0.0036940463,1,['Glycolysis']
Hk3,-0.20986083,0.19485912,0,"['Neutrophil degranulation', 'Glycolysis']"
Hkdc1,-0.18596223,0.012346395,2,
Hlcs,-0.26454553,0.07209239,2,['Biotin transport and metabolism']
Hlf,0.018800633,0.1488119,3,
Hltf,0.27043027,0.28745046,3,['E3 ubiquitin ligases ubiquitinate target proteins']
Hlx,0.2828124,-0.0499788,1,
Hmbox1,-0.041356582,-0.115411684,2,
Hmbs,0.02475627,0.117220126,0,['Heme biosynthesis']
Hmces,-0.41042906,-0.16826934,2,
Hmcn1,-0.006682478,0.0020792296,2,
Hmcn2,-0.010417379,-0.18845062,1,
Hmg20a,0.11336408,0.3049044,3,
Hmg20b,0.20396285,0.3294421,3,"['HDACs deacetylate histones', 'Factors involved in megakaryocyte development and platelet production']"
Hmga1,-0.076360926,0.14716072,2,['Formation of Senescence-Associated Heterochromatin Foci (SAHF)']
Hmga2,0.17810541,0.3259622,3,['Formation of Senescence-Associated Heterochromatin Foci (SAHF)']
Hmgb1,0.51987875,0.14134012,3,"['Apoptosis induced DNA fragmentation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'Pyroptosis', 'Regulation of TLR by endogenous ligand', 'Neutrophil degranulation', 'Advanced glycosylation endproduct receptor signaling', 'TRAF6 mediated NF-kB activation']"
Hmgb2,0.19072019,0.35809672,3,['Apoptosis induced DNA fragmentation']
Hmgb3,0.067966476,0.10663947,0,
Hmgb4,-0.20786099,0.07200783,2,
Hmgcl,-0.19475941,0.12306299,2,"['Synthesis of Ketone Bodies', 'Peroxisomal protein import']"
Hmgcll1,-0.17721726,0.021891596,2,['Synthesis of Ketone Bodies']
Hmgcr,0.05645443,-0.1189749,2,['Cholesterol biosynthesis']
Hmgcs1,-0.25987202,-0.022661472,2,['Cholesterol biosynthesis']
Hmgcs2,-0.15505627,-0.104594365,2,['Synthesis of Ketone Bodies']
Hmgn1,0.23243603,0.25823358,3,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER']"
Hmgn2,-0.03317375,0.0776747,2,
Hmgn3,-0.1657304,0.10642029,0,
Hmgn5,-0.10576688,0.2442995,2,
Hmgxb3,-0.2730807,-0.01729509,2,
Hmgxb4,-0.014616348,0.181685,0,
Hmmr,0.2910948,0.32398346,3,"['Hyaluronan uptake and degradation', 'AURKA Activation by TPX2']"
Hmox1,0.32276538,-0.021144817,1,"['Heme degradation', 'Iron uptake and transport', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane', 'Cytoprotection by HMOX1', 'Regulation of HMOX1 expression and activity']"
Hmox2,0.19259977,-0.055489022,1,"['Heme degradation', 'Neutrophil degranulation', 'RHOA GTPase cycle', 'Iron uptake and transport', 'Cytoprotection by HMOX1']"
Hmx3,0.07522222,0.10597741,0,
Hnf1a,0.15671138,0.11943939,3,
Hnf1b,0.18033615,0.08045599,3,
Hnf4a,0.39449054,-0.022155533,3,['Nuclear Receptor transcription pathway']
Hnf4g,0.11536076,-0.04884744,1,
Hnmt,-0.036519255,0.00875086,2,
Hnrnpa0,0.06407516,0.2704075,0,['mRNA Splicing - Major Pathway']
Hnrnpa1,0.3172124,0.48435673,0,"['FGFR2 alternative splicing', 'mRNA Splicing - Major Pathway']"
Hnrnpa2b1,0.22756472,0.38657448,0,['mRNA Splicing - Major Pathway']
Hnrnpa3,-0.021482838,0.384754,0,['mRNA Splicing - Major Pathway']
Hnrnpab,0.0070064818,0.30620122,0,
Hnrnpc,0.08521999,0.6191315,0,"['SUMOylation of RNA binding proteins', 'mRNA Splicing - Major Pathway', 'RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle']"
Hnrnpd,0.32377928,0.5312718,0,"['AUF1 (hnRNP D0) binds and destabilizes mRNA', 'mRNA Splicing - Major Pathway']"
Hnrnpdl,0.095689446,0.2870159,0,
Hnrnpf,-0.04512811,0.48994413,0,['mRNA Splicing - Major Pathway']
Hnrnph1,0.035281274,0.43811327,0,['mRNA Splicing - Major Pathway']
Hnrnph2,0.006836999,0.28246504,0,['mRNA Splicing - Major Pathway']
Hnrnph3,0.016259074,0.11512898,0,
Hnrnpk,0.27885112,0.4852108,0,"['SUMOylation of RNA binding proteins', 'mRNA Splicing - Major Pathway']"
Hnrnpl,0.03097776,0.4685286,0,['mRNA Splicing - Major Pathway']
Hnrnpll,-0.0056191073,0.33207315,0,
Hnrnpm,-0.05636656,0.42136666,0,
Hnrnpr,0.08562941,0.45967525,0,['mRNA Splicing - Major Pathway']
Hnrnpu,0.2872759,0.43000582,0,['mRNA Splicing - Major Pathway']
Hnrnpul1,0.13011733,0.33966482,0,['mRNA Splicing - Major Pathway']
Hnrnpul2,0.02063837,0.07261613,2,
Hoatz,-0.00344361,0.044977397,2,
Hoga1,-0.09011128,-0.097724706,2,['Glyoxylate metabolism and glycine degradation']
Homer1,0.22061373,-0.2504708,1,['Neurexins and neuroligins']
Homer2,0.2507198,0.071786106,3,['Neurexins and neuroligins']
Homer3,0.06342339,-0.14905837,1,['Neurexins and neuroligins']
Hook1,-0.09486719,-0.103927314,2,
Hook2,-0.056214362,0.12878874,2,
Hook3,-0.012540465,-0.15631542,2,
Hopx,0.2505458,0.07645892,3,
Hormad1,-0.042276468,0.22548412,3,
Hormad2,-0.011229128,0.043631133,2,
Hoxa1,-0.09510499,0.08426757,2,
Hoxa10,0.12788163,0.09871877,3,
Hoxa11,0.059232045,0.12034489,3,
Hoxa2,0.044424865,-0.14761807,2,
Hoxa4,-0.16152292,-0.07324027,2,
Hoxa5,-0.18693817,0.011402011,2,
Hoxa6,-0.117437236,0.043826338,2,
Hoxa7,0.015583037,0.09157922,3,
Hoxa9,0.17141087,0.2466589,3,
Hoxb1,-0.12025441,0.2752385,3,
Hoxb13,-0.06490481,0.14299229,2,
Hoxb4,-0.10996967,-0.014461767,2,
Hoxb5,-0.17083402,-0.013786318,2,
Hoxb6,-0.25356385,0.17324126,2,
Hoxb7,-0.17063914,0.13143098,2,
Hoxb8,-0.2699734,0.0759882,2,
Hoxb9,-0.15430616,0.044643585,2,
Hoxc10,-0.19571143,-0.05039811,2,
Hoxc12,-0.020300325,-0.08622677,2,
Hoxc13,-0.12360237,-0.06462763,2,
Hoxc4,-0.23862047,-0.05280287,2,
Hoxc5,-0.33497122,0.11888153,2,
Hoxc6,-0.30710852,0.19274254,2,
Hoxc8,-0.088792115,0.021725701,2,
Hoxc9,-0.115512714,0.09508482,2,
Hoxd1,-0.10493677,0.12063731,2,
Hoxd10,-0.0938615,-0.14834349,2,
Hoxd11,-0.2076705,-0.2211429,2,
Hoxd12,0.07003948,0.11823686,3,
Hoxd13,0.04179734,0.18069406,3,
Hoxd4,-0.3171829,0.01285169,2,
Hoxd9,-0.22996731,0.0879989,2,
Hp,0.18681897,-0.066232376,1,"['Scavenging of heme from plasma', 'Neutrophil degranulation']"
Hp1bp3,-0.149812,-0.036953118,2,
Hpca,-0.38846782,-0.22845273,2,
Hpcal1,0.003524812,0.06831416,2,
Hpcal4,-0.298177,-0.1538707,2,
Hpd,-0.11093193,-0.1374973,2,['Tyrosine catabolism']
Hpdl,-0.10021719,-0.089457884,2,
Hpf1,0.099567935,0.085627764,3,
Hpgds,0.14940415,0.015565633,1,"['Glutathione conjugation', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']"
Hpn,-0.05662121,-0.10471142,2,"['MET Receptor Activation', 'Signaling by MST1']"
Hprt,0.114187256,-0.00900283,1,"['Purine salvage', 'Azathioprine ADME']"
Hps1,-0.04658264,-0.17172842,2,
Hps3,-0.021463376,-0.06751434,2,
Hps4,-0.061846353,-0.05759181,2,['RAB GEFs exchange GTP for GDP on RABs']
Hps5,-0.14846021,-0.1900665,2,
Hps6,-0.06693182,-0.14491852,2,
Hpse,-0.09189117,-0.292922,1,"['HS-GAG degradation', 'Neutrophil degranulation']"
Hpse2,-0.15766211,-0.38941666,1,['HS-GAG degradation']
Hpx,0.1731694,-0.08458308,1,['Scavenging of heme from plasma']
Hras,0.68677723,-0.29824147,1,"['Activation of RAS in B cells', 'SHC1 events in ERBB4 signaling', 'Signaling by SCF-KIT', 'p38MAPK events', 'GRB2 events in EGFR signaling', 'SHC1 events in EGFR signaling', 'Downstream signal transduction', 'GRB2 events in ERBB2 signaling', 'Tie2 Signaling', 'EGFR Transactivation by Gastrin', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'NCAM signaling for neurite out-growth', 'EPHB-mediated forward signaling', 'VEGFR2 mediated cell proliferation', 'CD209 (DC-SIGN) signaling', 'SHC-mediated cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'Regulation of RAS by GAPs', 'RAF activation', 'RAF/MAP kinase cascade', 'MAP2K and MAPK activation', 'Negative regulation of MAPK pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'MET activates RAS signaling', 'FLT3 Signaling', 'Estrogen-stimulated signaling through PRKCZ', 'RAS processing']"
Hrc,-0.04089969,-0.05490947,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Hrg,0.13713641,-0.15483546,1,
Hrh1,-0.02817439,-0.17455077,1,"['Histamine receptors', 'G alpha (q) signalling events']"
Hrh2,-0.050067082,-0.3258697,2,"['Histamine receptors', 'G alpha (s) signalling events']"
Hrh3,-0.18838531,-0.0992881,2,['Histamine receptors']
Hrh4,-0.20417939,0.03474995,2,"['Histamine receptors', 'G alpha (i) signalling events']"
Hrk,0.20821811,0.057333615,3,
Hrnr,-0.060333896,0.029322898,2,
Hs1bp3,-0.11376407,-0.122458786,2,
Hs2st1,-0.11355267,-0.114639066,2,['HS-GAG biosynthesis']
Hs3st1,-0.34255794,-0.15714,2,['HS-GAG biosynthesis']
Hs3st2,-0.03583671,-0.17133132,1,['HS-GAG biosynthesis']
Hs3st3a1,-0.020793455,-0.17569962,1,['HS-GAG biosynthesis']
Hs3st3b1,-0.04988082,-0.32800642,1,['HS-GAG biosynthesis']
Hs3st4,-0.13730629,-0.23248346,2,['HS-GAG biosynthesis']
Hs3st5,0.056100413,-0.21967448,1,['HS-GAG biosynthesis']
Hs3st6,0.02708114,-0.11394187,1,['HS-GAG biosynthesis']
Hs6st1,-0.22199832,-0.19580005,2,['HS-GAG biosynthesis']
Hs6st2,-0.100051284,-0.17521249,2,['HS-GAG biosynthesis']
Hs6st3,-0.15672474,-0.18583448,2,['HS-GAG biosynthesis']
Hsbp1,0.12957057,0.12122825,0,"['Attenuation phase', 'HSF1-dependent transactivation']"
Hsbp1l1,-0.13871637,-0.2986721,2,
Hscb,-0.039393835,0.12479629,0,
Hsd11b1,-0.1559679,-0.14586112,2,['Glucocorticoid biosynthesis']
Hsd11b2,-0.0046518203,-0.07413421,2,['Glucocorticoid biosynthesis']
Hsd17b1,-0.1504692,0.074611515,2,['Estrogen biosynthesis']
Hsd17b10,-0.052195422,0.057597023,2,
Hsd17b11,-0.11837033,0.008709889,2,['Estrogen biosynthesis']
Hsd17b12,-0.15530236,-0.10831711,2,"['Androgen biosynthesis', 'Synthesis of very long-chain fatty acyl-CoAs']"
Hsd17b2,-0.2236365,0.033464603,2,['Estrogen biosynthesis']
Hsd17b3,-0.060229238,-0.059369747,2,"['Androgen biosynthesis', 'Synthesis of very long-chain fatty acyl-CoAs']"
Hsd17b4,-0.23922035,0.06282036,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'alpha-linolenic acid (ALA) metabolism', 'Beta-oxidation of pristanoyl-CoA', 'Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Hsd17b6,-0.25315404,-0.08775897,2,['The canonical retinoid cycle in rods (twilight vision)']
Hsd17b7,-0.41209143,-0.162491,2,['Cholesterol biosynthesis']
Hsd3b1,-0.17644727,-0.14086504,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsd3b2,-0.31572798,-0.07985989,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsd3b3,-0.3350981,-0.07522055,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsd3b4,-0.18905926,0.05449683,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsd3b5,-0.28087837,-0.20846513,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsd3b6,-0.227403,-0.09787521,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsd3b7,-0.15625592,0.027681604,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol']"
Hsd3b8,-0.30337992,-0.075603046,2,"['Androgen biosynthesis', 'Mineralocorticoid biosynthesis', 'Glucocorticoid biosynthesis']"
Hsdl2,-0.19962573,-0.079377614,2,
Hsf1,0.38531226,0.19878721,3,"['Regulation of HSF1-mediated heat shock response', 'HSF1 activation', 'Attenuation phase', 'HSF1-dependent transactivation']"
Hsf2,0.08291245,0.0441401,3,
Hsf2bp,-0.2512436,0.16104773,2,
Hsf3,-0.045602225,0.18000598,3,
Hsf4,-0.18144505,0.044118904,2,
Hsf5,-0.22532159,0.13597697,2,
Hsp90aa1,0.38784072,0.11446022,3,"['Signaling by ERBB2', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'Regulation of actin dynamics for phagocytic cup formation', 'eNOS activation', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'HSF1 activation', 'Attenuation phase', 'HSF1-dependent transactivation', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Sema3A PAK dependent Axon repulsion', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated vascular permeability', 'Anchoring of the basal body to the plasma membrane', 'Regulation of necroptotic cell death', 'Neutrophil degranulation', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'Downregulation of ERBB2 signaling', 'ESR-mediated signaling', 'Extra-nuclear estrogen signaling', 'RHOBTB2 GTPase cycle', 'Estrogen-dependent gene expression', 'Drug-mediated inhibition of ERBB2 signaling']"
Hsp90ab1,0.53875154,0.060591925,3,"['DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'Regulation of actin dynamics for phagocytic cup formation', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'HSF1 activation', 'Attenuation phase', 'HSF1-dependent transactivation', 'Sema3A PAK dependent Axon repulsion', 'Neutrophil degranulation', 'The NLRP3 inflammasome', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Aryl hydrocarbon receptor signalling', 'ESR-mediated signaling', 'RHOBTB2 GTPase cycle', 'Estrogen-dependent gene expression']"
Hsp90b1,0.4304817,-0.075858265,1,"['Trafficking and processing of endosomal TLR', 'Scavenging by Class A Receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Interleukin-4 and Interleukin-13 signaling', 'Post-translational protein phosphorylation']"
Hspa12a,0.023878466,0.36457855,0,['Regulation of HSF1-mediated heat shock response']
Hspa12b,0.10135156,0.2797075,0,['Regulation of HSF1-mediated heat shock response']
Hspa13,0.09470113,0.27046302,3,['Regulation of HSF1-mediated heat shock response']
Hspa14,0.06900926,0.43236327,0,['Regulation of HSF1-mediated heat shock response']
Hspa1a,0.19572358,0.1754092,3,"['Regulation of HSF1-mediated heat shock response', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase', 'HSF1-dependent transactivation', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Neutrophil degranulation']"
Hspa1b,0.50108314,0.15679973,3,"['Regulation of HSF1-mediated heat shock response', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase', 'HSF1-dependent transactivation', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Neutrophil degranulation']"
Hspa1l,0.25481156,0.2510771,3,"['Regulation of HSF1-mediated heat shock response', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase', 'HSF1-dependent transactivation']"
Hspa2,0.25704798,0.26296926,3,"['Regulation of HSF1-mediated heat shock response', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase']"
Hspa4,0.35527018,0.25986645,3,
Hspa5,0.3198071,0.14083402,3,"['Regulation of HSF1-mediated heat shock response', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Hspa8,0.3292688,0.14274772,3,"['Regulation of HSF1-mediated heat shock response', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Attenuation phase', 'HSF1-dependent transactivation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Neutrophil degranulation', 'mRNA Splicing - Major Pathway', 'Clathrin-mediated endocytosis', 'Protein methylation', 'GABA synthesis, release, reuptake and degradation']"
Hspa9,0.21906076,0.09873057,0,['Regulation of HSF1-mediated heat shock response']
Hspb1,0.40204823,0.12522008,3,"['VEGFA-VEGFR2 Pathway', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'MAPK6/MAPK4 signaling', 'Extra-nuclear estrogen signaling']"
Hspb11,0.122271016,0.34547037,3,['Intraflagellar transport']
Hspb2,0.40862536,-0.09156756,1,
Hspb3,0.12623377,-0.11415552,1,
Hspb6,0.18510714,-0.041601807,3,
Hspb7,0.10109379,-0.08730369,1,
Hspb8,0.17996827,0.09435111,3,['HSF1-dependent transactivation']
Hspb9,-0.07340528,-0.08775001,2,
Hspbap1,-0.32458895,0.11484979,2,
Hspbp1,-0.07313975,0.15278827,0,
Hspd1,0.17377047,0.11764137,0,['Mitochondrial protein import']
Hspe1,0.10081154,0.12610152,0,['RHOG GTPase cycle']
Hspg2,0.11245122,-0.28783518,1,
Hsph1,0.16739616,0.106476575,3,['Regulation of HSF1-mediated heat shock response']
Htatip2,0.005503933,-0.074624576,2,
Htatsf1,-0.09956829,0.5589835,0,
Htr1a,0.112099975,-0.4449015,1,['Serotonin receptors']
Htr1b,0.24939777,-0.3095414,1,"['Serotonin receptors', 'G alpha (i) signalling events']"
Htr1d,0.025768962,-0.316849,1,"['Serotonin receptors', 'G alpha (i) signalling events']"
Htr1f,0.05715977,-0.29715475,1,"['Serotonin receptors', 'G alpha (i) signalling events']"
Htr2a,0.078248344,-0.35175824,1,"['Serotonin receptors', 'G alpha (q) signalling events']"
Htr2b,-0.043666434,-0.32476518,1,"['Serotonin receptors', 'G alpha (q) signalling events']"
Htr2c,0.09691795,-0.42498043,1,"['Serotonin receptors', 'G alpha (q) signalling events']"
Htr3a,0.053664267,-0.25774863,1,
Htr3b,0.044965953,-0.1813327,1,['Neurotransmitter receptors and postsynaptic signal transmission']
Htr4,-0.050630286,-0.24147813,2,"['Serotonin receptors', 'G alpha (s) signalling events']"
Htr5a,-0.04907447,-0.3581281,1,"['Serotonin receptors', 'G alpha (i) signalling events']"
Htr5b,0.060497794,-0.20995003,1,
Htr6,-0.014992791,-0.18341805,2,"['Serotonin receptors', 'G alpha (s) signalling events']"
Htr7,0.09689498,-0.35924536,1,"['Serotonin receptors', 'G alpha (s) signalling events', 'RHOBTB3 ATPase cycle']"
Htra1,0.007760184,-0.089275695,2,['Degradation of the extracellular matrix']
Htra2,0.43211502,0.009270683,3,
Htra3,-0.169262,-0.2685618,2,
Htt,0.48905504,-0.006213113,3,
Hunk,-0.2776209,-0.21937029,2,
Hus1,0.31048393,0.2796624,3,"['Activation of ATR in response to replication stress', 'HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Hus1b,0.07266316,0.29463345,3,
Huwe1,0.1937098,0.20301643,3,"['Neutrophil degranulation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Hyal1,-0.16826177,0.021740355,2,"['CS/DS degradation', 'Hyaluronan uptake and degradation']"
Hyal2,0.08110615,-0.10783367,1,['Hyaluronan uptake and degradation']
Hyal3,-0.23004924,-0.03642938,2,"['CS/DS degradation', 'Hyaluronan uptake and degradation']"
Hyal4,-0.18462457,-0.11640879,2,
Hyal5,-0.25894794,-0.10897854,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Hyal6,0.040559232,-0.20193832,1,
Hydin,-0.13742754,0.27481237,0,
Hykk,-0.21314268,0.12023127,2,['Lysine catabolism']
Hyou1,-0.020479476,0.046072815,2,
Hypk,0.04415925,0.18448102,0,
I830077J02Rik,-0.17879766,0.06189259,2,
Iapp,0.31711826,-0.064203314,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Iars,-0.08795711,0.24842268,0,
Iars2,-0.13587818,0.029859591,0,
Iba57,-0.16579396,-0.097984254,2,
Ibsp,0.24288933,-0.419736,1,['Integrin cell surface interactions']
Ibtk,0.21998487,-0.17194799,1,
Ica1,0.039970145,-0.10835094,2,
Ica1l,-0.15370765,-0.060164478,2,
Icam1,0.4563301,-0.29426697,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions']"
Icam2,0.3409982,-0.16044565,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions', 'CD209 (DC-SIGN) signaling']"
Icam4,0.07836169,-0.23540285,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions']"
Icam5,0.29075128,-0.2345303,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions']"
Ice1,0.17751293,0.072232,3,['RNA polymerase II transcribes snRNA genes']
Ice2,-0.14970115,0.07390232,2,['RNA polymerase II transcribes snRNA genes']
Icmt,0.24404915,0.16744666,0,
Icos,0.15544276,-0.1803859,1,"['PIP3 activates AKT signaling', 'Costimulation by the CD28 family', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Icosl,0.2126235,-0.290707,1,['Costimulation by the CD28 family']
Id1,0.29351577,-0.05414558,1,['Oncogene Induced Senescence']
Id2,0.2897933,-0.0009110453,3,
Id3,0.07335387,-0.010210531,3,
Id4,-0.06616858,-0.060847465,2,
Ide,0.4452809,0.04932884,3,
Idh1,0.010461254,-0.041053392,2,"['NADPH regeneration', 'Neutrophil degranulation', 'Peroxisomal protein import']"
Idh2,0.04292028,-0.04570909,2,"['Transcriptional activation of mitochondrial biogenesis', 'Citric acid cycle (TCA cycle)']"
Idh3a,-0.110633545,-0.09872208,2,['Citric acid cycle (TCA cycle)']
Idh3b,-0.16352788,-0.03646134,2,['Citric acid cycle (TCA cycle)']
Idh3g,-0.13544826,-0.0043569067,2,['Citric acid cycle (TCA cycle)']
Idi1,-0.38957444,-0.033014722,2,['Cholesterol biosynthesis']
Idi2,-0.13231818,-0.08025633,2,['Cholesterol biosynthesis']
Idnk,-0.24477577,0.05260936,2,
Ido1,-0.044371944,-0.23119839,1,['Tryptophan catabolism']
Ido2,-0.04460192,-0.18051638,1,['Tryptophan catabolism']
Ids,-0.3366637,-0.18736504,2,"['HS-GAG degradation', 'CS/DS degradation']"
Idua,-0.25406238,-0.16617166,2,
Ier2,0.27672604,-0.113522135,1,
Ier3,0.1335292,0.11972706,3,
Ier3ip1,-0.035137013,0.005555749,2,
Ier5,-0.119185455,0.20332217,2,
Ifi203,-0.0935306,-0.06961765,2,
Ifi204,0.28182882,0.04182098,3,['Neutrophil degranulation']
Ifi206,0.06564844,0.022840174,2,
Ifi207,-0.00020514068,-0.029611202,2,
Ifi208,0.015401852,-0.07842666,1,
Ifi209,-0.08148507,-0.04501425,2,
Ifi211,0.111990854,0.06994816,3,['Neutrophil degranulation']
Ifi214,-0.21781385,-0.24785008,2,
Ifi27,-0.094427034,0.12035901,2,
Ifi27l2a,0.008143966,0.00523899,2,
Ifi27l2b,-0.03620501,0.07284298,0,
Ifi35,0.1158018,0.15455867,3,
Ifi44,0.16033821,0.01059039,1,
Ifi44l,0.17651498,0.14528759,3,
Ifi47,0.047189724,0.08470961,3,
Ifih1,0.24966125,0.21889915,3,['Ub-specific processing proteases']
Ifit1,0.14317559,0.054601956,3,
Ifit1bl1,-0.13409793,-0.0350384,2,
Ifit1bl2,-0.11013093,0.08825479,0,['ISG15 antiviral mechanism']
Ifit2,0.06435387,0.040812943,0,
Ifit3,0.2285249,0.07537071,3,
Ifit3b,-0.15636899,-0.012639767,2,
Ifitm1,0.20997044,-0.038585175,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Ifitm10,-0.08678186,-0.037573986,2,
Ifitm2,0.13505788,-0.24307445,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Ifitm3,0.17002867,-0.16005458,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Ifitm5,-0.033709824,-0.096194886,2,
Ifna,-0.13496447,-0.09068061,2,
Ifna1,0.18179472,-0.18506895,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna11,0.011708383,-0.15513492,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna12,0.04916012,-0.34760642,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna13,-0.24569535,-0.21616648,2,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna14,0.07213459,-0.0654309,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna15,0.15102236,-0.21186419,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna16,-0.0082371775,-0.23695345,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna2,0.13791402,-0.2168231,1,
Ifna4,0.20248024,-0.09798869,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifna5,0.18965295,-0.07243493,1,
Ifna6,0.02221033,-0.20181657,1,
Ifna7,0.06785051,-0.04436149,1,
Ifna9,0.18159643,-0.17639403,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifnab,0.14741832,-0.2631406,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifnar1,0.3305411,-0.14449881,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifnar2,0.14004315,-0.15580359,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifnb1,0.45000058,0.033921104,1,"['Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling']"
Ifne,-0.050812066,-0.2108972,1,
Ifng,0.5307364,-0.1170489,1,"['Interferon gamma signaling', 'Regulation of IFNG signaling']"
Ifngr1,0.29501286,-0.22704653,1,"['Interferon gamma signaling', 'Regulation of IFNG signaling']"
Ifngr2,0.35306892,-0.245327,1,"['Interferon gamma signaling', 'Regulation of IFNG signaling']"
Ifnk,0.095755525,-0.15349689,1,
Ifnl2,0.034783754,-0.06769187,1,['Interleukin-20 family signaling']
Ifnl3,-0.06854732,-0.24885656,1,['Interleukin-20 family signaling']
Ifnlr1,0.05035727,-0.22115928,1,['Interleukin-20 family signaling']
Ifrd1,-0.21393976,0.17914146,2,
Ifrd2,-0.44054866,0.07890359,0,
Ift122,-0.15059654,0.23983376,2,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Ift140,-0.07974672,0.105961725,2,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Ift172,-0.08214242,0.22317137,3,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Ift20,0.03522402,0.045195073,1,['Intraflagellar transport']
Ift22,-0.057525087,0.040818643,2,['Intraflagellar transport']
Ift27,-0.065146506,0.0667648,2,['Intraflagellar transport']
Ift43,-0.10639952,0.14694443,2,['Intraflagellar transport']
Ift46,-0.14949565,0.09202512,2,['Intraflagellar transport']
Ift52,-0.08148603,0.14561109,2,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Ift57,0.078596085,0.022837728,3,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Ift74,-0.1560265,0.17549746,2,['Intraflagellar transport']
Ift80,-0.22099987,0.16422784,2,['Intraflagellar transport']
Ift81,-0.05860895,0.007255885,2,['Intraflagellar transport']
Ift88,0.12365306,0.08649831,3,
Iftap,-0.19881897,-0.20409611,2,
Igbp1,0.028543677,0.050116293,3,
Igbp1b,0.1002827,-0.039230913,2,
Igdcc3,0.026018128,-0.21633273,1,
Igf1,0.5573373,-0.28037968,1,"['Platelet degranulation ', 'Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)', 'IRS-related events triggered by IGF1R', 'SHC-related events triggered by IGF1R', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Synthesis, secretion, and deacylation of Ghrelin']"
Igf1r,0.61668307,-0.3149894,1,
Igf2,0.44068858,-0.24270649,1,"['Platelet degranulation ', 'Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)', 'IRS-related events triggered by IGF1R', 'SHC-related events triggered by IGF1R', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)']"
Igf2bp1,-0.051833846,0.17038135,0,
Igf2bp2,-0.02664628,0.124296784,2,
Igf2bp3,-0.03160805,0.062259328,0,
Igf2r,0.17372379,-0.34151885,1,"['Golgi Associated Vesicle Biogenesis', 'Neutrophil degranulation', 'Retrograde transport at the Trans-Golgi-Network', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Igfals,-0.06661241,-0.15389553,2,
Igfbp1,0.37609825,-0.31336984,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Igfbp2,0.16189337,-0.14307085,1,['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)']
Igfbp3,0.3221548,0.01595478,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'TP53 Regulates Transcription of Death Receptors and Ligands', 'Post-translational protein phosphorylation']"
Igfbp4,0.18835075,-0.052416347,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Igfbp5,0.17438658,-0.15418886,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Igfbp6,0.12569053,-0.0733646,1,['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)']
Igfbp7,0.10735146,-0.1843041,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Igfl3,-0.22368705,0.19523178,2,
Igflr1,-0.4125795,-0.050014354,2,
Igfn1,0.012070866,0.00017852349,2,
Ighe,0.23854364,-0.16604215,1,
Ighg2c,0.2885494,-0.16804022,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'Regulation of Complement cascade']"
Ighm,-0.14171249,-0.17406291,2,
Ighmbp2,0.15269756,-0.027618555,1,
Igkv1-99,-0.10229809,0.026472587,2,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'Scavenging of heme from plasma', 'Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation', 'CD22 mediated BCR regulation', 'Regulation of Complement cascade', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Iglc2,0.28163818,-0.28378552,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'Scavenging of heme from plasma', 'Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation', 'CD22 mediated BCR regulation', 'Regulation of Complement cascade', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Igll1,0.0033157284,-0.09266207,1,"['Initial triggering of complement', 'Classical antibody-mediated complement activation', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'Scavenging of heme from plasma', 'Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation', 'CD22 mediated BCR regulation', 'Regulation of Complement cascade', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Iglon5,-0.17723905,-0.0065789064,2,
Igsf1,-0.014757624,-0.030015036,2,
Igsf11,-0.0501025,-0.13881196,2,
Igsf21,-0.07864191,0.10165234,2,
Igsf23,-0.095917046,-0.14772892,2,
Igsf5,0.13298208,-0.10631409,1,
Igsf6,-0.06226388,-0.14004497,2,
Igsf8,-0.058848236,-0.1834155,1,
Igsf9,0.016523305,0.08175085,3,
Igtp,0.21947345,0.022872299,3,
Ihh,0.29031217,-0.11884021,1,"['Hedgehog ligand biogenesis', 'Release of Hh-Np from the secreting cell', 'Ligand-receptor interactions', 'Activation of SMO']"
Iho1,0.025887247,0.1558791,3,
Iigp1,0.030719098,-0.06453592,2,
Ik,-0.22573192,0.43967187,0,
Ikbkb,0.5882625,-0.05566043,1,
Ikbke,0.33218536,0.12682894,3,"['SUMOylation of immune response proteins', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon']"
Ikbkg,0.6130333,0.074373126,3,"['Activation of NF-kappaB in B cells', 'NOD1/2 Signaling Pathway', 'RIP-mediated NFkB activation via ZBP1', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'SUMOylation of immune response proteins', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'CLEC7A (Dectin-1) signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Interleukin-1 signaling', 'TRAF6 mediated NF-kB activation', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'Regulation of NF-kappa B signaling']"
Ikzf1,0.37090594,0.15882593,3,
Ikzf2,-0.13842292,0.13944395,2,
Ikzf3,0.40195608,-0.0046233432,1,
Ikzf4,0.060468275,-0.018215455,2,
Il10,0.3974057,-0.17926016,1,
Il10ra,0.21477176,0.04392426,1,['Interleukin-10 signaling']
Il10rb,0.15138507,-0.12463984,1,
Il11,0.21404693,-0.05071302,1,['IL-6-type cytokine receptor ligand interactions']
Il11ra1,0.081168465,-0.04447115,1,['IL-6-type cytokine receptor ligand interactions']
Il11ra2,-0.06324567,-0.017743655,2,
Il12a,0.19483078,0.03459225,1,
Il12b,0.20149554,-0.16292055,1,
Il12rb1,0.38827696,-0.078639306,1,"['Interleukin-12 signaling', 'Interleukin-23 signaling']"
Il12rb2,0.34228772,-0.044477716,1,"['Interleukin-35 Signalling', 'Interleukin-12 signaling']"
Il13,0.23013648,-0.11680008,1,
Il13ra1,0.14854585,0.0062350584,1,['Interleukin-4 and Interleukin-13 signaling']
Il13ra2,0.13087192,-0.07775175,1,
Il15,0.19709672,-0.103213914,1,['Interleukin-15 signaling']
Il15ra,0.09344067,-0.065359965,1,['Interleukin-15 signaling']
Il16,0.1914227,-0.17174424,1,['Other interleukin signaling']
Il17a,0.3939185,-0.15381406,1,
Il17af,0.013925828,-0.045396764,2,
Il17b,-0.06665642,-0.112791896,2,
Il17c,0.04529529,-0.06928783,2,
Il17d,0.32176796,-0.18837188,1,
Il17f,0.21994404,-0.027111232,1,
Il17ra,0.3082364,-0.13133565,1,
Il17rb,0.13699031,-0.051964857,1,
Il17rc,0.20238335,-0.0010881999,3,
Il17rd,0.23085989,-0.1353887,1,['MAP2K and MAPK activation']
Il17re,0.07064541,-0.05501169,3,
Il18,0.38711762,-0.13085036,1,
Il18bp,-0.18717328,-0.06238649,2,
Il18r1,0.109950826,-0.1316913,1,
Il18rap,0.060254525,-0.17206037,1,
Il19,-0.016933927,-0.20348103,1,
Il1a,0.31777236,0.0023734125,1,"['Interleukin-1 processing', 'Pyroptosis', 'Interleukin-1 signaling']"
Il1b,0.4297804,-0.20059218,1,"['Interleukin-1 processing', 'Pyroptosis', 'CLEC7A/inflammasome pathway', 'Interleukin-1 signaling']"
Il1f10,0.10115036,0.069333896,3,"['Interleukin-38 signaling', 'Interleukin-36 pathway']"
Il1f5,-0.23598705,0.097019576,2,
Il1f6,-0.2541712,-0.084256634,2,
Il1f8,0.07106284,-0.03765989,1,
Il1f9,-0.10166894,-0.05673151,2,
Il1r1,0.3033657,0.063841015,1,['Interleukin-1 signaling']
Il1r2,0.07407266,-0.019538563,2,['Interleukin-1 signaling']
Il1rap,0.17502917,-0.05437186,1,"['PIP3 activates AKT signaling', 'Receptor-type tyrosine-protein phosphatases', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-36 pathway', 'Interleukin-33 signaling', 'Interleukin-1 signaling']"
Il1rapl1,0.101465486,-0.15577225,1,
Il1rapl2,-0.13793433,-0.11922474,2,['Receptor-type tyrosine-protein phosphatases']
Il1rl1,0.15473448,0.06829763,3,"['PIP3 activates AKT signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-33 signaling']"
Il1rl2,0.06858359,0.017499724,2,"['Interleukin-38 signaling', 'Interleukin-36 pathway']"
Il1rn,0.09164031,-0.13686517,1,['Interleukin-1 signaling']
Il2,0.52902377,-0.2154454,1,
Il20,-0.057974868,-0.078530245,0,
Il20ra,0.19332336,-0.12136706,1,['Interleukin-20 family signaling']
Il20rb,0.13644552,-0.06357132,1,['Interleukin-20 family signaling']
Il21,0.14369658,-0.1405004,1,['Interleukin-21 signaling']
Il21r,0.25472546,-0.1369373,1,['Interleukin-21 signaling']
Il22,0.22096466,-0.007132488,1,
Il22b,-0.114448495,-0.06919007,2,
Il22ra1,0.24690117,-0.054687805,1,['Interleukin-20 family signaling']
Il22ra2,-0.063779294,-0.112769194,2,
Il23a,0.22433646,0.039272618,1,['Interleukin-23 signaling']
Il23r,0.16995686,-0.028202988,1,['Interleukin-23 signaling']
Il24,0.13666631,-0.0064877067,1,
Il25,0.011131058,-0.10956819,2,
Il27,0.2192578,0.019550186,1,['Interleukin-27 signaling']
Il27ra,0.26627213,-0.08994692,1,"['Interleukin-35 Signalling', 'Interleukin-27 signaling']"
Il2ra,0.36300185,-0.24057533,1,"['RAF/MAP kinase cascade', 'Interleukin-2 signaling', 'Interleukin receptor SHC signaling']"
Il2rb,0.48810372,-0.25873184,1,"['RAF/MAP kinase cascade', 'Interleukin-15 signaling', 'Interleukin-2 signaling', 'Interleukin receptor SHC signaling']"
Il2rg,0.446355,-0.1203017,1,"['Interleukin-7 signaling', 'RAF/MAP kinase cascade', 'Interleukin-4 and Interleukin-13 signaling', 'Interleukin-15 signaling', 'Interleukin-9 signaling', 'Interleukin-2 signaling', 'Interleukin-21 signaling', 'Interleukin receptor SHC signaling']"
Il3,0.2719275,-0.097116284,1,
Il31,0.021795634,-0.26462305,1,['IL-6-type cytokine receptor ligand interactions']
Il31ra,0.0033083067,-0.21109797,1,['IL-6-type cytokine receptor ligand interactions']
Il33,0.23863043,-0.04915587,1,"['PIP3 activates AKT signaling', 'Ub-specific processing proteases', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-33 signaling']"
Il34,0.08213818,-0.21633123,1,['Other interleukin signaling']
Il36a,0.15936087,0.07168466,1,['Interleukin-36 pathway']
Il36b,0.19633396,0.12281851,3,['Interleukin-36 pathway']
Il36g,0.042169455,-0.059746817,1,
Il36rn,0.099604584,0.064725175,1,['Interleukin-36 pathway']
Il3ra,0.30062628,-0.26417944,1,
Il4,0.42664096,-0.09609996,1,['Interleukin-4 and Interleukin-13 signaling']
Il4i1,-0.16964814,-0.26090676,2,
Il4r,-0.032321174,0.09610118,2,
Il4ra,0.3174825,-0.1276268,1,['Interleukin-4 and Interleukin-13 signaling']
Il5,0.3124191,-0.1909868,1,
Il5ra,0.3095313,-0.26324698,1,"['Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RAF/MAP kinase cascade', 'Interleukin receptor SHC signaling']"
Il6,0.5658177,-0.17040744,1,"['Interleukin-6 signaling', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Il6r,0.21233648,-0.0002779894,1,
Il6ra,0.4472547,-0.13562036,1,"['Interleukin-6 signaling', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation']"
Il6st,0.41286126,-0.09423927,1,"['Interleukin-6 signaling', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation', 'IL-6-type cytokine receptor ligand interactions', 'Interleukin-35 Signalling', 'Interleukin-27 signaling']"
Il7,0.27419308,-0.17446797,1,
Il7r,0.2198669,-0.13510476,1,"['Interleukin-7 signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Il9,0.17068772,0.061584923,1,['Interleukin-9 signaling']
Il9r,0.19013971,0.053779088,1,['Interleukin-9 signaling']
Ildr1,-0.062941596,0.05037889,2,
Ildr2,-0.0127203325,0.041775275,2,
Ilf2,0.094843045,0.48923674,0,['Neutrophil degranulation']
Ilf3,0.20723693,0.23639357,0,
Ilk,0.5102711,-0.2614807,1,"['Localization of the PINCH-ILK-PARVIN complex to focal adhesions', 'Cell-extracellular matrix interactions']"
Ilkap,-0.04977785,-0.08030243,2,
Ilvbl,-0.31993124,-0.061385065,2,
Immp1l,-0.26744366,-0.0813415,2,
Immp2l,-0.3149419,0.05303435,0,
Immt,0.047882367,-0.05198976,1,
Imp3,-0.19395067,0.36900142,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Imp4,-0.26146564,0.46575078,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Impa1,-0.023985645,-0.26731694,1,
Impa2,-0.07480389,-0.27213654,2,"['Synthesis of IP2, IP, and Ins in the cytosol']"
Impact,-0.16097184,0.03378749,0,
Impdh1,-0.12847705,0.28925687,0,"['Neutrophil degranulation', 'Purine ribonucleoside monophosphate biosynthesis', 'Azathioprine ADME']"
Impdh2,-0.24026363,0.28153253,0,"['Neutrophil degranulation', 'Purine ribonucleoside monophosphate biosynthesis', 'Azathioprine ADME']"
Impg1,-0.13470392,0.10986336,2,
Ina,0.14494789,-0.042551942,1,
Inafm1,-0.3402285,-0.096347585,2,
Inava,-0.14862739,-0.035777092,2,
Inca1,0.062927894,0.18488272,3,
Incenp,0.20870502,0.49664447,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA replication proteins', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Inf2,0.08170657,-0.25446662,1,
Ing1,0.36806467,0.36519957,3,
Ing2,0.27832595,0.36600694,3,"['SUMOylation of transcription cofactors', 'PI5P Regulates TP53 Acetylation']"
Ing3,0.26112652,0.24202606,3,
Ing4,0.2791298,0.37156898,3,['HATs acetylate histones']
Ing5,0.40254748,0.1838044,3,"['HATs acetylate histones', 'Regulation of TP53 Activity through Acetylation']"
Inha,-0.1329426,0.008597257,2,['Glycoprotein hormones']
Inhaba,-0.31442437,-0.25401917,2,
Inhabb,0.19402562,0.069942355,3,
Inhb,-0.083888076,0.07463417,2,
Inhba,0.12991567,-0.14443143,1,"['Signaling by Activin', 'Glycoprotein hormones', 'Antagonism of Activin by Follistatin']"
Inhbabb,-0.09562598,-0.04657191,2,
Inhbb,-0.01952837,0.026976565,2,"['Signaling by Activin', 'Glycoprotein hormones', 'Antagonism of Activin by Follistatin']"
Inhbc,-0.04345244,-0.06681385,2,['Glycoprotein hormones']
Inhbe,-0.008507324,-0.12565888,2,['Glycoprotein hormones']
Inhca,0.01740494,-0.23578395,1,
Inip,-0.12444012,0.06872552,2,
Inka2,-0.33104628,0.003481602,2,
Inmt,-0.2848442,-0.13134307,2,
Ino80,0.16142918,0.2590442,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Ino80b,0.23700781,0.25518152,3,
Ino80c,0.19248985,0.37898397,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Ino80e,0.13779898,0.23129897,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Inpp1,-0.07897848,-0.38865337,1,"['Synthesis of IP2, IP, and Ins in the cytosol']"
Inpp4a,0.023128776,-0.2705034,1,
Inpp4b,0.050536048,-0.20238698,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of IP2, IP, and Ins in the cytosol']"
Inpp5a,0.070682846,-0.24555254,1,"['Synthesis of IP2, IP, and Ins in the cytosol']"
Inpp5b,0.0973125,-0.27210185,1,"['Synthesis of IP2, IP, and Ins in the cytosol', 'Synthesis of IP3 and IP4 in the cytosol']"
Inpp5d,0.22806105,-0.34520495,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of IP3 and IP4 in the cytosol', 'Downstream TCR signaling', 'PECAM1 interactions', 'Interleukin receptor SHC signaling']"
Inpp5e,0.2316706,-0.15989539,1,"['Synthesis of PIPs at the Golgi membrane', 'ARL13B-mediated ciliary trafficking of INPP5E']"
Inpp5f,0.15535644,-0.2604975,1,['Synthesis of PIPs at the early endosome membrane']
Inpp5j,0.0055349567,-0.15040049,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of IP2, IP, and Ins in the cytosol', 'Synthesis of IP3 and IP4 in the cytosol']"
Inpp5k,0.038443975,-0.26207697,1,['Synthesis of PIPs at the plasma membrane']
Inppl1,0.31039634,-0.284003,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of IP3 and IP4 in the cytosol', 'Interleukin receptor SHC signaling']"
Ins1,0.42257738,-0.36512944,1,
Ins2,0.5422985,-0.11775609,1,"['Insulin processing', 'Synthesis, secretion, and deacylation of Ghrelin', 'COPI-mediated anterograde transport', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'IRS activation', 'Signal attenuation', 'Insulin receptor signalling cascade', 'Signaling by Insulin receptor', 'Insulin receptor recycling']"
Insc,0.17679892,-0.26955584,1,
Insig1,0.10508331,0.018439427,3,
Insig2,-0.06046449,0.097616345,2,
Insl3,-0.09173597,-0.15632205,2,
Insl5,-0.13158275,-0.3130878,2,"['G alpha (i) signalling events', 'Relaxin receptors']"
Insl6,-0.06804486,-0.09890853,2,
Insm1,0.13004369,0.19794512,3,
Insr,0.49539512,-0.20540054,1,"['PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'IRS activation', 'Signal attenuation', 'Insulin receptor signalling cascade', 'Signaling by Insulin receptor', 'Insulin receptor recycling']"
Insrr,0.29007816,-0.35026297,1,
Inssr,0.077228755,-0.12935826,1,
Insyn2a,-0.23921427,-0.06450295,2,
Insyn2b,-0.4060798,0.11623898,2,
Ints1,-0.033459317,0.14805631,2,['RNA polymerase II transcribes snRNA genes']
Ints10,0.09476137,0.3278717,0,['RNA polymerase II transcribes snRNA genes']
Ints11,0.03877674,0.37456018,0,['RNA polymerase II transcribes snRNA genes']
Ints12,-0.07354721,0.3220359,0,['RNA polymerase II transcribes snRNA genes']
Ints13,-0.16153055,0.1377803,2,['RNA polymerase II transcribes snRNA genes']
Ints14,-0.06646,0.20490518,0,['RNA polymerase II transcribes snRNA genes']
Ints2,-0.014016473,0.119586855,2,['RNA polymerase II transcribes snRNA genes']
Ints3,0.003999865,0.26722738,3,['RNA polymerase II transcribes snRNA genes']
Ints4,-0.041298937,0.21313697,0,['RNA polymerase II transcribes snRNA genes']
Ints5,-0.0042730877,0.20024423,0,['RNA polymerase II transcribes snRNA genes']
Ints6,0.08958793,0.11608256,3,['RNA polymerase II transcribes snRNA genes']
Ints6l,0.0014402838,0.11098953,2,
Ints7,-0.13320759,0.18865398,2,
Ints8,-0.07115409,0.13629599,2,['RNA polymerase II transcribes snRNA genes']
Ints9,-0.10719276,0.38353583,0,['RNA polymerase II transcribes snRNA genes']
Intu,0.041988336,0.06334714,3,"[""Hedgehog 'off' state""]"
Invs,0.26169816,-0.027155923,3,
Ip6k1,-0.036935885,0.046637796,2,"['Synthesis of pyrophosphates in the cytosol', 'Synthesis of IPs in the nucleus']"
Ip6k2,0.033923686,0.046645954,3,['Synthesis of IPs in the nucleus']
Ip6k3,-0.39086056,0.013625077,2,['Synthesis of pyrophosphates in the cytosol']
Ipcef1,0.25355405,-0.22208978,1,
Ipmk,0.12104247,-0.21632698,1,['Synthesis of IPs in the nucleus']
Ipo11,-0.029903421,0.35988006,0,
Ipo13,-0.05777497,0.33990863,0,
Ipo4,-0.14997342,0.5878566,0,
Ipo5,-0.0866937,0.51312494,0,
Ipo7,0.031374298,0.3249687,0,
Ipo8,-0.035587166,0.5815213,0,['Transcriptional regulation by small RNAs']
Ipo9,0.020282792,0.30981487,3,
Ippk,-0.041629236,0.045272402,2,"['Synthesis of pyrophosphates in the cytosol', 'Synthesis of IPs in the nucleus']"
Iqca,-0.15137158,-0.05314343,2,
Iqcb1,0.018981239,-0.033696037,2,['Anchoring of the basal body to the plasma membrane']
Iqcc,-0.12431395,0.061273146,2,
Iqcd,-0.08708076,0.10370073,2,
Iqce,-0.038041912,0.033738185,2,
Iqcf1,-0.1399147,-0.02999523,2,
Iqcf6,-0.09013828,-0.009568101,2,
Iqcg,-0.03370854,0.098954774,2,
Iqcj,-0.1113087,-0.0475442,2,
Iqck,-0.058622558,-0.004607962,2,
Iqgap1,0.41102543,-0.21777554,1,"['Nephrin family interactions', 'RHO GTPases activate IQGAPs', 'MAP2K and MAPK activation', 'Neutrophil degranulation', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Iqgap2,0.104301944,-0.26837602,1,"['RHO GTPases activate IQGAPs', 'Neutrophil degranulation', 'RAC1 GTPase cycle', 'RHOG GTPase cycle']"
Iqgap3,0.20647547,0.02541946,3,"['RHO GTPases activate IQGAPs', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RHOQ GTPase cycle']"
Iqsec2,0.12026463,-0.120407246,1,
Iqsec3,-0.11551212,-0.14992921,2,
Iqub,-0.12229599,0.12707572,2,
Irag1,0.0292805,-0.0816024,1,['cGMP effects']
Irag2,-0.31053466,-0.0018654609,2,
Irak1,0.43942317,0.099331595,3,"['PIP3 activates AKT signaling', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-1 signaling', 'IRAK1 recruits IKK complex', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation']"
Irak1bp1,-0.17860511,-0.025074555,2,
Irak2,0.24537727,0.12923284,3,"['TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'Interleukin-1 signaling', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Irak3,0.103906006,-0.043603756,1,['Interleukin-1 signaling']
Irak4,0.18396866,0.09514511,3,"['PIP3 activates AKT signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-1 signaling']"
Ireb2,0.14142014,0.06946456,3,['Iron uptake and transport']
Irf1,0.38411146,0.10318288,3,
Irf2,0.2636122,0.012327067,1,
Irf2bp1,-0.096112765,0.15695032,2,
Irf2bp2,-0.088242225,-0.18933743,2,
Irf2bpl,-0.05337396,-0.043780617,2,
Irf3,0.39711106,0.008329786,1,"['ISG15 antiviral mechanism', 'IRF3 mediated activation of type 1 IFN', 'DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production', 'Regulation of innate immune responses to cytosolic DNA', 'IRF3-mediated induction of type I IFN', 'TICAM1-dependent activation of IRF3/IRF7', 'TRAF3-dependent IRF activation pathway', 'TRAF6 mediated IRF7 activation', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon']"
Irf4,0.50522983,0.13555287,3,
Irf5,0.2679908,0.07855411,3,
Irf6,0.06535565,-0.0770896,1,
Irf7,0.50876015,0.05453239,3,"['DEx/H-box helicases activate type I IFN and inflammatory cytokines production ', 'TICAM1-dependent activation of IRF3/IRF7', 'TRAF3-dependent IRF activation pathway', 'TRAF6 mediated IRF7 activation', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling']"
Irf8,0.2900166,-0.12629528,1,
Irf9,0.18542607,-0.019986471,1,['Interferon alpha/beta signaling']
Irgc1,-0.18971977,-0.14179732,2,
Irgm1,0.14836617,0.020613257,3,
Irgm2,0.122692876,0.044583794,3,
Irs1,0.7049842,-0.16525976,1,
Irs2,0.5524023,-0.1645848,1,"['PI3K Cascade', 'IRS-mediated signalling', 'SOS-mediated signalling', 'PIP3 activates AKT signaling', 'Interleukin-7 signaling', 'PI3K/AKT activation', 'IRS-related events triggered by IGF1R', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'IRS activation', 'Signal attenuation', 'RET signaling', 'Signaling by Erythropoietin', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Erythropoietin activates RAS']"
Irs3,0.40526566,-0.22135313,1,
Irs4,0.39590922,-0.14721464,1,['IRS-related events triggered by IGF1R']
Irx1,-0.33567297,0.0095450925,2,
Irx2,-0.22692636,-0.13656814,2,
Irx3,-0.27611306,-0.018161472,2,
Irx4,-0.13806488,-0.037062373,2,
Irx6,-0.117582455,0.06493805,2,
Isca1,-0.19339608,0.019196754,2,['Mitochondrial iron-sulfur cluster biogenesis']
Isca2,-0.13042054,0.018865198,2,['Mitochondrial iron-sulfur cluster biogenesis']
Iscu,-0.06018964,-0.03875205,2,['Mitochondrial iron-sulfur cluster biogenesis']
Isg15,0.3835063,0.18210727,3,"['ISG15 antiviral mechanism', 'Termination of translesion DNA synthesis']"
Isg20,0.095283985,0.055992205,3,
Isg20l2,-0.028128894,0.19654249,0,
Isl1,0.27175796,-0.057474717,3,
Isl2,-0.044470333,-0.11721352,2,
Islr2,-0.27409193,-0.04028199,2,
Ism1,-0.022707788,0.15581109,0,
Ism2,-0.065328605,-0.15435943,2,
Isoc1,-0.23994927,-0.13769372,2,
Isoc2a,-0.035054117,-0.062947735,2,
Isoc2b,-0.16285633,-0.33005163,2,
Ist1,0.08324148,0.06542089,3,"['Neutrophil degranulation', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Isx,-0.20250003,0.041753974,2,
Isy1,-0.21668658,0.42061186,0,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'mRNA Splicing - Major Pathway']"
Isyna1,-0.1316105,-0.24475092,2,"['Synthesis of IP2, IP, and Ins in the cytosol']"
Itch,0.41766763,0.052967727,3,"['Downregulation of ERBB4 signaling', 'NOD1/2 Signaling Pathway', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Degradation of GLI1 by the proteasome', ""Hedgehog 'on' state"", 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Itfg1,-0.22080529,-0.13991292,2,
Itfg2,0.012813648,0.052127004,2,['Amino acids regulate mTORC1']
Itga1,0.32230124,-0.45820642,1,"['Integrin cell surface interactions', 'Smooth Muscle Contraction']"
Itga10,0.0104756085,-0.28243476,1,['Integrin cell surface interactions']
Itga11,0.22344325,-0.2569838,1,
Itga2,0.3217466,-0.3745894,1,"['Integrin cell surface interactions', 'Syndecan interactions', 'ECM proteoglycans', 'MET activates PTK2 signaling']"
Itga2b,0.32968655,-0.32985952,1,"['Platelet degranulation ', 'Integrin cell surface interactions', 'ECM proteoglycans', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'Signal transduction by L1', 'MAP2K and MAPK activation']"
Itga3,0.27371955,-0.36995065,1,"['Integrin cell surface interactions', 'MET activates PTK2 signaling']"
Itga4,0.38377798,-0.30359596,1,
Itga5,0.4024701,-0.42714489,1,"['Elastic fibre formation', 'Fibronectin matrix formation', 'Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'Signal transduction by L1', 'GPER1 signaling']"
Itga6,0.32713804,-0.3051018,1,"['Laminin interactions', 'Syndecan interactions', 'Type I hemidesmosome assembly']"
Itga7,0.20735921,-0.38593072,1,
Itga8,0.16188319,-0.23563221,1,"['Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs', 'ECM proteoglycans']"
Itga9,0.101716556,-0.48688576,1,"['Integrin cell surface interactions', 'ECM proteoglycans', 'Signal transduction by L1']"
Itgad,0.25809008,-0.28093886,1,['Integrin cell surface interactions']
Itgae,0.26641035,-0.10599876,1,['Integrin cell surface interactions']
Itgal,0.36438757,-0.21344656,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'Neutrophil degranulation']"
Itgam,0.47657555,-0.29760185,1,
Itgav,0.44827572,-0.3599321,1,"['Cross-presentation of particulate exogenous antigens (phagosomes)', 'Elastic fibre formation', 'PECAM1 interactions', 'Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs', 'Syndecan interactions', 'ECM proteoglycans', 'VEGFA-VEGFR2 Pathway', 'Signal transduction by L1', 'Neutrophil degranulation']"
Itgax,0.35415947,-0.16614538,1,"['Cell surface interactions at the vascular wall', 'Integrin cell surface interactions', 'ECM proteoglycans', 'Neutrophil degranulation']"
Itgb1,0.43670577,-0.38500577,1,"['Elastic fibre formation', 'Fibronectin matrix formation', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs', 'Laminin interactions', 'Syndecan interactions', 'ECM proteoglycans', 'Signal transduction by L1', 'Localization of the PINCH-ILK-PARVIN complex to focal adhesions', 'MET activates PTK2 signaling', 'MET interacts with TNS proteins', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'GPER1 signaling']"
Itgb1bp1,0.23965444,-0.0870092,1,
Itgb1bp2,0.2129364,-0.07236792,1,
Itgb2,0.44306466,-0.329317,1,
Itgb2l,0.28775993,-0.30426225,1,
Itgb3,0.56782514,-0.3661805,1,"['Platelet degranulation ', 'Elastic fibre formation', 'PECAM1 interactions', 'Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs', 'Syndecan interactions', 'ECM proteoglycans', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'VEGFA-VEGFR2 Pathway', 'Signal transduction by L1', 'MAP2K and MAPK activation']"
Itgb3bp,0.1931318,0.1808311,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'NRIF signals cell death from the nucleus', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Itgb4,0.42560637,-0.32978776,1,"['Syndecan interactions', 'Type I hemidesmosome assembly']"
Itgb5,0.38562608,-0.33835185,1,
Itgb6,0.33748385,-0.24279156,1,"['Elastic fibre formation', 'Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs', 'ECM proteoglycans']"
Itgb7,0.3551504,-0.3591108,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions']"
Itgb8,0.238413,-0.3871656,1,"['Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'TGF-beta receptor signaling activates SMADs']"
Itgbl1,0.046206273,-0.1197065,1,
Itih1,-0.0862815,-0.24398033,2,
Itih2,-0.025273602,0.013127753,2,
Itih3,-0.13242777,-0.03882809,2,['Platelet degranulation ']
Itih4,0.038832325,0.04670343,2,['Platelet degranulation ']
Itk,0.2654178,-0.36674422,1,"['Generation of second messenger molecules', 'FCERI mediated Ca+2 mobilization']"
Itln1,0.040902965,-0.070500836,1,['Antimicrobial peptides']
Itm2b,-0.0053481506,-0.16054483,2,
Itpa,-0.103533246,-0.00042525493,2,['Purine catabolism']
Itpk1,-0.072353914,-0.15148287,2,"['Synthesis of pyrophosphates in the cytosol', 'Synthesis of IP3 and IP4 in the cytosol', 'Factors involved in megakaryocyte development and platelet production']"
Itpka,0.072828464,-0.2633839,1,['Synthesis of IP3 and IP4 in the cytosol']
Itpkb,0.07626895,-0.2986502,1,['Synthesis of IP3 and IP4 in the cytosol']
Itpkc,0.037497777,-0.26035997,1,['Synthesis of IP3 and IP4 in the cytosol']
Itpr1,0.34014952,-0.24265343,1,"['Effects of PIP2 hydrolysis', 'Elevation of cytosolic Ca2+ levels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'cGMP effects', 'Ion homeostasis', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Itpr2,0.2075869,-0.35654417,1,"['Effects of PIP2 hydrolysis', 'Elevation of cytosolic Ca2+ levels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Ion homeostasis', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Itpr3,0.29803312,-0.2621337,1,"['Effects of PIP2 hydrolysis', 'Elevation of cytosolic Ca2+ levels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Ion homeostasis', 'Sensory perception of sweet, bitter, and umami (glutamate) taste', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Itprid1,-0.092981555,0.029283542,2,
Itpripl1,-0.12912351,0.12018984,2,
Itsn1,0.20508735,-0.32885942,1,"['NRAGE signals death through JNK', 'EPHB-mediated forward signaling', 'G alpha (12/13) signalling events', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'CDC42 GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle']"
Itsn2,0.24288984,-0.2694159,1,
Ivd,-0.25327045,-0.07203002,2,['Branched-chain amino acid catabolism']
Ivl,-0.03502946,0.10956387,2,
Ivns1abp,-0.028006973,0.10488659,0,
Iws1,0.007684497,0.29993147,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Iyd,-0.24512812,-0.20817776,2,['Thyroxine biosynthesis']
Izumo1,-0.1555317,-0.07020401,2,['Acrosome Reaction and Sperm:Oocyte Membrane Binding']
Izumo1r,-0.16498485,-0.12450707,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Izumo2,-0.26439875,-0.09378231,2,['Acrosome Reaction and Sperm:Oocyte Membrane Binding']
Izumo3,-0.21255606,-0.0025950335,2,['Acrosome Reaction and Sperm:Oocyte Membrane Binding']
Izumo4,-0.065964766,-0.055820275,2,['Acrosome Reaction and Sperm:Oocyte Membrane Binding']
Jade1,0.12890393,0.1000952,3,['HATs acetylate histones']
Jade2,0.070666015,0.11887933,3,['HATs acetylate histones']
Jade3,-0.08878794,0.14688502,2,['HATs acetylate histones']
Jag1,0.25672835,0.03623977,3,"['RAC1 GTPase cycle', 'RAC3 GTPase cycle', 'NOTCH3 Activation and Transmission of Signal to the Nucleus']"
Jag2,0.28049055,-0.044648793,1,"['Activated NOTCH1 Transmits Signal to the Nucleus', 'NOTCH3 Activation and Transmission of Signal to the Nucleus']"
Jak1,0.56212544,-0.23887058,1,
Jak2,0.52472836,-0.2269673,1,"['Interleukin-6 signaling', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation', 'Prolactin receptor signaling', 'Signaling by SCF-KIT', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RAF activation', 'RAF/MAP kinase cascade', 'Interleukin-4 and Interleukin-13 signaling', 'IL-6-type cytokine receptor ligand interactions', 'Cyclin D associated events in G1', 'Interferon gamma signaling', 'Regulation of IFNG signaling', 'Interleukin-20 family signaling', 'Interleukin-35 Signalling', 'Signaling by Erythropoietin', 'Interleukin-12 signaling', 'Interleukin-23 signaling', 'Interleukin-27 signaling', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Erythropoietin activates RAS', 'Interleukin receptor SHC signaling', 'Signaling by CSF3 (G-CSF)', 'Inactivation of CSF3 (G-CSF) signaling', 'Growth hormone receptor signaling', 'Factors involved in megakaryocyte development and platelet production']"
Jak3,0.4900415,-0.037212912,1,
Jakmip1,0.03209856,-0.15155283,1,
Jakmip2,-0.2018447,0.17552502,0,
Jam1,-0.028758764,-0.21846534,1,
Jam2,0.21647839,-0.28272223,1,"['Cell surface interactions at the vascular wall', 'Integrin cell surface interactions']"
Jam3,0.21932055,-0.16356422,1,"['Cell surface interactions at the vascular wall', 'Integrin cell surface interactions']"
Jaml,0.04123877,-0.12732735,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall']"
Jarid2,0.14430472,0.19607964,3,['PRC2 methylates histones and DNA']
Jazf1,0.08986094,0.036594577,3,
Jcad,-0.22277187,-0.18207632,2,
Jchain,-0.020755382,-0.32696682,1,"['Cell surface interactions at the vascular wall', 'Scavenging of heme from plasma']"
Jdp2,0.2296867,-0.020826634,1,
Jmjd1c,0.19904476,-0.026123691,3,['Factors involved in megakaryocyte development and platelet production']
Jmjd4,-0.21011753,0.11952977,2,
Jmjd6,-0.090382,0.24984042,2,['HDMs demethylate histones']
Jmjd7,-0.2965011,0.18519457,2,
Jmjd8,-0.22837827,0.05102923,2,
Jmy,0.21357135,0.2858061,3,
Josd1,0.059840348,0.1372437,3,['Josephin domain DUBs']
Josd2,0.10989989,0.03680636,3,['Josephin domain DUBs']
Jph1,0.024759011,0.02399984,2,
Jph2,0.080475666,-0.3110566,1,
Jph3,0.045293603,0.03478228,3,
Jrk,-0.0082874885,-0.0368257,2,
Jsrp1,-0.22370264,-0.2060655,2,
Jun,0.6416518,-0.031112164,3,"['Oxidative Stress Induced Senescence', 'FCERI mediated MAPK activation', 'Activation of the AP-1 family of transcription factors']"
Junb,0.43859997,-0.1423003,1,
Jund,0.3452337,0.029473104,3,
Jup,0.25683266,0.009531928,1,"['Adherens junctions interactions', 'VEGFR2 mediated vascular permeability', 'Neutrophil degranulation', 'Keratinization', 'Formation of the cornified envelope', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle']"
Kalrn,0.41614276,-0.36466223,1,"['NRAGE signals death through JNK', 'EPHB-mediated forward signaling', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'MAPK6/MAPK4 signaling', 'RHOA GTPase cycle', 'RAC1 GTPase cycle', 'RHOG GTPase cycle']"
Kank1,-0.051627044,0.05760556,2,
Kank2,-0.0515176,-0.14355119,2,
Kank3,-0.3626418,-0.1697516,2,
Kank4,-0.18115777,-0.14941914,2,
Kansl1,0.09349564,0.21740207,3,['HATs acetylate histones']
Kansl1l,0.07620879,0.10176754,3,
Kansl2,0.086061575,0.24445775,3,['HATs acetylate histones']
Kansl3,0.14905085,0.069065064,3,['HATs acetylate histones']
Kars,-0.0072340155,0.13910595,0,
Kash5,-0.26668346,0.055520132,2,
Kat14,0.18249784,0.15982667,3,
Kat2a,0.40267012,0.44634786,3,"['NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'B-WICH complex positively regulates rRNA expression', 'Ub-specific processing proteases', 'RUNX3 regulates NOTCH signaling']"
Kat2b,0.44956753,0.45914787,3,"['YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'B-WICH complex positively regulates rRNA expression', 'Metalloprotease DUBs', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX3 regulates NOTCH signaling', 'Estrogen-dependent gene expression', 'Regulation of FOXO transcriptional activity by acetylation']"
Kat5,0.4683156,0.22976154,3,"['DNA Damage/Telomere Stress Induced Senescence', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Sensing of DNA Double Strand Breaks', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Nonhomologous End-Joining (NHEJ)', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint', 'Estrogen-dependent gene expression']"
Kat6a,0.37663788,0.33628747,3,
Kat6b,0.29630327,0.34679353,3,['HATs acetylate histones']
Kat7,0.28120345,0.4014741,3,['HATs acetylate histones']
Kat8,0.38357356,0.29605785,3,['HATs acetylate histones']
Katna1,0.10957315,0.09968576,3,
Katnal1,-0.07569025,-0.0060221353,2,
Katnal2,-0.09015899,0.05509551,2,
Katnb1,-0.019371334,0.04533792,3,
Katnbl1,-0.15671365,-0.12097001,2,
Katnip,-0.11321246,0.07109679,2,
Kazn,-0.055613626,-0.17461027,2,['Formation of the cornified envelope']
Kbtbd12,-0.07557617,0.03724389,2,
Kbtbd13,0.078517735,-0.04743496,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Kbtbd2,-0.2655104,-0.111744985,2,
Kbtbd3,0.040399227,-0.039343864,2,
Kbtbd4,-0.20642525,-0.022154275,2,
Kbtbd7,0.06083625,0.08650687,3,"['Regulation of RAS by GAPs', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Kbtbd8,0.062960826,0.24737743,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Kcmf1,-0.16520277,-0.089011386,2,['Neutrophil degranulation']
Kcna1,-0.08934886,-0.23197389,2,['Voltage gated Potassium channels']
Kcna10,-0.18051085,-0.42395404,2,['Voltage gated Potassium channels']
Kcna2,-0.013572867,-0.15469813,1,['Voltage gated Potassium channels']
Kcna3,0.057333995,-0.34032068,1,['Voltage gated Potassium channels']
Kcna4,0.017357742,-0.113983504,2,['Voltage gated Potassium channels']
Kcna5,0.11400044,-0.24933937,1,"['Voltage gated Potassium channels', 'Phase 3 - rapid repolarisation']"
Kcna6,-0.053123157,-0.11626874,2,['Voltage gated Potassium channels']
Kcna7,-0.10824831,-0.16933401,2,['Voltage gated Potassium channels']
Kcnab1,-0.11626725,-0.2987357,2,['Voltage gated Potassium channels']
Kcnab2,-0.019823441,-0.32516253,1,"['Voltage gated Potassium channels', 'Neutrophil degranulation']"
Kcnab3,-0.24029233,-0.056552906,2,
Kcnb1,-0.09938959,-0.30030444,2,"['Voltage gated Potassium channels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion']"
Kcnb2,-0.20032084,-0.255895,2,['Voltage gated Potassium channels']
Kcnc1,-0.02464796,-0.24117641,1,['Voltage gated Potassium channels']
Kcnc2,0.0009775507,-0.1911204,2,"['Voltage gated Potassium channels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion']"
Kcnc3,-0.18787713,-0.17159861,2,['Voltage gated Potassium channels']
Kcnc4,-0.0964353,-0.25189942,2,['Voltage gated Potassium channels']
Kcnd1,-0.26367646,-0.16295077,2,"['Voltage gated Potassium channels', 'Phase 1 - inactivation of fast Na+ channels']"
Kcnd2,-0.10214582,-0.3052926,2,"['Voltage gated Potassium channels', 'Phase 1 - inactivation of fast Na+ channels']"
Kcnd3,-0.02523314,-0.19889063,2,"['Voltage gated Potassium channels', 'Phase 1 - inactivation of fast Na+ channels']"
Kcne1,0.07810105,-0.11723096,1,
Kcne1l,-0.15254545,-0.108198,2,"['Phase 3 - rapid repolarisation', 'Phase 2 - plateau phase']"
Kcne2,-0.0063436506,-0.22271079,2,
Kcne3,-0.15235433,-0.16278324,2,"['Phase 3 - rapid repolarisation', 'Phase 2 - plateau phase']"
Kcne4,-0.06023175,-0.116476215,2,"['Phase 3 - rapid repolarisation', 'Phase 2 - plateau phase']"
Kcnf1,-0.097583264,0.10756722,2,
Kcng1,-0.28290892,-0.19545148,2,['Voltage gated Potassium channels']
Kcng2,0.005015278,0.0034643617,2,"['Voltage gated Potassium channels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion']"
Kcng3,-0.16610809,-0.056944303,2,['Voltage gated Potassium channels']
Kcng4,-0.29451352,-0.1265007,2,['Voltage gated Potassium channels']
Kcnh1,-0.1076317,-0.29924536,2,
Kcnh2,-0.038610257,-0.19562966,2,
Kcnh3,-0.24375047,-0.16535863,2,['Voltage gated Potassium channels']
Kcnh4,-0.13235252,0.02557837,2,['Voltage gated Potassium channels']
Kcnh5,-0.22631331,-0.10209912,2,['Voltage gated Potassium channels']
Kcnh6,-0.3007246,-0.094613135,2,['Voltage gated Potassium channels']
Kcnh7,-0.21804069,-0.11381475,2,['Voltage gated Potassium channels']
Kcnh8,-0.036518577,-0.07531196,2,
Kcnip1,-0.120514914,-0.09788272,2,['Phase 1 - inactivation of fast Na+ channels']
Kcnip2,-0.15071341,-0.1555197,2,['Phase 1 - inactivation of fast Na+ channels']
Kcnip3,-0.09832065,-0.06337081,2,['Phase 1 - inactivation of fast Na+ channels']
Kcnip4,0.07395767,-0.047597423,1,['Phase 1 - inactivation of fast Na+ channels']
Kcnj1,0.1638227,-0.036428276,3,['Potassium transport channels']
Kcnj10,0.13812155,-0.33182302,1,"['Activation of G protein gated Potassium channels', 'Potassium transport channels', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj11,0.21113725,-0.13252798,1,"['ATP sensitive Potassium channels', 'ABC-family proteins mediated transport', 'Regulation of insulin secretion', 'Ion homeostasis']"
Kcnj12,0.15450653,-0.23952764,1,"['Activation of G protein gated Potassium channels', 'Classical Kir channels', 'Phase 4 - resting membrane potential', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj13,-0.23980819,-0.13911536,2,
Kcnj14,-0.00045318354,-0.31553316,1,"['Classical Kir channels', 'Phase 4 - resting membrane potential']"
Kcnj15,-0.15010849,-0.13114,2,"['Activation of G protein gated Potassium channels', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj16,-0.006044703,-0.23210014,1,"['Activation of G protein gated Potassium channels', 'Potassium transport channels', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj2,0.09981539,-0.21745116,1,"['Activation of G protein gated Potassium channels', 'Classical Kir channels', 'Phase 4 - resting membrane potential', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj3,0.17894985,-0.26289582,1,"['Activation of G protein gated Potassium channels', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj4,0.14198871,-0.2502026,1,
Kcnj5,0.07459461,-0.24914758,1,"['Activation of G protein gated Potassium channels', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnj6,0.27885506,-0.07948812,3,
Kcnj8,0.05229509,-0.222606,1,['ATP sensitive Potassium channels']
Kcnj9,0.13563375,-0.18591131,1,"['Activation of G protein gated Potassium channels', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits']"
Kcnk1,-0.33246258,-0.2123965,2,"['Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)', 'Phase 4 - resting membrane potential']"
Kcnk10,-0.29357958,-0.17352086,2,"['TWIK related potassium channel (TREK)', 'Phase 4 - resting membrane potential']"
Kcnk12,-0.35662013,-0.13649696,2,['Phase 4 - resting membrane potential']
Kcnk13,-0.22228901,-0.06627933,2,"['Tandem pore domain halothane-inhibited K+ channel (THIK)', 'Phase 4 - resting membrane potential']"
Kcnk15,-0.28522116,-0.12546916,2,['Phase 4 - resting membrane potential']
Kcnk16,-0.22004007,-0.034457203,2,"['TWIK-related alkaline pH activated K+ channel (TALK)', 'Phase 4 - resting membrane potential']"
Kcnk18,-0.35023323,-0.12748522,2,"['TWIK-related spinal cord K+ channel (TRESK)', 'Phase 4 - resting membrane potential']"
Kcnk2,-0.11281603,-0.047190137,2,"['TWIK related potassium channel (TREK)', 'Phase 4 - resting membrane potential']"
Kcnk3,0.0444603,-0.17349334,1,"['TWIK-releated acid-sensitive K+ channel (TASK)', 'Phase 4 - resting membrane potential']"
Kcnk4,-0.295659,-0.23746422,2,"['TWIK related potassium channel (TREK)', 'Phase 4 - resting membrane potential']"
Kcnk5,-0.2872227,-0.12655585,2,['Phase 4 - resting membrane potential']
Kcnk6,-0.25293037,-0.21774898,2,"['Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)', 'Phase 4 - resting membrane potential']"
Kcnk7,-0.3752295,-0.1796346,2,
Kcnk9,-0.3786254,-0.06258228,2,"['TWIK-releated acid-sensitive K+ channel (TASK)', 'Phase 4 - resting membrane potential']"
Kcnma1,0.1685995,-0.37912613,1,
Kcnmb1,0.046253894,-0.25421593,1,
Kcnmb2,0.072460584,-0.1749444,1,['Ca2+ activated K+ channels']
Kcnmb3,-0.0019419945,-0.13840173,2,['Ca2+ activated K+ channels']
Kcnmb4,0.054350223,-0.18110184,1,['Ca2+ activated K+ channels']
Kcnn1,-0.10375138,-0.0950952,2,
Kcnn2,-0.07555032,-0.095234655,2,['Ca2+ activated K+ channels']
Kcnn3,0.050771218,-0.21039729,1,['Ca2+ activated K+ channels']
Kcnn4,-0.07393351,-0.27532002,2,['Ca2+ activated K+ channels']
Kcnq1,0.19355239,-0.2799893,1,"['Voltage gated Potassium channels', 'Phase 3 - rapid repolarisation', 'Phase 2 - plateau phase']"
Kcnq2,-0.06460503,-0.30286235,2,
Kcnq3,-0.039838754,-0.21882649,2,
Kcnq4,-0.17457828,-0.24745812,2,['Voltage gated Potassium channels']
Kcnq5,0.08932991,-0.28779435,1,['Voltage gated Potassium channels']
Kcnrg,-0.23942162,0.034457784,2,
Kcns1,-0.4170551,-0.12595095,2,['Voltage gated Potassium channels']
Kcns2,-0.34383336,0.0027741778,2,['Voltage gated Potassium channels']
Kcns3,0.032194786,-0.106195904,2,"['Voltage gated Potassium channels', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion']"
Kcnt1,-0.14980221,-0.12853229,2,
Kcnt2,-0.03260492,-0.12977825,2,
Kcnu1,-0.043943103,-0.107355565,2,
Kcnv1,-0.2776904,-0.15043609,2,['Voltage gated Potassium channels']
Kcnv2,-0.110756464,-0.26802796,2,['Voltage gated Potassium channels']
Kcp,-0.17315598,0.03616831,2,
Kctd1,-0.00559974,-0.15866774,2,['Negative regulation of activity of TFAP2 (AP-2) family transcription factors']
Kctd10,-0.023551086,0.027437696,2,
Kctd11,0.042776495,-0.028371682,2,
Kctd12b,0.074734494,0.072834894,1,
Kctd13,0.030970821,0.111622795,3,"['RND3 GTPase cycle', 'RND2 GTPase cycle']"
Kctd14,-0.2062112,0.12434906,2,
Kctd15,-0.17875755,-0.12176337,2,
Kctd16,0.06313596,-0.17148764,1,
Kctd17,-0.15473321,0.001876971,2,
Kctd18,-0.065457836,0.036338612,2,
Kctd19,-0.3813327,0.35585135,0,
Kctd2,-0.0094794035,0.009221527,2,
Kctd3,-0.18097681,-0.13331762,2,
Kctd4,-0.21849932,0.15808974,2,
Kctd5,0.01716945,-0.045320097,2,
Kctd6,-0.023742527,0.011522636,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Kctd7,-0.11868119,0.1534214,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Kctd8,-0.08428159,-0.14998184,2,
Kctd9,-0.3103082,0.07642931,2,
Kdelr1,-0.21087745,-0.13846573,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Kdelr2,-0.08926712,-0.15223496,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Kdelr3,-0.08015923,-0.014997532,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Kdf1,-0.2280222,-0.013276203,2,
Kdm1a,0.40611112,0.40311435,3,"['HDACs deacetylate histones', 'HDMs demethylate histones', 'Estrogen-dependent gene expression', 'Factors involved in megakaryocyte development and platelet production']"
Kdm1b,0.26465628,0.24645813,3,"['HDMs demethylate histones', 'UCH proteinases']"
Kdm2a,0.042116452,0.34461564,3,
Kdm2b,0.30301154,0.10833259,3,['HDMs demethylate histones']
Kdm3a,0.09110421,0.17550278,3,['HDMs demethylate histones']
Kdm3b,0.036981486,0.022719689,2,
Kdm4a,0.22022612,0.2687736,3,"['HDMs demethylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']"
Kdm4b,0.33108222,0.17713499,3,"['HDMs demethylate histones', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']"
Kdm4c,0.10364867,0.34347627,3,['HDMs demethylate histones']
Kdm4d,0.12374651,0.158216,3,['HDMs demethylate histones']
Kdm5b,0.2196472,0.19968145,3,"['HDMs demethylate histones', 'TFAP2 (AP-2) family regulates transcription of cell cycle factors']"
Kdm5c,-0.054590825,0.31960788,3,['HDMs demethylate histones']
Kdm5d,0.01777877,0.3028203,0,
Kdm6a,0.25195634,0.3642735,3,['HDMs demethylate histones']
Kdm6b,0.2608863,0.14256692,3,"['Oxidative Stress Induced Senescence', 'HDMs demethylate histones']"
Kdm7a,-0.0041576736,0.26707166,3,['HDMs demethylate histones']
Kdm8,-0.030037772,0.20757888,0,
Kdr,0.65679675,-0.32434013,1,"['Neurophilin interactions with VEGF and VEGFR', 'VEGF binds to VEGFR leading to receptor dimerization', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated cell proliferation']"
Kdsr,-0.32378176,-0.16837633,2,['Sphingolipid de novo biosynthesis']
Keap1,0.3365013,0.0047365944,3,"['Ub-specific processing proteases', 'Neddylation', 'KEAP1-NFE2L2 pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Keg1,-0.19008878,-0.21047696,2,
Kel,-0.024651226,-0.04335009,2,['Peptide ligand-binding receptors']
Kera,-0.19698027,-0.010336233,2,"['Keratan sulfate biosynthesis', 'Keratan sulfate degradation']"
Khdc3,-0.34933698,-0.12712032,2,
Khdc4,-0.20375237,0.25224474,0,
Khdrbs1,0.3481378,0.17431682,1,['PTK6 Regulates Proteins Involved in RNA Processing']
Khdrbs2,0.17228809,-0.01206468,1,['PTK6 Regulates Proteins Involved in RNA Processing']
Khdrbs3,0.08003978,0.030777449,1,['PTK6 Regulates Proteins Involved in RNA Processing']
Khk,-0.036960836,-0.118847385,2,
Khnyn,-0.13340393,0.1933206,2,
Khsrp,0.15601693,0.32683674,3,['KSRP (KHSRP) binds and destabilizes mRNA']
Kics2,-0.016115373,0.024554705,2,['Amino acids regulate mTORC1']
Kidins220,0.24090862,-0.19013365,1,"['ARMS-mediated activation', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Kif11,0.21105519,0.47890556,3,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif12,-0.11651545,0.07080194,2,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif13a,-0.045044445,0.020007525,2,
Kif13b,0.17751314,-0.1733619,1,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif14,0.28916168,0.2577412,3,"['RHO GTPases activate CIT', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Kif15,0.1667462,0.32171267,3,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif17,-0.0075556347,0.1417643,2,['Intraflagellar transport']
Kif18a,0.06329062,0.3602357,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation', 'Kinesins']"
Kif18b,0.004808531,0.31408918,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif19a,-0.06796367,0.25661537,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif1a,0.10823725,-0.044189956,1,
Kif1b,0.037747286,-0.14809489,2,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif1c,0.039165862,-0.035543643,2,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif20a,0.14248243,0.24605817,3,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Telophase/Cytokinesis', 'Kinesins']"
Kif20b,0.11072673,0.34119222,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif21a,-0.019805465,0.020638837,2,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif21b,-0.053046316,0.20921728,3,
Kif22,0.1382774,0.31464827,3,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif23,0.369679,0.2566338,3,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Telophase/Cytokinesis', 'Kinesins']"
Kif24,-0.010003083,0.095030904,2,['Anchoring of the basal body to the plasma membrane']
Kif26a,0.076668344,-0.1878095,1,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif26b,-0.024328334,-0.094263025,2,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif27,0.02250845,0.29695585,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif28,-0.2493671,0.013027726,2,
Kif2a,0.16796021,0.24974962,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation', 'Kinesins']"
Kif2b,-0.14283139,0.23156583,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation', 'Kinesins']"
Kif2c,0.21453659,0.43043315,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation', 'Kinesins']"
Kif3a,0.23927574,-0.056937378,1,"['MHC class II antigen presentation', ""Hedgehog 'off' state"", 'Intraflagellar transport', 'Activation of SMO', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif3b,0.0887261,-0.040233925,1,"['MHC class II antigen presentation', 'Intraflagellar transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif3c,0.06351441,0.11134203,3,"['MHC class II antigen presentation', 'Intraflagellar transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif4,0.12723224,0.3815451,3,"['MHC class II antigen presentation', 'Recycling pathway of L1', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif5a,0.28615487,-0.110034846,1,"['MHC class II antigen presentation', 'RHO GTPases activate KTN1', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif5b,0.26356,-0.26212412,1,"['MHC class II antigen presentation', 'RHO GTPases activate KTN1', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif5c,0.24078387,-0.036047753,1,
Kif6,0.015698858,0.17611809,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kif7,0.074328735,0.17734206,3,
Kif9,-0.10019216,0.08127966,2,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kifap3,0.027792735,0.16583322,3,"['MHC class II antigen presentation', 'Intraflagellar transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kifbp,-0.20415504,0.109034754,2,
Kifc1,0.168588,0.32535064,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kifc2,0.2402957,0.17564534,3,
Kifc3,0.12316854,0.03416676,3,
Kifc5b,0.04668813,0.3701495,3,"['COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Kin,0.055200156,0.15025985,0,['Protein methylation']
Kir3dl1,0.1529809,-0.16593447,1,
Kir3dl2,-0.06968991,-0.2996001,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Kirrel,0.21294646,-0.27321535,1,['Nephrin family interactions']
Kirrel2,-0.027091999,-0.0024391394,2,['Nephrin family interactions']
Kirrel3,-0.07139116,-0.093037836,2,['Nephrin family interactions']
Kiss1,-0.15922922,-0.2258633,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Kiss1r,0.16569713,-0.26290414,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Kit,0.5024722,-0.2536325,1,"['PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Kitl,0.44111463,-0.249403,1,"['PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Kiz,0.022709236,0.14324644,3,
Kl,0.25441173,-0.26615828,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'FGFR1c and Klotho ligand binding and activation', 'Phospholipase C-mediated cascade: FGFR1', 'Downstream signaling of activated FGFR1', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'Negative regulation of FGFR1 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Klb,0.28526783,-0.11629619,1,"['PI3K Cascade', 'PIP3 activates AKT signaling', 'betaKlotho-mediated ligand binding', 'Phospholipase C-mediated cascade; FGFR4', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR4 signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Klc1,0.20180003,-0.22217287,1,
Klc2,0.26643255,-0.064724855,1,
Klc3,0.13295607,-0.08805467,1,"['MHC class II antigen presentation', 'RHO GTPases activate KTN1', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Klc4,0.11279504,-0.08796913,1,"['MHC class II antigen presentation', 'RHO GTPases activate KTN1', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Kinesins']"
Klf1,0.13266647,0.22046016,3,
Klf10,0.12902129,0.17781027,3,
Klf11,0.14254087,0.0070906235,3,
Klf12,-0.06673386,0.12985402,2,
Klf13,0.077708215,0.1862849,3,
Klf15,0.14713676,0.093778886,3,
Klf2,0.22711007,-0.090498246,1,
Klf3,0.087164514,0.05176832,3,
Klf4,0.2178752,0.009774602,3,
Klf5,0.24490586,0.14651468,3,
Klf6,0.11157903,0.13773619,3,
Klf7,-0.056371074,-0.05095461,2,
Klf8,-0.106251806,0.06589676,2,
Klf9,0.15400556,0.14218374,3,
Klhdc1,0.020688994,0.037349474,2,
Klhdc10,-0.18424334,-0.056312535,2,
Klhdc2,-0.1546467,-0.15978621,2,
Klhdc3,0.1154069,0.07674112,3,
Klhdc4,-0.23557073,0.2170108,0,
Klhdc7a,-0.19636868,-0.045094583,2,
Klhdc8a,-0.20884484,-0.103377335,2,
Klhdc8b,-0.15080854,0.27388048,0,
Klhdc9,-0.15235487,0.16631979,2,
Klhl1,-0.07353119,-0.23450658,2,
Klhl10,0.080980726,0.07633051,3,
Klhl11,0.048097767,0.047713496,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl12,0.112345874,0.13993727,3,['Degradation of DVL']
Klhl13,0.1527062,0.19405188,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl15,0.033887174,0.08897496,3,
Klhl18,-0.007050684,0.113936186,2,
Klhl2,0.004847533,0.09341427,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl20,0.08154701,0.08965724,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl21,-0.07300879,0.23933858,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl23,-0.022028789,-0.26089346,2,
Klhl24,-0.035897672,0.019750118,2,
Klhl25,0.03954037,0.18850204,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl29,0.11872851,0.07889826,3,
Klhl30,-0.10212627,-0.06341141,2,
Klhl31,-0.045033034,0.0064562233,2,
Klhl34,-0.26013467,0.000283649,2,
Klhl36,-0.05288638,0.1266679,2,
Klhl38,-0.06935371,0.0026306729,2,
Klhl40,0.088621445,-0.06349416,1,
Klhl41,-0.018618561,0.05401378,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl42,-0.04771373,0.18178448,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klhl6,-0.10714792,-0.17949075,2,
Klhl7,0.10973773,0.03388331,3,
Klhl8,-0.009147789,-0.048767764,2,
Klhl9,0.12073239,0.17878613,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Klk1,0.089862786,-0.049018946,1,
Klk1b1,-0.01908303,-0.282509,1,
Klk1b11,0.032180272,-0.16718878,2,
Klk1b16,0.12767678,-0.14427698,1,
Klk1b21,-0.09751855,-0.20353092,2,
Klk1b22,0.007765952,-0.090926714,2,
Klk1b24,-0.09972047,-0.123873785,2,
Klk1b26,0.09749532,-0.11450055,1,
Klk1b27,-0.0662156,-0.16827573,2,
Klk1b3,0.16861378,0.006430803,3,
Klk1b4,0.3217664,-0.12154519,1,
Klk1b5,-0.026189703,-0.1663364,2,
Klk1b8,0.05645724,-0.19767506,1,
Klk1b9,0.111193255,-0.17761734,1,
Klk4,-0.044312596,-0.100351416,2,
Klk5,-0.03550545,-0.047098033,2,['Formation of the cornified envelope']
Klk6,0.07112218,-0.12528668,2,
Klk7,-0.03701993,-0.0054181768,2,['Degradation of the extracellular matrix']
Klk8,0.021446262,-0.021206228,2,['Formation of the cornified envelope']
Klra,-0.15620121,-0.08266024,2,
Klra1,0.073979184,-0.13367514,1,
Klra17,-0.277114,0.008617676,2,
Klra3,0.0024630919,-0.1455745,1,
Klra4,0.0555138,-0.29873922,1,
Klra6,0.12981077,0.06681564,1,
Klra7,-0.19972824,-0.09646926,2,
Klra8,-0.10258409,-0.18927777,2,
Klra9,0.018048245,-0.11631014,1,
Klrb1,-0.1187103,-0.08848361,2,
Klrb1a,-0.000996224,-0.3893973,1,
Klrb1b,-0.16533923,0.1096067,2,
Klrb1c,0.16196467,-0.17680477,1,
Klrb1f,-0.16765255,0.22722901,2,
Klrc1,0.13224381,-0.06018401,1,"['DAP12 interactions', 'DAP12 signaling']"
Klrc2,0.08222101,-0.20172,1,"['DAP12 interactions', 'DAP12 signaling']"
Klrc3,-0.0542988,-0.18136723,1,"['DAP12 interactions', 'DAP12 signaling']"
Klrd1,0.27490726,-0.15291682,1,"['DAP12 interactions', 'DAP12 signaling']"
Klrg1,0.20298317,-0.20091672,1,
Klrg2,-0.12866661,-0.14617026,2,
Klrk1,0.29102567,-0.13959044,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'DAP12 signaling']"
Kmo,-0.07040679,-0.10381957,2,['Tryptophan catabolism']
Kmt2a,0.3063289,0.35430703,3,"['PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Kmt2b,0.38176656,0.22564317,3,"['PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Kmt2c,0.36423832,0.31952533,3,
Kmt2d,0.4074383,0.33328816,3,"['Formation of the beta-catenin:TCF transactivating complex', 'PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Kmt2e,0.20325264,0.3352558,3,"['PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Kmt5a,0.40400186,0.10726844,3,
Kmt5b,0.16593832,0.19040714,3,['PKMTs methylate histone lysines']
Kmt5c,0.13584776,0.15206012,3,['PKMTs methylate histone lysines']
Kncn,-0.077498704,-0.0032188648,2,
Kndc1,0.027469521,-0.0809232,1,
Kng1,0.13618667,-0.209364,1,
Kng2,0.057271972,-0.12940034,1,"['Platelet degranulation ', 'Intrinsic Pathway of Fibrin Clot Formation', 'Peptide ligand-binding receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'G alpha (q) signalling events', 'G alpha (i) signalling events', 'Post-translational protein phosphorylation']"
Knl1,0.14299156,0.28838846,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Knstrn,0.11052457,0.2823131,3,
Kntc1,0.1688694,0.48110384,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Kpna1,0.35579962,0.43193656,3,"['Apoptosis induced DNA fragmentation', 'Assembly of the ORC complex at the origin of replication', 'Interferon alpha/beta signaling']"
Kpna2,0.30767402,0.5638107,3,['Sensing of DNA Double Strand Breaks']
Kpna3,0.2316914,0.40967175,0,
Kpna4,0.05686546,0.39125553,0,
Kpna6,0.26058307,0.3043964,0,['Assembly of the ORC complex at the origin of replication']
Kpna7,0.16308372,0.40636736,3,
Kpnb1,0.17555773,0.5339169,0,"['Apoptosis induced DNA fragmentation', 'Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'Initiation of Nuclear Envelope (NE) Reformation', 'Neutrophil degranulation', 'Assembly of the ORC complex at the origin of replication', 'Interferon alpha/beta signaling']"
Kprp,-0.12712988,-0.07479004,2,
Kptn,0.21121645,-0.048833,1,
Kras,0.5115769,-0.063456215,1,"['Activation of RAS in B cells', 'SHC1 events in ERBB4 signaling', 'Signaling by SCF-KIT', 'p38MAPK events', 'GRB2 events in EGFR signaling', 'SHC1 events in EGFR signaling', 'Downstream signal transduction', 'GRB2 events in ERBB2 signaling', 'Tie2 Signaling', 'EGFR Transactivation by Gastrin', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'NCAM signaling for neurite out-growth', 'Ca2+ pathway', 'VEGFR2 mediated cell proliferation', 'CD209 (DC-SIGN) signaling', 'SHC-mediated cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'Regulation of RAS by GAPs', 'RAF activation', 'RAF/MAP kinase cascade', 'MAP2K and MAPK activation', 'Negative regulation of MAPK pathway', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'MET activates RAS signaling', 'FLT3 Signaling', 'Estrogen-stimulated signaling through PRKCZ', 'RAS processing', 'Signaling by CSF3 (G-CSF)']"
Krba1,-0.18307161,-0.043794684,2,['Generic Transcription Pathway']
Krcc1,-0.01628059,0.018565716,3,
Kremen1,-0.087052695,-0.13280088,2,['Negative regulation of TCF-dependent signaling by WNT ligand antagonists']
Kremen2,-0.14810371,0.093875825,2,['Negative regulation of TCF-dependent signaling by WNT ligand antagonists']
Kri1,-0.28344414,0.4169087,0,
Krit1,0.13419794,-0.22753705,1,
Krr1,-0.20292562,0.36580557,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Krt1,-0.109980226,0.015405741,2,"['Neutrophil degranulation', 'Keratinization', 'Formation of the cornified envelope']"
Krt10,-0.22317997,0.08249495,2,
Krt12,-0.3327053,0.1611137,2,
Krt13,-0.19044353,0.057007566,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt14,0.010719356,0.04770856,2,"['Type I hemidesmosome assembly', 'Keratinization', 'Formation of the cornified envelope']"
Krt15,-0.26284352,-0.079518735,2,
Krt16,-0.18295403,0.11597327,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt17,0.02805635,-0.02318248,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt18,0.06472332,-0.042669974,1,"['Keratinization', 'Formation of the cornified envelope']"
Krt19,0.2821471,-0.15517083,1,"['Keratinization', 'Formation of the cornified envelope']"
Krt2,-0.06117453,0.041435607,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt20,0.012961327,-0.09455613,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt222,-0.12962554,0.041839134,2,
Krt24,-0.33508706,0.083557345,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt25,-0.20483541,-0.19299304,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt27,-0.30339956,-0.11901593,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt31,-0.27398017,-0.06544514,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt32,-0.33679548,-0.04081642,2,
Krt33a,0.0423718,-0.008995816,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt34,-0.3284876,-0.016796723,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt35,-0.34876326,-0.07582629,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt39,-0.06207,-0.12678804,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt4,-0.0221701,-0.0076347315,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt40,-0.13338107,-0.0191866,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt5,0.20502642,-0.025063643,3,"['Type I hemidesmosome assembly', 'Keratinization', 'Formation of the cornified envelope']"
Krt6a,-0.07978951,0.05825735,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt6b,-0.08180138,-0.076571755,2,
Krt7,0.0061084726,-0.11084484,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt71,-0.26594716,-0.019429414,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt72,0.02127442,0.04426233,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt73,-0.080058426,-0.10527079,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt75,-0.2252456,-0.081729494,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt76,-0.06423991,-0.046896864,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt77,-0.07921521,-0.107841946,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt78,-0.20730342,-0.111179575,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt79,-0.2682354,-0.1084849,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt8,0.38276008,-0.068339154,1,"['Keratinization', 'Formation of the cornified envelope']"
Krt80,-0.1923671,0.08991709,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt82,-0.18498921,0.014588416,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt84,-0.25592107,0.17668888,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt87,-0.16669267,-0.21473278,2,
Krt9,0.011763332,0.0790218,2,"['Keratinization', 'Formation of the cornified envelope']"
Krt90,-0.26069185,0.08865716,2,
Krtap11-1,-0.28100908,-0.01889068,2,['Keratinization']
Krtap12-1,-0.07975741,0.060234793,0,['Keratinization']
Krtap13-1,-0.111263484,0.048024938,2,
Krtap14,-0.24151349,-0.08574687,2,
Krtap15,-0.10696565,-0.06268573,2,
Krtap16-3,-0.29556474,0.014693802,2,['Keratinization']
Krtap19-2,-0.1964701,0.018973552,2,['Keratinization']
Krtap19-3,-0.1904063,0.09193183,2,['Keratinization']
Krtap19-4,-0.15340847,-0.028284296,2,['Keratinization']
Krtap19-5,-0.32357192,0.13757457,2,
Krtap20-2,-0.1119102,0.0645597,2,['Keratinization']
Krtap21-1,-0.32859668,-0.15219893,2,
Krtap24-1,-0.14126632,0.004407138,2,['Keratinization']
Krtap26-1,-0.11700551,-0.03394551,2,
Krtap3-1,-0.18884659,0.07941792,2,['Keratinization']
Krtap3-2,-0.15242887,-0.1856641,2,['Keratinization']
Krtap3-3,-0.30116773,0.10890759,2,['Keratinization']
Krtap4-1,-0.17892382,-0.06591303,2,
Krtap4-2,-0.07656985,0.11227515,0,
Krtap4-9,-0.10853819,0.11550635,2,['Keratinization']
Krtap5-1,-0.21165933,0.169244,2,['Keratinization']
Krtap5-4,-0.08603069,0.005000914,2,['Keratinization']
Krtap6-2,-0.08643984,-0.013422774,2,
Krtap6-3,-0.11892652,0.028736211,2,['Keratinization']
Krtap6-5,-0.20515321,0.02777945,2,['Keratinization']
Krtap7-1,-0.13427596,-0.056906294,2,
Krtap8-1,-0.24027595,0.13839401,2,['Keratinization']
Krtap9-1,-0.060076337,0.084054984,0,['Keratinization']
Krtap9-3,-0.1887673,0.0014947734,2,
Krtcap2,-0.1281848,-0.03759799,2,
Krtdap,-0.20016506,-0.22307076,2,
Ksr1,0.46835843,-0.119144306,3,"['RAF activation', 'MAP2K and MAPK activation', 'Negative regulation of MAPK pathway']"
Ksr2,0.29223382,-0.015148589,3,
Kti12,-0.12421582,0.4029118,0,
Ktn1,0.13827872,-0.14782646,1,
Kxd1,-0.020475222,-0.11230042,2,
Ky,-0.0967731,-0.016181136,2,
Kyat1,-0.1547398,-0.16150668,2,"['Tryptophan catabolism', 'Phenylalanine metabolism', 'Glutamate and glutamine metabolism']"
Kyat3,-0.13602763,-0.16099067,2,
Kynu,-0.1554075,-0.08066327,2,
L1cam,0.31560448,-0.5003925,1,
L1td1,0.03464089,0.106462464,0,
L2hgdh,-0.10245278,-0.1483731,2,['Interconversion of 2-oxoglutarate and 2-hydroxyglutarate']
L3hypdh,-0.13346474,-0.08265344,2,
L3mbtl1,0.10171013,0.09127735,3,['Regulation of TP53 Activity through Methylation']
L3mbtl2,0.2203061,0.11005996,3,"['SUMOylation of chromatin organization proteins', 'Transcriptional Regulation by E2F6']"
L3mbtl3,-0.23812386,-0.006348071,2,
LTO1,-0.0380525,0.09909826,0,
Lacc1,-0.15239476,-0.106844895,2,
Lactb2,-0.061867237,-0.027494045,2,
Lag3,0.27054766,-0.13529436,1,['MHC class II antigen presentation']
Lage3,0.02496865,-0.011439228,2,
Lair1,0.17085306,-0.22863631,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Lalba,0.00081598613,-0.01589576,2,['Lactose synthesis']
Lama1,0.23632371,-0.31808162,1,
Lama2,0.16340375,-0.26302588,1,
Lama3,0.15144569,-0.4194835,1,
Lama4,0.17619823,-0.3542567,1,"['Laminin interactions', 'MET activates PTK2 signaling']"
Lama5,0.11255435,-0.40294918,1,
Lamb1,0.2601495,-0.30915934,1,
Lamb2,0.19365911,-0.3753927,1,
Lamb3,0.12798332,-0.4321494,1,
Lamc1,0.23443614,-0.3123592,1,
Lamc2,0.23510143,-0.2778335,1,
Lamc3,0.21367651,-0.29707444,1,
Lamp1,0.20988831,-0.31173894,1,['Neutrophil degranulation']
Lamp2,0.19950753,-0.16077423,1,"['Platelet degranulation ', 'Neutrophil degranulation']"
Lamp3,-0.026133407,-0.2611663,1,
Lamtor1,0.16814473,0.06356416,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Neutrophil degranulation', 'Regulation of PTEN gene transcription', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'Amino acids regulate mTORC1']"
Lamtor2,0.1687072,0.17324261,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'MAP2K and MAPK activation', 'Neutrophil degranulation', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Lamtor3,0.19993731,-0.020040547,1,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'MAP2K and MAPK activation', 'Neutrophil degranulation', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Lamtor4,0.13137238,0.08411278,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Lamtor5,0.14696267,0.12556788,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Lancl1,-0.094164275,-0.13128567,2,
Lancl3,-0.3087203,0.03705467,2,
Lao1,-0.15655163,-0.2584801,2,
Lap3,-0.28514373,-0.13075002,2,
Laptm4a,0.04530365,-0.14202121,1,
Laptm4b,-0.0730776,-0.23644228,2,
Laptm5,0.16044599,-0.29219392,1,
Large1,-0.13638026,-0.12545644,2,['O-linked glycosylation']
Large2,0.09773006,-0.039367836,1,['O-linked glycosylation']
Larp1,0.18092927,0.3259208,3,
Larp1b,-0.12842068,0.030069124,2,
Larp4,-0.058551528,0.22614887,0,
Larp4b,-0.12704556,0.062316764,0,
Larp6,0.019015681,0.021656305,0,
Larp7,0.032795858,0.06511855,0,
Lars,-0.048454616,0.24137257,0,
Lars2,-0.0022392187,0.08818369,0,
Las1l,-0.0019506447,0.3958781,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Lasp1,0.3322022,-0.1371388,1,
Lat,0.30144072,-0.17983906,1,"['GPVI-mediated activation cascade', 'Generation of second messenger molecules', 'DAP12 signaling', 'Fc epsilon receptor (FCERI) signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'RAF/MAP kinase cascade']"
Lat2,0.21403141,-0.25615072,1,['Role of LAT2/NTAL/LAB on calcium mobilization']
Lats1,0.1406391,-0.029001866,3,['Signaling by Hippo']
Lats2,0.19836931,0.12252879,3,['Signaling by Hippo']
Lax1,0.09145862,-0.2627301,1,
Layn,0.02328577,0.28832164,3,
Lbhd1,-0.04644443,0.13790813,3,
Lbp,0.053794444,-0.03002011,1,"['Toll Like Receptor 4 (TLR4) Cascade', 'Transfer of LPS from LBP carrier to CD14', 'Regulation of TLR by endogenous ligand']"
Lbr,0.14919068,0.21550417,3,"['Cholesterol biosynthesis', 'Initiation of Nuclear Envelope (NE) Reformation', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'Regulation of MECP2 expression and activity']"
Lbx1,-0.3929781,0.09999235,2,
Lbx2,-0.047134247,-0.123683,2,
Lca5,-0.18168749,-0.088734865,2,
Lca5l,-0.023469612,0.16490175,0,
Lcat,0.024691781,-0.14958286,1,['HDL remodeling']
Lce1a1,-0.27250755,-0.16252539,2,
Lce1a2,-0.06648102,-0.04016961,2,
Lce1b,-0.13477379,-0.18805814,2,
Lce1c,-0.26325664,-0.040760588,2,
Lce1e,-0.09326472,-0.15527508,2,
Lce1f,-0.25383762,-0.11358521,2,
Lce1g,-0.10535847,-0.14013289,2,
Lce1h,-0.20120908,-0.029049698,2,
Lce1j,-0.18760194,-0.072663814,2,
Lce1k,-0.07920082,-0.119052395,2,
Lce1l,-0.20671532,-0.00014713027,2,
Lce1m,-0.0918322,-0.054937705,2,
Lce3f,0.21444488,0.104878075,3,
Lce6a,-0.34336144,0.104455344,2,
Lck,0.5337561,-0.3220216,1,"['GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'Downstream TCR signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'PECAM1 interactions', 'DAP12 signaling', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'CD28 dependent Vav1 pathway', 'CTLA4 inhibitory signaling', 'PD-1 signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RHOH GTPase cycle', 'Interleukin-2 signaling', 'FLT3 signaling through SRC family kinases']"
Lclat1,-0.20735572,-0.0788897,2,"['Acyl chain remodeling of CL', 'Synthesis of PA']"
Lcmt1,0.14401619,-0.079176836,1,['Cyclin A/B1/B2 associated events during G2/M transition']
Lcmt2,-0.19864285,0.0816179,2,
Lcn10,-0.28059912,-0.03768578,2,
Lcn11,-0.064040095,0.08634099,2,
Lcn12,-0.18199058,-0.17471543,2,['Transport of fatty acids']
Lcn2,0.16228701,-0.1360355,1,"['Neutrophil degranulation', 'Metal sequestration by antimicrobial proteins', 'Iron uptake and transport']"
Lcn4,-0.21054846,-0.00021301289,2,
Lcn5,-0.2310156,-0.0076244134,2,
Lcn6,-0.27912894,-0.06835207,2,
Lcn8,-0.18809552,0.068802655,2,
Lcn9,-0.040147316,0.0694905,2,['Transport of fatty acids']
Lcor,0.0076122894,0.16422018,3,
Lcorl,-0.26315168,0.05162685,2,
Lcp1,0.29110155,-0.10430669,1,
Lcp2,0.2877153,-0.2871117,1,"['GPVI-mediated activation cascade', 'Generation of second messenger molecules', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization']"
Lct,-0.12264071,0.0046121473,2,['Digestion of dietary carbohydrate']
Ldah,0.0024976542,0.061352037,2,
Ldb1,0.20572351,-0.10233449,3,['RUNX1 regulates transcription of genes involved in differentiation of HSCs']
Ldb2,0.107097045,-0.005949094,3,
Ldb3,0.0067504747,-0.2649295,1,
Ldc1,-0.09917324,0.17253141,2,
Ldha,-0.04949126,0.062414717,2,['Pyruvate metabolism']
Ldhal6b,-0.1844005,0.038062632,2,['Pyruvate metabolism']
Ldhb,-0.056963567,0.092066966,0,['Pyruvate metabolism']
Ldhc,-0.12140938,0.11128653,2,['Pyruvate metabolism']
Ldhd,-0.22273804,0.004597995,2,['Mitochondrial protein import']
Ldlr,0.20525005,-0.07201265,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Chylomicron clearance', 'LDL clearance']"
Ldlrad3,0.04092296,0.06483689,2,
Ldlrad4,-0.12920122,-0.08507153,2,
Ldlrap1,0.18302035,-0.3144412,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Chylomicron clearance', 'LDL clearance', 'Transport of RCbl within the body']"
Lect2,0.028862864,-0.21925132,2,
Lef1,0.44443133,0.04715311,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Ca2+ pathway', 'Repression of WNT target genes', 'Transcriptional Regulation by VENTX', 'RUNX3 regulates WNT signaling']"
Lefty1,0.07017691,0.06698568,3,['Platelet degranulation ']
Lefty2,0.038853228,-0.11964758,2,['Platelet degranulation ']
Lekr1,-0.045531984,0.36919132,3,
Lelp1,-0.1487319,0.06093367,2,
Lemd2,0.20471022,0.016148062,3,
Lemd3,0.24508077,0.21388115,3,
Lenep,-0.102653,-0.073936135,2,
Leng1,-0.38471875,0.121873215,2,
Leng8,-0.1506177,0.15247886,2,
Leo1,0.1714879,0.39364207,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the beta-catenin:TCF transactivating complex', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Lep,0.40198785,-0.31037977,1,"['Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'Synthesis, secretion, and deacylation of Ghrelin']"
Lepr,0.4245631,-0.24907844,1,
Leprot,-0.024159823,0.03311469,2,
Leprotl1,-0.13762009,-0.22963065,2,
Letm1,-0.19546936,-0.11431166,2,['RHOG GTPase cycle']
Letm2,0.08929034,0.15294,3,
Lexm,0.017984368,0.12116043,3,
Lfng,0.04205742,0.03889613,2,
Lgals1,0.22756484,-0.09552953,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Lgals12,-0.13490677,0.0034050094,2,
Lgals3,0.2832067,-0.2552171,1,
Lgals3bp,0.30495748,-0.05295165,1,['Platelet degranulation ']
Lgals4,0.34950486,0.19574985,3,
Lgals7,-0.026989754,0.051268283,2,
Lgals8,0.25031525,-0.1475811,1,
Lgals9,0.30827615,-0.03337397,1,
Lgalsl,-0.03627064,0.034298133,2,
Lgi1,-0.04481982,-0.21496302,2,['LGI-ADAM interactions']
Lgi2,-0.04628388,0.094111346,2,['LGI-ADAM interactions']
Lgi3,-0.26822126,0.0742226,2,['LGI-ADAM interactions']
Lgi4,-0.08486101,0.118145764,2,['LGI-ADAM interactions']
Lgmn,0.13911417,-0.10187971,1,"['Trafficking and processing of endosomal TLR', 'MHC class II antigen presentation']"
Lgr4,0.13748148,-0.10697324,3,['Regulation of FZD by ubiquitination']
Lgr5,0.35696232,0.17674646,3,['Regulation of FZD by ubiquitination']
Lgr6,-0.0051007075,0.12950696,3,
Lgsn,-0.12813917,-0.17103851,2,
Lhb,-0.036908977,-0.11646797,2,
Lhcgr,0.0071434965,-0.20138049,1,"['Hormone ligand-binding receptors', 'G alpha (s) signalling events']"
Lhfpl4,-0.31646565,-0.115781024,2,
Lhfpl5,-0.050968483,-0.11537565,2,
Lhpp,-0.011888534,-0.063168846,2,['Pyrophosphate hydrolysis']
Lhx1,0.09538998,-0.005384078,3,
Lhx2,0.106883205,0.094768815,3,
Lhx3,0.16075657,-0.15836814,3,
Lhx4,-0.14440487,-0.11066239,2,
Lhx5,0.085664086,0.15438499,3,
Lhx6,0.11802177,-0.19384946,1,
Lhx8,-0.07682699,-0.10295885,2,
Lhx9,-0.0037011693,-0.06348183,2,
Lias,0.037548862,0.021963313,2,['Glyoxylate metabolism and glycine degradation']
Lif,0.25607145,-0.0017631543,3,['IL-6-type cytokine receptor ligand interactions']
Lifr,0.2676811,-0.069140784,1,['IL-6-type cytokine receptor ligand interactions']
Lig1,0.21798436,0.4525255,3,
Lig3,0.09728875,0.16318221,3,
Lig4,0.21236704,0.28641772,3,['Nonhomologous End-Joining (NHEJ)']
Lilra5,-0.11485865,-0.3447842,1,['Neutrophil degranulation']
Lilra6,-0.07926039,-0.28959244,1,['Neutrophil degranulation']
Lim2,-0.16302039,0.039764967,2,
Lima1,0.17112559,-0.12933029,1,
Limd1,0.0868021,0.2177183,0,['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha']
Limd2,-0.2755889,-0.18932796,2,
Lime1,-0.022766829,-0.2423698,1,
Limk1,0.33155072,-0.1161158,1,"['Regulation of actin dynamics for phagocytic cup formation', 'Sema3A PAK dependent Axon repulsion', 'RHO GTPases activate PAKs']"
Limk2,0.28009173,-0.097723745,1,
Lims1,0.19247474,-0.14681351,1,
Lims2,-0.18753068,-0.15033938,2,['Cell-extracellular matrix interactions']
Lin28a,-0.074137494,0.31708086,0,
Lin28b,-0.16278504,0.17732844,2,
Lin37,0.28414062,0.21579164,3,['G0 and Early G1']
Lin52,0.10974942,0.10234844,3,['G0 and Early G1']
Lin7a,0.07154896,-0.14888866,1,['Dopamine Neurotransmitter Release Cycle']
Lin7b,-0.032370765,-0.13175827,1,"['Dopamine Neurotransmitter Release Cycle', 'RHO GTPases Activate Rhotekin and Rhophilins']"
Lin7c,0.04219703,-0.08959844,1,['Dopamine Neurotransmitter Release Cycle']
Lingo1,0.20952094,-0.13618185,1,['Axonal growth inhibition (RHOA activation)']
Lingo2,-0.22796461,-0.07530885,2,
Lipa,-0.010074935,-0.0306754,2,['LDL clearance']
Lipc,0.084862165,-0.19756176,1,"['Assembly of active LPL and LIPC lipase complexes', 'Chylomicron clearance']"
Lipe,0.09040341,-0.20100924,2,
Lipf,0.023665398,-0.11418375,2,['Digestion of dietary lipid']
Lipg,0.014739576,0.01795178,2,['HDL remodeling']
Lipi,-0.23159555,-0.055655386,2,['Synthesis of PA']
Lipn,-0.26959416,0.059263013,2,['Formation of the cornified envelope']
Lipt1,-0.29985037,-0.038140554,2,['Glyoxylate metabolism and glycine degradation']
Lipt2,-0.19124384,-0.039636012,2,['Glyoxylate metabolism and glycine degradation']
Litaf,0.26793292,0.15312327,3,
Lix1,-0.32230505,0.05734321,2,
Llcfc1,-0.14089693,-0.09179103,2,
Llgl1,0.13334101,-0.06395269,1,
Llgl2,0.15854944,-0.16118997,1,
Llph,-0.16487281,0.27436253,0,
Lman1,0.013099778,-0.19980669,1,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Lman1l,-0.1673446,-0.18719837,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Lman2,-0.1842083,-0.060699645,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Lman2l,-0.14422894,-0.20883147,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Lmbr1,-0.14161013,-0.08842114,2,
Lmbr1l,-0.20071296,0.056757655,2,
Lmbrd1,-0.12781486,0.019255418,2,"['Uptake of dietary cobalamins into enterocytes', 'Transport of RCbl within the body']"
Lmbrd2,-0.32235578,0.027097346,2,
Lmcd1,-0.17184398,-0.15218832,2,['Surfactant metabolism']
Lmf1,-0.25852087,-0.17925331,2,['Assembly of active LPL and LIPC lipase complexes']
Lmf2,-0.064082645,0.02740869,2,['Assembly of active LPL and LIPC lipase complexes']
Lmna,0.3592781,0.2605282,3,"['Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation', 'Breakdown of the nuclear lamina', 'Depolymerisation of the Nuclear Lamina']"
Lmnb1,0.44677117,0.25408214,3,"['Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation', 'Breakdown of the nuclear lamina', 'Depolymerisation of the Nuclear Lamina', 'RHOD GTPase cycle', 'RHOF GTPase cycle']"
Lmnb2,0.14649448,0.14069213,3,
Lmntd1,-0.04919689,0.13213573,2,
Lmo1,0.25963828,0.1104684,3,['RUNX1 regulates transcription of genes involved in differentiation of HSCs']
Lmo2,0.15198874,-0.094300225,3,['RUNX1 regulates transcription of genes involved in differentiation of HSCs']
Lmo3,-0.11651877,-0.022678329,2,
Lmo4,0.33637184,0.01307467,1,
Lmo7,0.22074951,-0.17581716,1,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Lmod1,-0.007420715,-0.08962203,2,
Lmod2,0.19188249,0.012077487,1,
Lmod3,-0.0924303,-0.10846887,2,
Lmtk2,-0.10869124,-0.10886837,2,
Lmx1a,0.13500288,-0.2773023,1,
Lmx1b,0.11485487,0.2671636,3,
Lnpep,0.26974452,-0.34451833,1,"['Endosomal/Vacuolar pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Lnpk,-0.27776867,-0.19723189,2,
Lnx1,0.21778232,-0.10842904,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Lnx2,0.016186232,0.03732526,2,
Lonp1,-0.12032652,0.26535872,0,
Lonp2,-0.1573346,0.10400687,2,['Peroxisomal protein import']
Lonrf2,-0.22049427,-0.06915119,2,
Lor,-0.08288815,-0.069139205,2,
Lox,0.3007572,-0.10334855,1,"['Elastic fibre formation', 'Crosslinking of collagen fibrils']"
Loxhd1,-0.29146823,-0.13299671,2,
Loxl1,0.093671076,-0.15400475,1,
Loxl2,0.14975452,0.020695772,3,"['Elastic fibre formation', 'Crosslinking of collagen fibrils']"
Loxl3,0.19193171,-0.032445837,1,"['Elastic fibre formation', 'Crosslinking of collagen fibrils']"
Loxl4,-0.06937728,-0.07253943,2,"['Elastic fibre formation', 'Crosslinking of collagen fibrils']"
Lpar1,0.3421687,-0.30297133,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Lysosphingolipid and LPA receptors']"
Lpar2,0.12363412,-0.32363743,1,
Lpar3,0.27982137,-0.23218904,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'Lysosphingolipid and LPA receptors']"
Lpar4,-0.08480034,-0.4053549,1,"['G alpha (q) signalling events', 'P2Y receptors']"
Lpar5,0.061736323,-0.21306208,1,
Lpar6,0.10474224,-0.18207185,1,"['G alpha (q) signalling events', 'P2Y receptors']"
Lpcat1,-0.13742903,0.022875754,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PG', 'Synthesis of PA', 'Synthesis of PC', 'Neutrophil degranulation']"
Lpcat2,-0.12604687,-0.06074656,2,['Acyl chain remodelling of PC']
Lpcat2b,-0.25715464,0.00559695,2,
Lpcat3,-0.1564493,-0.17650509,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE']"
Lpcat4,-0.26848003,-0.15228343,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Lpgat1,-0.2539833,-0.031729944,2,['Acyl chain remodelling of PG']
Lpin1,0.07286522,-0.08690606,3,
Lpin2,0.11183226,0.02693519,3,"['Synthesis of PC', 'Synthesis of PE', 'Depolymerisation of the Nuclear Lamina', 'Triglyceride biosynthesis']"
Lpin3,0.023508992,0.05670498,3,"['Synthesis of PC', 'Synthesis of PE', 'Depolymerisation of the Nuclear Lamina', 'Triglyceride biosynthesis']"
Lpl,0.20607178,-0.18654285,1,"['Assembly of active LPL and LIPC lipase complexes', 'Chylomicron remodeling', 'Retinoid metabolism and transport']"
Lpo,-0.37583733,-0.10602265,2,['Events associated with phagocytolytic activity of PMN cells']
Lpp,0.24157816,-0.29884565,1,
Lpxn,0.36791137,-0.27223858,1,
Lrat,-0.25539595,-0.19763812,2,"['The canonical retinoid cycle in rods (twilight vision)', 'Retinoid metabolism and transport']"
Lratd1,-0.06550701,0.04492175,2,
Lratd2,-0.14119966,0.048656583,2,
Lrba,-0.29905185,-0.14120121,2,
Lrch1,0.014629869,-0.06310402,2,
Lrch3,0.07177919,0.03476982,3,
Lrfn1,0.030780364,-0.11750232,1,['Synaptic adhesion-like molecules']
Lrfn2,0.060462303,-0.14305267,1,['Synaptic adhesion-like molecules']
Lrfn3,-0.15442613,0.07669116,2,['Synaptic adhesion-like molecules']
Lrfn4,0.038449444,-0.26988286,1,['Synaptic adhesion-like molecules']
Lrfn5,-0.01860243,-0.10597514,2,
Lrg1,-0.1673831,-0.19325678,2,
Lrif1,-0.18283826,0.0940736,2,
Lrig1,0.25343424,-0.12019804,1,"['Signaling by EGFR', 'Negative regulation of MET activity']"
Lrig2,0.00066541403,-0.31884757,1,
Lrig3,-0.10253231,-0.23779713,2,
Lrit1,-0.0557238,-0.032141887,2,
Lrit2,-0.17066945,0.014579228,2,
Lrit3,-0.015083965,-0.087021045,2,
Lrmda,-0.10271038,0.4100698,0,
Lrp1,0.52117455,-0.2914757,1,
Lrp10,0.26998755,-0.14643995,1,['Retinoid metabolism and transport']
Lrp11,-0.13641149,0.10786065,2,
Lrp12,0.09112606,-0.15019737,1,['Retinoid metabolism and transport']
Lrp1b,0.16633503,-0.34818986,1,
Lrp2,0.282776,-0.37302223,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Retinoid metabolism and transport', 'Transport of RCbl within the body']"
Lrp2bp,-0.17181818,-0.075718924,2,
Lrp3,-0.06660413,-0.07549053,2,
Lrp4,0.011421083,-0.059030656,2,
Lrp5,0.24192983,0.042160396,3,"['Negative regulation of TCF-dependent signaling by WNT ligand antagonists', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'Regulation of FZD by ubiquitination']"
Lrp6,0.2670716,-0.083159044,3,
Lrp8,0.3143823,-0.23140381,1,"['Platelet sensitization by LDL', 'Retinoid metabolism and transport']"
Lrpap1,-0.024096172,-0.24763228,2,
Lrpprc,0.029733554,0.10355108,0,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Lrr1,0.12053892,0.22175926,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Lrrc1,-0.24048203,0.046111524,2,['RND2 GTPase cycle']
Lrrc10,-0.18709154,0.17003977,2,
Lrrc14,0.0028956085,0.07390255,2,['Regulation of NF-kappa B signaling']
Lrrc14b,-0.121900775,0.03469421,2,
Lrrc17,-0.30035388,0.084083125,2,
Lrrc18,-0.19082898,-0.025568768,2,
Lrrc19,-0.22956735,0.16865024,2,
Lrrc2,-0.027825065,0.10669213,2,
Lrrc23,-0.31573978,-0.07160906,2,
Lrrc24,-0.07846135,0.043504626,2,
Lrrc26,-0.11931883,-0.27943948,2,
Lrrc27,-0.064334065,-0.07554589,2,
Lrrc28,-0.27500397,0.0043098344,2,
Lrrc29,-0.17154707,-0.12703422,2,
Lrrc3,-0.09698352,0.10203218,2,
Lrrc30,-0.10751318,0.0019325454,2,
Lrrc31,0.0720744,-0.0072023855,1,
Lrrc32,0.017012512,-0.102447204,1,
Lrrc34,-0.2789419,-0.06817111,2,
Lrrc38,0.019613298,-0.19292313,2,
Lrrc39,-0.2750231,0.20570312,2,
Lrrc4,-0.11807072,-0.060666803,2,
Lrrc40,-0.10086219,0.016061146,2,
Lrrc41,0.057680957,0.22270289,3,"['Neddylation', 'RHOBTB3 ATPase cycle', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Lrrc42,-0.19014557,-0.022621125,2,
Lrrc45,-0.27160802,0.009696474,2,
Lrrc47,-0.15516466,0.28690952,0,
Lrrc49,-0.16505195,0.02067178,2,
Lrrc4b,-0.009105774,-0.014507802,2,['Receptor-type tyrosine-protein phosphatases']
Lrrc4c,-0.024383504,-0.2734643,1,
Lrrc51,0.039577156,0.21856558,0,
Lrrc52,-0.035077773,-0.12363909,2,
Lrrc55,-0.0035064132,-0.1521177,2,
Lrrc56,-0.27549836,0.083464734,2,
Lrrc57,-0.14725606,0.0725005,2,
Lrrc59,0.017803736,0.046619643,0,
Lrrc6,-0.26850775,0.22060943,2,
Lrrc61,-0.38081568,-0.103840075,2,
Lrrc63,-0.052765254,0.1831176,2,
Lrrc69,-0.28982222,-0.07285116,2,
Lrrc7,0.2513067,-0.141049,1,
Lrrc71,-0.25973207,-0.20643277,2,
Lrrc72,-0.1413423,0.41082138,0,
Lrrc74a,-0.08139285,-0.074184,2,
Lrrc8a,-0.16712546,-0.09477597,2,['Miscellaneous transport and binding events']
Lrrc8b,-0.09986232,-0.0024983636,2,['Miscellaneous transport and binding events']
Lrrc8c,-0.13559681,-0.15037599,2,['Miscellaneous transport and binding events']
Lrrc8d,-0.31171274,0.06939222,2,['Miscellaneous transport and binding events']
Lrrc8e,-0.107246704,-0.078473456,2,['Miscellaneous transport and binding events']
Lrrc9,-0.21137889,-0.12653583,2,
Lrrfip1,-0.09425578,0.14120986,2,
Lrrfip2,-0.00069017743,-0.008671773,2,
Lrriq1,-0.26723322,0.29435804,2,
Lrriq3,-0.1955255,-0.06099644,2,
Lrriq4,-0.10470931,-0.026482092,2,
Lrrk1,0.06771219,-0.10161828,1,
Lrrk2,0.30823228,-0.14544885,1,['PTK6 promotes HIF1A stabilization']
Lrrn1,-0.14569253,0.08763374,2,
Lrrn2,-0.16158052,-0.006669179,2,
Lrrn3,0.05349327,-0.030792104,1,
Lrrn4,-0.24830507,0.23472421,0,
Lrrtm1,-0.06128934,-0.12091359,2,['Neurexins and neuroligins']
Lrrtm2,-0.039886523,-0.29618365,2,['Neurexins and neuroligins']
Lrrtm3,-0.18386634,-0.11453421,2,['Neurexins and neuroligins']
Lrrtm4,0.051781923,-0.070825525,1,['Neurexins and neuroligins']
Lrsam1,-0.13130035,0.016021514,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Lrwd1,-0.07644859,0.18562156,2,
Lsamp,-0.034833614,0.039870176,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Lsg1,-0.19597648,0.31114617,0,
Lsm1,0.019464739,0.5458737,0,"[""mRNA decay by 5' to 3' exoribonuclease""]"
Lsm10,-0.07313575,0.56419855,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Lsm11,-0.07355699,0.5757381,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Lsm12,-0.04279896,0.24652904,0,
Lsm14a,0.06726494,0.38765895,0,
Lsm14b,-0.08637983,0.08720128,2,
Lsm2,0.023750978,0.5342567,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'mRNA Splicing - Major Pathway']"
Lsm3,-0.12465146,0.5344318,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'mRNA Splicing - Major Pathway']"
Lsm4,-0.21714577,0.58031267,0,
Lsm5,-0.14067419,0.57990783,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'mRNA Splicing - Major Pathway']"
Lsm6,-0.074355096,0.61843103,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'mRNA Splicing - Major Pathway']"
Lsm7,-0.07022067,0.4839039,0,"[""mRNA decay by 5' to 3' exoribonuclease"", 'mRNA Splicing - Major Pathway']"
Lsm8,-0.047879223,0.6127291,0,['mRNA Splicing - Major Pathway']
Lsp1,0.26715136,-0.09908698,1,
Lsr,0.18775563,-0.035051264,1,
Lss,-0.25728044,0.020858744,2,['Cholesterol biosynthesis']
Lta,0.1915164,-0.11817855,1,"['TNFR2 non-canonical NF-kB pathway', 'TNFs bind their physiological receptors', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Lta4h,-0.20649454,0.013438682,2,"['Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Neutrophil degranulation', 'Biosynthesis of D-series resolvins', 'Biosynthesis of protectins', 'Biosynthesis of E-series 18(S)-resolvins', 'Biosynthesis of aspirin-triggered D-series resolvins', 'Biosynthesis of E-series 18(R)-resolvins']"
Ltb,0.27586707,0.099351466,3,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Ltb4r1,-0.09798947,-0.075729296,2,"['Leukotriene receptors', 'G alpha (q) signalling events']"
Ltb4r2,0.0023164207,-0.14325385,2,"['Leukotriene receptors', 'G alpha (q) signalling events']"
Ltbp1,0.17774825,-0.10895166,1,"['Molecules associated with elastic fibres', 'TGF-beta receptor signaling activates SMADs', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Ltbp3,0.14749536,-0.07676682,1,"['Molecules associated with elastic fibres', 'TGF-beta receptor signaling activates SMADs']"
Ltbp4,0.043054845,-0.1621845,2,"['Molecules associated with elastic fibres', 'TGF-beta receptor signaling activates SMADs']"
Ltbr,0.211181,-0.05396,1,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Ltc4s,-0.059973955,-0.07494045,2,"['Synthesis of 5-eicosatetraenoic acids', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of Lipoxins (LX)', 'Biosynthesis of maresin conjugates in tissue regeneration (MCTR)', 'Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)']"
Ltf,0.08939666,-0.06306495,1,"['Neutrophil degranulation', 'Metal sequestration by antimicrobial proteins', 'Antimicrobial peptides']"
Ltk,-0.23851484,-0.15283148,2,
Ltn1,-0.090916984,0.2705628,0,['Antigen processing: Ubiquitination & Proteasome degradation']
Ltv1,-0.08458351,0.44350815,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Luc7l,0.055917025,0.26972997,0,
Luc7l2,-0.000587006,0.28753063,0,
Luc7l3,-0.040697332,0.29242986,0,
Lum,0.08237336,-0.15756094,1,"['Keratan sulfate biosynthesis', 'Keratan sulfate degradation', 'Integrin cell surface interactions']"
Lurap1,-0.011403519,-0.25508192,1,
Luzp1,-0.22206023,-0.0040159593,2,
Luzp2,-0.25240293,-0.10261479,2,
Lxa4,-0.025144381,-0.17033969,1,
Lxn,-0.06962479,-0.2358863,2,
Ly6a,0.12080205,-0.2835014,1,
Ly6c1,0.26997736,-0.03756122,1,
Ly6c2,0.14113884,-0.15727697,1,
Ly6g,0.22350277,-0.09877664,1,
Ly6g2,-0.1481394,-0.0737301,2,
Ly6g5b,-0.06015201,-0.11633098,2,
Ly6g5c,-0.10670249,0.0026295665,2,
Ly6g6c,-0.25900808,-0.053087328,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Ly6g6d,-0.09009299,0.15326814,0,['Post-translational modification: synthesis of GPI-anchored proteins']
Ly6g6e,-0.10106792,0.05342908,2,
Ly6h,-0.314764,-0.027652726,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Ly6k,-0.22894599,-0.0025210571,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Ly6l,-0.38057378,-0.14363644,2,
Ly6m,-0.24201922,-0.18338363,2,
Ly75,0.14383948,0.008613944,1,
Ly86,0.07138131,-0.29489404,1,['Toll Like Receptor 4 (TLR4) Cascade']
Ly9,0.078873314,-0.053235527,1,
Ly96,0.4590605,-0.019110115,1,"['Caspase activation via Death Receptors in the presence of ligand', 'Toll Like Receptor 4 (TLR4) Cascade', 'MyD88-independent TLR4 cascade ', 'TRIF-mediated programmed cell death', 'Regulation of TLR by endogenous ligand', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IKK complex recruitment mediated by RIP1', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Heme signaling', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Lyar,-0.12577961,0.45820034,0,
Lyg1,-0.22322795,-0.16143943,2,
Lyl1,0.053626955,-0.07357177,2,
Lyn,0.5514853,-0.45146802,1,"['GPVI-mediated activation cascade', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'Cell surface interactions at the vascular wall', 'FCGR activation', 'PECAM1 interactions', 'Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation', 'CD28 co-stimulation', 'CTLA4 inhibitory signaling', 'EPHB-mediated forward signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells', 'Dectin-2 family', 'CD209 (DC-SIGN) signaling', 'CD22 mediated BCR regulation', 'Cyclin D associated events in G1', 'Platelet Adhesion to exposed collagen', 'Signaling by Erythropoietin', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Erythropoietin activates RAS', 'Regulation of signaling by CBL', 'Signaling by CSF3 (G-CSF)', 'Inactivation of CSF3 (G-CSF) signaling', 'Growth hormone receptor signaling']"
Lypd1,-0.1367968,-0.016417114,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Lypd11,-0.21965045,-0.03137628,2,
Lypd2,-0.21305802,-0.15665348,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Lypd3,-0.18798627,-0.12839614,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Lypd4,-0.14012031,0.048276234,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Lypd5,-0.081096865,0.16512,0,['Post-translational modification: synthesis of GPI-anchored proteins']
Lypd6,-0.21599859,-0.03086665,2,
Lypd6b,-0.23808679,-0.10836363,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Lypd9,-0.461823,-0.0134106465,2,
Lypla1,0.023891568,-0.13226882,1,"['eNOS activation', 'RAS processing']"
Lypla2,-0.25601128,-0.26962456,2,['L1CAM interactions']
Lyplal1,-0.16516896,-0.15551564,2,
Lyrm1,-0.16535789,0.09263914,2,
Lyrm2,-0.14857484,0.047312293,2,
Lyrm4,-0.077133335,-0.06323259,2,['Mitochondrial iron-sulfur cluster biogenesis']
Lyrm7,-0.09468533,-0.13039127,2,
Lyrm9,-0.26244134,-0.06489501,2,
Lysmd1,-0.12575743,0.04762441,2,
Lysmd2,-0.09507761,0.13070025,2,
Lysmd3,-0.052549314,-0.09413431,2,
Lyst,-0.08172446,0.003006111,2,
Lyve1,0.1766007,-0.09243022,1,['Hyaluronan uptake and degradation']
Lyz1,0.032431204,-0.09874716,1,
Lyz2,0.11481543,-0.041004486,1,"['Neutrophil degranulation', 'Antimicrobial peptides']"
Lyzl4,-0.3065831,0.08251479,2,
Lyzl6,-0.15619193,0.10160525,2,
Lztfl1,-0.16697648,0.015010848,2,['BBSome-mediated cargo-targeting to cilium']
Lzts1,-0.1894205,-0.2803551,2,
Lzts3,-0.09407132,0.07013402,2,
M1ap,-0.079074174,0.0537922,2,
M6pr,-0.0076175784,-0.30600697,1,"['Lysosome Vesicle Biogenesis', 'Retrograde transport at the Trans-Golgi-Network', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Mab21l1,-0.14271718,0.040156838,2,
Mab21l2,-0.031043649,-0.027485369,2,
Macc1,-0.17681196,-0.115929835,2,
Macf1,0.071374886,-0.18165667,1,
Macir,-0.074506156,-0.01342902,2,
Maco1,0.01296977,-0.099381514,2,"['RHOA GTPase cycle', 'RHOC GTPase cycle']"
Macrod1,-0.022522751,0.06417993,2,
Macrod2,0.02415734,0.19580972,3,
Macroh2a1,0.36830273,0.325581,3,
Macroh2a2,0.19050659,0.21495083,3,
Mad1l1,0.18683897,0.28235862,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Mad2l1,0.26574427,0.44043696,3,"['Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components', 'Inactivation of APC/C via direct inhibition of the APC/C complex', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Mad2l1bp,-0.018213362,0.16816701,3,
Mad2l2,0.18612239,0.3965931,3,"['Translesion synthesis by REV1', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI']"
Madcam1,0.2027474,-0.14794256,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions']"
Madd,0.08451828,-0.010766115,3,
Maea,-0.003785757,-0.086836,2,
Mael,-0.020355677,-0.03791512,2,
Maf,0.3938625,0.070659846,3,
Maf1,-0.039944947,0.09959857,2,['Regulation of PTEN gene transcription']
Mafa,-0.17865716,-0.027295187,2,
Mafb,-0.03411076,0.060201418,2,
Maff,0.15630111,-0.16184822,1,['Factors involved in megakaryocyte development and platelet production']
Mafg,0.005074388,-0.0158902,2,['Factors involved in megakaryocyte development and platelet production']
Mafk,0.019175362,0.10538394,3,"['Heme signaling', 'Regulation of BACH1 activity', 'Factors involved in megakaryocyte development and platelet production']"
Mag,0.21910985,-0.19988102,1,['Axonal growth inhibition (RHOA activation)']
Magea1,-0.10514298,-0.056702733,2,
Magea13,-0.016684387,-0.19678918,2,
Magea2,0.18753134,0.03703087,3,
Magea3,0.07159995,0.0066300095,2,
Magea5,-0.03817868,-0.12190822,2,
Magea6,0.06925741,0.10106089,3,
Mageb16,-0.4724495,-0.1665301,2,
Mageb18,-0.08565671,0.12086002,2,
Mageb2,-0.075468615,0.011502986,2,
Maged1,0.1443115,-0.10095969,1,
Maged2,0.0013024563,0.09467805,2,['Platelet degranulation ']
Magee2,-0.1104715,-0.09236755,2,
Mageh1,0.1856152,-0.102210015,1,
Magel2,0.1143658,0.060414344,3,
Magi1,0.11004946,-0.22869404,1,
Magi2,0.20120837,-0.31472138,1,
Magi3,0.17935376,-0.02087097,3,
Magoh,-0.06650269,0.5118554,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Magohb,-0.16467515,0.4882393,0,
Magt1,-0.007834525,0.009778305,2,"['Miscellaneous transport and binding events', 'Neutrophil degranulation']"
Maip1,0.01776642,0.060228493,0,['Processing of SMDT1']
Majin,-0.14341335,0.29122543,2,
Mak16,-0.23975337,0.3970935,0,
Mal2,-0.27600077,-0.10297515,2,
Malrd1,-0.116648875,-0.077227525,2,
Malsu1,-0.062031392,-0.034398675,2,
Malt1,0.37530637,-0.05118711,1,"['Activation of NF-kappaB in B cells', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'CLEC7A (Dectin-1) signaling', 'CLEC7A/inflammasome pathway']"
Mamdc2,-0.11891846,0.16477849,2,
Mamdc4,0.0041327104,0.14587492,3,
Maml1,0.09027365,0.3668044,3,"['NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'RUNX3 regulates NOTCH signaling']"
Maml2,0.06742206,0.26315176,3,"['NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'RUNX3 regulates NOTCH signaling']"
Maml3,0.15648003,0.24786103,3,"['NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'RUNX3 regulates NOTCH signaling']"
Mamld1,-0.043491505,0.21450076,3,"['NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'RUNX3 regulates NOTCH signaling']"
Man1a,-0.30727887,0.0141728325,2,"['Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2']"
Man1a2,-0.114069514,0.20794047,2,"['Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2']"
Man1b1,-0.28507897,-0.006682526,2,
Man1c1,-0.20633136,0.038963478,2,"['Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2']"
Man2a1,-0.27744108,-0.123819284,2,['Reactions specific to the complex N-glycan synthesis pathway']
Man2a2,-0.2989622,0.0061297277,2,['Reactions specific to the complex N-glycan synthesis pathway']
Man2b1,-0.29021558,0.040070463,2,"['Neutrophil degranulation', 'Lysosomal oligosaccharide catabolism']"
Man2b2,-0.1132566,-0.053709358,2,['Lysosomal oligosaccharide catabolism']
Man2c1,-0.18245994,-0.11783795,2,['Lysosomal oligosaccharide catabolism']
Manba,-0.13128066,0.011193676,2,
Manf,0.049024496,-0.3363355,1,
Maoa,-0.03021299,-0.15019646,1,"['Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB', 'Norepinephrine Neurotransmitter Release Cycle', 'Enzymatic degradation of dopamine by COMT', 'Enzymatic degradation of Dopamine by monoamine oxidase', 'Dopamine clearance from the synaptic cleft', 'Metabolism of serotonin']"
Maob,-0.19517155,-0.24192628,2,['Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB']
Map10,-0.22968096,-0.12830193,2,
Map1a,0.18846244,-0.07514035,1,
Map1b,0.1568953,-0.011589325,1,
Map1lc3a,0.13367714,-0.06744709,1,"['Macroautophagy', 'PINK1-PRKN Mediated Mitophagy', 'Receptor Mediated Mitophagy']"
Map1lc3b,0.3678425,-0.11648068,1,"['Macroautophagy', 'PINK1-PRKN Mediated Mitophagy', 'TBC/RABGAPs', 'Receptor Mediated Mitophagy', 'Pexophagy', 'KEAP1-NFE2L2 pathway']"
Map1s,0.14296222,-0.06376662,1,
Map2,0.27386305,-0.30934942,1,
Map2k1,0.62950647,-0.14991619,1,"['MAPK3 (ERK1) activation', 'Frs2-mediated activation', 'Signal transduction by L1', 'RAF activation', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway']"
Map2k2,0.53821325,-0.08646731,1,"['MAPK1 (ERK2) activation', 'Frs2-mediated activation', 'Signal transduction by L1', 'RAF activation', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway']"
Map2k3,0.4499011,-0.05138564,1,"['Oxidative Stress Induced Senescence', 'activated TAK1 mediates p38 MAPK activation']"
Map2k4,0.4784353,-0.12654993,1,"['Oxidative Stress Induced Senescence', 'FCERI mediated MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1']"
Map2k5,0.3993597,-0.0071299896,3,
Map2k6,0.43942863,-0.08303174,1,"['NOD1/2 Signaling Pathway', 'Oxidative Stress Induced Senescence', 'activated TAK1 mediates p38 MAPK activation', 'PI5P Regulates TP53 Acetylation', 'Interleukin-1 signaling']"
Map2k7,0.5029513,-0.1226858,1,"['Oxidative Stress Induced Senescence', 'FCERI mediated MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1']"
Map3k1,0.56698555,-0.17534778,1,
Map3k10,0.30473912,-0.05125179,1,
Map3k11,0.34955212,-0.21052478,1,"['RAF activation', 'RHOG GTPase cycle', 'RHOV GTPase cycle']"
Map3k12,0.13547316,-0.11356347,1,
Map3k13,0.22276433,-0.1432189,1,
Map3k14,0.4091839,0.114908546,3,"['CD28 dependent PI3K/Akt signaling', 'Dectin-1 mediated noncanonical NF-kB signaling', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Map3k15,0.4283082,-0.08552987,1,
Map3k2,0.3958472,0.006663104,1,
Map3k20,0.070999116,0.0007449186,2,
Map3k21,0.0346865,-0.18653062,1,
Map3k3,0.42202932,-0.17366661,1,['Interleukin-1 signaling']
Map3k4,0.32486153,-0.028345542,1,
Map3k5,0.3498878,-0.10148869,1,['Oxidative Stress Induced Senescence']
Map3k6,-0.029326558,-0.03295959,2,
Map3k7,0.5425879,-0.06619484,3,"['NOD1/2 Signaling Pathway', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'Ca2+ pathway', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'TNFR1-induced NFkappaB signaling pathway', 'CLEC7A (Dectin-1) signaling', 'Ub-specific processing proteases', 'Interleukin-1 signaling', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Map3k7cl,-0.059904303,0.050624665,2,
Map3k8,0.43138936,0.0681468,3,"['CD28 dependent PI3K/Akt signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation']"
Map3k9,0.14426093,-0.073649585,1,
Map4,-0.03144696,-0.11693955,2,
Map4k1,0.23960318,-0.27101764,1,
Map4k2,0.2662194,0.011861627,3,
Map4k3,0.21184084,-0.1276344,1,
Map4k4,0.17507228,0.010243811,1,
Map4k5,-0.05607802,-0.039664824,2,
Map6,-0.0511551,-0.039292846,2,
Map7,-0.10329589,-0.18353142,2,
Map7d2,-0.3109216,0.07586873,2,
Map7d3,-0.03665911,0.056249544,2,
Map9,-0.09807693,0.082969986,2,
Mapk1,0.6746231,-0.2505392,1,"['phospho-PLA2 pathway', 'RAF-independent MAPK1/3 activation', 'MAPK1 (ERK2) activation', 'Signaling by NODAL', 'Spry regulation of FGF signaling', 'Signaling by Activin', 'Golgi Cisternae Pericentriolar Stack Reorganization', 'Frs2-mediated activation', 'ERK/MAPK targets', 'ERKs are inactivated', 'Regulation of actin dynamics for phagocytic cup formation', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'FCERI mediated MAPK activation', 'Regulation of HSF1-mediated heat shock response', 'NCAM signaling for neurite out-growth', 'Recycling pathway of L1', 'Signal transduction by L1', 'Activation of the AP-1 family of transcription factors', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RHO GTPases Activate WASPs and WAVEs', 'RHO GTPases Activate NADPH Oxidases', 'RAF/MAP kinase cascade', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway', 'Negative regulation of MAPK pathway', 'Neutrophil degranulation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Signal attenuation', 'Gastrin-CREB signalling pathway via PKC and MAPK', 'ESR-mediated signaling', 'Regulation of the apoptosome activity', 'Estrogen-stimulated signaling through PRKCZ', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'Growth hormone receptor signaling']"
Mapk10,0.5084509,-0.19605005,1,
Mapk11,0.6227698,-0.1352987,1,"['NOD1/2 Signaling Pathway', 'p38MAPK events', 'ERK/MAPK targets', 'Oxidative Stress Induced Senescence', 'DSCAM interactions', 'VEGFA-VEGFR2 Pathway', 'activated TAK1 mediates p38 MAPK activation', 'Activation of the AP-1 family of transcription factors', 'Myogenesis', 'RHO GTPases Activate NADPH Oxidases', 'Regulation of TP53 Activity through Phosphorylation']"
Mapk12,0.586018,-0.21431847,1,"['NOD1/2 Signaling Pathway', 'DSCAM interactions', 'VEGFA-VEGFR2 Pathway', 'Myogenesis', 'Negative regulation of MAPK pathway']"
Mapk13,0.47719303,-0.19772394,1,"['NOD1/2 Signaling Pathway', 'DSCAM interactions', 'VEGFA-VEGFR2 Pathway']"
Mapk14,0.6380187,-0.18658018,1,"['NOD1/2 Signaling Pathway', 'p38MAPK events', 'ERK/MAPK targets', 'Oxidative Stress Induced Senescence', 'DSCAM interactions', 'ADP signalling through P2Y purinoceptor 1', 'Platelet sensitization by LDL', 'VEGFA-VEGFR2 Pathway', 'activated TAK1 mediates p38 MAPK activation', 'Activation of the AP-1 family of transcription factors', 'Myogenesis', 'RHO GTPases Activate NADPH Oxidases', 'Neutrophil degranulation', 'Regulation of TP53 Activity through Phosphorylation']"
Mapk15,0.067043565,-0.14462845,2,
Mapk3,0.72144556,-0.2641449,1,"['MAPK3 (ERK1) activation', 'RAF-independent MAPK1/3 activation', 'ISG15 antiviral mechanism', 'Signaling by NODAL', 'Spry regulation of FGF signaling', 'Signaling by Activin', 'Golgi Cisternae Pericentriolar Stack Reorganization', 'Frs2-mediated activation', 'ERK/MAPK targets', 'ERKs are inactivated', 'Regulation of actin dynamics for phagocytic cup formation', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'FCERI mediated MAPK activation', 'Regulation of HSF1-mediated heat shock response', 'NCAM signaling for neurite out-growth', 'Signal transduction by L1', 'Activation of the AP-1 family of transcription factors', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'RHO GTPases Activate WASPs and WAVEs', 'RHO GTPases Activate NADPH Oxidases', 'RAF/MAP kinase cascade', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway', 'Negative regulation of MAPK pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RNA Polymerase I Promoter Opening', 'Signal attenuation', 'Gastrin-CREB signalling pathway via PKC and MAPK', 'ESR-mediated signaling', 'Regulation of the apoptosome activity', 'Growth hormone receptor signaling']"
Mapk4,0.15214324,0.13997744,3,['MAPK6/MAPK4 signaling']
Mapk6,0.4742035,0.16795085,3,['MAPK6/MAPK4 signaling']
Mapk7,0.53787506,-0.077465616,3,"['ERK/MAPK targets', 'Signalling to ERK5', 'ERKs are inactivated', 'Senescence-Associated Secretory Phenotype (SASP)', 'Gastrin-CREB signalling pathway via PKC and MAPK', 'RET signaling']"
Mapk8,0.6402721,-0.22910795,1,"['Activation of BIM and translocation to mitochondria ', 'Activation of BMF and translocation to mitochondria', 'NRAGE signals death through JNK', 'Oxidative Stress Induced Senescence', 'FCERI mediated MAPK activation', 'DSCAM interactions', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'Activation of the AP-1 family of transcription factors', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Interleukin-38 signaling']"
Mapk8ip1,0.2881805,-0.25414428,1,
Mapk8ip2,0.21495335,-0.24435341,1,
Mapk8ip3,0.279568,-0.15438528,1,
Mapk9,0.5464514,-0.22581108,1,"['Oxidative Stress Induced Senescence', 'FCERI mediated MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'Activation of the AP-1 family of transcription factors']"
Mapkap1,0.28024417,0.02867832,1,"['PIP3 activates AKT signaling', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability', 'Regulation of TP53 Degradation']"
Mapkapk2,0.41173318,-0.1532052,1,"['p38MAPK events', 'CREB phosphorylation', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Oxidative Stress Induced Senescence', 'Regulation of HSF1-mediated heat shock response', 'VEGFA-VEGFR2 Pathway', 'activated TAK1 mediates p38 MAPK activation', 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA']"
Mapkapk3,0.21486753,-0.10104713,1,"['p38MAPK events', 'Oxidative Stress Induced Senescence', 'VEGFA-VEGFR2 Pathway', 'activated TAK1 mediates p38 MAPK activation']"
Mapkapk5,0.36421424,0.10196982,3,"['Oxidative Stress Induced Senescence', 'MAPK6/MAPK4 signaling', 'Regulation of TP53 Activity through Phosphorylation']"
Mapkbp1,0.013807195,0.08096743,2,
Mapre1,0.23787065,0.121727176,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'EML4 and NUDC in mitotic spindle formation']"
Mapre2,0.10181793,0.26066208,3,
Mapre3,0.18473099,0.24196945,3,
Mapt,0.55245256,-0.06785706,3,['Caspase-mediated cleavage of cytoskeletal proteins']
Marchf10,-0.30048445,-0.07024676,2,
Marchf11,-0.16590635,-0.08576852,2,
Marchf2,-0.08425624,-0.0646399,2,
Marchf3,0.116809115,0.019048143,3,
Marchf4,-0.23505527,0.0124342935,2,
Marchf5,0.05517252,-0.111198545,2,
Marchf6,0.06453429,0.022074392,2,
Marchf7,-0.003511164,0.24757364,3,
Marcks,0.36521703,-0.11135011,1,['Acetylcholine regulates insulin secretion']
Marcksl1,0.1106115,-0.045812413,1,
Marco,-0.07824558,0.083026856,0,
Marf1,-0.12113976,0.021654189,2,
Mark1,0.28508312,-0.10896093,1,
Mark2,0.3226288,-0.08992301,1,
Mark3,0.43185258,-0.2860968,1,"['RAF activation', 'MAP2K and MAPK activation', 'Negative regulation of MAPK pathway']"
Mark4,0.20726952,-0.09835912,1,['Anchoring of the basal body to the plasma membrane']
Mars1,-0.09524535,0.33327448,0,
Mars2,-0.17636207,-0.051962107,2,
Marveld2,0.1691016,0.037189797,3,
Marveld3,-0.057121687,-0.16922747,2,
Mas1,-0.07220339,-0.0788367,2,
Masp1,-0.05591471,-0.07463919,2,"['Lectin pathway of complement activation', 'Initial triggering of complement', 'Ficolins bind to repetitive carbohydrate structures on the target cell surface', 'Scavenging by Class A Receptors']"
Masp2,-0.18043154,-0.23426354,2,"['Lectin pathway of complement activation', 'Initial triggering of complement', 'Ficolins bind to repetitive carbohydrate structures on the target cell surface']"
Mast1,-0.04844983,-0.15123583,2,
Mast2,0.07656184,-0.1761276,1,
Mast3,0.10396293,-0.08835423,1,
Mast4,-0.08119304,-0.07824862,2,
Mastl,-0.035961565,0.28747818,3,['MASTL Facilitates Mitotic Progression']
Mat1a,0.020879922,-0.105339706,1,"['Methylation', 'Sulfur amino acid metabolism', 'Metabolism of ingested SeMet, Sec, MeSec into H2Se']"
Mat2a,-0.089501075,-0.12045639,2,['Methylation']
Mat2b,0.015921157,-0.068755925,2,"['Methylation', 'Ub-specific processing proteases']"
Matk,0.37111256,-0.2039257,1,
Matn1,-0.079664476,-0.21665399,2,['ECM proteoglycans']
Matn2,0.043225657,-0.00950714,1,
Matn3,-0.07609323,-0.24480383,2,"['ECM proteoglycans', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Matn4,-0.2109308,-0.13401447,2,
Matr3,0.021588113,0.2701667,0,
Mau2,-0.13295268,0.23216946,2,['Cohesin Loading onto Chromatin']
Mavs,0.42490825,0.12249674,3,"['DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'Negative regulators of DDX58/IFIH1 signaling']"
Max,0.40188724,0.22916952,3,['Transcriptional Regulation by E2F6']
Maz,-0.12764159,0.29739922,2,
Mb,0.16140854,-0.18138917,1,['Intracellular oxygen transport']
Mbd1,0.22727014,0.106673576,3,
Mbd2,0.21705438,0.19509675,3,
Mbd3,0.27960372,0.319379,3,"['HDACs deacetylate histones', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Mbd3l1,0.11483074,-0.006139173,3,
Mbd3l2,0.20741577,0.23629868,3,
Mbd4,0.19506148,0.11669595,3,
Mbd5,0.20351973,0.30147818,3,['UCH proteinases']
Mbd6,0.2793454,0.23452352,3,['UCH proteinases']
Mbip,0.18653491,0.22496754,3,
Mbl1,-0.109344885,-0.20751826,2,
Mbl2,-0.043216906,-0.029611193,2,"['Lectin pathway of complement activation', 'Initial triggering of complement']"
Mblac1,-0.08234849,0.042491477,2,
Mblac2,-0.01622154,0.05790667,2,
Mbnl1,0.029342748,0.0845619,2,
Mbnl2,-0.017951364,-0.055905998,2,
Mbnl3,-0.04241779,0.01454656,2,
Mboat1,-0.25554186,-0.26039588,2,"['Acyl chain remodelling of PS', 'Acyl chain remodelling of PE']"
Mboat2,-0.23386271,-0.15170531,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PE']"
Mboat4,-0.031446,-0.1839064,2,"['Synthesis, secretion, and deacylation of Ghrelin']"
Mboat7,-0.29993987,0.06794458,2,['Acyl chain remodelling of PI']
Mbp,0.3671251,-0.20408612,1,
Mbtd1,0.1483188,0.11206067,3,
Mbtps1,0.09420894,-0.29929253,1,"['Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'ATF6 (ATF6-alpha) activates chaperones', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'CREB3 factors activate genes', 'Post-translational protein phosphorylation']"
Mbtps2,0.16471447,-0.08226416,3,"['Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'ATF6 (ATF6-alpha) activates chaperones', 'CREB3 factors activate genes']"
Mc1r,0.13866247,-0.34659335,1,"['Peptide ligand-binding receptors', 'G alpha (s) signalling events']"
Mc2r,-0.11666008,-0.27840063,2,"['Peptide ligand-binding receptors', 'G alpha (s) signalling events']"
Mc3r,-0.028122498,-0.2554773,1,"['Peptide ligand-binding receptors', 'G alpha (s) signalling events']"
Mc4r,0.02478503,-0.30801114,1,"['Peptide ligand-binding receptors', 'G alpha (s) signalling events']"
Mc5r,-0.09835413,-0.20410033,2,"['Peptide ligand-binding receptors', 'G alpha (s) signalling events']"
Mcam,0.24558853,-0.3476897,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Mcat,-0.07270363,-0.15316397,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Mccc1,-0.20890118,-0.027025715,2,"['Biotin transport and metabolism', 'Branched-chain amino acid catabolism']"
Mccc2,-0.19276103,0.07651618,2,"['Biotin transport and metabolism', 'Branched-chain amino acid catabolism']"
Mcee,-0.16440292,0.05001905,2,['Propionyl-CoA catabolism']
Mcemp1,0.035231642,-0.032634728,2,['Neutrophil degranulation']
Mcf2,0.29928592,0.028899513,1,"['Axonal growth inhibition (RHOA activation)', 'NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Mcf2l,0.16797899,-0.09340203,1,
Mcfd2,-0.12861533,-0.25486365,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Mchr1,-0.07318711,0.06657426,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events', 'BBSome-mediated cargo-targeting to cilium']"
Mcidas,0.07000014,0.17818835,3,
Mcl1,0.45748,0.11612132,3,
Mcm10,0.18924922,0.35996434,3,"['Activation of ATR in response to replication stress', 'Activation of the pre-replicative complex']"
Mcm2,0.21093218,0.42170885,3,"['Activation of ATR in response to replication stress', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Mcm3,0.22199298,0.5538476,3,"['Activation of ATR in response to replication stress', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Mcm3ap,0.12506226,0.4998129,0,
Mcm4,0.23784731,0.3318107,3,"['Activation of ATR in response to replication stress', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Mcm5,0.3477054,0.48793018,3,"['Activation of ATR in response to replication stress', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Mcm6,0.21169038,0.44559404,3,"['Activation of ATR in response to replication stress', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Mcm7,0.2288628,0.36538774,3,"['Activation of ATR in response to replication stress', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex', 'Switching of origins to a post-replicative state']"
Mcm8,0.032049026,0.28324074,3,"['Activation of ATR in response to replication stress', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex']"
Mcm9,0.12117075,0.37122023,3,
Mcmbp,0.054622922,0.23432454,3,
Mcmdc2,0.057568945,0.35693565,3,
Mcoln1,0.04457645,0.027304567,2,"['TRP channels', 'Transferrin endocytosis and recycling']"
Mcoln2,0.08905931,0.0631118,1,['TRP channels']
Mcoln3,-0.05366446,-0.12175373,2,['TRP channels']
Mcph1,0.2333385,0.3461174,3,['Condensation of Prophase Chromosomes']
Mcpt2,-0.22166218,-0.17597334,2,
Mcpt4,-0.2245982,0.057055008,2,
Mcpt8,-0.06395431,-0.19319448,1,
Mcrip1,-0.08345225,0.2062096,0,
Mcrs1,0.29104745,0.32104257,3,"['HATs acetylate histones', 'UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Mctp1,-0.25422382,-0.0026829792,2,
Mcts1,0.017535275,0.18222219,0,
Mcts2,-0.11935495,0.14593528,2,
Mcu,-0.04173201,-0.11560967,2,"['Mitochondrial calcium ion transport', 'Processing of SMDT1']"
Mcub,-0.2511177,-0.102000915,2,"['Mitochondrial calcium ion transport', 'Processing of SMDT1']"
Mcur1,-0.21865278,-0.22394904,2,
Mdc1,0.28006685,0.2840068,3,
Mdga1,-0.17656854,-0.20473826,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Mdga2,-0.09611497,-0.11620393,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Mdh1,-0.22443396,-0.18907574,2,['Gluconeogenesis']
Mdh1b,-0.18551415,-0.06517342,2,
Mdh2,-0.12345767,-0.06832597,2,"['Gluconeogenesis', 'Citric acid cycle (TCA cycle)']"
Mdk,0.4432155,-0.247205,1,['Signaling by ALK']
Mdm1,-0.17186473,0.01276849,2,
Mdm2,0.5380569,0.30782422,3,"['AKT phosphorylates targets in the cytosol', 'Oxidative Stress Induced Senescence', 'Oncogene Induced Senescence', 'SUMOylation of ubiquitinylation proteins', 'Trafficking of AMPA receptors', 'Ub-specific processing proteases', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Stabilization of p53', 'Regulation of RUNX3 expression and activity']"
Mdm4,0.42247722,0.3087436,3,"['Oxidative Stress Induced Senescence', 'Oncogene Induced Senescence', 'Ub-specific processing proteases', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Stabilization of p53']"
Mdn1,-0.23584229,0.40258172,0,
Me1,-0.17059132,-0.041468438,2,['Pyruvate metabolism']
Me2,-0.22686073,-0.09929562,2,['Citric acid cycle (TCA cycle)']
Me3,-0.18711974,0.12047969,2,['Citric acid cycle (TCA cycle)']
Mea1,0.089222424,-0.02465092,1,
Meaf6,0.40203655,0.3072975,3,"['HATs acetylate histones', 'Regulation of TP53 Activity through Acetylation']"
Meak7,-0.10978223,0.05817776,2,
Mecom,0.09724517,0.0749661,3,"['PKMTs methylate histone lysines', 'Regulation of PTEN gene transcription']"
Mecp2,0.52179193,0.11234057,3,['Regulation of MECP2 expression and activity']
Mecr,-0.23765872,-0.21071884,2,['Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA']
Med1,0.40556443,0.23999436,3,"['Nuclear Receptor transcription pathway', 'Regulation of lipid metabolism by PPARalpha', 'Estrogen-dependent gene expression', 'Cytoprotection by HMOX1']"
Med10,0.033044983,0.2968564,0,
Med11,-0.02520077,0.10173343,2,
Med12,0.20784533,0.21598758,3,
Med12l,0.0016826876,0.1902034,0,
Med13,-0.014177296,0.2394993,3,
Med13l,0.19484371,0.18638958,3,
Med14,0.25606978,0.18153276,3,
Med15,0.23343904,0.06383548,3,
Med16,-0.04246695,0.061354388,2,
Med17,0.112998895,0.28800932,3,
Med18,-0.03175017,0.15761785,2,
Med19,-0.077271186,0.21880762,2,
Med20,-0.1911384,0.13474934,2,
Med21,-0.030004876,0.32824343,0,
Med22,-0.017124463,0.06353836,2,
Med23,0.14670603,0.14272651,3,
Med24,-0.00019589473,0.27253193,0,
Med25,-0.041891973,0.1365695,2,
Med26,0.017384933,0.21261013,0,
Med27,-0.0043006977,0.061851647,2,
Med28,-0.071506366,0.11674603,2,
Med29,-0.047487628,0.11448935,2,
Med30,-0.19486065,0.2013939,0,
Med31,0.031344127,0.36873177,0,
Med4,-0.08124749,0.13521065,2,
Med6,0.024661785,0.33010924,0,
Med7,0.09090034,0.3017161,0,
Med8,-0.05188045,0.21176803,3,
Med9,-0.06566769,0.19278051,2,
Medag,-0.25628614,0.02550591,2,
Mef2a,0.47476998,0.023882614,3,['Myogenesis']
Mef2b,0.27962562,0.014796893,3,
Mef2c,0.52236557,-0.037365276,3,['Myogenesis']
Mef2d,0.41088498,0.04890316,3,['Myogenesis']
Mefv,0.31340426,-0.058170557,1,['The NLRP3 inflammasome']
Megf10,0.04867528,-0.18937984,1,
Megf11,-0.06812208,-0.1912022,2,"['Laminin interactions', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Type I hemidesmosome assembly', 'MET activates PTK2 signaling', 'Post-translational protein phosphorylation']"
Megf6,-0.068185434,-0.052769884,2,
Megf8,0.13065074,-0.1174165,1,
Megf9,-0.036418255,-0.22590527,1,
Mei1,-0.12844013,0.1361725,2,
Mei4,-0.26374605,-0.21318378,2,
Meig1,-0.19522296,0.27562773,0,
Meiob,0.2238351,0.31840792,3,
Meioc,-0.14112796,0.22905351,0,
Meis1,-0.018190514,0.24968013,3,
Meis2,-0.046987493,0.098216146,2,
Melk,0.20062962,0.3820655,3,
Memo1,0.1422641,-0.2248114,1,['ERBB2 Regulates Cell Motility']
Men1,0.42117533,0.14142956,3,"['Formation of the beta-catenin:TCF transactivating complex', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'RHO GTPases activate IQGAPs', 'Post-translational protein phosphorylation']"
Meox1,-0.0481923,0.068036266,2,
Meox2,-0.17874745,-0.13631886,2,
Mep1a,-0.058331467,-0.07614783,2,
Mep1b,0.066718765,-0.22913013,1,
Mepce,0.06042031,0.25652122,0,
Mepe,0.12883921,-0.01517046,3,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Mertk,0.35026994,-0.22480105,1,['Cell surface interactions at the vascular wall']
Mesd,-0.24067289,0.066791676,2,
Mesp1,-0.05973236,0.040985074,2,
Mesp2,-0.14071137,-0.044891026,2,
Mest,0.027873399,-0.025066255,2,
Met,0.59709865,-0.33122888,1,
Metap1,-0.014907832,0.030350411,0,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Metap1d,-0.17555204,0.04134862,2,
Metap2,0.04863071,0.16238366,0,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Metrnl,-0.32764342,-0.09318855,2,
Mettl1,-0.11089413,0.4477814,0,
Mettl11b,-0.1783269,0.13928612,2,
Mettl14,0.13095152,0.33161116,0,['Processing of Capped Intron-Containing Pre-mRNA']
Mettl16,-0.10420262,0.116227,0,
Mettl17,-0.06977783,0.22403467,0,
Mettl18,-0.11417232,0.19465432,0,
Mettl2,-0.2009905,0.20929016,0,
Mettl21a,0.11613574,-0.010606617,1,['Protein methylation']
Mettl21c,-0.28603452,0.13577819,2,
Mettl22,-0.22506894,-0.10147136,2,['Protein methylation']
Mettl23,-0.18025315,0.021261165,2,
Mettl24,-0.0918446,0.1706726,2,
Mettl25,-0.2771112,0.23886411,2,
Mettl27,-0.15771149,0.3197342,0,
Mettl3,0.22022228,0.2813359,0,
Mettl4,-0.19485722,0.003822359,2,
Mettl5,-0.32609478,0.07568915,2,
Mettl6,-0.20624615,0.007868581,2,
Mettl7a1,-0.05218954,0.10538752,2,
Mettl7a2,-0.22667992,-0.0707427,2,
Mettl8,-0.34484476,0.11592438,2,
Mettl9,-0.19286518,0.15047325,2,
Mex3b,0.19284596,0.07612301,3,
Mex3c,-0.355604,0.023781685,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Mfap1a,-0.25140694,0.5147107,0,
Mfap1b,-0.24231347,0.43932673,0,
Mfap2,-0.002357668,-0.08746672,2,
Mfap3,-0.24760152,0.22203892,2,
Mfap4,-0.0782921,-0.012589988,2,['Molecules associated with elastic fibres']
Mfap5,0.22405979,0.12694827,3,"['Elastic fibre formation', 'Molecules associated with elastic fibres']"
Mff,-0.014266527,-0.028767692,2,
Mfge8,0.24284287,-0.15378234,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Mfhas1,-0.091091275,-0.08809592,2,
Mfn1,0.3498042,-0.12608013,1,"['PINK1-PRKN Mediated Mitophagy', 'RHOT2 GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Mfn2,0.33582145,-0.042021926,3,"['PINK1-PRKN Mediated Mitophagy', 'RHOT2 GTPase cycle', 'Factors involved in megakaryocyte development and platelet production']"
Mfng,0.0047592986,0.034497835,2,
Mfrp,-0.25684214,0.0025670636,2,
Mfsd1,-0.34387496,0.01639147,2,
Mfsd10,-0.2647527,0.09413313,2,
Mfsd11,-0.19693126,-0.05366122,2,
Mfsd12,-0.14441979,0.07186514,2,
Mfsd13a,-0.2791428,0.07023711,2,
Mfsd14b,-0.23550333,0.029192353,2,
Mfsd2b,-0.102930196,-0.049736027,2,
Mfsd3,-0.3799265,0.03299204,2,
Mfsd4a,-0.29498342,-0.1963991,2,
Mfsd5,-0.1475407,0.09232323,2,
Mfsd6,-0.18370381,0.020099891,2,
Mfsd6l,-0.30562687,-0.15456623,2,
Mfsd8,-0.27709246,0.15970755,2,
Mfsd9,-0.25897652,-0.023329671,2,
Mga,0.24405587,0.24121073,3,['Transcriptional Regulation by E2F6']
Mgam,-0.13766614,-0.23136286,2,"['Digestion of dietary carbohydrate', 'Neutrophil degranulation']"
Mgat1,-0.16248882,-0.11276508,2,['N-glycan trimming and elongation in the cis-Golgi']
Mgat2,-0.10691222,-0.058411013,2,['Reactions specific to the complex N-glycan synthesis pathway']
Mgat3,0.040754534,0.021824107,3,
Mgat4a,-0.056150127,0.032774787,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation', 'N-Glycan antennae elongation']"
Mgat4b,-0.09394186,0.029661823,2,['N-Glycan antennae elongation']
Mgat4c,-0.27091488,-0.11197197,2,['N-Glycan antennae elongation']
Mgat4d,-0.02905739,0.069768995,2,
Mgat5,-0.020309929,-0.12718004,2,['N-Glycan antennae elongation']
Mgat5b,-0.13577546,-0.045342516,2,
Mgl2,-0.027483594,0.07700214,2,
Mgll,-0.16413406,-0.21792547,2,"['Acyl chain remodeling of DAG and TAG', 'Arachidonate production from DAG']"
Mgme1,-0.14329112,0.054944783,2,
Mgmt,-0.081309885,0.0440933,2,
Mgp,0.13373114,-0.18226394,1,
Mgrn1,0.09164123,0.071837604,0,['Antigen processing: Ubiquitination & Proteasome degradation']
Mgst1,0.28930673,-0.18642014,1,"['Glutathione conjugation', 'Aflatoxin activation and detoxification', 'Neutrophil degranulation']"
Mgst2,-0.020229379,-0.05020587,0,"['Glutathione conjugation', 'Aflatoxin activation and detoxification']"
Mgst3,-0.046107955,-0.02086924,2,"['Glutathione conjugation', 'Aflatoxin activation and detoxification']"
Mia2,-0.054216597,0.18756028,0,
Mib1,0.22420777,-0.00222608,3,
Mib2,0.15259366,0.05331948,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Mical1,0.074261606,-0.05005731,2,
Mical2,-0.01933141,-0.28079793,1,
Mical3,0.12701133,0.0018680084,1,
Micall1,0.15127283,-0.16251858,1,
Micall2,-0.060470287,-0.25816384,1,
Micos10,-0.17780839,-0.14792933,2,
Micos13,-0.019973587,-0.06013106,2,
Micu1,-0.14439207,-0.044313528,2,"['Mitochondrial calcium ion transport', 'Processing of SMDT1']"
Micu2,-0.22128314,0.09583067,2,"['Mitochondrial calcium ion transport', 'Processing of SMDT1']"
Micu3,-0.079270124,0.06315512,2,"['Mitochondrial calcium ion transport', 'Processing of SMDT1']"
Mid1,0.02985435,-0.03287774,2,
Mid1ip1,-0.30379194,-0.17124483,2,['Carnitine metabolism']
Mid2,-0.022399763,0.16659619,2,
Mideas,0.12020795,0.22470431,3,
Mief1,-0.05264022,-0.035054296,2,
Mief2,0.016242038,-0.17878772,2,
Mien1,-0.21851926,-0.20656258,2,
Mier1,0.032577448,-0.09623674,2,
Mier3,-0.045056205,0.20791343,2,
Mif,0.04898394,-0.23471746,1,"['Cell surface interactions at the vascular wall', 'Neutrophil degranulation']"
Mif4gd,-0.062591955,0.20490578,0,
Miga1,-0.12021411,0.26510638,0,['Synthesis of PA']
Miga2,0.04433682,0.02158301,2,['Synthesis of PA']
Miip,-0.032108717,0.005602455,2,
Mill1,0.03641874,0.06425233,0,
Mill2,0.08387485,-0.15757152,1,
Mindy1,0.099771746,0.01998387,3,
Mindy2,-0.12128262,0.102133356,2,
Mindy3,-0.1683979,0.010011894,2,
Mindy4,-0.119357795,-0.114702284,2,
Mink1,0.06426573,0.057360496,3,['Oxidative Stress Induced Senescence']
Minpp1,-0.06352807,-0.082328126,2,['Synthesis of IPs in the ER lumen']
Mios,0.02013618,0.058929995,2,['Amino acids regulate mTORC1']
Miox,-0.08090704,-0.22674471,2,"['Synthesis of IP2, IP, and Ins in the cytosol']"
Mip,-0.13560075,-0.14004792,2,['Passive transport by Aquaporins']
Mipep,-0.08392786,-0.08767503,2,
Mipol1,-0.18897517,-0.06415053,2,
Mis12,-0.00571987,0.30819392,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Mis18a,-0.05885747,0.14159092,2,['Deposition of new CENPA-containing nucleosomes at the centromere']
Mis18bp1,0.21367203,0.41477954,3,['Deposition of new CENPA-containing nucleosomes at the centromere']
Mitd1,-0.18702227,-0.022318577,2,
Mitf,0.38929415,-0.04316515,1,['SUMOylation of transcription factors']
Mixl1,-0.011469961,-0.010430716,2,
Mki67,0.5255813,0.2983882,3,
Mkks,0.051113628,0.18188362,0,
Mkln1,-0.24184507,-0.14520197,2,
Mknk1,0.15299277,0.05425455,3,
Mknk2,0.10507341,0.0081710415,0,
Mkrn1,0.37658313,0.081830114,3,"['AKT phosphorylates targets in the cytosol', 'Regulation of PTEN stability and activity', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Mkrn3,-0.0625191,-0.072617315,2,
Mks1,0.06808156,0.08555693,3,"[""Hedgehog 'off' state"", 'Anchoring of the basal body to the plasma membrane']"
Mkx,-0.015608677,0.052749753,2,
Mlana,-0.051570702,-0.15927164,2,
Mlec,-0.16339308,-0.120404415,2,['Neutrophil degranulation']
Mlf1,-0.044179652,0.0086948015,2,
Mlf2,0.011677825,-0.12630539,2,
Mlh1,0.18303557,0.3688731,3,['Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)']
Mlh3,0.08571774,0.2430275,3,
Mlip,0.33043215,0.09997343,3,
Mlkl,0.28399616,-0.014090543,1,"['TRP channels', 'RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death']"
Mllt1,0.11686971,0.46948475,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Mllt10,-0.005832394,0.24604289,3,
Mllt11,0.009078313,-0.07696029,2,
Mllt3,0.21190837,0.31365687,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Mllt6,0.14628506,0.2453451,3,
Mlph,0.094853275,-0.07948723,1,
Mlst8,0.21459581,0.102136515,3,"['PIP3 activates AKT signaling', 'Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'HSF1-dependent transactivation', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Degradation', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Mlx,0.3363279,0.019060211,1,
Mlxip,0.10837665,0.0060202684,3,
Mlxipl,0.11960233,0.07242365,3,
Mlycd,-0.13358136,-0.01333727,2,"['Beta-oxidation of very long chain fatty acids', 'Peroxisomal protein import']"
Mmaa,-0.18597865,0.020793717,2,"['Propionyl-CoA catabolism', 'Cobalamin (Cbl) metabolism']"
Mmab,-0.18216954,-0.033304345,2,['Cobalamin (Cbl) metabolism']
Mmachc,-0.1524096,0.04472517,2,['Cobalamin (Cbl) metabolism']
Mmadhc,-0.17879738,0.018521609,2,['Cobalamin (Cbl) metabolism']
Mmd,-0.24177155,-0.34477615,2,
Mme,0.3368301,-0.18236713,1,"['Metabolism of Angiotensinogen to Angiotensins', 'Physiological factors', 'Neutrophil degranulation']"
Mmgt1,-0.17093515,0.008928839,2,
Mmgt2,-0.17914796,-0.075859204,2,
Mmp10,0.1365068,-0.2049503,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases']"
Mmp11,0.104959786,-0.22226949,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases']"
Mmp12,0.03945846,-0.40200463,1,"['Collagen degradation', 'Degradation of the extracellular matrix']"
Mmp13,0.2566123,-0.3750139,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Assembly of collagen fibrils and other multimeric structures']"
Mmp14,0.2651322,-0.37726077,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases']"
Mmp15,0.039249126,-0.18039952,1,"['Collagen degradation', 'Activation of Matrix Metalloproteinases']"
Mmp16,-0.07853296,-0.38237718,1,['Activation of Matrix Metalloproteinases']
Mmp17,-0.07373165,-0.13912086,1,['Activation of Matrix Metalloproteinases']
Mmp19,-0.08062115,-0.2145506,1,['Degradation of the extracellular matrix']
Mmp1b,-0.14038296,-0.2661369,2,
Mmp2,0.48163202,-0.25236818,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'EPH-ephrin mediated repulsion of cells', 'Extra-nuclear estrogen signaling']"
Mmp20,0.023712277,-0.13903151,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Assembly of collagen fibrils and other multimeric structures']"
Mmp21,-0.23749448,0.015974028,2,
Mmp23,-0.08876185,-0.10324692,2,
Mmp24,0.059388775,-0.2812751,1,['Activation of Matrix Metalloproteinases']
Mmp25,0.07162903,-0.07839743,1,"['Activation of Matrix Metalloproteinases', 'Neutrophil degranulation']"
Mmp27,0.3502701,-0.339329,1,
Mmp28,-0.03348179,-0.20223154,1,
Mmp3,0.26935437,-0.38273826,1,
Mmp7,0.25386983,-0.31361705,1,
Mmp8,0.13444623,-0.2480709,1,"['Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation']"
Mmp9,0.50822324,-0.28723618,1,"['Signaling by SCF-KIT', 'Collagen degradation', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Assembly of collagen fibrils and other multimeric structures', 'EPH-ephrin mediated repulsion of cells', 'Neutrophil degranulation', 'Extra-nuclear estrogen signaling']"
Mmrn1,-0.0476987,-0.098883614,2,
Mmrn2,-0.12606718,-0.32325795,1,
Mms19,-0.07379139,0.19856773,2,
Mms22l,0.13555935,0.20198575,3,
Mmut,-0.17283285,0.02703728,2,"['Propionyl-CoA catabolism', 'Cobalamin (Cbl) metabolism']"
Mnat1,0.3847619,0.4041749,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Formation of Incision Complex in GG-NER', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Cyclin A:Cdk2-associated events at S phase entry', 'mRNA Capping', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Mnd1,-0.25276658,0.33869514,2,
Mns1,-0.27449042,0.065552935,2,
Mnt,0.18634878,0.34497926,3,
Mnx1,-0.0030165503,-0.012638069,2,
Moap1,-0.13844553,0.11082907,2,
Mob1a,0.048632752,-0.032880303,2,['Signaling by Hippo']
Mob1b,0.046266057,-0.01684201,2,['Signaling by Hippo']
Mob2,-0.0243848,-0.044756755,2,
Mob3a,-0.18188286,-0.119321674,2,
Mob3b,-0.16221319,-0.13977861,2,
Mob3c,-0.062022295,0.04849428,2,
Mob4,0.19540258,-0.02380508,3,
Mobp,0.11819539,-0.06439354,1,
Mocos,-0.15401237,0.13690992,2,['Molybdenum cofactor biosynthesis']
Mocs1,0.030226534,0.16483694,3,['Molybdenum cofactor biosynthesis']
Mocs2,0.18821348,0.11114465,3,
Mocs3,0.0926652,0.28380826,3,['Molybdenum cofactor biosynthesis']
Mog,0.24596187,-0.14084142,1,
Mogat1,-0.10923248,-0.12996641,2,['Triglyceride biosynthesis']
Mogat2,-0.03878865,-0.15953843,2,['Triglyceride biosynthesis']
Mogs,-0.16090667,-0.2026671,2,
Mok,-0.19088024,-0.076915406,2,
Mon1a,-0.2240497,-0.036929313,2,
Mon1b,-0.28330883,-0.30424488,2,['RAB GEFs exchange GTP for GDP on RABs']
Mon2,-0.1835092,0.1118856,2,
Morc2b,-0.2179744,0.015890507,2,
Morc3,-0.19573052,0.112823196,2,
Morf4l1,0.2561889,0.4907325,3,
Morf4l2,0.076668896,0.23404719,3,
Morn1,-0.1543777,-0.08524789,2,
Morn2,-0.06449497,0.055478215,2,
Morn3,-0.19503601,0.12140231,2,
Morn4,-0.30361298,-0.2930432,2,
Morn5,-0.33914128,-0.025872756,2,
Mos,0.24996854,-0.0036454224,3,
Mosmo,-0.012650593,-0.22940493,2,
Mospd1,-0.13362797,-0.21898924,2,
Mospd2,-0.17858303,-0.23288782,2,"['Neutrophil degranulation', 'RHOD GTPase cycle']"
Mospd3,-0.1330744,-0.013113445,2,
Mov10,0.006912028,0.4125074,0,
Mov10l1,0.09008811,-0.021529905,3,
Moxd1,-0.17251444,-0.05336381,2,
Moxd2,-0.024727423,-0.048219264,2,
Mpc1,-0.021262998,0.052457042,2,
Mpc2,-0.005874508,-0.047205616,2,
Mpdu1,-0.11055157,-0.2118862,2,
Mpdz,0.14079838,-0.28414148,1,
Mpeg1,0.09777236,-0.3142439,1,
Mpg,-0.027391896,-0.04668567,2,"['Cleavage of the damaged purine', 'Displacement of DNA glycosylase by APEX1']"
Mphosph10,-0.27227384,0.4159668,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Mphosph6,-0.43110546,0.16074744,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Mphosph8,0.062447727,0.26065677,3,
Mphosph9,-0.17386855,0.05862627,2,
Mpi,-0.09012512,0.13789941,2,['Synthesis of GDP-mannose']
Mpig6b,0.10612837,-0.36923406,1,['GPVI-mediated activation cascade']
Mpl,0.32884058,-0.17110468,1,
Mpnd,0.105433896,0.36181846,3,
Mpo,0.17647146,-0.14313932,1,"['Neutrophil degranulation', 'Events associated with phagocytolytic activity of PMN cells']"
Mpp1,-0.039911315,-0.23875757,1,
Mpp2,-0.011660006,0.17822787,0,
Mpp3,-0.11181426,-0.27434367,2,
Mpp4,-0.058147933,-0.0052448204,2,
Mpp7,0.013367145,-0.03179131,1,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Mppe1,-0.1343417,0.06624649,2,
Mpped1,-0.1089396,0.09630667,2,
Mpped2,-0.25159046,0.042565506,2,
Mprip,0.20491141,-0.066764265,1,
Mpst,-0.086102426,0.026970578,2,['Degradation of cysteine and homocysteine']
Mptx2,-0.058285136,-0.1761756,2,
Mpv17,-0.22645122,-0.22084457,2,['Peroxisomal protein import']
Mpv17l,-0.090674736,-0.19031252,2,
Mpv17l2,-0.20181578,-0.20794955,2,
Mpz,-0.0033214975,-0.051487233,1,
Mpzl1,-0.14037418,-0.32472226,1,
Mpzl2,-0.14807059,0.12550524,2,
Mr1,-0.11280258,-0.113165885,2,
Mrap,0.051659282,-0.22207497,1,
Mrap2,-0.25050402,-0.11415559,2,
Mras,0.44997853,-0.39269245,1,['RAF activation']
Mrc1,0.28520146,-0.061216533,1,['Cross-presentation of soluble exogenous antigens (endosomes)']
Mrc2,0.10545961,-0.17108567,1,['Cross-presentation of soluble exogenous antigens (endosomes)']
Mre11a,0.32326064,0.37067303,3,"['Cytosolic sensors of pathogen-associated DNA ', 'DNA Damage/Telomere Stress Induced Senescence', 'HDR through Single Strand Annealing (SSA)', 'HDR through MMEJ (alt-NHEJ)', 'HDR through Homologous Recombination (HRR)', 'Sensing of DNA Double Strand Breaks', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Nonhomologous End-Joining (NHEJ)', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Mreg,-0.11698103,-0.121063404,2,
Mrfap1,-0.07451834,0.13994579,2,
Mrgbp,0.057195112,0.31118095,3,
Mrgpra3,-0.023644507,0.08047527,2,
Mrgpra9,-0.06090435,-0.21374366,2,
Mrgprb8,-0.07035824,-0.08414301,2,
Mrgprd,-0.12534377,-0.057926748,2,
Mrgpre,0.07048765,0.02181832,1,
Mrgprx1,-0.028140327,-0.13619131,2,
Mri1,-0.110107824,0.11245063,2,['Methionine salvage pathway']
Mrm1,-0.2694396,0.22878605,2,
Mrm2,-0.30462137,0.18122353,0,
Mrm3,0.025834067,0.12251095,0,
Mro,-0.30841047,-0.26161236,2,
Mroh1,-0.27620196,0.26734108,0,
Mroh2a,-0.16388892,-0.15827644,2,
Mroh5,-0.29046366,-0.03956361,2,
Mroh6,-0.3316978,-0.066902824,2,
Mroh8,-0.17164335,0.048376538,2,
Mroh9,-0.0703295,-0.15993169,2,
Mrpl1,-0.18875733,0.27482858,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl10,-0.1519987,0.10199351,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl11,-0.048147347,0.20019212,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl12,-0.07859773,0.18004826,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl13,0.045892105,0.19975188,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl14,0.0013570283,0.16580932,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl15,-0.12748899,0.21025783,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl16,-0.049514227,0.15698676,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl17,-0.11816884,0.14942087,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl18,-0.017118445,0.098212525,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl19,-0.15850186,0.27190882,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl2,0.049626336,0.31724992,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl20,0.061658498,0.19605188,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl21,-0.05027036,0.099339664,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl22,-0.062275242,0.24209435,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl23,-0.17433223,0.16365348,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl24,-0.06436613,0.1605935,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl27,-0.00073168264,0.24895953,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl28,-0.04406915,0.11376453,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl3,-0.15609147,0.1567902,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl30,-0.28441063,-0.038092293,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl32,-0.17029254,0.18931004,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl33,-0.16080146,0.12533179,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl34,-0.18687044,-0.012706745,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl35,-0.14831498,-0.10239707,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl36,-0.08198873,0.32015616,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl37,-0.059226524,0.09548595,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl38,-0.08703085,-0.046668623,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl39,0.015089848,0.19979748,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl4,-0.09738779,0.20623407,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl40,-0.13377216,0.08995096,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl41,-0.16668434,0.103544466,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl42,-0.102030076,0.047182,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl43,-0.081606776,0.054977577,0,
Mrpl44,-0.1020854,0.013893498,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl45,-0.07007379,0.11862203,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl46,-0.12171146,0.12738888,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl47,-0.18467353,0.0524733,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl48,-0.029032847,-0.01689463,0,
Mrpl49,-0.1002868,0.07309713,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl50,-0.12313713,-0.036126852,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl51,-0.050642475,0.12160363,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl52,-0.09588989,0.15194608,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl53,0.0056012864,0.08560908,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl54,-0.030031338,0.22345336,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl55,-0.06848809,0.25072703,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl57,-0.15996206,-0.020539287,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl58,-0.027394412,0.16879696,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrpl9,-0.12545587,0.18828362,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps10,0.0013355023,0.10680264,0,
Mrps11,-0.1734796,0.18750373,0,
Mrps12,-0.0148082115,0.17265038,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps14,-0.07139988,0.20492473,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps15,-0.067709275,0.16728544,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps16,-0.012046395,0.24922782,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps17,0.07754425,0.13654365,3,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps18a,-0.11357312,0.02906597,0,
Mrps18b,-0.10512803,0.025152553,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps18c,-0.03833233,0.14018567,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps2,-0.12194809,0.037866656,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps21,-0.13063271,0.101328135,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps22,-0.1091735,0.083138235,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps23,0.028648276,0.1933123,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps24,-0.076487325,-0.012243422,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps25,-0.12338566,0.032446966,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps26,-0.0709139,-0.089232765,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps27,-0.15996876,0.0936476,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps28,-0.045334335,0.04694009,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps30,-0.13184685,0.07957543,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps31,-0.09130885,0.061420444,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps33,-0.056620598,0.07038274,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps34,-0.14087877,0.1319979,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps35,-0.037300278,0.00993834,2,
Mrps36,-0.17962359,0.11432545,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps5,-0.026668588,0.21703967,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps6,-0.1922613,0.11048704,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps7,-0.09568909,0.32562515,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrps9,0.039454523,0.27927908,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Mrrf,-0.1315735,0.06791686,0,['Mitochondrial translation termination']
Mrs2,-0.052909806,-0.20644848,2,['Miscellaneous transport and binding events']
Mrtfa,0.14751917,0.11644037,3,"['SUMOylation of transcription cofactors', 'RHO GTPases Activate Formins']"
Mrtfb,-0.19320996,-0.03832242,2,
Mrto4,-0.17752327,0.46691942,0,
Ms4a1,-0.023630958,-0.23988003,1,
Ms4a12,-0.17551914,-0.122680515,2,
Ms4a14,-0.09330394,0.10081956,2,
Ms4a15,-0.40396342,0.07079801,2,
Ms4a18,-0.24444167,-0.046734888,2,
Ms4a19,-0.1309,0.077929236,2,
Ms4a2,0.13182643,-0.27465564,1,"['Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'FCERI mediated NF-kB activation']"
Ms4a3,-0.22686951,-0.08078783,2,['Neutrophil degranulation']
Ms4a4b,-0.11206278,-0.20114848,2,
Ms4a4c,-0.33619976,-0.09597905,2,
Ms4a5,-0.3097901,0.118462764,2,
Ms4a6b,-0.25269327,-0.095979095,2,
Ms4a6c,-0.22946386,-0.15370202,2,
Ms4a6d,-0.03374592,-0.23196666,1,
Msantd1,-0.100507975,0.0029768846,2,
Msc,-0.05781124,-0.0002613685,2,
Msgn1,-0.09605847,-0.073912024,2,
Msh2,0.14277719,0.522508,3,"['Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)']"
Msh3,0.16409191,0.37724677,3,
Msh4,0.13160029,0.3847374,3,
Msh5,0.16873546,0.076866634,3,
Msh6,0.17817335,0.46104792,3,['Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)']
Msi1,-0.016184675,0.10984289,3,
Msi2,-0.022400124,0.11983545,0,['RHOBTB2 GTPase cycle']
Msl1,0.21307383,0.25535834,3,['HATs acetylate histones']
Msl2,0.27304518,0.27604964,3,['HATs acetylate histones']
Msl3,0.297397,0.22285235,3,['HATs acetylate histones']
Msl3l2,-0.03278307,0.30012882,0,
Msln,-0.030515008,-0.19351426,2,"['Post-translational modification: synthesis of GPI-anchored proteins', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Msmb,-0.20948052,0.061922777,2,
Msmo1,-0.18499705,-0.1608415,2,['Cholesterol biosynthesis']
Msmp,-0.17172118,-0.056190677,2,
Msn,0.40089557,-0.27202368,1,['Recycling pathway of L1']
Msr1,0.09392221,0.03892451,1,['Scavenging by Class A Receptors']
Msra,0.001782038,-0.07760249,2,['Protein repair']
Msrb1,-0.14014825,-0.20047116,2,['Protein repair']
Msrb2,-0.08288151,-0.053601287,2,['Protein repair']
Msrb3,-0.08929347,-0.064195156,2,
Mss51,-0.11484094,-0.08238288,2,
Mst1,0.18976763,0.0034266966,3,['Signaling by MST1']
Mst1r,0.34162045,-0.30559048,1,['Signaling by MST1']
Mstn,0.27578446,-0.08909557,3,
Msto1,-0.361067,-0.15077497,2,
Msx1,0.118392944,0.010062068,3,
Msx2,0.17973988,-0.073697254,1,
Msx3,-0.14827815,-0.028046412,2,
Mt1,-0.22584972,-0.062371057,2,['Metallothioneins bind metals']
Mt2,-0.23546489,-0.02616856,2,['Metallothioneins bind metals']
Mta1,0.2598908,0.3189828,3,"['HDACs deacetylate histones', 'SUMOylation of transcription factors', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Mta2,0.30850995,0.261304,3,"['HDACs deacetylate histones', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Mta3,0.3055015,0.2950814,3,"['HDACs deacetylate histones', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription']"
Mtap,-0.0677259,0.109093174,2,['Methionine salvage pathway']
Mtarc1,-0.16708389,0.061743762,2,['Phase I - Functionalization of compounds']
Mtarc2,-0.30138594,0.026067145,2,['Phase I - Functionalization of compounds']
Mtbp,0.15410998,0.13271132,3,
Mtch1,0.14591633,-0.04353984,3,
Mtch2,-0.029230282,-0.18606111,1,
Mtcl1,-0.016968949,-0.15494011,2,
Mtcp1,0.14198762,-0.11325322,1,
Mtdh,-0.116104744,-0.02595877,2,
Mterf1a,-0.31054518,0.018236384,2,
Mterf1b,-0.23204306,0.07550926,2,
Mterf2,-0.24535127,-0.03288461,2,
Mterf3,0.07428956,0.0735353,3,['PINK1-PRKN Mediated Mitophagy']
Mterf4,-0.29231116,0.13849677,0,
Mtf1,-0.40590996,-0.18863955,2,
Mtf2,0.024537515,0.08015477,3,['PRC2 methylates histones and DNA']
Mtfmt,-0.1970644,-0.15614262,2,
Mtfr1l,-0.07438988,0.03309566,2,
Mtg1,-0.32945442,-0.033176515,0,
Mtg2,-0.21822995,-0.030389102,2,
Mthfd1,-0.007531969,-0.023346873,2,['Metabolism of folate and pterines']
Mthfd1l,-0.04219357,-0.045668576,2,['Metabolism of folate and pterines']
Mthfd2,-0.14448854,-0.040351305,2,['Metabolism of folate and pterines']
Mthfd2l,-0.14038195,0.1207497,2,['Metabolism of folate and pterines']
Mthfr,0.13414484,0.00036162554,1,['Metabolism of folate and pterines']
Mthfs,-0.052807998,0.08654913,2,['Metabolism of folate and pterines']
Mthfsd,-0.09860474,-0.15848812,2,
Mthfsl,-0.17499058,-0.038553204,2,
Mtif2,-0.13327564,0.09592931,0,
Mtif3,-0.08433678,0.051161,0,
Mtm1,0.064825825,-0.23121345,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane']"
Mtmr1,0.016722627,-0.026671972,1,"['Synthesis of PIPs at the plasma membrane', 'RHOF GTPase cycle']"
Mtmr10,-0.017998517,0.077195615,2,
Mtmr12,0.027321462,-0.13941601,1,['Synthesis of PIPs at the early endosome membrane']
Mtmr14,-0.064111486,-0.2936163,2,"['Macroautophagy', 'Synthesis of PIPs at the plasma membrane']"
Mtmr2,0.09244639,-0.09711182,1,"['Synthesis of PIPs at the ER membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane']"
Mtmr3,-0.038190827,-0.23368797,1,
Mtmr4,0.018818054,-0.13263172,1,"['Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane', 'Downregulation of TGF-beta receptor signaling']"
Mtmr6,0.2317213,-0.24557553,1,['Synthesis of PIPs at the plasma membrane']
Mtmr7,-0.036507744,-0.17081556,1,['Synthesis of PIPs at the late endosome membrane']
Mtmr9,-0.08070073,-0.06243183,2,['Synthesis of PIPs at the plasma membrane']
Mtnr1a,0.058393873,-0.11862213,1,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Mtnr1b,0.09162439,-0.19023158,1,
Mto1,-0.2741986,0.057104908,0,
Mtor,0.546916,0.0949888,3,"['PIP3 activates AKT signaling', 'Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'HSF1-dependent transactivation', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Degradation', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Mtpap,-0.20743097,-0.12659693,2,
Mtpn,0.19607097,0.24591216,0,
Mtr,-0.10265719,-0.041549575,2,"['Methylation', 'Sulfur amino acid metabolism', 'RHOH GTPase cycle', 'Cobalamin (Cbl) metabolism']"
Mtrex,-0.18334733,0.52909255,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Mtrf1,-0.05107743,0.033472333,0,
Mtrf1l,-0.23921113,-0.09314493,2,['Mitochondrial translation termination']
Mtrr,-0.12988466,-0.05974653,2,
Mtss1,0.25123972,0.043197248,1,
Mtss2,-0.16808218,-0.260615,2,
Mttp,0.17449962,-0.32465002,1,"['VLDL assembly', 'Chylomicron assembly', 'LDL remodeling']"
Mturn,-0.31970277,-0.22507723,2,
Mtus1,-0.08287844,-0.039655313,2,
Mtus2,-0.120249204,0.08844854,2,
Mtx1,-0.14235424,-0.18193349,2,
Mtx2,-0.10161592,-0.07169372,2,
Mtx3,0.03181367,-0.10399003,1,
Muc1,0.081070885,-0.3173272,1,
Muc13,-0.18730904,-0.06670851,2,"['O-linked glycosylation of mucins', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle', 'Termination of O-glycan biosynthesis']"
Muc15,-0.14519693,-0.16662244,2,"['O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Muc16,0.0036081942,-0.29670134,2,"['O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Muc20,0.035119742,-0.1644412,2,"['MET activates RAS signaling', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Muc21,0.039684944,-0.11401393,2,"['O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Muc3,-0.2962048,-0.114419654,2,"['O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Muc3a,-0.3896619,-0.085012965,2,
Muc5ac,-0.08160826,-0.19656579,2,"['O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Muc5b,-0.18830374,-0.16710673,2,"['O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis']"
Mug1,-0.3109202,-0.0059161475,2,
Mug2,-0.13882133,-0.046416327,2,
Mul1,0.1718599,0.098129176,3,"['Ub-specific processing proteases', 'Neddylation', 'KEAP1-NFE2L2 pathway']"
Mup11,-0.2714925,0.011689668,2,
Mup16,-0.19639955,0.030372018,2,
Mup18,-0.2037051,-0.122993164,2,
Mup19,-0.24192779,-0.13576221,2,
Mup3,-0.17337434,-0.027884265,2,
Mup4,-0.12310501,0.06425141,2,
Mup5,-0.19284824,0.05816441,2,
Mus81,0.15973902,0.3784056,3,"['Resolution of D-loop Structures through Holliday Junction Intermediates', 'Fanconi Anemia Pathway']"
Musk,0.27119303,-0.14897764,1,
Mutyh,0.13092044,0.21437176,3,"['Cleavage of the damaged purine', 'Displacement of DNA glycosylase by APEX1']"
Mvb12a,0.06676747,0.009115215,2,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Mvb12b,0.11320826,0.012317215,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Mvd,-0.2946169,-0.17724448,2,"['Cholesterol biosynthesis', 'Synthesis of Dolichyl-phosphate']"
Mvk,-0.2174299,0.0040124008,2,['Cholesterol biosynthesis']
Mvp,0.11476139,0.051873967,0,
Mx1,0.04166551,0.0440933,2,
Mxd1,0.24525891,0.14488223,3,
Mxd3,-0.1620578,0.04050213,2,
Mxd4,0.2822997,0.20951019,3,
Mxi1,0.17225339,0.28857383,3,
Mxra7,-0.17967072,-0.042966485,2,
Mxra8,-0.11207366,0.0030357216,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Myadm,-0.22125253,-0.04940703,2,
Myadml2,-0.27523592,0.056174003,2,
Myb,0.42511073,0.17578396,3,
Mybbp1a,0.06230365,0.47264555,0,['B-WICH complex positively regulates rRNA expression']
Mybl1,-0.10759648,-0.11171606,2,
Mybl2,0.43084025,0.34067267,3,
Mybpc1,-0.03202574,-0.056178473,2,['Striated Muscle Contraction']
Mybpc2,-0.024029631,-0.052501436,2,['Striated Muscle Contraction']
Mybpc3,0.0010243058,-0.07148136,2,
Mybph,0.0114633925,-0.10024655,1,
Mybphl,-0.18948685,-0.093516916,2,
Myc,0.5520882,0.15643819,3,"['Ub-specific processing proteases', 'TFAP2 (AP-2) family regulates transcription of cell cycle factors']"
Mycbp,0.052496977,0.16517171,3,
Mycbp2,0.07775946,0.16355136,3,
Mycbpap,-0.2754513,0.031861093,2,
Mycl,-0.017880434,0.1309655,2,
Mycn,0.383766,0.24300143,3,
Mycs,-0.2926829,0.06535329,2,
Myct1,-0.15129437,-0.14560717,2,
Myd88,0.43125045,-0.038860116,1,"['PIP3 activates AKT signaling', 'RIP-mediated NFkB activation via ZBP1', 'p75NTR recruits signalling complexes', 'DEx/H-box helicases activate type I IFN and inflammatory cytokines production ', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-1 signaling']"
Myef2,-0.14339167,0.106621526,2,
Myf5,0.35333452,-0.0291075,3,['Myogenesis']
Myf6,0.2922334,-0.03820584,3,['Myogenesis']
Myg1,-0.11510961,-0.018263716,2,
Myh1,0.1322312,0.045579273,3,
Myh10,0.22517784,-0.3839116,1,['RHO GTPases activate PAKs']
Myh11,0.188763,-0.34476805,1,
Myh13,0.023462068,0.06306398,3,
Myh14,0.18670656,-0.28756624,1,['RHO GTPases activate PAKs']
Myh15,-0.010034926,-0.067777246,2,
Myh2,0.32622617,-0.15954573,1,['Regulation of actin dynamics for phagocytic cup formation']
Myh3,0.11081882,-0.0948047,3,['Striated Muscle Contraction']
Myh4,0.13315979,-0.12240992,1,
Myh6,0.16558646,-0.19614331,1,['Striated Muscle Contraction']
Myh7,0.16732171,-0.2117499,1,
Myh7b,0.005486599,-0.06059153,2,
Myh8,-0.07060419,-0.13312194,2,['Striated Muscle Contraction']
Myh9,0.28964126,-0.21800958,1,"['Regulation of actin dynamics for phagocytic cup formation', 'RHO GTPases activate PAKs']"
Myl1,0.0986096,-0.31016478,1,['Striated Muscle Contraction']
Myl10,0.074578814,-0.3186493,1,['Smooth Muscle Contraction']
Myl12a,0.14438188,-0.11961426,1,
Myl12b,0.20348091,-0.10830639,1,"['Smooth Muscle Contraction', 'RHO GTPases activate PAKs']"
Myl2,0.18638767,-0.1832962,1,['Striated Muscle Contraction']
Myl3,-0.009086066,-0.15429415,2,['Striated Muscle Contraction']
Myl4,0.092237756,-0.066625126,2,
Myl6,0.22847933,-0.2534588,1,"['Smooth Muscle Contraction', 'RHO GTPases activate PAKs']"
Myl6b,0.09423735,-0.19882204,1,['Smooth Muscle Contraction']
Myl7,0.11250224,-0.21503484,1,['Smooth Muscle Contraction']
Myl9,0.28999406,-0.21356402,1,"['Smooth Muscle Contraction', 'RHO GTPases activate PAKs']"
Mylip,-0.07207008,0.13561727,2,"['VLDLR internalisation and degradation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Mylk,0.2946417,-0.35805103,1,"['Smooth Muscle Contraction', 'RHO GTPases activate PAKs']"
Mylk2,0.060853064,-0.14285891,2,
Mylk3,0.075858675,-0.1307307,2,
Mylpf,0.16102229,-0.1855516,1,['Smooth Muscle Contraction']
Mymk,-0.09516889,0.017632034,2,
Mymx,-0.12025617,0.07957144,2,
Mynn,0.030098917,-0.023989312,2,
Myo10,0.15443347,-0.3301341,1,['Regulation of actin dynamics for phagocytic cup formation']
Myo15,-0.15054671,-0.045163665,2,
Myo16,-0.12417008,0.18302792,0,
Myo18a,-0.051932994,0.03858292,2,
Myo18b,-0.22906214,-0.07170088,2,
Myo19,-0.0860812,-0.1206243,2,"['RHOT2 GTPase cycle', 'RHOT1 GTPase cycle']"
Myo1a,0.07265007,-0.08027024,1,
Myo1c,0.27251697,-0.045319986,1,"['Regulation of actin dynamics for phagocytic cup formation', 'B-WICH complex positively regulates rRNA expression']"
Myo1d,0.08277219,-0.27753845,1,
Myo1e,-0.07576769,-0.3670041,1,
Myo1f,0.20505072,-0.033584382,1,
Myo1g,0.08477715,-0.01928551,3,
Myo3a,0.05601436,-0.10440523,1,
Myo3b,-0.32968515,-0.28732002,2,
Myo5a,0.2586291,-0.31856713,1,['Regulation of actin dynamics for phagocytic cup formation']
Myo5b,-0.0006389226,-0.04343964,2,
Myo5c,-0.22438009,0.053758,2,
Myo6,0.39494038,-0.1312557,1,
Myo7a,0.13581418,-0.2136633,1,['The canonical retinoid cycle in rods (twilight vision)']
Myo7b,-0.23733577,-0.1552359,2,
Myo9a,0.15741108,0.031895757,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOV GTPase cycle']"
Myo9b,0.21784133,-0.1157914,1,
Myoc,0.033262767,0.0018739112,1,
Myocd,0.30968732,0.028423775,3,
Myod1,0.5043637,0.10879273,3,['Myogenesis']
Myof,0.07713059,-0.2648651,1,
Myog,0.37638974,-0.07613994,1,['Myogenesis']
Myom1,-0.08119917,-0.056571014,2,
Myom2,0.16503635,-0.15020928,1,
Myorg,-0.05613482,0.12132817,0,
Myot,0.09826675,-0.2149145,1,
Myoz1,-0.14454801,-0.07639866,2,
Myoz2,0.1403948,-0.13565075,1,
Myoz3,-0.10453889,0.037330844,2,
Mypn,-0.012077033,-0.09865528,2,
Myrf,0.029501276,-0.024833933,1,
Myrip,0.010184882,-0.16127545,1,
Mysm1,0.35713172,0.2622966,3,['Metalloprotease DUBs']
Myt1,0.16927986,0.12897663,3,
Myt1l,-0.12866396,-0.087254226,2,
Myzap,-0.018651318,-0.13016346,2,
Mzb1,0.06938863,-0.14373982,1,
Mzt1,-0.09769494,0.0050450913,2,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Mzt2,0.013084548,-0.039789636,2,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
N4bp1,-0.120439634,0.09317638,2,['Regulation of NF-kappa B signaling']
N4bp3,-0.24461046,-0.09134492,2,
N6amt1,-0.37899992,0.16202642,0,"['Methylation', 'Eukaryotic Translation Termination']"
Naa10,0.24741451,0.071676634,3,
Naa11,0.028022587,-0.0035752056,2,
Naa12,0.13533407,0.04079706,1,
Naa15,-0.031837378,0.15550457,0,
Naa16,-0.11707781,0.13995361,2,
Naa20,-0.17095977,0.03639518,2,
Naa25,0.02944477,-0.013293257,1,
Naa30,-0.0806404,0.03189818,2,
Naa35,0.05869412,0.0072331983,1,
Naa38,0.055444557,0.48597166,0,
Naa40,-0.16453426,0.007026434,2,
Naa50,0.14151669,0.29514295,3,
Naa60,-0.13538651,0.039733034,2,
Naa80,0.0076378426,0.24680886,0,
Naaa,-0.08525945,0.05531751,2,['Neurotransmitter release cycle']
Nab1,0.059156198,0.1917558,3,
Nab2,-0.033074845,0.19947799,3,['NGF-stimulated transcription']
Nabp1,-0.21415557,0.15823297,2,['RNA polymerase II transcribes snRNA genes']
Nabp2,-0.1326621,0.19756615,2,['RNA polymerase II transcribes snRNA genes']
Naca,0.07443992,0.1606192,0,
Nacad,-0.08596325,0.20640929,0,
Nacc1,0.0152208535,0.1770089,3,
Nadk,-0.23900622,-0.08744203,2,['Nicotinate metabolism']
Nadsyn1,-0.15770914,0.028136814,2,['Nicotinate metabolism']
Nae1,0.32124338,0.0657672,3,['Neddylation']
Naf1,-0.16948093,0.40250778,0,
Naga,-0.10878592,-0.021372939,2,
Nagk,-0.3558286,-0.17261206,2,['Synthesis of UDP-N-acetyl-glucosamine']
Naglu,-0.27132723,-0.026098998,2,['HS-GAG degradation']
Nagpa,0.07602907,-0.08417471,2,
Nags,-0.2443491,-0.06295166,2,['Urea cycle']
Naif1,-0.13593191,0.11254833,2,
Naip1,0.15835004,0.027872505,1,
Naip2,0.070276834,0.00067091454,1,
Naip5,0.064239584,0.062592566,0,
Naip6,-0.07402433,0.2401262,2,
Nalcn,-0.092265554,-0.3043548,2,
Nalf1,-0.17450511,-0.2674241,2,
Nalf2,-0.184048,-0.14382695,2,
Nampt,0.17709567,-0.024363112,3,['Nicotinamide salvaging']
Nanog,0.38097084,0.28405923,3,
Nanos1,-0.20343322,0.19942863,2,
Nanos2,-0.05430112,0.13533327,2,
Nanos3,-0.019613892,0.23388103,3,
Nanp,-0.11614846,-0.030719118,2,['Sialic acid metabolism']
Nans,-0.04070244,-0.110549,2,['Sialic acid metabolism']
Nap1l2,-0.07897326,0.07687781,2,
Nap1l3,-0.12500675,0.013614751,2,
Nap1l4,0.020180352,0.3139146,3,
Nap1l5,-0.00047742695,0.08263115,0,
Napa,-0.30526465,-0.063930966,2,"['COPII-mediated vesicle transport', 'Golgi Associated Vesicle Biogenesis', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Napb,-0.3329318,-0.018957509,2,"['COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Napepld,-0.047750894,0.11562519,2,
Napg,-0.16189592,-0.14560659,2,"['COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Naprt,-0.26436248,-0.030114487,2,"['Nicotinamide salvaging', 'Neutrophil degranulation']"
Napsa,-0.0026567185,-0.15421554,2,['Surfactant metabolism']
Narf,0.02879372,0.017334364,2,
Nars,-0.18595791,-0.032542624,2,
Nars2,-0.121708594,0.030650359,2,
Nasp,0.15845534,0.52547157,3,
Nat1,-0.30378014,-0.122943565,2,"['Acetylation', 'Paracetamol ADME']"
Nat10,-0.20188124,0.5125621,0,
Nat14,-0.21611832,-0.074813955,2,
Nat2,-0.12224158,-0.15159391,2,"['Acetylation', 'Paracetamol ADME']"
Nat3,-0.099392705,0.025728509,2,"['Acetylation', 'Paracetamol ADME']"
Nat8,-0.06728072,-0.09468471,2,
Nat8f1,-0.04329195,-0.14316432,2,
Nat8f2,-0.11971946,-0.22025126,2,
Nat8f3,0.044789255,-0.16285492,1,
Nat8f5,-0.22203651,-0.16774587,2,
Nat8f6,-0.10641171,-0.30641744,2,
Nat8f7,0.02064908,-0.103179805,2,
Nat8l,-0.23728718,-0.2766223,2,
Nat9,-0.19970359,0.030293167,2,
Natd1,-0.26876608,-0.051955238,2,
Nav3,-0.1400588,-0.01269412,2,
Naxd,-0.25883648,-0.17726448,2,
Naxe,-0.15001582,-0.023816062,2,['Nicotinamide salvaging']
Nbas,-0.19488189,0.04176964,2,['COPI-dependent Golgi-to-ER retrograde traffic']
Nbea,0.039308697,0.122641936,0,
Nbeal1,-0.18923365,-0.111340396,2,
Nbeal2,-0.18591739,0.14755706,2,['Neutrophil degranulation']
Nbl1,-0.08737081,-0.068920925,2,
Nbn,0.3922668,0.31949815,3,"['DNA Damage/Telomere Stress Induced Senescence', 'HDR through Single Strand Annealing (SSA)', 'HDR through MMEJ (alt-NHEJ)', 'HDR through Homologous Recombination (HRR)', 'Sensing of DNA Double Strand Breaks', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Nonhomologous End-Joining (NHEJ)', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Nbr1,0.28411892,0.033793844,3,['Pexophagy']
Ncald,0.13149628,-0.3617017,1,['Activation of Ca-permeable Kainate Receptor']
Ncam1,0.35265204,-0.36942247,1,
Ncam2,0.165395,-0.13078573,1,
Ncan,-0.08209925,-0.31352353,1,
Ncapd2,0.112422965,0.405596,3,
Ncapd3,0.1616128,0.4203127,3,
Ncapg,0.18907477,0.38647616,3,['Condensation of Prometaphase Chromosomes']
Ncapg2,0.12636971,0.32269353,3,['Condensation of Prophase Chromosomes']
Ncaph,0.018937057,0.34785867,3,['Condensation of Prometaphase Chromosomes']
Ncaph2,-0.017597929,0.17512262,2,['Condensation of Prophase Chromosomes']
Ncbp1,0.11305581,0.59020895,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'RNA Polymerase II Pre-transcription Events', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', ""mRNA 3'-end processing"", 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs', 'Processing of Intronless Pre-mRNAs', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Ncbp2,0.108521104,0.615169,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'RNA Polymerase II Pre-transcription Events', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', ""mRNA 3'-end processing"", 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs', 'Processing of Intronless Pre-mRNAs', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Ncbp3,-0.06417122,0.27843338,0,
Nccrp1,-0.1273105,0.04954231,2,
Ncdn,-0.15316226,-0.047426075,2,
Nceh1,-0.20477389,-0.08345873,2,['LDL clearance']
Ncf1,0.41979435,-0.16275819,1,"['ROS and RNS production in phagocytes', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'Detoxification of Reactive Oxygen Species', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Ncf2,0.30756935,-0.16200301,1,"['ROS and RNS production in phagocytes', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'Detoxification of Reactive Oxygen Species', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Ncf4,0.3664929,-0.3204493,1,"['ROS and RNS production in phagocytes', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'Detoxification of Reactive Oxygen Species', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Nck1,0.53457445,-0.3744517,1,"['Downstream signal transduction', 'Generation of second messenger molecules', 'Regulation of actin dynamics for phagocytic cup formation', 'Nephrin family interactions', 'DCC mediated attractive signaling', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RHOU GTPase cycle', 'RHOV GTPase cycle', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Nck2,0.504944,-0.29302388,1,"['Downstream signal transduction', 'Nephrin family interactions', 'Ephrin signaling', 'VEGFA-VEGFR2 Pathway', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Nckap1,0.2573564,-0.1099742,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Nckap1l,0.20387264,-0.106712565,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'Neutrophil degranulation', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Nckap5,-0.15502264,-0.0382935,2,
Nckap5l,-0.18363562,-0.13974957,2,
Nckipsd,0.11149477,-0.1984526,1,"['Regulation of actin dynamics for phagocytic cup formation', 'RHO GTPases Activate WASPs and WAVEs']"
Ncl,0.40730178,0.32230753,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Ncln,-0.06270674,0.07371988,2,
Ncoa1,0.41578427,0.21411256,3,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Endogenous sterols', 'HATs acetylate histones', 'SUMOylation of transcription cofactors', 'Regulation of lipid metabolism by PPARalpha', 'Estrogen-dependent gene expression', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis', 'Cytoprotection by HMOX1']"
Ncoa2,0.43189636,0.13473922,3,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Endogenous sterols', 'HATs acetylate histones', 'Regulation of lipid metabolism by PPARalpha', 'Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'Estrogen-dependent gene expression', 'Cytoprotection by HMOX1']"
Ncoa3,0.5026339,0.26151764,3,
Ncoa4,0.15205579,0.000790038,1,
Ncoa5,0.108262874,0.31999353,3,
Ncoa6,0.3099685,0.2655939,3,
Ncoa7,0.15653364,0.08644135,3,
Ncor1,0.45445722,0.24165386,3,
Ncor2,0.40746132,0.22918665,3,"['Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'Notch-HLH transcription pathway', 'Transcriptional regulation of white adipocyte differentiation', 'Nuclear Receptor transcription pathway', 'Regulation of lipid metabolism by PPARalpha', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis', 'Cytoprotection by HMOX1']"
Ncr1,0.043987606,-0.19510423,1,
Ncr3-ps,-0.15884534,0.12163592,2,
Ncs1,0.24987005,-0.15776005,1,
Ncstn,0.27039286,-0.20402074,1,"['Nuclear signaling by ERBB4', 'Regulated proteolysis of p75NTR', 'NRIF signals cell death from the nucleus', 'EPH-ephrin mediated repulsion of cells', 'Neutrophil degranulation', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Noncanonical activation of NOTCH3']"
Ndc1,0.0625798,0.38620108,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Ndc80,0.14430451,0.5132133,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Nde1,0.11928898,0.255012,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'AURKA Activation by TPX2', 'EML4 and NUDC in mitotic spindle formation']"
Ndel1,0.20460366,0.010856389,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ndfip1,0.05434915,-0.1658929,1,
Ndfip2,0.10375382,0.008728516,3,
Ndn,0.29942128,0.16115229,3,
Ndor1,-0.08940472,0.084017634,2,
Ndp,-0.14062133,0.039799366,2,
Ndrg1,0.16051589,-0.12108933,1,
Ndrg2,-0.034941386,-0.039400015,2,
Ndrg3,-0.06464289,-0.26027033,2,
Ndrg4,-0.15919869,0.010265406,2,
Ndst1,-0.07694919,-0.23512264,1,['HS-GAG biosynthesis']
Ndst2,-0.37604228,-0.20706035,2,['HS-GAG biosynthesis']
Ndst3,-0.07249205,-0.059447035,2,['HS-GAG biosynthesis']
Ndst4,-0.022705786,-0.018253138,2,['HS-GAG biosynthesis']
Ndufa1,0.05995087,-0.032061644,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa10,0.11091303,-0.035034783,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa11,0.014502439,0.1520909,3,
Ndufa12,0.02581829,-0.014738663,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa13,0.16943812,0.06322037,3,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa2,0.16790728,0.09040335,0,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa3,0.055651523,-0.10220355,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa4,0.08902674,-0.103609644,1,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Ndufa4l2,0.15066066,-0.05708279,1,
Ndufa5,0.022989,0.0020335603,2,"['Respiratory electron transport', 'Complex I biogenesis', 'RHOG GTPase cycle']"
Ndufa6,0.14594537,-0.038114324,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa7,0.113511465,0.1905906,3,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa8,0.04803619,-0.051193807,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufa9,0.12574662,0.047147665,3,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufab1,-0.002699392,-0.043601096,0,"['Glyoxylate metabolism and glycine degradation', 'Respiratory electron transport', 'Complex I biogenesis', 'Mitochondrial Fatty Acid Beta-Oxidation']"
Ndufaf1,-0.08867381,0.04677634,2,
Ndufaf2,0.14316306,0.04787686,3,['Complex I biogenesis']
Ndufaf3,-0.09253451,0.0032013105,2,['Complex I biogenesis']
Ndufaf4,0.06542445,-0.07787359,1,['Complex I biogenesis']
Ndufaf5,0.022794876,-0.047870815,1,['Complex I biogenesis']
Ndufaf6,-0.11903804,0.04950027,2,['Complex I biogenesis']
Ndufaf7,-0.0921247,-0.122163914,2,['Complex I biogenesis']
Ndufb10,0.0436628,0.012231449,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb11,0.11808493,0.051056065,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb11b,-0.042730138,0.03556046,2,
Ndufb2,0.076606795,-0.04237547,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb3,0.11181485,0.023657909,3,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb4,0.10339691,-0.05222772,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb5,0.006106858,-0.06742663,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb6,-0.0075950376,-0.08800217,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb7,0.10914268,0.061897755,0,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufb8,0.109221466,0.12719677,0,"['Mitochondrial protein import', 'Respiratory electron transport', 'Complex I biogenesis']"
Ndufb9,0.014271724,-0.01508483,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufc1,0.031729117,-0.06672548,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufc2,0.027649784,-0.003338186,2,"['Respiratory electron transport', 'Neutrophil degranulation', 'Complex I biogenesis']"
Ndufs1,0.100643754,-0.06930394,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufs2,0.020629441,-0.1826126,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufs3,0.020354932,-0.07703869,1,"['Respiratory electron transport', 'Complex I biogenesis', 'RHOG GTPase cycle']"
Ndufs4,0.16220482,0.013700191,1,
Ndufs5,0.030170895,0.0007761862,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufs6,0.04109374,-0.0063020186,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufs7,0.061138436,0.12574422,3,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufs8,0.17259693,-0.023923595,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufv1,0.07554711,-0.049529713,1,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufv2,-0.011090198,-0.120351955,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Ndufv3,0.020589037,0.03437281,2,"['Respiratory electron transport', 'Complex I biogenesis']"
Neb,-0.01908133,-0.16387807,2,['Striated Muscle Contraction']
Nebl,-0.0074597676,-0.13767722,2,
Necab3,-0.20418747,-0.12421228,2,
Necap1,0.040603366,-0.19093041,1,"['Golgi Associated Vesicle Biogenesis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Necap2,0.018981561,-0.2259353,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Nectin1,0.34934816,-0.31722447,1,"['Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization']"
Nectin2,0.23882858,-0.22112228,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization']"
Nectin3,0.21092518,-0.22703688,1,"['Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization']"
Nectin4,0.088053755,-0.27168393,1,"['Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization']"
Nedd1,0.0724875,0.05958786,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Nedd4,0.5312546,-0.28865388,1,"['ISG15 antiviral mechanism', 'Downregulation of ERBB4 signaling', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Nedd4l,0.45044878,-0.20802572,1,"['Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'Stimuli-sensing channels', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Nedd8,0.40936276,0.35782316,3,"['TGF-beta receptor signaling activates SMADs', 'UCH proteinases', 'Cargo recognition for clathrin-mediated endocytosis', 'Neddylation', 'Iron uptake and transport']"
Nedd9,0.3415237,-0.38071796,1,
Nefh,0.27784452,-0.09289545,1,
Nefl,0.34928685,-0.29565623,1,"['Unblocking of NMDA receptors, glutamate binding and activation', 'RAF/MAP kinase cascade']"
Nefm,0.2129358,-0.17855488,1,
Negr1,0.04044022,-0.13275908,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Neil1,0.053743735,0.08707242,3,"['Recognition and association of DNA glycosylase with site containing an affected pyrimidine', 'Cleavage of the damaged pyrimidine ', 'APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway']"
Neil2,0.123301126,0.18145452,0,"['Cleavage of the damaged pyrimidine ', 'APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway']"
Neil3,0.05745642,0.20725055,3,['Cleavage of the damaged purine']
Nek1,-0.15088741,0.015154959,2,
Nek2,0.20418987,0.27902043,3,"['APC-Cdc20 mediated degradation of Nek2A', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Nek4,-0.1449794,-0.07067722,2,
Nek6,-0.31423855,0.07766914,2,
Nek7,-0.051455863,0.03364347,2,
Nek8,-0.075076304,-0.07842097,2,
Nek9,-0.14157619,0.24574682,2,"['Activation of NIMA Kinases NEK9, NEK6, NEK7']"
Nelfa,-0.1233495,0.23174988,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Nelfb,0.31716675,0.21000214,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Nelfcd,0.09034397,0.077027224,1,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Nelfe,0.12305433,0.25076023,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Nell1,0.10970214,-0.09773802,1,
Nell2,-0.111096315,-0.027987113,2,
Nemf,-0.17761017,0.22219627,0,
Nemp1,-0.04531344,-0.015422279,2,
Nenf,-0.13918635,-0.09766512,2,
Neo1,0.039282188,-0.23047452,1,
Nepn,-0.25666618,0.025261013,2,
Nes,0.37026674,-0.22583765,1,
Net1,0.15768296,-0.048193123,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle']"
Neto1,0.025282517,-0.18432488,1,
Neto2,-0.024292478,-0.12550198,1,
Neu1,-0.19412352,-0.15018843,2,"['Glycosphingolipid metabolism', 'Sialic acid metabolism', 'Neutrophil degranulation']"
Neu2,-0.1679439,-0.16938737,2,"['Glycosphingolipid metabolism', 'Sialic acid metabolism']"
Neu3,-0.16345294,-0.32108125,2,"['Glycosphingolipid metabolism', 'Sialic acid metabolism']"
Neu4,-0.31611243,-0.059400402,2,"['Glycosphingolipid metabolism', 'Sialic acid metabolism']"
Neurl1a,0.06270813,0.098710254,3,
Neurl1b,0.08149039,0.03046742,1,
Neurl2,0.2791038,0.021202015,3,
Neurl4,0.15184622,0.064614944,3,
Neurod1,0.30355704,-0.09817851,3,
Neurod2,-0.21984062,-0.03989333,2,
Neurod4,-0.12950373,-0.124095395,2,
Neurog1,0.12800397,0.040788516,3,
Neurog2,0.23016857,-0.058854412,3,
Neurog3,0.22464514,-0.08216714,3,
Nexmif,-0.055518877,-0.036869206,2,
Nexn,0.12658499,-0.09404701,1,
Nf1,0.6098061,0.036626715,3,['Regulation of RAS by GAPs']
Nf2,0.2953326,-0.12426108,1,"['Regulation of actin dynamics for phagocytic cup formation', 'RHO GTPases activate PAKs']"
Nfasc,-0.057819624,-0.2773201,2,"['Neurofascin interactions', 'Neutrophil degranulation']"
Nfat5,0.12182695,0.0050436077,3,
Nfatc1,0.5236917,-0.03878832,1,
Nfatc2,0.46278465,0.052916933,3,"['Calcineurin activates NFAT', 'FCERI mediated Ca+2 mobilization', 'CLEC7A (Dectin-1) induces NFAT activation']"
Nfatc2ip,0.24211472,0.3083645,3,
Nfatc3,0.39619178,-0.14335303,1,
Nfatc4,0.26475546,-0.085526034,1,
Nfe2,0.10803052,0.03724071,3,
Nfe2l1,0.040867757,-0.03488629,2,
Nfe2l2,0.4040987,0.14246452,3,"['Neddylation', 'KEAP1-NFE2L2 pathway', 'Nuclear events mediated by NFE2L2', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2']"
Nfe2l3,-0.038349513,0.08378441,2,
Nfia,-0.13584048,-0.08503167,2,
Nfib,0.18867044,-0.10042576,3,
Nfic,0.14436744,-0.017252496,3,
Nfil3,0.2636302,0.01073231,3,
Nfix,0.16675588,0.05101996,3,
Nfkb1,0.62519175,0.09696879,3,"['Activation of NF-kappaB in B cells', 'RIP-mediated NFkB activation via ZBP1', 'Regulated proteolysis of p75NTR', 'Downstream TCR signaling', 'NF-kB is activated and signals survival', 'FCERI mediated NF-kB activation', 'DEx/H-box helicases activate type I IFN and inflammatory cytokines production ', 'PKMTs methylate histone lysines', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'Interleukin-1 processing', 'CLEC7A (Dectin-1) signaling', 'CD209 (DC-SIGN) signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Neutrophil degranulation', 'Interleukin-1 signaling', 'TRAF6 mediated NF-kB activation']"
Nfkb2,0.45380914,0.13349995,3,"['RIP-mediated NFkB activation via ZBP1', 'DEx/H-box helicases activate type I IFN and inflammatory cytokines production ', 'PKMTs methylate histone lysines', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'Interleukin-1 processing', 'SUMOylation of immune response proteins', 'Dectin-1 mediated noncanonical NF-kB signaling', 'NIK-->noncanonical NF-kB signaling', 'TRAF6 mediated NF-kB activation']"
Nfkbia,0.46513817,0.17967944,3,"['Activation of NF-kappaB in B cells', 'RIP-mediated NFkB activation via ZBP1', 'Downstream TCR signaling', 'NF-kB is activated and signals survival', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'SUMOylation of immune response proteins', 'CLEC7A (Dectin-1) signaling', 'Ub-specific processing proteases', 'Interleukin-1 signaling', 'TRAF6 mediated NF-kB activation']"
Nfkbib,0.39542866,0.2307266,3,"['Activation of NF-kappaB in B cells', 'RIP-mediated NFkB activation via ZBP1', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'TRAF6 mediated NF-kB activation']"
Nfkbid,-0.0034992797,0.09546944,2,
Nfkbie,0.24384426,0.1517619,3,['Activation of NF-kappaB in B cells']
Nfkbiz,0.34613293,0.05893396,3,
Nfrkb,0.20632324,0.22194728,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Nfs1,-0.030527769,0.14971454,0,"['Mitochondrial iron-sulfur cluster biogenesis', 'Molybdenum cofactor biosynthesis']"
Nfu1,-0.17022437,0.012322245,2,
Nfx1,0.015162823,0.08536375,2,
Nfxl1,-0.22482349,-0.18630464,2,
Nfya,0.2921753,0.06170491,3,
Nfyb,0.13587236,0.31148976,3,
Nfyc,0.08983639,0.11062845,3,
Ngb,0.07513754,-0.22934873,1,['Intracellular oxygen transport']
Ngdn,-0.12372237,0.42673102,0,
Ngef,0.32201058,-0.21283256,1,"['NRAGE signals death through JNK', 'EPHA-mediated growth cone collapse', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Ngf,0.6384677,-0.17102425,1,"['NGF processing', 'Frs2-mediated activation', 'ARMS-mediated activation', 'Retrograde neurotrophin signalling', 'TRKA activation by NGF', 'PI3K/AKT activation', 'NFG and proNGF binds to p75NTR', 'NADE modulates death signalling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Axonal growth stimulation']"
Ngfa,-0.08212252,-0.22573504,2,
Ngfr,0.6176406,-0.12997779,1,"['Axonal growth inhibition (RHOA activation)', 'Regulated proteolysis of p75NTR', 'NFG and proNGF binds to p75NTR', 'NADE modulates death signalling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Axonal growth stimulation']"
Ngly1,-0.02070301,0.24745242,3,['N-glycan trimming in the ER and Calnexin/Calreticulin cycle']
Ngp,0.0040299343,0.13674021,2,
Ngrn,-0.3117789,-0.051628564,2,
Nhej1,0.17635351,0.40402853,3,['Nonhomologous End-Joining (NHEJ)']
Nhlrc1,0.047881678,0.024367057,3,
Nhlrc2,-0.21715924,-0.20057291,2,['Platelet degranulation ']
Nhlrc3,-0.13805659,-0.005982766,2,['Neutrophil degranulation']
Nhp2,-0.053358126,0.5523841,0,['Telomere Extension By Telomerase']
Nhs,-0.18466297,-0.15815656,2,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Niban1,-0.084124744,-0.059664298,2,
Niban2,-0.03468049,-0.001540392,2,
Nicn1,-0.27282938,0.18353333,2,
Nid1,0.09143233,-0.38060597,1,"['Degradation of the extracellular matrix', 'Laminin interactions']"
Nid2,0.147952,-0.18174115,1,['Laminin interactions']
Nif3l1,-0.065923244,-0.12974761,2,
Nifk,-0.24782108,0.48553392,0,
Nin,0.07373698,-0.009108497,3,
Ninl,-0.05747945,0.11864424,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Nip7,-0.21072435,0.40659848,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nipa1,-0.04123601,-0.17100224,2,['Miscellaneous transport and binding events']
Nipa2,-0.14890063,0.06060376,2,['Miscellaneous transport and binding events']
Nipal1,-0.15424876,-0.06623287,2,['Miscellaneous transport and binding events']
Nipal2,-0.050392687,-0.06595449,2,
Nipal4,-0.33736295,-0.02792025,2,['Miscellaneous transport and binding events']
Nipbl,0.09372266,0.48170796,3,['Cohesin Loading onto Chromatin']
Nipsnap2,0.0776304,-0.06323773,1,
Nipsnap3b,-0.33806384,0.10593896,2,
Nisch,-0.088814124,-0.25075608,2,"['RAC1 GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle']"
Nit1,-0.059092045,-0.03756684,2,
Nit2,-0.17248996,-0.13727657,2,['Neutrophil degranulation']
Nkain1,-0.27003816,-0.09636787,2,
Nkain2,-0.30562764,0.114930324,2,
Nkap,-0.15879658,0.35599297,0,
Nkapl,-0.016222345,0.10999725,2,
Nkd1,0.17283945,-0.05289443,1,
Nkd2,0.14024036,0.0782136,3,
Nkg7,0.025087375,-0.13400874,1,
Nkiras1,0.060051206,0.09682837,3,"['RIP-mediated NFkB activation via ZBP1', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'TRAF6 mediated NF-kB activation']"
Nkiras2,0.07101949,0.0042265886,1,"['RIP-mediated NFkB activation via ZBP1', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'TRAF6 mediated NF-kB activation']"
Nkpd1,-0.17710212,0.049773384,2,
Nkrf,-0.04315267,0.14378901,2,
Nktr,0.08104605,0.10963097,3,
Nkx2-1,0.26769188,-0.10820321,1,
Nkx2-2,0.22633506,-0.04636936,1,
Nkx2-3,0.168465,0.085906886,3,
Nkx2-5,0.24631333,-0.12343606,3,
Nkx3-1,0.22271742,-0.10903438,1,
Nkx3-2,0.19200197,0.16330265,3,
Nkx6-1,0.18544298,-0.10111367,3,
Nkx6-2,-0.12497758,0.16894846,2,
Nkx6-3,-0.080085725,-0.04184947,2,
Nle1,-0.13716856,0.4264744,0,
Nlgn1,0.14833762,-0.21439655,1,['Neurexins and neuroligins']
Nlgn2,-0.056976255,-0.28442797,1,['Neurexins and neuroligins']
Nlgn3,0.10641004,-0.043373015,1,['Neurexins and neuroligins']
Nlk,0.3227247,-0.042378586,3,['Ca2+ pathway']
Nln,-0.08815231,-0.12429711,2,['Peptide ligand-binding receptors']
Nlrc3,0.10694477,0.056687552,3,
Nlrc4,0.019611431,0.010679465,2,
Nlrc5,0.060093623,0.049121883,2,['Regulation of NF-kappa B signaling']
Nlrp12,0.20525508,0.17226702,3,
Nlrp1a,0.06495158,-0.022278402,2,['The NLRP1 inflammasome']
Nlrp1b,0.043875616,0.071635716,0,
Nlrp2,0.021813612,-0.14226316,1,
Nlrp3,0.42251676,-0.092593245,1,"['Metalloprotease DUBs', 'The NLRP3 inflammasome']"
Nlrp4a,-0.15299246,-0.030418148,2,
Nlrp4c,0.07590297,0.070290774,3,"['Regulation of innate immune responses to cytosolic DNA', 'IRF3-mediated induction of type I IFN']"
Nlrp4e,-0.09201972,-0.01305461,2,
Nlrp4f,-0.268773,-0.12540083,2,
Nlrp5,-0.26379085,-0.03682975,2,
Nlrp6,-0.03608275,0.17542619,0,
Nlrp9a,-0.08534457,0.0016695096,2,
Nlrp9b,0.008447548,0.22866711,0,
Nlrp9c,-0.23099805,-0.039589033,2,
Nlrx1,0.22368707,-0.07819063,1,"['Negative regulators of DDX58/IFIH1 signaling', 'Regulation of NF-kappa B signaling']"
Nmb,0.09789264,-0.13617894,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Nmbr,-0.18384789,0.17247151,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Nmd3,-0.14749078,0.37281564,0,
Nme1,0.1771086,0.08791579,1,"['Interconversion of nucleotide di- and triphosphates', 'Azathioprine ADME']"
Nme2,0.096566804,0.06567578,1,"['Interconversion of nucleotide di- and triphosphates', 'Neutrophil degranulation', 'Azathioprine ADME']"
Nme3,-0.16182525,0.101790555,2,['Interconversion of nucleotide di- and triphosphates']
Nme4,-0.09242594,0.14412072,2,['Interconversion of nucleotide di- and triphosphates']
Nme5,-0.20977235,0.046064146,2,
Nme7,-0.08011779,0.10943426,2,
Nme8,-0.14322372,0.04283595,2,
Nmi,0.3854965,0.12836769,3,
Nmnat1,-0.037078783,-0.031775508,2,['Nicotinate metabolism']
Nmnat2,-0.045395352,0.07524648,2,['Nicotinate metabolism']
Nmnat3,-0.32233042,0.032906823,2,['Nicotinate metabolism']
Nmral1,0.037002478,-0.17648457,1,['Urea cycle']
Nmrk1,-0.27628168,0.024452936,2,['Nicotinate metabolism']
Nmrk2,-0.19023336,-0.30003726,2,['Nicotinate metabolism']
Nms,-0.12236341,-0.10065338,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Nmt1,-0.0995363,-0.24088684,2,"['Inactivation, recovery and regulation of the phototransduction cascade', 'Activation, myristolyation of BID and translocation to mitochondria']"
Nmt2,-0.053131364,-0.12482134,2,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Nmu,-0.16573267,-0.19748974,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Nmur1,-0.19421373,-0.048202015,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Nmur2,-0.23634201,-0.0017900112,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Nnat,-0.056060567,0.064580284,2,
Nnmt,0.09831508,-0.2064692,2,"['Methylation', 'Nicotinamide salvaging']"
Nnt,-0.117305554,-0.14456588,2,
Noa1,-0.19550058,-0.17487527,2,
Nob1,-0.24863686,0.4638976,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nobox,-0.089489125,0.088182285,2,
Noc2l,-0.079388216,0.4885139,0,
Noc3l,-0.26419133,0.26274237,0,
Noc4l,-0.27533138,0.37906674,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Noct,0.038010985,0.2131189,0,
Nod1,0.35052833,-0.06638006,1,"['NOD1/2 Signaling Pathway', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'Ovarian tumor domain proteases']"
Nod2,0.35324827,-0.075651415,1,"['NOD1/2 Signaling Pathway', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'Ovarian tumor domain proteases']"
Nodal,0.080002494,0.005259952,2,
Nog,0.25305986,-0.00283915,3,['Signaling by BMP']
Nol10,-0.3156208,0.3973483,0,
Nol11,-0.2408694,0.2868084,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nol12,-0.28873655,0.2829075,0,
Nol4,-0.25160313,-0.16121419,2,
Nol4l,0.01333197,0.048592195,3,
Nol6,-0.17673029,0.43586278,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nol7,0.02065558,0.27315408,0,
Nol8,-0.24300678,0.15406418,2,
Nol9,-0.1303834,0.2803896,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nolc1,-0.10104373,0.4393898,0,
Nom1,-0.23017587,0.2707896,0,
Nomo1,-0.03848205,0.04699291,2,
Nono,0.27857843,0.131064,0,
Nop10,0.028601294,0.5244683,0,['Telomere Extension By Telomerase']
Nop14,-0.18614398,0.30401385,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nop16,-0.16693829,0.36026794,0,
Nop2,-0.25178802,0.4178966,0,
Nop53,-0.13381508,0.39106214,0,
Nop56,-0.15874498,0.5575488,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Nop58,-0.07132088,0.499928,0,"['SUMOylation of RNA binding proteins', 'Major pathway of rRNA processing in the nucleolus and cytosol']"
Nop9,-0.117837235,0.33549657,0,
Nos1,0.3962138,-0.40156397,1,"['ROS and RNS production in phagocytes', 'Nitric oxide stimulates guanylate cyclase', 'Ion homeostasis']"
Nos1ap,0.31538367,0.003657157,3,
Nos2,0.38274342,-0.20283343,1,"['ROS and RNS production in phagocytes', 'Nitric oxide stimulates guanylate cyclase', 'Peroxisomal protein import']"
Nos3,0.54275185,-0.27372018,1,"['ROS and RNS production in phagocytes', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'eNOS activation', 'NOSTRIN mediated eNOS trafficking', 'NOSIP mediated eNOS trafficking', 'Nitric oxide stimulates guanylate cyclase', 'VEGFR2 mediated vascular permeability', 'Extra-nuclear estrogen signaling']"
Nostrin,0.12939271,-0.18105343,1,['NOSTRIN mediated eNOS trafficking']
Notch1,0.4027126,0.1587991,3,"['Pre-NOTCH Processing in Golgi', 'NOTCH1 Intracellular Domain Regulates Transcription', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Notch-HLH transcription pathway', 'RUNX3 regulates NOTCH signaling']"
Notch2,0.32757857,0.032101512,3,
Notch3,0.46452522,0.049266398,3,"['Pre-NOTCH Processing in Golgi', 'Notch-HLH transcription pathway', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Noncanonical activation of NOTCH3']"
Notch4,0.3337537,0.15187897,3,"['Pre-NOTCH Processing in Golgi', 'Notch-HLH transcription pathway', 'NOTCH4 Activation and Transmission of Signal to the Nucleus', 'Negative regulation of NOTCH4 signaling']"
Notum,-0.041409288,0.045942307,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Release of Hh-Np from the secreting cell', 'Post-translational protein phosphorylation']"
Nova1,-0.030121643,0.026339011,2,
Nox1,0.272455,-0.33586055,1,"['RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Nox3,0.15773238,-0.2661885,1,"['RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Nox4,0.19187494,-0.24021982,1,['Detoxification of Reactive Oxygen Species']
Noxa1,0.07149732,-0.24290605,1,"['RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Noxo1,0.10531865,-0.4481584,1,"['RHO GTPases Activate NADPH Oxidases', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Noxred1,-0.39878038,0.00623084,2,
Npas1,-0.023818828,-0.028779548,2,
Npas2,0.25166073,0.108130306,3,
Npas3,-0.13426673,0.15848047,2,
Npas4,0.071774736,0.14936014,3,
Npat,0.21315438,0.3034807,3,
Npb,-0.1651991,-0.13187939,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npbwr1,-0.04357708,-0.05035138,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npc1,-0.11254386,-0.29000947,2,['LDL clearance']
Npc1l1,0.22041301,-0.13057348,1,
Npc2,0.044959873,-0.07282398,1,"['Neutrophil degranulation', 'LDL clearance']"
Npcd,0.048970014,0.09465085,3,
Npdc1,0.00071958255,0.025565656,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Npepl1,-0.23530121,-0.055842597,2,
Npepps,0.10476465,0.073042005,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Npff,-0.09042303,-0.08613,2,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Npffr1,0.023878016,-0.12029427,1,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Npffr2,-0.08674543,0.069459185,2,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Nphp1,0.05760787,-0.07689707,2,
Nphp3,-0.08952348,0.009177282,2,['Trafficking of myristoylated proteins to the cilium']
Nphp4,0.109913826,-0.14158359,1,"['Signaling by Hippo', 'Anchoring of the basal body to the plasma membrane']"
Nphs1,0.22547409,-0.3607137,1,['Nephrin family interactions']
Nphs2,0.2364523,-0.19994777,1,['Nephrin family interactions']
Npl,-0.34365323,-0.03303375,2,['Sialic acid metabolism']
Nploc4,0.23815505,0.28116706,3,"['Translesion Synthesis by POLH', 'Neddylation', 'KEAP1-NFE2L2 pathway']"
Npm1,0.4446092,0.4057929,3,"['SUMOylation of transcription cofactors', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain', 'TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation']"
Npm2,-0.10401033,0.39158803,0,
Npm3,-0.057086784,0.25984615,0,
Npnt,-0.1653355,0.044004403,2,
Npnt1,-0.17287762,0.15068032,2,
Npnt2,-0.10243755,-0.12490491,2,
Nppa,0.28870395,-0.20439868,1,['Physiological factors']
Nppb,-0.19163978,-0.22447301,2,
Nppc,-0.0811702,-0.08179667,2,['Physiological factors']
Npr1,-0.1390826,-0.3486336,2,['Physiological factors']
Npr2,-0.079156384,-0.24102618,2,['Physiological factors']
Npr3,-0.09061585,-0.1566187,2,
Nprl2,-0.030300915,-0.01868583,2,['Amino acids regulate mTORC1']
Nprl3,-0.055937793,0.16081695,0,['Amino acids regulate mTORC1']
Nps,-0.08981577,-0.14354506,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (s) signalling events']"
Npsr1,-0.06875351,0.25670114,0,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (s) signalling events']"
Nptn,0.005381526,-0.12200628,1,
Nptx1,-0.10385128,-0.18998578,2,
Nptxr,-0.048296437,0.0043656677,2,
Npvf,-0.061397243,-0.050004106,2,
Npw,-0.09894559,-0.17495161,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npy,0.12219011,-0.4056244,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npy1r,0.115774415,-0.30563027,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npy2r,-0.17897044,-0.3648406,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npy4r,-0.09931237,-0.17847905,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npy5r,-0.105488166,0.01569403,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Npy6r,-0.13202062,-0.20538531,2,
Nqo1,0.30433697,-0.040742423,1,['Regulation of ornithine decarboxylase (ODC)']
Nr0b1,0.0409389,0.2579307,0,['Nuclear Receptor transcription pathway']
Nr0b2,0.4013941,-0.13558514,1,['Nuclear Receptor transcription pathway']
Nr1d1,0.20372124,0.07215231,3,['Nuclear Receptor transcription pathway']
Nr1d2,0.12004624,0.11874499,3,['Nuclear Receptor transcription pathway']
Nr1h2,0.32203034,0.16448647,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors', 'VLDLR internalisation and degradation', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis']"
Nr1h3,0.27677724,0.1580398,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors', 'VLDLR internalisation and degradation', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis']"
Nr1h4,0.2506615,-0.01771707,1,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Endogenous sterols', 'Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Nr1i2,0.18722509,0.22094202,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Nr1i3,0.0011439068,0.15365797,3,['Nuclear Receptor transcription pathway']
Nr2c1,0.24720652,0.2667877,3,['Nuclear Receptor transcription pathway']
Nr2c2,0.285833,0.15632574,3,['Nuclear Receptor transcription pathway']
Nr2c2ap,-0.14297046,-0.11893832,2,
Nr2e1,0.28972012,0.09927708,3,['Nuclear Receptor transcription pathway']
Nr2e3,-0.005356188,-0.07470532,2,['Nuclear Receptor transcription pathway']
Nr2f1,0.3267438,0.09100823,3,
Nr2f2,0.20026736,0.052482735,3,
Nr2f6,0.11937748,-0.020769786,3,['Nuclear Receptor transcription pathway']
Nr3c1,0.50604695,0.020821942,3,
Nr3c2,0.29263994,0.1272443,3,
Nr4a1,0.34225962,0.056132503,3,"['AKT phosphorylates targets in the nucleus', 'Nuclear Receptor transcription pathway']"
Nr4a2,0.39686903,0.03942643,3,['Nuclear Receptor transcription pathway']
Nr4a3,0.067604795,0.10940499,3,['Nuclear Receptor transcription pathway']
Nr5a1,0.23390609,0.063702,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Nr5a2,0.19106627,-0.021015372,1,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Nr6a1,0.27918538,0.29286525,3,['Nuclear Receptor transcription pathway']
Nradd,-0.04187583,-0.034909815,2,
Nrap,-0.027583983,-0.3031565,1,
Nrarp,-0.047304142,-0.008057788,2,
Nras,0.6365148,-0.33020797,1,
Nrbf2,-0.0016178857,-0.18253139,1,['Nuclear Receptor transcription pathway']
Nrbp1,-0.018311022,-0.07740308,2,
Nrbp2,-0.100524776,0.11184512,2,
Nrcam,0.34290203,-0.24303547,1,
Nrd1,0.054319613,0.2784289,0,
Nrde2,-0.15289097,0.2739883,0,
Nrf1,-0.07049784,0.051166784,0,
Nrg1,0.44403934,-0.3449934,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'GRB7 events in ERBB2 signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Downregulation of ERBB2 signaling']"
Nrg2,0.32798794,-0.27675048,1,
Nrg3,0.1598773,-0.1922184,1,"['Signaling by ERBB2', 'Signaling by ERBB4', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'GRB2 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'RAF/MAP kinase cascade', 'ERBB2 Regulates Cell Motility', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'ERBB2 Activates PTK6 Signaling', 'Downregulation of ERBB2 signaling']"
Nrg4,0.10429482,-0.22492754,1,
Nrgn,-0.043068934,-0.18220146,2,
Nrip1,0.3895199,0.16655327,3,"['SUMOylation of transcription cofactors', 'Estrogen-dependent gene expression']"
Nrip2,-0.24479711,-0.1618715,2,
Nrk,0.12698098,-0.03153936,3,
Nrl,0.02314628,-0.04262198,1,
Nrm,-0.08963397,-0.038791202,0,
Nrn1,0.072623275,-0.043771148,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Nrp1,0.3264805,-0.32031822,1,"['Neurophilin interactions with VEGF and VEGFR', 'Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'CRMPs in Sema3A signaling', 'Signal transduction by L1']"
Nrp2,0.056132514,-0.39937857,1,['Neurophilin interactions with VEGF and VEGFR']
Nrros,-0.059771534,0.019934352,2,
Nrsn1,-0.14312497,-0.15439872,2,
Nrsn2,-0.2918532,0.1236065,2,
Nrtn,0.22574735,-0.37291694,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Nrxn1,-0.03031544,-0.19497877,1,['Neurexins and neuroligins']
Nrxn2,0.13563405,-0.202833,1,['Neurexins and neuroligins']
Nrxn3,-0.035355765,-0.19444539,2,['Neurexins and neuroligins']
Nsa2,-0.1113981,0.36803892,0,
Nscme3l,0.0016410712,0.12114137,2,
Nsd1,0.24574442,0.23391646,3,
Nsd2,0.21154945,0.12793995,3,"['PKMTs methylate histone lysines', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Nsd3,0.053710476,0.12960121,3,['PKMTs methylate histone lysines']
Nsdhl,-0.2990122,0.05994706,2,['Cholesterol biosynthesis']
Nsf,-0.02708059,-0.28018183,1,"['COPII-mediated vesicle transport', 'Trafficking of GluR2-containing AMPA receptors', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Nsfl1c,0.16042033,0.1643769,3,['RHOH GTPase cycle']
Nsg1,-0.41127053,-0.013269075,2,
Nsl1,-0.07007887,0.10075315,2,
Nsmaf,0.13077019,0.059402887,3,['TNFR1-mediated ceramide production']
Nsmce1,0.12995665,0.29765972,3,
Nsmce2,0.17412186,0.39719716,3,['SUMOylation of DNA damage response and repair proteins']
Nsmce3,0.2825321,0.15717934,3,['SUMOylation of DNA damage response and repair proteins']
Nsmce4a,0.025177306,0.26680195,3,['SUMOylation of DNA damage response and repair proteins']
Nsrp1,-0.22860643,0.21770024,0,
Nsun2,-0.14847498,0.4361765,0,
Nsun3,-0.40206268,0.30852225,0,
Nsun4,-0.11826749,0.0043354398,2,
Nsun5,-0.19160272,0.3248835,0,
Nsun6,-0.32257113,0.30606946,0,
Nt5c,-0.12473943,0.13238035,2,"['Pyrimidine catabolism', 'Purine catabolism']"
Nt5c1a,-0.13985726,0.06049233,2,"['Pyrimidine catabolism', 'Purine catabolism']"
Nt5c1b,-0.252406,0.15721655,2,['Purine catabolism']
Nt5c2,-0.08531868,0.09098268,2,"['Abacavir metabolism', 'Purine catabolism']"
Nt5c3,-0.204937,-0.016611364,2,['Pyrimidine catabolism']
Nt5c3b,-0.060976736,-0.074515976,2,"[""mRNA decay by 3' to 5' exoribonuclease""]"
Nt5dc1,-0.02400204,0.014626838,2,
Nt5dc2,-0.2952476,0.12314099,2,
Nt5dc3,-0.18077625,0.16462849,2,
Nt5e,0.19932987,-0.14754857,1,"['Nicotinate metabolism', 'Pyrimidine catabolism', 'Purine catabolism']"
Nt5el,-0.14409223,0.118583985,2,
Nt5m,-0.08519011,-0.018533126,2,['Pyrimidine catabolism']
Ntan1,0.004259098,-0.18550003,1,
Ntf3,0.32865316,-0.37585837,1,"['NTF3 activates NTRK3 signaling', 'Activated NTRK3 signals through PLCG1', 'Activated NTRK3 signals through PI3K']"
Ntf5,0.3228353,-0.056916714,1,"['Activated NTRK2 signals through PLCG1', 'Activated NTRK2 signals through FRS2 and FRS3']"
Nthl1,0.0048442734,0.11787442,3,"['Cleavage of the damaged pyrimidine ', 'Displacement of DNA glycosylase by APEX1']"
Ntmt1,-0.03514938,0.25698477,0,
Ntn1,0.34370992,-0.2230895,1,
Ntn3,-0.06509246,-0.18160683,2,
Ntn4,0.11694679,-0.37381366,1,['Netrin-1 signaling']
Ntn5,-0.097508,-0.16256393,2,
Ntng1,-0.024727594,-0.19217831,1,
Ntng2,-0.044942826,-0.12669203,2,
Ntpcr,-0.07909544,0.10735738,2,
Ntrk1,0.55444646,-0.4014438,1,"['Frs2-mediated activation', 'ARMS-mediated activation', 'Retrograde neurotrophin signalling', 'TRKA activation by NGF', 'PI3K/AKT activation']"
Ntrk2,0.517191,-0.32648334,1,"['Activated NTRK2 signals through PLCG1', 'Activated NTRK2 signals through FRS2 and FRS3', 'NTRK2 activates RAC1']"
Ntrk3,0.42900497,-0.32393578,1,"['Receptor-type tyrosine-protein phosphatases', 'NTF3 activates NTRK3 signaling', 'Activated NTRK3 signals through PLCG1', 'Activated NTRK3 signals through PI3K']"
Nts,0.096565485,-0.35378245,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Ntsr1,-0.15362398,-0.14530392,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Ntsr2,-0.032205533,-0.17475004,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Nuak1,-0.17595588,0.05333701,2,['Regulation of TP53 Activity through Phosphorylation']
Nub1,0.18063188,-0.014280217,3,['Neddylation']
Nubp1,-0.24396826,-0.026583761,2,
Nubp2,-0.23951022,0.029170072,2,
Nubpl,-0.23375885,0.008421726,2,['Complex I biogenesis']
Nucb1,0.20017028,-0.04756102,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Nucb2,-0.12910452,-0.01558449,2,
Nucks1,-0.24394108,0.025337191,2,
Nudc,0.29331562,0.15645425,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation', 'RND2 GTPase cycle']"
Nudcd1,-0.020132383,0.20000468,0,
Nudcd2,0.09109883,-0.048864175,3,
Nudcd3,0.003263362,0.08112284,3,
Nudt1,-0.1262077,0.17107193,2,['Phosphate bond hydrolysis by NUDT proteins']
Nudt10,-0.4413271,-0.08265317,2,['Synthesis of pyrophosphates in the cytosol']
Nudt11,-0.27205002,0.088974744,2,['Synthesis of pyrophosphates in the cytosol']
Nudt12,-0.33072665,0.02478584,2,['Nicotinamide salvaging']
Nudt13,-0.36645603,-0.15626629,2,['Interconversion of nucleotide di- and triphosphates']
Nudt14,-0.41918123,-0.104812816,2,['Synthesis of dolichyl-phosphate-glucose']
Nudt15,-0.25710526,0.034960695,2,"['Phosphate bond hydrolysis by NUDT proteins', 'Azathioprine ADME']"
Nudt16,-0.18943411,0.11802571,2,['Phosphate bond hydrolysis by NUDT proteins']
Nudt16l1,0.07986451,0.14679366,3,
Nudt16l2,-0.050683945,0.023224821,2,
Nudt17,-0.4201885,-0.034517433,2,
Nudt18,-0.25293553,0.020233251,2,['Phosphate bond hydrolysis by NUDT proteins']
Nudt19,-0.2231173,-0.12271245,2,"['Peroxisomal lipid metabolism', 'Peroxisomal protein import']"
Nudt2,-0.349087,-0.11679691,2,['Detoxification of Reactive Oxygen Species']
Nudt21,-0.25828877,0.4248581,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Nudt22,-0.48259467,0.16245672,2,
Nudt3,-0.50118303,0.05237086,2,['Synthesis of pyrophosphates in the cytosol']
Nudt4,-0.39171076,0.16636457,2,['Synthesis of pyrophosphates in the cytosol']
Nudt5,-0.35215595,0.09974564,2,['Phosphate bond hydrolysis by NUDT proteins']
Nudt6,-0.22585796,0.03632543,2,
Nudt7,-0.5023471,0.0011070007,2,['Peroxisomal protein import']
Nudt8,-0.12945572,0.029616127,2,
Nudt9,-0.37474638,0.10707325,2,['Phosphate bond hydrolysis by NUDT proteins']
Nuf2,-0.010333735,0.3700525,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Nufip1,0.08254276,0.5088109,0,
Nufip2,0.16864838,0.26041698,3,
Numa1,0.20750697,0.23854168,3,"['Recruitment of NuMA to mitotic centrosomes', 'Mitotic Prophase']"
Numb,0.5571894,-0.08132404,1,"['Recycling pathway of L1', 'Degradation of GLI1 by the proteasome', ""Hedgehog 'on' state""]"
Numbl,0.30204237,-0.20771365,1,
Nup107,0.08062498,0.56640804,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Nup133,0.07115228,0.43707207,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Nup153,0.20613003,0.49951872,3,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup155,0.064970605,0.46684152,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Nup160,0.11670796,0.3993693,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Nup188,0.14893322,0.45566967,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Nup205,0.09273964,0.3724071,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Nup210,0.06890173,0.40959144,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup210l,-0.026049677,0.20205155,0,
Nup214,0.2645885,0.47608823,3,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'HuR (ELAVL1) binds and stabilizes mRNA', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup35,-0.028965171,0.22859022,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Nup37,0.11423036,0.51777357,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Nup43,-0.06857573,0.4679675,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Nup50,0.06543662,0.40199393,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup54,0.17401123,0.48447096,3,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup62,0.19882084,0.40518734,3,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup62cl,0.07041091,0.26297653,3,
Nup85,0.26152644,0.40752968,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Nup88,0.17906697,0.41972828,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Nup93,0.14167602,0.45044234,3,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Nup98,0.17155237,0.5391775,3,
Nupl2,0.0041333577,0.3907653,0,
Nupr1l,-0.08960677,-0.026810868,2,
Nus1,0.02910691,-0.07533041,2,['Synthesis of Dolichyl-phosphate']
Nusap1,0.1953988,0.4167617,3,
Nutf2,0.0972008,0.33872443,0,
Nutf2-ps1,0.05565968,0.37542576,0,
Nutm1,0.008684826,0.15217109,3,
Nutm2,-0.09175441,-0.08946375,2,
Nvl,-0.1998238,0.41287884,0,
Nwd1,-0.07314299,0.11082567,3,
Nwd2,-0.30298722,0.042117216,2,
Nxf1,0.042223044,0.52497184,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript']"
Nxf2,0.04234946,0.46161395,0,['Transport of Mature mRNA derived from an Intron-Containing Transcript']
Nxf3,-0.12671806,0.4451206,0,
Nxf7,0.079643354,0.3821809,0,['Transport of Mature mRNA derived from an Intron-Containing Transcript']
Nxn,0.040007003,0.10797214,3,
Nxnl1,-0.20823804,-0.0034510577,2,
Nxnl2,0.10427184,-0.03586846,1,
Nxpe2,-0.3083914,-0.17711122,2,
Nxph1,-0.14476575,-0.00179808,2,
Nxph2,-0.14243132,-0.034561608,2,
Nxt1,-0.01596076,0.27432773,0,['Transport of Mature mRNA derived from an Intron-Containing Transcript']
Nxt2,-0.048830044,0.3586932,0,
Nyap1,-0.13304181,-0.060159303,2,
Nyap2,-0.18298796,-0.23623854,2,
Nynrin,-0.24546644,0.05238318,2,
Nyx,-0.18302143,-0.0915334,2,
Oacyl,-0.23642047,-0.030428989,2,
Oas1a,0.10530151,0.03986697,3,
Oas1c,0.24404664,0.038061883,1,
Oas1d,-0.2775332,-0.0015045995,2,
Oas1f,-0.12609565,-0.03593481,2,
Oas1g,-0.015565862,0.06715903,2,
Oas1h,-0.07805184,-0.09562341,2,
Oas2,0.059083354,0.16803052,0,
Oas3,0.06866872,0.038644426,2,
Oasl1,0.08743934,0.066434234,3,['OAS antiviral response']
Oasl2,0.057894003,0.1397531,3,
Oat,-0.11343487,-0.11734652,2,['Glutamate and glutamine metabolism']
Oaz1,0.14975482,0.3320723,3,['Regulation of ornithine decarboxylase (ODC)']
Oaz2,0.014003886,0.37710124,3,['Regulation of ornithine decarboxylase (ODC)']
Oaz3,0.044745103,0.2581036,3,['Regulation of ornithine decarboxylase (ODC)']
Obi1,-0.06075589,-0.12774579,2,
Obp1a,-0.13029703,0.0041751433,2,
Obp1b,-0.14233007,-0.00047579306,2,
Obp2a,-0.08610976,0.019102307,2,
Obscn,0.083005466,-0.2769037,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOQ GTPase cycle']"
Obsl1,0.24215312,0.06030528,3,
Oc90,-0.19522688,0.0015974675,2,
Oca2,0.067836985,-0.24691133,1,['Melanin biosynthesis']
Ociad1,-0.43183067,0.26951173,2,
Ociad2,-0.041548014,-0.08316297,2,
Ocln,0.40452206,-0.1670723,1,['Apoptotic cleavage of cell adhesion  proteins']
Ocm,-0.03860318,0.051241893,2,
Ocrl,0.2056529,-0.3593689,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of PIPs at the Golgi membrane', 'Synthesis of IP2, IP, and Ins in the cytosol', 'Synthesis of IP3 and IP4 in the cytosol', 'Golgi Associated Vesicle Biogenesis', 'Clathrin-mediated endocytosis', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle']"
Ocstamp,0.086522385,-0.07857156,1,
Odad1,-0.13351388,0.13679717,2,
Odad2,-0.08925813,0.07208238,2,
Odad3,-0.20753004,-0.0714194,2,
Odad4,-0.22855636,-0.10069879,2,
Odam,-0.1892985,-0.09303966,2,
Odaph,-0.33212036,-0.17712241,2,
Odc1,0.08357896,0.28438413,3,"['Regulation of ornithine decarboxylase (ODC)', 'Metabolism of polyamines']"
Odf1,0.15071902,-0.0682416,1,
Odf2,0.10050672,0.18547286,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Odf2l,-0.15972447,0.18348455,2,
Odf3,0.041262295,-0.014034866,2,
Odf4,-0.087602675,-0.12764587,2,
Odr4,-0.2742078,-0.0909478,2,
Ofd1,0.14191441,0.14180276,3,
Oga,0.079263106,0.060371745,3,
Ogdh,-0.23427913,0.0042404626,2,"['Glyoxylate metabolism and glycine degradation', 'Lysine catabolism', 'Citric acid cycle (TCA cycle)']"
Ogdhl,-0.23534796,-0.0033251718,2,
Ogfod1,-0.2238159,0.09389542,0,
Ogfod2,-0.23168902,-0.13283978,2,
Ogfod3,-0.31108359,-0.17716913,2,
Ogfrl1,-0.20662825,0.057932194,2,
Ogg1,0.17481257,0.23422031,3,"['Cleavage of the damaged pyrimidine ', 'Recognition and association of DNA glycosylase with site containing an affected purine', 'Cleavage of the damaged purine', 'Displacement of DNA glycosylase by APEX1', 'APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway']"
Ogn,-0.15208033,-0.166483,2,"['Keratan sulfate biosynthesis', 'Keratan sulfate degradation']"
Ogt,0.5457049,0.12710235,3,"['HATs acetylate histones', 'Regulation of necroptotic cell death', 'UCH proteinases']"
Oip5,0.0968179,0.38699478,3,['Deposition of new CENPA-containing nucleosomes at the centromere']
Ola1,0.081668,0.1690962,0,['Platelet degranulation ']
Olah,-0.2866616,-0.15349463,2,
Olfm1,0.1274536,-0.13130708,1,
Olfm2,0.05355875,-0.16007654,1,
Olfm3,0.11493162,-0.177671,1,
Olfm4,0.025734005,-0.017202025,2,['Neutrophil degranulation']
Olfml1,-0.38625082,-0.101129115,2,
Olfml2a,-0.23255691,0.058854446,2,
Olfml2b,-0.12295146,-0.15368807,2,
Olfml3,-0.2189273,-0.087588914,2,
Olfr1,-0.123346165,-0.14963457,2,['Olfactory Signaling Pathway']
Olfr1008,-0.056038726,-0.15151134,2,
Olfr1012,0.047623076,-0.21880496,1,
Olfr1013,-0.23095866,-0.12625611,2,
Olfr1018,-0.022219134,-0.13635594,2,
Olfr1020,-0.17481184,-0.16887622,2,
Olfr1023,-0.03722572,-0.13173568,2,
Olfr1024,-0.17826624,0.13691653,2,
Olfr1031,-0.022209596,0.011145442,2,
Olfr1047,-0.16314502,-0.122742966,2,['Olfactory Signaling Pathway']
Olfr1055,-0.41282234,-0.010264538,2,
Olfr107,-0.07839953,-0.2634497,2,
Olfr1086,-0.17382775,-0.020738699,2,
Olfr110,-0.13802263,-0.16961037,2,
Olfr1143,-0.34553057,-0.004908539,2,
Olfr1152,-0.17776124,-0.12111025,2,
Olfr1167,-0.12750047,-0.001152763,2,
Olfr1176,-0.31123617,-0.2354906,2,
Olfr1183,-0.17163731,-0.29965696,2,
Olfr119,-0.19308072,0.109603755,2,
Olfr1198,-0.3877339,0.033184733,2,
Olfr120,-0.2972845,-0.27334428,2,
Olfr1208,-0.32450342,-0.2736256,2,
Olfr121,-0.046931524,0.029044313,2,
Olfr1215,-0.13223137,-0.12694727,2,
Olfr122,-0.085282154,-0.0708843,2,
Olfr1222,-0.16673526,-0.034788646,2,
Olfr124,-0.114564866,-0.23790672,2,
Olfr1249,-0.03449094,-0.13231611,2,
Olfr1280,-0.15786074,0.06414499,2,
Olfr1283,-0.06444312,0.09465033,2,
Olfr129,-0.16269279,-0.13109432,2,
Olfr1303,-0.18952699,-0.1525667,2,
Olfr1305,0.03992953,-0.30615532,1,
Olfr1308,-0.1692262,-0.2847849,2,
Olfr131,-0.12582639,-0.17219153,2,
Olfr1312,-0.07395379,-0.10327975,2,
Olfr1314,-0.2484453,-0.00016184869,2,
Olfr1328,-0.19993296,-0.10181255,2,
Olfr1330,-0.15653495,-0.20139334,2,
Olfr1335,-0.007363235,-0.14664114,1,
Olfr1337,-0.057647366,-0.14964342,2,
Olfr1352,-0.07051523,-0.11600207,2,
Olfr1353,-0.2023216,0.0149638625,2,
Olfr1354,-0.14412344,-0.1356255,2,
Olfr1356,-0.10519654,-0.047047473,2,
Olfr1362,-0.19032407,-0.20713806,2,
Olfr1378,-0.18820426,-0.12728538,2,
Olfr1387,-0.060004495,-0.098730616,2,
Olfr1392,-0.10486458,-0.14110258,2,
Olfr1413,-0.24182095,-0.05933931,2,
Olfr1414,-0.12708557,-0.16730653,2,
Olfr1462,-0.16796097,-0.008281249,2,
Olfr1465,-0.19736715,-0.22626074,2,
Olfr147,-0.25097737,0.055842478,2,['Olfactory Signaling Pathway']
Olfr15,-0.2644062,-0.0045967954,2,['Olfactory Signaling Pathway']
Olfr1507,-0.09629782,-0.3629478,1,
Olfr154,0.035220236,-0.16091758,1,
Olfr16,0.0099938465,-0.17951941,1,['Olfactory Signaling Pathway']
Olfr160,-0.09118602,-0.28857192,2,
Olfr17,-0.1178727,-0.12769595,2,
Olfr175,0.104106896,-0.05399962,1,
Olfr177,0.06952694,-0.3344139,1,
Olfr178,0.07008826,-0.06820689,1,
Olfr180,0.18907021,-0.14689519,1,
Olfr181,0.12402951,-0.20979024,1,
Olfr190,-0.05293505,-0.1078094,2,
Olfr195,0.16418661,-0.21654479,1,
Olfr198,-0.23992899,-0.1117348,2,
Olfr215,-0.086842276,0.16416746,2,
Olfr218,-0.14431053,-0.100560546,2,
Olfr26,0.06730231,-0.15566319,1,
Olfr285,-0.048780195,-0.25787714,1,
Olfr287,-0.13053147,-0.14911276,2,
Olfr297,-0.14133781,-0.18792981,2,
Olfr299,-0.16881688,-0.02849915,2,
Olfr3,-0.2502311,-0.16456893,2,
Olfr303,-0.17622985,-0.2163154,2,
Olfr322,-0.09590505,0.04742676,2,['Olfactory Signaling Pathway']
Olfr344,-0.16870525,-0.14001107,2,
Olfr345,0.11657332,-0.09459304,1,
Olfr355,-0.06765111,-0.30547386,2,
Olfr370,-0.15068957,-0.037575036,2,
Olfr39,-0.3868769,0.03756098,2,['Olfactory Signaling Pathway']
Olfr394,-0.12175771,-0.30119726,2,['Olfactory Signaling Pathway']
Olfr401,-0.19886304,-0.031201404,2,
Olfr403,0.0399713,-0.20889318,1,
Olfr43,-0.10647625,-0.17026924,2,['Olfactory Signaling Pathway']
Olfr44,0.005095114,0.048387952,2,
Olfr456,-0.12726389,-0.29172176,2,
Olfr457,-0.14140452,-0.2543668,2,
Olfr458,-0.2092515,-0.33293563,2,
Olfr48,-0.044883247,-0.09262688,1,
Olfr493,-0.27738094,-0.07608496,2,
Olfr520,-0.14139232,-0.19912855,2,['Olfactory Signaling Pathway']
Olfr53,-0.27606916,-0.009999436,2,
Olfr532,-0.09180317,-0.42136067,1,
Olfr543,-0.09536849,-0.2200653,2,
Olfr544,0.051173974,-0.19431388,2,
Olfr545,-0.22233833,-0.05680722,2,
Olfr547,-0.22433548,-0.18660857,2,
Olfr553,-0.19566664,-0.033146627,2,
Olfr558,-0.042283706,-0.12787384,2,['Olfactory Signaling Pathway']
Olfr56,-0.061872125,-0.17999399,1,
Olfr574,-0.3467642,0.030290667,2,
Olfr578,-0.06675487,-0.21558708,2,
Olfr591,-0.21490346,-0.08995249,2,
Olfr597,-0.023687497,-0.12160685,2,
Olfr598,-0.18539526,-0.27172172,2,
Olfr599,-0.042469177,-0.09362224,2,
Olfr601,-0.061851438,-0.16703765,1,
Olfr616,-0.15379947,-0.10373774,2,
Olfr62,-0.22794509,0.07585151,2,
Olfr654,-0.22424647,-0.27265754,2,
Olfr661,-0.005377193,-0.11788819,2,
Olfr672,-0.0031379114,-0.15986592,2,
Olfr675,-0.033473816,-0.39384097,1,
Olfr676,-0.108807765,-0.12539196,2,
Olfr677,0.03341418,-0.11329109,2,
Olfr678,-0.14260648,-0.3095579,2,
Olfr679,-0.037687164,-0.18722159,2,
Olfr68,0.102681234,-0.18789993,1,
Olfr683,-0.036043555,-0.26863742,1,
Olfr684,0.027732117,-0.14894055,2,['Olfactory Signaling Pathway']
Olfr685,-0.020031251,-0.028495958,2,
Olfr69,-0.11002054,-0.05663862,2,
Olfr691,-0.22018059,-0.2612632,2,
Olfr692,-0.020549426,-0.15534078,2,
Olfr693,-0.07568133,-0.16631301,2,
Olfr697,-0.2712904,-0.09176903,2,
Olfr703,-0.114089414,-0.013825234,2,
Olfr71,-0.11762715,0.001568328,2,
Olfr711,-0.24476077,0.053597923,2,
Olfr713,-0.17697431,-0.32390153,2,
Olfr714,-0.1742206,-0.14231516,2,
Olfr73,0.0070199464,-0.30246475,1,
Olfr747,-0.3163526,-0.0013405718,2,
Olfr77,-0.16710955,-0.008022183,2,
Olfr777,-0.26222646,-0.19995566,2,
Olfr78,4.3375647e-05,-0.2077344,1,['Olfactory Signaling Pathway']
Olfr794,-0.022004802,0.16378464,3,
Olfr8,-0.037725434,-0.18922104,1,
Olfr800,-0.0781136,-0.20568086,2,
Olfr819,-0.20644021,0.0153053645,2,
Olfr821,-0.13482647,-0.06936995,2,
Olfr828,-0.22542939,-0.13592912,2,
Olfr857,-0.057765413,-0.09433848,2,
Olfr860,-0.08770096,-0.1598022,2,
Olfr875,-0.056769706,-0.22046848,2,
Olfr877,-0.154269,-0.22597001,2,
Olfr917,0.053269222,-0.05539289,1,
Olfr918,0.01390977,-0.23983204,1,['Olfactory Signaling Pathway']
Olfr920,-0.24210075,-0.1081742,2,
Olfr921,-0.23124208,-0.105708495,2,
Olfr922,-0.11337881,-0.17833498,2,
Olfr923,-0.14809784,-0.31194252,2,['Olfactory Signaling Pathway']
Olfr924,-0.015393255,-0.17147852,1,
Olfr94,-0.28381893,0.09719748,2,
Olfr967,-0.20904256,-0.13112438,2,
Olfr972,-0.16720566,-0.09113136,2,
Olfr976,-0.102273084,-0.075191975,2,
Olfr985,0.0680116,-0.022601066,3,
Olfr99,-0.072397634,-0.14683491,2,
Olfr994,-0.03904805,-0.0059519815,2,
Olfr995,-0.032591544,0.0429559,2,
Olig1,0.058805175,0.040653173,3,
Olig2,0.28491455,-0.052429035,1,
Olr1,0.2406895,-0.046088364,1,"['Cell surface interactions at the vascular wall', 'Neutrophil degranulation']"
Oma1,0.032500423,-0.14623964,2,['Regulation of Apoptosis']
Omd,-0.17092875,-0.056480084,2,"['Keratan sulfate biosynthesis', 'Keratan sulfate degradation']"
Omg,0.3554296,-0.0593906,1,
Omp,-0.08281886,-0.12414026,2,
Omt2b,-0.08163706,-0.09980456,2,
Onecut1,0.16794354,-0.014524558,3,
Onecut3,-0.08696073,0.1533945,0,
Ooep,-0.24086498,-0.12320269,2,
Oog1,-0.07843427,-0.12526073,2,
Oosp1,-0.25382718,-0.0705105,2,
Oosp2,-0.37874654,-0.10100949,2,
Oosp3,-0.16697255,-0.09923722,2,
Opa1,-0.06978175,-0.18753357,2,['Regulation of Apoptosis']
Opa3,-0.16642356,0.14710025,2,
Opalin,-0.02271026,-0.09556354,2,
Opcml,-0.35098314,-0.04156047,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Ophn1,0.1665736,-0.0833325,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle']"
Oplah,-0.38977897,-0.24856426,2,['Glutathione synthesis and recycling']
Opn1mw,-0.0071558254,-0.16206501,2,"['The retinoid cycle in cones (daylight vision)', 'G alpha (i) signalling events', 'Opsins']"
Opn1sw,-0.029631255,-0.34950146,1,"['The retinoid cycle in cones (daylight vision)', 'G alpha (i) signalling events', 'Opsins']"
Opn3,0.12594144,-0.24011675,1,"['G alpha (i) signalling events', 'Opsins']"
Opn4,0.19615723,-0.09307541,1,"['G alpha (q) signalling events', 'Opsins']"
Opn5,-0.010858603,-0.25624073,1,"['G alpha (i) signalling events', 'Opsins']"
Oprd1,0.14917056,-0.28335467,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Oprk1,0.0377624,-0.15097204,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Oprl1,-0.008914702,0.03980136,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Oprm1,0.31551224,-0.18436447,1,"['Opioid Signalling', 'G-protein activation', 'Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Optc,-0.030235974,-0.23718295,1,
Optn,0.316663,0.054821316,1,"['Regulation of PLK1 Activity at G2/M Transition', 'TBC/RABGAPs']"
Orai1,0.119446136,-0.1882204,1,
Orai2,-0.131665,-0.047491234,2,
Orai3,-0.16796288,-0.2398983,2,
Orc1,0.2820465,0.54300284,3,"['Activation of ATR in response to replication stress', 'Assembly of the ORC complex at the origin of replication', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex']"
Orc2,0.22013442,0.31825805,3,"['Activation of ATR in response to replication stress', 'Assembly of the ORC complex at the origin of replication', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex']"
Orc3,0.10373073,0.38025904,3,"['Activation of ATR in response to replication stress', 'Assembly of the ORC complex at the origin of replication', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex']"
Orc4,0.031069694,0.30358455,3,"['Activation of ATR in response to replication stress', 'Assembly of the ORC complex at the origin of replication', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex']"
Orc5,0.14607619,0.22624499,3,"['Activation of ATR in response to replication stress', 'Assembly of the ORC complex at the origin of replication', 'CDC6 association with the ORC:origin complex', 'Orc1 removal from chromatin', 'Activation of the pre-replicative complex']"
Orc6,0.022809697,0.3520479,3,
Orm1,0.052756116,0.04446002,2,"['Platelet degranulation ', 'Neutrophil degranulation']"
Orm2,-0.08136007,0.040529765,2,"['Platelet degranulation ', 'Neutrophil degranulation']"
Ormdl1,-0.19169608,-0.23364122,2,['Sphingolipid de novo biosynthesis']
Ormdl2,-0.44013727,-0.16053902,2,['Sphingolipid de novo biosynthesis']
Ormdl3,-0.075392835,-0.22939013,2,"['Sphingolipid de novo biosynthesis', 'Neutrophil degranulation']"
Os9,0.07317931,-0.015040475,2,"['ABC-family proteins mediated transport', 'Hedgehog ligand biogenesis']"
Osbp,-0.04247768,-0.25918132,1,['Synthesis of bile acids and bile salts']
Osbp2,-0.13620962,-0.121459946,2,
Osbpl10,0.0032675494,0.023448467,2,['Acyl chain remodelling of PS']
Osbpl11,-0.0975135,0.07188752,0,
Osbpl1a,-0.20028564,-0.22326456,2,"['Synthesis of bile acids and bile salts', 'MHC class II antigen presentation']"
Osbpl2,-0.14637604,-0.030500492,2,['Synthesis of bile acids and bile salts']
Osbpl5,-0.16693954,-0.07543063,2,['Acyl chain remodelling of PS']
Osbpl6,-0.061399497,-0.057775576,2,['Synthesis of bile acids and bile salts']
Osbpl7,-0.17026067,-0.2193296,2,['Synthesis of bile acids and bile salts']
Osbpl8,-0.11551728,-0.14150882,2,['Acyl chain remodelling of PS']
Osbpl9,-0.15273094,-0.07522207,2,['Synthesis of bile acids and bile salts']
Oscar,0.12801453,-0.32906783,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Oser1,-0.35038862,-0.047048904,2,
Osgep,0.056445412,0.11146266,3,
Osgepl1,-0.2956293,0.011227964,2,
Osgin2,-0.20971909,-0.13964148,2,
Osm,0.22321254,-0.156352,1,['IL-6-type cytokine receptor ligand interactions']
Osmr,0.27459,-0.23727335,1,
Osr2,-0.18753286,-0.060975667,2,
Ost4,-0.2796094,0.09318952,2,
Ostc,-0.40568483,-0.06069606,2,
Ostf1,0.011492593,-0.21560507,1,['Neutrophil degranulation']
Ostm1,-0.30452764,-0.08275614,2,['Stimuli-sensing channels']
Ostn,-0.23118393,0.018175464,2,
Otc,0.01653986,-0.19727938,1,"['Mitochondrial protein import', 'Urea cycle']"
Otoa,-0.04339591,0.19600254,0,['Post-translational modification: synthesis of GPI-anchored proteins']
Otof,0.05467213,-0.20569173,1,
Otog,-0.16945618,0.15139347,2,
Otogl,-0.20720318,0.04083099,2,
Otol1,-0.22909616,0.0854409,2,
Otop1,-0.28880343,-0.0013268203,2,
Otop2,-0.12504128,0.021584257,2,
Otos,-0.3972349,-0.12867728,2,
Otp,-0.2199108,-0.15863772,2,
Otub1,0.2988824,0.12738115,3,"['Ub-specific processing proteases', 'Ovarian tumor domain proteases']"
Otub2,0.26815432,0.082865015,3,['Ovarian tumor domain proteases']
Otud1,-0.02518224,-8.6239817e-07,2,
Otud3,0.14250626,-0.05298089,1,"['Ovarian tumor domain proteases', 'Regulation of PTEN stability and activity']"
Otud4,0.0043785493,-0.049869698,2,
Otud5,0.06612451,-0.012919986,1,
Otud7a,0.10178819,0.032570563,3,['Ovarian tumor domain proteases']
Otud7b,0.29198557,0.08073683,3,"['TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Ovarian tumor domain proteases']"
Otulin,0.20222309,-0.08800942,1,"['Regulation of TNFR1 signaling', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes']"
Otx2,0.24731554,0.09461288,3,
Ovca2,-0.297936,0.21409994,2,
Ovch2,-0.3954915,-0.27851093,2,
Ovgp1,-0.118541375,0.08045575,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Ovol2,0.05789565,-0.055687197,2,
Oxa1l,-0.08690986,0.09703306,0,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Oxct1,-0.30417758,0.092152394,2,['Utilization of Ketone Bodies']
Oxct2a,-0.19734475,0.1601436,2,['Utilization of Ketone Bodies']
Oxct2b,-0.21333951,0.025366247,2,
Oxld1,-0.32596117,-0.061527025,2,
Oxnad1,-0.16804284,-0.086824,2,
Oxr1,0.023225717,0.11915235,0,
Oxsm,-0.33082157,-0.17250955,2,
Oxsr1,-0.26707023,-0.12809092,2,
Oxt,0.20348921,-0.37758482,1,"['Vasopressin-like receptors', 'G alpha (q) signalling events']"
Oxtr,0.27530465,-0.27868596,1,"['Vasopressin-like receptors', 'G alpha (q) signalling events']"
P2rx1,0.03517362,-0.08119716,1,"['Elevation of cytosolic Ca2+ levels', 'Platelet homeostasis', 'Neutrophil degranulation']"
P2rx2,-0.025012435,-0.15657428,1,"['Elevation of cytosolic Ca2+ levels', 'Platelet homeostasis']"
P2rx3,0.06601018,-0.076429926,1,"['Elevation of cytosolic Ca2+ levels', 'Platelet homeostasis']"
P2rx4,-0.17013678,-0.15778293,2,
P2rx5,-0.2720913,-0.0988316,2,"['Elevation of cytosolic Ca2+ levels', 'Platelet homeostasis']"
P2rx6,-0.046212964,-0.08358133,2,"['Elevation of cytosolic Ca2+ levels', 'Platelet homeostasis']"
P2rx7,0.16859731,-0.04020203,1,"['Elevation of cytosolic Ca2+ levels', 'Platelet homeostasis', 'The NLRP3 inflammasome']"
P2ry1,0.14637564,-0.20025603,1,"['G alpha (q) signalling events', 'P2Y receptors', 'ADP signalling through P2Y purinoceptor 1']"
P2ry10,-0.033154767,-0.17828484,1,"['G alpha (q) signalling events', 'P2Y receptors']"
P2ry12,0.13339509,-0.31051186,1,"['ADP signalling through P2Y purinoceptor 12', 'P2Y receptors', 'G alpha (i) signalling events']"
P2ry13,-0.14160442,-0.20709503,2,"['P2Y receptors', 'G alpha (i) signalling events']"
P2ry14,-0.12966454,0.04995864,2,"['P2Y receptors', 'G alpha (i) signalling events']"
P2ry2,0.13703424,-0.20714448,1,
P2ry4,0.0014000128,-0.05267777,2,"['P2Y receptors', 'G alpha (i) signalling events']"
P2ry6,-0.10531133,-0.02571021,2,"['G alpha (q) signalling events', 'P2Y receptors']"
P3h1,-0.122409195,-0.20485188,2,['Collagen biosynthesis and modifying enzymes']
P3h2,-0.19987977,-0.32773307,2,['Collagen biosynthesis and modifying enzymes']
P3h3,-0.1298363,-0.15269943,2,['Collagen biosynthesis and modifying enzymes']
P3h4,-0.13972202,0.024444439,0,
P3r3urf,0.18173556,-0.24855238,1,
P4ha1,-0.21274456,-0.40577865,2,['Collagen biosynthesis and modifying enzymes']
P4ha2,-0.1310622,-0.30653507,1,['Collagen biosynthesis and modifying enzymes']
P4ha3,-0.12078495,-0.35917696,1,
P4hb,0.2351155,-0.12347925,1,"['Collagen biosynthesis and modifying enzymes', 'Detoxification of Reactive Oxygen Species', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Hedgehog ligand biogenesis', 'VLDL assembly', 'Post-translational protein phosphorylation', 'Chylomicron assembly', 'LDL remodeling']"
P4htm,-0.1464085,-0.022900121,2,
Pa2g4,-0.059046596,0.49029115,0,['Neutrophil degranulation']
Pabpc1,0.10789992,0.56955135,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'Deadenylation of mRNA', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Translation initiation complex formation', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Pabpc1l,-0.07868582,0.39476088,0,
Pabpc2,0.06934063,0.37653244,0,
Pabpc4,-0.050663125,0.29278705,0,
Pabpc4l,-0.15989208,0.05431515,2,
Pabpc5,-0.119348206,0.15707996,0,
Pabpc6,-0.031138038,0.2689155,0,
Pabpn1,-0.086084135,0.46934763,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Pabpn1l,-0.08200412,0.23879445,0,
Pacc1,-0.16277541,-0.109754145,2,
Pacrg,-0.09347943,-0.011440358,2,
Pacs1,0.07567276,-0.03418893,1,
Pacs2,0.049308773,-0.092055485,2,
Pacsin1,-0.020906212,-0.13896172,1,['Clathrin-mediated endocytosis']
Pacsin2,0.14664422,-0.18356866,1,['Clathrin-mediated endocytosis']
Pacsin3,-0.056276865,-0.025878577,2,['Clathrin-mediated endocytosis']
Padi1,-0.012669696,0.033558324,2,['Chromatin modifying enzymes']
Padi2,0.18470477,0.24231003,3,"['Chromatin modifying enzymes', 'Neutrophil degranulation']"
Padi3,-0.04809096,0.16367355,3,['Chromatin modifying enzymes']
Padi4,0.14001285,-0.037480976,3,['Chromatin modifying enzymes']
Padi6,-0.11843,0.16377316,2,['Chromatin modifying enzymes']
Paf1,0.03042695,0.30953777,0,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Pafah1b1,0.28850126,0.1572837,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'AURKA Activation by TPX2', 'EML4 and NUDC in mitotic spindle formation']"
Pafah1b2,-0.07070229,-0.13987848,2,"['Neutrophil degranulation', 'COPI-independent Golgi-to-ER retrograde traffic']"
Pafah1b3,0.08684035,-0.1574998,1,['COPI-independent Golgi-to-ER retrograde traffic']
Pafah2,-0.044294003,-0.05317728,2,['Platelet homeostasis']
Pag1,0.24297245,-0.40196058,1,"['GAB1 signalosome', 'Phosphorylation of CD3 and TCR zeta chains']"
Pah,0.027258983,-0.24976853,1,['Phenylalanine metabolism']
Paics,-0.23707375,-0.055806093,2,['Purine ribonucleoside monophosphate biosynthesis']
Paip1,-0.08924866,0.3903128,0,['Deadenylation of mRNA']
Paip2,-0.01465318,0.22529216,0,
Paip2b,-0.08601077,0.19411701,2,
Pak1,0.52120143,-0.09226054,1,
Pak1ip1,-0.25390917,0.44166774,0,
Pak2,0.5297652,-0.27812228,1,"['Generation of second messenger molecules', 'FCERI mediated MAPK activation', 'CD28 dependent Vav1 pathway', 'Ephrin signaling', 'Sema3A PAK dependent Axon repulsion', 'VEGFA-VEGFR2 Pathway', 'Smooth Muscle Contraction', 'VEGFR2 mediated vascular permeability', 'CD209 (DC-SIGN) signaling', 'RHO GTPases activate PAKs', 'MAPK6/MAPK4 signaling', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle']"
Pak3,0.40524194,-0.27874592,1,"['Generation of second messenger molecules', 'CD28 dependent Vav1 pathway', 'Ephrin signaling', 'Sema3A PAK dependent Axon repulsion', 'VEGFR2 mediated vascular permeability', 'CD209 (DC-SIGN) signaling', 'RHO GTPases activate PAKs', 'MAPK6/MAPK4 signaling', 'RAC1 GTPase cycle', 'RHOU GTPase cycle']"
Pak5,0.33724895,-0.23542069,1,"['RAC1 GTPase cycle', 'RHOD GTPase cycle', 'RHOH GTPase cycle']"
Pak6,0.42703554,-0.21077573,1,"['RAC1 GTPase cycle', 'RHOD GTPase cycle', 'RHOH GTPase cycle', 'RHOV GTPase cycle']"
Pakap,-0.21918948,0.14074811,2,
Palb2,0.25432116,0.29386175,3,"['HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange']"
Palld,0.068624444,-0.2634313,1,
Palm,-0.16181788,-0.09889701,2,
Palmd,-0.0885662,0.027410299,2,
Pals1,0.2745693,-0.24873957,1,
Pals2,-0.075269066,0.027078133,2,
Pam,-0.10823641,-0.15015668,2,
Pam16,-0.03915534,-0.05893057,2,
Pam16l,-0.032249663,-0.08871012,2,
Pan2,-0.10724651,0.28761226,0,['Deadenylation of mRNA']
Pan3,-0.055247918,0.48485038,0,['Deadenylation of mRNA']
Pank1,-0.06753357,-0.30563018,1,['Coenzyme A biosynthesis']
Pank2,-0.13270387,-0.19324371,2,['Coenzyme A biosynthesis']
Pank3,-0.07719455,-0.20100881,2,['Coenzyme A biosynthesis']
Pank4,-0.3267318,0.045917057,2,['Coenzyme A biosynthesis']
Panx1,0.14601097,-0.13325512,1,"['Electric Transmission Across Gap Junctions', 'The NLRP3 inflammasome']"
Panx2,-0.053686313,-0.06545515,2,['Electric Transmission Across Gap Junctions']
Panx3,-0.008911987,-0.055758357,2,
Paox,-0.12908052,0.022576611,2,"['PAOs oxidise polyamines to amines', 'Interconversion of polyamines', 'Peroxisomal protein import']"
Papln,-0.15265392,-0.31938833,2,
Papola,-0.16889083,0.37411502,0,"['mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Papolb,-0.039925452,0.24474548,3,
Papolg,-0.19717513,0.3611709,0,
Pappa,0.020112006,-0.01312161,2,['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)']
Pappa2,0.050746806,-0.08320487,2,['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)']
Papss1,0.0051750904,-0.09185267,1,['Transport and synthesis of PAPS']
Papss2,-0.10138139,-0.005247489,2,['Transport and synthesis of PAPS']
Paqr3,0.16355304,-0.15476888,1,['Negative regulation of MAPK pathway']
Paqr4,-0.25573418,-0.05132383,2,
Paqr5,-0.048755903,-0.039607797,2,
Paqr7,-0.04007328,-0.29857716,1,
Paqr8,-0.23729472,0.10010254,2,
Paqr9,-0.16744773,-0.09934922,2,
Pard3,0.3304974,-0.33005178,1,"['TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Tight junction interactions']"
Pard3b,0.10733453,-0.21230593,1,
Pard6a,0.2867509,-0.33777362,1,"['TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Tight junction interactions', 'Asymmetric localization of PCP proteins', 'RAC1 GTPase cycle', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Pard6b,0.31533858,-0.16274603,1,"['Tight junction interactions', 'RHOV GTPase cycle']"
Pard6g,0.05240752,-0.21699159,1,['Tight junction interactions']
Parg,0.0929261,0.021141112,3,['POLB-Dependent Long Patch Base Excision Repair']
Park7,0.4382645,-0.14083098,1,"['SUMOylation of transcription cofactors', 'Aggrephagy']"
Parl,0.047401275,-0.11532809,2,['Processing of SMDT1']
Parn,-0.15681526,0.5505643,0,
Parp1,0.48376217,0.28239238,3,
Parp10,0.009453921,0.0912425,3,['Nicotinamide salvaging']
Parp11,-0.14364038,-0.0479772,2,
Parp12,-0.053056885,0.1612678,2,
Parp14,0.07304426,0.11232006,3,['Nicotinamide salvaging']
Parp16,-0.01124874,0.12027968,3,['Nicotinamide salvaging']
Parp2,0.37249625,0.31482035,3,"['POLB-Dependent Long Patch Base Excision Repair', 'HDR through MMEJ (alt-NHEJ)', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER']"
Parp3,0.2529053,0.031987254,3,
Parp4,0.09625448,0.20651089,0,['Nicotinamide salvaging']
Parp6,-0.012418871,0.062699676,3,
Parp8,-0.066911824,-0.043245427,2,['Nicotinamide salvaging']
Parp9,0.059534803,0.15343924,0,['Nicotinamide salvaging']
Parpbp,0.08711523,0.43446636,3,
Pars2,-0.11064781,-0.01426928,2,
Parva,0.060315754,-0.23746215,1,"['Localization of the PINCH-ILK-PARVIN complex to focal adhesions', 'Cell-extracellular matrix interactions', 'Regulation of cytoskeletal remodeling and cell spreading by IPP complex components']"
Parvb,0.17707683,-0.14680791,1,"['Cell-extracellular matrix interactions', 'Regulation of cytoskeletal remodeling and cell spreading by IPP complex components']"
Parvg,0.012929374,-0.19118573,1,
Pask,-0.12964426,0.07210295,2,
Pate1,-0.21806931,0.06479673,2,
Pate10,-0.23822619,0.05173555,2,
Pate11,-0.37448144,-0.06842765,2,
Pate12,-0.12708476,0.23455076,2,
Pate13,-0.3708385,0.06613228,2,
Pate14,-0.4405174,-0.0665011,2,
Pate2,-0.25173607,-0.010063742,2,
Pate3,-0.35024723,0.05983861,2,
Pate4,-0.23160218,0.03940598,2,
Pate5,-0.23377651,0.05715495,2,
Pate6,-0.15002799,0.0085051,2,
Pate7,-0.27146113,0.16238526,2,
Pate8,-0.27919278,-0.1476337,2,
Pate9,-0.103354245,-0.0140016135,2,
Patj,0.23178656,-0.1806775,1,
Patl1,-0.1454233,0.36201447,0,"[""mRNA decay by 5' to 3' exoribonuclease""]"
Patl2,-0.1029395,0.3474946,0,
Patz1,0.1172286,0.18485665,3,
Pawr,0.14417812,-0.0650032,1,
Pax1,-0.14489736,0.1986658,2,
Pax2,0.23659493,0.11800765,3,
Pax3,0.285078,0.003627753,3,['HATs acetylate histones']
Pax4,0.11398205,-0.264675,1,
Pax5,0.23281112,-0.017848816,3,['RUNX1 regulates transcription of genes involved in BCR signaling']
Pax6,0.14568096,0.083253495,3,
Pax7,0.40906128,-0.017471753,3,
Pax8,0.23948061,-0.07190651,3,
Pax9,-0.28070495,-0.09871436,2,
Paxbp1,-0.17847556,0.3035567,0,
Paxip1,0.32852647,0.3529375,3,['Nonhomologous End-Joining (NHEJ)']
Paxx,0.1821781,0.32822213,3,
Pbdc1,-0.08128766,0.44809678,0,
Pbk,0.10771639,0.38541567,3,
Pbld2,-0.18501158,0.021416368,2,
Pbp2,0.020857478,0.00021754878,2,
Pbrm1,0.25909075,0.34724766,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Pbsn,-0.20795007,0.11695855,2,
Pbx1,0.09183311,0.077772595,3,
Pbx2,-0.20008397,0.17514503,2,
Pbx3,-0.39512467,0.17457041,2,
Pbx4,-0.2445033,-0.01713658,2,
Pbxip1,-0.12599747,-0.21458066,2,
Pcbd1,-0.23314765,-0.35838804,2,['Phenylalanine metabolism']
Pcbd2,-0.0048661116,-0.19962463,2,
Pcbp1,0.15966913,0.3056249,0,['mRNA Splicing - Major Pathway']
Pcbp2,0.17653401,0.45704517,0,['mRNA Splicing - Major Pathway']
Pcbp3,-0.13923402,-0.033014588,2,
Pcbp4,-0.07322113,0.13650824,0,
Pcca,-0.38804656,-0.07399861,2,"['Biotin transport and metabolism', 'Propionyl-CoA catabolism']"
Pccb,-0.35057113,-0.010809557,2,"['Biotin transport and metabolism', 'Propionyl-CoA catabolism']"
Pcdh10,-0.007428813,-0.18850166,1,
Pcdh11x,-0.019967502,-0.026290117,2,
Pcdh15,-0.23024891,-0.13061062,2,
Pcdh19,0.011822199,-0.24964678,1,
Pcdh7,-0.08192189,0.065535195,2,"['Platelet degranulation ', 'RHOA GTPase cycle', 'RHOB GTPase cycle']"
Pcdhb1,-0.11481941,-0.038095396,2,
Pced1a,-0.39427698,-0.0008785852,2,
Pcf11,-0.07270056,0.5284615,0,"['RNA polymerase II transcribes snRNA genes', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Pcgf1,0.16440621,0.14400876,3,
Pcgf2,0.34178013,0.31534907,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'Transcriptional Regulation by E2F6']"
Pcgf3,0.099992625,0.15991153,3,
Pcgf5,0.15419005,0.10490294,3,['RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']
Pcgf6,0.2108579,0.19427682,3,['Transcriptional Regulation by E2F6']
Pcid2,0.13491601,0.4806512,3,
Pcif1,-0.21790904,-0.049742747,2,
Pck1,0.08450687,-0.0033593234,2,['Gluconeogenesis']
Pck2,-0.03021533,-0.056557916,2,['Gluconeogenesis']
Pclaf,0.062782586,0.41133657,3,['Termination of translesion DNA synthesis']
Pclo,0.10523366,-0.22572178,1,
Pcm1,0.021671826,-0.15732016,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Pcmt1,0.09044573,0.08507127,3,
Pcna,0.33276927,0.5416056,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Removal of the Flap Intermediate from the C-strand', 'SUMOylation of DNA replication proteins', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Pcnt,0.13106985,0.14279221,3,
Pcnx2,-0.32452098,-0.012030299,2,
Pcolce,-0.07301359,-0.2980443,1,"['Collagen biosynthesis and modifying enzymes', 'Crosslinking of collagen fibrils']"
Pcolce2,-0.2040618,-0.40216896,2,['Collagen biosynthesis and modifying enzymes']
Pcp2,0.17158759,-0.14569722,1,['G alpha (i) signalling events']
Pcsk1,0.25999966,-0.14498648,1,"['Peptide hormone biosynthesis', 'Synthesis, secretion, and deacylation of Ghrelin']"
Pcsk1n,-0.084099926,-0.11335106,2,
Pcsk2,0.15057534,-0.24703953,1,
Pcsk4,0.022438698,-0.17675874,1,
Pcsk5,0.17955385,-0.22111124,1,"['NGF processing', 'Assembly of active LPL and LIPC lipase complexes']"
Pcsk6,0.09692716,-0.02287021,1,"['NGF processing', 'Assembly of active LPL and LIPC lipase complexes']"
Pcsk7,0.09375009,-0.29285246,1,
Pcsk9,0.2689728,-0.20764339,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'VLDLR internalisation and degradation', 'Post-translational protein phosphorylation', 'LDL clearance']"
Pctp,-0.21909045,-0.021169532,2,
Pcx,-0.16506232,-0.01668985,2,
Pcyox1,-0.002844745,-0.05625898,2,
Pcyox1l,-0.2156423,-0.10515012,2,['Platelet degranulation ']
Pcyt1a,0.3157202,0.08469473,3,['Synthesis of PC']
Pcyt1b,0.19349281,-0.1537057,1,['Synthesis of PC']
Pcyt2,-0.2512442,-0.18280272,2,['Synthesis of PE']
Pdap1,-0.09583357,0.08475561,2,['Neutrophil degranulation']
Pdc,0.017970573,-0.14785953,1,
Pdcd1,0.2911089,-0.026369853,1,['PD-1 signaling']
Pdcd10,0.18847872,-0.055433426,1,
Pdcd11,-0.26768324,0.5441236,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Pdcd1lg2,0.050836883,-0.12819856,1,['PD-1 signaling']
Pdcd2,0.07927703,0.2500747,3,
Pdcd2l,0.04420639,0.2268854,0,
Pdcd4,0.048692737,0.15003388,0,
Pdcd5,-0.010141961,0.18786806,3,
Pdcd6,-0.08174349,0.12618119,2,
Pdcd6ip,0.18956941,-0.040125776,3,"['RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death']"
Pdcd7,-0.07936227,0.15124018,0,
Pdcl,0.20078085,-0.15946613,1,['Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']
Pdcl2,-0.16630444,0.28670463,3,
Pdcl3,0.04483425,0.07633571,2,
Pde10a,0.14097106,-0.26972023,1,"['cGMP effects', 'G alpha (s) signalling events']"
Pde11a,-0.10586223,-0.26437318,2,"['cGMP effects', 'G alpha (s) signalling events']"
Pde12,-0.15178451,-0.20184268,2,['OAS antiviral response']
Pde1a,-0.0655273,-0.25305822,2,"['Cam-PDE 1 activation', 'cGMP effects', 'G alpha (s) signalling events']"
Pde1b,-0.058322616,-0.3553714,1,"['Cam-PDE 1 activation', 'cGMP effects', 'G alpha (s) signalling events']"
Pde1c,-0.007691164,-0.30384907,1,['Cam-PDE 1 activation']
Pde2a,-0.094725065,-0.2631226,2,"['cGMP effects', 'G alpha (s) signalling events']"
Pde3a,-0.06439949,-0.3054198,2,['G alpha (s) signalling events']
Pde3b,0.20236109,-0.17637317,1,
Pde4a,-0.0831086,-0.20292133,2,"['DARPP-32 events', 'G alpha (s) signalling events']"
Pde4b,0.14794685,-0.041316092,1,['DARPP-32 events']
Pde4c,0.06985754,-0.23494437,1,"['DARPP-32 events', 'G alpha (s) signalling events']"
Pde4d,0.20746414,-0.17313714,1,"['DARPP-32 events', 'G alpha (s) signalling events']"
Pde4dip,-0.105184674,0.00017290837,2,
Pde5a,0.022795465,-0.27649093,2,"['cGMP effects', 'Smooth Muscle Contraction', 'RHOBTB1 GTPase cycle']"
Pde6a,-0.062358543,-0.43318895,1,
Pde6b,0.0994965,-0.2985903,1,"['Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Ca2+ pathway']"
Pde6c,-0.0046228,-0.38451555,1,
Pde6d,0.083130054,-0.16850534,1,"['ARL13B-mediated ciliary trafficking of INPP5E', 'RAS processing']"
Pde6g,-0.095383,-0.32429516,2,"['Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Ca2+ pathway']"
Pde6h,-0.10718213,-0.31148142,2,
Pde7a,-0.146879,-0.2615512,2,['G alpha (s) signalling events']
Pde7b,-0.14906628,-0.25878498,2,['G alpha (s) signalling events']
Pde8a,-0.12534195,-0.044930078,2,['G alpha (s) signalling events']
Pde8b,-0.24239893,-0.14169705,2,['G alpha (s) signalling events']
Pde9a,-0.15699433,-0.32305178,2,['cGMP effects']
Pdf,-0.23159376,-0.11926735,2,
Pdgfa,0.3638117,-0.2295529,1,
Pdgfb,0.4736075,-0.33167985,1,
Pdgfc,0.39042497,-0.24499059,1,['Signaling by PDGF']
Pdgfd,0.3205976,-0.17241472,1,['Signaling by PDGF']
Pdgfra,0.48167875,-0.26949877,1,"['PIP3 activates AKT signaling', 'Downstream signal transduction', 'Signaling by PDGF', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Pdgfrb,0.61683637,-0.27639744,1,"['PIP3 activates AKT signaling', 'Downstream signal transduction', 'Signaling by PDGF', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Pdha1,-0.087830834,0.09598686,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Glyoxylate metabolism and glycine degradation', 'Signaling by Retinoic Acid', 'Pyruvate metabolism']"
Pdha2,-0.14814582,0.14987999,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Glyoxylate metabolism and glycine degradation', 'Signaling by Retinoic Acid', 'Pyruvate metabolism']"
Pdhb,-0.007105978,0.017949322,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Glyoxylate metabolism and glycine degradation', 'Signaling by Retinoic Acid', 'Pyruvate metabolism']"
Pdhx,-0.15115288,-0.02516377,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Glyoxylate metabolism and glycine degradation', 'Signaling by Retinoic Acid', 'Pyruvate metabolism']"
Pdia2,-0.016062833,-0.12071132,1,
Pdia3,0.21517746,0.10119426,3,"['ER-Phagosome pathway', 'Calnexin/calreticulin cycle', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Pdia4,0.024126383,-0.13570186,1,
Pdia5,0.07522067,-0.04712681,2,
Pdia6,-0.058275893,-0.10022973,2,
Pdik1l,-0.048810136,-0.22325882,2,
Pdilt,-0.17443286,0.0079177795,2,
Pdk1,0.20738964,-0.052948277,1,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Signaling by Retinoic Acid']"
Pdk2,0.26546928,0.018939195,3,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Signaling by Retinoic Acid']"
Pdk3,-0.17480831,-0.03700107,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Signaling by Retinoic Acid']"
Pdk4,0.03234186,-0.23273581,2,"['Regulation of pyruvate dehydrogenase (PDH) complex', 'Signaling by Retinoic Acid']"
Pdlim1,0.021240998,-0.19816695,1,
Pdlim2,-0.024481943,-0.14795078,1,
Pdlim3,0.008915118,-0.36695313,1,
Pdlim4,0.18797573,-0.18443812,1,
Pdlim5,0.30521148,-0.1848489,1,
Pdlim7,0.2757823,-0.23985307,1,['RET signaling']
Pdp1,-0.11079146,0.06912656,2,['Regulation of pyruvate dehydrogenase (PDH) complex']
Pdp2,-0.08815141,-0.09338468,2,['Regulation of pyruvate dehydrogenase (PDH) complex']
Pdpk1,0.49643868,-0.0988021,1,"['GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Activation of AKT2', 'Downstream TCR signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated NF-kB activation', 'Integrin signaling', 'CD28 dependent PI3K/Akt signaling', 'G beta:gamma signalling through PI3Kgamma', 'VEGFR2 mediated vascular permeability', 'VEGFR2 mediated cell proliferation', 'CLEC7A (Dectin-1) signaling', 'RHO GTPases activate PKNs', 'Regulation of TP53 Degradation', 'Estrogen-stimulated signaling through PRKCZ']"
Pdpn,0.18419763,-0.33660427,1,['GPVI-mediated activation cascade']
Pdpr,-0.1287795,0.054882754,2,['Regulation of pyruvate dehydrogenase (PDH) complex']
Pdrg1,0.10543298,0.17474632,3,
Pds5a,0.15961583,0.35940114,3,
Pds5b,-0.027226452,0.25284258,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion']"
Pdss1,-0.26418358,0.036603555,2,['Ubiquinol biosynthesis']
Pdss2,-0.086941466,-0.049560755,2,['Ubiquinol biosynthesis']
Pdx1,0.21254778,-0.14992374,1,
Pdxdc1,-0.12757014,0.043135814,2,
Pdxk,-0.27566403,-0.06805856,2,"['Neutrophil degranulation', 'Vitamins B6 activation to pyridoxal phosphate']"
Pdyn,0.12814909,-0.19681895,1,
Pdzd11,-0.08303545,-0.11104651,2,"['Biotin transport and metabolism', 'Vitamin B5 (pantothenate) metabolism', 'Transport of vitamins, nucleosides, and related molecules', 'Ion influx/efflux at host-pathogen interface', 'Ion transport by P-type ATPases']"
Pdzd2,-0.120603226,-0.12738486,2,
Pdzd3,-0.10508959,0.1262587,2,
Pdzd7,-0.16757101,-0.144943,2,
Pdzd8,-0.06106948,0.22781001,3,
Pdzk1,0.117814474,-0.021141004,3,
Pdzk1ip1,0.09128813,-0.09346587,1,
Pdzrn3,-0.15146731,-0.16661942,2,
Pdzrn4,-0.25688326,0.009029321,2,
Pea15a,0.15824854,-0.032011952,1,"['RAF-independent MAPK1/3 activation', 'RAF/MAP kinase cascade']"
Peak1,0.20860803,-0.14046137,1,"['RHOU GTPase cycle', 'RHOV GTPase cycle']"
Pear1,-0.059053577,-0.19672617,2,
Pebp1,0.32448936,-0.27802736,1,"['MAP2K and MAPK activation', 'Negative regulation of MAPK pathway']"
Pebp4,0.04334195,-0.057903755,1,
Pecam1,0.46818385,-0.25991407,1,"['Platelet degranulation ', 'Cell surface interactions at the vascular wall', 'PECAM1 interactions', 'Integrin cell surface interactions', 'Platelet sensitization by LDL', 'Neutrophil degranulation']"
Pecr,-0.3082221,0.13918771,2,"['Alpha-oxidation of phytanate', 'Peroxisomal protein import']"
Peds1,-0.22536084,-0.14775178,2,
Pef1,-0.050383724,0.06578257,2,
Peg10,0.12753595,0.024703993,1,
Peg12,0.15700367,0.010123575,3,
Peg3,0.05580716,0.14631394,3,
Peli1,0.11483001,0.04241971,3,"['Regulation of necroptotic cell death', 'Interleukin-1 signaling', 'IRAK1 recruits IKK complex', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation']"
Peli2,0.2001873,-0.0059923176,3,
Peli3,0.16537295,0.0154232085,1,
Pelo,-0.013062255,0.10328685,0,
Pelp1,0.4132904,0.17536713,3,['Major pathway of rRNA processing in the nucleolus and cytosol']
Pemt,-0.19408089,-0.16369383,2,['Synthesis of PC']
Penk,0.062828645,-0.12299609,1,"['Peptide ligand-binding receptors', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'G alpha (i) signalling events', 'Post-translational protein phosphorylation']"
Pepd,-0.1755322,-0.084914535,2,
Per1,0.21293586,0.17045358,3,
Per2,0.31603268,0.18523313,3,
Per3,0.14845505,0.1323651,3,
Perm1,-0.03173197,0.033537254,2,
Perp,0.018276544,0.0004123931,2,['Formation of the cornified envelope']
Pes1,-0.19661883,0.37086782,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Pet100,0.11556711,0.1323671,0,
Pet117,-0.022971474,0.029332077,0,
Pex1,-0.04541228,0.18029633,2,['Peroxisomal protein import']
Pex10,-0.18645592,0.14650184,2,"['E3 ubiquitin ligases ubiquitinate target proteins', 'Peroxisomal protein import']"
Pex11a,-0.16773845,-0.025738344,2,
Pex11b,-0.31910247,-0.021283086,2,['Class I peroxisomal membrane protein import']
Pex11g,-0.12851144,-0.016094053,2,
Pex12,-0.25752002,0.2181233,2,"['E3 ubiquitin ligases ubiquitinate target proteins', 'Peroxisomal protein import', 'Class I peroxisomal membrane protein import']"
Pex13,-0.11780278,0.11506343,2,"['E3 ubiquitin ligases ubiquitinate target proteins', 'Peroxisomal protein import', 'Class I peroxisomal membrane protein import']"
Pex14,-0.2771549,0.15593998,2,"['E3 ubiquitin ligases ubiquitinate target proteins', 'Peroxisomal protein import', 'Class I peroxisomal membrane protein import']"
Pex16,-0.18179004,0.0465287,2,['Class I peroxisomal membrane protein import']
Pex19,-0.0053553353,0.23410803,3,"['ABC transporters in lipid homeostasis', 'Class I peroxisomal membrane protein import']"
Pex2,-0.0757701,0.196837,2,
Pex26,-0.38612363,0.13841236,2,"['Peroxisomal protein import', 'Class I peroxisomal membrane protein import']"
Pex3,-0.037488986,0.1255775,2,"['ABC transporters in lipid homeostasis', 'Class I peroxisomal membrane protein import']"
Pex5,0.10022354,0.2213155,3,"['E3 ubiquitin ligases ubiquitinate target proteins', 'Peroxisomal protein import', 'Pexophagy']"
Pex5l,-0.19009076,-0.049085155,2,
Pex6,0.031831935,0.15261385,3,['Peroxisomal protein import']
Pex7,-0.21050276,0.0466307,2,['Peroxisomal protein import']
Pf4,0.34552684,-0.18562436,1,"['Platelet degranulation ', 'Common Pathway of Fibrin Clot Formation', 'Cell surface interactions at the vascular wall', 'Chemokine receptors bind chemokines', 'G alpha (i) signalling events']"
Pfas,-0.20164934,0.1877158,2,['Purine ribonucleoside monophosphate biosynthesis']
Pfdn1,-0.030805506,0.47605973,3,
Pfdn2,0.047707677,0.43118498,0,
Pfdn4,-0.10098973,0.38949373,0,
Pfdn5,0.112636186,0.33670008,0,
Pfdn6,-0.13688901,0.37776354,0,
Pfkfb1,0.12302615,0.007983069,3,"['Regulation of glycolysis by fructose 2,6-bisphosphate metabolism']"
Pfkfb2,0.2499599,-0.0075069265,3,
Pfkfb3,-0.08787786,0.093549475,2,"['Regulation of glycolysis by fructose 2,6-bisphosphate metabolism']"
Pfkfb4,-0.31476086,0.004420364,2,"['Regulation of glycolysis by fructose 2,6-bisphosphate metabolism']"
Pfkl,-0.06358731,0.023660421,2,"['Neutrophil degranulation', 'Glycolysis']"
Pfkm,-0.024243478,-0.06715326,2,['Glycolysis']
Pfkp,-0.085747674,0.119077556,2,['Glycolysis']
Pfn1,0.29066628,-0.24041954,1,"['Signaling by ROBO receptors', 'PCP/CE pathway', 'RHO GTPases Activate Formins']"
Pfn2,0.20647289,-0.08596719,1,"['Signaling by ROBO receptors', 'RHO GTPases Activate Formins']"
Pfn3,-0.010828778,-0.28795093,1,
Pfn4,0.12835169,-0.2971681,1,
Pga5,0.21030802,-0.0035926301,3,
Pgam1,-0.029820729,0.03133776,2,"['Neutrophil degranulation', 'Glycolysis', 'Gluconeogenesis']"
Pgam2,-0.049793843,0.058151305,2,"['Glycolysis', 'Gluconeogenesis']"
Pgam5,0.057690192,-0.0073240143,2,['Receptor Mediated Mitophagy']
Pgap1,-0.06302921,0.0014470739,2,['Attachment of GPI anchor to uPAR']
Pgap2,-0.050582808,0.116343796,2,
Pgap3,-0.08000285,-0.014057549,2,
Pgap4,-0.18255597,-0.006272098,2,
Pgap6,-0.026821721,-0.30193257,1,
Pgbd1,-0.16556303,0.018579625,2,
Pgbd5,-0.1880155,-0.0018914689,2,
Pgd,-0.107536696,0.21083665,2,['Pentose phosphate pathway']
Pgf,0.4208559,-0.27307782,1,"['VEGF ligand-receptor interactions', 'VEGF binds to VEGFR leading to receptor dimerization']"
Pgghg,-0.08674479,0.07834715,2,
Pggt1b,-0.15876712,0.008291731,2,
Pgk1,0.11071176,0.12941106,0,"['Glycolysis', 'Gluconeogenesis']"
Pgk2,0.010632732,0.28191194,0,"['Glycolysis', 'Gluconeogenesis']"
Pgls,-0.39739212,-0.15003185,2,['Pentose phosphate pathway']
Pglyrp1,0.07764981,-0.112770535,1,"['Neutrophil degranulation', 'Antimicrobial peptides']"
Pglyrp2,-0.27825287,-0.18595818,2,['Antimicrobial peptides']
Pglyrp3,-0.30464634,0.024841838,2,['Antimicrobial peptides']
Pglyrp4,-0.2761212,-0.09505214,2,['Antimicrobial peptides']
Pgm1,-0.16126582,0.13029645,2,"['Glycogen synthesis', 'Neutrophil degranulation', 'Glycogen breakdown (glycogenolysis)', 'Galactose catabolism']"
Pgm2,-0.28105006,0.09064373,2,"['Neutrophil degranulation', 'Pentose phosphate pathway']"
Pgm2l1,-0.2949729,-0.14208995,2,['Glycolysis']
Pgm3,-0.23272386,-0.030370668,2,['Synthesis of UDP-N-acetyl-glucosamine']
Pgm5,-0.09943316,-0.21568222,2,
Pgp,-0.025378147,-0.012711881,2,
Pgpep1,-0.20627868,-0.08592384,2,
Pgr,0.61007756,0.06302431,3,"['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors', 'Estrogen-dependent gene expression']"
Pgr15l,0.15222436,-0.056035794,1,
Pgrmc1,0.2557157,-0.12663926,1,['Neutrophil degranulation']
Pgrmc2,-0.049562123,0.2499973,0,"['RHOA GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Pgs1,-0.2467652,-0.021914834,2,
Phactr1,-0.09771985,0.015093651,2,
Phaf1,-0.09370125,-0.104634054,2,
Phax,-0.056148913,0.32118604,0,['RNA polymerase II transcribes snRNA genes']
Phb,0.376346,-0.018802859,1,"['RAF activation', 'Processing of SMDT1']"
Phb2,0.29840675,0.1889666,0,['Processing of SMDT1']
Phc1,0.2827015,0.28114468,3,
Phc2,0.28223616,0.25387824,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription']"
Phc3,0.29114273,0.29020354,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Pheta1,-0.0601443,-0.18453528,2,
Pheta2,-0.029436905,-0.035264336,2,
Phex,0.07371462,-0.20387007,2,
Phf1,0.07739579,0.20066136,3,['PRC2 methylates histones and DNA']
Phf10,0.1915557,0.261388,3,
Phf11a,-0.1929045,0.027415937,2,
Phf11c,-0.0074693603,0.09520157,0,
Phf11d,0.0035016087,0.046236243,0,
Phf12,0.14127617,0.19512583,3,
Phf13,-0.25293532,-0.10404494,2,
Phf14,-0.078401245,0.23838568,0,
Phf19,0.060825936,0.35926875,3,['PRC2 methylates histones and DNA']
Phf2,-0.071761675,-0.08300258,2,['HDMs demethylate histones']
Phf20,0.3635557,0.26749405,3,"['HATs acetylate histones', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Association with Co-factors', 'Stabilization of p53']"
Phf20l1,0.06802135,0.15499067,3,
Phf21a,0.2234135,0.44219175,3,
Phf21b,0.1590788,0.27140313,3,
Phf23,0.13170286,0.26740852,3,
Phf24,-0.13740946,-0.13541627,2,
Phf3,-0.09490477,-0.03703367,2,
Phf5a,0.026346998,0.47409672,0,['mRNA Splicing - Major Pathway']
Phf6,0.07872058,0.10186057,3,
Phf7,-0.009706913,0.03767632,2,
Phf8,-0.057981685,0.249623,3,['HDMs demethylate histones']
Phgdh,-0.06457885,0.006335897,2,['Serine biosynthesis']
Phip,0.27321264,0.23988917,3,
Phka1,0.0012545058,-0.25068754,2,['Glycogen breakdown (glycogenolysis)']
Phka2,-0.076094605,-0.26775858,2,['Glycogen breakdown (glycogenolysis)']
Phkb,0.044002965,-0.22941443,2,['Glycogen breakdown (glycogenolysis)']
Phkg1,0.05317138,-0.2953736,2,['Glycogen breakdown (glycogenolysis)']
Phkg2,-0.03407845,-0.33156046,2,['Glycogen breakdown (glycogenolysis)']
Phlda1,-0.08385132,0.03882248,2,['Interaction between PHLDA1 and AURKA']
Phlda2,-0.033955712,-0.04191076,2,
Phlda3,0.022137953,0.011659791,2,
Phldb1,0.025035648,0.2338899,3,
Phldb2,0.10867083,-0.030426871,3,
Phldb3,-0.23631059,-0.13295943,2,
Phlpp1,0.39704302,0.16996545,3,['Negative regulation of the PI3K/AKT network']
Phlpp2,0.19355288,-0.05258788,1,['Negative regulation of the PI3K/AKT network']
Phospho1,-0.16111086,0.026076034,2,"['Synthesis of PC', 'Synthesis of PE']"
Phospho2,-0.15374194,-0.17274468,2,
Phox2a,-0.03765699,0.07865302,2,
Phox2b,0.0929624,-0.23215005,1,
Phpt1,0.10587463,0.09641114,0,
Phrf1,-0.23416854,0.004245866,2,
Phtf1,-0.36603966,-0.024921065,2,
Phyh,-0.26941463,0.035035376,2,"['Alpha-oxidation of phytanate', 'Peroxisomal protein import']"
Phyhip,-0.2400613,-0.08104299,2,
Phykpl,-0.28593314,0.030378764,2,"['Collagen degradation', 'Lysine catabolism']"
Pi16,0.04621784,-0.20689069,1,
Pi4k2a,0.21910433,-0.09521422,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane']"
Pi4k2b,0.07322208,-0.16737807,1,"['Synthesis of PIPs at the ER membrane', 'Synthesis of PIPs at the plasma membrane', 'Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane']"
Pi4ka,0.12341102,-0.26262808,1,
Pi4kb,0.20262477,-0.22454226,1,['Synthesis of PIPs at the Golgi membrane']
Pianp,-0.07390117,-0.13114262,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Pias1,0.4962216,0.3021786,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription factors', 'SUMOylation of ubiquitinylation proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins', 'Formation of Incision Complex in GG-NER', 'Regulation of IFNG signaling']"
Pias2,0.43606907,0.07932562,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription factors', 'SUMOylation of ubiquitinylation proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins']"
Pias3,0.49668607,0.34172922,3,"['SUMOylation of transcription factors', 'SUMOylation of transcription cofactors', 'SUMOylation of intracellular receptors', 'SUMOylation of DNA replication proteins', 'SUMOylation of immune response proteins', 'Formation of Incision Complex in GG-NER']"
Pias4,0.4526831,0.22375448,3,"['Vitamin D (calciferol) metabolism', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription factors', 'SUMOylation of ubiquitinylation proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of SUMOylation proteins', 'SUMOylation of intracellular receptors', 'SUMOylation of DNA replication proteins', 'SUMOylation of immune response proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Pibf1,-0.15000582,-0.03777942,2,
Picalm,0.19894913,-0.34220025,1,"['Golgi Associated Vesicle Biogenesis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'RND3 GTPase cycle']"
Pick1,0.2914265,-0.1675254,1,
Pidd1,0.28497475,-0.0110813435,3,['TP53 Regulates Transcription of Caspase Activators and Caspases']
Piezo1,-0.013943922,0.11380363,2,
Piezo2,0.18565935,0.113822296,3,
Pif1,0.09998791,0.15504369,3,['Telomere Extension By Telomerase']
Pifo,-0.035228655,-0.22007865,2,
Piga,-0.14001982,-0.10405385,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigb,-0.15750203,-0.070116065,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigc,0.024294412,0.033637058,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigf,-0.17714123,-0.12715954,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigg,-0.10418387,0.0054620006,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigh,-0.053333946,-0.21982644,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigk,0.08089603,0.01999239,1,['Attachment of GPI anchor to uPAR']
Pigl,-0.1424271,-0.09014782,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigm,-0.13567652,-0.06619263,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pign,-0.20129918,-0.040186424,2,
Pigo,-0.14832579,-0.026171288,2,
Pigp,-0.153441,-0.07250832,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigq,-0.080333024,-0.071091086,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigr,-0.08594595,0.15508457,2,['Neutrophil degranulation']
Pigs,-0.07589922,0.020245062,2,['Attachment of GPI anchor to uPAR']
Pigt,0.079027206,-0.1369417,1,['Attachment of GPI anchor to uPAR']
Pigu,0.01947656,0.021236809,2,['Attachment of GPI anchor to uPAR']
Pigv,-0.22865035,-0.13222778,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigw,-0.17251694,-0.019266004,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigx,-0.19759916,-0.08090251,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigyl,-0.018492525,-0.07187955,1,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pigz,-0.19565986,-0.08066479,2,['Synthesis of glycosylphosphatidylinositol (GPI)']
Pih1d1,0.28992894,0.43230695,3,
Pih1d2,-0.050804634,0.1862716,3,
Pik3ap1,0.17783184,-0.23062097,1,"['PIP3 activates AKT signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Pik3c2a,0.2594078,-0.38390452,1,
Pik3c2b,0.20191763,-0.2978565,1,['Synthesis of PIPs at the plasma membrane']
Pik3c2g,0.22810401,-0.21898435,1,
Pik3c3,0.28110436,-0.14518629,1,"['PI3K Cascade', 'Macroautophagy', 'Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane', 'Toll Like Receptor 9 (TLR9) Cascade', 'RHO GTPases Activate NADPH Oxidases']"
Pik3ca,0.5908839,-0.35318333,1,"['PI3K Cascade', 'IRS-mediated signalling', 'GPVI-mediated activation cascade', 'PI3K events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'Synthesis of PIPs at the plasma membrane', 'GAB1 signalosome', 'Downstream signal transduction', 'PI3K events in ERBB2 signaling', 'PI3K/AKT activation', 'Signaling by ALK', 'Downstream TCR signaling', 'Role of phospholipids in phagocytosis', 'Tie2 Signaling', 'DAP12 signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'Costimulation by the CD28 family', 'CD28 dependent PI3K/Akt signaling', 'G alpha (q) signalling events', 'VEGFA-VEGFR2 Pathway', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'PI-3K cascade:FGFR1', 'PI-3K cascade:FGFR2', 'PI-3K cascade:FGFR3', 'PI-3K cascade:FGFR4', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'MET activates PI3K/AKT signaling', 'RET signaling', 'Extra-nuclear estrogen signaling', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL', 'FLT3 Signaling']"
Pik3cb,0.47636625,-0.40739602,1,"['PI3K Cascade', 'IRS-mediated signalling', 'GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Synthesis of PIPs at the plasma membrane', 'Downstream signal transduction', 'PI3K/AKT activation', 'Signaling by ALK', 'Downstream TCR signaling', 'Role of phospholipids in phagocytosis', 'Tie2 Signaling', 'DAP12 signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'VEGFA-VEGFR2 Pathway', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RET signaling', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL']"
Pik3cd,0.4482697,-0.41079363,1,"['PIP3 activates AKT signaling', 'Synthesis of PIPs at the plasma membrane', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RET signaling', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Pik3cg,0.46309358,-0.36174574,1,"['GPVI-mediated activation cascade', 'Synthesis of PIPs at the plasma membrane', 'G beta:gamma signalling through PI3Kgamma', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)']"
Pik3ip1,-0.05028957,-0.10715337,2,
Pik3r1,0.5325998,-0.32417524,1,"['PI3K Cascade', 'IRS-mediated signalling', 'GPVI-mediated activation cascade', 'PI3K events in ERBB4 signaling', 'PIP3 activates AKT signaling', 'Interleukin-7 signaling', 'Signaling by SCF-KIT', 'Synthesis of PIPs at the plasma membrane', 'GAB1 signalosome', 'Downstream signal transduction', 'PI3K events in ERBB2 signaling', 'PI3K/AKT activation', 'Signaling by ALK', 'Downstream TCR signaling', 'Role of phospholipids in phagocytosis', 'Tie2 Signaling', 'DAP12 signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'Costimulation by the CD28 family', 'CD28 dependent PI3K/Akt signaling', 'G alpha (q) signalling events', 'GP1b-IX-V activation signalling', 'VEGFA-VEGFR2 Pathway', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'PI-3K cascade:FGFR1', 'PI-3K cascade:FGFR2', 'PI-3K cascade:FGFR3', 'PI-3K cascade:FGFR4', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'MET activates PI3K/AKT signaling', 'RET signaling', 'RHOA GTPase cycle', 'Extra-nuclear estrogen signaling', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'RHOF GTPase cycle', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL', 'FLT3 Signaling', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Pik3r2,0.5300639,-0.2697528,1,"['PI3K Cascade', 'IRS-mediated signalling', 'GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Interleukin-7 signaling', 'Signaling by SCF-KIT', 'Synthesis of PIPs at the plasma membrane', 'Downstream signal transduction', 'PI3K/AKT activation', 'Signaling by ALK', 'Downstream TCR signaling', 'Role of phospholipids in phagocytosis', 'Tie2 Signaling', 'DAP12 signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'Costimulation by the CD28 family', 'CD28 dependent PI3K/Akt signaling', 'G alpha (q) signalling events', 'VEGFA-VEGFR2 Pathway', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RAF/MAP kinase cascade', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RET signaling', 'RHOA GTPase cycle', 'Extra-nuclear estrogen signaling', 'RHOB GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOJ GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Pik3r3,0.46295965,-0.34212154,1,"['GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Interleukin-7 signaling', 'Signaling by SCF-KIT', 'Synthesis of PIPs at the plasma membrane', 'Costimulation by the CD28 family', 'CD28 dependent PI3K/Akt signaling', 'G alpha (q) signalling events', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RET signaling', 'Extra-nuclear estrogen signaling', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'Interleukin receptor SHC signaling', 'Regulation of signaling by CBL']"
Pik3r4,0.29224077,-0.25321212,1,"['PI3K Cascade', 'Macroautophagy', 'Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane', 'Toll Like Receptor 9 (TLR9) Cascade', 'RHO GTPases Activate NADPH Oxidases']"
Pik3r5,0.41529438,-0.35745153,1,"['GPVI-mediated activation cascade', 'Synthesis of PIPs at the plasma membrane', 'G beta:gamma signalling through PI3Kgamma', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)']"
Pik3r6,0.41642806,-0.35879308,1,"['GPVI-mediated activation cascade', 'Synthesis of PIPs at the plasma membrane', 'G beta:gamma signalling through PI3Kgamma']"
Pikfyve,0.14138731,-0.26985556,1,"['Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane']"
Pilra,0.104551844,-0.2689078,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Pilrb1,0.08532569,-0.2807413,1,
Pilrb2,-0.17909968,-0.2569293,2,
Pim1,0.31858474,0.18465106,3,
Pim2,-0.080232635,-0.082103714,2,
Pim3,0.119654,0.025547108,1,
Pimreg,-0.025973503,0.3232249,3,
Pin1,0.5660452,0.028803283,3,"['RHO GTPases Activate NADPH Oxidases', 'Regulation of TP53 Activity through Phosphorylation', 'PI5P Regulates TP53 Acetylation', 'Negative regulators of DDX58/IFIH1 signaling']"
Pin1rt1,0.12835893,0.16772555,3,
Pin4,-0.17907864,0.23892261,0,
Pink1,0.3319439,-0.07159421,1,['PINK1-PRKN Mediated Mitophagy']
Pinlyp,-0.27835914,-0.047095712,2,
Pinx1,-0.08268628,0.55251026,0,
Pip,-0.013291655,-0.1199081,2,['Miscellaneous transport and binding events']
Pip4k2a,0.12105051,-0.24673101,1,"['Synthesis of PIPs at the plasma membrane', 'PI5P Regulates TP53 Acetylation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Synthesis of PIPs in the nucleus']"
Pip4k2b,0.17515896,-0.22336583,1,"['Synthesis of PIPs at the plasma membrane', 'PI5P Regulates TP53 Acetylation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Synthesis of PIPs in the nucleus']"
Pip4k2c,0.117693804,-0.23207858,1,"['Synthesis of PIPs at the plasma membrane', 'PI5P Regulates TP53 Acetylation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Synthesis of PIPs in the nucleus']"
Pip4p1,0.11266141,-0.117812574,1,"['PI5P Regulates TP53 Acetylation', 'Synthesis of PIPs in the nucleus']"
Pip4p2,0.1400468,-0.23431832,1,
Pip5k1a,0.31899127,-0.27594903,1,"['Synthesis of PIPs at the plasma membrane', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Pip5k1b,0.19602095,-0.20487309,1,"['Synthesis of PIPs at the plasma membrane', 'WNT mediated activation of DVL', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Pip5k1c,0.22525132,-0.315649,1,"['Synthesis of PIPs at the plasma membrane', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Clathrin-mediated endocytosis']"
Pip5kl1,0.16102995,-0.051276427,1,
Pipox,-0.20677055,0.17960009,2,"['Lysine catabolism', 'Peroxisomal protein import']"
Pir,-0.045600064,-0.14759298,2,['Digestion']
Pira12,0.16121265,-0.30585098,1,['Neutrophil degranulation']
Pira13,0.04427623,-0.18300122,1,['Neutrophil degranulation']
Pira2,-0.021576615,-0.28777888,1,['Neutrophil degranulation']
Pirb,0.28606975,-0.17486821,1,['Neutrophil degranulation']
Pirt,0.083483405,0.118067235,3,
Pisd,-0.11449533,-0.22793259,2,
Pithd1,0.035830826,0.06136912,3,
Pitpna,-0.18242887,-0.011151063,2,
Pitpnc1,-0.25389498,-0.009117875,2,
Pitpnm1,0.12511994,-0.03003311,1,['Synthesis of PI']
Pitpnm2,0.102030724,-0.047378443,1,['Synthesis of PI']
Pitpnm3,0.034806572,-0.3279829,1,['Synthesis of PI']
Pitrm1,0.25890753,-0.075841926,1,['Mitochondrial protein import']
Pitx1,0.06430659,-0.102041826,2,
Pitx2,0.26328957,-0.15050258,3,
Pitx3,0.19834168,-0.09705561,1,
Piwil1,-0.036841616,0.15412271,2,
Piwil2,0.145298,0.079879954,3,
Piwil4,0.16392958,0.0397072,3,
Pja1,-0.077629216,0.022727033,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Pja2,0.087357804,0.021771338,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Pjvk,-0.26053628,-0.07506021,2,
Pkd1,0.15443483,-0.26702183,1,['VxPx cargo-targeting to cilium']
Pkd1l2,0.009081445,-0.06570636,1,
Pkd1l3,-0.05713494,-0.11811608,2,
Pkd2,0.28735334,-0.087631725,1,['VxPx cargo-targeting to cilium']
Pkd2l1,0.025065234,-0.02469429,2,
Pkd2l2,-0.095274016,0.116477,2,
Pkdrej,-0.36414444,0.05564935,2,
Pkia,-0.0585393,0.003226566,2,
Pklr,-0.06333662,0.17523201,0,
Pkm,-0.018621827,0.11403719,0,"['Neutrophil degranulation', 'Glycolysis']"
Pkmyt1,0.297616,0.14041145,3,"['Polo-like kinase mediated events', 'Cyclin A/B1/B2 associated events during G2/M transition', 'G2/M DNA replication checkpoint']"
Pkn1,0.34456477,-0.01773777,3,"['RHO GTPases activate PKNs', 'Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle']"
Pkn2,0.08207247,-0.057648256,1,"['RHO GTPases activate PKNs', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle']"
Pkn3,0.17288409,0.050035145,3,"['RHO GTPases activate PKNs', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Pknox1,0.2282576,0.10326089,3,
Pkp1,0.24140884,0.13557625,0,"['Apoptotic cleavage of cell adhesion  proteins', 'Neutrophil degranulation', 'Keratinization', 'Formation of the cornified envelope']"
Pkp2,0.17352518,-0.12547135,1,"['Keratinization', 'Formation of the cornified envelope']"
Pkp3,0.14446165,0.14549136,0,"['Keratinization', 'Formation of the cornified envelope']"
Pkp4,0.27987748,-0.04310855,1,"['Keratinization', 'Formation of the cornified envelope', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Pla1a,-0.31522772,-0.16624554,2,['Acyl chain remodelling of PS']
Pla2g10,0.028198399,-0.12707515,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Pla2g12a,-0.15103543,-0.043978516,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Pla2g12b,-0.18726042,-0.014084727,2,
Pla2g15,-0.24926528,-0.057434365,2,['Hydrolysis of LPC']
Pla2g1b,0.121781126,-0.1118768,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Pla2g2c,-0.107825845,-0.1898622,2,
Pla2g2d,0.12130516,-0.05190127,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Pla2g2e,-0.12060291,-0.013718853,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Pla2g2f,-0.059069365,-0.14113294,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Pla2g3,0.026886618,-0.1491482,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PG']"
Pla2g4a,0.2739214,-0.3413749,1,"['phospho-PLA2 pathway', 'Acyl chain remodelling of PC', 'Acyl chain remodeling of CL', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Hydrolysis of LPC', 'Synthesis of PA', 'Arachidonic acid metabolism', 'ADP signalling through P2Y purinoceptor 1', 'Platelet sensitization by LDL', 'COPI-independent Golgi-to-ER retrograde traffic']"
Pla2g4b,0.044483647,-0.19307834,1,
Pla2g4c,0.06469921,-0.15073037,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Hydrolysis of LPC', 'Hydrolysis of LPE']"
Pla2g4d,0.03257671,-0.19719975,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Hydrolysis of LPC', 'Synthesis of PA']"
Pla2g4e,0.030441703,-0.34542805,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Hydrolysis of LPC']"
Pla2g4f,-0.08186829,-0.09226579,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Hydrolysis of LPC']"
Pla2g5,-0.13037483,-0.20522082,2,
Pla2g6,0.0078476565,-0.20093377,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PE', 'Role of phospholipids in phagocytosis', 'COPI-independent Golgi-to-ER retrograde traffic']"
Pla2g7,0.09504389,-0.09541886,1,"['Synthesis, secretion, and deacylation of Ghrelin']"
Pla2r1,0.01685264,-0.0887276,1,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI', 'Acyl chain remodelling of PG', 'Synthesis of PA']"
Plaa,0.162933,0.20189124,3,
Plaat1,-0.07322407,-0.031823907,2,
Plaat3,-0.06443416,-0.18564671,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PS', 'Acyl chain remodelling of PE', 'Acyl chain remodelling of PI']"
Plaat5,-0.05264838,-0.014046509,2,['Acyl chain remodelling of PE']
Plac1,-0.14532848,0.16677979,2,
Plac8,-0.2685267,-0.11801818,2,['Neutrophil degranulation']
Plac8l1,-0.31440443,0.12001842,2,
Plac9,-0.09406394,-0.0019338331,2,
Plag1,-0.12804371,0.062797144,2,
Plagl1,0.06929149,-0.033542115,2,
Plat,0.2136254,-0.069824144,1,"['Signaling by PDGF', 'Dissolution of Fibrin Clot']"
Plau,0.31588784,-0.16861917,1,"['Neutrophil degranulation', 'Dissolution of Fibrin Clot']"
Plaur,0.46111822,-0.21300654,1,"['Attachment of GPI anchor to uPAR', 'Neutrophil degranulation', 'Dissolution of Fibrin Clot']"
Plbd1,-0.34923416,0.040265013,2,
Plcb1,0.2967553,-0.40446132,1,"['PLC beta mediated events', 'Synthesis of IP3 and IP4 in the cytosol', 'Acetylcholine regulates insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G beta:gamma signalling through PLC beta', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Presynaptic function of Kainate receptors']"
Plcb2,0.31424487,-0.41694167,1,"['PLC beta mediated events', 'Synthesis of IP3 and IP4 in the cytosol', 'Acetylcholine regulates insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G beta:gamma signalling through PLC beta', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Presynaptic function of Kainate receptors']"
Plcb3,0.24611773,-0.40728462,1,"['PLC beta mediated events', 'Synthesis of IP3 and IP4 in the cytosol', 'Acetylcholine regulates insulin secretion', 'Ca2+ pathway', 'G alpha (q) signalling events', 'G beta:gamma signalling through PLC beta', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Presynaptic function of Kainate receptors']"
Plcb4,0.41172817,-0.3290678,1,"['PLC beta mediated events', 'Synthesis of IP3 and IP4 in the cytosol', 'G alpha (q) signalling events']"
Plcd1,0.2270773,-0.28017363,1,['Synthesis of IP3 and IP4 in the cytosol']
Plcd3,0.09735957,-0.22109352,1,['Synthesis of IP3 and IP4 in the cytosol']
Plcd4,0.054208472,-0.2632754,1,['Synthesis of IP3 and IP4 in the cytosol']
Plce1,0.25789487,-0.4660222,1,['Synthesis of IP3 and IP4 in the cytosol']
Plcg1,0.5722211,-0.37257814,1,"['ISG15 antiviral mechanism', 'Synthesis of IP3 and IP4 in the cytosol', 'Downstream signal transduction', 'Signaling by ALK', 'Generation of second messenger molecules', 'Role of phospholipids in phagocytosis', 'PECAM1 interactions', 'EGFR interacts with phospholipase C-gamma', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'VEGFR2 mediated cell proliferation', 'Phospholipase C-mediated cascade: FGFR1', 'Phospholipase C-mediated cascade; FGFR2', 'Phospholipase C-mediated cascade; FGFR3', 'Phospholipase C-mediated cascade; FGFR4', 'RET signaling', 'Activated NTRK2 signals through PLCG1', 'Activated NTRK3 signals through PLCG1']"
Plcg2,0.453489,-0.47180024,1,"['GPVI-mediated activation cascade', 'Toll Like Receptor 4 (TLR4) Cascade', 'Synthesis of IP3 and IP4 in the cytosol', 'Generation of second messenger molecules', 'Role of phospholipids in phagocytosis', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'CLEC7A (Dectin-1) signaling', 'Dectin-2 family', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Plch1,-0.05717884,-0.2785882,1,['Synthesis of IP3 and IP4 in the cytosol']
Plch2,0.09567893,-0.24827178,1,['Synthesis of IP3 and IP4 in the cytosol']
Plcl1,-0.20441565,-0.2395786,2,
Plcxd1,-0.0803405,-0.04529437,2,
Plcxd2,-0.32956144,0.060137358,2,
Plcz1,0.09840764,-0.23670971,1,['Synthesis of IP3 and IP4 in the cytosol']
Pld1,0.2101823,-0.29069838,1,
Pld2,0.19892383,-0.41409364,1,"['Synthesis of PA', 'Role of phospholipids in phagocytosis', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle']"
Pld3,0.0029851922,-0.23518488,1,['Role of phospholipids in phagocytosis']
Pld4,-0.22321588,-0.14635007,2,"['Synthesis of IP3 and IP4 in the cytosol', 'Role of phospholipids in phagocytosis']"
Pld5,-0.04824183,-0.16478892,2,
Pld6,0.021920007,-0.010138647,2,['Synthesis of PA']
Plec,0.095445365,-0.09616339,1,"['Caspase-mediated cleavage of cytoskeletal proteins', 'Type I hemidesmosome assembly']"
Plek,0.42613834,-0.38064688,1,['Platelet degranulation ']
Plek2,-0.021553544,-0.1020901,2,
Plekha1,-0.020812979,-0.21013793,1,['Synthesis of PIPs at the plasma membrane']
Plekha2,-0.14596123,-0.045507304,2,['Synthesis of PIPs at the plasma membrane']
Plekha3,-0.13056679,-0.055994064,2,['Synthesis of PIPs at the plasma membrane']
Plekha4,-0.06254596,-0.113743946,2,
Plekha5,-0.0909198,0.044267803,2,['Synthesis of PIPs at the plasma membrane']
Plekha6,-0.14106618,-0.11572199,2,['Synthesis of PIPs at the plasma membrane']
Plekha7,0.15972891,-0.06808062,1,
Plekha8,-0.09343877,-0.13045663,2,['Synthesis of PIPs at the plasma membrane']
Plekhf1,-0.036065947,-0.028699176,2,
Plekhg1,-0.04111207,-0.048933398,2,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Plekhg2,0.06487793,-0.15371591,1,
Plekhg3,-0.31721538,-0.121478006,2,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle']"
Plekhg5,0.12840052,-0.31146964,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RND3 GTPase cycle', 'RND1 GTPase cycle']"
Plekhg6,0.25234884,-0.07786207,1,"['RHOA GTPase cycle', 'RAC1 GTPase cycle']"
Plekhh2,-0.046892226,-0.14581336,2,
Plekhj1,-0.015644275,0.10075632,2,
Plekhm1,-0.18085356,-0.1727604,2,
Plekhm2,-0.05131269,0.20655684,0,
Plekhm3,-0.30076048,-0.050659604,2,
Plekhn1,-0.18716842,-0.13384742,2,
Plekho1,0.13757291,-0.0010521734,3,
Plekho2,-0.26249123,0.20686956,0,['Neutrophil degranulation']
Plekhs1,-0.044189826,-0.12727852,2,
Plg,0.09628921,-0.15305033,1,"['Platelet degranulation ', 'Activation of Matrix Metalloproteinases', 'Signaling by PDGF', 'Dissolution of Fibrin Clot', 'LDL remodeling']"
Plgrkt,-0.1735459,-0.029322095,2,
Plin1,0.21172735,-0.21502408,3,
Plin2,0.057552252,-0.2163465,2,
Plin3,-0.065980196,-0.20466025,2,"['Retrograde transport at the Trans-Golgi-Network', 'RHOBTB3 ATPase cycle']"
Plin4,-0.18086585,-0.015263685,2,
Plin5,-0.0069094454,-0.16295016,2,
Plk1,0.34883493,0.43416423,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Polo-like kinase mediated events', 'Golgi Cisternae Pericentriolar Stack Reorganization', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Phosphorylation of the APC/C', 'Phosphorylation of Emi1', 'Condensation of Prophase Chromosomes', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Activation of NIMA Kinases NEK9, NEK6, NEK7', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Mitotic Metaphase/Anaphase Transition', 'Mitotic Telophase/Cytokinesis', 'Cyclin A/B1/B2 associated events during G2/M transition', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'EML4 and NUDC in mitotic spindle formation']"
Plk2,0.24889049,0.36094373,3,['TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']
Plk3,0.26435238,0.23460796,3,
Plk4,0.24441019,0.29217646,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Plk5,0.090610325,0.14902449,3,
Pllp,-0.18180011,-0.11014567,2,
Pln,0.08896638,-0.22253186,1,"['Ion homeostasis', 'Ion transport by P-type ATPases']"
Plod1,0.12740675,-0.19682974,1,['Collagen biosynthesis and modifying enzymes']
Plod2,-0.04602542,-0.15398641,1,['Collagen biosynthesis and modifying enzymes']
Plod3,0.049362347,-0.02508726,1,['Collagen biosynthesis and modifying enzymes']
Plp1,0.2987701,-0.16706812,1,
Plp2,-0.20352736,-0.09293399,2,
Plpbp,-0.23928489,-0.14238967,2,
Plpp1,-0.31975004,-0.25739047,2,['Sphingolipid de novo biosynthesis']
Plpp2,-0.24067828,-0.2057818,2,['Sphingolipid de novo biosynthesis']
Plpp3,-0.23327243,-0.10326838,2,['Sphingolipid de novo biosynthesis']
Plpp4,-0.052638393,-0.15191287,2,['Role of phospholipids in phagocytosis']
Plpp5,-0.103037305,-0.23899102,2,['Role of phospholipids in phagocytosis']
Plpp6,-0.022358209,0.2788721,0,['Cholesterol biosynthesis']
Plpp7,-0.04114319,0.13152632,2,
Plppr2,-0.24342152,-0.20422688,2,['Lysosphingolipid and LPA receptors']
Plppr3,-0.39001837,-0.09992782,2,
Plppr4,-0.34549117,-0.13047652,2,['Lysosphingolipid and LPA receptors']
Plrg1,-0.10640202,0.4893996,0,['mRNA Splicing - Major Pathway']
Pls1,0.13746637,-0.21698917,1,
Pls3,0.09256975,0.21939066,3,
Plscr1,0.15440856,-0.20385578,1,
Plscr3,-0.4003292,-0.1932997,2,
Plscr5,-0.29779807,-0.16545384,2,
Pltp,0.05354485,-0.07279005,2,['HDL remodeling']
Plxdc1,0.0025829163,-0.08146803,1,
Plxdc2,-0.19883963,-0.22329745,2,
Plxna1,0.19317128,-0.4416596,1,"['Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'CRMPs in Sema3A signaling', 'Other semaphorin interactions', 'RHOD GTPase cycle', 'RND1 GTPase cycle']"
Plxna2,0.22092208,-0.25091577,1,"['Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'CRMPs in Sema3A signaling']"
Plxna3,0.24537005,-0.14302488,1,"['Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'CRMPs in Sema3A signaling']"
Plxna4,0.16769786,-0.23158333,1,"['Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'CRMPs in Sema3A signaling']"
Plxnb1,0.17982392,-0.28949103,1,"['G alpha (12/13) signalling events', 'Sema4D mediated inhibition of cell attachment and migration', 'Sema4D induced cell migration and growth-cone collapse', 'RHOD GTPase cycle']"
Plxnb2,0.1911702,-0.31151378,1,
Plxnb3,0.10023778,-0.24168625,1,['Other semaphorin interactions']
Plxnc1,-0.027597692,-0.35489896,1,['Other semaphorin interactions']
Plxnd1,0.07341116,-0.25431922,1,"['Other semaphorin interactions', 'RND2 GTPase cycle']"
Pm20d1,-0.12938209,-0.11044391,2,['Oleoyl-phe metabolism']
Pmaip1,0.17833962,0.032805502,3,"['Activation of NOXA and translocation to mitochondria', 'BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members']"
Pmch,0.12331435,-0.042530112,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events', 'G alpha (i) signalling events']"
Pmel,0.07155579,-0.11301352,1,
Pmepa1,0.100945234,0.032398216,3,
Pmf1,-0.065280944,0.08821238,2,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Pml,0.34673408,0.27741316,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Regulation of TP53 Activity through Acetylation', 'Regulation of RUNX1 Expression and Activity', 'Regulation of PTEN localization']"
Pmm1,-0.17206036,0.028910672,2,['Synthesis of GDP-mannose']
Pmm2,-0.19487584,-0.078819335,2,['Synthesis of GDP-mannose']
Pmp2,-0.2780481,-0.043195833,2,
Pmp22,0.18074964,-0.36563095,1,
Pmpca,-0.056387406,0.24493183,0,['Processing of SMDT1']
Pmpcb,0.060256805,0.033873204,0,['Processing of SMDT1']
Pms1,-0.11107806,0.21090706,2,
Pms2,0.11655305,0.34217697,3,
Pmvk,-0.23611951,0.042295396,2,['Cholesterol biosynthesis']
Pnck,-0.057502404,0.05082908,2,
Pnisr,0.007753296,0.21641791,0,
Pnkp,-0.005347597,0.27946025,3,
Pnldc1,-0.17886367,0.21914776,2,
Pnlip,-0.11380438,-0.2162723,2,"['Digestion of dietary lipid', 'Retinoid metabolism and transport']"
Pnliprp1,0.011190897,-0.12788104,2,['Digestion of dietary lipid']
Pnliprp2,0.0014017107,-0.21210182,2,['Digestion of dietary lipid']
Pnma2,-0.06831766,0.083899744,2,
Pnma3,-0.06758465,0.09117733,2,
Pnma5,-0.15945816,-0.049378395,2,
Pnma8a,-0.2112444,-0.028774394,2,
Pnma8b,-0.17155208,-0.07347995,2,
Pnmt,-0.059054334,0.04460028,2,['Catecholamine biosynthesis']
Pnn,-0.00026482964,0.4158962,0,
Pno1,-0.06605953,0.3941288,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Pnoc,-0.2045558,0.043249756,2,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Pnp,-0.08789211,0.019177008,2,
Pnp2,-0.031333946,0.0945492,2,"['Neutrophil degranulation', 'Purine salvage', 'Purine catabolism']"
Pnpla1,-0.18266976,-0.12194602,2,
Pnpla2,0.01026319,-0.21099724,2,"['Acyl chain remodeling of DAG and TAG', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Pnpla3,0.010523585,-0.119191036,2,
Pnpla6,-0.18401216,-0.11153925,2,['Glycerophospholipid catabolism']
Pnpla7,-0.24182773,-0.041019443,2,
Pnpla8,-0.23143123,-0.20893735,2,"['Acyl chain remodelling of PC', 'Acyl chain remodelling of PE']"
Pnpo,-0.36644784,-0.24308361,2,['Vitamins B6 activation to pyridoxal phosphate']
Pnpt1,-0.16497034,0.1478463,0,
Pnrc1,-0.14057979,-0.096728906,2,
Pnrc2,-0.07176211,0.17626698,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Poc1a,-0.120700814,-0.0013631816,2,
Poc1b,-0.11469827,0.15937135,2,
Poc5,-0.021830603,0.32940194,0,
Podxl,-0.031169211,-0.33482707,1,
Podxl2,-0.049070895,-0.17021807,2,
Pof1b,-0.08775754,0.05678991,2,
Pofut1,-0.007896034,0.0010846576,2,
Pofut2,0.0015769629,-0.04672283,1,['O-glycosylation of TSR domain-containing proteins']
Pogk,-0.04366658,-0.18020493,2,
Poglut1,0.07986627,0.2194099,3,
Poglut3,-0.08881817,0.033002473,2,
Pogz,0.14715616,0.13492766,3,
Pola1,0.13108635,0.47540307,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation', 'DNA replication initiation', 'Activation of the pre-replicative complex', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Pola2,0.056692902,0.4112468,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation', 'DNA replication initiation', 'Activation of the pre-replicative complex', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Polb,0.17308617,0.30280414,3,"['POLB-Dependent Long Patch Base Excision Repair', 'Resolution of AP sites via the multiple-nucleotide patch replacement pathway', 'Resolution of AP sites via the single-nucleotide replacement pathway', 'APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway', 'PCNA-Dependent Long Patch Base Excision Repair', 'Ub-specific processing proteases', 'Abasic sugar-phosphate removal via the single-nucleotide replacement pathway']"
Pold1,0.22061235,0.48782662,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Removal of the Flap Intermediate from the C-strand', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'PCNA-Dependent Long Patch Base Excision Repair', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Pold2,0.1878168,0.29652855,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Removal of the Flap Intermediate from the C-strand', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'PCNA-Dependent Long Patch Base Excision Repair', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Pold3,0.1538404,0.3473111,3,
Pold4,0.064092696,0.18250741,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Removal of the Flap Intermediate from the C-strand', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'PCNA-Dependent Long Patch Base Excision Repair', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Poldip2,-0.09687527,-0.32763714,2,
Poldip3,0.040298045,0.3573173,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Pole,0.17928459,0.52214205,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'PCNA-Dependent Long Patch Base Excision Repair', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'DNA replication initiation', 'Activation of the pre-replicative complex']"
Pole2,0.19959594,0.4069416,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'PCNA-Dependent Long Patch Base Excision Repair', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'DNA replication initiation', 'Activation of the pre-replicative complex']"
Pole3,0.30717632,0.38369155,3,
Pole4,0.17983164,0.389288,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'PCNA-Dependent Long Patch Base Excision Repair', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'DNA replication initiation', 'Activation of the pre-replicative complex']"
Polg,0.04464494,0.30859885,3,
Polg2,-0.008132941,0.35216916,0,
Polh,0.12690388,0.28488943,3,"['Translesion Synthesis by POLH', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)']"
Poli,0.13909532,0.3474391,3,
Polk,0.20694104,0.37000132,3,"['Translesion synthesis by POLK', 'Termination of translesion DNA synthesis', 'HDR through Homologous Recombination (HRR)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER']"
Poll,-0.058827143,0.1696847,2,['Nonhomologous End-Joining (NHEJ)']
Polm,-0.010886018,0.2551792,3,['Nonhomologous End-Joining (NHEJ)']
Poln,-0.025003275,0.2687296,3,
Polq,0.073874265,0.18175085,3,['HDR through MMEJ (alt-NHEJ)']
Polr1a,0.012649645,0.5311551,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Polr1b,-0.017136157,0.4336432,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Polr1c,0.034957886,0.54488873,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr1d,-0.020663854,0.49695078,0,
Polr1e,-0.0050916267,0.3189072,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Polr1f,-0.0217326,0.39741558,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Polr1h,0.003139056,0.3540115,0,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Polr2a,0.4273294,0.51424533,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2b,0.22080752,0.6373587,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2c,0.21072288,0.5058458,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2d,0.13910349,0.463668,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2e,0.1316304,0.51315093,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'B-WICH complex positively regulates rRNA expression', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2f,0.3151062,0.55521184,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'B-WICH complex positively regulates rRNA expression', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2g,0.16497865,0.50054795,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2h,0.19400017,0.53888726,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'B-WICH complex positively regulates rRNA expression', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2i,0.17204858,0.4214437,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2j,0.19674686,0.4762325,0,
Polr2k,0.077649176,0.47546032,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'B-WICH complex positively regulates rRNA expression', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2l,0.21658309,0.51593935,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'B-WICH complex positively regulates rRNA expression', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'FGFR2 alternative splicing', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intron-Containing Pre-mRNA', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Elongation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'RNA Pol II CTD phosphorylation and interaction with CE', 'Estrogen-dependent gene expression']"
Polr2m,0.15507452,0.20427887,3,
Polr3a,-0.06401877,0.26199168,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3b,-0.048782088,0.36672774,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3c,-0.09734218,0.3750225,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3d,-0.034831185,0.24418204,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3e,0.06569099,0.16190977,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3f,-0.0748128,0.3263226,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3g,-0.09179604,0.14646553,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3gl,-0.15382685,0.12296925,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3h,-0.060699284,0.4146122,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polr3k,0.03252883,0.34144175,0,"['RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Polrmt,-0.30408618,0.07831967,2,['Mitochondrial transcription initiation']
Pom121,0.07624813,0.45472565,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Pom121l2,-0.112192035,0.18200992,2,
Pomc,0.17162903,-0.38234502,1,"['Opioid Signalling', 'Androgen biosynthesis', 'Glucocorticoid biosynthesis', 'G-protein activation', 'Peptide hormone biosynthesis', 'Endogenous sterols', 'Peptide ligand-binding receptors', 'G alpha (s) signalling events', 'G alpha (i) signalling events']"
Pomgnt1,-0.21038914,-0.383734,2,['O-linked glycosylation']
Pomgnt2,-0.13444673,-0.24914926,2,['O-linked glycosylation']
Pomk,-0.09002074,-0.1690881,2,['O-linked glycosylation']
Pomp,0.023874588,0.06740934,2,
Pomt1,-0.10373213,-0.21381016,2,['O-linked glycosylation']
Pomt2,-0.104211286,-0.21748757,2,['O-linked glycosylation']
Pon1,0.21049675,-0.08738552,1,"['Synthesis of 5-eicosatetraenoic acids', 'Atorvastatin ADME']"
Pon3,0.032717835,0.036587104,2,"['Synthesis of 5-eicosatetraenoic acids', 'Atorvastatin ADME']"
Pop1,-0.1675995,0.15628053,0,
Pop4,-0.06425335,0.17850524,0,
Pop5,-0.034063403,0.30406246,0,
Pop7,-0.117788635,0.2955933,0,
Popdc2,-0.050831724,-0.041720346,2,
Por,-0.16952072,0.14731012,2,
Porcn,0.17800419,-0.15426092,1,
Postn,0.08009029,-0.3366075,1,
Pot1a,0.027607113,0.42674258,0,"['Telomere Extension By Telomerase', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Telomere C-strand synthesis initiation', 'Removal of the Flap Intermediate from the C-strand']"
Pot1b,-0.10606232,0.20192094,2,
Poteg,-0.166816,-0.11965972,2,
Pou1f1,-0.11268623,-0.22081636,2,
Pou2af1,-0.029551988,-0.23538478,1,
Pou2f1,0.27164063,0.23214501,3,"['RNA polymerase II transcribes snRNA genes', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Pou2f2,0.08087982,0.19369113,3,['RNA polymerase II transcribes snRNA genes']
Pou2f3,0.11238817,0.030928366,3,
Pou3f1,-0.07898337,0.04990245,2,
Pou3f2,0.16523473,0.09838487,3,
Pou3f3,-0.0031158337,-0.10337316,2,
Pou4f1,0.30371496,0.072028376,3,['Regulation of TP53 Activity through Association with Co-factors']
Pou4f2,0.09889698,-0.1644471,1,['Regulation of TP53 Activity through Association with Co-factors']
Pou4f3,-0.023684276,-0.15745234,2,
Pou5f1,0.4131027,0.3194303,3,
Pou6f1,-0.08547313,-0.0007300108,2,
Pp2d1,-0.11959968,-0.020438334,2,
Ppa1,-0.004521914,0.17186454,3,"['Cytosolic tRNA aminoacylation', 'Pyrophosphate hydrolysis']"
Ppa2,-0.08145882,0.11943914,2,"['Mitochondrial tRNA aminoacylation', 'Pyrophosphate hydrolysis']"
Ppan,-0.20936573,0.2695988,0,
Ppara,0.4238375,-0.122937,3,"['Nuclear Receptor transcription pathway', 'Regulation of lipid metabolism by PPARalpha', 'SUMOylation of intracellular receptors', 'Cytoprotection by HMOX1']"
Ppard,0.13409819,0.03571643,3,"['Carnitine metabolism', 'Regulation of pyruvate dehydrogenase (PDH) complex', 'Nuclear Receptor transcription pathway', 'Signaling by Retinoic Acid']"
Pparg,0.58196497,-0.0136401905,3,
Ppargc1a,0.4107394,-0.04894675,3,
Ppargc1b,0.06096002,0.09817181,3,
Ppat,-0.23865968,0.00072493125,2,['Purine ribonucleoside monophosphate biosynthesis']
Ppbp,0.15857136,-0.19454402,1,"['Platelet degranulation ', 'Chemokine receptors bind chemokines', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Ppcdc,-0.3115117,0.012571123,2,['Coenzyme A biosynthesis']
Ppcs,-0.29697508,-0.2816877,2,['Coenzyme A biosynthesis']
Ppdpf,-0.17461412,-0.06209746,2,
Ppef1,-0.26713783,-0.24183771,2,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Ppef2,-0.10367402,0.058501277,2,
Ppfia1,0.10134499,-0.07454265,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Receptor-type tyrosine-protein phosphatases']"
Ppfia2,0.13949318,-0.1278013,1,
Ppfia3,0.14328149,-0.14745237,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Receptor-type tyrosine-protein phosphatases']"
Ppfia4,-0.105118625,-0.14922428,2,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Receptor-type tyrosine-protein phosphatases']"
Ppfibp1,0.011600693,-0.071300775,2,['Receptor-type tyrosine-protein phosphatases']
Ppfibp2,-0.12641081,-0.04456436,2,['Receptor-type tyrosine-protein phosphatases']
Pphln1,-0.043433744,0.006885362,2,
Ppia,0.26988563,0.19401108,0,['Neutrophil degranulation']
Ppib,0.09049804,-0.26224712,1,['Collagen biosynthesis and modifying enzymes']
Ppic,0.036556143,-0.11625301,2,
Ppid,0.20344426,-0.10280279,1,['ESR-mediated signaling']
Ppie,-0.1827862,0.41300327,0,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Neutrophil degranulation', 'mRNA Splicing - Major Pathway']"
Ppif,0.3714603,0.07270731,3,
Ppig,-0.11157007,0.08056818,2,
Ppih,-0.23985437,0.5615617,0,['mRNA Splicing - Major Pathway']
Ppil1,-0.10247945,0.5035084,0,['mRNA Splicing - Major Pathway']
Ppil2,-0.35857365,-0.27460468,2,
Ppil3,-0.15805459,0.16345072,0,['mRNA Splicing - Major Pathway']
Ppil4,0.038491983,0.30493566,0,['mRNA Splicing - Major Pathway']
Ppil6,-0.21612585,-0.10411624,2,
Ppip5k1,-0.24020381,0.16945577,2,['Synthesis of pyrophosphates in the cytosol']
Ppip5k2,-0.34321,0.17437202,2,['Synthesis of pyrophosphates in the cytosol']
Ppl,0.24279489,-0.05162729,1,
Ppm1a,0.26003012,0.04408319,3,"['Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'Energy dependent regulation of mTOR by LKB1-AMPK']"
Ppm1b,0.12162424,0.08590563,3,['ISG15 antiviral mechanism']
Ppm1d,0.2733932,0.110635914,3,['Transcriptional regulation by RUNX2']
Ppm1e,-0.23049825,-0.011689425,2,
Ppm1f,-0.0538452,0.12229159,2,
Ppm1g,-0.07649178,0.2653286,3,
Ppm1h,-0.11109336,0.10471205,0,
Ppm1j,-0.23771624,-0.1078287,2,
Ppm1k,-0.24680342,0.085385606,0,['Branched-chain amino acid catabolism']
Ppm1l,0.047259003,-0.057034682,1,
Ppm1m,-0.029439284,0.009737305,2,
Ppme1,0.047614105,-0.1878503,2,['Cyclin A/B1/B2 associated events during G2/M transition']
Ppox,-0.11219612,0.16793595,2,['Heme biosynthesis']
Ppp1ca,0.35234523,0.07481044,3,['DARPP-32 events']
Ppp1cb,0.43395174,0.0020224035,3,"['Regulation of PLK1 Activity at G2/M Transition', 'RHO GTPases activate PKNs', 'RHO GTPases activate PAKs', 'RAF activation']"
Ppp1cc,0.35354888,0.0034718865,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'RAF activation', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ppp1r10,0.13298036,-0.046231363,1,
Ppp1r11,0.1701192,0.100406125,3,
Ppp1r12a,0.31871897,-0.18766846,1,"['Regulation of PLK1 Activity at G2/M Transition', 'RHO GTPases activate PKNs', 'RHO GTPases activate PAKs']"
Ppp1r12b,0.25892514,-0.085551456,1,"['Regulation of PLK1 Activity at G2/M Transition', 'RHO GTPases activate PKNs', 'RHO GTPases activate PAKs']"
Ppp1r12c,0.1188126,-0.21869577,1,
Ppp1r13b,0.19192612,0.017763695,3,['Regulation of TP53 Activity through Association with Co-factors']
Ppp1r13l,0.27200815,0.14733164,3,['Regulation of TP53 Activity through Association with Co-factors']
Ppp1r14a,0.2744688,-0.18531151,1,['RHO GTPases activate PKNs']
Ppp1r14c,-0.09234564,-0.10475428,2,
Ppp1r15a,0.2995479,0.02202437,1,
Ppp1r15b,0.11411459,-0.11724766,1,
Ppp1r16a,0.034283657,0.060505092,3,
Ppp1r16b,0.009674703,-0.20101011,2,
Ppp1r17,0.05100305,-0.0167967,2,
Ppp1r18,-0.12586738,-0.09049141,2,
Ppp1r1a,0.18699016,-0.105224736,1,
Ppp1r1b,0.12993173,-0.0691098,1,['DARPP-32 events']
Ppp1r2,-0.010543078,0.047176033,3,
Ppp1r26,-0.19637406,-0.045623366,2,
Ppp1r27,-0.32366937,0.06427237,2,
Ppp1r32,-0.15273373,-0.021044297,2,
Ppp1r35,-0.33878666,0.1178931,2,
Ppp1r3a,0.2480361,0.04261024,3,
Ppp1r3b,0.08133029,-0.17684501,1,
Ppp1r3c,0.03545212,-0.082649805,2,['Glycogen synthesis']
Ppp1r3d,0.024691666,-0.043756068,2,
Ppp1r3e,0.0426466,-0.076036744,1,
Ppp1r3f,0.10913397,-0.010466316,1,
Ppp1r3g,-0.048486307,-0.15850921,2,
Ppp1r42,-0.27215996,0.5582341,0,
Ppp1r7,0.16316506,0.15595226,3,
Ppp1r8,0.18729435,0.21326642,3,
Ppp1r9a,0.072852366,-0.11171112,1,
Ppp1r9b,0.3261857,-0.31296682,1,
Ppp2ca,0.4441783,0.040532805,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Spry regulation of FGF signaling', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'DARPP-32 events', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'ERK/MAPK targets', 'ERKs are inactivated', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Initiation of Nuclear Envelope (NE) Reformation', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'Regulation of TP53 Degradation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'EML4 and NUDC in mitotic spindle formation', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Ppp2cb,0.5330174,-0.0053206105,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Spry regulation of FGF signaling', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'DARPP-32 events', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'ERK/MAPK targets', 'ERKs are inactivated', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'Regulation of TP53 Degradation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'EML4 and NUDC in mitotic spindle formation']"
Ppp2r1a,0.43209735,-0.056689598,1,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Spry regulation of FGF signaling', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'DARPP-32 events', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'ERK/MAPK targets', 'ERKs are inactivated', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'Initiation of Nuclear Envelope (NE) Reformation', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'Regulation of TP53 Degradation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'AURKA Activation by TPX2', 'EML4 and NUDC in mitotic spindle formation', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Ppp2r1b,0.49385762,-0.07714952,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'DARPP-32 events', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'ERK/MAPK targets', 'ERKs are inactivated', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'Regulation of TP53 Degradation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'EML4 and NUDC in mitotic spindle formation']"
Ppp2r2a,0.2660086,0.08946601,3,"['Initiation of Nuclear Envelope (NE) Reformation', 'Cyclin D associated events in G1', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Ppp2r2b,0.28816894,0.0076796417,1,
Ppp2r2c,0.17537984,0.013240333,3,
Ppp2r2d,0.13157524,0.05793965,3,
Ppp2r3a,0.043729454,-0.22105804,1,
Ppp2r3c,0.22111076,0.02821191,3,
Ppp2r3d,0.15824014,-0.06975309,1,
Ppp2r5a,0.30953506,-0.09939589,1,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ppp2r5b,0.3535423,-0.06600256,1,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ppp2r5c,0.32424584,-0.07749973,1,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'Regulation of TP53 Degradation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ppp2r5d,0.4179929,-0.053296596,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'DARPP-32 events', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'ERK/MAPK targets', 'ERKs are inactivated', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ppp2r5e,0.42489696,-0.07923326,1,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'CTLA4 inhibitory signaling', 'Platelet sensitization by LDL', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'RHO GTPases Activate Formins', 'RAF activation', 'Negative regulation of MAPK pathway', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ppp3ca,0.3284584,-0.15322538,1,"['Calcineurin activates NFAT', 'FCERI mediated Ca+2 mobilization', 'Ca2+ pathway', 'CLEC7A (Dectin-1) induces NFAT activation']"
Ppp3cb,0.372079,-0.13524304,1,"['Calcineurin activates NFAT', 'FCERI mediated Ca+2 mobilization', 'Ca2+ pathway', 'CLEC7A (Dectin-1) induces NFAT activation']"
Ppp3cc,0.30192092,-0.13724238,1,['Activation of BAD and translocation to mitochondria ']
Ppp3r1,0.2255311,-0.08061947,1,"['Activation of BAD and translocation to mitochondria ', 'Calcineurin activates NFAT', 'FCERI mediated Ca+2 mobilization', 'Ca2+ pathway', 'CLEC7A (Dectin-1) induces NFAT activation']"
Ppp3r2,0.1795328,-0.048452463,1,
Ppp4c,0.17489976,0.11844635,3,['Processing of DNA double-strand break ends']
Ppp4r1,0.10604247,-0.03680617,3,
Ppp4r2,0.14777997,-0.030488828,3,
Ppp4r3a,0.12630096,-0.048426896,3,
Ppp4r3b,0.09305496,-0.17507376,1,
Ppp4r4,0.14690593,-0.09036798,1,
Ppp5c,0.40205035,0.1629147,3,"['Negative regulation of MAPK pathway', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'ESR-mediated signaling']"
Ppp6c,-0.0017047764,0.20117255,0,"['Telomere Extension By Telomerase', 'COPII-mediated vesicle transport']"
Ppp6r1,-0.13377017,-0.14150009,2,['COPII-mediated vesicle transport']
Ppp6r2,-0.1909704,-0.049454942,2,
Ppp6r3,-0.11164628,0.3050224,0,"['Telomere Extension By Telomerase', 'COPII-mediated vesicle transport']"
Pprc1,0.041751456,0.16902074,0,
Ppt1,-0.3678972,-0.16362686,2,['Fatty acyl-CoA biosynthesis']
Ppt2,-0.22481178,0.0081307925,2,['Fatty acyl-CoA biosynthesis']
Pptc7,-0.042319667,-0.09174294,2,
Ppwd1,0.019507535,0.3835349,0,['mRNA Splicing - Major Pathway']
Ppy,0.110066175,-0.17430308,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Pqbp1,-0.06528145,0.3386447,0,['mRNA Splicing - Major Pathway']
Praf2,-0.03646817,-0.09616811,2,
Prag1,0.09603243,-0.117910355,1,['RND2 GTPase cycle']
Pram1,0.06249215,0.100023456,3,
Pramel11,-0.36864752,0.1214451,2,
Pramel13,-0.06898766,-0.0077163232,2,
Pramel15,-0.3340448,-0.042881947,2,
Pramel17,-0.26161295,0.1515339,2,
Pramel18,-0.0806879,0.12219747,2,
Pramel19,-0.30055994,0.0054022446,2,
Pramel37,-0.2293264,-0.01769812,2,
Pramel48,-0.13590492,0.1123458,0,
Pramel50,-0.15968004,0.018538874,2,
Prap1,-0.21642865,-0.001355344,2,
Prc1,0.20078713,0.43946406,3,['RHO GTPases activate CIT']
Prcc,0.0055598575,0.12211071,0,['mRNA Splicing - Major Pathway']
Prcp,-0.044506557,-0.05628594,2,"['Intrinsic Pathway of Fibrin Clot Formation', 'Neutrophil degranulation']"
Prdm1,0.2822903,0.064189404,3,
Prdm10,-0.1147114,-0.20763461,2,
Prdm11,-0.37245083,-0.2820299,2,
Prdm12,-0.15894957,-0.013971603,2,
Prdm13,-0.18034816,-0.14404024,2,
Prdm14,0.050314922,0.31168222,3,
Prdm15,-0.1864977,0.17326495,2,
Prdm16,0.2510472,0.02502119,3,['PKMTs methylate histone lysines']
Prdm2,0.14754668,0.15787715,3,
Prdm4,0.11302215,-0.03431496,1,
Prdm5,-0.138122,-0.096737824,2,
Prdm6,-0.08973111,0.067808196,2,
Prdm8,-0.15261514,0.21253617,2,
Prdm9,0.102102175,0.37209144,3,"['Generic Transcription Pathway', 'PKMTs methylate histone lysines']"
Prdx1,0.19879179,0.01139849,1,"['Detoxification of Reactive Oxygen Species', 'TP53 Regulates Metabolic Genes', 'KEAP1-NFE2L2 pathway']"
Prdx2,0.22488028,0.07865275,3,"['Detoxification of Reactive Oxygen Species', 'TP53 Regulates Metabolic Genes']"
Prdx3,0.21112159,-0.026818266,1,['Detoxification of Reactive Oxygen Species']
Prdx4,0.09734777,-0.14705464,1,['Neutrophil degranulation']
Prdx5,0.11622073,0.12464096,0,"['Detoxification of Reactive Oxygen Species', 'TP53 Regulates Metabolic Genes']"
Prdx6,0.07378775,-0.09491878,1,
Prdx6b,-0.06777261,-0.10642024,2,
Preb,-0.1415356,-0.012115391,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER']"
Prelid1,-0.24947138,0.031372603,2,['TP53 Regulates Transcription of Genes Involved in Cytochrome C Release']
Prelid2,-0.16550866,-0.0013328302,2,
Prelid3a,-0.32845753,0.016666794,2,['TP53 Regulates Transcription of Genes Involved in Cytochrome C Release']
Prelid3b,-0.11670289,0.032374118,2,
Prelp,-0.11444861,-0.039675545,2,"['Keratan sulfate biosynthesis', 'Keratan sulfate degradation']"
Prep,-0.024614902,-0.1582019,2,
Prepl,-0.11729191,0.18552855,0,
Prex1,0.44424212,-0.24960183,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle']"
Prex2,0.33816612,-0.11591385,1,"['Regulation of PTEN stability and activity', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Prf1,0.16266774,-0.17408702,1,
Prg2,-0.3402635,0.16113244,2,['Neutrophil degranulation']
Prg4,0.012011222,-0.2430622,1,
Prickle1,0.344815,0.09162982,3,['Asymmetric localization of PCP proteins']
Prickle2,0.27811903,-0.15839571,1,
Prickle3,-0.027458265,-0.018839808,2,
Prickle4,0.0953224,0.04336225,3,
Prim1,0.17611338,0.3609363,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation', 'DNA replication initiation', 'Activation of the pre-replicative complex', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Prim2,0.124312714,0.39911494,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation', 'DNA replication initiation', 'Activation of the pre-replicative complex', 'Polymerase switching', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand']"
Prima1,-0.080413565,-0.031607788,2,
Primpol,0.005859724,0.08325486,3,
Prkaa1,0.22903305,-0.048335318,3,"['Macroautophagy', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkaa2,0.34415472,-0.05797804,3,"['Macroautophagy', 'AMPK inhibits chREBP transcriptional activation activity', 'Carnitine metabolism', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkab1,0.24194376,0.061257124,3,"['Macroautophagy', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkab2,0.2590858,-0.009235975,3,"['Macroautophagy', 'AMPK inhibits chREBP transcriptional activation activity', 'Carnitine metabolism', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkaca,0.4922134,-0.17286013,1,"['PKA activation', 'PKA activation in glucagon signalling', 'DARPP-32 events', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Rap1 signalling', 'Regulation of insulin secretion', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'VEGFA-VEGFR2 Pathway', 'CREB1 phosphorylation through the activation of Adenylate Cyclase', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'Ion homeostasis', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'off' state"", 'Anchoring of the basal body to the plasma membrane', 'CD209 (DC-SIGN) signaling', 'MAPK6/MAPK4 signaling', 'RET signaling', 'AURKA Activation by TPX2', 'HDL assembly', 'GPER1 signaling', 'Factors involved in megakaryocyte development and platelet production']"
Prkacb,0.36724168,-0.21539341,1,"['PKA activation', 'PKA activation in glucagon signalling', 'DARPP-32 events', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Rap1 signalling', 'Regulation of insulin secretion', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'VEGFA-VEGFR2 Pathway', 'CREB1 phosphorylation through the activation of Adenylate Cyclase', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'off' state"", 'CD209 (DC-SIGN) signaling', 'MAPK6/MAPK4 signaling', 'RET signaling', 'HDL assembly', 'GPER1 signaling', 'Factors involved in megakaryocyte development and platelet production']"
Prkag1,0.24938852,-0.117231555,3,"['Macroautophagy', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkag2,0.139549,-0.062279236,3,"['Macroautophagy', 'AMPK inhibits chREBP transcriptional activation activity', 'Carnitine metabolism', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkag3,0.14115362,-0.09599339,3,"['Macroautophagy', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of TP53 Activity through Phosphorylation']"
Prkar1a,0.29747352,-0.27192944,1,"['PKA activation', 'PKA activation in glucagon signalling', 'DARPP-32 events', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'CREB1 phosphorylation through the activation of Adenylate Cyclase', ""Hedgehog 'off' state"", 'GPER1 signaling', 'Factors involved in megakaryocyte development and platelet production']"
Prkar1b,0.41044658,-0.15362616,1,"['PKA activation', 'PKA activation in glucagon signalling', 'DARPP-32 events', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'CREB1 phosphorylation through the activation of Adenylate Cyclase', ""Hedgehog 'off' state"", 'GPER1 signaling', 'Factors involved in megakaryocyte development and platelet production']"
Prkar2a,0.32889408,0.04949252,3,
Prkar2b,0.43016422,-0.09532976,1,"['PKA activation', 'PKA activation in glucagon signalling', 'DARPP-32 events', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'CREB1 phosphorylation through the activation of Adenylate Cyclase', ""Hedgehog 'off' state"", 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2', 'GPER1 signaling', 'Factors involved in megakaryocyte development and platelet production']"
Prkca,0.57503384,-0.32318786,1,
Prkcb,0.50696015,-0.34314838,1,"['Disinhibition of SNARE formation', 'Activation of NF-kappaB in B cells', 'Trafficking of GluR2-containing AMPA receptors', 'Depolymerisation of the Nuclear Lamina', 'WNT5A-dependent internalization of FZD4', 'VEGFR2 mediated cell proliferation', 'RHO GTPases Activate NADPH Oxidases', 'Response to elevated platelet cytosolic Ca2+']"
Prkcd,0.38372397,-0.07978189,1,"['Apoptotic cleavage of cellular proteins', 'Calmodulin induced events', 'Effects of PIP2 hydrolysis', 'SHC1 events in ERBB2 signaling', 'DAG and IP3 signaling', 'Role of phospholipids in phagocytosis', 'HuR (ELAVL1) binds and stabilizes mRNA', 'VEGFR2 mediated cell proliferation', 'CLEC7A (Dectin-1) signaling', 'RHO GTPases Activate NADPH Oxidases', 'Neutrophil degranulation', 'Interferon gamma signaling']"
Prkce,0.5010059,-0.3529436,1,"['Effects of PIP2 hydrolysis', 'SHC1 events in ERBB2 signaling', 'DAG and IP3 signaling', 'Role of phospholipids in phagocytosis']"
Prkcg,0.35871163,-0.43192095,1,"['Calmodulin induced events', 'Disinhibition of SNARE formation', 'Trafficking of GluR2-containing AMPA receptors', 'WNT5A-dependent internalization of FZD4', 'Response to elevated platelet cytosolic Ca2+']"
Prkch,0.3268583,-0.043912437,1,['Effects of PIP2 hydrolysis']
Prkci,0.5432902,-0.23790851,1,"['Pre-NOTCH Transcription and Translation', 'p75NTR recruits signalling complexes', 'Tight junction interactions']"
Prkcq,0.4615728,-0.16156292,1,"['Apoptotic cleavage of cellular proteins', 'Effects of PIP2 hydrolysis', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'Netrin-1 signaling', 'RAS processing']"
Prkcsh,0.12120926,-0.039573573,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Prkcz,0.59455186,-0.23855889,1,"['TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'VEGFR2 mediated cell proliferation', 'RHO GTPases Activate NADPH Oxidases', 'Estrogen-stimulated signaling through PRKCZ']"
Prkd1,0.3339333,-0.26497564,1,
Prkd2,0.050805353,-0.29807526,1,
Prkd3,0.03600935,-0.35896105,1,
Prkdc,0.38136387,0.30289808,3,"['Nonhomologous End-Joining (NHEJ)', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Prkg1,0.28927886,-0.27629364,1,"['Rap1 signalling', 'cGMP effects']"
Prkg2,0.30151772,-0.34538686,1,
Prkn,0.4222174,0.03702957,3,"['PINK1-PRKN Mediated Mitophagy', 'Josephin domain DUBs', 'Aggrephagy', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Prkra,-0.011521949,0.20911054,0,"['MicroRNA (miRNA) biogenesis', 'Small interfering RNA (siRNA) biogenesis']"
Prkrip1,-0.31887832,0.33114198,0,
Prkx,0.18946894,-0.013610784,3,
Prl,0.35238966,-0.31154513,1,"['Prolactin receptor signaling', 'Growth hormone receptor signaling']"
Prl2a1,-0.10680167,0.0706108,2,
Prl2b1,-0.1969473,-0.06419708,2,
Prl2c1,-0.0809053,0.09453951,2,
Prl2c2,-0.07260577,0.013434148,2,
Prl2c3,-0.10969917,0.053822104,2,
Prl2c5,0.0171871,0.0053147804,2,
Prl3a1,-0.16312619,0.14099956,2,
Prl3b1,-0.14915939,-0.12133936,2,
Prl3c1,-0.12837507,0.013477627,2,
Prl3d1,-0.14244805,0.09366088,2,
Prl3d2,-0.13389887,0.02787681,2,
Prl3d3,0.05980016,0.09911123,3,
Prl4a1,0.026296431,-0.048034135,2,
Prl5a1,0.13273878,-0.09871881,1,
Prl6a1,0.27004677,-0.079031765,1,
Prl7a1,-0.18953791,-0.06319432,2,
Prl7a2,-0.23992181,-0.11592202,2,
Prl7b1,-0.033098426,0.073639594,2,
Prl7c1,-0.112980194,-0.11630334,2,
Prl7d1,-0.120061494,-0.08295614,2,
Prl8a1,-0.2316458,-0.020643098,2,
Prl8a2,-0.041868765,0.05310606,2,
Prl8a6,-0.07526412,-0.04320974,2,
Prl8a8,-0.23350558,-0.027166583,2,
Prl8a9,-0.275628,-0.053869206,2,
Prlh,-0.30144292,0.022186635,2,['Peptide ligand-binding receptors']
Prlhr,-0.18422152,-0.1475771,2,['Peptide ligand-binding receptors']
Prlr,0.13659751,-0.08529158,1,"['Prolactin receptor signaling', 'Growth hormone receptor signaling']"
Prm1,-0.045042146,0.026125045,2,
Prm2,0.039977677,0.19962269,3,
Prm3,-0.13620229,-0.06011886,2,
Prmt1,0.3466358,0.5070392,3,"['RMTs methylate histone arginines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Extra-nuclear estrogen signaling', 'Estrogen-dependent gene expression']"
Prmt2,0.081059486,0.17870027,3,
Prmt3,-0.012562772,0.4985783,0,"['RMTs methylate histone arginines', 'Protein methylation']"
Prmt5,0.41189387,0.4294962,3,
Prmt6,0.1774802,0.32459098,3,"['RMTs methylate histone arginines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Prmt7,-0.012255996,0.12673776,2,['RMTs methylate histone arginines']
Prmt8,0.05297121,0.37040094,3,
Prmt9,-0.04147953,-0.0005391787,2,
Prn,-0.061736766,-0.1666293,2,
Prnd,0.041555163,-0.1089376,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Prnp,0.57112914,-0.17092688,1,['Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']
Proc,0.37340334,-0.15178445,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins', 'Cell surface interactions at the vascular wall', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Proca1,-0.14919907,-0.044528313,2,
Procr,0.052333463,-0.11238159,1,"['Common Pathway of Fibrin Clot Formation', 'Cell surface interactions at the vascular wall']"
Prodh,-0.19134058,-0.23655246,2,['Proline catabolism']
Prodh2,-0.19098856,0.0415999,2,"['Glyoxylate metabolism and glycine degradation', 'Proline catabolism']"
Prok1,-0.103284806,-0.13050987,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Prok2,0.010924988,-0.09419719,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Prokr1,-0.24489923,-0.12685072,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Prokr2,0.008304274,0.0014828333,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Prom1,0.4021005,-0.032490555,1,
Prom2,0.0074944673,-0.00053862587,2,
Prop1,0.05441621,-0.06703633,2,
Prorp,-0.049316995,0.16803463,0,
Pros1,0.10765738,-0.1495164,1,"['Platelet degranulation ', 'Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins', 'Cell surface interactions at the vascular wall']"
Proser1,0.0031572669,0.08078465,2,
Proser2,-0.26687095,0.0365016,2,
Proser3,0.015221067,0.103714354,2,
Prox1,0.0393331,-0.24875459,1,
Proz,-0.0015524775,-0.12939027,2,"['Gamma-carboxylation of protein precursors', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins']"
Prpf18,0.043980543,0.37198988,0,
Prpf19,0.12593623,0.51927304,0,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'mRNA Splicing - Major Pathway']"
Prpf3,-0.08893515,0.47725847,0,['mRNA Splicing - Major Pathway']
Prpf31,-0.0912497,0.6216155,0,['mRNA Splicing - Major Pathway']
Prpf38a,-0.31324896,0.4808552,0,['mRNA Splicing - Major Pathway']
Prpf38b,-0.0054753004,0.1456297,0,
Prpf39,0.011642561,0.3417202,0,
Prpf4,-0.13244481,0.42898107,0,['mRNA Splicing - Major Pathway']
Prpf40a,0.036488708,0.3795542,0,['mRNA Splicing - Major Pathway']
Prpf40b,-0.018885573,0.2735673,0,
Prpf4b,-0.11170597,0.4513704,0,
Prpf6,-0.08180796,0.45307854,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Prpf8,-0.08277955,0.60858876,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Prph,0.11212967,-0.16460754,1,
Prph2,-0.08838871,-0.109864734,2,
Prps1,-0.43976215,0.20686567,0,['5-Phosphoribose 1-diphosphate biosynthesis']
Prps1l1,-0.16454294,0.077515714,2,
Prps1l3,-0.1726607,0.04310349,2,
Prps2,-0.26356372,0.052881237,0,['5-Phosphoribose 1-diphosphate biosynthesis']
Prpsap1,-0.28842175,-0.09170326,2,
Prpsap2,-0.31613907,-0.014867872,2,
Prr11,0.03848475,0.3724242,3,
Prr12,-0.36627603,-0.03488261,2,
Prr14,-0.19965823,0.14602849,2,
Prr15,-0.11078675,-0.011609419,2,
Prr15l,-0.034384903,-0.050653014,2,
Prr16,-0.2548958,0.0009845166,2,
Prr18,-0.09357779,0.08194439,2,
Prr19,-0.22629498,-0.056279264,2,
Prr23a1,-0.29414827,-0.06675928,2,
Prr27,-0.31909558,0.027235053,2,
Prr3,-0.11101816,0.0032166739,2,
Prr30,-0.44195846,0.08806341,2,
Prr36,-0.34871253,0.1845646,2,
Prr5,0.21838228,-0.023904812,1,"['PIP3 activates AKT signaling', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability', 'Regulation of TP53 Degradation']"
Prr5l,-0.0019368213,0.08511291,2,
Prr7,-0.22340494,0.049700577,2,
Prr9,-0.2779469,0.066314146,2,
Prrc1,-0.21171087,0.028517857,2,
Prrc2a,0.08622352,0.12222761,3,
Prrc2b,-0.073109254,0.13224673,2,
Prrc2c,0.09118959,0.24873963,3,
Prrg1,-0.24819764,-0.17944199,2,
Prrg4,-0.16476645,0.11596047,2,
Prrt1,-0.22112101,-0.064553976,2,
Prrt2,0.20760326,0.030608863,3,
Prrt3,-0.18948096,0.0067625893,2,
Prrt4,-0.28541237,-0.07321951,2,
Prrx1,0.062152326,-0.05196585,3,
Prrxl1,-0.22436541,-0.07557931,2,
Prss1,-0.10769428,-0.109377645,2,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Prss12,-0.11514265,-0.1609278,2,
Prss16,-0.18384464,0.09110465,2,
Prss2,-0.029868178,-0.2894601,1,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Prss3,-0.1693189,-0.21073297,2,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Prss32,0.12769185,0.10489298,3,
Prss37,-0.22293043,0.06827683,2,
Prss40,0.01112647,0.06325837,2,
Prss45,-0.22036675,-0.065899454,2,
Prss54,-0.12895091,0.10027246,2,
Prss56,-0.3291958,-0.086034715,2,
Prss57,0.0032528848,0.037089188,3,
Prss58,-0.12814076,-0.09945856,2,
Prss59,-0.09709779,-0.18263851,2,
Prss8,0.08590835,-0.081105955,1,
Prtn3,-0.024211641,-0.15525849,1,
Prune1,-0.00061308173,0.044167414,2,
Prx,0.05416796,-0.080355346,1,
Prxl2b,-0.012492691,0.004216923,2,
Psap,-0.03574415,-0.29449227,2,"['Platelet degranulation ', 'Glycosphingolipid metabolism', 'Peptide ligand-binding receptors', 'G alpha (i) signalling events', 'Neutrophil degranulation']"
Psapl1,-0.3523445,-0.188804,2,
Psat1,-0.106740825,-0.2191217,2,['Serine biosynthesis']
Psca,0.06707498,-0.06164695,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Psd,-0.09055528,-0.29366356,2,
Psd2,-0.13332951,-0.072706714,2,
Psd3,0.0078074476,-0.0071440395,2,
Psd4,-0.10229385,-0.056114916,2,
Psen1,0.40990043,-0.18713853,1,"['Nuclear signaling by ERBB4', 'Regulated proteolysis of p75NTR', 'NRIF signals cell death from the nucleus', 'EPH-ephrin mediated repulsion of cells', 'Neutrophil degranulation', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Noncanonical activation of NOTCH3']"
Psen2,0.3938493,-0.15208414,1,
Psenen,0.2828733,-0.16428912,1,"['Nuclear signaling by ERBB4', 'Regulated proteolysis of p75NTR', 'NRIF signals cell death from the nucleus', 'EPH-ephrin mediated repulsion of cells', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Noncanonical activation of NOTCH3']"
Psg17,0.028726535,-0.075193055,1,
Psg19,0.017339565,-0.090958275,2,
Psg25,-0.24739055,-0.2314749,2,
Psg28,-0.15309092,0.008237083,2,
Psip1,0.3242259,0.16332021,3,
Psma1,0.20917238,0.48123342,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma2,0.15644863,0.32909945,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma3,0.26633134,0.42360538,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma4,0.29169214,0.20512706,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma5,0.2574542,0.2572368,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma6,0.28355035,0.3473852,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma7,0.19937441,0.34047914,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psma8,0.33404142,0.25464535,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb1,0.22033498,0.32361427,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb10,0.2093216,0.28261474,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb11,0.21078396,0.22107098,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb2,0.23096839,0.35035035,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb3,0.232004,0.3319867,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb4,0.2906978,0.32779542,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb5,0.37754914,0.17347819,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb6,0.35534468,0.28911585,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb7,0.33496314,0.38232815,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb8,0.32559416,0.25193733,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmb9,0.3205155,0.23677167,3,
Psmc1,0.1699575,0.37238434,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmc2,0.32500014,0.4759496,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmc3,0.25233087,0.17163718,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmc3ip,-0.17371194,0.23382199,2,
Psmc4,0.27502638,0.44087136,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmc5,0.4915773,0.41650924,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmc6,0.2080797,0.36935344,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd1,0.35595572,0.27920794,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd10,0.31306285,0.27319735,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd11,0.2172163,0.47636193,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd12,0.28592762,0.30423152,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd13,0.19668595,0.381596,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd14,0.22326069,0.33412173,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Metalloprotease DUBs', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd2,0.24769986,0.38064402,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd3,0.24798593,0.26520705,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd4,0.35227537,0.06883568,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd5,0.2641865,0.31712037,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd6,0.23500495,0.2804658,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd7,0.29075065,0.37489784,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Neutrophil degranulation', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd8,0.06335229,0.41984582,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmd9,0.2521517,0.29843986,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psme1,0.36080208,0.14930029,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psme2,0.29351026,0.32979944,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psme2b,0.295601,0.12623666,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psme3,0.281093,0.33152983,0,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psme3ip1,-0.14369336,0.055716414,2,
Psme4,0.20180844,0.26749748,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmf1,0.22379369,0.33187848,3,"['Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Separation of Sister Chromatids', 'FCERI mediated NF-kB activation', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Regulation of ornithine decarboxylase (ODC)', 'ABC-family proteins mediated transport', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Ub-specific processing proteases', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'G2/M Checkpoints', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN stability and activity', 'Neddylation', 'Interleukin-1 signaling', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Psmg1,0.22904839,0.22364722,3,
Psmg2,0.20112406,0.089387126,3,
Psmg3,-0.03608954,0.103694834,0,
Psmg4,0.00423829,-0.0044056904,2,
Pspc1,-0.025641384,0.20386289,0,
Psph,0.0030885548,-0.052824292,2,['Serine biosynthesis']
Pspn,0.04570242,-0.24322893,1,
Psrc1,-0.16297707,-0.1728646,2,
Pstk,-0.262066,-0.031115577,2,
Pstpip1,0.02174108,-0.27459732,1,
Pstpip2,-0.06949569,-0.1789358,2,
Ptafr,-0.047386985,0.013700618,2,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (q) signalling events', 'Neutrophil degranulation']"
Ptar1,-0.08255815,0.038672145,2,
Ptbp1,0.11654006,0.47119087,0,
Ptbp2,-0.022829277,0.24055992,0,
Ptcd1,-0.20480287,-0.08956599,2,
Ptcd2,-0.19798838,-0.029990636,2,
Ptcd3,-0.039161388,0.035641998,2,"['Mitochondrial translation elongation', 'Mitochondrial translation termination']"
Ptch1,0.36652553,-0.091101065,1,"[""Hedgehog 'off' state"", 'Ligand-receptor interactions', ""Hedgehog 'on' state"", 'Activation of SMO']"
Ptch2,0.25394517,0.15311041,3,
Ptchd1,-0.24040197,-0.11595934,2,
Ptchd3,0.028159736,-0.015010018,2,
Ptchd4,-0.26220185,-0.1111499,2,
Ptcra,0.15839612,0.120124996,3,
Ptdss1,-0.20500836,-0.09840761,2,['Synthesis of PS']
Ptdss2,-0.26448867,-0.15985167,2,['Synthesis of PS']
Pten,0.6102216,-0.09150841,1,"['Synthesis of PIPs at the plasma membrane', 'Synthesis of IP3 and IP4 in the cytosol', 'Negative regulation of the PI3K/AKT network', 'Downstream TCR signaling', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity']"
Ptf1a,0.059659876,0.00655389,2,
Ptgdr,0.08174825,0.06371889,3,"['Prostanoid ligand receptors', 'G alpha (s) signalling events']"
Ptgdr2,-0.43395114,-0.16903067,2,"['Prostanoid ligand receptors', 'G alpha (i) signalling events']"
Ptgds,0.15337843,-0.1828234,1,['Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']
Ptger1,0.20028047,-0.12775701,1,"['Prostanoid ligand receptors', 'G alpha (q) signalling events']"
Ptger2,0.010783411,-0.3056733,1,"['Prostanoid ligand receptors', 'G alpha (s) signalling events']"
Ptger3,0.14994407,-0.29868278,1,
Ptger4,-0.001208342,-0.32663888,1,"['Prostanoid ligand receptors', 'G alpha (s) signalling events']"
Ptges,-0.081317894,-0.1000954,2,['Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']
Ptges2,-0.018798096,-0.011309411,2,"['Synthesis of Prostaglandins (PG) and Thromboxanes (TX)', 'Neutrophil degranulation']"
Ptges3,0.29891893,0.20786247,3,"['Synthesis of Prostaglandins (PG) and Thromboxanes (TX)', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'HSF1 activation', 'Attenuation phase', 'Aryl hydrocarbon receptor signalling', 'ESR-mediated signaling', 'Estrogen-dependent gene expression']"
Ptges3l,0.16623144,-0.0446414,1,
Ptgfr,-0.080074325,-0.36243558,1,"['Prostanoid ligand receptors', 'G alpha (q) signalling events']"
Ptgfrn,0.08656452,-0.14302735,1,
Ptgir,0.0032582295,-0.10035581,1,"['Prostanoid ligand receptors', 'Prostacyclin signalling through prostacyclin receptor', 'G alpha (s) signalling events']"
Ptgis,-0.06918836,0.035646148,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Nicotinamide salvaging', 'Eicosanoids', 'Sterols are 12-hydroxylated by CYP8B1', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']"
Ptgr1,-0.23200352,0.023774622,2,
Ptgs1,-0.05109521,-0.12667243,2,"['COX reactions', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']"
Ptgs2,0.3252372,-0.09141586,1,"['Nicotinamide salvaging', 'Synthesis of 15-eicosatetraenoic acid derivatives', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)', 'Biosynthesis of DHA-derived SPMs', 'Biosynthesis of EPA-derived SPMs', 'Biosynthesis of DPAn-3 SPMs', 'Biosynthesis of electrophilic -3 PUFA oxo-derivatives']"
Pth,0.2577331,-0.17063138,1,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Pth1r,0.2687891,-0.077998415,1,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Pth2,-0.042842954,0.07352829,2,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Pth2r,-0.00013601121,0.08241173,0,"['Class B/2 (Secretin family receptors)', 'G alpha (s) signalling events']"
Pthlh,0.09243798,-0.00019886652,1,
Ptk2,0.5634127,-0.4495737,1,"['Apoptotic cleavage of cellular proteins', 'Regulation of actin dynamics for phagocytic cup formation', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'NCAM signaling for neurite out-growth', 'EPHB-mediated forward signaling', 'DCC mediated attractive signaling', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAF/MAP kinase cascade', 'MET activates PTK2 signaling', 'Extra-nuclear estrogen signaling']"
Ptk2b,0.5235491,-0.3447461,1,"['Signal regulatory protein family interactions', 'VEGFA-VEGFR2 Pathway', 'RHOU GTPase cycle', 'Interleukin-2 signaling']"
Ptk6,0.45812228,-0.19655898,1,"['SCF(Skp2)-mediated degradation of p27/p21', 'Cyclin D associated events in G1', 'ERBB2 Activates PTK6 Signaling', 'PTK6 Regulates Proteins Involved in RNA Processing', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'PTK6 Regulates Cell Cycle', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'PTK6 Down-Regulation', 'PTK6 Activates STAT3', 'PTK6 promotes HIF1A stabilization']"
Ptk7,0.22652012,-0.1689324,1,
Ptma,0.2595489,0.17687674,3,
Ptms,-0.06527588,0.093850575,2,
Ptn,0.25921345,-0.06384334,1,['Signaling by ALK']
Ptov1,0.07484592,-0.02526726,3,
Ptp4a1,0.12089175,-0.15826285,1,
Ptp4a2,-0.1169573,0.13965806,2,['RAB geranylgeranylation']
Ptp4a3,-0.027546102,-0.22270884,1,
Ptpa,0.2559113,0.0119932685,3,
Ptpn1,0.52910864,-0.3784015,1,"['Integrin signaling', 'Negative regulation of MET activity', 'PTK6 Down-Regulation', 'Regulation of IFNA/IFNB signaling', 'Growth hormone receptor signaling']"
Ptpn11,0.5450212,-0.31390822,1,"['Interleukin-6 signaling', 'PI3K Cascade', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation', 'GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Spry regulation of FGF signaling', 'Signaling by SCF-KIT', 'GAB1 signalosome', 'Downstream signal transduction', 'PECAM1 interactions', 'Tie2 Signaling', 'Costimulation by the CD28 family', 'CTLA4 inhibitory signaling', 'PD-1 signaling', 'Platelet sensitization by LDL', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'PI-3K cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'PI-3K cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'FRS-mediated FGFR3 signaling', 'PI-3K cascade:FGFR3', 'FRS-mediated FGFR4 signaling', 'PI-3K cascade:FGFR4', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RET signaling', 'Interleukin-20 family signaling', 'MET activates PTPN11', 'Regulation of RUNX1 Expression and Activity', 'Regulation of IFNA/IFNB signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'Signaling by CSF3 (G-CSF)']"
Ptpn12,0.24100842,-0.4057129,1,"['SHC1 events in ERBB2 signaling', 'EGFR downregulation', 'Signaling by PDGF', 'Downregulation of ERBB2 signaling']"
Ptpn13,0.45354348,-0.26702932,1,
Ptpn14,0.23098502,-0.005280634,3,
Ptpn18,0.047951635,-0.3339899,1,['Downregulation of ERBB2 signaling']
Ptpn2,0.29135317,-0.32780546,1,"['Negative regulation of MET activity', 'Regulation of IFNG signaling']"
Ptpn20,-0.028986858,-0.14812112,2,
Ptpn21,0.26709208,-0.2086666,1,
Ptpn22,0.19560179,-0.30523974,1,"['Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse']"
Ptpn23,0.17106275,-0.14368889,1,
Ptpn3,0.15156192,-0.30847925,1,"['EGFR downregulation', 'Negative regulation of MAPK pathway']"
Ptpn4,0.0353182,-0.1553542,2,['Toll Like Receptor 4 (TLR4) Cascade']
Ptpn5,0.34718743,-0.27729416,1,
Ptpn6,0.395955,-0.42085165,1,"['GPVI-mediated activation cascade', 'Regulation of KIT signaling', 'Signaling by ALK', 'PECAM1 interactions', 'Costimulation by the CD28 family', 'PD-1 signaling', 'Platelet sensitization by LDL', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'CD22 mediated BCR regulation', 'Neutrophil degranulation', 'Interferon gamma signaling', 'Interleukin receptor SHC signaling', 'Regulation of IFNA/IFNB signaling', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Ptpn7,0.16075535,-0.10381865,1,['Negative regulation of MAPK pathway']
Ptpra,0.2709538,-0.3177754,1,"['NCAM signaling for neurite out-growth', 'RAF/MAP kinase cascade']"
Ptprb,0.36363786,-0.245804,1,['Neutrophil degranulation']
Ptprc,0.34579095,-0.15200366,1,"['Phosphorylation of CD3 and TCR zeta chains', 'Other semaphorin interactions', 'Neutrophil degranulation']"
Ptprcap,0.1092,-0.10923982,1,
Ptprd,-0.006418743,-0.057622664,2,"['Receptor-type tyrosine-protein phosphatases', 'Synaptic adhesion-like molecules']"
Ptpre,0.093452446,-0.17036411,1,
Ptprf,0.2242758,-0.08228924,1,"['Receptor-type tyrosine-protein phosphatases', 'Synaptic adhesion-like molecules']"
Ptprj,0.3345569,-0.23818694,1,
Ptprk,0.28653783,-0.047833297,1,['EGFR downregulation']
Ptprm,0.14744774,-0.102738924,1,
Ptprn,-0.1296959,-0.3016727,2,
Ptprn2,0.0431911,-0.38299778,1,['Neutrophil degranulation']
Ptpro,0.060977265,-0.06519944,2,
Ptprq,0.05199163,-0.27522668,1,
Ptprr,0.358955,-0.07352514,1,
Ptprs,0.31341052,-0.12667021,1,"['Receptor-type tyrosine-protein phosphatases', 'Synaptic adhesion-like molecules']"
Ptprt,-0.017079145,0.0056549255,2,
Ptpru,0.29238373,-0.14828183,1,['Signaling by SCF-KIT']
Ptprz1,0.25598964,-0.25781098,1,"['Signaling by ALK', 'Other interleukin signaling']"
Ptrh1,-0.23116787,-0.11275358,2,
Ptrh2,0.17790473,-0.06791527,3,['Ub-specific processing proteases']
Ptrhd1,0.050053705,0.09513407,3,
Pts,0.09216633,-0.27281612,1,"['Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation']"
Pttg1,0.12928681,0.4279289,3,"['APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Separation of Sister Chromatids']"
Ptx3,0.17339757,-0.13249597,1,['Neutrophil degranulation']
Ptx4,-0.025628204,-0.027293986,2,
Pudp,-0.06520469,-0.01540437,2,
Puf60,-0.189951,0.5050592,0,['mRNA Splicing - Major Pathway']
Pum1,-0.027892662,0.24515297,0,['Golgi Associated Vesicle Biogenesis']
Pum2,0.08675385,0.28186658,0,
Pum3,-0.38889688,0.39003167,0,
Pura,0.21181533,0.24895123,3,
Purb,0.03142656,0.17961793,3,
Pus1,-0.20397113,0.23878011,0,
Pus10,-0.24674957,0.2325204,2,
Pus3,-0.23189119,0.40338188,0,
Pus7,-0.26625428,0.3433438,0,
Pus7l,-0.122843064,0.12821257,0,
Pusl1,-0.2220528,-0.08960897,2,
Pvalb,0.20047824,-0.31012592,1,
Pvr,0.34163028,-0.063733235,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Nectin/Necl  trans heterodimerization']"
Pwp1,-0.23258816,0.4062962,0,
Pwp2,-0.26650247,0.32861704,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Pwwp2a,-0.17972758,-0.12027381,2,
Pwwp2b,-0.1748466,-0.09226788,2,
Pwwp3b,0.07331602,-0.11282582,1,
Pxdc1,-0.14862457,0.16883102,2,
Pxdn,-0.12947397,-0.14691715,2,['Crosslinking of collagen fibrils']
Pxk,-0.17836285,0.15557079,2,
Pxmp2,-0.28709343,-0.01771956,2,
Pxmp4,-0.28375915,0.09240613,2,['Class I peroxisomal membrane protein import']
Pxn,0.4696803,-0.39739946,1,"['GAB1 signalosome', 'VEGFA-VEGFR2 Pathway', 'Smooth Muscle Contraction', 'Localization of the PINCH-ILK-PARVIN complex to focal adhesions', 'Regulation of cytoskeletal remodeling and cell spreading by IPP complex components', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases']"
Pxylp1,-0.22393818,0.059751302,2,
Pycard,0.15541612,0.028209198,1,"['CLEC7A/inflammasome pathway', 'Neutrophil degranulation', 'The NLRP3 inflammasome']"
Pycr1,-0.3313189,-0.17151219,2,['Glutamate and glutamine metabolism']
Pycr2,-0.27386323,-0.057617895,2,['Glutamate and glutamine metabolism']
Pycrl,-0.18391705,-0.18328032,2,['Glutamate and glutamine metabolism']
Pygb,-0.008144073,-0.16635078,2,['Neutrophil degranulation']
Pygl,-0.118053466,-0.22786705,2,"['Neutrophil degranulation', 'Glycogen breakdown (glycogenolysis)']"
Pygm,-0.13182853,-0.08646439,2,['Glycogen breakdown (glycogenolysis)']
Pygo1,0.08155773,0.08079516,3,['Formation of the beta-catenin:TCF transactivating complex']
Pygo2,0.11403365,0.026652846,3,['Formation of the beta-catenin:TCF transactivating complex']
Pym1,-0.013710396,0.24687478,0,
Pyroxd1,-0.23990095,-0.07599609,2,
Pyroxd2,-0.0793341,-0.04112854,2,
Pyurf,-0.17208906,-0.032390952,2,
Pyy,0.038205728,-0.16561879,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Qars,-0.21650113,0.20123382,0,
Qdpr,-0.21375628,-0.22348793,2,['Phenylalanine metabolism']
Qk,0.075298175,0.18633571,0,
Qpctl,-0.18996939,0.03581719,2,
Qprt,-0.23297635,-0.08392257,2,['Nicotinate metabolism']
Qrfp,-0.1332245,-0.062766075,2,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Qrfpr,-0.20825472,-0.096820645,2,"['Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'G alpha (q) signalling events']"
Qrich1,-0.1318748,-0.027434345,2,
Qrich2,-0.019868996,0.062675275,2,
Qrsl1,-0.27038085,-0.055698507,2,
Qser1,-0.09759883,0.08838436,2,
Qsox1,0.016064204,0.117462024,3,"['Platelet degranulation ', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Neutrophil degranulation', 'Post-translational protein phosphorylation']"
Qtrt1,-0.071404904,0.24406746,3,
Qtrt2,-0.33015567,-0.04636299,2,
R3hcc1,-0.06585098,-0.017494012,0,
R3hdm1,-0.3203527,-0.11530292,2,
R3hdm2,0.08257058,-0.035352085,1,
R3hdm4,-0.33249262,-0.17492361,2,
R3hdml,-0.040661454,0.0034559844,2,
Rab10,0.07446345,-0.030684259,1,"['Neutrophil degranulation', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab11a,0.14288242,-0.17645732,1,"['Vasopressin regulates renal water homeostasis via Aquaporins', 'Anchoring of the basal body to the plasma membrane', 'VxPx cargo-targeting to cilium', 'TBC/RABGAPs', 'RAB geranylgeranylation']"
Rab11b,-0.007961283,-0.18134342,2,"['TBC/RABGAPs', 'RAB geranylgeranylation']"
Rab11fip1,-0.009028057,-0.1719539,1,
Rab11fip2,0.018669667,-0.19452047,1,['Vasopressin regulates renal water homeostasis via Aquaporins']
Rab11fip3,-0.059698053,-0.13404262,2,['VxPx cargo-targeting to cilium']
Rab11fip4,-0.057823714,-0.14675069,2,
Rab11fip5,-0.050496545,-0.12947255,2,
Rab12,0.010365662,-0.03565747,2,
Rab13,0.027563324,-0.14001644,1,"['RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab14,0.09088492,-0.17030713,1,"['Synthesis of PIPs at the plasma membrane', 'Neutrophil degranulation', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab15,-0.29312298,0.06328471,2,
Rab17,-0.17842269,-0.1293733,2,['RAB geranylgeranylation']
Rab18,0.036274724,-0.027867272,2,"['Neutrophil degranulation', 'COPI-independent Golgi-to-ER retrograde traffic', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab1a,-0.016999478,0.09425089,0,"['Golgi Cisternae Pericentriolar Stack Reorganization', 'COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab1b,-0.14463833,-0.04175791,2,"['Golgi Cisternae Pericentriolar Stack Reorganization', 'COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab20,-0.084130354,-0.0807047,2,['RAB geranylgeranylation']
Rab21,-0.09452039,-0.22303756,2,"['RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab22a,-0.26744935,-0.20994967,2,['RAB geranylgeranylation']
Rab23,0.007221556,0.01787081,2,
Rab24,-0.15843605,-0.0995126,2,"['Neutrophil degranulation', 'RAB geranylgeranylation']"
Rab25,0.039176486,-0.0681634,2,['RAB geranylgeranylation']
Rab26,-0.042114783,-0.15079148,2,['RAB geranylgeranylation']
Rab27a,0.031757098,-0.11176305,2,"['Neutrophil degranulation', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab27b,0.1154339,-0.18818256,1,"['Platelet degranulation ', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab28,-0.06634384,-0.025376465,2,
Rab29,-0.018989284,-0.055118836,2,
Rab2a,0.27367294,-0.07605552,1,"['Golgi Cisternae Pericentriolar Stack Reorganization', 'RAB geranylgeranylation']"
Rab2b,-0.31899884,-0.104110084,2,['RAB geranylgeranylation']
Rab30,-0.2989962,0.0005334898,2,"['Intra-Golgi traffic', 'RAB geranylgeranylation']"
Rab31,-0.18273793,-0.1416717,2,
Rab32,-0.19044468,0.03898396,2,"['RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab33a,-0.09483021,-0.16996442,2,"['TBC/RABGAPs', 'RAB geranylgeranylation']"
Rab33b,0.07981637,-0.1432396,2,"['Intra-Golgi traffic', 'TBC/RABGAPs', 'RAB geranylgeranylation']"
Rab34,-0.030641543,-0.024950845,2,
Rab35,0.02260953,0.06531017,2,"['TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab36,-0.13713007,-0.08529528,2,"['Intra-Golgi traffic', 'RAB geranylgeranylation']"
Rab38,-0.04299872,-0.112438716,2,"['RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab39,-0.026267275,0.04282885,2,"['Intra-Golgi traffic', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab39b,0.04056763,0.024895571,1,"['RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab3a,0.14970638,-0.15679081,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Neutrophil degranulation', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs', 'GABA synthesis, release, reuptake and degradation']"
Rab3b,-0.10741743,-0.17336561,2,['RAB geranylgeranylation']
Rab3c,-0.18297757,-0.10212876,2,['RAB geranylgeranylation']
Rab3d,-0.25917542,-0.2675373,2,"['Neutrophil degranulation', 'RAB geranylgeranylation']"
Rab3gap1,0.05612545,0.13000852,3,"['COPI-independent Golgi-to-ER retrograde traffic', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab3gap2,-0.014155395,0.0179622,2,
Rab3il1,-0.049159177,-0.19402936,1,['RAB GEFs exchange GTP for GDP on RABs']
Rab3ip,0.019285897,-0.008147783,1,"['Anchoring of the basal body to the plasma membrane', 'VxPx cargo-targeting to cilium', 'BBSome-mediated cargo-targeting to cilium', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab40b,-0.012933216,0.04669127,2,
Rab40c,-0.008026438,-0.097155415,1,['RAB geranylgeranylation']
Rab42,-0.09535243,-0.117559314,2,
Rab43,-0.09508379,0.00090074923,2,"['Retrograde transport at the Trans-Golgi-Network', 'RAB geranylgeranylation']"
Rab44,-0.24740484,-0.18803729,2,"['Neutrophil degranulation', 'RAB geranylgeranylation']"
Rab4a,0.21468972,-0.33788267,1,"['Synthesis of PIPs at the plasma membrane', 'TBC/RABGAPs', 'RAB geranylgeranylation', 'MET receptor recycling']"
Rab4b,0.17839979,-0.36011687,1,"['Neutrophil degranulation', 'RAB geranylgeranylation', 'MET receptor recycling']"
Rab5a,0.24580611,-0.37452772,1,"['Synthesis of PIPs at the plasma membrane', 'Clathrin-mediated endocytosis', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs', 'Factors involved in megakaryocyte development and platelet production']"
Rab5b,-0.08807766,-0.09247709,2,"['Neutrophil degranulation', 'Clathrin-mediated endocytosis', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab5c,0.09115054,-0.2879184,1,"['Golgi Associated Vesicle Biogenesis', 'Neutrophil degranulation', 'Clathrin-mediated endocytosis', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab5if,0.06002888,-0.015437351,1,
Rab6a,-0.16846377,0.0532282,2,"['Neutrophil degranulation', 'COPI-independent Golgi-to-ER retrograde traffic', 'Retrograde transport at the Trans-Golgi-Network', 'TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab6b,-0.09911181,0.06500861,2,"['COPI-independent Golgi-to-ER retrograde traffic', 'Retrograde transport at the Trans-Golgi-Network', 'TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab7,0.10166156,-0.23714456,1,"['MHC class II antigen presentation', 'Neutrophil degranulation', 'TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Rab7b,-0.017540464,-0.21783987,2,"['TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab8a,0.13735346,-0.1876083,1,"['Regulation of PLK1 Activity at G2/M Transition', 'Anchoring of the basal body to the plasma membrane', 'VxPx cargo-targeting to cilium', 'TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab8b,-0.11796077,-0.06949645,0,"['TBC/RABGAPs', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs']"
Rab9,-0.2626185,-0.04119183,2,"['Retrograde transport at the Trans-Golgi-Network', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs', 'RHOBTB3 ATPase cycle']"
Rab9b,-0.19523746,-0.039282527,2,"['Neutrophil degranulation', 'Retrograde transport at the Trans-Golgi-Network', 'RAB geranylgeranylation', 'RAB GEFs exchange GTP for GDP on RABs', 'RHOBTB3 ATPase cycle']"
Rabac1,-0.13579755,-0.0022847832,2,
Rabep1,0.3068428,-0.08903459,1,
Rabep2,-0.23000257,0.10141243,2,
Rabepk,-0.18647888,-0.2103387,2,['Retrograde transport at the Trans-Golgi-Network']
Rabgap1,-0.29865283,0.01646204,2,['TBC/RABGAPs']
Rabgap1l,-0.24617924,0.053863674,2,
Rabgef1,0.101977855,-0.007916826,3,['RAB GEFs exchange GTP for GDP on RABs']
Rabggta,-0.1810261,0.10944705,2,"['TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain', 'RAB geranylgeranylation']"
Rabggtb,-0.016152976,0.10231779,0,"['TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain', 'RAB geranylgeranylation']"
Rabif,-0.18917271,-0.035516724,2,
Rabl2,-0.09774708,-0.050938964,2,
Rabl6,-0.20500048,-0.029575722,2,
Rac1,0.5183398,-0.2695433,1,"['GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'NRAGE signals death through JNK', 'Regulation of actin dynamics for phagocytic cup formation', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'DSCAM interactions', 'CD28 dependent Vav1 pathway', 'EPHB-mediated forward signaling', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells', 'Sema3A PAK dependent Axon repulsion', 'PCP/CE pathway', 'Sema4D mediated inhibition of cell attachment and migration', 'DCC mediated attractive signaling', 'VEGFA-VEGFR2 Pathway', 'Signal transduction by L1', 'VEGFR2 mediated vascular permeability', 'RHO GTPases activate PKNs', 'RHO GTPases activate CIT', 'RHO GTPases activate KTN1', 'RHO GTPases activate IQGAPs', 'RHO GTPases activate PAKs', 'RHO GTPases Activate WASPs and WAVEs', 'RHO GTPases Activate Formins', 'RHO GTPases Activate NADPH Oxidases', 'MAPK6/MAPK4 signaling', 'Neutrophil degranulation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'MET activates RAP1 and RAC1', 'RAC1 GTPase cycle', 'NTRK2 activates RAC1', 'Azathioprine ADME', 'Factors involved in megakaryocyte development and platelet production']"
Rac2,0.45362723,-0.33416972,1,"['GPVI-mediated activation cascade', 'ROS and RNS production in phagocytes', 'PIP3 activates AKT signaling', 'PCP/CE pathway', 'RHO GTPases Activate NADPH Oxidases', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RAC2 GTPase cycle']"
Rac3,0.4906691,-0.34167016,1,"['PCP/CE pathway', 'RAC3 GTPase cycle']"
Racgap1,0.28974283,0.31073758,3,"['MHC class II antigen presentation', 'COPI-dependent Golgi-to-ER retrograde traffic', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RAC3 GTPase cycle', 'Kinesins']"
Rack1,0.33749703,0.081406094,0,"['Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'TNFR1-mediated ceramide production']"
Rad1,0.20385824,0.30086502,3,"['Activation of ATR in response to replication stress', 'HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Rad17,0.19005696,0.32224935,3,"['Activation of ATR in response to replication stress', 'HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Rad18,0.32035318,0.42692333,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Rad21,0.22247954,0.2858633,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins']"
Rad21l,0.006141749,0.3088879,3,
Rad23a,0.2072138,0.38789338,3,"['Josephin domain DUBs', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER']"
Rad23b,0.25949135,0.44897854,3,"['N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Josephin domain DUBs', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER']"
Rad50,0.22387893,0.41234893,3,
Rad51,0.30207804,0.43651542,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Presynaptic phase of homologous DNA pairing and strand exchange']"
Rad51ap1,0.18621843,0.43412694,3,
Rad51b,0.22703262,0.3200286,3,"['HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Factors involved in megakaryocyte development and platelet production']"
Rad51c,0.10488194,0.39559746,3,"['HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Factors involved in megakaryocyte development and platelet production']"
Rad51d,0.27977684,0.342213,3,"['HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Presynaptic phase of homologous DNA pairing and strand exchange']"
Rad52,0.24690627,0.3650897,3,"['SUMOylation of DNA damage response and repair proteins', 'HDR through Single Strand Annealing (SSA)', 'HDR through MMEJ (alt-NHEJ)']"
Rad54b,0.13069108,0.388646,3,
Rad54l,0.23882203,0.4715736,3,
Rad54l2,-0.0041626417,0.13868478,2,
Rad9a,0.3636323,0.36974317,3,"['Activation of ATR in response to replication stress', 'HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Rad9b,0.19169489,0.2306216,3,"['Activation of ATR in response to replication stress', 'HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Radx,-0.19303331,0.16809122,2,
Rae1,0.18657543,0.47493666,0,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Raet1a,-0.07559222,0.022943633,2,
Raet1d,0.0151167065,0.14106686,3,
Raet1e,-0.16465402,-0.12369114,2,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Raf1,0.65607375,-0.22390671,1,"['Stimuli-sensing channels', 'Rap1 signalling', 'GP1b-IX-V activation signalling', 'CD209 (DC-SIGN) signaling', 'RAF activation', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway', 'Negative regulation of MAPK pathway']"
Rag1,0.43140393,0.26420462,3,
Rag2,0.25945437,0.13124835,3,
Rai14,-0.13051367,-0.00690293,2,
Rai2,-0.4459647,-0.05457273,2,
Rala,0.34922108,-0.38459,1,
Ralb,0.16977279,-0.30903682,1,
Ralbp1,0.37504026,-0.16319734,1,"['CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Ralgapa1,-0.018614318,-0.038748417,2,['RHOH GTPase cycle']
Ralgapa2,-0.04329529,-0.11488738,2,
Ralgapb,0.17403595,0.05428001,3,
Ralgds,0.43038303,-0.3114837,1,"['p38MAPK events', 'RAF/MAP kinase cascade']"
Ralgps1,-0.011363351,-0.08892112,2,
Ralgps2,-0.26892507,-0.14528036,2,
Raly,-0.14118806,0.24234298,0,
Ramac,0.039590128,0.15634677,2,
Ramp1,0.12746975,-0.044601746,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Ramp2,0.26267096,-0.08910123,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Ramp3,0.19385655,-0.15321326,1,"['G alpha (s) signalling events', 'Calcitonin-like ligand receptors']"
Ran,0.12544757,0.50930923,0,"['Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'Transcriptional regulation by small RNAs', 'Postmitotic nuclear pore complex (NPC) reformation']"
Ranbp1,0.20253964,0.49791527,0,
Ranbp10,0.15703562,-0.30859667,1,['MET activates RAS signaling']
Ranbp2,0.33095473,0.4138526,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ranbp3,0.17503722,0.21955518,3,
Ranbp6,-0.26605165,0.42969695,0,
Ranbp9,0.11251579,-0.20132595,1,"['L1CAM interactions', 'RAF/MAP kinase cascade', 'MET activates RAS signaling']"
Rangap1,0.26416853,0.4882738,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation of DNA replication proteins', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'EML4 and NUDC in mitotic spindle formation']"
Rangrf,-0.025550881,0.031761684,2,
Rap1a,0.43153894,-0.38984686,1,"['Frs2-mediated activation', 'ARMS-mediated activation', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Rap1 signalling', 'MAP2K and MAPK activation', 'Neutrophil degranulation', 'MET activates RAP1 and RAC1']"
Rap1b,0.5113103,-0.34666455,1,"['Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'Rap1 signalling', 'MAP2K and MAPK activation', 'Neutrophil degranulation', 'MET activates RAP1 and RAC1']"
Rap1gap,0.1666227,-0.17009638,1,"['Rap1 signalling', 'RET signaling']"
Rap1gap2,0.032986153,-0.23605238,1,['Rap1 signalling']
Rap1gds1,0.06506133,-0.03304339,2,
Rap2a,-0.056430556,-0.3265353,1,
Rap2b,0.017841399,-0.13890485,1,['Neutrophil degranulation']
Rap2c,0.117064856,-0.38471925,1,['Neutrophil degranulation']
Rapgef1,0.4096087,-0.48747343,1,"['Frs2-mediated activation', 'Downstream signal transduction', 'MET activates RAP1 and RAC1', 'RAC3 GTPase cycle', 'Erythropoietin activates RAS', 'Regulation of signaling by CBL']"
Rapgef2,0.2889535,-0.42767456,1,['RAF/MAP kinase cascade']
Rapgef3,0.28311214,-0.31272662,1,"['Integrin signaling', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Rap1 signalling', 'Regulation of insulin secretion']"
Rapgef4,0.32223123,-0.430605,1,"['Integrin signaling', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Rap1 signalling', 'Regulation of insulin secretion']"
Rapgef5,0.3324003,-0.25448245,1,
Rapgef6,0.3699795,-0.397959,1,
Rapgefl1,0.16047601,-0.10187957,1,
Raph1,0.12327816,-0.08836573,1,
Rapsn,0.15982443,-0.20398228,1,
Rara,0.49655032,0.20201166,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors', 'Signaling by Retinoic Acid', 'Transcriptional regulation of granulopoiesis']"
Rarb,0.24690525,0.073103935,3,"['Nuclear Receptor transcription pathway', 'Signaling by Retinoic Acid']"
Rarg,0.31347364,0.09547813,3,"['Nuclear Receptor transcription pathway', 'Signaling by Retinoic Acid']"
Rarres1,-0.20437056,-0.12443834,2,
Rarres2,-0.004070808,-0.08891698,2,['Platelet degranulation ']
Rars,0.12744917,0.17308252,0,
Rars2,-0.13871588,0.13472518,0,
Rasa1,0.5107238,-0.13954237,1,"['Downstream signal transduction', 'EPHB-mediated forward signaling', 'VEGFR2 mediated cell proliferation', 'Regulation of RAS by GAPs', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases']"
Rasa2,0.15808803,-0.27969688,1,['Regulation of RAS by GAPs']
Rasa3,0.13371336,-0.060537945,1,['Regulation of RAS by GAPs']
Rasa4,0.09571215,-0.16769908,1,['Regulation of RAS by GAPs']
Rasal1,0.27253565,-0.12387992,1,['Regulation of RAS by GAPs']
Rasal2,0.32249427,-0.11998231,1,"['Regulation of RAS by GAPs', 'RND3 GTPase cycle', 'RND1 GTPase cycle']"
Rasal3,0.20348759,-0.07998352,1,['Regulation of RAS by GAPs']
Rasd1,0.2593972,-0.057768498,1,
Rasd2,0.15882541,-0.19440348,1,
Rasef,-0.14649977,0.038284373,2,
Rasgef1b,0.15008911,-0.17567565,1,
Rasgef1c,-0.10821659,0.12177536,2,
Rasgrf1,0.3450528,-0.3706338,1,['RAF/MAP kinase cascade']
Rasgrp1,0.31150463,-0.33037186,1,"['Activation of RAS in B cells', 'Integrin signaling', 'Rap1 signalling', 'RAF/MAP kinase cascade']"
Rasgrp2,0.17929234,-0.27530944,1,"['Integrin signaling', 'Rap1 signalling']"
Rasgrp3,0.103606865,-0.19774294,1,"['Activation of RAS in B cells', 'RAF/MAP kinase cascade']"
Rasgrp4,0.38681278,-0.11434017,1,['RAF/MAP kinase cascade']
Rasip1,0.18329063,0.0042062113,3,
Rasl10a,-0.23170805,-0.08821169,2,
Rasl2-9,0.10970957,0.38188377,0,
Rassf1,0.37821344,0.021786215,3,
Rassf10,-0.0970571,-0.2062326,2,
Rassf2,0.13861136,0.066948414,3,
Rassf3,-0.07977126,-0.0879083,2,
Rassf4,-0.035358023,-0.08586171,2,
Rassf5,0.39574248,-0.15450683,1,
Rassf6,0.09312674,-0.093122564,2,
Rassf7,-0.077836365,0.040865775,2,
Rassf8,0.14409016,-0.07985827,3,
Rassf9,0.039773654,-0.13876228,2,
Raver1,0.019936165,0.26746306,0,
Rax,0.019558402,-0.009599123,2,
Rb1,0.596167,0.2868612,3,"['Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Condensation of Prophase Chromosomes', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes', 'Cyclin E associated events during G1/S transition ', 'Cyclin D associated events in G1', 'Cyclin A:Cdk2-associated events at S phase entry']"
Rb1cc1,0.09516163,-0.1384537,3,['Macroautophagy']
Rbak,-0.1628321,0.016901506,2,
Rbbp4,0.4377618,0.43037674,3,"['G0 and Early G1', 'PRC2 methylates histones and DNA', 'Oxidative Stress Induced Senescence', 'HDACs deacetylate histones', 'PKMTs methylate histone lysines', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Rbbp5,0.44043568,0.32129565,3,"['Formation of the beta-catenin:TCF transactivating complex', 'PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Neddylation']"
Rbbp6,0.10002179,0.25541413,3,"['RHOBTB1 GTPase cycle', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rbbp7,0.49358308,0.4066036,3,"['PRC2 methylates histones and DNA', 'Oxidative Stress Induced Senescence', 'HDACs deacetylate histones', 'PKMTs methylate histone lysines', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Regulation of TP53 Activity through Acetylation', 'RNA Polymerase I Transcription Initiation', 'Regulation of PTEN gene transcription', 'Neddylation', 'Transcriptional Regulation by E2F6']"
Rbbp8,0.3544706,0.3349709,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through MMEJ (alt-NHEJ)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Rbbp8nl,-0.14547631,-0.0032232068,2,
Rbbp9,-0.16525635,0.13070735,2,
Rbck1,0.111141846,-0.021520382,1,"['Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rbfa,-0.14189261,-0.0058079185,2,
Rbfox1,0.13065313,0.16737267,0,
Rbfox2,0.024976632,0.13572426,0,
Rbfox3,0.3433412,-0.12227637,1,
Rbks,-0.426296,0.15378082,2,['Pentose phosphate pathway']
Rbl1,0.4806545,0.372505,3,"['G0 and Early G1', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Cyclin D associated events in G1']"
Rbl2,0.50304925,0.24675216,3,"['G0 and Early G1', 'Cyclin D associated events in G1']"
Rbm10,-0.04740963,0.1680468,0,
Rbm11,-0.07426681,0.17467897,2,
Rbm12,-0.23340426,-0.15996012,2,
Rbm14,-0.09226916,0.34527278,0,['RUNX2 regulates bone development']
Rbm15,0.05580665,0.3094531,0,
Rbm15b,0.03794193,0.22600143,0,
Rbm17,-0.19666646,0.29256403,0,['mRNA Splicing - Major Pathway']
Rbm19,-0.15858176,0.28461662,0,
Rbm20,-0.10080034,-0.1146788,2,
Rbm22,-0.25265744,0.3747683,0,['mRNA Splicing - Major Pathway']
Rbm24,0.10122804,-0.02655623,1,
Rbm25,0.0116945375,0.33899787,0,
Rbm26,-0.273836,0.17439307,2,
Rbm27,-0.17775615,-0.0042519043,2,
Rbm28,-0.2680641,0.5350775,0,
Rbm3,-0.030390745,0.19257998,0,
Rbm31y,-0.24373111,0.07518575,2,
Rbm33,-0.1927849,0.010499047,2,
Rbm34,-0.31285134,0.28691664,0,
Rbm38,0.008300577,0.15252823,3,
Rbm39,-0.043841653,0.43678585,0,"['Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation', 'Depolymerisation of the Nuclear Lamina', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Rbm4,0.01488461,0.32151923,0,
Rbm42,-0.06416175,0.43799987,0,['mRNA Splicing - Major Pathway']
Rbm43,-0.24656214,-0.10341494,2,
Rbm44,-0.08478735,-0.045410745,2,
Rbm47,-0.077062465,-0.15337677,2,
Rbm5,-0.36736208,0.2328771,2,['mRNA Splicing - Major Pathway']
Rbm6,-0.14057243,0.13869493,2,
Rbm7,-0.1238057,0.32447082,0,
Rbm8a,-0.14433774,0.5364124,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rbm8a2,-0.15071376,0.4119751,0,
Rbms2,-0.11351877,0.07114036,2,
Rbms3,-0.09720829,0.10844161,2,
Rbmx,-0.21967696,0.29104507,0,"['mRNA Splicing - Major Pathway', 'RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Rbmx2,-0.10576772,0.48878783,0,
Rbmxl1,0.026011761,0.500315,0,
Rbmxl2,-0.054112513,-0.16644165,2,
Rbmy,0.072758704,0.17772023,3,
Rbp1,0.082970314,-0.18436252,1,"['The canonical retinoid cycle in rods (twilight vision)', 'Retinoid metabolism and transport']"
Rbp2,-0.032037098,-0.16548872,1,['Retinoid metabolism and transport']
Rbp3,-0.18944198,-0.36437997,2,
Rbp4,0.22155714,-0.2305717,1,"['The canonical retinoid cycle in rods (twilight vision)', 'Retinoid metabolism and transport']"
Rbpj,0.401201,0.26923913,3,"['NOTCH1 Intracellular Domain Regulates Transcription', 'Notch-HLH transcription pathway', 'RUNX3 regulates NOTCH signaling']"
Rbpjl,0.3560958,0.27716288,3,
Rbpms,0.055406436,0.06720445,1,
Rbpms2,-0.042484816,-0.14775296,1,
Rbsn,-0.04614459,-0.30542415,1,"['Toll Like Receptor 9 (TLR9) Cascade', 'Factors involved in megakaryocyte development and platelet production']"
Rbx1,0.5102545,0.33799818,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Prolactin receptor signaling', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Degradation of beta-catenin by the destruction complex', 'Degradation of DVL', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Regulation of RAS by GAPs', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Orc1 removal from chromatin', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Regulation of RUNX2 expression and activity', 'Neddylation', 'Interleukin-1 signaling', 'Regulation of BACH1 activity', 'KEAP1-NFE2L2 pathway', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rc3h1,-0.09355748,0.19860739,0,
Rc3h2,0.060267173,0.26662907,3,
Rcan1,0.022453297,0.04485946,2,
Rcan2,-0.02763816,0.08471286,2,
Rcan3,-0.14271262,-0.040099613,2,
Rcbtb1,-0.0812532,0.094246745,0,
Rcc1,0.28737622,0.5227109,3,['Postmitotic nuclear pore complex (NPC) reformation']
Rcc1l,-0.052796364,0.10166201,0,
Rcc2,0.027021507,0.17537914,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Rccd1,-0.07941383,0.13177505,2,
Rce1,0.15426773,0.011877727,3,"['Ub-specific processing proteases', 'RAS processing']"
Rchy1,0.30667788,0.41639477,3,"['Translesion Synthesis by POLH', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rcl1,-0.2944757,0.41485268,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rcn1,-0.24762341,-0.06835225,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Rcn2,-0.10905864,-0.22942384,2,
Rcor1,0.15834765,0.429568,3,"['HDACs deacetylate histones', 'Factors involved in megakaryocyte development and platelet production']"
Rcor2,0.30370727,0.22336909,3,
Rcor3,0.051371414,0.2465649,3,
Rcsd1,-0.086063035,0.060841803,2,
Rcvrn,0.085634,-0.38614675,1,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Rd3l,-0.11792317,-0.03603337,2,
Rdh1,-0.21035431,0.0033489575,2,"['The canonical retinoid cycle in rods (twilight vision)', 'RA biosynthesis pathway']"
Rdh10,-0.16003382,-0.20960625,2,"['The canonical retinoid cycle in rods (twilight vision)', 'RA biosynthesis pathway']"
Rdh11,-0.2188505,-0.29979873,2,"['The canonical retinoid cycle in rods (twilight vision)', 'RA biosynthesis pathway', 'Retinoid metabolism and transport']"
Rdh12,-0.14746782,-0.2650953,2,['The canonical retinoid cycle in rods (twilight vision)']
Rdh13,-0.067407876,-0.08108098,2,['RA biosynthesis pathway']
Rdh14,-0.35732576,-0.19664666,2,['RA biosynthesis pathway']
Rdh16,-0.03243902,0.013502563,0,
Rdh16f2,-0.08229188,-0.101865284,2,
Rdh19,-0.13604134,0.0745741,2,
Rdh5,-0.100774005,-0.3185985,2,"['The canonical retinoid cycle in rods (twilight vision)', 'RA biosynthesis pathway']"
Rdh7,-0.15335356,-0.038032006,2,
Rdh8,-0.16260101,-0.01761644,2,
Rdh9,-0.20041567,0.061639342,2,
Rdm1,-0.32552788,0.04871109,2,
Rdx,0.4164579,-0.2685015,1,['Recycling pathway of L1']
Rec114,-0.2011768,-0.0032675618,2,
Rec8,0.09503477,0.26598632,3,
Reck,0.09765494,-0.13422498,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Recql,0.104406744,0.25404203,3,
Recql4,0.241789,0.37848312,3,
Recql5,0.22274008,0.3574564,3,
Reep1,-0.19854738,-0.016016385,2,
Reep2,-0.10388905,-0.065120935,2,
Reep5,-0.29576445,-0.05543274,2,
Reep6,-0.08839025,-0.055241443,2,
Reg1,-0.059337262,-0.0843078,2,
Reg2,-0.00296096,0.04127749,2,
Reg3a,-0.05332253,-0.16090947,1,['Antimicrobial peptides']
Reg3b,0.0136928465,-0.23970339,1,['Antimicrobial peptides']
Reg3d,-0.24577649,-0.24770895,2,['Antimicrobial peptides']
Reg3g,-0.055231746,-0.047859456,2,['Antimicrobial peptides']
Reg4,-0.3386084,0.11622501,2,
Rel,0.2965843,0.25199527,3,
Rela,0.66821885,0.1497975,3,"['Activation of NF-kappaB in B cells', 'RIP-mediated NFkB activation via ZBP1', 'Regulated proteolysis of p75NTR', 'Downstream TCR signaling', 'NF-kB is activated and signals survival', 'FCERI mediated NF-kB activation', 'DEx/H-box helicases activate type I IFN and inflammatory cytokines production ', 'PKMTs methylate histone lysines', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'Interleukin-1 processing', 'SUMOylation of immune response proteins', 'CLEC7A (Dectin-1) signaling', 'CD209 (DC-SIGN) signaling', 'Interleukin-1 signaling', 'TRAF6 mediated NF-kB activation']"
Relb,0.46454632,0.19143032,3,"['Dectin-1 mediated noncanonical NF-kB signaling', 'CD209 (DC-SIGN) signaling', 'NIK-->noncanonical NF-kB signaling']"
Relch,-0.047265753,-0.05428116,2,
Rell1,-0.22976746,-0.03552851,2,
Rell2,-0.06720329,-0.151382,2,
Reln,0.39017454,-0.38782337,1,['Reelin signalling pathway']
Relt,-0.4044657,-0.021064043,2,
Rem1,0.5993839,-0.29666635,1,
Rem2,0.017577648,-0.29475057,1,
Ren1,0.15299505,-0.089502685,1,['Metabolism of Angiotensinogen to Angiotensins']
Renbp,-0.33337367,-0.12123633,2,['Synthesis of UDP-N-acetyl-glucosamine']
Rep15,-0.17605518,-0.07518673,2,
Reps1,0.0658085,-0.19794923,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Reps2,0.054110374,-0.3647012,1,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Rer1,0.03168667,-0.07197119,2,
Rere,0.20133875,0.15748821,3,
Rest,0.17811231,0.3049723,3,['HDACs deacetylate histones']
Ret,0.48282295,-0.3442237,1,"['RAF/MAP kinase cascade', 'RET signaling']"
Retn,0.28575355,-0.21629532,1,['Neutrophil degranulation']
Retnla,0.18219987,-0.007552566,1,
Retnlb,-0.25828904,-0.03388559,2,
Retreg1,-0.019561214,-0.19416903,2,
Retsat,-0.29188046,-0.26331514,2,
Rev1,0.17612417,0.3322482,3,"['Translesion synthesis by REV1', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis']"
Rev3l,0.06041281,0.32036203,3,"['Translesion synthesis by REV1', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI']"
Rexo1,-0.23835514,-0.046101946,2,
Rexo2,-0.103775226,0.2619174,2,
Rexo4,-0.1750033,0.21295348,0,
Rexo5,-0.106878065,0.059827138,0,
Rfc2,0.2788043,0.3977245,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Polymerase switching on the C-strand of the telomere', 'Activation of ATR in response to replication stress', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Regulation of TP53 Activity through Phosphorylation', 'Polymerase switching', 'G2/M DNA damage checkpoint']"
Rfc3,0.25519913,0.38391072,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Polymerase switching on the C-strand of the telomere', 'Activation of ATR in response to replication stress', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Regulation of TP53 Activity through Phosphorylation', 'Polymerase switching', 'G2/M DNA damage checkpoint']"
Rfc4,0.21865395,0.4481291,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Polymerase switching on the C-strand of the telomere', 'Activation of ATR in response to replication stress', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Regulation of TP53 Activity through Phosphorylation', 'Polymerase switching', 'G2/M DNA damage checkpoint']"
Rfc5,0.23826914,0.4282993,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Polymerase switching on the C-strand of the telomere', 'Activation of ATR in response to replication stress', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Regulation of TP53 Activity through Phosphorylation', 'Polymerase switching', 'G2/M DNA damage checkpoint']"
Rfesd,-0.013022602,0.25368145,0,
Rffl,0.20403865,0.17944008,3,['Regulation of TP53 Degradation']
Rfk,0.07868416,-0.28389788,1,['Vitamin B2 (riboflavin) metabolism']
Rfng,0.020362776,-0.019954098,2,
Rfpl4,-0.23710005,0.048339944,2,
Rft1,-0.19436519,-0.09315013,2,
Rftn1,-0.4123972,0.094434164,2,
Rfwd3,0.14913544,0.36260915,3,
Rfx1,0.15199764,-0.018183077,1,
Rfx2,0.04095671,-0.028607683,1,
Rfx3,-0.10006649,0.23657686,2,
Rfx4,-0.24950907,-0.013691994,2,
Rfx5,0.12109609,-0.09858588,3,
Rfx6,-0.07483233,0.043111373,2,
Rfx7,-0.10221586,-0.07945717,2,
Rfxank,0.057622682,0.068318404,3,
Rfxap,-0.068470635,-0.15313867,2,
Rgcc,-0.04863364,0.0724385,2,
Rgl1,0.12803638,-0.38194188,1,['RAF/MAP kinase cascade']
Rgl2,0.15478204,-0.2395025,1,
Rgl3,0.0756999,-0.14647491,1,['RAF/MAP kinase cascade']
Rgma,0.01852972,-0.040061682,2,
Rgmb,0.036926873,0.033350106,2,
Rgn,-0.24455993,0.11925614,2,
Rgp1,-0.016699538,-0.19911794,1,"['Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network', 'RAB GEFs exchange GTP for GDP on RABs']"
Rgr,-0.044598937,-0.24472259,1,"['G alpha (i) signalling events', 'Opsins']"
Rgs1,0.24507304,-0.25108984,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs10,0.013258266,-0.19890489,1,
Rgs11,0.16165952,-0.13415298,1,
Rgs12,0.22948276,-0.1943549,1,['G alpha (i) signalling events']
Rgs13,0.100556634,-0.1696689,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs14,0.23255262,-0.31879354,1,['G alpha (i) signalling events']
Rgs16,0.11404397,-0.103306234,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'G alpha (z) signalling events']"
Rgs17,-0.026719676,-0.13376476,2,"['G alpha (q) signalling events', 'G alpha (i) signalling events', 'G alpha (z) signalling events']"
Rgs18,0.186749,-0.27313104,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs19,0.21935691,-0.19982742,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs2,0.08159249,-0.28943977,1,['G alpha (q) signalling events']
Rgs20,0.14993615,-0.18010175,1,"['G alpha (i) signalling events', 'G alpha (z) signalling events']"
Rgs21,0.08410392,-0.07361418,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs22,-0.09026604,0.090632066,2,
Rgs3,0.3976511,-0.24077499,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs4,0.08323953,-0.24419446,1,
Rgs5,0.13070008,-0.24586663,1,"['G alpha (q) signalling events', 'G alpha (i) signalling events']"
Rgs6,0.18378508,-0.2089596,1,"['G alpha (i) signalling events', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Rgs7,0.16450812,-0.24055663,1,"['G alpha (i) signalling events', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Rgs7bp,0.19398242,-0.086302824,1,
Rgs8,0.08939142,-0.024400774,1,['G alpha (i) signalling events']
Rgs9,0.08060902,-0.21301319,1,"['Inactivation, recovery and regulation of the phototransduction cascade', 'G alpha (i) signalling events', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Rgs9bp,0.03561081,-0.24335606,1,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Rgsl1,-0.031304624,-0.24100918,1,['G alpha (q) signalling events']
Rhag,-0.12908454,0.024854396,2,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Rhesus glycoproteins mediate ammonium transport.']"
Rhbdd1,-0.1916423,0.044676278,2,
Rhbdd2,-0.0461498,-0.10469514,2,
Rhbdd3,-0.21487007,-0.11712924,2,
Rhbdf1,-0.18184814,-0.09871314,2,
Rhbdf2,-0.14800999,-0.33767882,2,
Rhbdl1,-0.28529203,0.052057564,2,
Rhbdl2,-0.06310698,-0.13894624,2,
Rhbdl3,-0.24174114,-0.30299267,2,
Rhcg,-0.18726479,-0.06458458,2,['Rhesus glycoproteins mediate ammonium transport.']
Rhd,-0.14367777,0.012566816,2,
Rheb,0.28877333,0.09540296,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Rhebl1,-0.02386427,0.09558074,2,
Rhno1,0.23999976,0.37326542,3,
Rho,0.054116078,-0.3044331,1,"['The canonical retinoid cycle in rods (twilight vision)', 'Activation of the phototransduction cascade', 'Inactivation, recovery and regulation of the phototransduction cascade', 'G alpha (i) signalling events', 'Opsins', 'VxPx cargo-targeting to cilium']"
Rhoa,0.6639682,-0.31842458,1,"['GPVI-mediated activation cascade', 'Axonal growth inhibition (RHOA activation)', 'PI3K/AKT activation', 'Axonal growth stimulation', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'G beta:gamma signalling through PI3Kgamma', 'EPHB-mediated forward signaling', 'EPHA-mediated growth cone collapse', 'PCP/CE pathway', 'G alpha (12/13) signalling events', 'Sema4D mediated inhibition of cell attachment and migration', 'Sema4D induced cell migration and growth-cone collapse', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases activate PKNs', 'RHO GTPases activate CIT', 'RHO GTPases activate KTN1', 'RHO GTPases Activate ROCKs', 'RHO GTPases Activate Formins', 'RHO GTPases Activate Rhotekin and Rhophilins', 'Ovarian tumor domain proteases', 'ERBB2 Regulates Cell Motility', 'Neutrophil degranulation', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'RHOA GTPase cycle', 'SLIT2:ROBO1 increases RHOA activity', 'RHOC GTPase cycle']"
Rhob,0.4087945,-0.19999263,1,"['GPVI-mediated activation cascade', 'G alpha (12/13) signalling events', 'Sema4D induced cell migration and growth-cone collapse', 'RHO GTPases activate PKNs', 'RHO GTPases activate CIT', 'RHO GTPases Activate ROCKs', 'RHO GTPases Activate Formins', 'RHOB GTPase cycle']"
Rhobtb1,0.24629617,-0.109002344,1,['RHOBTB1 GTPase cycle']
Rhobtb2,0.08077617,-0.06709236,1,['RHOBTB2 GTPase cycle']
Rhobtb3,0.16402675,-0.07114665,1,"['Retrograde transport at the Trans-Golgi-Network', 'RHOBTB3 ATPase cycle']"
Rhoc,0.4599222,-0.21216969,1,"['G alpha (12/13) signalling events', 'Sema4D induced cell migration and growth-cone collapse', 'RHO GTPases activate PKNs', 'RHO GTPases activate CIT', 'RHO GTPases Activate ROCKs', 'RHO GTPases Activate Formins', 'RHOC GTPase cycle']"
Rhod,0.16900828,-0.10597947,1,"['RHO GTPases Activate Formins', 'RHOD GTPase cycle']"
Rhof,0.17803727,-0.26032004,1,"['Neutrophil degranulation', 'RHOF GTPase cycle']"
Rhog,0.3818575,-0.23053837,1,"['GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'RHO GTPases activate KTN1', 'Neutrophil degranulation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RHOG GTPase cycle']"
Rhoh,0.31175575,-0.26223573,1,['RHOH GTPase cycle']
Rhoj,0.16768618,-0.18849477,1,['RHOJ GTPase cycle']
Rhoq,0.18480255,-0.35712475,1,"['RHO GTPases regulate CFTR trafficking', 'RHOQ GTPase cycle']"
Rhot1,0.21412209,-0.03714359,3,"['Ub-specific processing proteases', 'RHOT1 GTPase cycle']"
Rhot2,0.27288684,-0.113670565,1,['RHOT2 GTPase cycle']
Rhou,0.085963584,-0.14056991,1,['RHOU GTPase cycle']
Rhov,0.022094827,-0.19755024,1,['RHOV GTPase cycle']
Rhox1,-0.30259022,0.014987732,2,
Rhox11,-0.2705004,0.039347835,2,
Rhox12,-0.10420427,-0.039877817,2,
Rhox3a,-0.17093195,-0.031415593,2,
Rhox3e,-0.3874646,-0.075683065,2,
Rhox3f,-0.18641816,0.11977808,2,
Rhox4g,-0.12017536,0.07427002,2,
Rhox5,-0.24751492,-0.040630646,2,
Rhox7b,-0.015578433,-0.112204835,2,
Rhox9,-0.24717881,0.19050524,2,
Rhpn1,0.18342306,-0.003624376,1,"['RHO GTPases Activate Rhotekin and Rhophilins', 'RHOA GTPase cycle']"
Rhpn2,0.12905419,-0.27777645,1,"['RHO GTPases Activate Rhotekin and Rhophilins', 'RHOA GTPase cycle', 'RHOB GTPase cycle']"
Ribc1,-0.057792567,-0.047159042,2,
Ribc2,-0.0721162,0.079256624,2,
Ric1,0.06311866,-0.10472672,1,
Ric3,-0.2631165,-0.08926399,2,
Ric8a,0.025094435,-0.27156422,1,
Ric8b,0.09479548,-0.19646713,1,
Rictor,0.3385099,0.091101065,3,"['PIP3 activates AKT signaling', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability', 'Regulation of TP53 Degradation']"
Rida,-0.18819633,-0.13543452,2,['Threonine catabolism']
Rif1,0.26120952,0.39982,3,['Nonhomologous End-Joining (NHEJ)']
Riiad1,-0.07768895,0.012341726,2,
Rilp,-0.158027,-0.10627893,2,['MHC class II antigen presentation']
Rilpl1,0.02643413,0.09182269,2,
Rilpl2,-0.17944437,-0.26091614,2,
Rimbp2,0.036167093,-0.23363696,1,
Rimbp3,-0.44552854,-0.21292202,2,
Rimkla,-0.14302455,-0.27410647,2,['Glutamate and glutamine metabolism']
Rimklb,-0.23686153,-0.05816302,2,['Glutamate and glutamine metabolism']
Rims2,-0.20004864,-0.19012412,2,
Rims3,-0.283022,-0.10605861,2,
Rims4,-0.22024898,-0.13030362,2,
Rin1,0.23845315,-0.3318896,1,['RAB GEFs exchange GTP for GDP on RABs']
Rin2,-0.07713112,-0.2880099,1,['RAB GEFs exchange GTP for GDP on RABs']
Rin3,-0.11027752,-0.12138985,2,['RAB GEFs exchange GTP for GDP on RABs']
Ring1,0.29762533,0.24282205,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Rinl,0.09579096,-0.12458834,1,['RAB GEFs exchange GTP for GDP on RABs']
Rint1,-0.07136901,0.21236746,2,['COPI-dependent Golgi-to-ER retrograde traffic']
Riok1,-0.08395014,0.33689386,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Riok3,-0.11694433,0.4368479,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Riox1,-0.19285922,0.22703537,2,
Riox2,-0.30244038,0.26309103,2,['HDMs demethylate histones']
Ripk1,0.46203786,0.03643545,1,"['Caspase activation via Death Receptors in the presence of ligand', 'TRIF-mediated programmed cell death', 'TRP channels', 'Regulation by c-FLIP', 'RIPK1-mediated regulated necrosis', 'CASP8 activity is inhibited', 'TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Regulation of necroptotic cell death', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Dimerization of procaspase-8', 'TNF signaling', 'IKK complex recruitment mediated by RIP1']"
Ripk2,0.40684897,-0.058265302,1,"['NOD1/2 Signaling Pathway', 'Downstream TCR signaling', 'p75NTR recruits signalling complexes', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'Ovarian tumor domain proteases']"
Ripk3,0.41419107,-0.108594544,3,"['TRIF-mediated programmed cell death', 'TRP channels', 'RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death', 'IKK complex recruitment mediated by RIP1']"
Ripk4,-0.106289536,-0.11847374,2,
Ripor2,-0.0064223446,-0.17258331,1,
Ripor3,-0.19514276,-0.035428595,2,
Ripply1,-0.27330643,-0.103421204,2,
Ripply3,-0.06602718,0.016718153,2,
Rit1,0.1502251,-0.08764868,1,
Rit2,-0.0060443752,0.0057071606,2,
Rlbp1,0.0071093747,-0.40870443,1,"['The retinoid cycle in cones (daylight vision)', 'The canonical retinoid cycle in rods (twilight vision)']"
Rlim,0.070645735,0.10892704,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Rln1,-0.22785309,-0.18266094,2,
Rln3,-0.10679168,-0.087500274,2,"['G alpha (s) signalling events', 'G alpha (i) signalling events', 'Relaxin receptors']"
Rmc1,-0.26098692,-0.07126455,2,
Rmdn1,-0.083523884,0.1532005,2,
Rmdn2,-0.16057749,-0.312822,2,
Rmdn3,0.16239111,-0.17480522,1,
Rmi1,0.29036847,0.40250495,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Rmi2,0.1396936,0.34197962,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Rmnd1,-0.29165694,-0.08290616,2,
Rmnd5a,-0.1567316,0.07500769,2,
Rmnd5b,-0.03408616,-0.05405606,2,
Rnase1,0.021937357,-0.048342973,2,
Rnase10,-0.03571735,0.11511708,2,
Rnase11,-0.24185453,-0.08427661,2,
Rnase13,-0.062100183,-0.21070383,2,
Rnaseh1,-0.11329933,0.30152795,3,
Rnaseh2a,0.14276311,0.30214655,3,
Rnaseh2b,-0.019310819,0.2560458,3,
Rnaseh2c,0.048010446,0.13480677,0,
Rnasek,-0.1925529,-0.17651838,2,
Rnasel,0.21996155,0.19540979,0,"['OAS antiviral response', 'Interferon alpha/beta signaling']"
Rnd1,0.4014477,-0.16647704,1,"['Sema4D mediated inhibition of cell attachment and migration', 'Sema4D induced cell migration and growth-cone collapse', 'RND1 GTPase cycle']"
Rnd2,0.11271377,-0.2574523,1,['RND2 GTPase cycle']
Rnd3,0.19223826,-0.12389624,1,['RND3 GTPase cycle']
Rnf11,0.10703983,-0.010692641,3,
Rnf111,0.2651373,0.20296842,3,"['SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Formation of Incision Complex in GG-NER', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rnf113a1,-0.16393466,0.3176222,0,
Rnf113a2,0.0009128616,0.19769484,0,
Rnf114,-0.03384393,0.03631327,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf115,-0.029851014,0.04802421,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf121,-0.22363296,-0.09164538,2,
Rnf123,0.17136186,0.09091767,3,"['Ub-specific processing proteases', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rnf125,0.027309157,0.048186813,3,
Rnf126,-0.19248232,0.110585846,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf128,-0.026178261,0.041843172,2,"['Ub-specific processing proteases', 'Ovarian tumor domain proteases']"
Rnf13,-0.0984315,0.013263646,2,
Rnf135,-0.12193757,-0.07207882,2,
Rnf138,-0.26274955,0.028294135,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf139,0.07625253,-0.12651423,1,
Rnf14,0.07583531,0.00889907,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf141,-0.10136391,-0.042311527,2,
Rnf144a,-0.1329919,0.00858846,2,['E3 ubiquitin ligases ubiquitinate target proteins']
Rnf144b,-0.24896461,-0.32299665,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf145,-0.14698465,-0.005316229,2,
Rnf146,0.24115016,0.18437508,3,"['TCF dependent signaling in response to WNT', 'Degradation of AXIN', 'Ub-specific processing proteases', 'Regulation of PTEN stability and activity']"
Rnf149,-0.33895677,0.084256366,2,
Rnf150,0.0006748856,0.04847488,2,
Rnf151,-0.16427226,0.021120083,2,
Rnf152,0.06257656,-0.07116071,2,['E3 ubiquitin ligases ubiquitinate target proteins']
Rnf165,-0.1699204,-0.05838509,2,
Rnf166,-0.25772282,-0.10150443,2,
Rnf168,0.14811,0.3170073,3,"['SUMOylation of DNA damage response and repair proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Rnf169,-0.2342229,0.077842765,2,
Rnf17,0.018108921,0.008387321,2,
Rnf170,0.051864732,-0.2152674,1,
Rnf181,0.075894825,0.17572093,3,['E3 ubiquitin ligases ubiquitinate target proteins']
Rnf183,-0.13148388,0.06764985,2,
Rnf185,-0.060666285,-0.18360575,2,['ABC-family proteins mediated transport']
Rnf187,0.06247069,0.038977712,2,
Rnf19a,-0.20139855,-0.07179476,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf19b,-0.24170317,0.01439001,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf2,0.43366265,0.3391099,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Rnf20,0.14063773,0.40348598,3,"['E3 ubiquitin ligases ubiquitinate target proteins', 'RHOBTB1 GTPase cycle']"
Rnf208,-0.2949909,-0.20540299,2,
Rnf212,-0.0732347,0.28259057,3,
Rnf213,0.16591053,0.052210797,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf214,-0.2482323,0.007800287,2,
Rnf215,-0.2947087,-0.19646852,2,
Rnf216,-0.22885476,-0.20554778,2,
Rnf220,-0.2071654,0.10594688,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf222,-0.036563706,0.03939097,2,
Rnf225,0.024280613,-0.102904916,1,
Rnf24,-0.06340167,0.020029763,2,
Rnf25,-0.07324733,0.013759965,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf26,-0.07923118,-0.06499422,2,
Rnf31,0.23812114,0.03452139,3,"['Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway']"
Rnf32,-0.17178863,0.053791836,2,
Rnf34,0.097879745,0.09650882,3,"['Regulation of TP53 Degradation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rnf38,-0.045974728,0.06577206,3,
Rnf39,-0.10420497,0.23825088,0,
Rnf4,0.08562925,0.2560253,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf40,0.23570518,0.3385957,3,['E3 ubiquitin ligases ubiquitinate target proteins']
Rnf41,0.41759604,-0.0072080563,3,"['Downregulation of ERBB2:ERBB3 signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rnf43,0.06907071,0.21715689,0,['Regulation of FZD by ubiquitination']
Rnf5,-0.055671938,0.10101855,3,['ABC-family proteins mediated transport']
Rnf6,-0.005706034,-0.15372501,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Rnf7,0.30203792,0.2160919,3,"['Neddylation', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rnf7l,0.24143204,-0.11483815,3,
Rnf8,0.33800852,0.25214407,3,"['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Rngtt,-0.057414476,0.23904443,0,"['mRNA Capping', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Rnh1,-0.2255613,0.0152735645,2,
Rnls,-0.24426562,0.14795946,2,
Rnmt,-0.07099672,0.39695626,0,"['mRNA Capping', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Rnpc3,-0.056908432,0.2951175,0,['mRNA Splicing - Minor Pathway']
Rnps1,-0.039393533,0.42938593,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Ro60,0.19122578,0.2547682,0,
Robo1,0.45989984,-0.16728023,1,
Robo2,0.33373785,-0.17310189,1,
Robo3,0.19059815,-0.13206215,1,
Robo4,0.031879406,-0.18522568,1,
Rock1,0.43473545,-0.26324907,1,"['Apoptotic cleavage of cellular proteins', 'EPHB-mediated forward signaling', 'G alpha (12/13) signalling events', 'Sema4D induced cell migration and growth-cone collapse', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate ROCKs', 'Neutrophil degranulation', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RHOH GTPase cycle', 'RHOBTB1 GTPase cycle', 'RND3 GTPase cycle']"
Rock2,0.56995577,-0.20530027,1,
Rogdi,-0.24704437,0.20437703,2,
Rom1,-0.12941422,-0.22679253,2,
Romo1,0.04824035,0.12068423,0,
Ropn1,-0.008814188,-0.06454863,2,
Ropn1l,-0.012341651,0.005524442,2,
Ror1,0.18708754,-0.29469958,1,"['WNT5A-dependent internalization of FZD2, FZD5 and ROR2']"
Ror2,0.1615529,-0.1805897,1,
Rora,0.3268555,0.029459951,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Rorb,0.2199525,0.16354007,3,['Nuclear Receptor transcription pathway']
Rorc,0.34860355,0.09374309,3,['Nuclear Receptor transcription pathway']
Ros1,0.17183675,-0.26872215,1,
Rp1,-0.15982519,-0.26239365,2,
Rp1l1,-0.10902555,0.062072977,2,
Rp2,-0.09532369,0.20067044,0,['Trafficking of myristoylated proteins to the cilium']
Rp9,-0.24009366,0.30978706,0,
Rpa1,0.22002745,0.5444864,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Removal of the Flap Intermediate from the C-strand', 'Activation of ATR in response to replication stress', 'SUMOylation of DNA damage response and repair proteins', 'Regulation of HSF1-mediated heat shock response', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Regulation of TP53 Activity through Phosphorylation', 'Activation of the pre-replicative complex', 'Removal of the Flap Intermediate', 'G2/M DNA damage checkpoint']"
Rpa2,0.19268417,0.4660844,3,
Rpa3,0.20740137,0.46307388,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Removal of the Flap Intermediate from the C-strand', 'Activation of ATR in response to replication stress', 'Regulation of HSF1-mediated heat shock response', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'PCNA-Dependent Long Patch Base Excision Repair', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Regulation of TP53 Activity through Phosphorylation', 'Activation of the pre-replicative complex', 'Removal of the Flap Intermediate', 'G2/M DNA damage checkpoint']"
Rpap1,0.021570224,0.21849324,3,
Rpap2,0.093753606,0.4189626,0,['RNA polymerase II transcribes snRNA genes']
Rpap3,0.09362217,0.34766483,3,
Rpe,-0.44507897,-0.000685927,2,['Pentose phosphate pathway']
Rpe65,0.0891019,-0.40374023,1,['The canonical retinoid cycle in rods (twilight vision)']
Rpf1,-0.24544138,0.3895931,0,
Rpf2,0.015563352,0.31382048,0,
Rpgr,0.19069934,-0.07776041,1,
Rpgrip1,-0.23660906,-0.01938228,2,
Rpgrip1l,0.031838607,0.03351729,2,"[""Hedgehog 'off' state"", 'Anchoring of the basal body to the plasma membrane']"
Rph3a,-0.21188925,-0.19742657,2,
Rph3al,-0.13108504,-0.096116364,2,
Rpia,-0.21772647,0.17928931,0,['Pentose phosphate pathway']
Rpl10,-0.10608462,0.20331565,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl10-ps3,-0.17263304,0.20419419,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl10a,-0.08172734,0.30086276,0,
Rpl10l,-0.053898744,0.1670915,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl11,-0.045121573,0.3322689,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl12,-0.088098794,0.2259638,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl13,-0.1827394,0.20286039,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl13a,0.0999146,0.20570084,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl14,-0.20424108,0.23113981,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl15,-0.01823816,0.2717616,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl17,-0.04613999,0.22013235,0,
Rpl18a,-0.1215628,0.16043715,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl19,0.0058919406,0.20555834,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl21,-0.252928,0.23664947,0,
Rpl22,-0.12459045,0.1497833,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl22l1,-0.0097425645,0.37814426,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl23,-0.18396825,0.27391958,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl23a,-0.037240062,0.19638902,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl24,-0.026040997,0.24247995,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl26,-0.0823743,0.3013591,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl27,-0.015613814,0.34173787,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl27a,-0.08894023,0.17810643,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl28,-0.029328473,0.18820001,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl29,-0.043271784,0.11984749,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl3,-0.07205844,0.30672666,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl30,-0.23143709,0.3223976,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl31,-0.17501725,0.19980557,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl32,-0.084932245,0.15871805,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl34,-0.14003319,0.11715851,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl35,0.015102378,0.25226572,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl35a,-0.14183545,0.2053939,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl36,-0.03694287,0.12329221,0,
Rpl36-ps4,-0.11547345,0.25807106,0,
Rpl36a,-0.07252333,0.2123075,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl36al,0.029242786,0.27448905,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl37,-0.087682724,0.18351996,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl37a,0.09846426,0.16682655,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl38,-0.29210544,0.21625909,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl39,-0.08127033,0.35026178,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl39l,-0.050580963,0.26715955,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl3l,-0.09458567,0.23905985,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl4,-0.03840343,0.36604595,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl41,-0.14154238,0.2618185,0,
Rpl5,0.012302819,0.5071676,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl6,-0.102912374,0.27897257,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl7,-0.10448994,0.27796918,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl7a,-0.19967216,0.22870341,0,
Rpl7l1,-0.08805657,0.33647424,0,
Rpl8,-0.06234384,0.44122568,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl9,-0.12235551,0.32002676,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpl9-ps6,0.005179033,0.2553381,0,
Rplp0,0.017631281,0.21892256,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rplp1,-0.07602096,0.26052818,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rplp2,-0.01607893,0.22590986,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpn1,-0.17728032,0.19400351,0,
Rpn2,0.044563588,-0.027683338,2,
Rpp14,-0.21867214,0.20879823,2,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rpp21,-0.1450215,0.28278655,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rpp25,-0.039041005,0.49156976,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rpp25l,-0.3497149,0.19641145,0,
Rpp30,-0.15285967,0.49403486,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rpp38,-0.24569887,0.48228374,0,
Rpp40,-0.14041139,0.37106687,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rprd1a,0.04998412,0.34226748,0,['RNA polymerase II transcribes snRNA genes']
Rprd1b,-0.02081444,0.2927058,3,['RNA polymerase II transcribes snRNA genes']
Rprd2,0.039776765,0.33929238,0,['RNA polymerase II transcribes snRNA genes']
Rps10,0.012384598,0.2572427,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps11,-0.110152714,0.3646151,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps12,-0.035845406,0.35910162,0,
Rps13,-0.13087551,0.3880033,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps14,-0.12000383,0.4385153,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps15,-0.029599622,0.32908338,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps15a,-0.11757505,0.34179693,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps16,-0.17483987,0.40790355,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps17,0.082081765,0.41019183,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps18,-0.06334943,0.20211852,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps18-ps6,-0.04204091,0.09029389,0,
Rps19,-0.04766207,0.3442996,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps19bp1,0.14780037,0.32028115,3,['Regulation of HSF1-mediated heat shock response']
Rps2,-0.19571187,0.41143858,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'RMTs methylate histone arginines', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Protein methylation', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps20,-0.085106,0.34889618,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps21,0.035590373,0.3397106,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps23,-0.16010714,0.47680217,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps24,-0.123661526,0.3849076,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps25,-0.19553414,0.25713688,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps26,-0.1071333,0.31927657,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps27,-0.17311025,0.34326226,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Mitotic Prometaphase', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'EML4 and NUDC in mitotic spindle formation', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps27a,0.49552482,0.36488855,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Downregulation of ERBB4 signaling', 'Spry regulation of FGF signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'NOD1/2 Signaling Pathway', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC-Cdc20 mediated degradation of Nek2A', 'EGFR downregulation', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'TCF dependent signaling in response to WNT', 'Downstream TCR signaling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Separation of Sister Chromatids', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Regulation of PLK1 Activity at G2/M Transition', 'Stimuli-sensing channels', 'FCERI mediated NF-kB activation', 'Regulation of innate immune responses to cytosolic DNA', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Deactivation of the beta-catenin transactivating complex', 'ABC-family proteins mediated transport', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Regulation of FZD by ubiquitination', 'PINK1-PRKN Mediated Mitophagy', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'Negative regulation of MAPK pathway', 'Regulation of necroptotic cell death', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'HDR through Homologous Recombination (HRR)', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Josephin domain DUBs', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Negative regulation of MET activity', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin D associated events in G1', 'G2/M Checkpoints', 'Stabilization of p53', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'VLDLR internalisation and degradation', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Neddylation', 'ER Quality Control Compartment (ERQC)', 'Regulation of expression of SLITs and ROBOs', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Interleukin-1 signaling', 'Peroxisomal protein import', 'Regulation of signaling by CBL', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Iron uptake and transport', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'Aggrephagy', 'RAS processing', 'Pexophagy', 'Inactivation of CSF3 (G-CSF) signaling', 'Negative regulation of FLT3', 'Regulation of BACH1 activity', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'KEAP1-NFE2L2 pathway', 'Regulation of NF-kappa B signaling', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Rps27l,-0.14009748,0.22593774,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps27rt,-0.11328162,0.20437975,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Mitotic Prometaphase', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'EML4 and NUDC in mitotic spindle formation', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps28,-0.22729453,0.4311143,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps29,-0.04973026,0.27749896,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps3,-0.023294708,0.3675477,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps3a1,-0.0128928255,0.3868064,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps4x,-0.109996594,0.29984236,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps5,-0.08345746,0.3841904,0,
Rps6,-0.0027523346,0.38332945,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'mTORC1-mediated signalling', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps6ka1,0.39463568,0.0021110899,3,"['ERK/MAPK targets', 'CREB phosphorylation', 'Senescence-Associated Secretory Phenotype (SASP)', 'CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling', 'RSK activation', 'Gastrin-CREB signalling pathway via PKC and MAPK']"
Rps6ka2,0.35582715,-0.09062446,1,"['ERK/MAPK targets', 'CREB phosphorylation', 'Senescence-Associated Secretory Phenotype (SASP)', 'CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling', 'RSK activation', 'Gastrin-CREB signalling pathway via PKC and MAPK']"
Rps6ka3,0.39669934,0.14939608,3,"['ERK/MAPK targets', 'CREB phosphorylation', 'Senescence-Associated Secretory Phenotype (SASP)', 'CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling', 'RSK activation', 'Gastrin-CREB signalling pathway via PKC and MAPK']"
Rps6ka5,0.35906395,0.059230156,3,"['ERK/MAPK targets', 'CREB phosphorylation', 'NCAM signaling for neurite out-growth', 'CD209 (DC-SIGN) signaling']"
Rps6kb1,0.40063852,0.11929865,3,['mTORC1-mediated signalling']
Rps6kb2,0.46726608,0.16009827,3,['AKT phosphorylates targets in the nucleus']
Rps6kc1,-0.08225821,0.020112894,2,
Rps6kl1,-0.1061256,-0.08940156,2,
Rps7,-0.11056824,0.40610865,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps8,0.05183372,0.4175848,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rps9,-0.05783771,0.42686734,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rpsa,0.054036703,0.14034513,0,"['L13a-mediated translational silencing of Ceruloplasmin expression', 'SRP-dependent cotranslational protein targeting to membrane', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Rptn,-0.039384607,-0.10505939,2,['Formation of the cornified envelope']
Rptor,0.30304265,0.2021622,3,
Rpusd1,-0.099940635,0.16990286,2,
Rpusd2,-0.16374008,0.17508273,0,
Rpusd3,-0.29541364,0.020024879,2,
Rpusd4,-0.2180152,0.1433089,2,
Rrad,0.10110801,0.13866878,3,
Rraga,0.11420668,0.074495815,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Rragb,0.12572609,0.21777295,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Rragc,0.19868527,0.14621605,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Rragd,-0.016676398,0.16188912,2,
Rras,0.35829774,-0.4883583,1,['Sema4D mediated inhibition of cell attachment and migration']
Rras2,0.4690327,-0.37312678,1,['RND1 GTPase cycle']
Rrbp1,0.016172023,0.19134946,3,
Rreb1,0.041526794,0.08071659,3,
Rrh,-0.15184937,-0.25323924,2,"['G alpha (i) signalling events', 'Opsins']"
Rrm1,0.16740403,0.37404335,3,['Interconversion of nucleotide di- and triphosphates']
Rrm2,0.17664826,0.45254797,3,['Interconversion of nucleotide di- and triphosphates']
Rrm2b,0.20602627,0.27754197,3,['Interconversion of nucleotide di- and triphosphates']
Rrn3,0.24452151,0.25498545,3,"['RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape']"
Rrp1,-0.22754717,0.2891471,0,
Rrp12,-0.27102712,0.46614295,0,
Rrp15,-0.3253452,0.30571416,0,
Rrp1b,-0.20930715,0.23051132,0,
Rrp36,-0.21682188,0.41910473,0,
Rrp7a,-0.16479698,0.39060274,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rrp8,-0.20886695,0.38619122,0,
Rrp9,-0.21585688,0.4250839,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Rrs1,-0.122764595,0.4441134,0,
Rs1,-0.14878169,-0.22987494,2,
Rsad1,-0.019097747,0.14967263,2,
Rsad2,0.20622933,0.013633324,1,
Rsc1a1,-0.1310728,-0.10285402,2,
Rskr,-0.08224575,-0.0072900373,2,
Rsl1d1,-0.22627716,0.47545546,0,
Rsl24d1,-0.2151295,0.43498534,0,
Rsph1,0.00816704,0.1942208,0,
Rsph10b,-0.21100624,-0.02072543,2,
Rsph14,-0.13363399,-0.19394651,2,
Rsph3a,-0.103309035,-0.0068867034,2,
Rsph3b,-0.3208717,0.029997824,2,
Rsph4a,-0.07844661,0.088953204,2,
Rsph6a,0.014251108,0.17206487,0,
Rsph9,0.0014271616,0.26587588,0,
Rspo1,0.13930339,0.013512424,1,
Rspo2,-0.0051052817,0.10958944,0,['Regulation of FZD by ubiquitination']
Rspo3,0.049066618,0.17139696,3,['Regulation of FZD by ubiquitination']
Rspo4,-0.12893087,-0.02150361,2,['Regulation of FZD by ubiquitination']
Rspry1,-0.07374896,-0.0064525045,2,
Rsrc1,-0.110939905,0.34897298,0,
Rsrc2,-0.2393257,0.1296888,0,
Rsrp1,-0.066111326,0.15455288,0,
Rsu1,-0.06050505,-0.0012082428,2,
Rtca,-0.25897756,0.41886932,0,
Rtcb,-0.09297266,0.24196151,0,
Rtel1,0.12630033,0.41417965,0,['Telomere Extension By Telomerase']
Rtf1,0.20069018,0.2257023,3,
Rtf2,-0.12711975,0.052547775,2,
Rtkn,0.20924458,-0.28084603,1,"['RHO GTPases Activate Rhotekin and Rhophilins', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Rtl1,-0.01334077,-0.14149362,2,
Rtl3,-0.18163505,0.082382284,2,
Rtl4,-0.34326375,0.121468715,2,
Rtl5,-0.25801617,0.002919971,2,
Rtl6,-0.33018377,-0.004645048,2,
Rtl8a,-0.17231818,-0.10787631,2,
Rtl9,-0.21562462,0.04352537,2,
Rtn1,-0.22702396,-0.050746962,2,
Rtn2,-0.12086974,-0.2103363,2,
Rtn3,-0.17711014,-0.23183623,2,['Synaptic adhesion-like molecules']
Rtn4,0.2610254,-0.27660117,1,['Axonal growth inhibition (RHOA activation)']
Rtn4ip1,-0.17043486,-0.22998317,2,
Rtn4r,0.3066986,-0.2262912,1,
Rtn4rl1,0.19625948,-0.22839092,1,
Rtn4rl2,0.073474914,-0.23396996,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Rtp1,0.024330297,-0.058487076,2,
Rtp2,-0.2926387,0.1179025,2,
Rtp4,0.16887271,0.10448859,3,
Rtraf,-0.08780958,0.1593103,2,
Rttn,-0.14794499,-0.14878605,2,
Rubcn,0.11497584,-0.013386718,3,
Rubcnl,-0.27950558,-0.0357466,2,
Rufy1,0.15175371,-0.2432213,1,['Synthesis of PIPs at the plasma membrane']
Rufy2,-0.28573504,0.22601815,2,
Rufy3,-0.16677271,0.02519221,2,
Rufy4,-0.15636116,0.0907882,2,
Rundc1,-0.28843504,-0.005784506,2,
Rundc3a,-0.28069964,-0.02327704,2,
Rundc3b,-0.38910708,-0.11569035,2,
Runx1,0.50251937,-0.0013436978,3,
Runx1t1,0.32806015,-0.03445546,3,
Runx2,0.5868344,0.053627905,3,"['Transcriptional regulation by RUNX2', 'Regulation of RUNX2 expression and activity', 'RUNX2 regulates osteoblast differentiation', 'RUNX2 regulates bone development']"
Runx3,0.43347606,0.2594579,3,"['RUNX3 regulates CDKN1A transcription', 'RUNX3 regulates NOTCH signaling', 'Regulation of RUNX3 expression and activity', 'RUNX3 regulates WNT signaling', 'RUNX3 regulates YAP1-mediated transcription', 'RUNX3 regulates p14-ARF']"
Rusc1,-0.25467107,0.007080569,2,
Rusc2,-0.1299041,-0.06961553,2,
Rusf1,-0.11763796,0.017405711,2,
Ruvbl1,0.28815418,0.55333847,3,"['UCH proteinases', 'Ub-specific processing proteases', 'DNA Damage Recognition in GG-NER', 'Deposition of new CENPA-containing nucleosomes at the centromere']"
Ruvbl2,0.2784632,0.420351,3,
Rwdd1,-0.2948155,0.13393651,0,
Rwdd2b,-0.010128308,-0.042502906,2,"['SUMO is transferred from E1 to E2 (UBE2I, UBC9)']"
Rwdd3,0.05608372,0.2404642,3,
Rwdd4a,-0.062427767,0.102679834,0,
Rxfp1,0.06530015,-0.35478625,1,"['G alpha (s) signalling events', 'Relaxin receptors']"
Rxfp2,-0.07267438,-0.020318944,2,"['G alpha (s) signalling events', 'Relaxin receptors']"
Rxfp3,0.14175478,-0.19976279,1,"['G alpha (i) signalling events', 'Relaxin receptors']"
Rxfp4,0.028356358,-0.3538237,1,"['G alpha (i) signalling events', 'Relaxin receptors']"
Rxra,0.41104385,0.050695807,3,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Carnitine metabolism', 'Regulation of pyruvate dehydrogenase (PDH) complex', 'Endogenous sterols', 'Transcriptional regulation of white adipocyte differentiation', 'Nuclear Receptor transcription pathway', 'Regulation of lipid metabolism by PPARalpha', 'SUMOylation of intracellular receptors', 'Signaling by Retinoic Acid', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'Transcriptional regulation of granulopoiesis', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis', 'Cytoprotection by HMOX1']"
Rxrb,0.37185073,0.19208236,3,"['Nuclear Receptor transcription pathway', 'Signaling by Retinoic Acid', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis']"
Rxrg,0.32601145,0.15335926,3,"['Nuclear Receptor transcription pathway', 'Signaling by Retinoic Acid']"
Rxylt1,-0.06855044,-0.1533246,2,
Rybp,0.27879888,0.04741057,3,"['RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Transcriptional Regulation by E2F6']"
Ryk,0.1497136,-0.17399181,2,['TCF dependent signaling in response to WNT']
Ryr1,0.2294088,-0.19200851,1,"['Stimuli-sensing channels', 'Ion homeostasis']"
Ryr2,0.3227783,-0.28782207,1,"['Stimuli-sensing channels', 'Ion homeostasis']"
Ryr3,0.28675616,-0.22552234,1,"['Stimuli-sensing channels', 'Ion homeostasis']"
S100a1,0.16601047,0.0180965,1,
S100a10,0.23159462,-0.17717113,1,['Dissolution of Fibrin Clot']
S100a11,0.13045317,-0.037247904,1,['Neutrophil degranulation']
S100a13,0.11854985,-0.034608085,1,
S100a14,-0.22733979,0.11740361,2,
S100a16,-0.2649599,-0.008685273,2,
S100a3,-0.39336482,-0.039343767,2,
S100a4,0.2209492,-0.06555948,1,
S100a6,0.12550083,-0.056783505,1,
S100a7l2,-0.08710986,-0.058110863,2,
S100a8,0.40432307,-0.23268056,1,"['RHO GTPases Activate NADPH Oxidases', 'Regulation of TLR by endogenous ligand', 'Neutrophil degranulation', 'Metal sequestration by antimicrobial proteins']"
S100a9,0.27127147,0.07890429,1,"['RHO GTPases Activate NADPH Oxidases', 'Regulation of TLR by endogenous ligand', 'Neutrophil degranulation', 'Metal sequestration by antimicrobial proteins']"
S100b,0.3557966,-0.086689085,1,"['TAK1-dependent IKK and NF-kappa-B activation  ', 'Advanced glycosylation endproduct receptor signaling', 'TRAF6 mediated NF-kB activation']"
S100g,9.094469e-05,0.061939508,2,
S1pr1,0.37143418,-0.39269957,1,['Lysosphingolipid and LPA receptors']
S1pr2,0.23460259,-0.23926722,1,"['G alpha (i) signalling events', 'Lysosphingolipid and LPA receptors']"
S1pr3,0.23361309,-0.3892827,1,"['G alpha (i) signalling events', 'Lysosphingolipid and LPA receptors', 'Extra-nuclear estrogen signaling']"
S1pr4,0.27901593,-0.2934482,1,"['G alpha (i) signalling events', 'Lysosphingolipid and LPA receptors']"
S1pr5,0.088240534,-0.28321126,1,"['G alpha (i) signalling events', 'Lysosphingolipid and LPA receptors']"
Saa1,0.12641984,0.044589076,1,
Saa2,0.1012678,-0.09348043,1,
Saa3,0.027152078,-0.14989509,1,
Saa4,0.05943153,-0.10630996,1,
Saal1,-0.033844277,0.1898557,2,
Sac3d1,0.19103958,0.14561602,3,
Sacm1l,0.25249952,-0.32417595,1,"['Synthesis of PIPs at the ER membrane', 'Synthesis of PIPs at the Golgi membrane']"
Sacs,-0.18077387,-0.03266013,2,
Sae1,0.20738696,0.49067461,3,"['SUMO is conjugated to E1 (UBA2:SAE1)', 'SUMO is transferred from E1 to E2 (UBE2I, UBC9)']"
Safb,0.2183505,0.32592678,0,['SUMOylation of transcription cofactors']
Safb2,0.053035975,-0.34444886,1,
Sag,0.3321113,-0.266754,1,"['Inactivation, recovery and regulation of the phototransduction cascade']"
Sall1,0.23403527,0.05739172,3,
Sall2,0.124952674,0.16167016,3,
Sall3,0.20065145,0.039786264,3,
Sall4,0.2516707,0.1262804,3,['Regulation of PTEN gene transcription']
Samd1,0.13904071,0.25756994,3,
Samd10,-0.107798316,0.017913032,2,
Samd11,-0.05836181,-0.07265183,2,
Samd12,-0.013361939,0.014442609,2,
Samd14,-0.042164773,-0.112207085,2,
Samd4,0.16286623,-0.02266736,1,
Samd4b,-0.1764524,-0.0069605713,2,
Samd5,-0.13033585,0.08002776,2,
Samd7,-0.12890387,-0.19758844,2,
Samd8,-0.37254956,-0.15955609,2,['Sphingolipid de novo biosynthesis']
Samd9l,-0.011493338,-0.15469173,2,
Samhd1,0.33604014,0.2401151,3,['Nucleotide catabolism']
Samm50,0.0750505,-0.12560824,1,['RAC2 GTPase cycle']
Samsn1,-0.11157061,-0.2779291,2,
Samt1,-0.20239796,-0.19193043,2,
Samt1b,-0.19651327,-0.028706523,2,
Samt4,-0.18358943,-0.14730284,2,
Sanbr,-0.15355927,-0.022178672,2,
Sap130,0.17050454,0.16745348,3,
Sap18,0.311092,0.44397986,3,
Sap18b,0.054131318,0.35485268,3,
Sap30,0.25551945,0.38982832,3,['HDACs deacetylate histones']
Sap30bp,-0.05508486,-0.0046732742,2,
Sap30l,0.20188941,0.32326758,3,['HDACs deacetylate histones']
Sar1a,0.0073798653,0.02507585,2,
Sar1b,-0.090207465,-0.08123202,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Chylomicron assembly', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Saraf,-0.2816459,-0.26649016,2,
Sardh,-0.14402579,0.022025432,2,['Choline catabolism']
Sarm1,0.14094746,-0.20875172,1,"['MyD88-independent TLR4 cascade ', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IKK complex recruitment mediated by RIP1', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex']"
Sarnp,-0.15002462,0.11906298,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Sars,-0.0961104,0.1498819,0,
Sars2,-0.2888099,0.013508875,0,
Sart1,-0.06688767,0.558306,0,['mRNA Splicing - Major Pathway']
Sart3,-0.028877636,0.39296007,0,
Sash1,-0.2671285,-0.03981392,2,
Sash3,0.1687998,-0.12999687,1,
Sass6,0.11698902,0.06841066,3,
Sat1,-0.1463734,0.045503885,2,['Interconversion of polyamines']
Sat2,-0.14466098,0.122131124,2,
Satb1,0.24743246,0.29633197,3,"['Apoptotic cleavage of cellular proteins', 'SUMOylation of chromatin organization proteins']"
Satb2,0.23230258,0.094416164,3,['SUMOylation of chromatin organization proteins']
Satl1,-0.09023659,-0.2004211,2,
Sav1,0.051042695,0.09008655,3,['Signaling by Hippo']
Saysd1,-0.29015478,-0.1711412,2,
Sbds,-0.03506718,0.22372387,0,
Sbf1,-0.074486606,-0.11299907,2,"['Synthesis of PIPs at the ER membrane', 'RAB GEFs exchange GTP for GDP on RABs']"
Sbf2,0.081039295,-0.059039444,1,['RAB GEFs exchange GTP for GDP on RABs']
Sbk1,-0.18696441,0.0029764776,2,
Sbk2,0.11231685,0.06214183,3,
Sbno1,-0.12979685,0.26269042,2,
Sbp,-0.21155629,-0.20686847,2,
Sbsn,-0.2813212,-0.0011838239,2,
Sbspon,0.04786404,-0.07961397,1,['O-glycosylation of TSR domain-containing proteins']
Sc5d,-0.29805923,-0.011378874,2,"['Cholesterol biosynthesis via desmosterol', 'Cholesterol biosynthesis via lathosterol']"
Scaf1,-0.26404554,0.07123799,2,
Scaf11,-0.009312313,0.27330288,3,
Scaf4,0.11246415,0.19694696,3,
Scaf8,-0.09399737,0.37857723,0,
Scai,-0.16762753,-0.12781683,2,['RHO GTPases Activate Formins']
Scamp1,-0.09369981,-0.12302104,2,['Neutrophil degranulation']
Scamp2,-0.012070139,-0.19678947,2,
Scamp3,-0.04913081,0.00041062856,2,
Scamp5,0.015001433,0.0309259,2,
Scand1,-0.05532273,-0.14863402,2,
Scap,0.010365757,0.040170435,2,['Regulation of cholesterol biosynthesis by SREBP (SREBF)']
Scaper,-0.037467014,0.26583114,3,
Scara3,-0.115717754,0.0959607,2,
Scara5,-0.35158855,-0.075764135,2,
Scarb1,0.21060354,-0.16982721,1,"['Scavenging by Class B Receptors', 'HDL clearance']"
Scarb2,-0.092189886,-0.17301604,2,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Scarf1,-0.071235955,0.089116454,0,
Scarf2,0.046783093,-0.073687546,1,
Sccpdh,-0.22394215,-0.09632856,2,['Platelet degranulation ']
Scd1,-0.063572876,-0.20840493,2,['Fatty acyl-CoA biosynthesis']
Scd2,-0.29202878,-0.24228905,2,
Scd3,-0.22597872,-0.13922405,2,
Scd4,-0.008740912,-0.19516346,1,
Scel,-0.013972661,-0.19087431,1,
Scfd1,-0.1338538,-0.31148124,2,"['COPII-mediated vesicle transport', 'RHOA GTPase cycle']"
Scfd2,-0.24402423,-0.075265914,2,
Scg2,-0.04411802,0.059005197,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Scg3,0.018679723,-0.07415084,2,"['Platelet degranulation ', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Scg5,-0.06803717,-0.09220063,2,
Scgb1a1,0.24335505,-0.017828027,1,
Scgb1b10,-0.10489834,-0.1552475,2,
Scgb1b12,-0.22451423,-0.061042976,2,
Scgb1b18,-0.16581927,0.15327355,2,
Scgb1b19,-0.22563797,0.17046584,2,
Scgb1b20,-0.2704332,-0.12841943,2,
Scgb1b24,-0.20487937,-0.046125248,2,
Scgb1b27,-0.16879138,-0.061162952,2,
Scgb1b29,-0.1670189,-0.13707745,2,
Scgb1b3,-0.10458481,0.07832921,2,
Scgb1b7,-0.15270628,-0.1729605,2,
Scgb2a2,-0.24546477,0.09521076,2,
Scgb2b12,-0.31450155,-0.017859057,2,
Scgb2b15,-0.20598458,-0.14306656,2,
Scgb2b19,-0.104523234,-0.024368279,2,
Scgb2b20,-0.21240571,0.08423473,2,
Scgb2b24,-0.060863856,-0.105629094,1,
Scgb2b26,-0.31312388,0.0635045,2,
Scgb2b27,-0.17031233,-0.15025212,2,
Scgb2b3,-0.22826934,-0.01582367,2,
Scgb2b7,-0.26006508,0.109301046,2,
Scgb3a1,-0.08741832,-0.059058815,2,
Scgb3a2,-0.045780294,-0.012716304,2,
Scgn,-0.19337101,-0.12543161,2,
Schip1,-0.26298827,-0.044769857,2,
Scimp,-0.08895818,-0.07305222,0,
Scin,0.10366437,-0.069474086,1,
Sclt1,0.10228012,-0.13887253,1,['Anchoring of the basal body to the plasma membrane']
Scly,-0.019978736,-0.038230717,0,
Scmh1,0.16076204,0.2744202,3,"['SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Regulation of PTEN gene transcription']"
Scml2,0.041632667,0.059790935,3,
Scn10a,0.18242489,-0.29405233,1,
Scn11a,-0.065426834,-0.18920572,2,
Scn1a,0.14815521,-0.44344082,1,
Scn1b,0.027653454,-0.13349253,2,
Scn2a,0.030133275,-0.14550045,1,
Scn2b,0.096228845,-0.22946882,1,
Scn3a,0.0772685,-0.20757604,1,
Scn3b,-0.07672648,-0.08329079,2,
Scn4a,0.19172698,-0.08975448,1,
Scn4b,0.08104266,-0.16682863,1,
Scn5a,0.22336148,-0.41033635,1,
Scn7a,0.06830504,-0.20669153,1,
Scn8a,0.050698787,-0.18637733,1,
Scn9a,0.108821176,-0.3041465,1,
Scnm1,-0.115618676,0.05588053,2,
Scnn1a,0.34930262,-0.0040129516,3,
Scnn1b,0.25602242,-0.005853677,3,"['Stimuli-sensing channels', 'Sensory perception of salty taste']"
Scnn1g,0.2591082,-0.06231877,1,"['Stimuli-sensing channels', 'Sensory perception of salty taste']"
Sco1,-0.08778088,-0.110900976,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Sco2,0.013396699,0.10527343,3,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Scoc,-0.27084124,0.16604654,2,['Retrograde transport at the Trans-Golgi-Network']
Scp2,-0.072696075,0.0018925917,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'alpha-linolenic acid (ALA) metabolism', 'Beta-oxidation of pristanoyl-CoA', 'Peroxisomal protein import']"
Scp2d1,-0.06598603,0.03579201,2,
Scpep1,-0.15971246,-0.12874794,2,
Scrg1,-0.08178995,-0.03299126,2,
Scrib,0.3583027,-0.010806278,1,"['RHOQ GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle']"
Scrn1,-0.014586034,-0.022219727,2,
Scrn2,-0.020545784,0.13227975,0,
Scrn3,0.014759022,-0.006943417,1,
Scrt1,-0.03866165,0.0096767545,2,
Sct,0.08482893,-0.2034088,1,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Sctr,0.07944532,-0.07628665,1,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Scube1,-0.15920085,0.011625765,2,['Degradation of the extracellular matrix']
Scube2,0.044381578,-0.020622227,1,['Release of Hh-Np from the secreting cell']
Scube3,0.2238981,0.07060859,1,['Degradation of the extracellular matrix']
Scx,-0.07001083,-0.1022019,2,
Scyl1,-0.11936403,0.12918757,0,
Scyl2,-0.17878182,0.16208757,2,
Sdad1,-0.28458336,0.3960708,0,
Sdc1,0.26906025,-0.41062698,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Cell surface interactions at the vascular wall', 'Syndecan interactions', 'Other interleukin signaling', 'Retinoid metabolism and transport']"
Sdc2,0.27777916,-0.40507066,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Cell surface interactions at the vascular wall', 'Syndecan interactions', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'EPHB-mediated forward signaling', 'Post-translational protein phosphorylation', 'Retinoid metabolism and transport']"
Sdc3,0.07635577,-0.2370582,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Cell surface interactions at the vascular wall', 'Syndecan interactions', 'Retinoid metabolism and transport']"
Sdc4,0.3486497,-0.27838272,1,"['A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG biosynthesis', 'HS-GAG degradation', 'Cell surface interactions at the vascular wall', 'Syndecan interactions', 'Retinoid metabolism and transport']"
Sdcbp,0.4092879,-0.2460139,1,"['Ephrin signaling', 'Neurofascin interactions', 'RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death', 'Neutrophil degranulation']"
Sdcbp2,-0.23607644,-0.20813484,2,
Sdccag8,-0.080126025,0.06402439,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Sde2,-0.286277,0.47179812,0,
Sdf2,-0.06251229,0.17058155,2,
Sdf2l1,-0.037887648,-0.011368629,2,
Sdf4,-0.1439838,-0.04772896,2,
Sdha,0.16226576,0.043969557,3,['Citric acid cycle (TCA cycle)']
Sdhaf1,-0.1314868,0.21839254,2,
Sdhaf2,0.021510238,-0.010524761,2,
Sdhaf3,-0.14669083,-0.0040094084,2,
Sdhaf4,-0.08271412,0.10794362,2,
Sdhb,0.024578873,-0.013400464,2,['Citric acid cycle (TCA cycle)']
Sdhc,0.011353398,0.06590876,2,['Citric acid cycle (TCA cycle)']
Sdhd,0.07367822,0.05290166,2,['Citric acid cycle (TCA cycle)']
Sdr16c5,-0.14239617,-0.16225229,2,['RA biosynthesis pathway']
Sdr16c6,-0.1709941,0.07487116,2,
Sdr39u1,-0.3358311,0.038182802,2,
Sdr9c7,-0.12311761,-0.3335937,2,['The canonical retinoid cycle in rods (twilight vision)']
Sds,-0.14427927,0.09882215,2,['Threonine catabolism']
Sdsl,-0.15368654,0.032079842,2,['Threonine catabolism']
Sebox,-0.051798765,-0.10171715,2,
Sec1,-0.1393825,-0.10268091,2,
Sec11a,-0.04395592,-0.10635998,2,"['Synthesis, secretion, and deacylation of Ghrelin']"
Sec11c,-0.12041839,-0.13999036,2,"['Synthesis, secretion, and deacylation of Ghrelin']"
Sec13,0.01738786,0.36919424,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'Amino acids regulate mTORC1', 'EML4 and NUDC in mitotic spindle formation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec14l1,-0.3438634,0.032399278,2,
Sec16a,-0.010104258,0.09901235,2,['COPII-mediated vesicle transport']
Sec16b,-0.14913818,-0.05440575,2,['COPII-mediated vesicle transport']
Sec22a,-0.1009091,-0.07502278,2,['COPII-mediated vesicle transport']
Sec22b,-0.1844999,-0.04524585,2,"['ER-Phagosome pathway', 'COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Sec22c,-0.25431252,-0.14121959,2,['COPII-mediated vesicle transport']
Sec23a,-0.15298589,0.073133714,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec23b,-0.0052445726,0.07345521,2,
Sec23ip,-0.095286034,-0.044791196,2,
Sec24a,-0.14982948,-0.0004981122,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec24b,-0.018558638,-0.012965452,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec24c,-0.089311585,-0.105801605,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec24d,0.004696392,0.012090712,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Cargo concentration in the ER', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec31a,-0.0411147,0.005686431,2,"['COPII-mediated vesicle transport', 'MHC class II antigen presentation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Sec31b,-0.07062406,0.17427412,2,
Sec61a1,0.008023967,0.1642027,0,
Sec61a2,-0.20533103,0.113997824,0,
Sec61b,-0.08385351,0.20097977,0,
Sec61g,-0.019701103,0.2161403,0,['Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']
Sec62,-0.07547863,0.011554567,2,
Sec63,0.034578115,0.19887711,0,
Secisbp2,-0.20540892,0.043410942,2,
Secisbp2l,-0.21823575,0.02788967,2,
Sectm1a,-0.08360653,-0.10643414,2,
Seh1l,0.01281416,0.3796508,0,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'Postmitotic nuclear pore complex (NPC) reformation', 'Amino acids regulate mTORC1', 'EML4 and NUDC in mitotic spindle formation']"
Sel1l,0.12861747,0.0411016,3,"['ABC-family proteins mediated transport', 'Hedgehog ligand biogenesis']"
Sel1l2,-0.063073836,0.035405405,2,
Sele,0.26178774,-0.072940394,1,
Selenbp1,0.004556474,-0.15769298,1,
Selenbp2,-0.023241205,-0.076468036,2,
Selenof,-0.08529574,-0.036172945,2,
Selenoh,-0.27844253,-0.067176975,2,
Selenoi,-0.1980439,-0.29163203,2,['Synthesis of PE']
Selenok,-0.15460423,-0.16376568,2,
Selenom,-0.12473869,-0.12461475,2,
Selenon,-0.07474876,-0.33056262,1,
Selenoo,-0.15502536,-0.23900203,2,
Selenop,0.04613967,-0.25870106,1,['Platelet degranulation ']
Selenos,-0.064230844,-0.15278777,2,
Selenot,-0.0037718967,-0.17581485,2,
Selenov,-0.1443736,-0.051214144,2,
Selenow,-0.1913123,-0.18297315,2,
Sell,0.27477866,-0.20861273,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'Neutrophil degranulation']"
Selp,0.38082832,-0.19477089,1,"['Platelet degranulation ', 'Cell surface interactions at the vascular wall']"
Selplg,0.054087706,-0.28026867,1,
Sem1,0.19795023,0.29632962,3,
Sema3a,0.20864126,-0.15293053,1,
Sema3b,-0.082042165,-0.39892173,1,
Sema3c,-0.012176529,-0.16274163,1,
Sema3d,-0.13841872,-0.29194248,2,
Sema3e,-0.16472888,-0.31472063,2,['Other semaphorin interactions']
Sema3f,0.009974869,-0.2330133,1,
Sema3g,-0.03469474,-0.116106525,2,
Sema4a,-0.1149895,-0.18003969,2,['Other semaphorin interactions']
Sema4b,0.02186876,-0.07110771,1,
Sema4c,-0.095505334,-0.13932002,2,
Sema4d,0.119788416,0.007994695,1,"['Sema4D mediated inhibition of cell attachment and migration', 'Sema4D induced cell migration and growth-cone collapse', 'Other semaphorin interactions']"
Sema4f,-0.23571227,-0.20405681,2,['RND3 GTPase cycle']
Sema4g,-0.15227576,-0.11183453,2,
Sema5a,0.026214685,-0.17940325,1,
Sema5b,0.041280422,-0.09571823,1,['O-glycosylation of TSR domain-containing proteins']
Sema6a,-0.14168896,-0.3160401,1,
Sema6b,0.027043588,-0.30523947,1,
Sema6c,-0.070131846,-0.28284597,1,
Sema6d,0.0037945595,-0.22775802,1,['Other semaphorin interactions']
Sema7a,0.056509193,-0.31197575,1,['Other semaphorin interactions']
Semg1,-0.3011168,0.21870655,2,
Semp2l1,0.013594219,0.16615166,3,
Semp2l2a,-0.10750141,0.19029568,2,
Semp2l2b,-0.11868841,0.20766397,2,
Senp1,0.110866226,0.32133958,3,"['SUMO is proteolytically processed', 'RHOF GTPase cycle']"
Senp2,0.08874307,0.2950661,3,['SUMO is proteolytically processed']
Senp3,0.14034516,0.45532238,3,['Major pathway of rRNA processing in the nucleolus and cytosol']
Senp5,0.21732253,0.47556943,3,['SUMO is proteolytically processed']
Senp6,0.13550732,0.32919103,3,
Senp7,-0.046435192,0.30496094,3,
Senp8,0.06574776,0.106157005,3,"['UCH proteinases', 'Neddylation']"
Sephs1,-0.004326656,0.19037855,3,
Sephs2,-0.22564277,-0.109730236,2,['Selenocysteine synthesis']
Sepsecs,-0.22961271,-0.0054965783,2,
Septin1,0.020568348,-0.22735074,1,
Septin10,-0.036744934,-0.15159483,2,
Septin11,-0.089022204,-0.17904176,2,
Septin12,-0.000414085,0.079633944,2,
Septin14,-0.0867144,-0.06001133,2,
Septin2,-0.00461336,-0.1741724,1,['Anchoring of the basal body to the plasma membrane']
Septin3,-0.030282274,-0.072412565,2,
Septin4,0.10775924,0.060494676,3,"['Release of apoptotic factors from the mitochondria', 'SMAC, XIAP-regulated apoptotic response']"
Septin5,-0.09627058,-0.1106147,2,
Septin6,0.050899368,-0.1628819,1,
Septin7,0.099300735,-0.006855908,3,
Septin8,-0.120578684,-0.10358933,2,
Septin9,0.15765446,-0.047823153,1,
Serac1,-0.12205249,0.1023917,2,
Serbp1,0.044810012,0.34184304,0,
Serf2,0.0015319277,-0.12412366,2,
Sergef,-0.10970684,0.09118707,2,
Serhl,-0.16062681,-0.12503876,2,
Serinc1,-0.038555156,-0.10729776,2,['Serine biosynthesis']
Serinc4,-0.16445509,-0.08245903,2,['Serine biosynthesis']
Serinc5,-0.15044329,0.12008179,2,['Serine biosynthesis']
Serp1,-0.050589904,0.14833182,0,['Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']
Serp2,-0.1484978,0.004377683,2,
Serpina10,-0.11704458,-0.23048043,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Serpina12,0.1491359,0.052685652,3,
Serpina1a,-0.025417874,-0.08075074,1,
Serpina1b,0.05181823,-0.15910518,1,
Serpina1c,0.22899407,-0.23541127,1,
Serpina1d,0.0116055515,-0.100691,1,
Serpina1e,-0.08218047,-0.060688034,2,
Serpina3a,-0.03751429,-0.02408468,2,
Serpina3b,-0.21972798,0.024639154,2,
Serpina3c,0.065907754,-0.015918184,3,
Serpina3f,-0.17051885,-0.035341404,2,
Serpina3g,-0.1252061,-0.024886651,2,
Serpina3i,-0.15989815,0.0027168605,2,"['Platelet degranulation ', 'Neutrophil degranulation']"
Serpina3k,0.009981318,-0.128313,2,
Serpina3m,-0.08411415,0.08507639,2,
Serpina3n,-0.029058887,-0.06436531,2,
Serpina5,0.19538611,-0.18895786,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation']"
Serpina6,-0.009840521,-0.027068762,2,['Glucocorticoid biosynthesis']
Serpina7,0.09850668,-0.060394254,1,
Serpinb11,-0.087958746,-0.20334804,2,
Serpinb13,0.019806162,-0.21508306,1,['RUNX1 regulates transcription of genes involved in differentiation of keratinocytes']
Serpinb1a,0.20523022,0.014381181,1,['Neutrophil degranulation']
Serpinb1b,0.18214765,-0.15956447,1,
Serpinb1c,0.061128933,-0.19576249,1,
Serpinb2,0.22295837,-0.16700964,1,['Dissolution of Fibrin Clot']
Serpinb3a,-0.05196903,0.060732782,2,['Neutrophil degranulation']
Serpinb3b,-0.1498917,-0.115646794,2,['Neutrophil degranulation']
Serpinb3c,0.2055384,-0.22788183,1,['Neutrophil degranulation']
Serpinb3d,-0.18347184,-0.16165583,2,['Neutrophil degranulation']
Serpinb5,0.40175724,-0.10519034,1,
Serpinb6a,0.13112564,-0.16100472,1,"['Neutrophil degranulation', 'Dissolution of Fibrin Clot']"
Serpinb6b,0.06941145,-0.11248163,1,
Serpinb6c,0.25468898,-0.103456296,1,
Serpinb6e,0.06733821,-0.1475251,1,
Serpinb7,0.11090138,-0.067270994,1,
Serpinb8,0.16888592,-0.090752944,1,['Dissolution of Fibrin Clot']
Serpinb9,0.14558187,-0.049974773,1,
Serpinb9b,0.3659559,-0.033647615,1,
Serpinb9c,0.09138584,-0.032266572,1,
Serpinb9d,0.19396156,-0.06385594,1,
Serpinb9e,0.19535814,-0.012511778,1,
Serpinb9f,0.13315831,-0.15804256,1,
Serpinb9g,0.0818085,-0.119194135,1,
Serpinc1,0.1207119,-0.14319573,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Serpind1,0.075948924,-0.16718122,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Serpine1,0.41931775,-0.17039219,1,
Serpine2,0.2660812,-0.08653286,1,"['Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Dissolution of Fibrin Clot']"
Serpine3,-0.08519076,-0.0027457336,2,
Serpinf1,0.022962125,-0.1361663,2,
Serpinf2,0.12049364,-0.19931884,1,"['Platelet degranulation ', 'Dissolution of Fibrin Clot']"
Serping1,0.12554061,-0.18425147,1,"['Platelet degranulation ', 'Intrinsic Pathway of Fibrin Clot Formation', 'Regulation of Complement cascade']"
Serpinh1,0.0022269373,-0.27263057,1,['Collagen biosynthesis and modifying enzymes']
Serpini1,-0.13336457,-0.15387693,2,
Serpini2,-0.15535468,-0.005049234,2,
Sertad1,-0.1379851,0.15255222,2,
Sertad4,-0.17381267,-0.21672645,2,
Sesn1,-0.0032942046,0.022814026,2,"['TP53 Regulates Metabolic Genes', 'Amino acids regulate mTORC1', 'KEAP1-NFE2L2 pathway']"
Sesn2,0.119881526,0.07710911,3,"['TP53 Regulates Metabolic Genes', 'Amino acids regulate mTORC1', 'KEAP1-NFE2L2 pathway']"
Sesn3,0.077901475,0.06511839,1,['TP53 Regulates Metabolic Genes']
Sestd1,-0.20143962,-0.093629666,2,
Set,0.3586094,0.3844001,3,"['Condensation of Prophase Chromosomes', 'HuR (ELAVL1) binds and stabilizes mRNA']"
Setd1a,0.26979023,0.3601714,3,"['PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Setd1b,0.1185965,0.30942616,3,"['PKMTs methylate histone lysines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function']"
Setd2,0.31032044,0.349896,3,['PKMTs methylate histone lysines']
Setd3,-0.110441566,0.14439282,2,['PKMTs methylate histone lysines']
Setd5,0.1411956,0.2173734,3,
Setd6,0.12999563,0.14356315,3,['PKMTs methylate histone lysines']
Setd7,0.38887852,0.23283744,3,['PKMTs methylate histone lysines']
Setdb1,0.30765602,0.13093771,3,
Setdb2,-0.03775902,0.37116647,3,['PKMTs methylate histone lysines']
Setmar,-0.20705737,0.22598061,2,
Setx,0.14683892,0.53671753,0,
Sez6l2,0.047589023,-0.014304161,3,
Sf1,-0.10211778,0.508085,0,
Sf3a1,-0.24325705,0.44868106,0,['mRNA Splicing - Major Pathway']
Sf3a2,-0.08384956,0.3452801,0,
Sf3a3,-0.09499265,0.53965,0,['mRNA Splicing - Major Pathway']
Sf3b1,-0.05355714,0.6229984,0,
Sf3b2,0.036610987,0.58646786,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Sf3b3,0.045408383,0.4684064,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Sf3b4,-0.020318624,0.39744362,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Sf3b5,0.03466531,0.50483483,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Sf3b6,-0.03732204,0.39837766,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Sfi1,-0.13172084,0.28644606,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Sfmbt1,-0.0036064961,0.1033508,3,
Sfn,0.5595122,0.11581997,3,"['Activation of BAD and translocation to mitochondria ', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'Regulation of localization of FOXO transcription factors']"
Sfpq,0.1433031,0.30790815,0,['PTK6 Regulates Proteins Involved in RNA Processing']
Sfr1,-0.07788145,0.22178039,3,
Sfrp1,0.026680432,-0.08933368,2,
Sfrp2,0.042718448,-0.12400241,2,
Sfrp4,0.03994086,0.015607019,2,
Sfrp5,-0.2426431,-0.10680554,2,
Sfswap,0.105108045,0.3227601,0,
Sft2d1,-0.22023645,0.14921586,2,
Sftpa1,0.013008614,-0.044174626,1,
Sftpc,-0.012781146,-0.15942924,1,
Sftpd,-0.021139054,0.08049702,2,"['Toll Like Receptor 4 (TLR4) Cascade', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Signal regulatory protein family interactions', 'Surfactant metabolism', 'Regulation of TLR by endogenous ligand']"
Sfxn1,-0.29442397,-0.038794663,2,
Sfxn2,-0.10686913,0.053852465,2,
Sfxn3,-0.2756737,-0.017697075,2,
Sfxn5,-0.09289325,0.12835123,0,
Sgca,-0.07356066,-0.21372679,2,
Sgcb,0.10934334,-0.10234078,1,
Sgcd,0.09053572,-0.19978051,1,
Sgce,0.12169759,-0.09859681,1,
Sgcg,0.03581765,-0.1311454,1,
Sgcz,0.019292217,-0.084927745,2,
Sgf29,0.19310598,0.19139715,3,
Sgip1,0.19678788,-0.22334628,1,
Sgk1,0.48666945,0.014701614,3,"['Stimuli-sensing channels', 'Regulation of TP53 Degradation', 'NGF-stimulated transcription']"
Sgk2,0.3415433,0.08166508,3,['Stimuli-sensing channels']
Sgk3,0.39512008,0.04241525,3,['Stimuli-sensing channels']
Sgms1,-0.2585403,-0.015580986,2,['Sphingolipid de novo biosynthesis']
Sgms2,-0.35829848,-0.016967706,2,['Sphingolipid de novo biosynthesis']
Sgo1,0.15913254,0.4089205,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Sgo2a,0.13958749,0.41373816,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Sgo2b,-0.19836667,-0.02819039,2,
Sgpl1,-0.23059605,-0.18822485,2,['Sphingolipid de novo biosynthesis']
Sgpp1,-0.10048309,0.03752327,2,['Sphingolipid de novo biosynthesis']
Sgpp2,-0.35472244,-0.06484802,2,['Sphingolipid de novo biosynthesis']
Sgsh,-0.40852034,-0.00013721877,2,['HS-GAG degradation']
Sgsm1,-0.22976702,-0.085160136,2,
Sgsm2,-0.36643496,-0.15172444,2,
Sgta,-0.11315499,0.11147813,2,['Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']
Sgtb,-0.2888557,-0.027743299,2,
Sh2b1,0.1700685,-0.32214284,1,"['Prolactin receptor signaling', 'Growth hormone receptor signaling', 'Factors involved in megakaryocyte development and platelet production']"
Sh2b2,0.25238732,-0.18300693,1,"['Regulation of KIT signaling', 'Factors involved in megakaryocyte development and platelet production']"
Sh2b3,0.15423821,-0.32501626,1,"['Regulation of KIT signaling', 'Negative regulation of FLT3', 'Factors involved in megakaryocyte development and platelet production']"
Sh2d1a,0.11623736,-0.14361711,1,
Sh2d1b2,0.21127963,-0.10334652,1,
Sh2d2a,0.19828165,-0.20186989,1,['VEGFA-VEGFR2 Pathway']
Sh2d3c,0.30539137,0.07156352,3,
Sh2d4a,-0.19317175,-0.068431936,2,
Sh2d4b,-0.017144708,0.13741383,0,
Sh2d5,-0.044285826,-0.14349924,1,
Sh2d6,-0.20422311,0.055410214,2,
Sh3bgr,-0.10754036,-0.15921001,2,
Sh3bp2,0.43328598,-0.10319591,1,
Sh3bp4,-0.27372766,-0.026671289,2,['Amino acids regulate mTORC1']
Sh3bp5,0.053663384,-0.28400558,1,
Sh3d19,-0.041730445,-0.18114059,2,['Golgi Associated Vesicle Biogenesis']
Sh3gl1,0.17833339,-0.3046807,1,"['EGFR downregulation', 'Negative regulation of MET activity', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Sh3gl2,0.17750716,-0.31010723,1,"['Retrograde neurotrophin signalling', 'EGFR downregulation', 'MHC class II antigen presentation', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Recycling pathway of L1', 'Negative regulation of MET activity', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Sh3gl3,0.17989855,-0.34598434,1,
Sh3glb1,0.07963978,-0.27978763,1,
Sh3glb2,-0.02539808,-0.27043092,1,"['Caspase-mediated cleavage of cytoskeletal proteins', 'Neurexins and neuroligins', 'Neutrophil degranulation']"
Sh3kbp1,0.39974916,-0.24579205,1,"['EGFR downregulation', 'Negative regulation of MET activity', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Reelin signalling pathway', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Sh3pxd2a,0.30014345,-0.22908801,1,['Invadopodia formation']
Sh3pxd2b,-0.113817535,-0.20554629,2,
Sh3rf1,0.20356081,-0.018586414,3,
Sh3rf2,-0.14728516,-0.057035126,2,
Sh3rf3,-0.23633602,-0.11187497,2,
Sh3tc1,-0.14811313,-0.06404421,2,
Sh3tc2,-0.078027956,0.2287081,0,
Sh3yl1,-0.053773098,-0.18885204,2,
Shank1,0.12867098,-0.22788337,1,['Neurexins and neuroligins']
Shank2,0.25089,-0.1749953,1,['Neurexins and neuroligins']
Shank3,0.39829624,-0.13043885,1,"['Neurexins and neuroligins', 'RET signaling']"
Sharpin,0.2754743,-0.0412823,1,"['Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway']"
Shb,0.42683005,-0.1670953,1,['VEGFA-VEGFR2 Pathway']
Shbg,0.110577166,-0.23202176,1,
Shc1,0.5886243,-0.25960135,1,"['SHC1 events in ERBB2 signaling', 'SHC1 events in ERBB4 signaling', 'Signalling to RAS', 'SHC1 events in EGFR signaling', 'Signaling by ALK', 'Tie2 Signaling', 'DAP12 signaling', 'SHC-related events triggered by IGF1R', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'Integrin signaling', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'SHC-mediated cascade:FGFR1', 'SHC-mediated cascade:FGFR2', 'SHC-mediated cascade:FGFR3', 'SHC-mediated cascade:FGFR4', 'RAF/MAP kinase cascade', 'Signal attenuation', 'Insulin receptor signalling cascade', 'MET activates RAS signaling', 'RET signaling', 'Interleukin-15 signaling', 'Extra-nuclear estrogen signaling', 'Interleukin-2 signaling', 'Erythropoietin activates RAS', 'Interleukin receptor SHC signaling', 'GPER1 signaling', 'Signaling by CSF3 (G-CSF)']"
Shc3,0.37676865,-0.31039423,1,"['Signalling to RAS', 'RAF/MAP kinase cascade', 'RET signaling']"
Shc4,0.4555563,-0.3296051,1,
Shcbp1,0.29605436,0.251142,3,
Shf,0.1172363,-0.1371537,1,
Shh,0.41613722,-0.04005685,3,"['Hedgehog ligand biogenesis', 'Release of Hh-Np from the secreting cell', 'Ligand-receptor interactions', 'Activation of SMO']"
Shisa3,0.0036610896,-0.026170094,2,
Shisa4,-0.16754882,-0.12899095,2,
Shisa6,0.12318063,-0.1619683,1,
Shisa9,0.0014059598,-0.13577653,2,
Shisal1,0.0061491835,0.060219772,2,
Shisal2a,-0.16281988,-0.04342359,2,
Shisal2b,-0.14707588,0.09947817,2,
Shkbp1,-0.053556018,-0.0030576657,2,
Shld1,-0.09050503,-0.02542013,2,
Shld2,-0.13242841,0.005442888,2,
Shmt1,-0.07521047,-0.03609907,2,"['Metabolism of folate and pterines', 'Carnitine synthesis']"
Shmt2,0.009758155,0.12295673,0,"['Metabolism of folate and pterines', 'RHOG GTPase cycle']"
Shoc1,-0.3537557,0.21355169,2,
Shoc2,0.26669943,-0.22304928,1,['RAF activation']
Shox2,-0.05228492,-0.029339783,2,
Shpk,-0.08793339,0.024171954,2,['Pentose phosphate pathway']
Shprh,-0.04368447,0.34562722,3,['E3 ubiquitin ligases ubiquitinate target proteins']
Shq1,-0.011064066,0.2676103,0,['Telomere Extension By Telomerase']
Shroom2,0.0835829,-0.064364225,1,
Shroom3,0.12644261,0.13473067,3,
Shtn1,-0.060770333,-0.18366255,2,
Siae,-0.16364467,-0.09104638,2,
Siah1a,0.27279624,0.06896773,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Siah1b,-0.008170704,0.040160704,3,
Siah2,0.18059528,0.06519469,3,"['Ub-specific processing proteases', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Siah3,0.1037819,-0.031404283,1,
Sigirr,0.0799522,-0.06931677,1,
Siglec1,0.22104093,-0.0849427,1,
Siglec15,-0.040691003,-0.16863595,1,['DAP12 interactions']
Siglece,0.1379862,-0.033962052,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Siglecf,-0.0071627595,-0.13673285,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Siglecg,0.06833045,-0.08385824,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'DAP12 interactions']"
Siglech,-0.010671506,-0.07738026,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Neutrophil degranulation']"
Sigmar1,0.1441971,-0.13126376,1,
Sik1,0.16349258,0.17264125,3,
Sik2,0.15514424,-0.1476657,3,
Sik3,0.1630754,-0.11324173,3,
Sike1,0.24245486,0.076946355,3,
Sil1,-0.06957081,0.2659267,0,
Sim1,0.007068627,-0.19770634,2,
Sim2,-0.01811469,0.05806234,2,
Sin3a,0.45070675,0.38112965,3,"['SUMOylation of transcription cofactors', 'Regulation of lipid metabolism by PPARalpha', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Regulation of MECP2 expression and activity', 'Cytoprotection by HMOX1']"
Sin3b,0.3267658,0.42195502,3,"['Regulation of lipid metabolism by PPARalpha', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Cytoprotection by HMOX1']"
Sinhcaf,0.1576348,0.3691313,3,
Sipa1,0.065393895,-0.08723016,1,
Sipa1l1,-0.13740419,-0.20719174,2,
Sipa1l2,0.11515367,0.04504498,3,
Sipa1l3,-0.122255735,0.08156815,2,
Sirpa,0.14365849,-0.39279056,1,"['Cell surface interactions at the vascular wall', 'DAP12 interactions', 'Signal regulatory protein family interactions', 'Neutrophil degranulation']"
Sirpb1a,0.09234095,-0.18533115,1,"['Cell surface interactions at the vascular wall', 'DAP12 interactions', 'Signal regulatory protein family interactions', 'Neutrophil degranulation']"
Sirpb1b,-0.10739887,-0.1558545,2,"['Cell surface interactions at the vascular wall', 'DAP12 interactions', 'Signal regulatory protein family interactions', 'Neutrophil degranulation']"
Sirpb1c,0.018021246,-0.22445709,1,"['Cell surface interactions at the vascular wall', 'DAP12 interactions', 'Signal regulatory protein family interactions', 'Neutrophil degranulation']"
Sirt1,0.57643825,0.19564475,3,"['Regulation of HSF1-mediated heat shock response', 'Regulation of FOXO transcriptional activity by acetylation']"
Sirt2,0.2745153,0.19371429,3,['Initiation of Nuclear Envelope (NE) Reformation']
Sirt3,0.16942792,0.22066076,3,"['Transcriptional activation of mitochondrial biogenesis', 'Regulation of FOXO transcriptional activity by acetylation']"
Sirt4,0.0745406,-0.027174685,3,['Transcriptional activation of mitochondrial biogenesis']
Sirt5,0.23410425,0.2477302,3,['Transcriptional activation of mitochondrial biogenesis']
Sirt6,0.3394618,0.28928915,3,['Processing of DNA double-strand break ends']
Sirt7,0.27770367,0.18924758,3,
Sis,-0.19337924,-0.0068601016,2,['Digestion of dietary carbohydrate']
Siva1,0.0722307,-0.031851333,2,
Six1,0.11839478,-0.03963592,3,
Six2,-0.03673437,-0.021284183,2,
Six3,0.14548798,0.18108478,3,
Six4,-0.039725974,0.109415516,3,
Six5,-0.17586173,0.16940814,2,
Six6,0.029205548,0.09781528,3,
Ska1,0.19369027,0.3433307,3,
Ska2,0.020374529,0.22457887,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Ska3,0.050616328,0.29058802,3,
Skap1,0.26225427,-0.1558807,1,
Skap2,-0.055553988,-0.3693524,1,['Signal regulatory protein family interactions']
Ski,0.33268413,0.07862057,3,
Skida1,-0.19609983,-0.1544464,2,
Skil,0.31613037,0.1787884,3,['Downregulation of SMAD2/3:SMAD4 transcriptional activity']
Skint11,-0.32164598,-0.22251756,2,
Skint7,-0.25840175,-0.078391336,2,
Skiv2l,-0.17676382,0.22276038,0,"[""mRNA decay by 3' to 5' exoribonuclease""]"
Skor1,0.19345655,0.08248047,3,
Skor2,0.07582526,-0.124411896,2,
Skp1,0.45961225,0.15207124,3,"['Activation of NF-kappaB in B cells', 'Prolactin receptor signaling', 'SCF-beta-TrCP mediated degradation of Emi1', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'Downstream TCR signaling', 'Regulation of PLK1 Activity at G2/M Transition', 'FCERI mediated NF-kB activation', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Orc1 removal from chromatin', 'Cyclin D associated events in G1', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Regulation of RUNX2 expression and activity', 'Neddylation', 'Interleukin-1 signaling', 'Iron uptake and transport', 'Regulation of BACH1 activity', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Skp2,0.6272765,0.23451772,3,"['APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'SCF(Skp2)-mediated degradation of p27/p21', 'Ub-specific processing proteases', 'Orc1 removal from chromatin', 'Cyclin D associated events in G1', 'Regulation of RUNX2 expression and activity', 'Neddylation', 'Regulation of BACH1 activity', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Sla,0.06207893,-0.43622914,1,['Negative regulation of FLT3']
Sla2,0.17631021,-0.30918214,1,['Negative regulation of FLT3']
Slain1,-0.37599695,0.21953155,2,
Slain2,-0.16670717,0.10103541,2,
Slamf1,0.2061451,-0.11585367,1,
Slamf6,0.112357296,-0.12244031,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Slamf7,-0.112391934,0.016511152,2,
Slamf9,-0.13276404,-0.04062177,2,
Slbp,0.019867282,0.6124828,0,"['Transport of the SLBP Dependant Mature mRNA', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Slc10a1,0.06590642,-0.12345346,1,['Recycling of bile acids and salts']
Slc10a2,-0.06311068,-0.12100818,2,['Recycling of bile acids and salts']
Slc10a3,-0.2514591,0.029981617,2,
Slc10a4,-0.19616836,0.04902218,2,
Slc10a5,-0.28949293,0.05206044,2,
Slc10a6,-0.12685175,0.033176307,2,"['Transport of bile salts and organic acids, metal ions and amine compounds']"
Slc10a7,-0.16518527,0.073355675,2,
Slc11a1,0.09877448,-0.14019883,1,"['ROS and RNS production in phagocytes', 'Metal ion SLC transporters', 'Neutrophil degranulation', 'Ion influx/efflux at host-pathogen interface']"
Slc11a2,0.0132641485,0.10870262,2,"['Metal ion SLC transporters', 'Iron uptake and transport']"
Slc12a1,-0.060765233,-0.0016523211,2,
Slc12a2,0.15174595,-0.2523014,1,
Slc12a3,0.04208465,0.051291242,2,['Cation-coupled Chloride cotransporters']
Slc12a4,0.20698637,0.037254594,1,['Cation-coupled Chloride cotransporters']
Slc12a5,0.18937592,-0.075344406,1,['Cation-coupled Chloride cotransporters']
Slc12a6,-0.008639025,-0.09582137,2,['Cation-coupled Chloride cotransporters']
Slc12a7,-0.05436967,0.0012262354,2,['Cation-coupled Chloride cotransporters']
Slc12a9,-0.33643386,0.074304275,2,
Slc13a1,-0.28070658,0.02795431,2,"['Sodium-coupled sulphate, di- and tri-carboxylate transporters']"
Slc13a3,0.05460837,-0.05085041,1,"['Sodium-coupled sulphate, di- and tri-carboxylate transporters']"
Slc13a4,-0.063041896,0.019323107,2,"['Sodium-coupled sulphate, di- and tri-carboxylate transporters']"
Slc14a2,-0.15560658,-0.058196254,2,
Slc15a1,-0.23354365,-0.2849499,2,['Proton/oligopeptide cotransporters']
Slc15a2,-0.11453552,0.10657903,2,
Slc15a3,-0.18177544,-0.1675974,2,['Proton/oligopeptide cotransporters']
Slc15a4,-0.26607502,-0.0084582,0,"['Proton/oligopeptide cotransporters', 'Neutrophil degranulation']"
Slc16a1,-0.104425095,-0.087518655,2,
Slc16a10,0.005419807,-0.04048509,2,['Amino acid transport across the plasma membrane']
Slc16a12,-0.23076199,-0.10641495,2,
Slc16a14,0.0010732774,0.058172584,3,
Slc16a2,0.035935406,0.048067074,2,['Transport of organic anions']
Slc16a3,0.04266585,0.04379673,3,
Slc16a5,-0.08431777,0.035917,2,
Slc16a7,-0.2762454,-0.13624051,2,['Proton-coupled monocarboxylate transport']
Slc16a8,-0.08751499,0.009563037,2,
Slc16a9,-0.23683944,0.17716528,2,
Slc17a1,-0.34035218,-0.09934324,2,['Organic anion transporters']
Slc17a3,-0.33167332,0.04424626,2,['Stimuli-sensing channels']
Slc17a4,-0.3789229,0.10440125,2,
Slc17a5,-0.34943458,-0.11496229,2,"['Sialic acid metabolism', 'Organic anion transporters']"
Slc17a6,0.03531151,-0.28338972,1,
Slc17a7,0.013128187,-0.49519685,1,"['Glutamate Neurotransmitter Release Cycle', 'Organic anion transporters']"
Slc17a8,-0.186196,-0.22364566,2,['Organic anion transporters']
Slc18a1,-0.076478615,-0.32510376,2,['Na+/Cl- dependent neurotransmitter transporters']
Slc18a2,0.11596259,-0.2350638,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc18a3,0.10825894,-0.29169634,1,
Slc18b1,-0.32526475,0.007547697,2,
Slc19a1,-0.05646259,-0.083440624,2,['Metabolism of folate and pterines']
Slc19a2,-0.31049365,0.11478574,2,['Vitamin B1 (thiamin) metabolism']
Slc19a3,-0.29085264,-0.0073368405,2,['Vitamin B1 (thiamin) metabolism']
Slc1a1,-0.42390278,-0.097562365,2,"['Glutamate Neurotransmitter Release Cycle', 'Transport of inorganic cations/anions and amino acids/oligopeptides']"
Slc1a2,0.046592068,-0.26594678,1,"['Astrocytic Glutamate-Glutamine Uptake And Metabolism', 'Glutamate Neurotransmitter Release Cycle', 'Transport of inorganic cations/anions and amino acids/oligopeptides']"
Slc1a3,0.12944987,-0.22012323,1,"['Astrocytic Glutamate-Glutamine Uptake And Metabolism', 'Glutamate Neurotransmitter Release Cycle', 'Transport of inorganic cations/anions and amino acids/oligopeptides']"
Slc1a4,-0.20572673,0.17246616,2,['Amino acid transport across the plasma membrane']
Slc1a5,-0.114015356,0.029492276,2,
Slc1a6,-0.08294623,-0.013535309,2,"['Glutamate Neurotransmitter Release Cycle', 'Transport of inorganic cations/anions and amino acids/oligopeptides']"
Slc1a7,-0.13048622,-0.05963326,2,"['Glutamate Neurotransmitter Release Cycle', 'Transport of inorganic cations/anions and amino acids/oligopeptides']"
Slc20a1,-0.31954938,-0.01053659,2,['Sodium-coupled phosphate cotransporters']
Slc20a2,-0.095985204,-0.2277279,2,['Sodium-coupled phosphate cotransporters']
Slc22a1,-0.33054906,-0.09378724,2,"['Neurotransmitter clearance', 'Norepinephrine Neurotransmitter Release Cycle', 'Abacavir transmembrane transport', 'Na+/Cl- dependent neurotransmitter transporters', 'Organic cation transport']"
Slc22a12,-0.21731064,0.021368511,2,
Slc22a13,-0.1422605,-0.093438216,2,['Nicotinamide salvaging']
Slc22a15,-0.24125527,-0.042875495,2,['Organic cation transport']
Slc22a16,-0.4084573,0.031028977,2,['Organic cation transport']
Slc22a17,-0.019036755,-0.14367789,1,['Iron uptake and transport']
Slc22a18,-0.04534048,-0.03890164,2,
Slc22a2,-0.047242675,-0.1207487,2,"['Neurotransmitter clearance', 'Norepinephrine Neurotransmitter Release Cycle', 'Abacavir transmembrane transport', 'Na+/Cl- dependent neurotransmitter transporters', 'Organic cation transport']"
Slc22a21,-0.14160694,-0.16840033,2,
Slc22a23,-0.36898637,-0.016234603,2,
Slc22a26,-0.33647445,-0.19109295,2,
Slc22a3,-0.31298104,-0.17720413,2,"['Abacavir transmembrane transport', 'Organic cation transport']"
Slc22a30,-0.13414083,0.038921867,0,
Slc22a5,-0.18758905,0.14003226,2,"['Carnitine metabolism', 'Organic cation transport']"
Slc22a6,-0.30109516,0.027355233,2,['Organic anion transport']
Slc22a7,-0.2260936,0.11457145,2,
Slc22a8,-0.18285437,0.17624688,0,['Organic anion transport']
Slc23a1,-0.25225234,-0.13171577,2,['Vitamin C (ascorbate) metabolism']
Slc23a2,-0.12281372,-0.14708342,2,['Vitamin C (ascorbate) metabolism']
Slc24a1,-0.2573097,0.09538973,2,['Sodium/Calcium exchangers']
Slc24a2,-0.19045316,-0.05520765,2,['Sodium/Calcium exchangers']
Slc24a3,-0.20646718,-0.18422084,2,['Sodium/Calcium exchangers']
Slc24a4,-0.1137521,-0.22482094,2,['Sodium/Calcium exchangers']
Slc24a5,-0.16894163,-0.15934479,2,['Sodium/Calcium exchangers']
Slc25a1,-0.16887721,-0.2103206,2,"['Gluconeogenesis', 'Fatty acyl-CoA biosynthesis']"
Slc25a10,-0.13534704,-0.22130692,2,"['Sulfide oxidation to sulfate', 'Organic anion transporters', 'Gluconeogenesis']"
Slc25a11,0.07512189,0.08446606,0,['Gluconeogenesis']
Slc25a12,-0.04301084,-0.030973665,2,"['Gluconeogenesis', 'Aspartate and asparagine metabolism']"
Slc25a13,-0.10781849,0.008474142,2,"['Gluconeogenesis', 'Aspartate and asparagine metabolism']"
Slc25a14,-0.33179095,0.15517758,2,"['The fatty acid cycling model', 'The proton buffering model']"
Slc25a17,-0.32535496,0.07149477,2,"['Alpha-oxidation of phytanate', 'Class I peroxisomal membrane protein import']"
Slc25a18,-0.2333962,-0.01989853,2,['Organic anion transporters']
Slc25a19,-0.1571645,-0.014319857,2,['Vitamin B1 (thiamin) metabolism']
Slc25a20,-0.040397644,-0.05524178,2,['Carnitine metabolism']
Slc25a21,-0.4292043,-0.13596544,2,['Lysine catabolism']
Slc25a22,-0.30904746,0.06932954,2,['Organic anion transporters']
Slc25a23,-0.032299735,-0.10552554,2,
Slc25a24,-0.1147875,-0.0047810385,2,
Slc25a25,-0.1757782,0.16408245,0,
Slc25a28,-0.16278976,-0.04745518,2,
Slc25a29,-0.043906752,-0.025507066,2,['Amino acid transport across the plasma membrane']
Slc25a3,0.0072638877,-0.058233302,2,
Slc25a30,0.08152619,-0.08657261,1,
Slc25a31,0.0610925,-0.04708703,2,
Slc25a32,-0.026273066,-0.2415219,2,['Metabolism of folate and pterines']
Slc25a34,-0.13870344,0.07627537,2,
Slc25a35,-0.3147293,-0.13825767,2,
Slc25a36,-0.385468,0.060954846,2,
Slc25a37,0.009781328,0.09903428,0,
Slc25a38,-0.016949855,0.107021,0,
Slc25a39,-0.19694231,0.065600924,2,
Slc25a4,0.043713663,-0.13474813,1,['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane']
Slc25a40,-0.13715607,-0.07461309,2,
Slc25a41,-0.3421218,-0.0030924338,2,
Slc25a42,-0.2586115,-0.08681549,2,
Slc25a44,-0.090715066,0.03343109,2,
Slc25a45,-0.11640509,-0.12692226,2,
Slc25a48,-0.09886818,0.048536826,2,
Slc25a5,0.13989623,0.0002504624,1,['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane']
Slc25a51,-0.14435251,0.11352062,0,
Slc25a54,-0.18521012,-0.030133406,2,
Slc26a1,-0.086618975,-0.043649454,2,"['Transport and synthesis of PAPS', 'Multifunctional anion exchangers']"
Slc26a11,-0.3598046,-0.20254095,2,['Multifunctional anion exchangers']
Slc26a2,-0.10725913,-0.008222683,2,"['Transport and synthesis of PAPS', 'Multifunctional anion exchangers']"
Slc26a3,-0.1686707,-0.16422258,2,['Multifunctional anion exchangers']
Slc26a4,-0.04137567,-0.17925084,2,['Multifunctional anion exchangers']
Slc26a5,0.075214736,0.052149937,3,
Slc26a7,-0.05551753,-0.037843127,2,['Multifunctional anion exchangers']
Slc26a8,-0.066411875,0.06182897,2,
Slc26a9,-0.107274435,-0.051476516,2,
Slc27a1,-0.16901194,-0.118837245,2,['Transport of fatty acids']
Slc27a2,-0.3060037,-0.020305542,2,"['Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Alpha-oxidation of phytanate', 'Neutrophil degranulation', 'Fatty acyl-CoA biosynthesis', 'Peroxisomal protein import']"
Slc27a3,-0.1446221,-0.037372638,2,
Slc27a4,-0.27741715,-0.27091917,2,['Transport of fatty acids']
Slc27a5,-0.071136884,-0.14742322,2,"['Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol']"
Slc27a6,-0.24043836,0.11929298,2,['Transport of fatty acids']
Slc28a1,-0.28099886,-0.26866397,2,['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane']
Slc28a2,-0.2823446,-0.17304514,2,"['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane', 'Azathioprine ADME']"
Slc28a3,-0.18753985,-0.17390539,2,"['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane', 'Azathioprine ADME']"
Slc29a1,-0.17985892,-0.27866736,2,"['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane', 'Azathioprine ADME']"
Slc29a2,-0.22452617,-0.2521769,2,"['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane', 'Azathioprine ADME']"
Slc29a3,-0.39359483,-0.0951987,2,['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane']
Slc29a4,-0.24779983,0.0031145848,2,['Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane']
Slc2a1,0.14278701,-0.10951585,1,"['Cellular hexose transport', 'Vitamin C (ascorbate) metabolism', 'Regulation of insulin secretion', 'Lactose synthesis']"
Slc2a10,-0.2111878,0.04249664,2,['Cellular hexose transport']
Slc2a12,0.029320847,-0.10620497,1,['Cellular hexose transport']
Slc2a13,-0.098793,0.060996525,2,['Inositol transporters']
Slc2a2,0.31294513,-0.23471045,1,"['Cellular hexose transport', 'Regulation of insulin secretion', 'Intestinal hexose absorption']"
Slc2a3,0.105695605,0.07554179,3,"['Cellular hexose transport', 'Vitamin C (ascorbate) metabolism', 'Neutrophil degranulation']"
Slc2a4,0.33138445,-0.18879077,1,['Cellular hexose transport']
Slc2a5,-0.094487555,-0.08222274,2,"['Neutrophil degranulation', 'Intestinal hexose absorption']"
Slc2a8,-0.10117278,0.019127209,2,"['Cellular hexose transport', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Slc2a9,-0.21751025,0.09651111,2,['Cellular hexose transport']
Slc30a1,-0.18589926,-0.17221884,2,['Zinc efflux and compartmentalization by the SLC30 family']
Slc30a10,-0.27381438,-0.039702117,2,['Metal ion SLC transporters']
Slc30a2,-0.12168406,-0.064762734,2,
Slc30a3,-0.21452767,-0.22989796,2,
Slc30a4,-0.20583923,-0.011596356,2,
Slc30a5,-0.11499622,-0.11394396,2,"['Insulin processing', 'Zinc efflux and compartmentalization by the SLC30 family']"
Slc30a6,-0.1724125,-0.14715233,2,"['Insulin processing', 'Zinc efflux and compartmentalization by the SLC30 family']"
Slc30a7,-0.33011538,-0.10007077,2,
Slc30a8,-0.1557715,-0.1634922,2,"['Insulin processing', 'Zinc efflux and compartmentalization by the SLC30 family']"
Slc30a9,-0.14807087,-0.00443078,2,
Slc31a1,-0.27728367,-0.077380754,2,['Metal ion SLC transporters']
Slc31a2,-0.29930738,-0.24782097,2,
Slc32a1,-0.06092375,-0.30406395,1,"['Transport of inorganic cations/anions and amino acids/oligopeptides', 'GABA synthesis, release, reuptake and degradation']"
Slc33a1,0.014200734,0.09270756,2,"['Transport of vitamins, nucleosides, and related molecules']"
Slc34a1,-0.08163572,-0.19439241,2,
Slc34a2,-0.13547444,-0.06707008,2,"['Type II Na+/Pi cotransporters', 'Surfactant metabolism']"
Slc34a3,-0.02060558,-0.09269676,2,['Type II Na+/Pi cotransporters']
Slc35a1,-0.09974657,-0.045003187,2,"['Sialic acid metabolism', 'Transport of nucleotide sugars']"
Slc35a2,-0.31871024,0.06322208,2,['Transport of nucleotide sugars']
Slc35a3,-0.44790336,0.044414382,2,['Transport of nucleotide sugars']
Slc35a4,-0.20720899,0.15263443,2,
Slc35a5,-0.13834102,0.12134556,2,
Slc35b1,-0.06546042,-0.19334488,2,
Slc35b2,-0.24559812,0.04607669,2,"['Transport and synthesis of PAPS', 'Transport of nucleotide sugars']"
Slc35b3,-0.14366883,0.12868917,2,"['Transport and synthesis of PAPS', 'Transport of nucleotide sugars']"
Slc35b4,-0.24212313,0.09352088,2,['Transport of nucleotide sugars']
Slc35c1,-0.18132381,0.04493131,2,"['GDP-fucose biosynthesis', 'Transport of nucleotide sugars']"
Slc35c2,-0.18284743,0.24670158,0,
Slc35d1,-0.11881335,0.1449984,2,"['Formation of the active cofactor, UDP-glucuronate', 'Transport of nucleotide sugars']"
Slc35d2,-0.1654993,0.034225035,2,
Slc35d3,-0.13716476,0.12231016,2,
Slc35e1,-0.13097642,0.051943067,2,
Slc35e2,-0.22506352,-0.06730212,2,
Slc35e3,-0.07883265,0.17929466,2,
Slc35e4,-0.14050028,0.100514375,2,
Slc35f1,-0.16301917,-0.13589627,2,
Slc35f2,-0.3267674,-0.20351544,2,
Slc35f4,-0.42395866,0.018491,2,
Slc35g1,-0.2530632,0.09918243,2,
Slc35g2,-0.23420332,-0.11584406,2,
Slc36a1,-0.12057912,-0.14719395,2,"['Amino acid transport across the plasma membrane', 'Proton-coupled neutral amino acid transporters']"
Slc36a2,-0.20802195,0.03583905,2,"['Amino acid transport across the plasma membrane', 'Proton-coupled neutral amino acid transporters']"
Slc36a4,-0.19079483,0.07196199,2,
Slc37a1,-0.2825048,0.13969249,2,['Gluconeogenesis']
Slc37a2,-0.22371206,-0.06653289,2,['Gluconeogenesis']
Slc37a3,-0.27676815,-0.086698845,2,
Slc37a4,-0.015855443,0.01037469,2,['Gluconeogenesis']
Slc38a1,-0.25462088,-0.11826791,2,"['Astrocytic Glutamate-Glutamine Uptake And Metabolism', 'Amino acid transport across the plasma membrane']"
Slc38a11,-0.32886133,-0.004432454,2,
Slc38a2,-0.31808957,-0.06253063,2,"['Glutamate Neurotransmitter Release Cycle', 'Amino acid transport across the plasma membrane']"
Slc38a3,-0.10552663,-0.06318756,2,['Amino acid transport across the plasma membrane']
Slc38a4,0.03225821,-0.02596064,1,['Amino acid transport across the plasma membrane']
Slc38a5,-0.061775018,0.018634573,2,['Amino acid transport across the plasma membrane']
Slc38a6,-0.27596942,0.08188869,2,
Slc38a7,-0.17752542,-0.11397703,2,
Slc38a9,0.17401348,0.07657196,3,"['Macroautophagy', 'MTOR signalling', 'mTORC1-mediated signalling', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'Regulation of PTEN gene transcription', 'Amino acids regulate mTORC1']"
Slc39a1,-0.12518038,0.14083873,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a10,-0.22855446,-0.0037499357,2,
Slc39a11,-0.20583318,-0.1788319,2,
Slc39a12,-0.119367465,0.034374475,2,
Slc39a13,-0.13056703,-0.14754511,2,
Slc39a14,-0.22245076,-0.028016513,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a2,-0.16003393,-0.008160017,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a3,-0.26759344,-0.050466195,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a4,-0.2499674,-0.082958356,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a5,-0.3165294,-0.16675662,2,
Slc39a6,-0.09763581,-0.17609085,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a7,-0.3968497,-0.030988825,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a8,-0.27021405,-0.1292763,2,['Zinc influx into cells by the SLC39 gene family']
Slc39a9,-0.19069527,-0.15961282,2,
Slc3a1,-0.41303778,0.09436411,2,['Amino acid transport across the plasma membrane']
Slc3a2,0.041103397,-0.007926612,2,"['Amino acid transport across the plasma membrane', 'Tryptophan catabolism']"
Slc40a1,-0.094230086,-0.03631053,2,"['Metal ion SLC transporters', 'Iron uptake and transport']"
Slc41a1,-0.11007977,-0.13230991,2,['Metal ion SLC transporters']
Slc41a2,0.011139211,0.013048124,0,['Metal ion SLC transporters']
Slc43a1,-0.32340556,-0.0941007,2,['Amino acid transport across the plasma membrane']
Slc43a2,-0.13539691,-0.013462586,2,['Amino acid transport across the plasma membrane']
Slc44a1,-0.066438116,-0.006055347,2,"['Synthesis of PC', 'Transport of bile salts and organic acids, metal ions and amine compounds', 'Choline catabolism']"
Slc44a2,-0.11213707,0.05305177,2,"['Synthesis of PC', 'Transport of bile salts and organic acids, metal ions and amine compounds', 'Neutrophil degranulation']"
Slc45a1,-0.08100539,-0.12015067,2,
Slc45a3,-0.123391464,-0.17404293,2,['Cellular hexose transport']
Slc45a4,-0.35719928,-0.0101604,2,
Slc46a1,-0.065731674,-0.070079654,2,"['Metabolism of folate and pterines', 'Iron uptake and transport', 'Heme signaling']"
Slc46a2,-0.4008955,0.095201366,2,
Slc46a3,-0.39616764,0.0077264993,2,
Slc47a1,-0.41498402,0.04730408,2,"['Transport of bile salts and organic acids, metal ions and amine compounds']"
Slc47a2,-0.11343714,0.08360058,2,
Slc49a4,-0.05475752,0.1185348,2,
Slc4a1,0.13286418,-0.07380144,1,"['Erythrocytes take up carbon dioxide and release oxygen', 'Erythrocytes take up oxygen and release carbon dioxide', 'Bicarbonate transporters']"
Slc4a10,-0.08596043,-0.14648084,2,['Bicarbonate transporters']
Slc4a11,-0.17017485,-0.02757927,2,
Slc4a2,-0.034524318,-0.110757396,2,
Slc4a3,-0.183949,0.060403284,2,['Bicarbonate transporters']
Slc4a4,0.032798536,-0.15147151,2,['Bicarbonate transporters']
Slc4a7,0.0074463044,-0.26431608,1,
Slc4a8,-0.4417478,-0.12527736,2,['Bicarbonate transporters']
Slc50a1,0.11162757,-0.009208266,1,['Cellular hexose transport']
Slc51a,-0.035741787,-0.22880791,1,['Recycling of bile acids and salts']
Slc51b,-0.09094385,0.0059397845,2,['Recycling of bile acids and salts']
Slc52a2,-0.19977328,-0.07565309,2,['Vitamin B2 (riboflavin) metabolism']
Slc5a1,0.019562252,-0.35004237,1,
Slc5a10,-0.17295083,-0.03945294,2,['Cellular hexose transport']
Slc5a12,-0.14298925,0.025544241,2,['Multifunctional anion exchangers']
Slc5a2,-0.0089589115,-0.12027722,2,['Cellular hexose transport']
Slc5a5,-0.043896794,-0.1713409,2,
Slc5a6,-0.17563227,-0.002223929,2,"['Biotin transport and metabolism', 'Vitamin B5 (pantothenate) metabolism', 'Transport of vitamins, nucleosides, and related molecules']"
Slc5a7,0.07236748,0.045444217,3,"['Acetylcholine Neurotransmitter Release Cycle', 'Transport of bile salts and organic acids, metal ions and amine compounds']"
Slc5a8,-0.2067265,-0.06973064,2,"['Nicotinamide salvaging', 'Organic anion transporters']"
Slc5a9,-0.34242764,-0.2249896,2,['Cellular hexose transport']
Slc66a1,-0.3771049,0.048751667,2,['Miscellaneous transport and binding events']
Slc66a2,-0.31603783,-0.029612422,2,
Slc6a1,0.11822678,-0.1393677,1,"['Na+/Cl- dependent neurotransmitter transporters', 'Reuptake of GABA']"
Slc6a11,-0.14259177,-0.30860528,2,"['Na+/Cl- dependent neurotransmitter transporters', 'Creatine metabolism', 'Reuptake of GABA']"
Slc6a12,0.007563519,-0.09159902,1,
Slc6a13,-0.22757104,-0.100095674,2,"['Na+/Cl- dependent neurotransmitter transporters', 'Reuptake of GABA']"
Slc6a14,-0.18267317,0.011169473,2,"['Amino acid transport across the plasma membrane', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc6a17,-0.11627669,-0.0220804,2,
Slc6a18,-0.05218387,-0.0129108,2,"['Amino acid transport across the plasma membrane', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc6a19,-0.36052334,-0.20000735,2,"['Amino acid transport across the plasma membrane', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc6a2,0.08815437,-0.3302439,1,['Na+/Cl- dependent neurotransmitter transporters']
Slc6a20a,-0.07341147,-0.017014205,2,"['Amino acid transport across the plasma membrane', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc6a3,0.3119113,-0.29290926,1,"['Dopamine clearance from the synaptic cleft', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc6a4,0.26044935,-0.5263865,1,['Serotonin clearance from the synaptic cleft']
Slc6a5,-0.022317227,-0.15696687,2,
Slc6a6,-0.14426525,0.04329035,2,"['Amino acid transport across the plasma membrane', 'Na+/Cl- dependent neurotransmitter transporters']"
Slc6a7,-0.053754885,0.16549441,2,"['Na+/Cl- dependent neurotransmitter transporters', 'Creatine metabolism']"
Slc6a8,-0.031578247,-0.031143295,2,['Creatine metabolism']
Slc6a9,-0.26443365,-0.1354952,2,['Na+/Cl- dependent neurotransmitter transporters']
Slc7a10,-0.20179595,0.00019771986,2,['Amino acid transport across the plasma membrane']
Slc7a11,-0.028075574,-0.056809135,2,['Amino acid transport across the plasma membrane']
Slc7a13,-0.14261281,0.008891638,2,
Slc7a15,-0.49034825,0.06529877,2,
Slc7a2,0.025584769,-0.19321975,2,
Slc7a4,-0.16412967,0.015666574,2,
Slc7a5,-0.29808918,0.0390776,2,"['Amino acid transport across the plasma membrane', 'Tryptophan catabolism']"
Slc7a6,-0.25276458,0.13447496,2,['Amino acid transport across the plasma membrane']
Slc7a6os,-0.028293984,0.08515347,2,
Slc7a7,-0.30695066,0.092845984,2,['Amino acid transport across the plasma membrane']
Slc7a8,-0.2181998,0.07640067,2,['Amino acid transport across the plasma membrane']
Slc7a9,-0.48978695,-0.14571972,2,['Amino acid transport across the plasma membrane']
Slc8a1,0.06987163,-0.08723518,1,
Slc8a2,-0.04107024,-0.016738249,2,"['Reduction of cytosolic Ca++ levels', 'Sodium/Calcium exchangers', 'Ion homeostasis']"
Slc8a3,-0.17806706,0.021174027,2,"['Reduction of cytosolic Ca++ levels', 'Sodium/Calcium exchangers', 'Ion homeostasis']"
Slc8b1,-0.34620538,-0.18071307,2,"['Sodium/Calcium exchangers', 'Mitochondrial calcium ion transport']"
Slc9a1,0.42408192,-0.3493851,1,"['Hyaluronan uptake and degradation', 'Sodium/Proton exchangers']"
Slc9a2,-0.1472136,-0.25207317,2,['Sodium/Proton exchangers']
Slc9a3,0.11871418,-0.1570814,1,['Sodium/Proton exchangers']
Slc9a3r1,0.29657444,-0.3097829,1,
Slc9a3r2,0.20350742,-0.29453534,1,
Slc9a4,-0.056494363,-0.22261517,1,['Sodium/Proton exchangers']
Slc9a5,-0.0362289,-0.080613956,2,['Sodium/Proton exchangers']
Slc9a6,-0.12604406,-0.14932723,2,['Sodium/Proton exchangers']
Slc9a7,-0.24552584,-0.18868461,2,['Sodium/Proton exchangers']
Slc9a8,-0.30516574,0.21915689,2,['Sodium/Proton exchangers']
Slc9a9,-0.1203478,-0.21080157,2,['Sodium/Proton exchangers']
Slc9b1,-0.08091756,0.12923495,2,
Slc9b2,-0.12272983,-0.21594268,2,['Stimuli-sensing channels']
Slc9c1,-0.040293455,-0.026301378,2,
Slco1a1,-0.0048833727,-0.033959363,2,
Slco1a4,-0.1042076,0.0061905053,2,"['Recycling of bile acids and salts', 'Transport of organic anions']"
Slco1a6,-0.056253754,-0.06593104,2,
Slco1b2,-0.1127996,-0.09641659,2,"['Recycling of bile acids and salts', 'Heme degradation', 'Transport of organic anions', 'Atorvastatin ADME']"
Slco1c1,-0.08476254,0.0015212945,2,['Transport of organic anions']
Slco2b1,-0.3557705,-0.036385372,2,"['Heme degradation', 'Transport of organic anions', 'Aspirin ADME', 'Atorvastatin ADME']"
Slco3a1,-0.14553696,-0.05706772,2,['Transport of organic anions']
Slco4a1,-0.28688857,0.010210707,2,['Transport of organic anions']
Slco4c1,-0.07398084,0.08478338,2,"['Neutrophil degranulation', 'Transport of organic anions']"
Slco5a1,-0.16353291,-0.07572425,2,
Slf1,0.21238716,0.33093512,3,
Slf2,-0.038588893,0.2075946,3,
Slfnl1,-0.13600701,-0.09117807,2,
Slirp,-0.12774557,-0.055124037,2,
Slit1,0.18067151,-0.20105892,1,
Slit2,0.2953784,-0.26840505,1,"['Signaling by ROBO receptors', 'Role of ABL in ROBO-SLIT signaling', 'SLIT2:ROBO1 increases RHOA activity', 'Regulation of expression of SLITs and ROBOs']"
Slit3,-0.053839203,-0.24704881,2,['Signaling by ROBO receptors']
Slitrk1,0.2220561,-0.07622366,1,['Receptor-type tyrosine-protein phosphatases']
Slitrk2,-0.119660564,0.06576114,2,['Receptor-type tyrosine-protein phosphatases']
Slitrk3,0.05237664,0.056276016,1,"['Receptor-type tyrosine-protein phosphatases', 'RAC3 GTPase cycle']"
Slitrk5,0.051062796,-0.07144836,2,"['Receptor-type tyrosine-protein phosphatases', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Slk,-0.026154144,0.14771032,3,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Slmap,0.16722159,-0.19235481,1,
Sln,-0.18128106,0.065381534,2,
Slpi,0.12294363,-0.0055455086,1,['Neutrophil degranulation']
Sltm,-0.10398446,0.28709847,0,
Slu7,-0.2608817,0.47931904,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Slurp1,-0.20023562,-0.10838278,2,
Slurp2,-0.16774821,-0.073897064,2,
Slx,0.028450742,0.026732266,1,
Slx1b,-0.028383018,0.258239,3,"['Resolution of D-loop Structures through Holliday Junction Intermediates', 'Fanconi Anemia Pathway']"
Slx4,0.13389416,0.3188778,3,"['Resolution of D-loop Structures through Holliday Junction Intermediates', 'Fanconi Anemia Pathway']"
Slx4ip,-0.3774078,0.29535612,2,
Slxl1,-0.17140746,0.10152136,2,
Smad1,0.32570288,0.16549212,3,"['Signaling by BMP', 'Ub-specific processing proteases', 'RUNX2 regulates bone development']"
Smad2,0.5752331,0.017724944,3,"['Signaling by NODAL', 'Signaling by Activin', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling activates SMADs', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Ub-specific processing proteases', 'FOXO-mediated transcription of cell cycle genes']"
Smad3,0.57844806,0.029215632,3,"['Signaling by NODAL', 'Signaling by Activin', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling activates SMADs', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Ub-specific processing proteases', 'RUNX3 regulates CDKN1A transcription', 'FOXO-mediated transcription of cell cycle genes']"
Smad4,0.455106,0.11792941,3,"['Signaling by NODAL', 'Signaling by Activin', 'Signaling by BMP', 'TGF-beta receptor signaling activates SMADs', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Ub-specific processing proteases', 'RUNX2 regulates bone development', 'RUNX3 regulates CDKN1A transcription', 'FOXO-mediated transcription of cell cycle genes']"
Smad5,0.3576099,0.026919005,3,['Signaling by BMP']
Smad6,0.27796254,0.06251173,3,['Signaling by BMP']
Smad7,0.49968553,-0.024765946,3,"['Signaling by BMP', 'Downregulation of TGF-beta receptor signaling', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Ub-specific processing proteases']"
Smad9,0.22165413,-0.0282519,3,['Signaling by BMP']
Smagp,-0.056536473,0.029027583,2,
Smap1,-0.031072957,-0.15908322,2,
Smarca1,0.105870984,0.34296823,3,
Smarca2,0.419864,0.34301037,3,
Smarca4,0.51078856,0.25382733,3,"['Interleukin-7 signaling', 'Formation of the beta-catenin:TCF transactivating complex', 'RMTs methylate histone arginines', 'Chromatin modifying enzymes', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smarca5,0.32340977,0.45368648,3,"['B-WICH complex positively regulates rRNA expression', 'Deposition of new CENPA-containing nucleosomes at the centromere']"
Smarcad1,0.014069964,0.40302363,3,
Smarcal1,-0.013168741,0.3163738,3,
Smarcb1,0.40517852,0.2862042,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smarcc1,0.23196177,0.32485884,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smarcc2,0.16577242,0.14856622,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smarcd1,0.28791308,0.26657975,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smarcd2,0.14680351,0.16829973,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smarcd3,0.2818046,0.27824968,3,"['RMTs methylate histone arginines', 'Regulation of lipid metabolism by PPARalpha', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Cytoprotection by HMOX1']"
Smarce1,0.29661468,0.21929008,3,"['RMTs methylate histone arginines', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known']"
Smbd1,-0.24444665,-0.098295905,2,
Smc1a,0.11459772,0.4410408,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins']"
Smc1b,0.11572698,0.49553695,3,
Smc2,0.07414987,0.5635293,3,"['Condensation of Prophase Chromosomes', 'Condensation of Prometaphase Chromosomes']"
Smc3,0.3048955,0.4926825,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins']"
Smc4,0.15988345,0.41325024,3,"['Condensation of Prophase Chromosomes', 'Condensation of Prometaphase Chromosomes']"
Smc5,0.25690347,0.44415456,3,['SUMOylation of DNA damage response and repair proteins']
Smc6,0.100595854,0.3241449,3,['SUMOylation of DNA damage response and repair proteins']
Smchd1,-0.0514155,-0.066304326,2,
Smco1,-0.26921085,0.0017587172,2,
Smco3,-0.18794881,0.0729079,2,
Smco4,-0.32125878,-0.10433998,2,
Smcp,-0.08653916,0.12670764,2,
Smcr8,0.16683213,-0.04083805,1,
Smdt1,0.039611742,0.0466675,2,"['Mitochondrial calcium ion transport', 'Processing of SMDT1']"
Smg1,0.23418628,0.57842827,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Smg5,0.058302376,0.4735433,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Smg6,0.1459554,0.40232083,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Smg7,0.11235875,0.16503453,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Smg8,-0.09059549,0.22687782,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Smg9,0.02945772,0.2895851,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Smgc,-0.164734,0.013915368,2,
Smim1,0.025412166,-0.025968678,1,
Smim14,-0.09808693,-0.062508754,2,
Smim15,-0.08232659,0.23070383,2,
Smim17,-0.21714832,0.13918011,2,
Smim23,-0.051455863,-0.0654669,2,
Smim24,-0.11572468,-0.016839689,2,
Smim26,-0.03910512,-0.10271721,2,
Smim3,-0.115082435,-0.12030945,2,
Smim45,-0.21393296,-0.050114773,2,
Smim5,-0.1376127,-0.016403913,2,
Smim6,-0.25806504,-0.22952582,2,
Smim7,-0.122001275,-0.019074675,2,
Smn1,-0.046668217,0.543834,0,['snRNP Assembly']
Smndc1,-0.08761247,0.44910818,0,['mRNA Splicing - Major Pathway']
Smo,0.2528607,-0.05543466,1,"[""Hedgehog 'off' state"", 'BBSome-mediated cargo-targeting to cilium', ""Hedgehog 'on' state"", 'Activation of SMO']"
Smoc1,-0.3016594,-0.17798848,2,
Smoc2,-0.062239185,-0.0012479412,2,
Smox,-0.070790246,0.13169631,2,"['PAOs oxidise polyamines to amines', 'Interconversion of polyamines']"
Smpd1,0.03281763,-0.17344472,1,['Glycosphingolipid metabolism']
Smpd2,0.10260834,0.022718154,1,"['Glycosphingolipid metabolism', 'TNFR1-mediated ceramide production']"
Smpd3,-0.0062067364,-0.0020351552,2,"['Glycosphingolipid metabolism', 'TNFR1-mediated ceramide production']"
Smpd4,-0.25909948,-0.10833889,2,['Glycosphingolipid metabolism']
Smpd5,-0.20525928,0.057978354,2,
Smpdl3a,-0.15004602,0.024318825,2,
Smpx,-0.020894416,-0.14272766,2,
Smr2,-0.16937877,0.023890488,2,
Smr3a,-0.15555787,0.07312694,2,
Sms,-0.12014836,0.1680643,2,['Metabolism of polyamines']
Smtn,0.15032068,-0.11237102,1,
Smtnl1,-0.16259196,-0.20854431,2,
Smtnl2,-0.19246042,-0.16521268,2,
Smu1,-0.198216,0.39451322,0,
Smug1,0.030852694,0.17232127,3,"['Cleavage of the damaged pyrimidine ', 'Displacement of DNA glycosylase by APEX1']"
Smurf1,0.36633492,-0.08660623,3,"['Signaling by BMP', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Asymmetric localization of PCP proteins', ""Hedgehog 'on' state"", 'Regulation of RUNX3 expression and activity', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Smurf2,0.29022065,-0.016790856,3,"['Signaling by BMP', 'Downregulation of TGF-beta receptor signaling', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', ""Hedgehog 'on' state"", 'Ub-specific processing proteases', 'Regulation of RUNX3 expression and activity', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Smyd1,0.26347083,0.040882517,3,
Smyd2,0.21589169,0.1255683,3,"['PKMTs methylate histone lysines', 'Regulation of TP53 Activity through Methylation']"
Smyd3,0.31200323,0.18636061,3,['PKMTs methylate histone lysines']
Smyd4,-0.27121425,-0.03721757,2,
Smyd5,-0.23906258,-0.019650524,2,
Snai1,0.5937351,0.16966243,3,
Snai2,0.4561095,0.029476196,3,
Snai3,0.043135513,-0.029808475,1,
Snap23,-0.17636538,-0.17814,2,"['ER-Phagosome pathway', 'trans-Golgi Network Vesicle Budding', 'Neutrophil degranulation', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RAC1 GTPase cycle', 'RHOQ GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Snap25,-0.017356234,-0.1945213,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Other interleukin signaling', 'Neutrophil degranulation', 'GABA synthesis, release, reuptake and degradation']"
Snap29,-0.17991145,-0.15803663,2,"['Neutrophil degranulation', 'Intra-Golgi traffic']"
Snap47,-0.34207502,-0.13370128,2,
Snap91,-0.04472992,-0.33301604,1,
Snapc1,0.009536104,0.2908479,0,"['RNA polymerase II transcribes snRNA genes', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Snapc2,0.27067173,0.20104772,0,"['RNA polymerase II transcribes snRNA genes', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Snapc3,0.013232398,0.2395785,0,"['RNA polymerase II transcribes snRNA genes', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Snapc4,0.008053918,0.1990169,3,"['RNA polymerase II transcribes snRNA genes', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter']"
Snapc5,0.233776,0.17383051,3,
Snapin,0.12132292,-0.2253516,1,['Golgi Associated Vesicle Biogenesis']
Snca,0.46951693,-0.20873828,1,
Sncaip,0.07434082,-0.08126628,1,
Sncb,0.0794679,-0.1546288,1,
Sncg,-0.029677935,0.13978949,3,
Snd1,0.037969865,0.43010366,0,
Snf8,-0.05743787,0.09987759,2,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Snip1,0.07149521,0.4878322,0,
Snph,-0.0054642144,-0.022055842,2,
Snrnp200,-0.028851654,0.5026285,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Snrnp25,0.011250566,0.33525297,0,['mRNA Splicing - Minor Pathway']
Snrnp27,-0.0601268,0.2400618,0,['mRNA Splicing - Major Pathway']
Snrnp35,0.015218292,0.49834132,0,['mRNA Splicing - Minor Pathway']
Snrnp40,-0.19983843,0.5108402,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Snrnp48,0.12343115,0.19621672,0,['mRNA Splicing - Minor Pathway']
Snrnp70,-0.120004624,0.5068915,0,['mRNA Splicing - Major Pathway']
Snrpa,-0.055939063,0.41255328,0,['mRNA Splicing - Major Pathway']
Snrpa1,-0.16002835,0.45872968,0,['mRNA Splicing - Major Pathway']
Snrpb,-0.010959373,0.5794586,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Snrpb2,-0.09902231,0.43788424,0,
Snrpc,0.0127407815,0.5116758,0,['mRNA Splicing - Major Pathway']
Snrpd1,-0.06311589,0.58741564,0,"['snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Snrpd2,-0.056346867,0.58760476,0,"['snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Snrpd3,0.055638492,0.6353127,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Snrpe,-0.0019727135,0.6257456,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Snrpf,-0.10222477,0.6020509,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Snrpg,-0.057066552,0.5182179,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'snRNP Assembly', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Snrpn,0.098592274,0.35784274,0,['mRNA Splicing - Major Pathway']
Snta1,0.26403853,-0.30867496,1,
Sntb1,0.1671289,-0.23236045,1,
Sntb2,-0.0837222,-0.22515355,1,
Sntg1,0.049443755,-0.07180221,2,
Sntg2,-0.12778753,-0.060091596,2,
Snu13,-0.2169109,0.61785567,0,"['Major pathway of rRNA processing in the nucleolus and cytosol', 'mRNA Splicing - Major Pathway']"
Snupn,0.14963478,0.3191476,0,['snRNP Assembly']
Snw1,0.17823873,0.5322835,0,
Snx1,0.05484824,-0.3858828,1,
Snx10,-0.31628644,0.07943262,2,
Snx12,-0.007125272,-0.17454298,2,
Snx13,-0.08607599,-0.26020712,2,
Snx16,-0.11857326,-0.10622381,2,
Snx17,0.09475111,-0.2939987,1,
Snx18,0.036198862,-0.1339864,1,
Snx2,-0.052689165,-0.35753825,1,['Golgi Associated Vesicle Biogenesis']
Snx20,-0.06831308,0.06128372,2,
Snx21,-0.12717786,-0.18327631,2,
Snx22,-0.21897098,-0.02165133,2,
Snx24,-0.017639393,0.07251652,2,
Snx27,0.15641241,-0.23741208,1,
Snx3,-0.032961648,-0.19647944,2,
Snx30,-0.24450725,-0.041877884,2,
Snx31,-0.17405416,-0.22293498,2,
Snx32,-0.16446725,-0.3005797,2,
Snx33,0.06399291,-0.2673225,1,
Snx4,-0.16228469,-0.18143891,2,
Snx5,0.03303343,-0.20904826,1,['Golgi Associated Vesicle Biogenesis']
Snx6,-0.10047431,-0.14757541,2,
Snx7,-0.15213777,-0.21485917,2,
Snx8,-0.094146736,-0.11555047,2,
Snx9,0.072793745,-0.42537823,1,"['Golgi Associated Vesicle Biogenesis', 'Clathrin-mediated endocytosis']"
Soat1,-0.18760844,-0.1000848,2,['LDL clearance']
Soat2,-0.15541993,-0.026820345,2,['LDL clearance']
Socs1,0.46985075,-0.0034931179,1,"['Interleukin-4 and Interleukin-13 signaling', 'Interferon gamma signaling', 'Regulation of IFNG signaling', 'Interferon alpha/beta signaling', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Socs2,0.28278205,-0.046249792,1,"['Neddylation', 'Negative regulation of FLT3']"
Socs3,0.4457321,-0.16212939,1,"['Interleukin-6 signaling', 'Interferon gamma signaling', 'Regulation of IFNG signaling', 'PTK6 Activates STAT3', 'Neddylation', 'Interferon alpha/beta signaling', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Socs4,0.4326949,-0.06879617,3,
Socs5,0.28334838,-0.2614603,1,"['Interleukin-4 and Interleukin-13 signaling', 'Neddylation']"
Socs6,0.3506712,0.09133584,3,"['Neddylation', 'Negative regulation of FLT3']"
Socs7,0.317396,-0.043753147,1,
Sod1,0.27548155,-0.036539007,1,"['Platelet degranulation ', 'Detoxification of Reactive Oxygen Species']"
Sod2,0.10325616,0.07084002,0,"['Transcriptional activation of mitochondrial biogenesis', 'Detoxification of Reactive Oxygen Species']"
Sod3,0.101510525,-0.002624599,2,['Detoxification of Reactive Oxygen Species']
Soga1,-0.062388778,0.14071733,2,
Soga3,-0.14347501,-0.06589079,2,
Sohlh1,-0.13625382,0.17059952,2,
Sohlh2,-0.25929227,0.08213268,2,
Son,-0.19684543,0.21358767,0,
Sorbs1,0.2701462,-0.34102926,1,
Sorbs2,0.24852207,-0.35845006,1,
Sorbs3,0.15312283,-0.4316482,1,['Smooth Muscle Contraction']
Sorcs1,0.17974277,-0.20287573,1,
Sorcs2,0.046032347,-0.11183384,1,
Sorcs3,-0.03403825,-0.18056615,2,
Sord,-0.09624396,-0.10773281,2,"['Fructose biosynthesis', 'Formation of xylulose-5-phosphate']"
Sorl1,0.09499875,-0.35885805,1,
Sort1,0.35205325,-0.23267274,1,['Golgi Associated Vesicle Biogenesis']
Sos1,0.6142139,-0.26082212,1,"['SOS-mediated signalling', 'SHC1 events in ERBB4 signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'Signalling to RAS', 'GRB2 events in EGFR signaling', 'SHC1 events in EGFR signaling', 'Downstream signal transduction', 'NRAGE signals death through JNK', 'GRB2 events in ERBB2 signaling', 'Tie2 Signaling', 'EGFR Transactivation by Gastrin', 'DAP12 signaling', 'SHC-related events triggered by IGF1R', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'NCAM signaling for neurite out-growth', 'G alpha (12/13) signalling events', 'SHC-mediated cascade:FGFR1', 'FRS-mediated FGFR1 signaling', 'SHC-mediated cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'SHC-mediated cascade:FGFR3', 'FRS-mediated FGFR3 signaling', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'RAF/MAP kinase cascade', 'Signal attenuation', 'Insulin receptor signalling cascade', 'MET activates RAS signaling', 'RET signaling', 'Interleukin-15 signaling', 'RAC1 GTPase cycle', 'Activated NTRK2 signals through FRS2 and FRS3', 'Interleukin receptor SHC signaling', 'FLT3 Signaling', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Sos2,0.48491335,-0.3101107,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'Interleukin-15 signaling', 'RAC1 GTPase cycle']"
Sost,0.27719194,-0.08806327,3,['Negative regulation of TCF-dependent signaling by WNT ligand antagonists']
Sostdc1,-0.01174227,-0.037815735,2,
Sowaha,0.0064291637,-0.15592095,2,
Sowahb,-0.16611336,0.049164996,2,
Sowahd,-0.06591925,0.08364068,2,
Sox1,0.13045609,-0.06933775,3,
Sox10,0.3575364,0.042704884,1,
Sox11,-0.20959716,0.046552412,2,
Sox13,-0.091941394,0.084445156,2,['Deactivation of the beta-catenin transactivating complex']
Sox15,0.05950856,0.09778934,3,
Sox17,0.111333475,0.06346023,3,['Deactivation of the beta-catenin transactivating complex']
Sox18,0.14102302,-0.10697267,1,
Sox2,0.48141128,0.16648702,3,
Sox21,0.030669833,0.04226894,3,
Sox3,0.11144241,-0.08562774,3,
Sox30,0.04857017,0.0132334735,2,
Sox4,0.29499584,0.024059149,3,['Deactivation of the beta-catenin transactivating complex']
Sox5,0.26853827,0.006766249,1,
Sox6,0.10601446,0.0044174525,3,['Deactivation of the beta-catenin transactivating complex']
Sox7,0.12909256,-0.28696218,1,['Deactivation of the beta-catenin transactivating complex']
Sox8,-0.02764164,0.011559074,2,
Sox9,0.34314996,-0.087731056,1,"['Deactivation of the beta-catenin transactivating complex', 'Transcriptional regulation by RUNX2']"
Sp1,0.48012868,0.032484673,3,"['SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'RNA polymerase II transcribes snRNA genes', 'Estrogen-dependent gene expression']"
Sp100,0.2661029,0.29311126,3,['SUMOylation of DNA damage response and repair proteins']
Sp110,-0.08336716,-0.21117938,2,
Sp140,0.0047688833,0.089742206,3,
Sp3,0.19396839,0.32089484,3,['SUMOylation of transcription factors']
Sp4,0.07541195,-0.1694551,1,
Sp7,0.2811105,-0.09235169,3,
Sp8,0.038200546,-0.11463898,2,
Sp9,-0.11546252,0.010304034,2,
Spa17,-0.1681183,0.06923636,2,
Spaca1,-0.17972508,-0.062214613,2,
Spaca3,-0.13302775,-0.013928189,2,
Spaca4,-0.08419445,0.018301656,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Spaca6,-0.014152413,-0.014200716,2,
Spaca7,-0.05388999,0.09351349,2,
Spaca9,-0.086762145,-0.035375293,2,
Spag1,-0.053041607,0.14665435,2,
Spag11a,-0.33633956,0.061755657,2,
Spag11b,-0.09154003,-0.28934708,2,
Spag16,-0.03727122,0.19870508,3,
Spag17,-0.1599478,0.25728345,2,
Spag4,-0.02875507,-0.02913627,2,
Spag5,0.056216557,0.35399047,3,
Spag6,0.028476715,0.22762626,3,
Spag6l,-0.04585364,0.27713406,3,
Spag8,-0.20842536,-0.038789626,2,
Spag9,0.27417436,-0.22258362,1,['Myogenesis']
Spam1,0.0074202833,-0.04799529,1,
Sparc,0.25587663,-0.37781432,1,"['Platelet degranulation ', 'ECM proteoglycans', 'Scavenging by Class H Receptors']"
Sparcl1,0.12670764,-0.088608354,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Spast,-0.08402526,-0.08377472,2,['Sealing of the nuclear envelope (NE) by ESCRT-III']
Spata1,-0.041683283,0.03218516,2,
Spata13,0.18090338,0.001396851,3,
Spata16,-0.21066014,-0.16023098,2,
Spata17,-0.12044211,0.21725753,2,
Spata18,0.15137908,0.046370856,3,
Spata2,-0.06921929,-0.0075449315,2,
Spata20,0.10433163,-0.025072329,1,
Spata21,-0.15242489,-0.025894236,2,
Spata22,0.020039337,0.2065488,3,
Spata24,-0.27121258,0.03684819,2,
Spata25,-0.09238355,-0.11186885,2,
Spata2l,0.04636091,0.04847485,3,
Spata3,-0.25959882,-0.2060127,2,
Spata31,-0.0369998,0.059144292,2,
Spata32,-0.12057661,-0.021639477,2,
Spata33,-0.07580717,-0.009446138,2,
Spata4,-0.06931986,-0.13778277,2,
Spata46,-0.052323185,-0.06269998,2,
Spata48,-0.11690132,0.20900477,2,
Spata5,0.093683414,0.36375356,3,
Spata6,-0.14056861,0.098526694,2,
Spata6l,-0.30305514,0.064393505,2,
Spata7,-0.0778607,-0.118845135,2,
Spata9,-0.19846576,-0.16438809,2,
Spatc1,-0.16284429,-0.038302206,2,
Spatc1l,-0.2912362,-0.0018898053,2,
Spats1,-0.2605057,0.13617429,2,
Spats2,-0.12678668,0.029257713,2,
Spc24,0.02698308,0.29555485,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Spc25,0.06479085,0.3324278,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Spcs2,0.009305293,-0.046216585,2,"['Synthesis, secretion, and deacylation of Ghrelin']"
Spcs3,0.06448622,-0.00082406297,2,"['Synthesis, secretion, and deacylation of Ghrelin']"
Spdef,0.05181633,-0.004176327,1,
Spdl1,0.11210839,0.31110182,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Spdya,0.0687397,0.31207252,3,
Spdye4a,-0.083982,0.26912633,0,
Spdye4b,0.18016876,0.29972604,3,
Spdye4c,0.19771065,-0.062448222,1,
Specc1,0.05108764,0.08480792,0,
Specc1l,0.23027286,-0.10693114,1,
Spef2,-0.22166374,0.19814745,2,
Speg,0.03441868,-0.036779735,1,
Spem1,-0.16650446,0.06097125,2,
Spen,0.22083125,0.5032161,3,
Spertl,-0.11858853,-0.15146992,2,
Spesp1,-0.2938146,0.07393126,2,
Spg11,-0.10571259,0.15284394,0,
Spg20,0.0015478359,-0.19736658,2,
Spg21,-0.13555856,-0.059870053,2,
Spg7,0.0050391527,-0.06259361,2,['Processing of SMDT1']
Sphk1,0.2176419,-0.29735947,1,"['Sphingolipid de novo biosynthesis', 'Association of TriC/CCT with target proteins during biosynthesis', 'VEGFR2 mediated cell proliferation', 'Extra-nuclear estrogen signaling']"
Sphk2,0.16916175,-0.25127977,1,['Sphingolipid de novo biosynthesis']
Sphkap,-0.014850009,-0.010470475,2,
Spi1,0.45695597,-0.14301339,1,
Spib,-0.045098823,-0.11325561,2,
Spice1,-0.26645532,0.014127317,2,
Spidr,-0.015456994,0.05493853,3,['Resolution of D-loop Structures through Holliday Junction Intermediates']
Spin1,-0.2402449,-0.0036662342,2,
Spin2d,-0.220776,-0.08824591,2,
Spin2e,-0.054893162,0.05015077,2,
Spindoc,-0.31707618,-0.031314097,2,
Spink1,-0.035361763,-0.21040642,2,
Spink10,-0.26457414,-0.05461139,2,
Spink11,-0.48897275,0.037731476,2,
Spink12,-0.28619677,0.07509077,2,
Spink14,-0.16648167,0.007461306,2,
Spink2,-0.25317177,0.04476333,2,
Spink4,-0.2920961,-0.08992777,2,
Spink5,-0.2927809,-0.043283794,2,['Formation of the cornified envelope']
Spink6,-0.08973402,0.0011260858,2,['Formation of the cornified envelope']
Spink7,-0.2786182,0.07933793,2,
Spinkl,-0.2471762,0.09440045,2,
Spint1,-0.11450631,-0.20558158,2,"['MET Receptor Activation', 'Signaling by MST1']"
Spint2,-0.11286568,-0.016354362,2,"['MET Receptor Activation', 'Signaling by MST1']"
Spint3,-0.12544921,0.057048388,2,
Spint4,-0.1909929,0.08548878,2,
Spint5,-0.29449433,-0.044566896,2,
Spire1,-0.03455319,0.03388559,2,
Spire2,-0.06427868,0.04999542,2,
Spn,0.36162564,-0.16393423,1,['Cell surface interactions at the vascular wall']
Spns2,-0.02820214,-0.07580398,2,['Sphingolipid de novo biosynthesis']
Spo11,0.099783614,0.38858554,3,
Spock1,-0.07119805,-0.2632171,2,
Spock3,-0.09986879,-0.28535903,1,['Activation of Matrix Metalloproteinases']
Spon1,0.20751269,-0.03256679,1,['O-glycosylation of TSR domain-containing proteins']
Spon2,-0.05147685,-0.063469686,2,['O-glycosylation of TSR domain-containing proteins']
Spop,0.3074852,0.18550317,3,"[""Hedgehog 'on' state""]"
Spopfm2,0.19786754,0.1770989,3,
Spopl,0.27783373,0.10679474,3,"[""Hedgehog 'on' state""]"
Spout1,-0.33345282,0.30326438,0,
Spp1,0.36165786,-0.29959628,1,"['Degradation of the extracellular matrix', 'Signaling by PDGF', 'Integrin cell surface interactions', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Spp2,-0.05155606,-0.09118074,2,"['Platelet degranulation ', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Sppl2a,0.13066821,-0.14561842,1,['Regulation of TNFR1 signaling']
Sppl2b,-0.070928,0.15004732,2,['Regulation of TNFR1 signaling']
Sppl2c,-0.31094003,-0.061759304,2,
Sppl3,-0.05509978,0.019900039,2,
Spr,-0.031627923,-0.30892467,1,
Spred1,0.3467185,0.13802107,3,"['Regulation of RAS by GAPs', 'FGFRL1 modulation of FGFR1 signaling']"
Spred2,0.31612614,0.09268339,3,"['Regulation of RAS by GAPs', 'FGFRL1 modulation of FGFR1 signaling']"
Spred3,0.20330456,0.24619967,3,
Sprn,-0.052352864,-0.17077076,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Sprr2d,-0.2512682,0.096794695,2,
Sprr2f,-0.30572495,-0.09423211,2,
Sprr2h,-0.24039681,-0.116619155,2,
Sprr2i,-0.34166974,0.10841252,2,
Sprr2j-ps,-0.2853924,-0.11721243,2,
Sprr3,0.010916289,0.03652576,2,
Sprr4,-0.17256132,-0.040467426,2,
Sprtn,0.12622006,0.21619712,3,['Translesion Synthesis by POLH']
Spry1,0.29731742,-0.24692601,1,['EGFR downregulation']
Spry2,0.37019265,-0.3422321,1,"['Spry regulation of FGF signaling', 'EGFR downregulation']"
Spry4,0.22727254,-0.20339938,1,
Spryd3,-0.011215888,-0.053990398,2,
Spryd4,-0.055071086,0.19000392,0,
Spryd7,-0.3098399,-0.02204395,2,
Spsb1,0.246699,0.10424322,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Spsb2,-0.10903864,-0.010822277,2,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Spsb3,0.13221963,-0.007488797,1,['Neddylation']
Spsb4,0.0738636,0.17749412,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Spta1,0.22647502,-0.3974617,1,"['NCAM signaling for neurite out-growth', 'Interaction between L1 and Ankyrins', 'RAF/MAP kinase cascade', 'COPI-mediated anterograde transport']"
Sptan1,0.29639053,-0.31352893,1,"['Caspase-mediated cleavage of cytoskeletal proteins', 'NCAM signaling for neurite out-growth', 'Interaction between L1 and Ankyrins', 'RAF/MAP kinase cascade', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Sptb,0.08055311,-0.15202181,1,
Sptbn1,0.30990458,-0.31990656,1,"['NCAM signaling for neurite out-growth', 'Interaction between L1 and Ankyrins', 'RAF/MAP kinase cascade', 'COPI-mediated anterograde transport', 'RHOU GTPase cycle', 'RHOV GTPase cycle']"
Sptbn2,0.16927908,-0.14083447,1,"['MHC class II antigen presentation', 'NCAM signaling for neurite out-growth', 'Interaction between L1 and Ankyrins', 'RAF/MAP kinase cascade', 'COPI-mediated anterograde transport']"
Sptbn4,-0.035132665,-0.2662082,1,"['NCAM signaling for neurite out-growth', 'Interaction between L1 and Ankyrins', 'RAF/MAP kinase cascade', 'COPI-mediated anterograde transport']"
Sptlc1,-0.069840655,-0.23081642,1,['Sphingolipid de novo biosynthesis']
Sptlc2,-0.13155314,-0.211327,2,['Sphingolipid de novo biosynthesis']
Sptlc3,-0.2329526,-0.115379564,2,['Sphingolipid de novo biosynthesis']
Sptssa,-0.17931455,-0.321938,2,['Sphingolipid de novo biosynthesis']
Sptssb,-0.12148424,0.0583217,2,['Sphingolipid de novo biosynthesis']
Spty2d1,-0.11168607,0.21707676,0,
Sqle,-0.22590506,-0.09663185,2,['Cholesterol biosynthesis']
Sqor,-0.081188545,0.039590605,2,['Sulfide oxidation to sulfate']
Sqstm1,0.4758533,0.0038849595,3,"['NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'PINK1-PRKN Mediated Mitophagy', 'Interleukin-1 signaling', 'Pexophagy', 'KEAP1-NFE2L2 pathway']"
Sra1,0.3873806,0.178342,3,
Srarp,-0.14589451,0.09119238,2,
Srbd1,-0.18721195,0.19374631,2,
Src,0.51160544,-0.21097834,1,"['Signaling by ERBB2', 'Nuclear signaling by ERBB4', 'Downregulation of ERBB4 signaling', 'PIP3 activates AKT signaling', 'Spry regulation of FGF signaling', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'Signaling by EGFR', 'GAB1 signalosome', 'Downstream signal transduction', 'Regulation of gap junction activity', 'FCGR activation', 'PECAM1 interactions', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'CD28 co-stimulation', 'CTLA4 inhibitory signaling', 'EPHB-mediated forward signaling', 'EPHA-mediated growth cone collapse', 'Ephrin signaling', 'EPH-ephrin mediated repulsion of cells', 'ADP signalling through P2Y purinoceptor 1', 'G alpha (i) signalling events', 'DCC mediated attractive signaling', 'GP1b-IX-V activation signalling', 'Recycling pathway of L1', 'VEGFA-VEGFR2 Pathway', 'Thrombin signalling through proteinase activated receptors (PARs)', 'VEGFR2 mediated cell proliferation', 'CLEC7A (Dectin-1) signaling', 'RHO GTPases Activate Formins', 'RAF activation', 'MAP2K and MAPK activation', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Cyclin D associated events in G1', 'RET signaling', 'MET activates PTK2 signaling', 'Receptor Mediated Mitophagy', 'Regulation of RUNX3 expression and activity', 'Extra-nuclear estrogen signaling', 'Activated NTRK3 signals through PI3K']"
Srcap,0.19127893,0.32721385,3,
Srcin1,0.123936996,0.08392895,3,
Srd5a1,-0.25116625,-0.20479727,2,
Srd5a2,-0.17873971,-0.09651063,2,['Androgen biosynthesis']
Srd5a3,-0.2492393,-0.16745606,2,"['Androgen biosynthesis', 'Synthesis of Dolichyl-phosphate']"
Srebf1,0.2691327,-0.11179589,3,"['Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'Cholesterol biosynthesis']"
Srebf2,0.1361298,-0.022886528,3,"['Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'Cholesterol biosynthesis']"
Srek1,-0.08969482,0.25896376,0,
Srek1ip1,-0.24085642,0.040101726,2,
Srf,0.42258453,-0.11414531,3,"['RHO GTPases Activate Formins', 'NGF-stimulated transcription']"
Srfbp1,-0.21104696,-0.09016728,2,
Srgap1,0.21314666,-0.23622464,1,"['RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle']"
Srgap2,0.32297057,-0.14874996,1,"['RHO GTPases Activate Formins', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOQ GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Srgap3,0.2866285,-0.09125309,1,
Srgn,0.08343527,-0.26072758,1,['Platelet degranulation ']
Sri,0.032622583,-0.018097885,2,"['Stimuli-sensing channels', 'Reduction of cytosolic Ca++ levels', 'Sodium/Calcium exchangers', 'Ion homeostasis', 'Ion transport by P-type ATPases']"
Srl,-0.052385885,-0.2929588,1,
Srm,-0.11044508,0.08774069,2,['Metabolism of polyamines']
Srms,-0.0040191165,-0.08223173,2,
Srp14,-0.08380383,0.057609055,0,"['SRP-dependent cotranslational protein targeting to membrane', 'Neutrophil degranulation']"
Srp19,0.047491968,0.2105275,0,
Srp54a,-0.034488536,0.087512925,0,['SRP-dependent cotranslational protein targeting to membrane']
Srp54b,-0.1416432,0.20571072,0,['SRP-dependent cotranslational protein targeting to membrane']
Srp68,-0.22017367,0.27516875,0,['SRP-dependent cotranslational protein targeting to membrane']
Srp72,-0.05748748,0.11531718,0,['SRP-dependent cotranslational protein targeting to membrane']
Srp9,-0.07581005,0.16345364,0,['SRP-dependent cotranslational protein targeting to membrane']
Srpk1,-0.17135964,0.32688594,0,
Srpk2,-0.1847986,0.26630956,0,
Srpk3,-0.3625977,0.21459234,0,
Srpr,-0.25561103,0.25369766,0,
Srprb,0.1551429,0.010911898,1,
Srpx2,-0.061293207,-0.10275301,2,
Srr,-0.15632352,-0.17469497,2,['Serine biosynthesis']
Srrd,-0.32933277,0.08064819,0,
Srrm1,-0.15244481,0.4842227,0,
Srrm2,-0.07065923,0.5228066,0,['mRNA Splicing - Major Pathway']
Srrm3,-0.007798186,0.32494876,0,
Srrm4,-0.069878206,0.07114739,2,
Srrt,-0.03203796,0.43985748,0,"['RNA polymerase II transcribes snRNA genes', 'mRNA Splicing - Major Pathway']"
Srsf1,0.18272524,0.49994546,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srsf10,-0.05141792,0.26437375,0,
Srsf11,-0.06813663,0.3576731,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srsf12,-0.28368327,0.09875816,2,
Srsf2,-0.06375459,0.5915345,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srsf3,-0.0981681,0.4706217,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srsf4,-0.30180758,0.41254,0,
Srsf5,-0.028715717,0.35076007,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srsf6,-0.13881294,0.516529,0,
Srsf7,-0.05027325,0.30606696,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srsf9,-0.12844712,0.5637153,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Srxn1,-0.036836293,-0.002136627,2,
Sry,-0.035762988,0.07961315,2,
Ss18,0.2614262,0.08986951,3,
Ss18l1,0.016349053,0.09566,3,
Ssb,-0.01826549,0.5146095,0,
Ssbp1,-0.16136523,0.28294334,0,
Ssbp2,-0.10403734,-0.03425439,2,
Ssbp3,-0.07328338,0.011243215,2,
Ssbp4,-0.07034798,-0.069699265,2,
Ssc5d,-0.18453918,-0.15641703,2,
Ssh1,0.24662186,-0.2679184,1,
Ssh2,0.076392196,-0.12239097,1,
Ssh3,0.21287231,-0.09411695,1,
Ssmem1,-0.30223718,-0.054368716,2,
Ssna1,-0.27602535,0.07974945,2,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Sspn,-0.18795948,-0.22271208,2,
Sspo,0.14230363,-0.15895495,1,['O-glycosylation of TSR domain-containing proteins']
Ssr1,-0.16095263,-0.10841658,2,
Ssr2,-0.28675818,-0.28390095,2,
Ssr3,-0.14027013,-0.048044138,2,
Ssr4,-0.23979656,-0.057506725,2,
Ssrp1,0.31369084,0.47754493,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Transcription Elongation']"
Sst,0.24251135,-0.36699253,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Sstr1,0.19868602,-0.23572321,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Sstr2,0.071126625,-0.18465726,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Sstr3,0.03491823,-0.23960243,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events', 'BBSome-mediated cargo-targeting to cilium']"
Sstr4,-0.16842374,-0.0948239,2,
Sstr5,0.10016013,-0.22814609,1,"['Peptide ligand-binding receptors', 'G alpha (i) signalling events']"
Ssty1,-0.26537874,-0.021223804,2,
Ssty2,-0.04108207,0.012925158,2,
Ssu2,-0.18524793,-0.12749901,2,
Ssu72,0.111892775,0.4134745,0,['RNA polymerase II transcribes snRNA genes']
Ssx2ip,0.07633351,-0.09807393,1,
Ssx9,-0.2858986,0.02117748,2,
Ssxa1,-0.17406958,0.029687906,2,
St13,0.035742093,0.26542404,3,['Regulation of HSF1-mediated heat shock response']
St14,-0.22446835,-0.011650943,2,
St3gal1,-0.104367055,-0.1194934,2,"['Keratan sulfate biosynthesis', 'Sialic acid metabolism', 'Termination of O-glycan biosynthesis']"
St3gal2,-0.12598231,-0.11456519,2,"['Keratan sulfate biosynthesis', 'Sialic acid metabolism', 'Termination of O-glycan biosynthesis']"
St3gal3,-0.20649749,-0.18462683,2,"['Keratan sulfate biosynthesis', 'Sialic acid metabolism', 'Lewis blood group biosynthesis', 'Termination of O-glycan biosynthesis']"
St3gal4,-0.1760218,-0.2414215,2,"['Keratan sulfate biosynthesis', 'Sialic acid metabolism', 'Lewis blood group biosynthesis', 'N-Glycan antennae elongation', 'Termination of O-glycan biosynthesis']"
St3gal5,-0.104090095,-0.0059249005,2,['Sialic acid metabolism']
St3gal6,-0.043378614,-0.028602855,2,"['Keratan sulfate biosynthesis', 'Sialic acid metabolism', 'Lewis blood group biosynthesis']"
St6gal1,-0.10139943,-0.1920286,2,"['Sialic acid metabolism', 'N-Glycan antennae elongation', 'Termination of O-glycan biosynthesis']"
St6gal2,-0.07694924,-0.025411481,2,['Sialic acid metabolism']
St6galnac1,-0.08077302,-0.022726107,2,['Sialic acid metabolism']
St6galnac2,-0.17426805,-0.049058855,2,"['Sialic acid metabolism', 'Termination of O-glycan biosynthesis']"
St6galnac3,-0.23646817,0.034123637,2,"['Sialic acid metabolism', 'Termination of O-glycan biosynthesis']"
St6galnac4,-0.020664576,-0.11721639,2,
St6galnac5,-0.25095075,0.011870265,2,
St6galnac6,-0.24232164,-0.20459688,2,"['Sialic acid metabolism', 'Lewis blood group biosynthesis']"
St8sia1,-0.057693392,-0.06631266,2,['Sialic acid metabolism']
St8sia2,-0.258717,-0.117417075,2,"['Sialic acid metabolism', 'NCAM1 interactions', 'N-Glycan antennae elongation']"
St8sia4,-0.109165214,-0.021562355,2,"['Sialic acid metabolism', 'NCAM1 interactions']"
St8sia5,-0.18561909,0.003776267,2,['Sialic acid metabolism']
Stab1,-0.09390728,-0.28374934,1,
Stab2,0.086536705,0.02341103,3,"['Hyaluronan uptake and degradation', 'Scavenging by Class H Receptors']"
Stac2,-0.044681992,0.02155755,2,
Stac3,0.011622347,-0.122510605,2,
Stag1,0.1700146,0.36051238,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins']"
Stag2,0.084860794,0.381904,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion', 'SUMOylation of DNA damage response and repair proteins']"
Stag3,-0.023921054,0.32762283,3,
Stam,0.22711994,-0.002873043,3,"['EGFR downregulation', 'Metalloprotease DUBs', 'Negative regulation of MET activity', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'RHOU GTPase cycle', 'Endosomal Sorting Complex Required For Transport (ESCRT)']"
Stam2,0.29807207,-0.11492773,1,"['EGFR downregulation', 'Ub-specific processing proteases', 'Negative regulation of MET activity', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'RHOU GTPase cycle', 'Endosomal Sorting Complex Required For Transport (ESCRT)']"
Stambp,0.2505656,0.05360631,3,['Metalloprotease DUBs']
Stambpl1,0.24261256,0.084904894,3,['Metalloprotease DUBs']
Stap1,0.15188877,-0.22111812,1,
Stap2,0.24210833,-0.0936282,1,['PTK6 Activates STAT3']
Star,-0.088125184,-0.15882887,2,['Pregnenolone biosynthesis']
Stard10,-0.22100753,-0.15103,2,['Synthesis of PC']
Stard13,0.22900012,-0.2934916,1,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle']"
Stard3,0.0076926006,-0.21107692,2,['Pregnenolone biosynthesis']
Stard3nl,-0.12973185,-0.1796913,2,['Pregnenolone biosynthesis']
Stard4,-0.26365164,0.0018117583,2,
Stard5,-0.20193884,0.16159327,2,['Recycling of bile acids and salts']
Stard6,-0.289502,0.11076932,2,['Pregnenolone biosynthesis']
Stard7,-0.07782438,-0.19342358,2,['Synthesis of PC']
Stard8,-0.021765841,-0.08873366,2,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'CDC42 GTPase cycle']"
Stat1,0.638879,0.038802788,1,
Stat2,0.4375894,0.04538017,1,
Stat3,0.6854059,-0.10587555,1,"['Interleukin-6 signaling', 'Interleukin-7 signaling', 'Signaling by SCF-KIT', 'Downstream signal transduction', 'Signaling by ALK', 'Interleukin-10 signaling', 'Interleukin-4 and Interleukin-13 signaling', 'PTK6 Activates STAT3', 'Interleukin-20 family signaling', 'MET activates STAT3', 'Interleukin-15 signaling', 'Interleukin-35 Signalling', 'Interleukin-9 signaling', 'Interleukin-37 signaling', 'Interleukin-23 signaling', 'Interleukin-27 signaling', 'Interleukin-21 signaling', 'STAT3 nuclear events downstream of ALK signaling']"
Stat4,0.31985196,-0.084266916,1,
Stat5a,0.56308854,-0.12389154,1,"['Nuclear signaling by ERBB4', 'Interleukin-7 signaling', 'Signaling by SCF-KIT', 'Downstream signal transduction', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'Interleukin-20 family signaling', 'Interleukin-15 signaling', 'Interleukin-9 signaling', 'Interleukin-2 signaling', 'Interleukin-21 signaling', 'Growth hormone receptor signaling']"
Stat5b,0.5122513,-0.11214988,1,"['Interleukin-7 signaling', 'Signaling by SCF-KIT', 'Downstream signal transduction', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'Interleukin-20 family signaling', 'Interleukin-15 signaling', 'Interleukin-9 signaling', 'Interleukin-2 signaling', 'Interleukin-21 signaling', 'Growth hormone receptor signaling']"
Stat6,0.43636656,0.08968233,1,"['Downstream signal transduction', 'STAT6-mediated induction of chemokines', 'Interleukin-4 and Interleukin-13 signaling']"
Stau1,0.0048148492,0.34668696,0,
Stau2,-0.0006962186,0.22815406,0,
Stbd1,0.035600133,-0.14011304,2,"['Neutrophil degranulation', 'RHOA GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Stc1,-0.10149033,-0.19424348,2,
Stc2,-0.08065785,0.1053001,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Steap1,-0.13425289,-0.13201472,2,
Steap2,-0.19139223,0.034548018,2,['Transferrin endocytosis and recycling']
Steap3,-0.085125014,-0.011859571,2,
Stfa2,-0.2146973,0.050430223,2,
Stfa2l1,-0.03422367,-0.11519618,2,
Stfa3,-0.00084055687,-0.09197151,2,['Formation of the cornified envelope']
Stil,0.195677,0.1245916,3,
Stim1,0.0866463,-0.19735336,1,"['Ion homeostasis', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Stim2,0.10231998,-0.051864654,1,
Stimate,-0.24472937,-0.28193903,2,
Sting1,0.23065,0.11384442,3,"['STING mediated induction of host immune responses', 'Regulation of innate immune responses to cytosolic DNA', 'STAT6-mediated induction of chemokines', 'IRF3-mediated induction of type I IFN', 'Neutrophil degranulation']"
Stip1,0.15868524,0.12953834,3,"['HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'RND1 GTPase cycle']"
Stk10,0.07992947,-0.0018823158,2,"['Neutrophil degranulation', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Stk11,0.42129713,0.014141635,3,"['Energy dependent regulation of mTOR by LKB1-AMPK', 'Regulation of TP53 Activity through Phosphorylation']"
Stk11ip,0.1366808,0.015846109,3,['Neutrophil degranulation']
Stk16,-0.22452271,-0.090696596,2,
Stk19,-0.042265717,-0.15027635,2,
Stk24,0.21039116,0.07014691,3,"['Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase']"
Stk25,0.23170295,-0.020084197,3,
Stk26,0.21044935,-0.022278598,3,['Apoptotic cleavage of cellular proteins']
Stk3,0.22104043,0.0045848736,3,['Signaling by Hippo']
Stk31,0.010567753,-0.08101841,2,
Stk32a,0.137438,0.16810879,0,
Stk32b,0.026243526,0.061236158,2,
Stk32c,0.11966031,0.033976696,3,
Stk33,0.0072679026,-0.13157824,2,
Stk35,-0.16095094,-0.16842677,2,
Stk36,-0.047059145,0.13068506,3,
Stk38,-0.121644765,-0.10048485,2,"['RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle']"
Stk38l,-0.036888383,-0.13333926,2,
Stk39,0.2164108,-0.14217772,1,
Stk4,0.34586686,0.07070073,3,['Signaling by Hippo']
Stk40,-0.09648365,0.069164455,2,
Stmn1,0.40159413,0.12587221,3,
Stmn2,-0.048819523,-0.19086944,2,['RND1 GTPase cycle']
Stmn3,0.016514191,-0.21678713,1,
Stmn4,0.13401558,0.031701397,3,
Stn1,0.23681815,0.3736081,3,"['Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation']"
Stom,0.23359239,0.1414747,3,"['Stimuli-sensing channels', 'Neutrophil degranulation', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle']"
Stoml1,-0.08190853,0.12308912,2,
Stoml2,0.22225286,-0.030031357,3,['Processing of SMDT1']
Stoml3,-0.22910358,-0.080537245,2,['Stimuli-sensing channels']
Ston1,-0.19289027,0.13493408,2,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Ston2,-0.04473329,-0.14239997,2,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Stox1,-0.11752167,0.03862889,2,
Stox2,-0.36391932,0.14282724,2,
Stpg2,-0.040850803,-0.020494565,2,
Stpg3,-0.23880197,-0.011585998,2,
Stra6,-0.17195235,0.009960321,2,
Stra6l,0.10303216,0.08251665,3,
Stra8,-0.07842404,0.21717505,3,
Strada,-0.005652534,-0.068854935,2,['Energy dependent regulation of mTOR by LKB1-AMPK']
Stradb,0.11543451,0.048926648,3,['Energy dependent regulation of mTOR by LKB1-AMPK']
Strap,0.2151784,0.06384513,1,['Downregulation of TGF-beta receptor signaling']
Strbp,-0.034577183,-0.19115347,1,
Strc,-0.33600333,-0.09719307,2,
Strip1,0.15288453,-0.019132214,3,
Strip2,0.18701062,0.045771703,3,
Strn,0.24588592,0.12156026,3,"['PIP3 activates AKT signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Extra-nuclear estrogen signaling']"
Strn3,0.20946176,0.020854013,3,
Strn4,0.086136416,0.07889837,3,
Stt3a,-0.11304584,0.019517776,2,
Stt3b,-0.2263205,-0.12794785,2,
Stub1,0.5361066,0.1420871,3,"['Downregulation of TGF-beta receptor signaling', 'Regulation of necroptotic cell death', 'Downregulation of ERBB2 signaling', 'Regulation of RUNX2 expression and activity', 'Regulation of PTEN stability and activity', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Stx11,-0.2812707,-0.03573442,2,
Stx12,-0.32368514,-0.21598688,2,
Stx16,-0.2660461,-0.06390749,2,"['Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Stx17,-0.011322277,-0.36503252,1,['COPII-mediated vesicle transport']
Stx18,-0.18468711,-0.003478099,2,['COPI-dependent Golgi-to-ER retrograde traffic']
Stx19,-0.3535843,-0.16569173,2,
Stx1a,-0.016277278,-0.24727215,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Other interleukin signaling', 'LGI-ADAM interactions', 'GABA synthesis, release, reuptake and degradation', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Stx1b,-0.40736538,-0.09636569,2,['LGI-ADAM interactions']
Stx2,-0.30024,-0.24872263,2,
Stx3,-0.24395712,-0.14958726,2,['Other interleukin signaling']
Stx4a,-0.020414004,-0.106566265,2,"['Disinhibition of SNARE formation', 'ER-Phagosome pathway', 'trans-Golgi Network Vesicle Budding', 'Other interleukin signaling']"
Stx5a,-0.21292797,-0.09358847,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'RHOA GTPase cycle', 'RHOC GTPase cycle', 'RHOG GTPase cycle', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Stx6,-0.23391995,-0.20753554,2,"['Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Stx7,-0.15348767,-0.18820712,2,
Stx8,-0.034385674,-0.28979945,1,
Stxbp1,-0.0061828513,-0.2603907,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'GABA synthesis, release, reuptake and degradation']"
Stxbp2,-0.025034629,-0.27350605,1,"['Platelet degranulation ', 'Other interleukin signaling']"
Stxbp3,-0.049005162,-0.26442307,2,['Disinhibition of SNARE formation']
Stxbp4,-0.014013684,0.0057884334,2,
Stxbp5,-0.032584023,-0.12587754,1,
Stxbp5l,-0.19515036,-0.13678116,2,
Stxbp6,-0.2774326,0.0850591,2,
Styk1,-0.15214492,-0.022999905,2,
Styxl1,-0.14885247,0.089841045,2,
Sub1,0.034258496,0.3752048,3,
Sucla2,-0.0006485389,0.061942343,2,['Citric acid cycle (TCA cycle)']
Suclg1,-0.12793204,0.15389095,2,['Citric acid cycle (TCA cycle)']
Suclg2,-0.11116758,-0.16579577,2,['Citric acid cycle (TCA cycle)']
Sucnr1,-0.17157032,-0.13680606,2,"['Class A/1 (Rhodopsin-like receptors)', 'G alpha (i) signalling events']"
Suco,-0.10821263,-0.14900966,2,
Suds3,0.29197124,0.34551173,3,"['HDACs deacetylate histones', 'Ub-specific processing proteases']"
Sufu,0.31864905,0.24632165,3,"['Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'off' state"", ""Hedgehog 'on' state""]"
Sugct,-0.11290253,-0.10501796,2,
Sugp1,-0.03754545,0.09080112,0,['mRNA Splicing - Major Pathway']
Sugp2,-0.07287864,-0.09664749,2,
Sugt1,0.19227226,0.024718745,3,['The NLRP3 inflammasome']
Sulf1,-0.058929425,0.24190497,3,
Sulf2,-0.053698074,-0.00089716056,2,
Sult1a1,-0.2193822,-0.067143716,2,
Sult1b1,-0.3450523,-0.09345733,2,['Cytosolic sulfonation of small molecules']
Sult1c2,-0.3661069,-0.1050874,2,['Cytosolic sulfonation of small molecules']
Sult1e1,-0.50851196,0.059058588,2,
Sult2a1,-0.27351254,0.05886141,2,
Sult2a2,-0.32706958,-0.0895226,2,
Sult2a5,-0.31267115,-0.0748905,2,
Sult2b1,-0.24505053,-0.13157333,2,['Cytosolic sulfonation of small molecules']
Sult3a1,-0.47322133,-0.19957656,2,
Sult4a1,-0.21893495,-0.13653745,2,['Cytosolic sulfonation of small molecules']
Sult6b1,-0.18895946,-0.0682855,2,['Cytosolic sulfonation of small molecules']
Sumf1,-0.10951802,0.031466506,2,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases']"
Sumf2,0.007179129,0.12550785,3,"['Glycosphingolipid metabolism', 'The activation of arylsulfatases']"
Sumo1,0.5228018,0.44747224,3,"['SUMO is conjugated to E1 (UBA2:SAE1)', 'SUMO is transferred from E1 to E2 (UBE2I, UBC9)', 'SUMO is proteolytically processed', 'SUMOylation of DNA damage response and repair proteins', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation of transcription factors', 'SUMOylation of ubiquitinylation proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of SUMOylation proteins', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'SUMOylation of DNA methylation proteins', 'SUMOylation of immune response proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Formation of Incision Complex in GG-NER', 'Regulation of IFNG signaling', 'Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Postmitotic nuclear pore complex (NPC) reformation']"
Sumo2,0.35586348,0.3901945,3,"['Vitamin D (calciferol) metabolism', 'SUMO is proteolytically processed', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription factors', 'SUMOylation of transcription cofactors', 'SUMOylation of SUMOylation proteins', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Processing of DNA double-strand break ends', 'Formation of Incision Complex in GG-NER']"
Sumo3,0.3828289,0.51500934,3,"['SUMO is proteolytically processed', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of transcription factors', 'SUMOylation of transcription cofactors', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of DNA replication proteins', 'SUMOylation of immune response proteins', 'Formation of Incision Complex in GG-NER']"
Sun1,0.110509634,0.34227416,3,
Sun2,0.042225473,0.05268873,3,
Sun3,-0.15476549,0.041265257,2,
Sun5,-0.18452263,-0.005810501,2,
Suox,-0.03438654,0.01124027,2,['Sulfide oxidation to sulfate']
Supt16,0.29184753,0.5351325,3,
Supt20,0.1759952,0.10826717,3,
Supt3,0.16126812,0.24775235,3,
Supt4a,0.070892766,0.23595972,0,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Transcription Elongation']"
Supt5,0.2509343,0.35187387,3,"['Formation of RNA Pol II elongation complex ', 'Formation of the Early Elongation Complex', 'RNA Polymerase II Pre-transcription Events', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA polymerase II transcribes snRNA genes', 'mRNA Capping', 'RNA Polymerase II Transcription Elongation', 'RNA Pol II CTD phosphorylation and interaction with CE']"
Supt6,0.12177976,0.43316308,0,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation']"
Supt7l,-0.004902704,0.23517746,0,
Supv3l1,-0.26393923,0.1022343,2,
Surf1,-0.114100955,-0.100668326,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Surf2,-0.115176596,-0.061791066,2,
Surf4,-0.088120006,-0.085259825,2,"['Neutrophil degranulation', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Surf6,-0.27161178,0.20511521,0,
Susd1,-0.28982612,0.0566655,2,
Susd2,-0.13306694,-0.086917445,2,
Susd5,-0.14841062,-0.112885475,2,
Suv39h1,0.4268321,0.3823049,3,['PKMTs methylate histone lysines']
Suv39h2,0.29098102,0.13693807,3,
Suz12,0.29788813,0.42760155,3,"['PRC2 methylates histones and DNA', 'Oxidative Stress Induced Senescence', 'PKMTs methylate histone lysines', 'SUMOylation of chromatin organization proteins', 'Regulation of PTEN gene transcription', 'Transcriptional Regulation by E2F6']"
Sv2a,0.116519146,-0.27960742,1,
Sv2b,-0.08627764,-0.21936227,1,
Sv2c,0.12275899,-0.109704465,1,
Sva,-0.24592483,0.19409595,2,
Sval2,-0.34958765,-0.03370602,2,
Svbp,-0.24594529,-0.2502856,2,
Svil,0.16497923,-0.03567746,1,
Svip,-0.13442636,0.10350617,2,['Neutrophil degranulation']
Svop,-0.45166296,0.065511726,2,
Svopl,-0.3590224,-0.040541217,2,
Svs3a,-0.13974965,0.09704049,2,['Antimicrobial peptides']
Svs3b,-0.36394772,0.11959753,2,['Antimicrobial peptides']
Svs4,-0.32592788,-0.0036895538,2,
Svs5,-0.25181502,0.12246343,2,
Svs6,-0.22490703,0.07089208,2,
Swap70,0.29115906,-0.03798736,3,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Swi5,0.14424564,0.20513439,3,
Swsap1,0.020311598,0.37819618,3,
Swt1,-0.11660417,0.06534829,2,
Syap1,-0.20318733,-0.012865161,2,
Sybu,-0.14843969,-0.26802847,2,
Syce1,-0.10625018,0.29190156,3,
Syce2,-0.03470591,0.19955218,3,
Syce3,-0.036071263,0.18221943,3,
Sycn,-0.18274863,-0.23103547,2,
Sycp1,-0.050925158,0.38596627,3,
Sycp2,-0.003924987,0.32499367,3,
Sycp2l,-0.14739473,0.036202963,2,
Sycp3,0.0054748557,0.31278145,3,
Syde1,-0.08490951,-0.029657774,2,
Syf2,-0.15303978,0.38736612,0,['mRNA Splicing - Major Pathway']
Syk,0.42473802,-0.57094234,1,"['GPVI-mediated activation cascade', 'FCGR activation', 'Regulation of actin dynamics for phagocytic cup formation', 'Role of phospholipids in phagocytosis', 'DAP12 signaling', 'Fc epsilon receptor (FCERI) signaling', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'Integrin signaling', 'Dectin-2 family', 'Interleukin-2 signaling', 'Regulation of signaling by CBL', 'Signaling by CSF3 (G-CSF)', 'Inactivation of CSF3 (G-CSF) signaling', 'FLT3 signaling through SRC family kinases', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Sympk,0.13882923,0.45336297,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Syn1,0.31883958,-0.15712084,1,"['Serotonin Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle']"
Syn2,-0.09485627,-0.10533275,2,"['Serotonin Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle']"
Syn3,-0.014640728,-0.1482297,1,"['Serotonin Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle']"
Syna,-0.08133561,-0.013896922,2,
Synb,-0.12794714,-0.04488882,2,
Sync,-0.07680224,-0.15203847,2,
Syncrip,0.12258667,0.38718623,0,
Syndig1,-0.12554853,-0.12921685,2,
Syndig1l,-0.0718634,-0.036058173,2,
Syne1,-0.07652229,0.0032453407,2,
Syne2,0.11091064,-0.11190199,1,
Syne3,-0.067230195,-0.08711233,2,
Syne4,-0.22980416,-0.11359888,2,
Syngap1,0.38901407,-0.2318238,1,['Regulation of RAS by GAPs']
Syngr1,0.016011283,-0.14341545,1,['Neutrophil degranulation']
Syngr2,-0.10507418,0.07442556,0,
Syngr3,-0.13581222,-0.12113156,2,
Syngr4,-0.27459064,-0.0131155895,2,
Synj1,0.23496243,-0.43887165,1,
Synj2,0.09312151,-0.26163068,1,"['Synthesis of PIPs at the plasma membrane', 'Clathrin-mediated endocytosis']"
Synj2bp,-0.14256455,-0.0067089763,2,
Synm,0.038263354,-0.26407093,1,
Synpo,0.17998041,-0.17447661,1,
Synpo2,0.041662328,-0.21154092,2,
Synpo2l,0.03174542,-0.13740204,2,
Synrg,0.064377576,-0.2355332,1,
Syp,0.25359485,-0.21024987,1,
Sypl2,-0.08241405,-0.0018311717,2,
Sys1,-0.09363136,-0.12847388,2,['Retrograde transport at the Trans-Golgi-Network']
Syt1,0.0007504803,-0.2897559,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'GABA synthesis, release, reuptake and degradation']"
Syt10,-0.30209944,0.04555455,2,
Syt11,-0.16479869,-0.17558543,2,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Syt12,-0.2737789,-0.12797564,2,
Syt13,-0.09699689,-0.17875247,2,
Syt14,-0.05836752,-0.09503172,2,
Syt15,-0.05698652,-0.036126733,2,
Syt16,-0.23084323,-0.36170012,2,
Syt2,-0.14508358,-0.18933176,2,
Syt3,-0.4991202,0.05021228,2,
Syt4,-0.16729301,-0.15297541,2,
Syt5,-0.026230529,-0.32011116,1,
Syt6,-0.2980247,0.13034052,2,
Syt7,-0.03667277,0.04000639,2,
Syt8,-0.2031113,-0.056334633,2,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Syt9,-0.35588065,-0.13393389,2,"['Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Sytl1,-0.29167703,0.108454086,2,
Sytl2,0.053327087,-0.066397905,1,
Sytl4,-0.088981695,-0.10083715,2,['Platelet degranulation ']
Sytl5,-0.0023686823,-0.058211245,2,
Syvn1,0.14908725,0.10316467,3,
Szrd1,-0.24890892,-0.029844705,2,
Szt2,-0.10657335,-0.026194362,2,['Amino acids regulate mTORC1']
T,0.17252167,0.019287974,3,
Taar1,-0.016651979,-0.07147205,2,"['Amine ligand-binding receptors', 'G alpha (s) signalling events']"
Taar2,-0.16008337,-0.14750127,2,"['Amine ligand-binding receptors', 'G alpha (s) signalling events']"
Taar3,-0.09276895,0.1471585,2,"['Amine ligand-binding receptors', 'G alpha (s) signalling events']"
Taar4,-0.15900803,0.037768006,2,
Taar5,-0.28833234,-0.414288,2,"['Amine ligand-binding receptors', 'G alpha (s) signalling events']"
Taar8a,-0.16740085,-0.070668384,2,"['Amine ligand-binding receptors', 'G alpha (s) signalling events']"
Taar8b,-0.21430174,0.08656109,2,"['Amine ligand-binding receptors', 'G alpha (s) signalling events']"
Tab1,0.39019698,0.02511089,3,"['NOD1/2 Signaling Pathway', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'TNFR1-induced NFkappaB signaling pathway', 'CLEC7A (Dectin-1) signaling', 'Ub-specific processing proteases', 'Interleukin-1 signaling', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Tab2,0.4589691,0.04996328,3,"['NOD1/2 Signaling Pathway', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'TNFR1-induced NFkappaB signaling pathway', 'CLEC7A (Dectin-1) signaling', 'Interleukin-1 signaling', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Tab3,0.38103387,-0.117635414,1,"['NOD1/2 Signaling Pathway', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'TNFR1-induced NFkappaB signaling pathway', 'CLEC7A (Dectin-1) signaling', 'Interleukin-1 signaling', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Tac1,0.2676503,-0.37449932,1,"['Tachykinin receptors bind tachykinins', 'G alpha (q) signalling events']"
Tac2,0.014131999,-0.1180605,2,"['Tachykinin receptors bind tachykinins', 'G alpha (q) signalling events']"
Tac4,-0.029704018,-0.29299662,2,
Tacc1,0.027838556,0.11102666,3,
Tacc2,-0.011513493,0.16268656,0,
Tacc3,0.2775213,0.32372984,3,
Taco1,-0.24851534,-0.13250333,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
Tacr1,0.17718238,-0.3166501,1,"['Tachykinin receptors bind tachykinins', 'G alpha (q) signalling events', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Tacr2,0.001491598,-0.08099168,2,"['Tachykinin receptors bind tachykinins', 'G alpha (q) signalling events']"
Tacr3,0.04165977,-0.1575969,1,"['Tachykinin receptors bind tachykinins', 'G alpha (q) signalling events']"
Tada1,0.1178069,0.1266048,3,
Tada2a,0.21632743,0.23069939,3,
Tada2b,0.27052674,0.35739103,3,['Ub-specific processing proteases']
Tada3,0.3764085,0.3234435,3,['Ub-specific processing proteases']
Taf1,0.35214722,0.4880329,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf10,0.3348402,0.29901236,3,"['Ub-specific processing proteases', 'RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf11,0.17915013,0.2579922,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf12,0.24839403,0.3732965,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf13,0.14235365,0.43137366,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf15,0.079262026,0.430584,0,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf1b,0.30588835,0.19101922,3,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Taf1c,0.26278704,0.26699334,3,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Taf1d,0.1834986,0.22494248,3,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Transcription Termination']"
Taf2,0.24863426,0.21547788,3,
Taf3,0.30165583,0.24982977,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf4,0.37467536,0.22570159,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf4b,0.36182544,0.22254267,3,
Taf5,0.1578762,0.30731478,0,
Taf5l,0.053056903,0.4288385,3,
Taf6,0.20933864,0.3885051,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf6l,0.10923496,0.28966382,3,
Taf7,0.29681662,0.4088031,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf7l,0.22688219,0.22651212,3,
Taf7l2,0.13676515,0.28280166,3,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf8,0.1078248,0.3117362,0,['RNA polymerase II transcribes snRNA genes']
Taf9,0.16036151,0.46053714,0,"['RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Taf9b,0.2811439,0.2157511,3,"['Ub-specific processing proteases', 'RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance']"
Tafa4,-0.094175756,0.008411099,2,
Tafa5,-0.32002002,-0.0034864452,2,
Tafazzin,-0.24947001,0.0007501121,2,['Acyl chain remodeling of CL']
Tagap1,-0.13245054,-0.13107373,2,
Tagln,0.13613321,-0.045919385,1,
Tagln2,0.13692603,-0.14379032,1,['Platelet degranulation ']
Tagln3,-0.061953314,-0.097564004,2,
Tal1,0.2316075,0.03826623,3,['RUNX1 regulates transcription of genes involved in differentiation of HSCs']
Tal2,0.02911673,-0.023972047,2,
Taldo1,-0.2062383,0.14750378,2,"['Insulin effects increased synthesis of Xylulose-5-Phosphate', 'Pentose phosphate pathway']"
Tamalin,0.20957345,-0.1013606,1,
Tamm41,-0.112774126,-0.077697374,2,
Tanc2,0.051371064,-0.07221174,1,
Tango2,-0.15758552,-0.11173365,2,
Tango6,-0.39243612,0.02775355,2,
Tank,0.40363577,0.14183173,3,['Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon']
Taok1,0.04829829,0.15741065,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Taok2,0.11080412,-0.00052419945,1,
Taok3,0.18667562,0.032900453,1,"['RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Tap1,0.13105756,0.036276057,1,"['ER-Phagosome pathway', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Tap2,-0.15579186,-0.030307176,2,"['ER-Phagosome pathway', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Tapbp,0.21701951,0.015365538,3,"['ER-Phagosome pathway', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC']"
Tapbpl,0.047383863,0.017339636,1,
Tapt1,-0.16516796,0.014962739,2,
Tarbp1,-0.11369019,0.21949522,0,
Tarbp2,-0.005254413,0.25495902,0,"['MicroRNA (miRNA) biogenesis', 'Small interfering RNA (siRNA) biogenesis']"
Tardbp,0.37753338,0.34749445,3,
Tars,-0.089590825,0.0773064,0,
Tars2,0.001099298,0.13681954,0,
Tarsl2,-0.15229055,-0.0817146,2,
Tas1r1,-0.05292011,-0.18348435,2,
Tas1r2,-0.036383685,-0.22671936,1,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas1r3,-0.054101594,-0.2239508,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r103,-0.28919095,-0.05424355,2,
Tas2r105,-0.0357947,-0.060535174,2,
Tas2r106,-0.19347885,-0.025740456,2,
Tas2r107,-0.20553905,-0.08645163,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r108,-0.3084927,-0.24891993,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r110,-0.10431296,-0.0061340425,2,
Tas2r118,-0.17791976,0.004261336,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r119,-0.027471416,-0.07959913,2,
Tas2r120,-0.14413556,-0.0326827,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r121,-0.055451944,-0.18639624,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r124,-0.16251944,-0.14618891,2,
Tas2r126,-0.057991695,-0.13736646,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r130,-0.36533272,-0.050671823,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r131,-0.2037003,-0.119507454,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)']"
Tas2r135,0.07774633,-0.19012071,2,
Tas2r136,0.026679492,-0.13640094,2,
Tas2r137,-0.16095619,-0.03414865,2,
Tas2r138,-0.14893052,-0.20560251,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r139,-0.030604517,-0.14772803,1,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r140,-0.11269826,-0.0057709,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tas2r144,0.021850264,0.033203717,2,"['G alpha (i) signalling events', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Sensory perception of sweet, bitter, and umami (glutamate) taste']"
Tasor,-0.13549474,0.017688189,2,
Tasor2,-0.23227789,-0.12666602,2,
Tat,-0.008847938,-0.1315723,1,['Tyrosine catabolism']
Tatdn1,-0.17577076,0.076195925,2,
Tatdn2,-0.18417503,-0.080613874,2,
Tatdn3,-0.27235213,0.014704473,2,
Tax1bp1,0.16773045,0.120979995,3,"['Regulation of TNFR1 signaling', 'Negative regulators of DDX58/IFIH1 signaling']"
Tax1bp3,0.07180584,-0.21536279,1,['RHO GTPases Activate Rhotekin and Rhophilins']
Tbata,-0.15604746,0.049280286,2,
Tbc1d1,0.27270377,-0.0158974,3,
Tbc1d10a,0.13921498,-0.028843464,1,['TBC/RABGAPs']
Tbc1d10b,-0.13435371,-0.1257335,2,['TBC/RABGAPs']
Tbc1d10c,0.047236525,0.011538995,2,"['Neutrophil degranulation', 'TBC/RABGAPs']"
Tbc1d12,-0.19391383,-0.29902261,2,
Tbc1d13,-0.18411364,0.039287243,2,['TBC/RABGAPs']
Tbc1d14,-0.21635637,-0.027876168,2,
Tbc1d15,-0.08174758,-0.24024883,2,['TBC/RABGAPs']
Tbc1d16,-0.028593812,-0.020948,2,['TBC/RABGAPs']
Tbc1d17,-0.016610747,-0.2213399,2,['TBC/RABGAPs']
Tbc1d19,-0.13359362,0.0054388964,2,
Tbc1d2,-0.02416725,0.10782454,0,['TBC/RABGAPs']
Tbc1d20,-0.08843146,-0.021314567,2,['COPII-mediated vesicle transport']
Tbc1d21,-0.14746676,0.0057590054,2,
Tbc1d22a,-0.13940445,0.12495526,2,
Tbc1d22b,-0.087225944,-0.10303267,2,
Tbc1d23,-0.047705043,-0.066222794,2,
Tbc1d24,-0.0075252727,-0.24081846,1,['TBC/RABGAPs']
Tbc1d25,-0.012153148,-0.1916983,2,['TBC/RABGAPs']
Tbc1d30,-0.023643624,-0.01989731,2,
Tbc1d31,-0.05637719,0.13687684,3,
Tbc1d32,-0.059598077,0.074769974,2,
Tbc1d4,0.3407141,-0.07869137,3,
Tbc1d5,0.06483147,-0.2307311,1,
Tbc1d7,0.26648048,-0.0055017276,1,['TBC/RABGAPs']
Tbc1d8,-0.1371617,-0.16118826,2,
Tbc1d8b,0.08155805,-0.075431705,1,['Golgi Associated Vesicle Biogenesis']
Tbc1d9,-0.03698627,-0.08967773,2,
Tbc1d9b,-0.21204704,-0.05652355,2,
Tbca,-0.069365986,0.02078037,2,
Tbcb,-0.093463115,-0.031602394,2,
Tbcc,-0.18458962,0.087287575,2,
Tbccd1,-0.10435536,-0.17234072,2,
Tbcd,-0.059653077,0.10263325,2,
Tbce,-0.06474807,-0.0218035,2,
Tbcel,-0.25946623,0.10914379,2,
Tbck,-0.14331265,-0.059044722,2,
Tbk1,0.36372226,0.09171498,3,"['DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'Regulation of innate immune responses to cytosolic DNA', 'STAT6-mediated induction of chemokines', 'IRF3-mediated induction of type I IFN', 'Interleukin-37 signaling', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon']"
Tbkbp1,0.15410475,0.06724951,3,
Tbl1x,0.40053847,0.1826674,3,"['Notch-HLH transcription pathway', 'Regulation of lipid metabolism by PPARalpha', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'Cytoprotection by HMOX1']"
Tbl1xr1,0.3107289,0.18275668,3,"['Notch-HLH transcription pathway', 'Regulation of lipid metabolism by PPARalpha', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'Cytoprotection by HMOX1']"
Tbl2,-0.22258656,-0.10327056,2,
Tbl3,-0.3236656,0.34291342,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Tbp,0.47906253,0.3330351,3,"['B-WICH complex positively regulates rRNA expression', 'RNA Polymerase II Pre-transcription Events', 'Regulation of TP53 Activity through Phosphorylation', 'RNA polymerase II transcribes snRNA genes', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase II Promoter Escape', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase II Transcription Initiation', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'Estrogen-dependent gene expression']"
Tbpl1,0.313085,0.24204832,3,
Tbpl2,0.26001555,0.16331233,3,
Tbr1,0.10188372,-0.1935965,1,
Tbrg1,0.090205304,-0.013685439,3,
Tbrg4,-0.19924755,-0.01552421,2,
Tbx1,-0.13187446,-0.095744,2,
Tbx15,0.11869509,-0.056123096,2,
Tbx18,0.061981793,-0.1105295,2,
Tbx19,-0.14242698,-0.111944094,2,
Tbx2,0.26094016,0.08325551,3,
Tbx20,0.008635007,-0.1136246,2,
Tbx21,0.41248202,-0.15017457,1,
Tbx22,-0.1543561,0.008340412,2,
Tbx3,0.2705925,-0.011635188,3,
Tbx4,-0.1673458,0.021639979,2,
Tbx5,0.29356366,0.09056657,3,['YAP1- and WWTR1 (TAZ)-stimulated gene expression']
Tbx6,0.009741343,-0.043654345,2,
Tbxa2r,0.07436412,-0.3299375,1,"['Prostanoid ligand receptors', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'Thromboxane signalling through TP receptor']"
Tbxas1,-0.13801953,0.013987266,2,"['Eicosanoids', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)']"
Tc2n,-0.19139573,0.0034393691,2,
Tcaf3,-0.21731412,-0.07970769,2,
Tcaim,-0.20489095,0.0488787,2,
Tcam1,-0.0068875193,-0.14565487,1,
Tcap,-0.0010492905,-0.13507845,2,['Striated Muscle Contraction']
Tcea1,0.21704154,0.4095964,3,"['Formation of RNA Pol II elongation complex ', 'RNA Polymerase II Pre-transcription Events', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'TP53 Regulates Transcription of DNA Repair Genes', 'RNA Polymerase II Transcription Elongation']"
Tcea2,0.10790076,0.3486792,0,
Tcea3,0.06071811,0.05829602,2,
Tceal1,-0.18795526,-0.08404254,2,
Tceal5,-0.03074046,-0.09677667,2,
Tceal7,-0.21574688,0.05066849,2,
Tceal8,-0.14197147,-0.023168627,2,
Tceanc,0.038074397,0.21684895,0,
Tceanc2,-0.091811776,0.34685975,0,
Tcerg1,-0.07135013,0.431427,0,
Tcerg1l,-0.23598365,0.28402463,0,
Tcf12,0.4038001,0.12673645,3,"['Myogenesis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Tcf15,-0.32134417,-0.057296798,2,
Tcf19,-0.082068674,0.47528425,3,
Tcf21,-0.04465803,0.09104188,2,
Tcf25,0.024078071,0.07746009,2,
Tcf3,0.40441766,0.09648859,3,"['Myogenesis', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Tcf4,0.3399253,0.07038311,3,['Myogenesis']
Tcf7,0.37420127,0.07041984,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Repression of WNT target genes', 'RUNX3 regulates WNT signaling']"
Tcf7l1,0.33676344,0.25630665,3,
Tcf7l2,0.3391048,0.18191753,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Ca2+ pathway', 'Repression of WNT target genes', 'Transcriptional Regulation by VENTX', 'RUNX3 regulates WNT signaling']"
Tchh,-0.09411841,-0.11386626,2,['Formation of the cornified envelope']
Tchhl1,-0.056448,-0.007175915,2,
Tchp,-0.041542992,0.004562294,2,
Tcirg1,-0.16031413,0.028037556,2,"['ROS and RNS production in phagocytes', 'Neutrophil degranulation', 'Insulin receptor recycling', 'Transferrin endocytosis and recycling', 'Amino acids regulate mTORC1', 'Ion channel transport']"
Tcl1,0.25229192,0.116389304,3,
Tcl1b1,0.1759837,-0.2009535,1,
Tcl1b2,0.15203725,-0.13570169,1,
Tcl1b3,-0.07276619,0.0631677,2,
Tcl1b4,0.062164407,-0.28418982,1,
Tcn2,-0.079544984,0.039543584,2,['Transport of RCbl within the body']
Tcof1,-0.10403806,0.12835473,0,
Tcp1,-0.041577477,0.37676817,0,"['Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding']"
Tcp10a,0.0197745,-0.0041838307,2,
Tcp10b,-0.11198363,0.10448904,2,
Tcp10c,-0.17867802,0.1892942,2,
Tcp11,-0.14897813,0.040660027,2,
Tcp11l1,-0.17618066,0.08338064,2,
Tcp11l2,-0.05932675,0.07383964,2,
Tcp11x2,-0.14445274,-0.09096403,2,
Tcstv1,-0.24720621,0.031058261,2,
Tcstv3,-0.26476276,-0.012496413,2,
Tcta,-0.2114373,-0.095743686,2,
Tcte2,-0.17078672,-0.07175569,2,
Tctn1,-0.21635097,-0.17662667,2,['Anchoring of the basal body to the plasma membrane']
Tctn3,-0.094334275,0.10835685,2,['Anchoring of the basal body to the plasma membrane']
Tdg,0.2221835,0.19293468,3,"['Cleavage of the damaged pyrimidine ', 'Displacement of DNA glycosylase by APEX1', 'SUMOylation of DNA damage response and repair proteins', 'TET1,2,3 and TDG demethylate DNA']"
Tdgf1,0.25012928,-0.017805817,1,
Tdh,-0.18397808,0.2025578,2,
Tdo2,-0.13427114,-0.28376204,1,['Tryptophan catabolism']
Tdp1,0.09019458,0.23663796,3,
Tdp2,0.12765688,0.23992127,3,['Nonhomologous End-Joining (NHEJ)']
Tdpoz1,-0.27700126,-0.2120916,2,
Tdpoz3,-0.06958078,0.22534555,3,
Tdpoz4,-0.06852775,0.077258356,2,
Tdpoz5,-0.25549492,0.16776319,0,
Tdpoz7,0.06428981,0.023758385,3,
Tdpoz9,-0.1684112,-0.116121456,2,
Tdrd1,0.056904998,0.11942754,3,
Tdrd12,-0.18024397,0.24571012,2,
Tdrd3,0.11106199,0.3187197,0,
Tdrd5,-0.036845423,0.018687317,2,
Tdrd6,-0.06628673,-0.010273124,2,
Tdrd7,-0.10959745,0.20275687,2,
Tdrd9,0.078704245,-0.008139993,3,
Tdrkh,0.046544775,-0.03736863,2,
Tdrp,-0.13603815,-0.11702699,2,
Tead1,0.1080283,-0.0660053,3,
Tead2,-0.016410617,-0.012044554,2,"['YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'RUNX3 regulates YAP1-mediated transcription']"
Tead3,-0.055785112,-0.029489445,2,"['YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'RUNX3 regulates YAP1-mediated transcription']"
Tead4,0.1115556,-0.038657576,3,"['YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'RUNX3 regulates YAP1-mediated transcription']"
Tec,0.31788328,-0.3145688,1,
Tecpr1,0.03594966,-0.06948325,2,
Tecpr2,-0.14392617,-0.026434897,2,
Tecr,-0.087958425,-0.09433442,2,['Synthesis of very long-chain fatty acyl-CoAs']
Tecrl,-0.15227267,0.04157747,2,['Synthesis of very long-chain fatty acyl-CoAs']
Tecta,-0.30079052,0.18677714,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Tectb,-0.18061273,-0.110083014,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Tedc1,-0.18959121,-0.03152548,2,
Tedc2,-0.2122934,0.1302186,2,
Teddm1a,-0.306155,0.13339621,2,
Teddm1b,-0.26343197,-0.13158515,2,
Teddm3,-0.2860604,0.12065913,2,
Tef,-0.061991148,0.065911524,2,
Tefm,-0.38896775,0.03900971,2,
Tek,0.456209,-0.24893942,1,"['Tie2 Signaling', 'RAF/MAP kinase cascade']"
Tekt1,-0.23825009,-0.03176091,2,
Tekt3,-0.19475658,0.082759544,2,
Tekt4,-0.16415024,0.05051143,2,
Tekt5,-0.25699538,-0.03528023,2,
Telo2,0.2286089,0.25408357,3,
Ten1,0.040050738,0.14969452,3,"['Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation']"
Tenm1,-0.23945102,-0.033366524,2,
Tenm2,-0.100287504,-0.25971603,2,
Tenm3,-0.03456606,-0.1751216,2,
Tenm4,-0.120096095,-0.035760127,2,
Tent2,-0.1841595,0.3576297,0,
Tent4a,-0.19066496,0.12764923,0,
Tent4b,-0.113869764,0.16749889,0,
Tent5c,-0.05823397,0.035453506,2,
Tent5d,-0.13278314,0.030842511,2,
Tep1,0.1796882,0.28751054,0,
Tepp,-0.023853408,0.009807932,2,
Tepsin,-0.26555422,-0.092598915,2,
Terb1,-0.18060616,0.27074525,2,
Terb2,-0.1883668,0.09831039,2,
Terf1,0.18372011,0.4197347,3,"['Telomere Extension By Telomerase', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Telomere C-strand synthesis initiation', 'Removal of the Flap Intermediate from the C-strand']"
Terf2,0.14355096,0.44808283,3,"['Telomere Extension By Telomerase', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Telomere C-strand synthesis initiation', 'Removal of the Flap Intermediate from the C-strand']"
Terf2ip,0.08172913,0.33485892,0,"['Telomere Extension By Telomerase', 'Polymerase switching on the C-strand of the telomere', 'Processive synthesis on the C-strand of the telomere', 'Telomere C-strand (Lagging Strand) Synthesis', 'Telomere C-strand synthesis initiation', 'Removal of the Flap Intermediate from the C-strand']"
Tert,0.5051184,0.369838,3,"['Telomere Extension By Telomerase', 'Formation of the beta-catenin:TCF transactivating complex']"
Tes,0.015553249,-0.026570808,2,
Tesc,-0.043243308,-0.18850479,2,
Tescl,-0.19119014,0.02473309,2,
Tesk1,-0.14387296,-0.10466504,2,['Regulation of cytoskeletal remodeling and cell spreading by IPP complex components']
Tesk2,-0.107802354,-0.00049285725,2,
Tesl1,-0.15584317,-0.008384171,2,
Tesl2,-0.07315233,0.1012794,2,
Tesmin,-0.0013636242,0.06962932,2,
Tespa1,0.06412403,-0.18814701,1,
Tet1,0.26497358,0.21996383,3,
Tet2,0.27384183,0.30490106,3,
Tet3,0.14392959,0.1126804,3,
Tex10,-0.07776025,0.51007617,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Tex101,-0.32526872,-0.23109637,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Tex11,-0.20505697,0.28384498,2,
Tex12,0.018856065,0.25121185,3,
Tex13a,-0.094957374,0.38149196,0,
Tex13b,-0.12259012,-0.08372882,2,
Tex14,0.016669774,0.23383465,3,
Tex15,-0.09486417,0.056733567,2,
Tex19.1,-0.086143605,0.11774552,2,
Tex19.2,-0.08561458,0.11317724,2,
Tex2,-0.10153424,-0.17979172,2,['RHOA GTPase cycle']
Tex21,-0.18923697,-0.10883843,2,
Tex22,-0.24956237,-0.19311348,2,
Tex24,-0.036554124,-0.06786594,2,
Tex264,-0.037028637,-0.15506512,2,['Platelet degranulation ']
Tex28,-0.032307003,-0.053056497,2,
Tex33,-0.15071401,-0.03161702,2,
Tex35,-0.3022863,-0.110428914,2,
Tex36,-0.2657671,0.033226836,2,
Tex48,-0.013207677,0.28099763,0,
Tex52,-0.31141344,-0.09352935,2,
Tex9,-0.17534249,-0.16234376,2,
Tfam,0.25499433,-0.01118298,1,['Mitochondrial transcription initiation']
Tfap2a,0.35321286,0.033426415,1,
Tfap2b,0.022358641,-0.07009571,2,"['Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Activation of the TFAP2 (AP-2) family of transcription factors']"
Tfap2c,0.29884276,0.16972077,3,"['SUMOylation of transcription factors', 'Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Activation of the TFAP2 (AP-2) family of transcription factors', 'TFAP2 (AP-2) family regulates transcription of cell cycle factors']"
Tfap2d,-0.009208913,0.12908569,3,"['Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Activation of the TFAP2 (AP-2) family of transcription factors']"
Tfap2e,0.04650567,0.12356922,3,"['Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Activation of the TFAP2 (AP-2) family of transcription factors']"
Tfap4,0.07454336,0.20236936,3,
Tfb1m,-0.21025111,0.04004094,2,
Tfb2m,-0.23175292,0.33468452,0,['Mitochondrial transcription initiation']
Tfcp2,0.1000051,-0.032630913,3,
Tfcp2l1,-0.12551044,0.15762909,2,
Tfdp1,0.5307546,0.34545115,3,"['G0 and Early G1', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Cyclin D associated events in G1', 'Transcriptional Regulation by E2F6']"
Tfdp2,0.35452414,0.21339385,3,
Tfe3,0.3028976,0.08688689,3,
Tfeb,0.29594657,-0.120885685,1,
Tff1,0.16958225,-0.32205254,1,
Tff2,0.14520836,-0.15467472,1,
Tff3,0.111434825,-0.11356611,1,
Tfg,0.052697018,-0.07084595,2,['COPII-mediated vesicle transport']
Tfip11,-0.22515003,0.41906998,0,
Tfpi,0.08217074,-0.16246901,1,['Extrinsic Pathway of Fibrin Clot Formation']
Tfpi2,-0.08123175,0.15130691,2,
Tfpt,0.06336702,0.28253126,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Tfr2,-0.074582435,-0.19654514,2,['Transferrin endocytosis and recycling']
Tfrc,0.20254934,-0.33270252,1,"['Golgi Associated Vesicle Biogenesis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'Transferrin endocytosis and recycling', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Tg,0.1923877,-0.17317681,1,
Tgds,-0.15174969,0.08583215,2,
Tgfa,0.19126743,-0.3448767,1,"['PIP3 activates AKT signaling', 'Signaling by EGFR', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'SHC1 events in EGFR signaling', 'EGFR downregulation', 'COPII-mediated vesicle transport', 'EGFR interacts with phospholipase C-gamma', 'RAF/MAP kinase cascade', 'Cargo concentration in the ER', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Extra-nuclear estrogen signaling']"
Tgfb1,0.5802862,-0.18197744,1,"['Platelet degranulation ', 'Cell surface interactions at the vascular wall', 'Molecules associated with elastic fibres', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling activates SMADs', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Syndecan interactions', 'RUNX3 regulates CDKN1A transcription', 'Regulation of RUNX3 expression and activity', 'RUNX3 regulates p14-ARF']"
Tgfb1i1,0.4485991,-0.26430258,1,
Tgfb2,0.20514265,-0.14600132,1,"['Platelet degranulation ', 'Molecules associated with elastic fibres', 'TGF-beta receptor signaling activates SMADs']"
Tgfb3,0.4023981,-0.18106025,1,
Tgfbi,0.14772959,-0.24013688,1,
Tgfbr1,0.45217144,-0.08547226,1,"['Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling activates SMADs', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Ub-specific processing proteases']"
Tgfbr2,0.44567078,-0.08708771,1,"['Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling activates SMADs', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)']"
Tgfbr3,0.06651164,-0.012456553,1,
Tgfbr3l,-0.053306673,0.039320055,2,
Tgfbrap1,0.18039607,0.0031032714,1,
Tgif1,0.25236422,0.16877346,3,['Downregulation of SMAD2/3:SMAD4 transcriptional activity']
Tgif2,0.20604649,0.008350284,1,['Downregulation of SMAD2/3:SMAD4 transcriptional activity']
Tgif2lx1,-0.09094628,0.05561304,2,
Tgif2lx2,0.10403043,0.04330745,3,
Tgm1,-0.14487058,-0.0095880125,2,
Tgm2,0.38869584,-0.06729022,1,
Tgm3,-0.24203116,-0.28144717,2,
Tgm4,-0.19655445,0.2274356,2,
Tgm5,-0.14469966,-0.16426659,2,
Tgoln1,0.11487068,-0.23207149,1,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Golgi Associated Vesicle Biogenesis', 'Retrograde transport at the Trans-Golgi-Network', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Post-translational protein phosphorylation']"
Tgs1,-0.0605836,0.3398526,0,"['snRNP Assembly', 'Regulation of lipid metabolism by PPARalpha', 'Cytoprotection by HMOX1']"
Tgtp1,-0.10343112,0.21230173,2,
Th,0.23274988,-0.47543418,1,['Catecholamine biosynthesis']
Tha1,-0.11310733,0.07598188,2,
Thada,-0.13628815,0.007842916,2,
Thap1,0.17543462,0.0346614,3,
Thap11,0.061224688,0.1260869,3,
Thap12,-0.38793954,-0.08011593,2,
Thap3,0.05463271,0.14625344,3,
Thap4,-0.2684755,-0.12219209,2,
Thap7,-0.1245898,-0.18315135,2,
Thbd,0.16553956,-0.011568692,1,"['Common Pathway of Fibrin Clot Formation', 'Cell surface interactions at the vascular wall']"
Thbs1,0.30223915,-0.2692671,1,
Thbs2,0.2861763,-0.24006855,1,"['Signaling by PDGF', 'O-glycosylation of TSR domain-containing proteins']"
Thbs3,0.07457301,-0.22452068,1,['Signaling by PDGF']
Thbs4,0.1652699,-0.3585356,1,['Signaling by PDGF']
Thegl,0.015724089,0.0915676,0,
Them4,0.12596095,-0.038538855,3,"['PIP3 activates AKT signaling', 'Activation of AKT2', 'Negative regulation of the PI3K/AKT network', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability', 'Mitochondrial Fatty Acid Beta-Oxidation']"
Them5,-0.122742586,-0.040150665,2,['Mitochondrial Fatty Acid Beta-Oxidation']
Them6,-0.15956305,-0.01837165,2,
Them7,-0.1682812,-0.00998107,2,
Themis,0.05469687,0.009462572,2,
Themis2,0.17071913,-0.24702276,1,
Themis3,-0.21819633,-0.15755641,2,
Thg1l,-0.23169325,0.036901597,2,
Thnsl2,-0.18647878,-0.008030295,2,
Thoc1,-0.1597233,0.3158155,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Thoc2,0.06620785,0.36926702,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Thoc2l,-0.016608777,0.29174566,0,
Thoc3,-0.115949735,0.1256477,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Thoc5,0.08048745,0.18603921,0,
Thoc6,-0.11876027,0.3112913,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Thoc7,-0.1350846,0.3373978,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
Thop1,0.044773288,-0.025831576,2,
Thpo,0.15931614,-0.2097549,1,
Thra,0.48896915,0.053323526,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Thrap3,0.07344636,0.28527108,3,
Thrb,0.4761616,-0.102485694,3,"['Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Thrsp,-0.32266548,-0.15337846,2,['Carnitine metabolism']
Thsd1,0.054524217,0.03644157,1,
Thsd4,0.17881106,-0.09254957,1,['O-glycosylation of TSR domain-containing proteins']
Thsd7b,0.082949646,0.0878065,0,['O-glycosylation of TSR domain-containing proteins']
Thtpa,-0.42360327,0.012782362,2,['Vitamin B1 (thiamin) metabolism']
Thumpd1,-0.124812484,0.19219987,0,
Thumpd2,-0.18281513,0.1681367,2,
Thumpd3,-0.15931176,-0.05336951,2,
Thy1,0.43832093,-0.27008963,1,['Post-translational modification: synthesis of GPI-anchored proteins']
Thyn1,-0.20853254,0.072258726,2,
Tia1,0.17006849,0.5539589,0,
Tial1,0.15922353,0.47831056,0,
Tiam1,0.5285583,-0.36708814,1,
Tiam2,0.253168,-0.049601324,1,"['NRAGE signals death through JNK', 'G alpha (12/13) signalling events', 'RAC1 GTPase cycle']"
Ticam1,0.2783043,0.08917344,3,"['Caspase activation via Death Receptors in the presence of ligand', 'MyD88-independent TLR4 cascade ', 'TRIF-mediated programmed cell death', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IKK complex recruitment mediated by RIP1', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Ticam2,0.3187156,0.02881567,3,"['Caspase activation via Death Receptors in the presence of ligand', 'Toll Like Receptor 4 (TLR4) Cascade', 'MyD88-independent TLR4 cascade ', 'TRIF-mediated programmed cell death', 'Neutrophil degranulation', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IKK complex recruitment mediated by RIP1', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Ticrr,0.088907905,0.35749996,3,
Tie1,0.3163951,-0.23959473,1,
Tifa,0.1618943,0.07455982,3,"['TAK1-dependent IKK and NF-kappa-B activation  ', 'Alpha-protein kinase 1 signaling pathway']"
Tigar,-0.11438354,0.094814055,2,['TP53 Regulates Metabolic Genes']
Tigd2,-0.15365069,-0.039000638,2,
Tigd3,-0.09899208,-0.09607106,2,
Tigd4,-0.026572555,-0.0060658883,2,
Tigit,0.18220197,-0.13603742,1,
Timd2,-0.1129007,-0.041093264,2,
Timd4,0.04614729,0.055762265,3,
Timeless,0.16430621,0.42181274,3,['Processing of DNA double-strand break ends']
Timm10,-0.013471121,0.30956835,0,
Timm10b,-0.08579464,-0.043027308,2,
Timm13,-0.0125144,0.26137143,0,
Timm17a,0.056190554,0.007328998,1,
Timm17b,-0.10408235,-0.0077712582,0,
Timm21,-0.026064614,0.04284068,2,
Timm22,-0.032385845,0.110229015,0,
Timm23,-0.06303513,0.17020267,0,
Timm29,-0.23024143,-0.02946691,2,
Timm44,0.16554987,0.09262063,0,
Timm50,0.065539084,0.06979129,0,
Timm8a1,-0.11900768,0.1541106,0,
Timm8a2,-0.049320918,-0.021970568,0,
Timm8b,0.049742483,0.06412458,0,
Timm9,0.004145329,0.10336013,0,
Timmdc1,-0.027240314,0.08292666,2,['Complex I biogenesis']
Timp1,0.22444358,-0.26084474,1,"['Platelet degranulation ', 'Activation of Matrix Metalloproteinases', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Timp2,0.20081541,-0.3247758,1,
Timp3,0.1751084,-0.20775819,1,['Platelet degranulation ']
Timp4,0.091463454,-0.2740752,1,
Tinag,-0.15404718,0.045900613,2,
Tinagl1,0.10800365,-0.21369213,1,
Tinf2,0.038338125,0.2866866,3,
Tiparp,-0.20677969,-0.024991985,2,
Tipin,0.1640062,0.31655005,3,['Processing of DNA double-strand break ends']
Tiprl,-0.08721833,0.0724251,2,
Tirap,0.23955633,0.0842938,1,
Tjap1,0.094420604,0.065720074,1,
Tjp1,0.49340838,-0.2527457,1,"['Regulation of gap junction activity', 'Signaling by Hippo', 'Apoptotic cleavage of cell adhesion  proteins']"
Tjp2,0.45867503,-0.15250587,1,"['Signaling by Hippo', 'Apoptotic cleavage of cell adhesion  proteins', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle']"
Tjp3,0.09160954,-0.17367521,1,
Tk1,0.03024408,0.2827402,3,['Pyrimidine salvage']
Tk2,-0.12358501,0.31059873,3,
Tkfc,-0.16132188,0.0077448916,2,['Fructose catabolism']
Tkt,-0.21996324,0.04911249,2,"['Insulin effects increased synthesis of Xylulose-5-Phosphate', 'Pentose phosphate pathway']"
Tktl1,-0.13502237,0.17641927,0,
Tktl2,-0.17957841,0.22185823,0,
Tlcd1,-0.26957536,0.08050005,2,
Tlcd2,-0.20309089,0.100872055,2,
Tlcd3a,-0.40736842,-0.010962632,2,
Tlcd3b,-0.19253147,-0.026220892,2,
Tlcd4,-0.04580097,-0.08456426,2,
Tlcd5,-0.1545958,-0.06272439,2,
Tle1,0.28562915,0.06997846,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Repression of WNT target genes']"
Tle2,0.30646986,0.17106158,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Repression of WNT target genes']"
Tle3,0.3152168,0.10610316,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Repression of WNT target genes', 'Estrogen-dependent gene expression']"
Tle4,0.25312403,0.27401882,3,"['Formation of the beta-catenin:TCF transactivating complex', 'Deactivation of the beta-catenin transactivating complex', 'Repression of WNT target genes']"
Tle5,0.18370822,0.026844673,3,
Tle6,-0.24555622,0.026889473,2,
Tlk1,0.018240187,0.33761004,3,
Tlk2,-0.05927619,0.369626,3,
Tll1,0.10605341,-0.05486557,1,
Tll2,0.028966796,-0.10434748,1,"['Collagen biosynthesis and modifying enzymes', 'Anchoring fibril formation', 'Crosslinking of collagen fibrils']"
Tln1,0.30568317,-0.4394521,1,"['Platelet degranulation ', 'Integrin signaling', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'p130Cas linkage to MAPK signaling for integrins', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'Smooth Muscle Contraction', 'MAP2K and MAPK activation']"
Tln2,0.088383995,-0.43703637,1,
Tlnrd1,-0.21354681,0.027618412,2,
Tlr1,0.31942385,0.006187105,1,"['Beta defensins', 'Regulation of TLR by endogenous ligand']"
Tlr11,-0.10697472,-0.010330135,2,
Tlr12,-0.025281345,-0.017296994,2,
Tlr13,0.086747386,-0.035772555,1,
Tlr2,0.4548243,-0.12507442,1,
Tlr3,0.31892988,-0.025533494,1,
Tlr4,0.558432,-0.15144767,1,"['Caspase activation via Death Receptors in the presence of ligand', 'Toll Like Receptor 4 (TLR4) Cascade', 'MyD88-independent TLR4 cascade ', 'TRIF-mediated programmed cell death', 'Regulation of TLR by endogenous ligand', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IKK complex recruitment mediated by RIP1', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Heme signaling', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation']"
Tlr6,0.31254464,0.089904636,1,['Regulation of TLR by endogenous ligand']
Tlr7,0.30015808,0.028254975,1,"['Trafficking and processing of endosomal TLR', 'Toll Like Receptor 7/8 (TLR7/8) Cascade']"
Tlr8,0.11228896,-0.0832254,1,['Trafficking and processing of endosomal TLR']
Tlr9,0.36864558,-0.026050452,1,"['PI3K Cascade', 'Trafficking and processing of endosomal TLR', 'Toll Like Receptor 9 (TLR9) Cascade']"
Tlx1,0.045357045,-0.022816818,3,
Tlx2,-0.33848143,0.01660408,2,
Tlx3,0.004315456,0.11634018,3,
Tm2d1,-0.2725221,0.055638727,2,
Tm2d2,-0.15430304,0.03462155,2,
Tm2d3,-0.2834486,-0.12385761,2,
Tm4sf1,0.046570465,-0.10640004,1,
Tm4sf19,-0.051062115,0.073147036,2,
Tm4sf20,-0.13535182,-0.0088175675,2,
Tm4sf4,-0.17783587,-0.008022932,2,
Tm4sf5,-0.019422997,-0.2349866,1,
Tm6sf1,-0.09788664,-0.038327333,2,
Tm6sf2,-0.16793004,0.11841306,2,
Tm7sf2,-0.33300772,0.035658162,2,['Cholesterol biosynthesis']
Tm7sf3,-0.2145798,-0.1640312,2,
Tm9sf1,-0.08907523,0.2963231,0,
Tm9sf2,-0.30180287,-0.0673446,2,
Tm9sf3,-0.44545352,0.023365319,2,
Tm9sf4,-0.25393572,0.168514,2,
Tma16,0.08944517,0.258926,0,
Tma7,0.02372357,0.10420228,3,
Tmbim1,-0.040685106,0.1136006,0,
Tmbim4,-0.114161365,-0.16112696,2,
Tmbim6,0.093832895,-0.122425996,1,
Tmbim7,-0.1350537,-0.018613506,2,
Tmc1,-0.18160804,-0.23582523,2,
Tmc2,-0.07696739,-0.23739523,2,
Tmc3,-0.15409373,7.050084e-05,2,
Tmc6,-0.1515108,-0.124092095,2,
Tmc8,-0.18788068,0.023898259,2,
Tmcc1,-0.08293764,-0.015298956,2,
Tmcc2,0.066143565,0.13833311,3,
Tmcc3,-0.060375165,0.04866434,2,
Tmco1,-0.10404118,0.09692148,2,
Tmco2,-0.33688015,0.14711379,2,
Tmco5,-0.3149457,0.015066305,2,
Tmco5b,-0.20492534,-0.019345788,2,
Tmed1,-0.27343017,-0.22367191,2,
Tmed10,-0.023145571,-0.11254239,2,"['COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Tmed11,-0.11353637,-0.12054533,2,
Tmed2,0.08179247,-0.1220195,1,"['Pre-NOTCH Processing in Golgi', 'COPII-mediated vesicle transport', 'Cargo concentration in the ER', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Tmed3,-0.24680024,-0.098979875,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Tmed4,-0.19778304,-0.2665187,2,
Tmed5,-0.095604666,-0.1790874,2,['WNT ligand biogenesis and trafficking']
Tmed6,-0.22293687,-0.3326136,2,
Tmed7,-0.091884576,-0.19837789,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Tmed9,-0.26780072,-0.13020463,2,"['COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic']"
Tmeff1,-0.2125874,0.03743995,2,
Tmeff2,-0.17359327,0.20267442,2,
Tmem104,-0.2785406,-0.1632181,2,
Tmem106b,-0.0056611183,-0.011733194,2,
Tmem107,-0.13292578,-0.10327655,2,
Tmem108,0.1254065,-0.059502438,1,
Tmem11,-0.13127674,0.04507967,2,
Tmem114,-0.19812854,-0.06762136,2,
Tmem115,-0.02169868,0.014392406,2,['COPI-mediated anterograde transport']
Tmem116,-0.21317935,-0.18175368,2,
Tmem117,-0.075595506,-0.11304376,2,
Tmem119,0.014219542,-0.2576491,2,
Tmem120a,-0.11672339,-0.04395062,2,
Tmem120b,-0.10079054,0.12665053,2,
Tmem125,-0.17333624,0.010087388,2,
Tmem126a,-0.080891676,0.016412599,2,
Tmem126b,-0.13972943,-0.15172367,2,['Complex I biogenesis']
Tmem127,0.096160986,-0.14415707,2,
Tmem128,-0.314094,-0.30185366,2,
Tmem129,0.09070089,0.18117994,3,
Tmem131,-0.2400983,0.14182857,2,
Tmem131l,-0.062131017,-0.12903045,2,
Tmem132a,-0.3944005,-0.026032964,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Tmem138,-0.14499806,0.0023607435,2,
Tmem141,-0.26244938,0.024874898,2,
Tmem144,-0.25686935,0.043245744,2,
Tmem145,0.030826904,-0.21605252,1,
Tmem147,-0.008780835,0.06878559,2,
Tmem14c,-0.21508677,0.23191456,2,
Tmem150a,-0.011051137,-0.006553681,2,
Tmem150b,-0.13158104,-0.14898212,2,
Tmem151a,-0.1629853,-0.08477329,2,
Tmem156,-0.27517697,0.0034589309,2,
Tmem159,-0.19761382,-0.07398815,2,
Tmem160,-0.15652765,0.10716846,2,
Tmem161a,-0.116425715,-0.11273672,2,
Tmem163,-0.12423506,-0.17080966,2,
Tmem164,-0.1871238,0.021597188,2,
Tmem165,-0.123257495,0.093917236,2,
Tmem167,-0.11138419,-0.12675627,2,
Tmem168,-0.2532061,-0.14930293,2,
Tmem169,-0.35928667,-0.12742619,2,
Tmem17,-0.011382844,-0.034654077,2,
Tmem170b,-0.07178977,-0.19721493,2,
Tmem171,-0.26012585,0.039250474,2,
Tmem174,-0.32390514,0.24140933,2,
Tmem175,0.15239514,0.004196279,3,
Tmem176a,-0.24524702,-0.16888736,2,
Tmem176b,-0.08824568,-0.10746395,2,
Tmem177,-0.17759164,-0.00834437,2,
Tmem178,-0.13811564,-0.111095086,2,
Tmem179,-0.16951881,0.07592757,2,
Tmem18,-0.057699952,-0.24117371,2,
Tmem181a,-0.043416794,0.069934316,2,
Tmem182,-0.12868181,-0.2547816,2,
Tmem183a,-0.3008166,0.14509258,2,
Tmem184b,0.10683199,-0.066618755,1,
Tmem184c,-0.32891974,-0.043042567,2,
Tmem185a,-0.14852604,-0.07092933,2,
Tmem19,0.036108855,0.08007147,3,
Tmem190,-0.03261518,-0.13232242,2,
Tmem196,-0.045374986,-0.081150904,2,
Tmem198b,-0.24065346,0.0113036465,2,
Tmem199,-0.040388566,-0.12396471,2,
Tmem200a,-0.20682785,0.08019273,2,
Tmem201,0.0009022547,0.20118195,3,
Tmem202,-0.19825152,-0.12911981,2,
Tmem204,-0.20518227,0.014577656,2,
Tmem207,-0.36927578,-0.09362822,2,
Tmem208,-0.08672051,0.01662036,2,
Tmem209,0.01366926,-0.06892854,2,
Tmem213,-0.39001402,-0.008092366,2,
Tmem216,-0.1305567,-0.10012105,2,['Anchoring of the basal body to the plasma membrane']
Tmem218,-0.114163816,-0.14450389,2,
Tmem219,-0.029846733,-0.19213638,1,['TP53 Regulates Transcription of Death Receptors and Ligands']
Tmem220,-0.15595683,-0.19943014,2,
Tmem225,-0.26701447,-0.11921098,2,
Tmem229b,-0.110443994,-0.23299803,1,
Tmem230,-0.061927818,-0.17780218,2,
Tmem231,-0.09170333,-0.053733602,2,
Tmem233,-0.07237618,-0.13604085,2,
Tmem235,-0.16576926,0.09996679,2,
Tmem236,-0.20249946,-0.0720513,2,
Tmem237,-0.1726188,0.016121237,2,
Tmem242,-0.20466685,0.03986596,0,
Tmem245,-0.059060954,0.05361913,2,
Tmem25,-0.08343227,0.060526565,2,
Tmem251,-0.16447134,-0.020639468,2,
Tmem252,-0.27463123,0.06722295,2,
Tmem254,-0.2778921,-0.11249663,2,
Tmem256,-0.044707995,-0.07934895,2,
Tmem258,-0.19324085,-0.0490166,2,
Tmem259,-0.23037143,-0.068244696,2,
Tmem26,-0.016495321,-0.07779347,2,
Tmem260,-0.053311538,0.13427106,2,
Tmem262,-0.03431625,0.13213398,2,
Tmem269,-0.15386575,0.16024786,2,
Tmem270,-0.22290492,-0.23374064,2,
Tmem30a,-0.1798994,0.1326107,2,['Neutrophil degranulation']
Tmem30b,-0.14087076,0.017982626,2,
Tmem30c,-0.10564855,0.10155672,2,
Tmem33,-0.3259452,-0.118422166,2,
Tmem35a,-0.25079829,-0.0694028,2,
Tmem37,-0.17528863,-0.03553261,2,
Tmem38a,-0.19249198,-0.23833637,2,
Tmem38b,-0.043051068,-0.10161539,2,
Tmem39a,-0.20855935,-0.010175473,2,
Tmem39b,0.07548204,0.08589605,0,
Tmem43,0.149838,0.08918718,1,
Tmem44,0.03663811,-0.08576903,1,
Tmem50a,-0.18937506,-0.081961766,2,
Tmem50b,-0.009025238,-0.03339436,2,
Tmem52,-0.28866547,0.04584287,2,
Tmem52b,-0.15051079,-0.09454605,2,
Tmem53,-0.23758845,-0.03612056,2,
Tmem54,0.012337981,-0.002860068,2,
Tmem59,-0.29806516,-0.085349716,2,"['RHOH GTPase cycle', 'RND1 GTPase cycle']"
Tmem59l,-0.24172115,-0.047638014,2,
Tmem60,-0.1723093,0.090528436,2,
Tmem63a,-0.10786653,-0.13298996,2,['Neutrophil degranulation']
Tmem63b,-0.3325221,-0.1306073,2,
Tmem63c,-0.29810515,-0.12924476,2,
Tmem64,-0.11192102,0.003302122,2,
Tmem67,0.08739484,-0.08335881,1,
Tmem68,-0.18565437,0.08579817,2,
Tmem69,-0.041577518,0.10967898,2,
Tmem70,-0.017382467,-0.1428223,2,
Tmem74,-0.24623871,0.26428512,2,
Tmem81,-0.23811843,0.16191739,2,
Tmem82,-0.13629974,0.056139126,2,
Tmem86a,-0.021832433,-0.1132298,1,
Tmem86b,-0.28776723,-0.14052323,2,['Acyl chain remodelling of PC']
Tmem88,0.043947086,0.10901221,3,
Tmem9,-0.12539032,0.057369694,2,
Tmem91,-0.09961866,-0.046960805,2,
Tmem92,-0.32495877,-0.027770175,2,
Tmem94,-0.20953506,-0.11517643,2,
Tmem95,-0.19604336,-0.03225781,2,
Tmem98,-0.19831623,-0.12883064,2,
Tmf1,-0.26162758,-0.038791645,2,['Retrograde transport at the Trans-Golgi-Network']
Tmie,-0.01144043,-0.05618899,2,
Tmigd1,-0.23653376,-0.15491597,2,
Tmigd3,0.0067679887,-0.09476147,1,
Tmod1,0.03864798,-0.019178957,3,['Striated Muscle Contraction']
Tmod2,-0.014178269,-0.04221349,2,['Striated Muscle Contraction']
Tmod3,0.052871946,-0.04797313,1,"['Striated Muscle Contraction', 'RHOBTB2 GTPase cycle', 'RND3 GTPase cycle']"
Tmod4,-0.085143976,0.059152503,2,['Striated Muscle Contraction']
Tmpo,0.043289967,0.22722964,3,
Tmppe,-0.16372755,-0.07815594,2,
Tmprss11a,-0.15256408,0.10639553,2,
Tmprss11c,0.00063333963,0.03707063,2,
Tmprss11e,0.04773952,-0.06990367,1,
Tmprss11f,-0.21278732,-0.16612442,2,
Tmprss13,-0.12835413,-0.023423832,2,
Tmprss15,-0.07092022,-0.10286949,2,
Tmprss2,0.17421365,-0.18190376,1,
Tmprss3,-0.05831593,-0.106545866,2,
Tmprss4,-0.12442334,-0.20886792,2,
Tmprss6,0.024316035,-0.13792636,1,"['Collagen degradation', 'Degradation of the extracellular matrix']"
Tmprss7,-0.089494035,-0.23001248,2,
Tmprss9,-0.31106403,-0.23981531,2,
Tmsb15l,-0.08059331,-0.094272256,2,
Tmsb4x,0.18877383,-0.15161392,1,['Platelet degranulation ']
Tmtc3,-0.33699313,-0.27343687,2,
Tmtc4,-0.19504508,-0.059185263,2,
Tmub1,-0.07537586,0.11184131,2,
Tmx1,-0.18036947,0.036829274,2,
Tmx2,-0.1737004,-0.06656797,2,
Tmx3,-0.1902513,0.101920344,2,['Platelet degranulation ']
Tmx4,-0.06628849,0.14808747,0,
Tnc,0.04449044,-0.40340272,1,"['Integrin cell surface interactions', 'ECM proteoglycans', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Tnf,0.46901688,-0.10975098,1,"['TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'TNFR1-mediated ceramide production', 'TNFR2 non-canonical NF-kB pathway', 'TNF signaling']"
Tnfaip1,0.03932893,0.019616919,2,"['RND3 GTPase cycle', 'RND2 GTPase cycle']"
Tnfaip2,0.120023526,-0.02867452,1,
Tnfaip3,0.19738832,-0.007088553,3,"['NOD1/2 Signaling Pathway', 'TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Ovarian tumor domain proteases', 'Negative regulators of DDX58/IFIH1 signaling']"
Tnfaip6,0.089600034,-0.03726135,1,['Neutrophil degranulation']
Tnfaip8,-0.06284067,0.0011958233,2,['PI Metabolism']
Tnfaip8l1,-0.16611388,-0.06506121,2,['PI Metabolism']
Tnfaip8l2,0.16892277,0.092326835,0,['PI Metabolism']
Tnfaip8l3,-0.17088467,0.057170663,2,['PI Metabolism']
Tnfrsf10b,0.30936033,0.0404435,1,"['Cell surface interactions at the vascular wall', 'Regulation by c-FLIP', 'CASP8 activity is inhibited', 'Dimerization of procaspase-8', 'TRAIL  signaling']"
Tnfrsf11a,0.0713099,-0.07104465,2,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfrsf11b,0.24498567,-0.0557878,1,['TNFs bind their physiological receptors']
Tnfrsf12a,0.12930694,-0.21527642,1,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfrsf13b,0.119050816,-0.20202036,1,['TNFs bind their physiological receptors']
Tnfrsf13c,0.1397162,-0.24773173,1,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfrsf14,0.15372513,-0.2796186,1,"['Costimulation by the CD28 family', 'TNFs bind their physiological receptors']"
Tnfrsf17,0.0517361,-0.1326043,1,['TNFs bind their physiological receptors']
Tnfrsf18,0.22668813,0.0872797,1,['TNFs bind their physiological receptors']
Tnfrsf19,0.05426184,-0.10851698,2,
Tnfrsf1a,0.47996733,-0.06939948,1,"['TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'TNFR1-mediated ceramide production', 'TNFs bind their physiological receptors', 'TNF signaling']"
Tnfrsf1b,0.31034797,-0.03366171,1,"['TNFR2 non-canonical NF-kB pathway', 'TNFs bind their physiological receptors', 'Neutrophil degranulation']"
Tnfrsf21,0.09676229,-0.12386002,1,
Tnfrsf22,-0.2016822,0.09761521,2,
Tnfrsf23,0.18812402,-0.05533659,1,
Tnfrsf25,0.3175837,0.030889016,1,['TNFs bind their physiological receptors']
Tnfrsf4,0.25589636,-0.16780831,1,
Tnfrsf8,0.31057242,-0.2450814,1,['TNFs bind their physiological receptors']
Tnfrsf9,0.20253281,-0.090430744,1,['TNFs bind their physiological receptors']
Tnfsf10,0.38459855,0.050794646,3,"['Regulation by c-FLIP', 'CASP8 activity is inhibited', 'Dimerization of procaspase-8', 'TRAIL  signaling']"
Tnfsf11,0.3136344,-0.28274435,1,"['TNFR2 non-canonical NF-kB pathway', 'TNFs bind their physiological receptors', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfsf12,0.21006803,-0.09875893,1,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfsf13,0.14312613,0.1818657,3,
Tnfsf13b,0.14381371,0.00070790155,1,"['TNFR2 non-canonical NF-kB pathway', 'TNFs bind their physiological receptors', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfsf14,0.20009114,-0.18490906,1,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway']"
Tnfsf15,0.12681335,0.00022237044,1,
Tnfsf18,0.05474313,0.038255032,1,['TNFs bind their physiological receptors']
Tnfsf4,0.1504645,-0.047601443,1,['TNFs bind their physiological receptors']
Tnfsf8,-0.15521798,-0.026310861,2,['TNFs bind their physiological receptors']
Tnfsf9,0.13106534,-0.03149372,1,['TNFs bind their physiological receptors']
Tnfsfm13,0.035976056,-0.1622729,1,
Tnik,0.25040635,-0.21736562,1,['Oxidative Stress Induced Senescence']
Tnip1,0.1911408,0.07696924,3,['Ovarian tumor domain proteases']
Tnip2,0.30441248,0.04358952,3,"['MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Ovarian tumor domain proteases']"
Tnip3,-0.22870004,0.014135706,2,['Ovarian tumor domain proteases']
Tnk2,0.19975713,-0.387008,1,
Tnks,0.3730903,0.118141994,3,"['TCF dependent signaling in response to WNT', 'Degradation of AXIN', 'Ub-specific processing proteases', 'Regulation of PTEN stability and activity']"
Tnks1bp1,-0.07016201,0.33203757,0,"['Deadenylation of mRNA', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain']"
Tnks2,0.22955479,0.14633115,3,"['TCF dependent signaling in response to WNT', 'Degradation of AXIN', 'Ub-specific processing proteases', 'Regulation of PTEN stability and activity']"
Tnmd,0.067255706,-0.19903176,1,
Tnn,0.072673574,-0.32262912,1,['ECM proteoglycans']
Tnnc1,-0.008961832,-0.15422818,2,['Striated Muscle Contraction']
Tnnc2,-0.11368185,-0.06747321,2,['Striated Muscle Contraction']
Tnni1,0.01721591,-0.09864093,2,['Striated Muscle Contraction']
Tnni2,0.028645014,-0.058595568,2,['Striated Muscle Contraction']
Tnni3,0.18080339,-0.2475,1,"['Striated Muscle Contraction', 'Ion homeostasis']"
Tnni3k,-0.16996163,-0.023840275,2,
Tnnt1,-0.09346984,-0.20418338,2,['Striated Muscle Contraction']
Tnnt2,0.08115551,-0.168816,2,['Striated Muscle Contraction']
Tnnt3,-0.062061924,-0.18111402,2,
Tnp1,0.12599443,0.27191487,3,
Tnp2,0.18332194,0.27930397,3,
Tnpo1,0.17591955,0.47456986,0,"['Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'Intraflagellar transport']"
Tnpo2,0.11453525,0.1907746,3,
Tnpo3,0.011839208,0.4638168,0,
Tnr,0.026350716,-0.29963934,1,['ECM proteoglycans']
Tnrc18,0.013608898,-0.0024781637,2,
Tnrc6a,-0.055317283,0.35421574,0,"['Post-transcriptional silencing by small RNAs', 'Transcriptional regulation by small RNAs']"
Tnrc6b,-0.13692567,0.15669763,0,['Post-transcriptional silencing by small RNAs']
Tnrc6c,-0.09906499,0.21372016,0,
Tns1,0.13543645,-0.3529207,1,
Tns2,0.19888026,-0.28810528,1,
Tns3,0.14876525,-0.31799075,1,['MET interacts with TNS proteins']
Tns4,-0.019976392,-0.23139274,2,['MET interacts with TNS proteins']
Tnxb,-0.06000789,-0.26886174,2,['ECM proteoglycans']
Tob1,-0.103414655,0.20863955,0,
Tob2,-0.24506779,0.108877696,2,
Toe1,-0.12967111,0.106079526,2,
Togaram2,-0.06458755,-0.11946621,2,
Tollip,0.18440762,0.00053616374,1,"['Neutrophil degranulation', 'Interleukin-1 signaling']"
Tom1,0.23956728,0.094320714,3,['Neutrophil degranulation']
Tom1l1,0.019963272,-0.124165595,1,
Tom1l2,0.0021038246,-0.3422344,1,
Tomm20,0.29116982,0.030750426,1,"['PINK1-PRKN Mediated Mitophagy', 'Ub-specific processing proteases']"
Tomm20l,-0.0019777399,0.07961641,2,
Tomm22,0.09346206,0.16820282,0,['PINK1-PRKN Mediated Mitophagy']
Tomm34,0.07113426,-0.08405318,1,
Tomm40,0.1482524,0.03620718,1,['PINK1-PRKN Mediated Mitophagy']
Tomm40l,-0.010467195,-0.13173792,1,
Tomm5,-0.030482572,-0.02852546,2,['PINK1-PRKN Mediated Mitophagy']
Tomm6,-0.042648945,0.125654,0,['PINK1-PRKN Mediated Mitophagy']
Tomm7,0.21527503,0.07909605,0,['PINK1-PRKN Mediated Mitophagy']
Tomm70a,0.19010878,-0.07508709,1,"['DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'PINK1-PRKN Mediated Mitophagy', 'Ub-specific processing proteases']"
Tomt,-0.19428559,-0.052507244,2,['Enzymatic degradation of dopamine by COMT']
Tonsl,0.28740773,0.20393088,3,
Top1,0.2722353,0.4167045,3,['SUMOylation of DNA replication proteins']
Top1mt,0.06583308,0.5727568,3,
Top2a,0.25818083,0.5569639,3,['SUMOylation of DNA replication proteins']
Top2b,0.20795098,0.4898382,3,['SUMOylation of DNA replication proteins']
Top3a,0.25581375,0.37866592,3,"['HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Top3b,0.1932995,0.25573432,3,
Topbp1,0.31891677,0.4145862,3,"['HDR through Single Strand Annealing (SSA)', 'Processing of DNA double-strand break ends', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Topors,0.27399343,0.22097687,3,"['SUMOylation of transcription cofactors', 'SUMOylation of SUMOylation proteins', 'SUMOylation of immune response proteins']"
Toporsl,-0.21216843,-0.031259645,2,
Tor1a,0.14885996,0.091677405,3,['Cargo recognition for clathrin-mediated endocytosis']
Tor1aip1,-0.06872514,0.089006536,2,"['RHOD GTPase cycle', 'RHOF GTPase cycle']"
Tor1aip2,-0.09761495,-0.0070280726,2,
Tor1b,-0.08979165,-0.059228413,2,['Cargo recognition for clathrin-mediated endocytosis']
Tor2a,-0.17532001,-0.053448845,2,
Tor3a,-0.26820058,-0.022106986,2,
Tor4a,-0.12170575,-0.039851256,2,['Platelet degranulation ']
Tox,-0.26369998,-0.117924325,2,
Tox3,0.017603513,0.017199086,2,
Tox4,0.21320397,-0.16449565,1,
Tpbg,-0.09409969,0.08030767,2,
Tpbpa,-0.2360992,0.01563462,2,
Tpbpb,-0.35436288,-0.18530427,2,
Tpcn1,0.08040795,-0.20694804,1,['Stimuli-sensing channels']
Tpcn2,0.018434301,-0.22269087,1,['Stimuli-sensing channels']
Tpd52,-0.0053277225,-0.23372652,1,['Golgi Associated Vesicle Biogenesis']
Tpd52l1,-0.067549534,-0.15435667,2,['Golgi Associated Vesicle Biogenesis']
Tpd52l2,-0.028821517,0.025984852,2,
Tpgs1,-0.057995595,0.0657631,2,
Tpgs2,-0.25990903,-0.11716132,2,
Tph1,-0.14224787,-0.37584978,2,['Serotonin and melatonin biosynthesis']
Tph2,0.078716524,-0.30517858,1,['Serotonin and melatonin biosynthesis']
Tpi1,-0.047937896,0.062377583,2,"['Glycolysis', 'Gluconeogenesis']"
Tpk1,-0.07495826,-0.07604861,2,['Vitamin B1 (thiamin) metabolism']
Tpm1,-0.015611821,-0.1280311,2,"['Striated Muscle Contraction', 'Smooth Muscle Contraction']"
Tpm2,0.03494898,-0.14805783,2,"['Striated Muscle Contraction', 'Smooth Muscle Contraction']"
Tpm3,0.23382951,-0.057119217,1,"['Striated Muscle Contraction', 'Smooth Muscle Contraction', 'RHOV GTPase cycle']"
Tpm4,0.09056064,-0.10724976,1,"['Striated Muscle Contraction', 'Smooth Muscle Contraction', 'RHOV GTPase cycle']"
Tpmt,-0.23615612,-0.037233517,2,
Tpo,0.048044186,-0.1681926,1,['Thyroxine biosynthesis']
Tpp1,-0.30946076,0.068523586,2,
Tpp2,0.010413333,-0.040953156,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Tppp,0.2604429,0.19573282,3,
Tppp2,-0.12466407,-0.06780147,2,
Tppp3,0.15028259,0.018241853,3,
Tpr,0.21714815,0.39583698,3,"['Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'snRNP Assembly', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of ubiquitinylation proteins', 'Nuclear Pore Complex (NPC) Disassembly', 'Regulation of HSF1-mediated heat shock response', 'SUMOylation of SUMOylation proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'Transcriptional regulation by small RNAs']"
Tpra1,-0.21551238,0.06013135,2,
Tprgl,-0.2529512,-0.1065697,2,
Tprkb,-0.040389214,-0.06235582,2,
Tprn,0.06413544,0.022549156,2,
Tpsab1,0.031309627,-0.3251808,1,
Tpsb2,-0.12532604,-0.22280529,2,
Tpst1,-0.07965999,-0.04277619,2,"['Cytosolic sulfonation of small molecules', 'Gamma carboxylation, hypusine formation and arylsulfatase activation']"
Tpst2,-0.14459153,-0.05116772,2,"['Cytosolic sulfonation of small molecules', 'Gamma carboxylation, hypusine formation and arylsulfatase activation']"
Tpt1,0.26289773,0.25108835,0,
Tpx2,0.28251573,0.4224482,3,"['Regulation of TP53 Activity through Phosphorylation', 'AURKA Activation by TPX2']"
Tra2a,-0.12456069,0.21973854,0,
Tra2b,-0.01611477,0.32457948,0,"['mRNA Splicing - Major Pathway', 'RHOBTB2 GTPase cycle', 'RHOBTB1 GTPase cycle']"
Trabd2b,-0.234265,-0.071663275,2,
Tradd,0.4218645,0.030922713,1,"['Regulation by c-FLIP', 'CASP8 activity is inhibited', 'TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Regulation of necroptotic cell death', 'Dimerization of procaspase-8', 'TNF signaling']"
Traf1,0.2417661,-0.021842007,1,"['Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway']"
Traf2,0.47080448,-0.17963615,1,"['Regulation by c-FLIP', 'CASP8 activity is inhibited', 'TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'TNFR2 non-canonical NF-kB pathway', 'Regulation of necroptotic cell death', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway', 'Ub-specific processing proteases', 'Dimerization of procaspase-8', 'TNF signaling', 'Regulation of NF-kappa B signaling']"
Traf3,0.43080854,-0.01051064,3,"['TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway', 'Ovarian tumor domain proteases', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon']"
Traf3ip1,-0.060847715,-0.024963256,2,['Intraflagellar transport']
Traf3ip2,0.2642628,-0.09659962,1,
Traf3ip3,0.08459627,0.096730255,3,
Traf4,0.174427,-0.18229727,1,
Traf6,0.5674228,-0.03300199,3,"['PIP3 activates AKT signaling', 'MyD88:MAL(TIRAP) cascade initiated on plasma membrane', 'NOD1/2 Signaling Pathway', 'Regulated proteolysis of p75NTR', 'Downstream TCR signaling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'CLEC7A (Dectin-1) signaling', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'Interleukin-1 signaling', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'Regulation of NF-kappa B signaling', 'MyD88 cascade initiated on plasma membrane']"
Traf7,0.18655778,-0.018658364,1,
Traip,0.03547109,0.113567285,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Trak1,0.10424009,-0.0393719,3,"['RHOT2 GTPase cycle', 'RHOT1 GTPase cycle']"
Trak2,-0.11033077,-0.11424697,2,"['RHOT2 GTPase cycle', 'RHOT1 GTPase cycle']"
Tram1,-0.23798846,-0.08430899,2,
Tram1l1,-0.25218976,-0.13554133,2,
Tram2,-0.105002336,-0.019147662,2,
Trank1,-0.10599695,0.20702885,2,
Trap1,0.2637812,0.17892367,0,
Trappc1,-0.21111372,-0.009917462,2,"['COPII-mediated vesicle transport', 'Neutrophil degranulation', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc10,-0.12363618,-0.073827684,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc11,-0.24786319,0.01146938,2,['RAB GEFs exchange GTP for GDP on RABs']
Trappc12,-0.11937992,0.029948652,2,['RAB GEFs exchange GTP for GDP on RABs']
Trappc13,-0.19650176,0.026666233,2,['RAB GEFs exchange GTP for GDP on RABs']
Trappc2,-0.12879953,-0.002569572,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc2l,-0.26535884,-0.004365557,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc3,-0.14383279,-0.06723925,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc3l,-0.3141776,-0.030308885,2,
Trappc4,-0.06685562,-0.049207125,0,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc5,-0.08983826,0.05210902,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc6a,-0.18931244,0.002126693,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc6b,-0.1796828,0.044716142,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trappc9,-0.049933583,-0.07383122,2,"['COPII-mediated vesicle transport', 'RAB GEFs exchange GTP for GDP on RABs']"
Trarg1,-0.1452834,-0.13208471,2,
Trat1,0.30071515,-0.11703232,3,"['PIP3 activates AKT signaling', 'Downstream TCR signaling', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling']"
Trcg1,-0.101807564,0.3547862,0,
Trdmt1,-0.16118452,0.20195173,2,
Trdn,0.14130811,-0.17191975,1,"['Stimuli-sensing channels', 'Ion homeostasis']"
Treh,-0.18619183,-0.057599206,2,
Trem1,0.17488441,0.028337957,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Cell surface interactions at the vascular wall', 'DAP12 interactions']"
Trem2,0.17159846,-0.2806119,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'DAP12 interactions', 'DAP12 signaling', 'Other semaphorin interactions']"
Trem3,-0.043413583,-0.101408735,2,
Treml1,0.1387314,0.026225358,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Treml2,0.038163938,-0.07130816,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Treml4,0.07503958,-0.15628232,1,['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell']
Trex1,-0.035424866,0.034145404,2,
Trf,0.18207476,-0.06402212,1,"['Platelet degranulation ', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Post-translational protein phosphorylation', 'Iron uptake and transport', 'Transferrin endocytosis and recycling']"
Trgc3,-0.10329642,-0.04386149,2,
Trh,0.049479723,-0.34896082,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Trhde,-0.19825865,-0.06005271,2,
Trhr,-0.020589346,-0.19923355,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Trhr2,-0.099984825,-0.20928022,2,
Triap1,-0.13163146,0.031178046,2,['TP53 Regulates Transcription of Genes Involved in Cytochrome C Release']
Trib1,0.003056064,0.07460706,2,
Trib2,-0.037646633,0.20576316,3,
Trib3,0.372172,0.15310954,3,"['PIP3 activates AKT signaling', 'Activation of AKT2', 'Negative regulation of the PI3K/AKT network', 'CD28 dependent PI3K/Akt signaling', 'VEGFR2 mediated vascular permeability']"
Tril,0.05963521,0.009053221,1,
Trim10,-0.2810482,-0.13530262,2,
Trim11,-0.12849443,0.0917704,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Trim12c,-0.19019848,-0.116530634,2,
Trim13,0.001896859,-0.039188076,2,
Trim14,0.24985816,0.10447175,3,
Trim16,-0.10950868,-0.21517882,2,
Trim17,-0.17565107,0.027226415,2,
Trim2,0.016107623,-0.1318589,2,
Trim21,0.4068143,0.14840616,3,
Trim23,-0.07597772,0.16990928,2,
Trim24,0.29726747,-0.016866567,3,
Trim25,0.39244533,0.06268247,3,"['ISG15 antiviral mechanism', 'Termination of translesion DNA synthesis']"
Trim26,0.0051983274,0.14593783,3,
Trim27,0.297066,0.16923715,3,"['SUMOylation of ubiquitinylation proteins', 'Regulation of PTEN stability and activity']"
Trim28,0.46325323,0.19509698,3,['Generic Transcription Pathway']
Trim29,0.024954641,0.051715165,3,
Trim3,-0.07903734,-0.13391775,2,
Trim30a,0.13957155,0.20931275,3,
Trim30d,-0.1714038,-0.05355887,2,
Trim31,0.1699471,0.09382134,3,
Trim32,0.12332634,0.117018215,3,"['Regulation of innate immune responses to cytosolic DNA', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Trim33,0.102641255,0.27617064,3,
Trim34a,-0.20916504,0.07070761,2,
Trim34b,0.09726197,-0.13666274,1,
Trim36,-0.28614914,0.104361326,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Trim38,-0.04523554,-0.031139875,2,
Trim40,0.03456695,0.03075909,0,
Trim43a,-0.039240625,0.08903968,2,
Trim43c,-0.0755353,0.08587841,2,
Trim44,-0.21679541,-0.032182455,2,
Trim46,-0.22829583,-0.13581502,2,
Trim5,0.19454882,0.063757226,1,
Trim54,-0.10195004,-0.08266079,2,
Trim55,0.042557985,-0.008664801,3,
Trim56,0.12708095,0.23145764,3,
Trim59,-0.115102515,-0.039034083,2,
Trim60,-0.14828052,-0.1699227,2,
Trim62,-0.065956645,-0.056232892,2,
Trim63,0.117667496,-0.08673702,1,
Trim67,-0.2615533,-0.0057139215,2,
Trim7,-0.1892218,-0.19816695,2,
Trim71,-0.12717788,0.117622346,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Trim72,0.18238725,-0.1106173,1,
Trim8,0.031306367,-0.06401274,2,
Trim80,-0.09530891,0.052397937,2,
Trim9,0.030439172,-0.14749901,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Trio,0.15230584,-0.20973696,1,"['NRAGE signals death through JNK', 'G alpha (q) signalling events', 'G alpha (12/13) signalling events', 'DCC mediated attractive signaling', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RHOJ GTPase cycle', 'RAC3 GTPase cycle']"
Triobp,0.041903704,0.05843185,3,
Trip10,0.19799317,-0.17363675,1,"['Clathrin-mediated endocytosis', 'RHOQ GTPase cycle']"
Trip11,0.085569076,-0.06546239,1,"['Intraflagellar transport', 'Intra-Golgi traffic']"
Trip12,0.30847052,0.29793993,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Trip13,0.25588295,0.40910313,3,
Trip4,-0.041023377,-0.1063768,2,
Trip6,0.34450772,-0.25342518,1,
Trir,0.14804384,0.32926574,0,
Trit1,-0.53982455,-0.09543189,2,
Trmo,-0.20313674,-0.060368452,2,
Trmt1,-0.39990398,0.30107385,0,
Trmt10a,-0.22351383,0.018022804,0,
Trmt10b,-0.25584048,0.18621576,2,
Trmt10c,-0.42791814,0.18359612,0,
Trmt11,-0.26289514,0.36938897,0,
Trmt112,-0.15638423,0.44649395,0,"['Methylation', 'Eukaryotic Translation Termination']"
Trmt12,-0.25433215,-0.08741607,2,
Trmt13,-0.222824,-0.106033914,2,
Trmt1l,-0.30810505,0.31797907,0,
Trmt2a,-0.13826875,0.13254978,0,
Trmt2b,-0.3008525,0.20480952,0,
Trmt44,-0.48527622,0.11285291,2,
Trmt5,-0.39303195,0.12239918,2,
Trmt6,-0.3718009,0.4462787,0,
Trmt61a,-0.3461866,0.3194392,0,
Trmt9b,-0.2665269,-0.30905008,2,
Trmu,-0.34430674,0.12977195,0,
Trnau1ap,-0.15770221,0.3326975,0,
Trnt1,-0.32758558,0.20367432,0,
Tro,-0.1882927,0.103415884,2,
Troap,0.11784028,0.39222476,3,
Trp53,0.5429856,0.2592692,3,"['Oxidative Stress Induced Senescence', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'Oncogene Induced Senescence', 'DNA Damage/Telomere Stress Induced Senescence', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Regulation of TP53 Expression', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Association with Co-factors', 'Regulation of TP53 Activity through Methylation', 'PI5P Regulates TP53 Acetylation', 'G2/M DNA damage checkpoint', 'G2/M Checkpoints', 'Stabilization of p53', 'Transcriptional  activation of  cell cycle inhibitor p21 ', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'RUNX3 regulates CDKN1A transcription']"
Trp53bp1,0.24174036,0.548307,3,"['SUMOylation of transcription factors', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'G2/M DNA damage checkpoint']"
Trp53bp2,0.2191951,-0.013700377,3,
Trp53inp1,0.087394595,0.07993666,3,['Regulation of TP53 Activity through Phosphorylation']
Trp53inp2,-0.0822021,0.005548715,2,
Trp53rka,-0.22347054,-0.20566012,2,
Trp53rkb,-0.032910097,0.14327148,3,
Trp63,0.4301685,0.23407508,3,['Regulation of TP53 Activity through Association with Co-factors']
Trp73,0.32655376,0.2755134,3,"['Regulation of TP53 Activity through Association with Co-factors', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs']"
Trpa1,0.1813296,-0.10429388,1,['TRP channels']
Trpc1,0.2466429,-0.18459207,1,
Trpc2,0.050801415,-0.30626804,1,
Trpc3,0.23991348,-0.20098938,1,
Trpc4,0.28698745,-0.2037363,1,['TRP channels']
Trpc4ap,0.039531596,0.08222578,0,['TRP channels']
Trpc5,-0.044312783,-0.0846132,2,['TRP channels']
Trpc6,0.15594953,-0.22596346,1,"['Effects of PIP2 hydrolysis', 'Elevation of cytosolic Ca2+ levels', 'TRP channels']"
Trpc7,-0.15500754,0.003313994,2,"['Effects of PIP2 hydrolysis', 'Elevation of cytosolic Ca2+ levels', 'TRP channels']"
Trpm1,0.03312618,-0.05804104,1,['TRP channels']
Trpm2,0.0855458,-0.17245263,1,"['TRP channels', 'Neutrophil degranulation']"
Trpm3,0.17167036,-0.08145143,1,['TRP channels']
Trpm4,0.015419027,-0.16541068,1,['TRP channels']
Trpm5,0.06486591,-0.18989235,1,['TRP channels']
Trpm6,0.055731803,0.10072175,0,['TRP channels']
Trpm7,0.11968717,-0.1089323,1,['TRP channels']
Trpm8,0.20567247,-0.06276062,1,['TRP channels']
Trps1,-0.07467488,0.14531022,2,
Trpt1,-0.4415273,0.13322088,2,
Trpv1,0.34410027,-0.22812817,1,['TRP channels']
Trpv2,0.24678035,-0.1846066,1,['TRP channels']
Trpv3,0.07542998,-0.18458058,1,['TRP channels']
Trpv4,0.13581567,-0.1827829,1,['TRP channels']
Trpv5,0.19924486,-0.2082,1,['TRP channels']
Trpv6,0.14373733,-0.07417046,1,['TRP channels']
Trrap,0.42718613,0.4463637,3,
Trub1,-0.09145224,0.3629953,0,
Trub2,-0.30305088,0.08772314,0,
Try10,-0.047863692,-0.246837,1,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Try4,-0.14373976,-0.29460087,2,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Try5,0.054210708,-0.22224648,1,"['Collagen degradation', 'Alpha-defensins', 'Activation of Matrix Metalloproteinases', 'Neutrophil degranulation', 'Antimicrobial peptides']"
Tsacc,-0.25044048,0.017252339,2,
Tsc1,0.4098688,0.14144,3,"['Macroautophagy', 'Inhibition of TSC complex formation by PKB', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'TP53 Regulates Metabolic Genes', 'TBC/RABGAPs']"
Tsc2,0.4118668,0.065354764,3,
Tsc22d1,-0.14949991,0.08056418,0,
Tsc22d2,-0.18670742,-0.10783279,2,
Tsc22d3,0.37399897,0.06162181,3,['Stimuli-sensing channels']
Tsc22d4,-0.34222338,-0.14861897,2,
Tsen15,-0.20850463,0.28252667,2,
Tsen2,-0.18957298,0.28103644,2,
Tsen34,-0.20438422,0.2733052,0,
Tsen54,-0.17680965,0.10797373,2,
Tsfm,-0.10622392,0.28452387,0,
Tsg101,0.33211097,0.11781588,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Tsga10,0.048899636,-0.07581138,1,
Tsga13,-0.18289934,-0.08185305,2,
Tshb,-0.07499087,-0.22840014,2,
Tshr,0.17265405,-0.099196546,1,"['Hormone ligand-binding receptors', 'G alpha (s) signalling events']"
Tshz2,-0.12541574,0.11838674,2,
Tsks,-0.04428429,-0.19504416,1,
Tsku,-0.27715328,-0.066730164,2,
Tslp,0.19958763,0.0075438847,3,['Interleukin-7 signaling']
Tsn,-0.08892402,0.12087048,2,['Small interfering RNA (siRNA) biogenesis']
Tsnax,0.121763706,-0.054025102,1,['Small interfering RNA (siRNA) biogenesis']
Tsnaxip1,-0.033806033,-0.057255264,2,
Tspan10,-0.06533454,-0.07635224,2,
Tspan12,0.032098908,0.085246794,2,
Tspan13,-0.21933368,-0.16875936,2,
Tspan14,0.05605803,-0.004010056,2,['Neutrophil degranulation']
Tspan15,-0.18689685,-0.2527532,2,
Tspan17,-0.08133251,-0.13872442,2,
Tspan2,-0.05998562,-0.13165233,2,
Tspan3,0.1531412,-0.3481607,1,
Tspan31,-0.1811715,0.002555362,2,
Tspan32,0.16561557,-0.11423803,1,
Tspan33,0.07727424,-0.002152755,2,
Tspan5,-0.0075064483,0.1415813,0,
Tspan6,-0.06152939,-0.2539271,1,
Tspan7,-0.053621244,-0.14261468,2,['Trafficking of GluR2-containing AMPA receptors']
Tspan8,0.25495857,-0.09668667,1,
Tspan9,-0.049763944,-0.023749338,2,
Tspo,0.018542306,-0.059818953,2,['Pregnenolone biosynthesis']
Tspo2,-0.23588622,0.15534423,2,
Tspoap1,0.08369361,-0.08347955,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Pregnenolone biosynthesis', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle']"
Tspyl1,-0.24562407,-0.061638273,2,
Tspyl2,-0.23634711,-0.058304645,2,
Tsr1,-0.23497465,0.4102781,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Tsr2,-0.31704673,0.30126578,0,
Tsr3,-0.32581106,-0.24607448,2,
Tssc4,-0.2346785,0.20870514,2,
Tssk1,-0.10823847,-0.108516395,2,
Tssk2,-0.26926082,-0.24837855,2,
Tssk3,-0.027642203,-0.12541535,1,
Tssk4,-0.10591379,-0.030448534,2,
Tssk5,-0.17174162,-0.035007168,2,
Tssk6,0.11580435,0.09567916,3,
Tst,-0.042063575,-0.002980159,0,['Degradation of cysteine and homocysteine']
Tstd2,-0.1134832,0.067011975,2,
Tstd3,-0.19469444,-0.1198248,2,
Tsx,-0.20086806,0.024596836,2,
Ttbk1,-0.03996656,0.049389444,2,
Ttbk2,0.08390833,-0.10339781,1,['Anchoring of the basal body to the plasma membrane']
Ttc1,0.14216997,-0.0059070317,3,
Ttc12,0.109578155,0.026056828,3,
Ttc13,-0.13545807,-0.06435779,2,
Ttc14,-0.09448457,0.16548243,0,
Ttc16,-0.30058366,-0.13208129,2,
Ttc19,0.017085869,0.016958855,2,
Ttc21a,-0.14798331,0.15862796,2,
Ttc21b,0.11614905,0.11827857,3,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Ttc23,-0.25299296,-0.04493201,2,
Ttc26,-0.08286617,0.08908658,2,['Intraflagellar transport']
Ttc27,-0.20069525,0.15579866,0,
Ttc28,0.19259118,-0.050203223,1,
Ttc29,-0.13253514,0.036877323,2,
Ttc3,-0.055036288,-0.090878695,2,
Ttc30a1,-0.019451214,0.1821071,0,['Intraflagellar transport']
Ttc30a2,-0.085701294,0.03664742,2,
Ttc30b,-0.1877936,0.11378019,2,['Intraflagellar transport']
Ttc33,-0.22396807,-0.14893477,2,
Ttc36,-0.3772334,0.08764347,2,
Ttc37,-0.13575193,0.12289106,0,"[""mRNA decay by 3' to 5' exoribonuclease""]"
Ttc39a,0.0030210048,-0.021782467,2,
Ttc39b,-0.09673066,-0.0064567556,2,
Ttc39c,-0.37642246,0.037178777,2,
Ttc39d,-0.30644938,-0.0884537,2,
Ttc4,-0.1552119,0.36594892,0,
Ttc41,-0.19775471,-0.022153387,2,
Ttc5,0.07923266,0.22637948,3,['Regulation of TP53 Activity through Methylation']
Ttc7,-0.15260266,0.020183798,2,
Ttc7b,0.03065075,-0.06624328,2,
Ttc8,-0.06790705,0.12285919,2,['BBSome-mediated cargo-targeting to cilium']
Ttc9,-0.14972788,-0.025280861,2,
Ttc9b,-0.1750921,0.07761111,2,
Ttc9c,-0.24997862,0.067412496,2,
Ttf1,0.118717365,0.14824958,3,"['Surfactant metabolism', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Transcription Termination']"
Ttf2,0.111825354,-0.04648142,1,
Tti1,0.11771619,0.31762356,3,
Tti2,-0.07167702,0.1298715,2,
Ttk,0.13310404,0.4256312,3,
Ttl,-0.21181615,-0.26393878,2,
Ttll1,-0.14403173,0.21372187,2,
Ttll10,-0.19287716,-0.06345658,2,
Ttll11,-0.1523418,-0.05217985,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll12,-0.26467288,0.01043288,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll13,-0.26756862,-0.06833248,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll2,-0.00633943,-0.08354485,1,['Carboxyterminal post-translational modifications of tubulin']
Ttll4,-0.25038916,-0.09112716,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll5,-0.289725,0.0364291,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll6,-0.05269201,0.048562583,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll8,-0.25342238,0.19736911,2,['Carboxyterminal post-translational modifications of tubulin']
Ttll9,-0.33415672,-0.061871942,2,['Carboxyterminal post-translational modifications of tubulin']
Ttn,0.28828004,-0.20617549,1,
Ttpa,-0.06468622,-0.08930944,2,['Vitamin E']
Ttr,0.22385025,-0.099881545,1,"['The canonical retinoid cycle in rods (twilight vision)', 'Neutrophil degranulation', 'Retinoid metabolism and transport']"
Ttyh1,-0.19674896,-0.020035334,2,['Stimuli-sensing channels']
Ttyh2,-0.12822045,0.004201224,2,['Stimuli-sensing channels']
Ttyh3,-0.0385091,-0.004977565,2,['Stimuli-sensing channels']
Tub,0.15596607,-0.11929119,1,
Tuba1a,0.3421205,0.0049242647,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Anchoring of the basal body to the plasma membrane', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tuba1b,0.23459718,-0.03347974,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'RHOH GTPase cycle', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tuba1c,0.35517254,-0.064990886,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tuba3a,-0.05861926,-0.00578282,2,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tuba3b,0.2653031,0.028944323,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tuba4a,0.2458823,-0.16094396,1,"['Platelet degranulation ', 'Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Anchoring of the basal body to the plasma membrane', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tuba8,0.28438702,-0.030656818,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', 'Cilium Assembly', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubal3,0.08073197,0.025663508,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', 'Cilium Assembly', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb1,0.15654962,0.13160662,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb2a,0.24215095,-0.11146956,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb2b,0.2673804,0.040948138,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb3,0.36725017,-0.13842922,1,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb4a,0.022403833,0.05420214,2,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Anchoring of the basal body to the plasma membrane', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb4b,0.20502731,0.08862956,3,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Regulation of PLK1 Activity at G2/M Transition', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Anchoring of the basal body to the plasma membrane', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'Neutrophil degranulation', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'AURKA Activation by TPX2', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubb5,0.21610211,-0.003844935,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'Neutrophil degranulation', 'AURKA Activation by TPX2']"
Tubb6,0.15150362,-0.06646248,1,"['Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'MHC class II antigen presentation', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Recruitment of NuMA to mitotic centrosomes', 'Recycling pathway of L1', ""Hedgehog 'off' state"", 'Cilium Assembly', 'Intraflagellar transport', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate Formins', 'COPI-mediated anterograde transport', 'COPI-dependent Golgi-to-ER retrograde traffic', 'COPI-independent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Carboxyterminal post-translational modifications of tubulin', 'Aggrephagy', 'EML4 and NUDC in mitotic spindle formation', 'Sealing of the nuclear envelope (NE) by ESCRT-III', 'Kinesins']"
Tubd1,-0.1457631,0.05670771,0,
Tube1,-0.18182197,-0.11362004,2,
Tubg1,0.15846361,0.13070334,3,"['Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'AURKA Activation by TPX2']"
Tubg2,-0.16398923,0.02221043,2,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Tubgcp2,0.16784005,0.27453882,3,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Tubgcp3,-0.11109909,0.051247094,2,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Tubgcp4,0.033409882,0.068674855,2,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Tubgcp5,-0.024277762,-0.041864723,1,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Tubgcp6,0.042241078,0.0069951713,1,"['Recruitment of mitotic centrosome proteins and complexes', 'Recruitment of NuMA to mitotic centrosomes']"
Tufm,0.07764955,0.12730692,0,
Tuft1,-0.11698868,-0.045561485,2,
Tulp1,-0.05692019,-0.075501904,2,
Tulp2,-0.21722378,-0.1365515,2,
Tulp3,0.11171088,-0.18252139,1,"[""Hedgehog 'off' state""]"
Tulp4,-0.29196417,-0.03388365,2,['Neddylation']
Tut1,-0.14641955,0.0447377,2,
Tut4,-0.047544166,0.40905127,0,['Deadenylation of mRNA']
Tut7,-0.016312525,0.32125622,0,
Tvp23a,-0.35282415,-0.1427468,2,
Tvp23b,-0.15084498,-0.10383293,2,
Twf1,-0.07686702,-0.103783436,2,['RHOBTB2 GTPase cycle']
Twf2,-0.07496295,-0.21757661,2,
Twist1,0.51457167,0.014430229,3,
Twist2,0.34431437,-0.09638182,3,
Twnk,-0.1928129,0.24626952,2,
Twsg1,-0.008612686,-0.070773885,2,
Txk,0.3082475,-0.38988742,1,['FCERI mediated Ca+2 mobilization']
Txlna,-0.24902172,0.046010874,2,['Other interleukin signaling']
Txlnb,-0.09195003,0.0008907887,2,
Txlng,-0.14368944,0.020184495,2,
Txn1,0.3267405,-0.095088795,1,"['Oxidative Stress Induced Senescence', 'Detoxification of Reactive Oxygen Species', 'Interconversion of nucleotide di- and triphosphates', 'TP53 Regulates Metabolic Genes', 'Protein repair', 'The NLRP3 inflammasome']"
Txn2,0.09495367,0.1808709,0,"['Degradation of cysteine and homocysteine', 'Detoxification of Reactive Oxygen Species']"
Txndc11,-0.20021024,-0.10911195,2,
Txndc12,-0.122699484,-0.048646435,0,
Txndc15,-0.29485953,-0.222005,2,
Txndc16,-0.41824678,-0.13256623,2,
Txndc17,-0.005804016,0.19012038,3,
Txndc2,-0.2677605,-0.069477364,2,
Txndc5,-0.057302862,-0.063599534,2,"['Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Neutrophil degranulation']"
Txndc8,0.0051392303,-0.058669638,2,
Txndc9,-0.026946466,-0.25366604,1,
Txnip,0.43600336,0.012112879,3,['The NLRP3 inflammasome']
Txnl1,0.018523194,0.32394674,0,"['RHOBTB2 GTPase cycle', 'RHOU GTPase cycle', 'RHOBTB1 GTPase cycle', 'RHOV GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Txnl4a,-0.14566883,0.43871215,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway']"
Txnl4b,-0.08190245,0.42096677,0,
Txnrd1,0.015500355,-0.060762685,2,"['Detoxification of Reactive Oxygen Species', 'Interconversion of nucleotide di- and triphosphates', 'Metabolism of ingested MeSeO2H into MeSeH', 'TP53 Regulates Metabolic Genes']"
Txnrd2,0.02694211,-0.14874288,1,
Txnrd3,-0.079479456,-0.053263042,2,
Tyk2,0.36787778,-0.1459414,1,"['Interleukin-6 signaling', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation', 'Interleukin-10 signaling', 'Interleukin-4 and Interleukin-13 signaling', 'IL-6-type cytokine receptor ligand interactions', 'Interleukin-20 family signaling', 'Interleukin-35 Signalling', 'Interleukin-12 signaling', 'Interleukin-23 signaling', 'Interleukin-27 signaling', 'Interferon alpha/beta signaling', 'Regulation of IFNA/IFNB signaling', 'Signaling by CSF3 (G-CSF)', 'Inactivation of CSF3 (G-CSF) signaling']"
Tymp,-0.048468307,0.1113861,2,"['Pyrimidine salvage', 'Pyrimidine catabolism']"
Tyms,0.108444504,0.43385768,3,['Interconversion of nucleotide di- and triphosphates']
Tyr,0.11688382,-0.2575929,1,['Melanin biosynthesis']
Tyro3,0.021677187,-0.19771695,1,
Tyrobp,0.2223858,-0.38460267,1,"['DAP12 interactions', 'DAP12 signaling', 'Signal regulatory protein family interactions', 'Other semaphorin interactions', 'Neutrophil degranulation']"
Tyrp1,0.033654094,-0.33585688,1,['Melanin biosynthesis']
Tysnd1,-0.38786134,0.21383253,2,"['Peroxisomal protein import', 'TYSND1 cleaves peroxisomal proteins']"
Tyw1,-0.31805483,0.32718033,0,
Tyw3,-0.2534379,-0.059999608,2,
Tyw5,-0.19260801,0.09542781,2,
U2af1,0.011410364,0.44257778,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
U2af1l4,-0.15230672,0.4858396,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
U2af2,-0.0015170956,0.5235963,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination']"
U2surp,0.009959231,0.4775369,0,['mRNA Splicing - Major Pathway']
Uaca,0.105895706,-0.029164594,1,
Uap1,-0.08765307,0.053088505,2,
Uap1l1,-0.29529738,-0.27341902,2,
Uba1,0.2244017,0.27190396,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Uba1y,0.3182381,0.21737246,3,
Uba2,0.31757385,0.43640116,3,"['SUMO is conjugated to E1 (UBA2:SAE1)', 'SUMO is transferred from E1 to E2 (UBE2I, UBC9)']"
Uba3,0.37048522,0.2847675,3,"['Dectin-1 mediated noncanonical NF-kB signaling', 'NIK-->noncanonical NF-kB signaling', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Uba5,0.08047248,0.21195196,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Uba52,0.531374,0.38515338,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Downregulation of ERBB4 signaling', 'Spry regulation of FGF signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'NOD1/2 Signaling Pathway', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC-Cdc20 mediated degradation of Nek2A', 'SRP-dependent cotranslational protein targeting to membrane', 'EGFR downregulation', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'TCF dependent signaling in response to WNT', 'Downstream TCR signaling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Separation of Sister Chromatids', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Regulation of PLK1 Activity at G2/M Transition', 'Stimuli-sensing channels', 'FCERI mediated NF-kB activation', 'Regulation of innate immune responses to cytosolic DNA', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Deactivation of the beta-catenin transactivating complex', 'ABC-family proteins mediated transport', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Regulation of FZD by ubiquitination', 'PINK1-PRKN Mediated Mitophagy', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'Negative regulation of MAPK pathway', 'Regulation of necroptotic cell death', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'HDR through Homologous Recombination (HRR)', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Josephin domain DUBs', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Negative regulation of MET activity', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin D associated events in G1', 'G2/M Checkpoints', 'Stabilization of p53', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Translation initiation complex formation', 'Formation of a pool of free 40S subunits', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Ribosomal scanning and start codon recognition', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'VLDLR internalisation and degradation', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Neddylation', 'ER Quality Control Compartment (ERQC)', 'Regulation of expression of SLITs and ROBOs', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Interleukin-1 signaling', 'Peroxisomal protein import', 'Regulation of signaling by CBL', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Iron uptake and transport', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'Aggrephagy', 'RAS processing', 'Pexophagy', 'Inactivation of CSF3 (G-CSF) signaling', 'Negative regulation of FLT3', 'Regulation of BACH1 activity', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'KEAP1-NFE2L2 pathway', 'Regulation of NF-kappa B signaling', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Uba6,0.33065146,0.24058503,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Uba7,0.4122969,0.34169194,3,"['ISG15 antiviral mechanism', 'Termination of translesion DNA synthesis', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ubac1,0.015303108,-0.18640278,1,['Antigen processing: Ubiquitination & Proteasome degradation']
Ubac2,-0.08201348,-0.0053009256,2,
Ubald2,-0.09215309,-0.012030127,2,
Ubap1,0.07149512,0.03085451,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Ubap2,0.023874858,0.15501617,0,
Ubap2l,0.19257396,0.24704939,3,
Ubash3a,0.045348514,-0.027045954,1,
Ubash3b,0.08049695,-0.37641636,1,
Ubb,0.56771517,0.28657556,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Downregulation of ERBB4 signaling', 'Spry regulation of FGF signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'NOD1/2 Signaling Pathway', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC-Cdc20 mediated degradation of Nek2A', 'SRP-dependent cotranslational protein targeting to membrane', 'EGFR downregulation', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'TCF dependent signaling in response to WNT', 'Downstream TCR signaling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Separation of Sister Chromatids', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Regulation of PLK1 Activity at G2/M Transition', 'Stimuli-sensing channels', 'FCERI mediated NF-kB activation', 'Regulation of innate immune responses to cytosolic DNA', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Deactivation of the beta-catenin transactivating complex', 'ABC-family proteins mediated transport', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Regulation of FZD by ubiquitination', 'PINK1-PRKN Mediated Mitophagy', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'Negative regulation of MAPK pathway', 'Regulation of necroptotic cell death', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'HDR through Homologous Recombination (HRR)', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Josephin domain DUBs', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Negative regulation of MET activity', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin D associated events in G1', 'G2/M Checkpoints', 'Stabilization of p53', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'VLDLR internalisation and degradation', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Neddylation', 'ER Quality Control Compartment (ERQC)', 'Regulation of expression of SLITs and ROBOs', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Interleukin-1 signaling', 'Peroxisomal protein import', 'Regulation of signaling by CBL', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Iron uptake and transport', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'Aggrephagy', 'RAS processing', 'Pexophagy', 'Inactivation of CSF3 (G-CSF) signaling', 'Negative regulation of FLT3', 'Regulation of BACH1 activity', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'KEAP1-NFE2L2 pathway', 'Regulation of NF-kappa B signaling', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ubc,0.5713642,0.25838634,3,"['Translesion synthesis by REV1', 'Recognition of DNA damage by PCNA-containing replication complex', 'Translesion Synthesis by POLH', 'Activation of NF-kappaB in B cells', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Downregulation of ERBB4 signaling', 'Spry regulation of FGF signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'NOD1/2 Signaling Pathway', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'SCF-beta-TrCP mediated degradation of Emi1', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC-Cdc20 mediated degradation of Nek2A', 'EGFR downregulation', 'SCF(Skp2)-mediated degradation of p27/p21', 'Degradation of beta-catenin by the destruction complex', 'TCF dependent signaling in response to WNT', 'Downstream TCR signaling', 'NRIF signals cell death from the nucleus', 'p75NTR recruits signalling complexes', 'NF-kB is activated and signals survival', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Separation of Sister Chromatids', 'Oxidative Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Oncogene Induced Senescence', 'Regulation of PLK1 Activity at G2/M Transition', 'Stimuli-sensing channels', 'FCERI mediated NF-kB activation', 'Regulation of innate immune responses to cytosolic DNA', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Deactivation of the beta-catenin transactivating complex', 'ABC-family proteins mediated transport', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'Asymmetric localization of PCP proteins', 'Degradation of AXIN', 'Degradation of DVL', 'Regulation of FZD by ubiquitination', 'PINK1-PRKN Mediated Mitophagy', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Hedgehog ligand biogenesis', 'Dectin-1 mediated noncanonical NF-kB signaling', 'CLEC7A (Dectin-1) signaling', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', ""Hedgehog 'on' state"", 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Translesion synthesis by POLK', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'Regulation of RAS by GAPs', 'TNFR2 non-canonical NF-kB pathway', 'Negative regulation of MAPK pathway', 'Regulation of necroptotic cell death', 'NIK-->noncanonical NF-kB signaling', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'HDR through Homologous Recombination (HRR)', 'MAPK6/MAPK4 signaling', 'UCH proteinases', 'Josephin domain DUBs', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Metalloprotease DUBs', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Fanconi Anemia Pathway', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Methylation', 'Negative regulation of MET activity', 'Assembly of the pre-replicative complex', 'Orc1 removal from chromatin', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cyclin D associated events in G1', 'G2/M Checkpoints', 'Stabilization of p53', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'Ubiquitin-dependent degradation of Cyclin D', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Downregulation of ERBB2 signaling', 'VLDLR internalisation and degradation', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of RUNX3 expression and activity', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Neddylation', 'ER Quality Control Compartment (ERQC)', 'Regulation of expression of SLITs and ROBOs', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Interleukin-1 signaling', 'Peroxisomal protein import', 'Regulation of signaling by CBL', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Iron uptake and transport', 'Negative regulators of DDX58/IFIH1 signaling', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'IRAK2 mediated activation of TAK1 complex', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'Alpha-protein kinase 1 signaling pathway', 'Aggrephagy', 'RAS processing', 'Pexophagy', 'Inactivation of CSF3 (G-CSF) signaling', 'Negative regulation of FLT3', 'Regulation of BACH1 activity', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'KEAP1-NFE2L2 pathway', 'Regulation of NF-kappa B signaling', 'GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ubd,0.21961936,0.18705855,3,['Neddylation']
Ube2a,0.2507549,0.34728432,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2b,0.37552524,0.4156298,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2c,0.33950692,0.43459046,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2cbp,-0.0595476,-0.15668604,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube2d1,0.45777136,0.20249479,3,"['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Signaling by BMP', 'Downstream TCR signaling', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'FCERI mediated NF-kB activation', 'CLEC7A (Dectin-1) signaling', 'Ovarian tumor domain proteases', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Neddylation', 'Peroxisomal protein import', 'IKK complex recruitment mediated by RIP1', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2d2a,0.43301153,0.1438087,3,"['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'CLEC7A (Dectin-1) signaling', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Neddylation', 'Peroxisomal protein import', 'IKK complex recruitment mediated by RIP1', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2d2b,0.14570187,0.050990067,3,
Ube2d3,0.3174215,0.11722462,3,"['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Signaling by BMP', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Neddylation', 'Peroxisomal protein import', 'IKK complex recruitment mediated by RIP1', 'Inactivation of CSF3 (G-CSF) signaling', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2dnl1,0.07028911,-0.0008959672,2,
Ube2dnl2,0.18369605,0.066459864,3,
Ube2e1,0.4148906,0.3102924,3,"['ISG15 antiviral mechanism', 'Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2e2,0.2697694,0.2555127,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube2e3,0.39078364,0.26141855,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2f,0.12331644,0.20798796,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2g1,0.11700335,0.15246488,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2g2,0.1386978,0.1723918,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2h,0.051074374,0.06065432,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2i,0.47251308,0.49483645,3,"['Vitamin D (calciferol) metabolism', 'SUMO is transferred from E1 to E2 (UBE2I, UBC9)', 'SUMOylation of DNA damage response and repair proteins', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation of transcription factors', 'SUMOylation of ubiquitinylation proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of SUMOylation proteins', 'SUMOylation of intracellular receptors', 'SUMOylation of chromatin organization proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of DNA replication proteins', 'SUMOylation of DNA methylation proteins', 'SUMOylation of immune response proteins', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Processing of DNA double-strand break ends', 'Formation of Incision Complex in GG-NER', 'Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Postmitotic nuclear pore complex (NPC) reformation']"
Ube2j1,-0.009591765,0.12026391,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube2j2,0.12852158,0.28125516,3,"['Insertion of tail-anchored proteins into the endoplasmic reticulum membrane', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2k,0.37324607,0.26565397,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2l6,0.3759955,0.17997874,3,"['ISG15 antiviral mechanism', 'Termination of translesion DNA synthesis', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2m,0.3631899,0.092138045,3,"['TGF-beta receptor signaling activates SMADs', 'Dectin-1 mediated noncanonical NF-kB signaling', 'NIK-->noncanonical NF-kB signaling', 'Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2n,0.48441157,0.31486914,3,"['ISG15 antiviral mechanism', 'NOD1/2 Signaling Pathway', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'CLEC7A (Dectin-1) signaling', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Formation of Incision Complex in GG-NER', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Interleukin-1 signaling', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'Aggrephagy', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2o,0.10689143,0.34310836,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube2q1,-0.011885767,0.10220372,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube2q2,-0.015325884,0.056920655,2,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2ql1,-0.025014024,0.12654482,2,
Ube2r2,0.26765245,0.15746285,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2s,0.31964803,0.34285316,3,"['Inactivation of APC/C via direct inhibition of the APC/C complex', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'APC/C:Cdc20 mediated degradation of Securin', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Regulation of APC/C activators between G1/S and early anaphase', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'Phosphorylation of the APC/C', 'APC-Cdc20 mediated degradation of Nek2A', 'Separation of Sister Chromatids', 'Senescence-Associated Secretory Phenotype (SASP)', 'Assembly of the pre-replicative complex', 'CDK-mediated phosphorylation and removal of Cdc6', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2t,0.237764,0.36813506,3,"['Fanconi Anemia Pathway', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes']"
Ube2u,0.17791446,0.30850762,3,
Ube2v1,0.32966003,0.1336654,3,"['NOD1/2 Signaling Pathway', 'Downstream TCR signaling', 'FCERI mediated NF-kB activation', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'activated TAK1 mediates p38 MAPK activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'CLEC7A (Dectin-1) signaling', 'Interleukin-1 signaling', 'IRAK1 recruits IKK complex', 'IKK complex recruitment mediated by RIP1', 'Aggrephagy', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2v2,0.22626421,0.35151646,3,"['Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Nonhomologous End-Joining (NHEJ)', 'Processing of DNA double-strand break ends', 'Formation of Incision Complex in GG-NER', 'G2/M DNA damage checkpoint', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2w,0.2131046,0.3165892,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube2z,0.017681029,0.16092376,3,"['Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ube3a,0.4260943,0.30488068,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube3b,-0.2307336,0.0010002711,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube3c,0.0005556938,-0.04915585,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube4a,0.17243299,0.11288139,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ube4b,0.11387445,0.06198289,3,
Ubfd1,0.1409693,0.28259364,3,
Ubiad1,0.1250483,0.029310131,3,['Metabolism of vitamin K']
Ubl3,-0.044918552,0.17860731,3,
Ubl4a,-0.18270834,0.09487841,2,
Ubl5,-0.06070824,0.32577792,0,
Ubl7,-0.08265232,-0.005331675,2,
Ublcp1,0.04923779,0.3455128,3,
Ubn1,0.08875456,0.28315997,3,['Formation of Senescence-Associated Heterochromatin Foci (SAHF)']
Ubn2,-0.009593361,0.04666208,2,
Ubox5,0.17933966,0.14137231,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ubp1,-0.30134958,-0.025927128,2,
Ubqln1,0.3513736,0.072820425,3,['Cargo recognition for clathrin-mediated endocytosis']
Ubqln2,0.4176684,0.04527407,3,['Cargo recognition for clathrin-mediated endocytosis']
Ubqln3,-0.08483449,0.081133716,2,
Ubqln4,0.103254065,0.14460069,3,
Ubqln5,0.062419504,-0.006409164,3,
Ubqlnl,0.08331135,0.09160038,3,
Ubr1,0.18746243,0.18669243,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ubr2,0.116335034,0.17205325,3,['Antigen processing: Ubiquitination & Proteasome degradation']
Ubr3,-0.05463012,0.03247365,2,
Ubr4,0.15693727,0.107091494,3,"['Neutrophil degranulation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Ubr5,0.17400132,0.34301746,0,
Ubr7,-0.112231195,0.29015994,3,
Ubtf,0.23326015,0.17611769,3,
Ubtfl1,-0.243253,0.10423535,2,
Ubxn1,0.11389764,0.20179835,3,"['N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks']"
Ubxn10,-0.039194398,-0.018693391,2,
Ubxn11,0.042920325,0.12270377,3,"['RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Ubxn2a,-0.09739431,0.21202423,2,
Ubxn2b,0.01640672,0.12164509,3,
Ubxn4,-0.022051964,0.09978774,2,
Ubxn6,0.05368307,0.25082934,3,
Ubxn7,0.37067893,0.48199943,3,"['Neddylation', 'KEAP1-NFE2L2 pathway']"
Ubxn8,0.07398434,0.22356173,3,
Uchl1,0.32718605,0.29673454,3,['UCH proteinases']
Uchl3,0.1732467,0.19838913,3,"['UCH proteinases', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'Neddylation']"
Uchl4,0.11085117,0.07781596,3,
Uchl5,0.26737618,0.33744392,3,['UCH proteinases']
Uck1,-0.3060994,0.117732644,0,
Uck2,-0.14202023,-0.02454464,2,['Pyrimidine salvage']
Uckl1,-0.30913576,0.36762363,0,['Pyrimidine salvage']
Ucma,0.10794022,0.16748151,3,
Ucn,-0.12791702,-0.15033138,2,['Class B/2 (Secretin family receptors)']
Ucn2,-0.01564775,0.057696883,3,['Class B/2 (Secretin family receptors)']
Ucn3,-0.09313609,-0.057293702,2,['Class B/2 (Secretin family receptors)']
Ucp1,0.16125624,-0.25697985,1,"['The fatty acid cycling model', 'The proton buffering model']"
Ucp2,0.06647254,-0.17735672,2,"['The fatty acid cycling model', 'The proton buffering model']"
Ucp3,0.023987466,-0.11436859,2,"['The fatty acid cycling model', 'The proton buffering model']"
Uevld,0.085941754,0.2215331,3,
Ufc1,-0.00924654,0.14473611,2,
Ufd1,0.18143946,0.24405265,3,"['Translesion Synthesis by POLH', 'Ub-specific processing proteases', 'Neddylation', 'KEAP1-NFE2L2 pathway']"
Ufl1,-0.15544228,0.086973794,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Ufm1,0.19505067,0.18117237,3,
Ufsp1,-0.08173664,0.17795677,2,
Ufsp2,-0.19406317,0.052978735,2,
Ugcg,-0.3856448,-0.11790031,2,['Glycosphingolipid metabolism']
Ugdh,-0.39100945,-0.17795357,2,"['Formation of the active cofactor, UDP-glucuronate']"
Uggt1,0.008893799,0.06471767,2,
Uggt2,-0.082571924,0.26004875,3,
Ugp2,-0.26805082,-0.116073936,2,"['Formation of the active cofactor, UDP-glucuronate', 'Glycogen synthesis']"
Ugt1a1,-0.2285199,-0.15396044,2,"['Glucuronidation', 'Heme degradation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt1a10,-0.32696506,-0.058453042,2,
Ugt1a2,-0.32379085,-0.07873831,2,"['Glucuronidation', 'Heme degradation', 'Aspirin ADME', 'Atorvastatin ADME']"
Ugt1a5,-0.19115101,0.010391388,2,"['Glucuronidation', 'Heme degradation', 'Aspirin ADME', 'Atorvastatin ADME']"
Ugt1a6a,-0.24944402,-0.089235134,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt1a6b,-0.2491437,-0.07767824,2,
Ugt1a7c,-0.32208255,-0.012662919,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt1a8,-0.30252108,-0.049747292,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt1a9,-0.32018423,-0.14370425,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2a1,-0.28647906,-0.12514777,2,"['Glucuronidation', 'Aspirin ADME']"
Ugt2a3,-0.4419965,0.06057592,2,
Ugt2b1,-0.38841793,-0.1515407,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2b34,-0.29058146,-0.075833194,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2b35,-0.29887894,-0.09074442,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2b36,-0.18158527,0.018723061,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2b37,-0.29795274,-0.08877391,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2b38,-0.3122112,-0.121598095,2,"['Glucuronidation', 'Aspirin ADME', 'Paracetamol ADME']"
Ugt2b5,-0.30556154,-0.05040996,2,
Ugt3a1,-0.14437279,0.044558164,2,"['Glucuronidation', 'Aspirin ADME']"
Ugt3a2,-0.07788456,-0.08435699,2,"['Glucuronidation', 'Aspirin ADME']"
Ugt8a,-0.18711777,-0.12734024,2,['Glycosphingolipid metabolism']
Uhmk1,0.17417498,0.17644203,3,['Estrogen-dependent nuclear events downstream of ESR-membrane signaling']
Uhrf1,0.26277506,0.35601842,3,
Uhrf1bp1l,-0.21333952,0.03073117,2,['RND2 GTPase cycle']
Uhrf2,0.026697954,0.0009790094,3,['SUMOylation of transcription cofactors']
Uimc1,0.2211262,0.25228357,3,
Ulbp1,-0.08654386,-0.023814676,2,
Ulk1,0.2892515,-0.105109125,3,
Ulk2,0.17366084,-0.05220697,3,
Ulk3,0.13730662,0.046466663,3,"[""Hedgehog 'on' state""]"
Ulk4,0.07994212,0.11950577,0,
Umod,-0.049845826,-0.043490704,2,['Asparagine N-linked glycosylation']
Umps,-0.19580214,0.14597037,2,['Pyrimidine biosynthesis']
Unc119,0.12496195,0.06305264,3,
Unc119b,-0.08921453,0.0059328843,2,['Trafficking of myristoylated proteins to the cilium']
Unc13a,-0.18258265,-0.0942821,2,
Unc13b,-0.15765892,-0.17010431,2,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle']"
Unc13c,-0.1699536,-0.10433972,2,
Unc13d,-0.13572945,-0.07489731,2,['Neutrophil degranulation']
Unc45a,-0.015260448,0.07783822,2,
Unc45b,0.30348936,-0.06852811,1,
Unc50,-0.17434776,0.027500208,2,
Unc5a,0.26174098,-0.3725118,1,['Netrin-1 signaling']
Unc5b,0.16944475,-0.29337507,1,
Unc5c,0.21237715,-0.26236996,1,
Unc5d,0.19511746,-0.05745226,1,
Unc79,-0.10127961,-0.019855913,2,['Stimuli-sensing channels']
Unc80,-0.29968703,-0.25148848,2,
Unc93a,-0.15520146,-0.015224866,2,
Unc93a2,-0.2125833,-0.013052763,2,
Unc93b1,0.05036341,-0.027533676,2,
Ung,0.16492309,0.26833275,3,"['Cleavage of the damaged pyrimidine ', 'Displacement of DNA glycosylase by APEX1']"
Unk,0.23031904,0.058908064,3,
Unkl,-0.24775441,0.11413439,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Uox,-0.21651435,-0.07823329,2,
Upb1,-0.28076297,-0.17665362,2,['Pyrimidine catabolism']
Upf1,0.027259165,0.49262753,0,"['Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Upf2,-0.1228818,0.31780818,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Upf3a,-0.027798153,0.32344007,0,['Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']
Upf3b,-0.16629903,0.43545642,0,"['Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)']"
Upk1a,-0.2718916,0.118193835,2,
Upk1b,-0.42339584,-0.0058094137,2,
Upk2,-0.15233946,0.009308395,2,
Upk3a,-0.13762027,-0.039814487,2,
Upk3b,-0.2991767,0.16351753,0,
Upp1,-0.2189172,0.015239912,2,"['Pyrimidine salvage', 'Pyrimidine catabolism']"
Upp2,-0.23031235,-0.027244138,2,"['Pyrimidine salvage', 'Pyrimidine catabolism']"
Uprt,-0.18638405,0.015370249,2,
Uqcc1,0.016975887,0.06800371,2,
Uqcc2,-0.15022102,-0.19180572,2,
Uqcc3,-0.087780334,-0.15639584,2,
Uqcr10,0.10191819,-0.010697765,1,['Respiratory electron transport']
Uqcr11,0.13354132,-0.0016906591,1,['Respiratory electron transport']
Uqcrb,0.046657883,-0.026764957,2,
Uqcrc1,0.023085952,-0.05451464,2,['Respiratory electron transport']
Uqcrc2,0.05576353,-0.098370425,1,['Respiratory electron transport']
Uqcrfs1,0.03428807,-0.030619709,2,['Respiratory electron transport']
Uqcrh,0.08114619,-0.009942445,1,['Respiratory electron transport']
Uqcrq,0.047205545,-0.037028387,1,['Respiratory electron transport']
Urad,-0.18147755,0.02119267,2,
Urah,-0.078101195,-0.14047593,2,
Urb1,-0.2816621,0.39914322,0,
Urb2,-0.18502145,0.088286884,2,
Uri1,0.114479795,0.13501364,3,
Urm1,0.15042174,0.36999267,3,
Uroc1,-0.05061007,-0.023735834,2,['Histidine catabolism']
Urod,-0.17504339,0.1550667,2,['Heme biosynthesis']
Uros,-0.10356598,0.24364586,0,['Heme biosynthesis']
Usb1,0.009342569,0.21141048,0,
Use1,-0.3084438,-0.052899156,2,['COPI-dependent Golgi-to-ER retrograde traffic']
Usf1,0.2750715,0.19380268,3,['Estrogen-dependent gene expression']
Usf2,0.16486752,0.008067136,3,['Estrogen-dependent gene expression']
Ush1c,-0.035423934,-0.31358847,1,
Ush1g,-0.060189314,-0.1131,2,
Ush2a,-0.08592374,-0.30623266,2,
Ushbp1,-0.18031727,-0.13762495,2,
Uso1,-0.00085791195,-0.21206744,1,"['COPII-mediated vesicle transport', 'COPI-mediated anterograde transport']"
Usp1,0.13131699,0.4149347,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Fanconi Anemia Pathway']"
Usp10,0.31357425,0.14448076,3,"['Termination of translesion DNA synthesis', 'Ub-specific processing proteases']"
Usp11,0.10819768,0.082322046,3,['Ub-specific processing proteases']
Usp12,0.098210655,0.0027936813,1,['Ub-specific processing proteases']
Usp13,0.31263512,0.29151645,3,"['Ub-specific processing proteases', 'Regulation of PTEN stability and activity']"
Usp14,0.110681,0.2800568,3,"['Ub-specific processing proteases', 'Regulation of NF-kappa B signaling']"
Usp15,0.31292093,0.1467746,3,['Ub-specific processing proteases']
Usp16,0.04914135,0.030278923,0,['Ub-specific processing proteases']
Usp17la,0.0058377786,0.1320622,2,"['Ub-specific processing proteases', 'RAS processing']"
Usp17lb,-0.24075766,0.20367885,2,"['Ub-specific processing proteases', 'RAS processing']"
Usp17lc,0.026908886,0.001948329,2,"['Ub-specific processing proteases', 'RAS processing']"
Usp17ld,0.0023202386,0.02948528,2,"['Ub-specific processing proteases', 'RAS processing']"
Usp17le,0.14682424,0.041981768,3,
Usp18,0.33040676,0.13882953,3,"['ISG15 antiviral mechanism', 'TAK1-dependent IKK and NF-kappa-B activation  ', 'Ub-specific processing proteases', 'Regulation of IFNA/IFNB signaling', 'Regulation of NF-kappa B signaling']"
Usp19,0.039814558,0.21223404,3,['Ub-specific processing proteases']
Usp2,0.21058074,0.1372541,3,"['TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Ub-specific processing proteases', 'Regulation of TP53 Degradation']"
Usp20,0.047030818,-0.013147353,2,['Ub-specific processing proteases']
Usp21,0.34262586,0.095729984,3,
Usp22,0.32190835,0.3033567,3,['Ub-specific processing proteases']
Usp24,0.16217744,0.10349582,3,['Ub-specific processing proteases']
Usp25,0.21957995,-0.11678323,1,['Ub-specific processing proteases']
Usp26,-0.0041841078,0.18967028,3,['Ub-specific processing proteases']
Usp27x,0.047726903,0.22676267,3,
Usp28,0.23282461,0.23822075,3,['Ub-specific processing proteases']
Usp29,-0.3755723,-0.046740156,2,['Ub-specific processing proteases']
Usp3,0.19039854,0.21160235,3,['Ub-specific processing proteases']
Usp30,0.2725111,0.15356539,3,"['Ub-specific processing proteases', 'Pexophagy']"
Usp32,0.07084149,-0.15595484,1,
Usp33,0.31721792,0.095332794,3,"['Ub-specific processing proteases', 'Regulation of expression of SLITs and ROBOs']"
Usp34,0.18394533,0.28003407,3,"['TCF dependent signaling in response to WNT', 'Ub-specific processing proteases']"
Usp35,-0.06705331,0.03041806,2,
Usp37,0.10833135,0.2466465,3,['Ub-specific processing proteases']
Usp38,-0.08464824,0.12941448,2,
Usp39,-0.11857038,0.47788802,0,['mRNA Splicing - Major Pathway']
Usp4,0.2073246,0.1635561,3,"['TNFR1-induced proapoptotic signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Ub-specific processing proteases']"
Usp40,0.075161055,0.3071828,3,
Usp42,0.20456617,0.0874499,3,['Ub-specific processing proteases']
Usp43,0.20580292,0.12991464,3,['Termination of translesion DNA synthesis']
Usp45,0.2310521,0.42000803,3,['Formation of Incision Complex in GG-NER']
Usp46,-0.028008718,0.20695458,3,
Usp47,0.097710624,0.19796912,3,['Ub-specific processing proteases']
Usp48,-0.016367435,0.032740027,2,['Ub-specific processing proteases']
Usp49,-0.026472285,0.11181615,0,
Usp5,0.15740484,0.15733048,3,"['Ub-specific processing proteases', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes']"
Usp51,0.010406404,0.13346498,2,
Usp6nl,0.03458209,-0.21449931,1,['Retrograde transport at the Trans-Golgi-Network']
Usp7,0.4299582,0.4127693,3,
Usp8,0.32997936,-0.05215902,3,"['Downregulation of ERBB2:ERBB3 signaling', 'Regulation of FZD by ubiquitination', 'Ub-specific processing proteases', 'Negative regulation of MET activity']"
Usp9x,0.36913696,0.027239617,3,
Usp9y,-0.03088344,0.18176585,3,
Uspl1,-0.13939145,-0.08990713,2,
Ust,-0.17030187,-0.20006502,2,['Dermatan sulfate biosynthesis']
Utf1,0.19451831,0.16531196,3,
Utp11,-0.23752499,0.39362028,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utp14a,-0.20832288,0.346077,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utp14b,-0.1809694,0.36800438,0,
Utp15,-0.25304583,0.27848002,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utp18,-0.31097367,0.33487687,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utp20,-0.25724733,0.2644761,0,
Utp23,-0.049759064,0.33214116,0,
Utp25,-0.24129285,0.40746614,0,
Utp3,-0.40953678,0.40588382,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utp4,-0.31556278,0.4329792,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utp6,-0.23315042,0.36372942,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Utrn,0.13707846,-0.2675548,1,
Uts2,0.034934066,-0.069921635,1,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Uts2b,-0.06018901,-0.1196515,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Uts2r,-0.13497439,-0.07459912,2,"['Peptide ligand-binding receptors', 'G alpha (q) signalling events']"
Uty,0.07283989,0.18424617,3,
Uvrag,-0.0054970384,-0.055595435,2,['Macroautophagy']
Uvssa,0.09472574,0.33941966,3,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER']"
Uxs1,-0.26676032,-0.15112899,2,
Uxt,0.0563176,0.17596865,0,
Vac14,0.21431282,-0.09993208,1,"['Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the early endosome membrane', 'Synthesis of PIPs at the late endosome membrane']"
Vamp1,-0.35810244,-0.21074782,2,
Vamp2,0.13694508,-0.31968603,1,"['Serotonin Neurotransmitter Release Cycle', 'Norepinephrine Neurotransmitter Release Cycle', 'trans-Golgi Network Vesicle Budding', 'Glutamate Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Acetylcholine Neurotransmitter Release Cycle', 'Lysosome Vesicle Biogenesis', 'Golgi Associated Vesicle Biogenesis', 'Other interleukin signaling', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'GABA synthesis, release, reuptake and degradation', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Vamp3,-0.14575477,-0.28809297,2,"['ER-Phagosome pathway', 'Retrograde transport at the Trans-Golgi-Network', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'RHOF GTPase cycle']"
Vamp4,-0.1755765,-0.14083062,2,"['Retrograde transport at the Trans-Golgi-Network', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Vamp5,-0.28984904,-0.11203759,2,
Vamp8,-0.12155808,-0.25832057,2,
Vangl1,0.21280415,0.06528293,3,"['RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOQ GTPase cycle', 'RHOH GTPase cycle', 'RHOG GTPase cycle', 'RHOU GTPase cycle', 'RAC3 GTPase cycle', 'RHOV GTPase cycle', 'RHOF GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Vangl2,0.12117139,-0.15876655,1,"['RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Vapa,0.006632075,-0.051834505,1,"['Neutrophil degranulation', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane']"
Vapb,0.11244523,-0.0884653,1,
Vars,-0.21863678,0.07589063,0,
Vars2,-0.0939108,0.09506538,0,
Vash1,-0.30480644,-0.186829,2,
Vash2,-0.049190585,-0.07998894,2,
Vasn,-0.10528195,0.08208027,2,
Vasp,0.40636212,-0.3135895,1,"['Signaling by ROBO receptors', 'Cell-extracellular matrix interactions']"
Vat1,-0.25660214,-0.19297513,2,['Neutrophil degranulation']
Vav1,0.5564608,-0.30760738,1,"['GPVI-mediated activation cascade', 'PIP3 activates AKT signaling', 'Signaling by SCF-KIT', 'NRAGE signals death through JNK', 'Regulation of actin dynamics for phagocytic cup formation', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'CD28 dependent Vav1 pathway', 'G alpha (12/13) signalling events', 'VEGFA-VEGFR2 Pathway', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'VEGFR2 mediated vascular permeability', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'RHOA GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'Erythropoietin activates RAS', 'Regulation of signaling by CBL', 'Azathioprine ADME', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers']"
Vav2,0.45658723,-0.36195135,1,"['GPVI-mediated activation cascade', 'NRAGE signals death through JNK', 'Regulation of actin dynamics for phagocytic cup formation', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'EPH-ephrin mediated repulsion of cells', 'G alpha (12/13) signalling events', 'VEGFA-VEGFR2 Pathway', 'Signal transduction by L1', 'VEGFR2 mediated vascular permeability', 'RHOA GTPase cycle', 'RHOB GTPase cycle', 'RHOC GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle', 'Azathioprine ADME']"
Vav3,0.35790437,-0.34007084,1,"['GPVI-mediated activation cascade', 'NRAGE signals death through JNK', 'Regulation of actin dynamics for phagocytic cup formation', 'DAP12 signaling', 'FCERI mediated MAPK activation', 'FCERI mediated Ca+2 mobilization', 'EPH-ephrin mediated repulsion of cells', 'G alpha (12/13) signalling events', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated vascular permeability', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOG GTPase cycle', 'Azathioprine ADME']"
Vax1,-0.12629934,0.05216756,2,
Vbp1,-0.0053812563,0.35071373,0,
Vcam1,0.49118736,-0.33640233,1,"['Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Integrin cell surface interactions']"
Vcan,0.19079375,-0.28613937,1,
Vcl,0.42292085,-0.31284776,1,"['Platelet degranulation ', 'Smooth Muscle Contraction', 'MAP2K and MAPK activation', 'Neutrophil degranulation']"
Vcp,0.40104106,0.09096825,3,"['Translesion Synthesis by POLH', 'HSF1 activation', 'ABC-family proteins mediated transport', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Hedgehog ligand biogenesis', 'Josephin domain DUBs', 'Ovarian tumor domain proteases', 'Neutrophil degranulation', 'Protein methylation', 'Neddylation', 'RHOH GTPase cycle', 'KEAP1-NFE2L2 pathway']"
Vcpip1,0.079419576,0.16198005,3,
Vcpkmt,0.0151249375,0.047558326,2,['Protein methylation']
Vdac1,0.35033727,-0.15863074,1,"['PINK1-PRKN Mediated Mitophagy', 'Ub-specific processing proteases', 'Pyruvate metabolism']"
Vdac2,0.18432996,-0.08716626,1,['Ub-specific processing proteases']
Vdac3,0.14433792,-0.037715588,1,['Ub-specific processing proteases']
Vdr,0.39237335,0.09695612,3,"['Vitamin D (calciferol) metabolism', 'Nuclear Receptor transcription pathway', 'SUMOylation of intracellular receptors']"
Vegfa,0.59049046,-0.37238333,1,"['Platelet degranulation ', 'VEGF ligand-receptor interactions', 'VEGF binds to VEGFR leading to receptor dimerization', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated cell proliferation']"
Vegfb,0.21914797,-0.30348533,1,"['Platelet degranulation ', 'VEGF ligand-receptor interactions', 'VEGF binds to VEGFR leading to receptor dimerization']"
Vegfc,0.3013638,-0.34709713,1,"['Platelet degranulation ', 'VEGF ligand-receptor interactions', 'VEGF binds to VEGFR leading to receptor dimerization']"
Vegfd,0.36486092,-0.33967483,1,"['Platelet degranulation ', 'VEGF ligand-receptor interactions', 'VEGF binds to VEGFR leading to receptor dimerization']"
Vegfr1,0.004259936,-0.09444988,1,
Vegfr1r2,0.10200957,-0.17783694,1,
Vegfr2,0.062238704,-0.04367984,1,
Vegfr2r3,0.05812648,-0.0340363,1,
Vegfr3,-0.07104434,-0.12221068,2,
Veph1,-0.100740284,-0.022783374,2,
Vezf1,0.07516603,0.09169594,3,
Vezt,-0.35166004,-0.20069575,2,
Vgf,-0.14672834,-0.13129123,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Vgll1,-0.2220735,-0.22712408,2,
Vgll2,-0.14840892,-0.14090386,2,
Vgll3,-0.10552789,-0.006697987,2,
Vgll4,-0.2711695,-0.15920205,2,
Vhl,0.4532525,0.13150388,3,"['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'SUMOylation of ubiquitinylation proteins', 'Neddylation', 'RHOBTB3 ATPase cycle', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Vil1,0.0015824301,-0.025166865,2,
Vill,-0.08234786,0.09591724,2,
Vim,0.42831588,0.03174714,3,"['Caspase-mediated cleavage of cytoskeletal proteins', 'Striated Muscle Contraction', 'RHOBTB1 GTPase cycle', 'Aggrephagy']"
Vip,0.030522725,-0.09600497,2,
Vipas39,-0.23653078,-0.083965145,2,
Vipr1,0.05787417,0.04631358,2,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Vipr2,0.11112792,-0.0494354,1,"['G alpha (s) signalling events', 'Glucagon-type ligand receptors']"
Virma,0.037919335,0.2919434,0,
Vkorc1,-0.027050218,0.08398285,2,['Metabolism of vitamin K']
Vkorc1l1,0.04702043,0.009905468,3,['Metabolism of vitamin K']
Vldlr,0.42154473,-0.21747793,1,"['Reelin signalling pathway', 'VLDLR internalisation and degradation', 'VLDL clearance']"
Vma21,-0.13655259,-0.09826101,2,
Vmn1r10,-0.081390575,-0.03181736,2,
Vmn1r114,-0.27301624,-0.16790381,2,
Vmn1r13,-0.24149048,0.0044709006,2,
Vmn1r158,-0.16825372,-0.12058005,2,
Vmn1r168,-0.07180355,-0.077874325,2,
Vmn1r177,-0.17431134,-0.07990356,2,
Vmn1r178,-0.034459054,-0.047395874,2,
Vmn1r180,-0.1734157,0.011339647,2,
Vmn1r184,-0.24662694,-0.06474348,2,
Vmn1r185,-0.28663877,-0.038183127,2,
Vmn1r188,-0.18484636,-0.120083764,2,
Vmn1r193,-0.08369583,-0.04381818,2,
Vmn1r194,-0.13974234,-0.049160864,2,
Vmn1r198,-0.14004795,-0.18779325,2,
Vmn1r199,-0.30189648,-0.0035510631,2,
Vmn1r201,-0.13648134,0.12251666,2,
Vmn1r216,-0.13621913,-0.07454055,2,
Vmn1r228,-0.13580537,0.01194591,2,
Vmn1r232,-0.41238463,-0.12733136,2,
Vmn1r236,-0.17327857,-0.039720464,2,
Vmn1r27,-0.21590865,0.1456039,2,
Vmn1r37,-0.059127692,-0.17116708,1,
Vmn1r44,-0.32109645,-0.021568995,2,
Vmn1r45,-0.12419052,-0.1064821,2,
Vmn1r46,-0.35556188,0.00747741,2,
Vmn1r47,-0.21950655,-0.03750171,2,
Vmn1r49,-0.16822086,-2.4107409e-05,2,
Vmn1r50,-0.19840476,-0.014875107,2,
Vmn1r51,-0.21380594,-0.31371564,2,
Vmn1r53,-0.2671831,0.15942535,2,
Vmn1r55,-0.25481057,-0.16568057,2,
Vmn1r58,-0.16178936,-0.0983848,2,
Vmn1r66,-0.22145794,-0.052468542,2,
Vmn1r69,-0.26390755,0.049923494,2,
Vmn1r7,-0.07262032,0.045748718,2,
Vmn1r71,-0.31249106,0.0014698398,2,
Vmn1r73,-0.18500634,0.024493309,2,
Vmn1r75,-0.04869903,-0.06259761,2,
Vmn1r8,-0.1627881,-0.05623782,2,
Vmn1r80,-0.15813193,-0.11052622,2,
Vmn1r85,-0.2772174,-0.0064973566,2,
Vmn1r86,-0.20334278,-0.12105531,2,
Vmn1r88,-0.3155583,-0.1193477,2,
Vmn1r89,-0.15086658,0.16459142,2,
Vmn1r9,-0.2326415,-0.09933951,2,
Vmn2r-ps158,-0.11399179,-0.13833824,2,
Vmn2r100,-0.2690245,0.023406861,2,
Vmn2r105,-0.11913573,-0.036718838,2,
Vmn2r111,-0.25300854,0.032115966,2,
Vmn2r112,-0.22108774,0.05713688,2,
Vmn2r114,-0.16798069,-0.00973864,2,
Vmn2r116,-0.02811201,0.12077394,2,
Vmn2r118,-0.060448337,-0.18546668,2,
Vmn2r121,-0.1832814,0.009588329,2,
Vmn2r14,-0.07687613,0.18003802,2,
Vmn2r16,-0.081695266,-0.15707862,2,
Vmn2r17,-0.29629707,0.014782984,2,
Vmn2r19,-0.124304295,-0.13192917,2,
Vmn2r2,-0.25749823,-0.13554664,2,
Vmn2r20,-0.11345521,-0.036994845,2,
Vmn2r22,-0.24598862,-0.12609042,2,
Vmn2r26,-0.20315585,-0.048794683,2,
Vmn2r28,-0.17868756,0.019059064,2,
Vmn2r29,-0.023042506,-0.103133574,2,
Vmn2r3,-0.12763447,0.041630186,2,
Vmn2r30,-0.026388455,0.005174323,2,
Vmn2r31,-0.3176232,0.049785674,2,
Vmn2r37,-0.15840007,-0.080548465,2,
Vmn2r43,-0.06829278,-0.07188554,2,
Vmn2r5,-0.28149205,-0.09679792,2,
Vmn2r50,-0.2581117,0.009927905,2,
Vmn2r6,-0.29726246,0.04704115,2,
Vmn2r65,-0.32750133,-0.10652216,2,
Vmn2r66,0.054363854,0.067949176,2,
Vmn2r69,-0.06443529,0.008288354,2,
Vmn2r7,-0.27679744,0.09541925,2,
Vmn2r72,-0.07696119,-0.027193476,2,
Vmn2r74,-0.17126215,0.101479694,2,
Vmn2r76,-0.16329253,-0.08164315,2,
Vmn2r82,-0.029973837,0.00019816738,2,
Vmn2r86,-0.12443147,0.003517708,2,
Vmn2r87,-0.023350919,-0.20201647,2,
Vmn2r88,-0.44468743,0.085188314,2,
Vmn2r91,-0.205542,-0.13862313,2,
Vmn2r95,-0.06061605,0.0607987,2,
Vmp1,0.046863448,-0.09978278,1,
Vnn1,-0.09119593,-0.25303948,2,"['Post-translational modification: synthesis of GPI-anchored proteins', 'Vitamin B5 (pantothenate) metabolism', 'Neutrophil degranulation']"
Vnn3,-0.08966363,-0.3040545,2,
Vopp1,-0.013631766,-0.09794279,2,
Vpreb1,-0.005187006,-0.09174675,1,
Vpreb2,-0.11258221,-0.2251587,2,['Cell surface interactions at the vascular wall']
Vpreb3,-0.16654885,-0.13105835,2,['Cell surface interactions at the vascular wall']
Vps11,-0.24024726,-0.15132253,2,
Vps13a,-0.10100805,-0.07213768,2,
Vps13b,0.089405775,0.1592752,3,
Vps13c,-0.11662292,-0.16035677,2,
Vps13d,-0.10348539,-0.06639318,2,
Vps16,-0.17053331,-0.13093178,2,
Vps18,-0.14412759,-0.22906443,2,
Vps25,0.028913703,0.07779069,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps26a,0.061173018,-0.27532074,1,['WNT ligand biogenesis and trafficking']
Vps26b,-0.05642772,-0.4239722,1,
Vps26c,-0.21902642,-0.04693518,2,
Vps29,-0.052628383,-0.22019076,2,['WNT ligand biogenesis and trafficking']
Vps33a,-0.1487614,-0.2582604,2,
Vps33b,-0.18291436,-0.10839784,2,
Vps35,0.13416025,-0.19548933,1,['WNT ligand biogenesis and trafficking']
Vps35l,-0.1775143,-0.04613301,2,['Neutrophil degranulation']
Vps36,0.33528754,0.055633154,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps37a,0.0928114,0.07479559,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps37b,0.25574172,0.15126187,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps37c,0.14473495,0.10102445,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps37d,0.105957024,0.07279375,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps39,0.017413802,-0.07369308,1,
Vps41,-0.15932411,-0.08856688,2,
Vps45,-0.3087941,-0.13671087,2,"['Intra-Golgi traffic', 'Factors involved in megakaryocyte development and platelet production']"
Vps4a,0.15938453,0.13341716,3,"['Endosomal Sorting Complex Required For Transport (ESCRT)', 'Sealing of the nuclear envelope (NE) by ESCRT-III']"
Vps4b,0.07680243,0.083553396,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vps50,-0.22322229,-0.09449986,2,
Vps52,-0.09865981,-0.021122929,2,['Retrograde transport at the Trans-Golgi-Network']
Vps53,-0.076826036,-0.053578205,2,['Retrograde transport at the Trans-Golgi-Network']
Vps54,-0.18206362,-0.123801135,2,['Retrograde transport at the Trans-Golgi-Network']
Vps72,0.04119032,0.27132735,3,
Vps8,-0.04977616,-0.090249464,2,
Vrk1,0.19336309,0.21704225,3,"['Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation']"
Vrk2,0.20252374,0.06603222,3,"['Nuclear Envelope Breakdown', 'Initiation of Nuclear Envelope (NE) Reformation', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RHOD GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Vrk3,0.21213807,-0.08302645,1,['ERKs are inactivated']
Vrtn,-0.21979335,-0.1579432,2,
Vsig1,0.09804444,-0.06276137,1,
Vsig4,-0.18716075,-0.18173392,2,
Vsir,-0.057294883,-0.029211545,2,
Vsnl1,-0.33107555,0.12170393,2,
Vstm2l,-0.11867622,-0.099605486,2,
Vstm4,-0.14800143,-0.21805188,2,
Vstm5,-0.099476464,-0.015572677,2,
Vsx1,-0.2267414,0.00714535,2,
Vsx2,0.122450024,0.019317329,3,
Vta1,0.11659051,0.13909028,3,['Endosomal Sorting Complex Required For Transport (ESCRT)']
Vtcn1,0.13658841,-0.13964541,1,
Vti1a,-0.26204982,-0.06724697,2,"['Intra-Golgi traffic', 'Retrograde transport at the Trans-Golgi-Network']"
Vti1b,-0.33997512,-0.22508247,2,
Vtn,0.34435123,-0.15750039,1,"['Molecules associated with elastic fibres', 'Integrin cell surface interactions', 'Syndecan interactions', 'ECM proteoglycans', 'Regulation of Complement cascade']"
Vwa1,-0.08352509,-0.06450195,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Vwa2,-0.10340865,-0.021279896,2,
Vwa3a,-0.09332412,0.023158405,2,
Vwa5b1,-0.32647264,0.15559068,2,
Vwa5b2,-0.10596207,-0.10355085,2,
Vwa7,-0.23052481,-0.09644881,2,
Vwa8,-0.21779944,0.28978252,0,
Vwc2,0.0029027741,-0.02220163,1,
Vwc2l,-0.02310151,-0.11969861,2,
Vwf,0.3558756,-0.43922734,1,
Vxn,-0.28464988,-0.032158677,2,
Wac,-0.29872555,0.2717826,0,['E3 ubiquitin ligases ubiquitinate target proteins']
Wap,0.1021577,0.2634337,3,
Wapl,0.17079556,0.36021477,3,"['Separation of Sister Chromatids', 'Establishment of Sister Chromatid Cohesion', 'Cohesin Loading onto Chromatin', 'Resolution of Sister Chromatid Cohesion']"
Wars,-0.036440346,-0.06002094,2,
Wars2,-0.08459902,0.09070199,2,
Was,0.26618248,-0.27778524,1,
Wasf1,0.3396842,0.018659854,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC3 GTPase cycle']"
Wasf2,0.28341594,-0.10013799,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle', 'RAC2 GTPase cycle', 'RAC3 GTPase cycle']"
Wasf3,0.29123595,-0.14885022,1,"['Regulation of actin dynamics for phagocytic cup formation', 'VEGFA-VEGFR2 Pathway', 'RHO GTPases Activate WASPs and WAVEs', 'RAC1 GTPase cycle']"
Washc1,-0.054775853,0.027550172,2,
Washc2,-0.0014720679,-0.22298895,2,
Washc3,-0.0061589326,0.08443015,3,
Washc4,0.028459795,0.007734965,2,
Washc5,-0.02701817,-0.046562,2,
Wasl,0.2819725,-0.12326358,1,
Wbp1,-0.07221115,0.027652934,2,
Wbp11,-0.055082854,0.26963788,0,['mRNA Splicing - Major Pathway']
Wbp2,0.111490786,-0.03345522,3,
Wbp2nl,0.044963554,-0.04950733,3,
Wbp4,-0.31844145,0.3767847,0,['mRNA Splicing - Major Pathway']
Wdfy1,-0.20380776,-0.07390954,2,
Wdfy2,0.10392452,-0.015521557,3,
Wdfy3,0.099240124,-0.004844717,3,
Wdfy4,0.13924776,0.083403945,3,
Wdpcp,0.025831884,-0.010963896,3,
Wdr1,0.2454027,-0.04920265,3,['Platelet degranulation ']
Wdr11,-0.006751454,0.08447736,0,
Wdr12,-0.10185685,0.43187618,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr17,-0.15823236,-0.054939277,2,
Wdr18,-0.2259521,0.38225234,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr19,-0.062317245,0.088506475,2,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Wdr20,-0.08425069,0.022519026,2,['Ub-specific processing proteases']
Wdr20rt,-0.08449775,0.1631829,2,
Wdr24,-0.09147229,0.048903737,0,['Amino acids regulate mTORC1']
Wdr25,-0.077380024,0.33842066,0,
Wdr26,-0.0223649,-0.09953543,2,
Wdr27,-0.11501219,0.100522816,2,
Wdr3,-0.27333963,0.3714741,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr31,-0.07025842,0.3254264,0,
Wdr33,0.08601259,0.43121758,0,"['Transport of Mature mRNA Derived from an Intronless Transcript', 'mRNA Splicing - Major Pathway', ""mRNA 3'-end processing"", 'RNA Polymerase II Transcription Termination', 'Processing of Intronless Pre-mRNAs']"
Wdr35,-0.09244107,0.040169857,2,"[""Hedgehog 'off' state"", 'Intraflagellar transport']"
Wdr36,-0.11246415,0.46010205,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr37,0.012250769,0.039387744,2,
Wdr38,0.2553113,0.31930733,3,
Wdr4,-0.21882693,0.4003071,0,
Wdr41,0.14156869,-0.02657949,1,
Wdr43,-0.22208029,0.43049943,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr44,0.0389551,-0.0012412851,2,
Wdr45,0.05479206,-0.13173738,2,['Macroautophagy']
Wdr45b,-0.13037837,-0.10257438,2,['Macroautophagy']
Wdr46,-0.10001018,0.34649876,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr47,-0.094929054,-0.046802424,2,
Wdr48,0.23449287,0.3525047,3,"['Recognition of DNA damage by PCNA-containing replication complex', 'Ub-specific processing proteases', 'Fanconi Anemia Pathway']"
Wdr5,0.42833328,0.311654,3,"['PKMTs methylate histone lysines', 'HATs acetylate histones', 'RMTs methylate histone arginines', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Neddylation']"
Wdr53,0.0921633,0.10513461,3,
Wdr54,0.0028634735,-0.03557665,2,
Wdr55,0.063998,0.18468456,0,
Wdr59,-0.18444845,0.29271507,0,['Amino acids regulate mTORC1']
Wdr5b,0.14694646,0.084420994,3,
Wdr6,-0.2079597,0.21281295,0,"['RHOU GTPase cycle', 'RHOV GTPase cycle', 'RND3 GTPase cycle', 'RND2 GTPase cycle', 'RND1 GTPase cycle']"
Wdr61,0.094277695,0.31577787,3,"['Formation of RNA Pol II elongation complex ', ""mRNA decay by 3' to 5' exoribonuclease"", 'RNA Polymerase II Pre-transcription Events', 'RNA Polymerase II Transcription Elongation', 'E3 ubiquitin ligases ubiquitinate target proteins']"
Wdr62,0.1807638,0.08802165,3,
Wdr64,0.10164344,0.08622411,3,
Wdr66,-0.10455047,0.125279,2,
Wdr7,-0.07312426,-0.057466134,2,
Wdr70,0.015269758,0.35802156,0,
Wdr72,0.037221003,-0.02714712,2,
Wdr73,0.33157638,0.42798546,3,
Wdr74,-0.13096748,0.3414604,0,
Wdr75,-0.21686003,0.46076658,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Wdr76,0.061319534,0.34888294,3,
Wdr77,0.2375015,0.36245492,0,"['snRNP Assembly', 'RMTs methylate histone arginines']"
Wdr81,-0.18695249,-0.07231051,2,
Wdr82,0.18918815,0.14616609,3,
Wdr83,0.24962206,0.12493513,3,['MAP2K and MAPK activation']
Wdr83os,-0.061428726,0.054388784,2,
Wdr86,0.030343086,0.08993425,3,
Wdr89,-0.03974416,0.111662075,0,
Wdr90,-0.0062830304,-0.0053953147,2,
Wdr91,-0.08036027,-0.021535227,2,
Wdr93,-0.26742813,0.020723645,2,
Wdr95,0.006020427,0.139386,2,
Wdsub1,-0.10437869,-0.06872671,2,
Wdtc1,0.1261278,0.25246498,3,['Neddylation']
Wdyhv1,-0.18541011,-0.06797678,2,
Wee1,0.4154035,0.31732145,3,"['Polo-like kinase mediated events', 'Cyclin E associated events during G1/S transition ', 'Cyclin A/B1/B2 associated events during G2/M transition', 'G2/M DNA replication checkpoint', 'Cyclin A:Cdk2-associated events at S phase entry', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex']"
Wee2,0.30267307,0.20708486,3,
Wfdc10,-0.31092873,-0.12830442,2,
Wfdc11,-0.22041501,-0.112743594,2,
Wfdc12,-0.27567065,-0.124875985,2,
Wfdc13,-0.30198956,-0.18222429,2,
Wfdc15a,0.03203634,-0.18864396,2,
Wfdc15b,-0.21642737,-0.12981525,2,
Wfdc16,-0.36899087,-0.20169827,2,
Wfdc2,-0.15036814,0.23433067,2,
Wfdc3,-0.029683666,0.108167,2,
Wfdc5,-0.20451316,-0.14283024,2,
Wfdc6a,-0.26350364,0.040372174,2,
Wfdc6b,-0.08129499,0.028741278,2,
Wfdc8,-0.3224441,-0.019079588,2,
Wfdc9,-0.3642181,0.06667536,2,
Wfikkn1,0.07148448,0.105244935,0,
Wfikkn2,-0.064397514,-0.07561476,2,
Wfs1,0.039675664,-0.18153419,2,"['Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Post-translational protein phosphorylation']"
Whamm,0.08880389,-0.10017353,1,['RHOD GTPase cycle']
Whrn,0.017356038,-0.36288285,1,
Wif1,-0.072095245,-0.06010717,2,
Wipf1,0.22512104,-0.17278773,1,"['Regulation of actin dynamics for phagocytic cup formation', 'RHO GTPases Activate WASPs and WAVEs']"
Wipf2,0.033263616,-0.008409591,1,
Wipf3,0.15244654,-0.24406168,1,
Wipi1,0.06901673,0.009626141,3,['Macroautophagy']
Wipi2,0.011743232,-0.07364019,2,['Macroautophagy']
Wiz,0.0688454,0.08544704,3,
Wls,0.019351756,-0.15772456,2,['WNT ligand biogenesis and trafficking']
Wmp,0.07060204,0.029397067,0,
Wnk1,0.1875297,0.11165191,3,
Wnk2,0.08407571,-0.028349908,3,
Wnk3,0.16346839,0.09331443,3,
Wnk4,0.15884607,0.13833323,3,
Wnt1,0.4050286,-0.13384117,1,"['TCF dependent signaling in response to WNT', 'WNT ligand biogenesis and trafficking', 'PCP/CE pathway', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane']"
Wnt10a,0.026004829,0.122401625,3,['WNT ligand biogenesis and trafficking']
Wnt10b,0.037462085,0.06721465,3,['WNT ligand biogenesis and trafficking']
Wnt11,0.02158911,-0.11041907,2,"['WNT ligand biogenesis and trafficking', 'Ca2+ pathway', 'PCP/CE pathway']"
Wnt16,-0.0850691,-0.03324835,2,['WNT ligand biogenesis and trafficking']
Wnt2,0.11967033,-0.06968293,2,['WNT ligand biogenesis and trafficking']
Wnt2b,0.054949436,0.06831266,3,['WNT ligand biogenesis and trafficking']
Wnt3,-0.001875467,-0.105149984,2,"['TCF dependent signaling in response to WNT', 'WNT ligand biogenesis and trafficking']"
Wnt3a,0.23127991,0.041137192,3,"['TCF dependent signaling in response to WNT', 'WNT ligand biogenesis and trafficking', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'Regulation of FZD by ubiquitination']"
Wnt4,0.10178162,0.101507306,3,"['WNT ligand biogenesis and trafficking', 'PCP/CE pathway']"
Wnt5a,0.1405505,-0.24919796,1,"['TCF dependent signaling in response to WNT', 'WNT ligand biogenesis and trafficking', 'Ca2+ pathway', 'PCP/CE pathway', 'Asymmetric localization of PCP proteins', 'WNT5A-dependent internalization of FZD4', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis']"
Wnt5b,0.073261864,0.011466481,3,"['WNT ligand biogenesis and trafficking', 'PCP/CE pathway']"
Wnt6,-0.02676593,0.014013535,2,['WNT ligand biogenesis and trafficking']
Wnt7a,-0.031595886,-0.07930081,2,['WNT ligand biogenesis and trafficking']
Wnt7b,0.030652458,0.11768142,3,['WNT ligand biogenesis and trafficking']
Wnt8a,0.028832246,0.05141921,2,"['WNT ligand biogenesis and trafficking', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane']"
Wnt8b,0.03836504,-0.023352565,2,
Wnt9a,0.018287675,-0.016561145,2,['WNT ligand biogenesis and trafficking']
Wnt9b,0.05214228,0.04069897,2,['WNT ligand biogenesis and trafficking']
Wrap53,0.114291646,0.40915138,0,['Telomere Extension By Telomerase']
Wrap73,-0.13480328,0.016056763,2,
Wrn,0.31054017,0.4272248,3,"['Processive synthesis on the C-strand of the telomere', 'Removal of the Flap Intermediate from the C-strand', 'HDR through Single Strand Annealing (SSA)', 'HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Processing of DNA double-strand break ends', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Regulation of TP53 Activity through Phosphorylation', 'G2/M DNA damage checkpoint']"
Wrnip1,0.057578836,0.16754115,3,
Wsb1,0.11109512,0.036800638,3,"['Neddylation', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Wsb2,0.13141367,0.05393522,3,['Neddylation']
Wt1,0.28778696,0.0710988,3,
Wtap,0.059802175,0.29051477,0,['Processing of Capped Intron-Containing Pre-mRNA']
Wtip,0.16774324,0.07192473,3,['Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha']
Wwc1,0.22144382,-0.13033356,1,['Signaling by Hippo']
Wwc2,-0.0820211,-0.10662969,2,
Wwox,0.17621405,-0.07827401,1,"['Nuclear signaling by ERBB4', 'Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Activation of the TFAP2 (AP-2) family of transcription factors']"
Wwp1,0.35199723,0.11753116,3,"['Downregulation of ERBB4 signaling', 'Stimuli-sensing channels', 'Antigen processing: Ubiquitination & Proteasome degradation']"
Wwp2,0.41614625,0.17692436,3,"['Regulation of PTEN stability and activity', 'RHOQ GTPase cycle', 'RHOU GTPase cycle', 'NOTCH3 Activation and Transmission of Signal to the Nucleus']"
Wwtr1,0.35254958,0.047057446,3,"['Signaling by Hippo', 'YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription']"
Xab2,0.0056214794,0.5678798,0,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'mRNA Splicing - Major Pathway']"
Xaf1,0.04735475,0.054262046,3,
Xbp1,0.4147466,0.15408023,3,
Xcl1,0.3136253,-0.05398273,1,"['Chemokine receptors bind chemokines', 'G alpha (q) signalling events']"
Xcr1,0.29518828,-0.115963034,1,"['Chemokine receptors bind chemokines', 'G alpha (q) signalling events']"
Xdh,-0.012065327,-0.19230211,1,"['Purine catabolism', 'Butyrophilin (BTN) family interactions', 'Azathioprine ADME']"
Xiap,0.5053341,0.054076526,3,"['Activation of caspases through apoptosome-mediated cleavage', 'SMAC (DIABLO) binds to IAPs ', 'SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ', 'SMAC, XIAP-regulated apoptotic response', 'Deactivation of the beta-catenin transactivating complex', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'Regulation of necroptotic cell death', 'Regulation of PTEN localization', 'Regulation of PTEN stability and activity', 'Regulation of the apoptosome activity']"
Xirp1,0.21246453,-0.06700459,1,
Xirp2,-0.03369022,-0.15011086,2,
Xk,0.0061126533,0.1216487,0,['Peptide ligand-binding receptors']
Xkr4,-0.32466397,-0.12278445,2,
Xkr5,-0.10533588,0.008048532,2,
Xkr6,-0.10212635,-0.21578452,2,
Xkr8,-0.17492482,-0.19964245,2,
Xkr9,-0.13896132,-0.042636532,2,
Xlr5b,-0.15722111,-0.019601753,2,
Xlr5c,-0.19045272,-0.3169643,2,
Xntrpc,-0.27622035,-0.3075924,2,
Xpa,0.33927226,0.522311,3,"['Formation of Incision Complex in GG-NER', 'Dual Incision in GG-NER', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER']"
Xpc,0.20674255,0.30609456,3,"['SUMOylation of DNA damage response and repair proteins', 'DNA Damage Recognition in GG-NER', 'Formation of Incision Complex in GG-NER']"
Xpnpep1,-0.015345652,-0.06678734,2,
Xpnpep2,-0.11687722,-0.14749086,2,['Post-translational modification: synthesis of GPI-anchored proteins']
Xpnpep3,-0.06114778,0.105820194,2,
Xpo1,0.42065963,0.44736654,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'Deactivation of the beta-catenin transactivating complex', 'HuR (ELAVL1) binds and stabilizes mRNA', 'RHO GTPases Activate Formins', 'MAPK6/MAPK4 signaling', 'Mitotic Prometaphase', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'EML4 and NUDC in mitotic spindle formation', 'Heme signaling']"
Xpo4,-0.12141923,0.2983904,0,
Xpo5,0.11229319,0.5559715,0,
Xpo6,0.052406326,0.2671842,0,
Xpo7,0.052899424,0.30769545,0,
Xpot,0.069991924,0.29741433,0,
Xpr1,-0.29717687,-0.16199584,2,
Xrcc1,0.19529997,0.32521108,3,"['Resolution of AP sites via the single-nucleotide replacement pathway', 'APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway', 'HDR through MMEJ (alt-NHEJ)', 'Gap-filling DNA repair synthesis and ligation in TC-NER']"
Xrcc2,0.1375126,0.2968876,3,"['HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange', 'Presynaptic phase of homologous DNA pairing and strand exchange']"
Xrcc3,0.2373072,0.35962397,3,"['HDR through Homologous Recombination (HRR)', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Homologous DNA Pairing and Strand Exchange']"
Xrcc4,0.2203329,0.30198166,3,
Xrcc5,0.12442663,0.3613549,3,"['Nonhomologous End-Joining (NHEJ)', 'Neutrophil degranulation']"
Xrcc6,0.3653147,0.32633334,3,
Xrn1,-0.067104824,0.54892546,0,
Xrn2,-0.060516775,0.4682093,0,['Major pathway of rRNA processing in the nucleolus and cytosol']
Xrra1,-0.10788787,-0.06650122,2,
Xxylt1,-0.10575285,0.2447043,3,
Xylb,-0.26977918,-0.04927528,2,['Formation of xylulose-5-phosphate']
Xylt1,-0.027554926,-0.12806764,1,
Xylt2,-0.05159514,-0.15801756,2,['A tetrasaccharide linker sequence is required for GAG synthesis']
Yae1d1,0.0074445205,0.1360324,0,
Yaf2,0.18696678,0.096800424,3,"['RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'Transcriptional Regulation by E2F6']"
Yap1,0.4882478,0.021868808,3,"['Nuclear signaling by ERBB4', 'Signaling by Hippo', 'YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'RUNX3 regulates YAP1-mediated transcription']"
Yars,-0.06079792,0.23017097,0,
Yars2,-0.22468229,-0.020838926,2,
Ybey,-0.053112738,0.1489164,2,
Ybx1,0.3140152,0.36959052,0,"['mRNA Splicing - Major Pathway', 'mRNA Splicing - Minor Pathway', 'Noncanonical activation of NOTCH3']"
Ybx2,-0.20036314,-0.07267278,2,
Ybx3,0.11078149,-0.08681135,1,
Ydjc,-0.34708044,-0.15242751,2,
Yeats2,0.24234842,0.25571147,3,
Yeats4,0.3138807,0.3657214,3,['Activation of the TFAP2 (AP-2) family of transcription factors']
Yes1,0.5231743,-0.31047732,1,"['Signaling by ERBB2', 'Signaling by SCF-KIT', 'Regulation of KIT signaling', 'FCGR activation', 'PECAM1 interactions', 'CD28 co-stimulation', 'CTLA4 inhibitory signaling', 'EPHB-mediated forward signaling', 'EPHA-mediated growth cone collapse', 'EPH-ephrin mediated repulsion of cells', 'Regulation of signaling by CBL']"
Yif1a,-0.19770952,-0.018034909,2,
Yif1b,-0.22331136,-0.18807876,2,
Yipf1,-0.27121222,0.09443141,2,
Yipf2,-0.29039502,-0.058849372,2,
Yipf3,-0.24687926,-0.102935165,2,
Yipf4,-0.27739704,0.07304936,2,
Yipf5,-0.2240902,0.00843421,2,
Yipf6,-0.09020503,-0.3092409,2,['Golgi Associated Vesicle Biogenesis']
Yipf7,-0.36742246,0.07337744,2,
Yjefn3,-0.14220913,-0.023016626,2,
Yju2,-0.24989481,0.22502266,0,
Ykt6,-0.14758225,-0.026033804,2,"['COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'Intra-Golgi traffic', 'RHOA GTPase cycle', 'CDC42 GTPase cycle', 'RAC1 GTPase cycle', 'RHOG GTPase cycle', 'RAC3 GTPase cycle']"
Ylpm1,0.008253627,0.014201746,2,
Yme1l1,0.17544551,0.109793715,3,['Processing of SMDT1']
Yod1,0.12846461,0.29004517,3,['Ovarian tumor domain proteases']
Ypel1,-0.246283,-0.17824411,2,
Ypel3,-0.025076585,0.034422386,2,
Ypel4,-0.16749606,-0.06414724,2,
Ypel5,-0.2574107,-0.018334456,2,['Neutrophil degranulation']
Yrdc,-0.4501364,0.09230332,2,
Ythdc1,-0.04833285,0.28484142,0,
Ythdc2,-0.14417036,0.5676921,0,
Ythdf1,0.011863088,0.13755946,0,
Ythdf2,-0.06726094,0.23779461,0,
Ythdf3,-0.02706659,0.30842495,0,
Ywhab,0.50556546,-0.124633506,3,"['Activation of BAD and translocation to mitochondria ', 'MTOR signalling', 'mTORC1-mediated signalling', 'Frs2-mediated activation', 'Signaling by Hippo', 'Rap1 signalling', 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'RAF activation', 'MAP2K and MAPK activation', 'Negative regulation of MAPK pathway', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'Regulation of localization of FOXO transcription factors']"
Ywhae,0.5840984,-0.016656058,3,"['Activation of BAD and translocation to mitochondria ', 'Signaling by Hippo', 'NADE modulates death signalling', 'Regulation of PLK1 Activity at G2/M Transition', 'Regulation of HSF1-mediated heat shock response', 'HSF1 activation', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'AURKA Activation by TPX2', 'RAB GEFs exchange GTP for GDP on RABs']"
Ywhag,0.55452144,0.008650505,3,"['Activation of BAD and translocation to mitochondria ', 'Regulation of PLK1 Activity at G2/M Transition', 'Loss of Nlp from mitotic centrosomes', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Recruitment of NuMA to mitotic centrosomes', 'Anchoring of the basal body to the plasma membrane', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'AURKA Activation by TPX2', 'Regulation of localization of FOXO transcription factors']"
Ywhah,0.56423384,-0.14209986,3,"['Activation of BAD and translocation to mitochondria ', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex']"
Ywhaq,0.3515623,0.057356,3,"['Activation of BAD and translocation to mitochondria ', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'Regulation of localization of FOXO transcription factors']"
Ywhaz,0.54114455,-0.1941635,1,"['Activation of BAD and translocation to mitochondria ', 'Deactivation of the beta-catenin transactivating complex', 'Rap1 signalling', 'GP1b-IX-V activation signalling', 'KSRP (KHSRP) binds and destabilizes mRNA', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'RHO GTPases activate PKNs', 'TP53 Regulates Metabolic Genes', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'NOTCH4 Activation and Transmission of Signal to the Nucleus', 'Regulation of localization of FOXO transcription factors']"
Yy1,0.5131009,0.34056988,3,"['UCH proteinases', 'DNA Damage Recognition in GG-NER']"
Yy2,0.15078801,0.10046489,3,
Zadh2,-0.27458626,-0.04200027,2,
Zan,0.042239066,0.029011542,2,
Zap70,0.32122537,-0.3963375,1,"['Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'RHOH GTPase cycle']"
Zar1,-0.33569717,0.26162022,2,
Zar1l,-0.058894593,0.053568542,2,
Zbbx,-0.17708917,-0.03126982,2,
Zbed3,-0.19376138,-0.062011514,2,
Zbed4,-0.17797732,0.100888185,2,
Zbp1,0.18881162,0.059367478,3,
Zbtb10,-0.31697476,0.030002413,2,
Zbtb11,-0.2950802,0.13603589,2,
Zbtb14,0.061629776,0.15001081,3,
Zbtb16,0.20635614,0.101970956,3,
Zbtb17,0.30121505,0.10417131,3,
Zbtb18,-0.1940987,-0.0033937956,2,
Zbtb20,-0.07925823,0.018509159,2,
Zbtb21,-0.30275968,-0.059356757,2,
Zbtb22,0.07303736,0.014663439,3,
Zbtb24,-0.25518173,0.18231405,2,
Zbtb32,0.044760253,0.021858828,3,
Zbtb33,0.32974002,0.15175582,3,
Zbtb34,-0.0033055625,0.056072906,1,
Zbtb37,-0.2548808,0.094466165,2,
Zbtb38,-0.17908882,-0.10640903,2,
Zbtb39,-0.05165122,-0.08444924,2,
Zbtb4,-0.21373567,0.030711308,2,
Zbtb40,-0.14984116,-0.20582497,2,
Zbtb43,0.014874223,-0.026547212,2,
Zbtb44,-0.2961972,-0.09910763,2,
Zbtb46,-0.005774692,-0.10954318,2,
Zbtb48,-0.017963093,0.2115712,3,
Zbtb7a,0.017741991,0.20449927,3,
Zbtb7b,0.19958156,0.03129201,3,
Zbtb7c,0.09019305,0.05365403,3,
Zbtb8os,-0.1667608,0.13843577,2,
Zc2hc1a,-0.13303347,-0.10380094,2,
Zc2hc1c,-0.12038563,-0.107540116,2,
Zc3h10,-0.16973968,-0.197031,2,
Zc3h12a,0.12178273,0.1232544,3,
Zc3h12c,-0.15985051,0.036254674,2,
Zc3h13,-0.008441731,0.2720683,0,
Zc3h14,0.0077127307,0.31345588,0,
Zc3h15,-0.14523341,0.36276618,0,
Zc3h18,-0.102339685,0.18899027,2,
Zc3h3,-0.24639529,0.29718822,0,
Zc3h4,-0.15672687,0.35786167,0,
Zc3h6,-0.2051483,0.27785996,2,
Zc3h7b,0.110638686,-0.019985504,3,
Zc3h8,0.086488,0.23284736,3,['RNA polymerase II transcribes snRNA genes']
Zc3hav1,-0.098124705,-0.014935332,2,
Zc3hc1,0.023313234,0.15921769,3,
Zc4h2,-0.25989565,-0.05271388,2,
Zcchc12,-0.21154423,0.033478644,2,
Zcchc14,-0.14601286,0.030336406,2,
Zcchc17,-0.29025707,0.40800717,0,
Zcchc18,-0.08446478,0.038499992,2,
Zcchc3,-0.17954513,-0.03916399,2,
Zcchc4,-0.36060178,-0.183652,2,
Zcchc7,-0.28387883,0.3698773,0,
Zcchc8,-0.1567681,0.35124654,0,
Zcchc9,0.05202807,0.007948011,2,
Zcrb1,0.040728346,0.18209448,0,['mRNA Splicing - Minor Pathway']
Zcwpw1,-0.1125545,-0.03696569,2,
Zdhhc11,-0.14143321,0.039096408,2,
Zdhhc12,-0.08331678,0.01279111,2,
Zdhhc13,-0.097471625,-0.044738863,2,
Zdhhc14,-0.23759457,-0.071732596,2,
Zdhhc15,-0.18751517,-0.02454669,2,
Zdhhc16,-0.043960284,0.19814983,0,
Zdhhc17,-0.10087401,0.08060109,2,
Zdhhc19,-0.06466443,0.18242405,0,
Zdhhc2,-0.2764092,0.014774029,2,['Surfactant metabolism']
Zdhhc20,-0.16443595,0.028694777,2,
Zdhhc21,0.08125215,0.09630059,3,"['eNOS activation', 'Extra-nuclear estrogen signaling']"
Zdhhc22,-0.1903345,-0.14087275,2,
Zdhhc23,-0.2945858,-0.11890614,2,
Zdhhc5,-0.008958307,0.017339613,2,
Zdhhc6,-0.19330043,-0.056169793,2,
Zdhhc7,0.014751056,0.12864187,3,['Extra-nuclear estrogen signaling']
Zdhhc8,-0.01533259,-0.0498345,2,['HDL assembly']
Zdhhc9,0.12530735,-0.33252648,1,['RAS processing']
Zeb1,0.46368492,0.024611441,3,
Zeb2,0.28282216,-0.011360376,3,
Zer1,0.07614257,-0.024368355,1,
Zfand1,0.033365525,-0.0006158608,2,
Zfand2a,-0.19740033,-0.12032605,2,
Zfand2b,-0.09145967,0.200109,3,
Zfand3,0.034597404,-0.14502387,2,
Zfand4,0.044382926,0.112583645,3,
Zfand5,0.06288558,0.06550421,0,
Zfand6,0.081658244,0.27631703,3,['Peroxisomal protein import']
Zfat,-0.11661914,0.17094122,2,
Zfc3h1,-0.040531326,0.36650303,0,
Zfhx2,-0.22032525,0.15412882,2,
Zfhx3,0.26179427,-0.021002263,3,
Zfhx4,-0.29693007,-0.020632753,2,
Zfp1,0.07076019,0.056512006,0,
Zfp101,-0.13298157,0.09581252,2,['Generic Transcription Pathway']
Zfp106,-0.22398187,-0.26502997,2,
Zfp110,0.21040882,-0.09926631,1,
Zfp112,-0.18154046,-0.007971526,2,['Generic Transcription Pathway']
Zfp119a,-0.017986212,0.22510171,3,
Zfp120,-0.10506657,-0.13868193,2,
Zfp128,-0.037652977,0.07148353,0,
Zfp131,0.036423113,0.30333465,3,['SUMOylation of transcription cofactors']
Zfp142,-0.32975772,0.0791363,2,
Zfp143,0.14863276,0.24103855,3,
Zfp148,0.15496257,0.17647158,3,
Zfp174,-0.18577945,-0.08649088,2,
Zfp182,-0.20672101,-0.26455376,2,
Zfp185,-0.05185532,-0.03153133,2,
Zfp189,-0.32895905,-0.0189014,2,['Generic Transcription Pathway']
Zfp207,0.04051134,0.3218333,3,
Zfp213,-0.3631489,-0.23765896,2,['Generic Transcription Pathway']
Zfp217,0.20991984,0.1870005,3,
Zfp219,0.20554051,0.12048185,3,
Zfp239,-0.1967748,-0.19896765,2,
Zfp24,-0.07198381,-0.06687813,2,
Zfp27,0.050394136,0.055264935,3,['Generic Transcription Pathway']
Zfp276,-0.09696902,0.23727663,3,
Zfp277,-0.21680509,0.00023583141,2,
Zfp28,-0.01766732,0.020523,2,['Generic Transcription Pathway']
Zfp280b,-0.17457075,0.049550474,2,
Zfp281,0.0373649,0.09632512,3,
Zfp286,-0.19895424,-0.052967217,2,['Generic Transcription Pathway']
Zfp287,-0.37833825,-0.0037185086,2,
Zfp292,-0.327725,-0.04397025,2,
Zfp3,-0.2711941,-0.013084491,2,
Zfp318,-0.04818439,0.11758343,2,
Zfp319,-0.24662463,0.0028104763,2,
Zfp324,-0.093202904,-0.029202484,2,['Generic Transcription Pathway']
Zfp326,-0.076120384,0.014107777,2,
Zfp329,-0.12140738,0.10073156,2,
Zfp335,-0.05350793,0.102122106,2,
Zfp346,-0.05273848,0.07394073,2,
Zfp352,-0.12943687,0.1715594,2,
Zfp354b,-0.23240949,-0.29077983,2,['Generic Transcription Pathway']
Zfp36,0.27045092,0.1284457,3,"['Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA']"
Zfp362,-0.052411266,-0.025728207,2,
Zfp365,-0.01536394,0.0068361284,2,
Zfp366,0.07611665,0.122208014,3,
Zfp369,0.043735877,-0.045657136,2,
Zfp36l1,0.15725733,0.13246493,0,['Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA']
Zfp36l2,0.036319636,0.05035839,3,
Zfp36l3,-0.07754428,-0.09034351,2,
Zfp37,-0.14895101,0.11785714,0,['Generic Transcription Pathway']
Zfp382,-0.227322,0.047116674,2,['Generic Transcription Pathway']
Zfp384,-0.00796275,-0.23810193,1,
Zfp385a,0.084562995,-0.019818332,3,"['Regulation of TP53 Activity through Association with Co-factors', 'Transcriptional  activation of  cell cycle inhibitor p21 ']"
Zfp397,-0.24529672,-0.08747191,2,
Zfp398,-0.057092015,-0.014356572,2,['Generic Transcription Pathway']
Zfp407,-0.30840752,0.10464417,2,
Zfp408,-0.36779103,-0.057284243,2,
Zfp414,-0.07498071,-0.08168702,2,
Zfp42,-0.016855199,0.19457062,3,
Zfp420,-0.041252073,0.045450874,2,"['Generic Transcription Pathway', 'TP53 Regulates Transcription of Genes Involved in Cytochrome C Release']"
Zfp422,-0.21263736,0.1455904,2,
Zfp423,0.25617972,0.058946263,3,
Zfp444,-0.16059156,0.010383641,2,
Zfp445,-0.13485873,0.1527889,2,['Generic Transcription Pathway']
Zfp446,-0.13322747,-0.11919765,2,['Generic Transcription Pathway']
Zfp451,-0.0634907,0.3219379,0,
Zfp46,-0.04478086,-0.10411385,2,['Generic Transcription Pathway']
Zfp462,-0.103776954,0.028785396,2,
Zfp467,0.032712933,-0.016280644,2,
Zfp473,0.08644843,0.3359263,0,"['SLBP independent Processing of Histone Pre-mRNAs', 'Generic Transcription Pathway', 'RNA Polymerase II Transcription Termination', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs']"
Zfp474,-0.2806925,0.1434607,2,
Zfp488,0.05083534,0.0096668815,2,
Zfp503,-0.1446801,-0.09552152,2,
Zfp507,-0.16122584,-0.054944444,2,
Zfp511,-0.044866193,-0.04789477,2,
Zfp512,-0.08258172,0.15610605,2,
Zfp512b,0.043684516,0.054234743,2,['RHOV GTPase cycle']
Zfp513,-0.011359312,0.044048965,0,
Zfp516,0.07315068,-0.06462132,2,
Zfp518a,-0.18294105,0.03246399,2,
Zfp518b,-0.14145112,-0.25702927,2,
Zfp521,0.24523889,-0.04261021,3,
Zfp523,-0.11503074,0.13443229,0,
Zfp524,-0.20172216,0.08069409,2,
Zfp526,-0.2003666,0.0023102725,2,
Zfp532,-0.22838373,-0.2350592,2,
Zfp536,-0.27471152,-0.02832597,2,
Zfp541,-0.026624518,-0.02121152,2,
Zfp553,0.058199205,-0.003379258,3,
Zfp563,-0.061326124,0.07972502,2,
Zfp568,-0.06974372,0.020585034,2,
Zfp57,0.09893528,0.06414091,3,
Zfp574,-0.027786233,-0.21149178,2,
Zfp575,-0.08185769,-0.007632124,2,
Zfp58,-0.09308904,-0.044175114,2,['Generic Transcription Pathway']
Zfp592,-0.124735475,0.116500385,2,
Zfp593,-0.25849035,0.29899743,0,
Zfp597,-0.23025815,0.12978692,2,
Zfp598,-0.10050109,0.14330697,2,
Zfp606,-0.2151728,0.041166533,2,['Generic Transcription Pathway']
Zfp608,-0.08553549,-0.12732068,2,
Zfp609,-0.12065912,0.18657567,0,
Zfp616,-0.13670713,0.07450617,2,['Generic Transcription Pathway']
Zfp617,-0.096940964,-0.119405955,2,['Generic Transcription Pathway']
Zfp62,0.032843124,0.07286016,3,
Zfp622,-0.011414678,0.45411104,0,
Zfp628,-0.17229357,-0.11526031,2,
Zfp629,-0.13207321,-0.024723182,2,
Zfp638,-0.16923073,0.29107878,2,
Zfp639,-0.04000913,0.0030102886,2,
Zfp641,-0.16057889,-0.098949865,2,['Generic Transcription Pathway']
Zfp644,-0.054413207,-0.2769999,2,
Zfp652,-0.08314104,-0.18009596,2,
Zfp653,-0.09180052,-0.011622712,2,
Zfp664,-0.070565544,0.04358782,2,
Zfp667,-0.14357446,0.028439388,2,['Generic Transcription Pathway']
Zfp668,-0.057682812,0.0629966,2,
Zfp687,-0.17210291,-0.047817443,2,
Zfp692,-0.12202896,-0.034372102,2,
Zfp697,-0.08940907,0.120713435,2,
Zfp703,-0.08133573,-0.24097358,2,['Generic Transcription Pathway']
Zfp710,-0.024007922,-0.14239249,2,['Generic Transcription Pathway']
Zfp711,0.0014279939,0.09601042,2,
Zfp719,-0.21341428,-0.22370188,2,['Generic Transcription Pathway']
Zfp729a,-0.12784147,-0.13063236,2,['Generic Transcription Pathway']
Zfp740,-0.021640822,-0.021511164,2,['Generic Transcription Pathway']
Zfp746,0.07179912,0.21853812,3,['Generic Transcription Pathway']
Zfp750,-0.09216368,0.031224392,2,['Generic Transcription Pathway']
Zfp758,-0.06465676,0.03258474,2,['Generic Transcription Pathway']
Zfp768,-0.2671861,0.042933796,2,
Zfp770,-0.22998141,0.009080467,2,['Generic Transcription Pathway']
Zfp775,-0.07363278,0.06295553,2,['Generic Transcription Pathway']
Zfp787,-0.04660517,0.05694946,2,
Zfp791,-0.087348305,-0.033419203,2,['Generic Transcription Pathway']
Zfp804b,-0.20581166,-0.0067723775,2,['Generic Transcription Pathway']
Zfp808,-0.14722127,0.028624183,2,['Generic Transcription Pathway']
Zfp809,0.14013745,-0.07652349,3,
Zfp811,-0.19797264,0.06093033,2,['Generic Transcription Pathway']
Zfp827,0.015149501,0.16435876,3,
Zfp830,-0.27723524,0.11264109,2,"['Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER']"
Zfp85,-0.12255189,0.020592533,2,['Generic Transcription Pathway']
Zfp866,-0.25009596,-0.06314727,2,['Generic Transcription Pathway']
Zfp869,-0.07863927,-0.16819873,2,['Generic Transcription Pathway']
Zfp91,-0.23662016,-0.0057264827,2,
Zfp92,0.02139042,0.10601706,3,
Zfp93,-0.14711188,0.005680746,2,['Generic Transcription Pathway']
Zfp931,-0.11340516,-0.13375697,2,['Generic Transcription Pathway']
Zfp932,-0.13643649,-0.026728274,2,
Zfp933,-0.17318816,0.11468068,2,
Zfp941,-0.16744383,0.062072184,2,['Generic Transcription Pathway']
Zfp951,-0.09889317,0.02703536,2,
Zfp957,-0.24999589,0.12029759,2,
Zfp966,-0.124927156,0.15924385,2,
Zfp975,-0.07537436,-0.011084873,2,
Zfp992,-0.06001537,0.061594818,2,['Generic Transcription Pathway']
Zfp995,-0.15516555,-0.20224261,2,
Zfpl1,-0.10683419,0.0031118856,2,
Zfpm1,0.24098407,0.19177963,3,"['RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Factors involved in megakaryocyte development and platelet production']"
Zfpm2,0.22656137,-0.055952545,1,['Factors involved in megakaryocyte development and platelet production']
Zfr,-0.18627526,0.20806085,0,
Zfr2,-0.12551062,0.23389263,0,
Zfx,-0.089497276,0.075305134,2,
Zfy1,0.120643385,0.12266767,3,
Zfy2,0.113658026,0.16905376,3,['Generic Transcription Pathway']
Zfyve1,-0.009248868,-0.033828337,2,
Zfyve16,0.18376426,-0.18977965,1,['Signaling by BMP']
Zfyve19,-0.039250556,0.019975165,2,
Zfyve21,-0.11792984,0.06533137,2,
Zfyve26,-0.07802882,0.0060250354,2,
Zfyve27,-0.15871713,-0.0673394,2,
Zfyve28,0.16065176,-0.07803116,1,
Zfyve9,0.29103124,-0.09533119,3,['TGF-beta receptor signaling activates SMADs']
Zg16,-0.052128,-0.04079963,2,
Zgrf1,-0.20847812,0.24324393,0,
Zhx1,0.22133526,0.057480548,3,
Zhx2,0.3348868,-0.29300332,1,
Zhx3,-0.034018874,0.016336272,2,
Zic1,-0.08972976,-0.23293348,2,
Zic2,0.20779149,0.027465973,3,
Zic3,-0.13200817,0.031160697,2,
Zic4,-0.21956417,-0.10922834,2,
Zim1,-0.086892255,-0.05259792,2,
Zkscan16,-0.35874835,0.09392944,2,['Generic Transcription Pathway']
Zkscan17,-0.048205793,-0.04473559,2,['Generic Transcription Pathway']
Zkscan3,-0.1436013,-0.18424056,2,
Zkscan4,-0.07199927,0.10185802,2,['Generic Transcription Pathway']
Zkscan6,-0.11526462,-0.012397969,2,['Generic Transcription Pathway']
Zmat1,-0.1280189,0.18802968,2,
Zmat2,-0.0920543,0.46296912,0,
Zmat3,-0.29586178,0.030434065,2,
Zmat4,-0.121237405,-0.16745843,2,
Zmat5,0.028334906,0.3440938,0,['mRNA Splicing - Minor Pathway']
Zmiz1,0.14864619,0.1375613,3,
Zmiz2,0.08820009,0.10716358,0,
Zmpste24,0.08490279,0.14553446,0,
Zmym2,0.20626506,0.073534586,3,
Zmym3,-0.16748528,0.07231867,2,
Zmym4,-0.17763887,0.24373977,2,
Zmynd10,-0.39611718,-0.045310963,2,
Zmynd11,-0.03521229,0.36492246,3,
Zmynd12,-0.22842845,0.046032663,0,
Zmynd15,-0.17529638,-0.03859405,2,
Zmynd19,-0.13871874,-0.0816962,2,
Zmynd8,-0.07937506,0.082023695,2,
Znfx1,0.10905201,0.24543013,3,
Znhit1,0.03997452,0.29288787,3,
Znhit2,0.018460553,0.26330274,3,
Znhit3,-0.1526366,0.33902955,0,
Znhit6,-0.11211495,0.38139945,0,
Znrd2,-0.21849863,-0.04819869,2,
Znrf1,-0.036987584,0.023632139,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Znrf2,-0.043203376,0.037621107,2,['Antigen processing: Ubiquitination & Proteasome degradation']
Znrf3,0.1765759,0.10077787,3,['Regulation of FZD by ubiquitination']
Znrf4,-0.28515533,-0.133168,2,
Zp1,-0.14257365,0.18399909,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Zp2,-0.1107993,0.064319596,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Zp3,-0.07321313,0.050953526,2,['Interaction With Cumulus Cells And The Zona Pellucida']
Zp3r,0.0023299546,0.113377035,0,
Zpbp,0.072850384,0.18284406,3,
Zpbp2,-0.0093456805,0.06774579,2,
Zpld1,-0.23495294,-0.011187422,2,
Zpr1,0.18276998,0.1102148,0,
Zranb1,0.18149084,0.063027956,3,"['Degradation of beta-catenin by the destruction complex', 'Ovarian tumor domain proteases']"
Zranb2,-0.24332346,0.20401579,0,
Zranb3,0.02948664,0.31403163,3,
Zrsr1,0.10358449,0.35013258,0,
Zrsr2,0.0036815905,0.34884262,0,
Zscan10,0.15820561,-0.058940712,3,
Zscan20,-0.2194636,0.05566052,2,
Zscan21,0.0924855,0.033036936,3,
Zscan22,-0.24161564,-0.15838042,2,
Zscan29,-0.15386581,0.052021526,2,
Zscan4b,-0.15839311,-0.0073139314,2,
Zscan4c,-0.31159353,0.13746361,2,
Zscan4d,-0.08780795,-0.07211437,2,
Zscan4f,-0.12571372,0.047137085,2,
Zswim2,-0.2130327,0.017058019,2,
Zswim7,0.057875816,0.3815868,3,
Zswim8,0.095065266,-0.051166024,2,
Zup1,-0.11161479,0.20901619,3,
Zw10,0.09685153,0.40161115,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Zwilch,0.12803546,0.45259124,3,
Zwint,-0.01291498,0.2904964,3,"['Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Separation of Sister Chromatids', 'Resolution of Sister Chromatid Cohesion', 'RHO GTPases Activate Formins', 'Mitotic Prometaphase', 'EML4 and NUDC in mitotic spindle formation']"
Zxdb,-0.15705802,0.15629725,2,
Zxdc,-0.02541954,-0.14517836,2,
Zyg11a,0.07324996,0.28160194,3,
Zyg11b,0.13453434,0.045318943,3,
Zyx,0.43031156,-0.33197942,1,
Zzef1,-0.20140882,0.19750103,2,
Zzz3,0.16226773,0.23582605,3,
a,-0.084361285,-0.34650946,1,
mt-Atp6,-0.10546831,-0.015857281,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
mt-Atp8,-0.052779905,-0.09247286,2,"['Formation of ATP by chemiosmotic coupling', 'Cristae formation']"
mt-Co1,-0.07903655,-0.18670589,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
mt-Co2,0.10381335,-0.21957867,1,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
mt-Co3,-0.07374141,-0.068099156,2,"['TP53 Regulates Metabolic Genes', 'Respiratory electron transport', 'Cytoprotection by HMOX1']"
mt-Cytb,0.1035521,-0.15052733,1,['Respiratory electron transport']
mt-Nd1,0.38835397,-0.08768695,1,"['Respiratory electron transport', 'Complex I biogenesis']"
mt-Nd2,0.062707424,-0.10818956,1,"['Respiratory electron transport', 'Complex I biogenesis']"
mt-Nd3,0.0085227825,-0.062423307,1,"['Respiratory electron transport', 'Complex I biogenesis']"
mt-Nd4,-0.00091016246,-0.06527955,2,"['Respiratory electron transport', 'Complex I biogenesis']"
mt-Nd4l,0.079617925,-0.04456747,2,
mt-Nd5,-0.042085048,-0.1683726,2,"['Respiratory electron transport', 'Complex I biogenesis']"
mt-Nd6,0.022952557,-0.13226831,1,"['Respiratory electron transport', 'Complex I biogenesis']"
